#version: 0.2 - Trained by `huggingface/tokenizers`
Ġ a
i n
Ġ t
r e
t i
o n
e n
h e
Ġ c
Ġ o
t e
Ġ p
Ġ in
Ġ s
Ġa n
Ġ w
Ġ m
a l
Ġo f
Ġt he
a ti
o r
i s
a n
r o
e l
a s
i t
Ġan d
Ġ d
e d
en t
e r
e s
i c
Ġ re
a r
l e
Ġ f
a t
Ġ (
Ġ b
in g
ati on
a te
it h
Ġw ith
i d
Ġ e
o s
Ġt o
o m
l y
u l
Ġ h
ent s
el l
v e
Ġt h
Ġ A
e c
Ġ n
r a
e m
Ġ T
Ġp ati
s i
i m
ti c
u r
re s
i a
M L
Ġc ell
l o
Ġp ro
Ġpati ents
Ġ le
Ġ C
i g
u s
o t
ate d
u n
g en
ti on
u t
e re
e t
u k
te r
Ġa c
el o
c e
Ġf or
i f
Ġle uk
a c
si on
Ġa s
Ġe x
s e
an t
h o
Ġw as
Ġleuk em
s p
y elo
Ġ is
Ġs t
v er
as e
u c
i b
Ġ I
Ġm yelo
Ġ 1
Ġcell s
r an
Ġ l
Ġc on
ra p
Ġ M
Ġth at
o p
i v
p res
i l
u p
Ġleukem ia
u m
Ġc om
ĠT he
in e
m ent
o c
ĠA ML
Ġ im
te d
o l
it y
Ġd e
Ġb e
Ġw ere
Ġ on
Ġ g
u d
Ġa l
ro m
t s
Ġc h
Ġmyelo id
a b
he r
Ġt re
u te
Ġ P
o d
ic al
a y
) .
Ġ H
ti v
ig n
Ġ v
gen e
he m
Ġd is
Ġb y
Ġo r
l as
g n
u g
Ġ 2
Ġh a
rap y
y t
re d
Ġ r
s t
i r
Ġt ran
gn os
d uc
Ġcom p
Ġex pres
f f
Ġin c
Ġac ute
) ,
Ġ B
an c
ation s
g e
Ġtre at
i es
a p
if ic
a m
a in
q u
s is
Ġs ur
y p
r i
Ġa re
ti ve
Ġa d
Ġ D
Ġtreat ment
ĠI n
Ġ F
t or
0 0
Ġ S
Ġ W
or m
Ġst ud
v iv
u b
ig h
Ġexpres sion
Ġre sp
Ġ un
t h
Ġc l
Ġn e
Ġs ign
Ġc yt
Ġsur viv
Ġas s
Ġe ff
Ġa t
lo w
lo g
Ġre l
p h
d er
Ġm o
Ġsurviv al
ĠC D
Ġ 3
o w
Ġw h
h ib
en ti
p or
Ġ k
Ġf rom
A ML
p ro
Ġm ut
i e
Ġ us
o us
e ar
v el
Ġa p
Ġ N
Ġw e
Ġc o
Ġin hib
Ġdis e
ot he
if f
y l
ul ar
Ġth is
in ical
al y
Ġ R
Ġs ho
Ġ 5
Ġre s
re as
on e
N A
oc i
en ce
c om
es s
Ġd iff
t her
Ġha ve
ere n
S C
an ce
Ġsign ific
Ġ O
ed i
Ġe v
Ġm ar
is k
â Ģ
ar y
Ġdise ase
Ġan ti
Ġre m
v ed
ati ve
o log
Ġg ro
i z
it or
Ġn ot
os t
Ġan aly
Ġresp on
y ear
Ġcl inical
Ġre g
Ġeff ec
r on
d e
d i
Ġdiff eren
Ġthe rapy
um or
Ġ gene
te m
Ġa b
Ġc hem
m un
al ly
Ġ en
el y
Ġsignific ant
Ġtran s
os e
Ġp er
Ġh igh
ly m
Ġpro gnos
al l
Ġm on
d ing
Ġass oci
Ġsho w
Ġ 4
f ter
p l
ĠW e
othe rapy
Ġrel ap
anc er
u re
Ġ gen
g es
c l
sp l
Ġ G
Ġstud y
C R
re n
Ġ E
t r
Ġin v
i ed
Ġh as
Ġp h
le c
Ġm et
Ġs y
Ġ hem
spl ant
Ġim mun
as es
Ġn o
Ġs e
ia gnos
Ġac tiv
Ġf ac
i ti
Ġa fter
âĢ ī
Ġres ul
Ġt umor
Ġp re
o un
ic h
Ġd iagnos
Ġs ub
Ġ 0
Ġbe en
Ġo ut
t ing
Ġin t
ab le
Ġa g
ra c
Ġb et
r ug
orm al
Ġ =
id e
Ġr isk
o re
Ġo ver
o x
Ġassoci ated
Ġp o
re l
Ġfac tor
Ġhem at
Ġwh ich
Ġin duc
Ġt ar
Ġchem otherapy
Ġ L
g et
Ġthe se
Ġc ancer
b in
Ġin f
in ib
Ġtran splant
ron ic
< /
re e
is sion
ĠT h
Ġm ay
p ho
Ġ it
Ġle vel
on g
Ġre ce
Ġ id
p ec
Ġre c
Ġ 6
Ġinhib itor
te in
Ġgro up
en d
Ġde v
D S
Ġp res
Ġmut ations
Ġrelap se
elo p
Ġd rug
por t
Ġmo lec
at ing
an d
Ġ lym
s ed
om e
Ġb ut
en c
Ġdev elop
ro w
Ġout com
Ġrespon se
i p
Ġcomp le
al u
yp e
enti f
sis t
Ġch ronic
l ud
h yl
ter m
Ġthe rap
Ġo b
ar i
Ġrem ission
ul ation
reas ed
Â ł
Ġ he
Ġp at
a ge
Ġth an
Ġmar row
en si
Ġid entif
e ver
Ġcyt o
tiv ely
Ġm od
Ġs tem
w e
di tion
a d
las tic
m s
ate s
Ġ low
year s
Ġha d
Ġtar get
s o
Ġin d
t ro
Ġinc lud
op o
Ġanaly sis
Ġc ases
c tion
Ġpro tein
we en
ĠC ML
oun d
ay s
e u
Ġ 7
Ġb lo
Ġbet ween
Ġal so
Ġun der
a red
Ġ ro
Ġ <
ug h
Ġresul ts
eu tic
Ġsignificant ly
Ġm al
Ġs up
% )
0 1
Ġp ot
er s
em ia
Ġmolec ular
st r
Ġprognos tic
f orm
gene tic
os is
Ġsy n
L T
Ġm ic
L L
at inib
Ġ years
ul d
Ġb one
or t
Ġex p
es ti
ic ation
ow ever
Ġs ug
Ġpati ent
ot h
Ġd ec
th s
Ġcom bin
Ġsug ges
Ġw ho
ec h
Ġ 9
Ġc an
s up
Ġpro m
ow n
Ġtransplant ation
ec tively
Ġre sist
in ase
ar d
rel ated
Ġcon s
iv ed
op t
is t
iz ed
Ġd at
u sion
Ġp ar
in es
duc ed
Ġd em
Ġcyto genetic
ĠTh is
Ġmo re
Ġal l
enti al
ie tic
Ġover all
p end
oc y
Ġo ther
Ġhemat opo
Ġlevel s
at or
Ġmal ign
Ġn on
os i
edi an
Ġne w
Ġshow ed
Ġ 8
Ġf ol
as t
Ġs pec
Ġb i
l if
Ġcomp ared
Ġm ul
id ence
p le
Ġlym pho
g res
Ġs uc
Ġmon ths
s es
ab ine
Ġh ig
Ġp red
Ġdifferen ti
t ain
Ġinc reased
ur ren
lif er
s er
Ġtherap eutic
b le
ac ter
Ġb oth
Ġdat a
t in
Ġal lo
3 4
he d
Ġn ormal
Ġp l
R NA
Ġcomple te
w o
ri al
Ġfol low
Ġgen es
um an
Ġst r
esti g
Ġc or
il ity
ent ly
Ġim pro
ti m
y c
on d
Ġap pro
Ġk inase
Ġev alu
Ġactiv ity
Ġinv estig
ro s
Ġm a
c t
ul t
ĠD NA
Ġthe ir
Ġstud ies
Ġdiagnos is
m on
ir st
om a
r im
Ġm ost
ri p
Ġin ter
Ġf ound
il d
Ġhig her
un ction
ar acter
Ġ K
Ġb las
Ġmar k
Ġblo od
Ġob ser
Ġit s
% ,
on str
ur ther
Ġ el
o ut
Ġh uman
Ġde te
Ġdem onstr
c rip
Ġinduc tion
iti es
v en
SC T
Ġap opt
A B
an is
ĠF LT
a il
T he
a us
as ed
Ġf irst
Ġch aracter
Ġro le
Ġtre ated
a g
Ġhematopo ietic
Ġd ur
ĠM DS
olog ical
ĠH owever
Ġus ed
Ġ1 0
Ġs am
i te
ech anis
Ġresp ectively
Ġ U
Ġa r
i on
u al
de pend
en e
Ġus ing
Ġprognos is
o gen
Ġresist ance
Ġm an
es t
h ie
u e
hyl ation
Ġtrans crip
Ġa ge
ĠThe se
Ġfactor s
re g
Ġac hie
Ġm echanis
Ġw ell
C T
Ġinclud ing
igh t
il l
re qu
1 1
Ġpro gres
Ġch rom
Ġt im
Ġpo or
c h
Ġr ate
Ġac c
f ree
R A
l l
Ġleukem ic
Ġpres ent
Ġpred ic
Ġoutcom e
Ġt wo
in ding
ot ype
F S
Ġd es
in ed
Ġf e
1 0
tion s
Ġw he
urren t
y sp
d rom
Ġp rim
Ġapopt osis
c y
Ġs ec
Ġpot ential
osi tive
Ġf requ
Ġobser ved
Ġim port
o ur
im en
Ġsyn drom
ĠC R
a v
Ġmut ation
Ġleuk a
c ell
Ġrem ain
Ġinhibitor s
Ġf unction
i le
Ġus e
Ġeffec ts
gene ic
ic in
Ġim atinib
M T
Ġh yp
Ġgro w
depend ent
ver s
sp ec
o g
Ġmod el
C D
ic ity
Ġs c
Ġmalign anc
Ġeffec t
Ġsuc h
K I
Ġcon tro
Ġt rial
i ted
n ormal
Ġ ra
Ġidentif ied
Ġdevelop ment
pres sion
Ġ up
Ġim p
Ġm edian
c c
Ġon ly
Ġeff ic
Ġv ari
ar abine
ra f
Ġdifferenti ation
ar ly
Ġth ose
l i
Ġpro v
Ġad dition
Ġm i
Ġon e
ter n
Ġind ic
SC s
Ġab normal
Ġint o
f ore
uc le
ate g
Ġo p
l u
Ġchrom os
m in
h w
Ġinv ol
Ġtim e
AB L
Ġ Ġ
Ġdur ing
c ent
d ysp
1 2
Ġgrow th
Ġcombin ation
a k
u res
Ġoutcom es
Ġcon f
ac h
t en
C ML
ac y
c r
i tion
Ġo ur
Ġsec ond
Ġdifferen t
Ġph ase
b er
Ġpat hw
Ġmul ti
id ual
Ġpre v
I T
Ġdis c
ie w
y ros
on or
Ġch ild
+ )
yros ine
Ġco uld
Ġthe re
L A
yp es
Ġno vel
Ġreg imen
i ve
ati c
ĠB CR
Ġallo geneic
Ġdrug s
Ġre por
Ġpro lifer
R D
Ġanti gen
ocy te
Ġm e
Ġleuka emia
Ġre v
Ġk n
lo c
Ġag ents
op las
ver y
si ve
p tor
Ġimport ant
Ġa m
Ġl ines
Ġl ong
op h
at h
j or
Ġo cc
1 5
al ity
Ġ qu
Ġn um
pl es
i ous
s tem
ul ated
Ġv s
Ġde term
Ġd onor
r ic
ot ox
ac t
Ġmyelo dysp
z ed
Ġc ar
Ġs el
ti t
Ġprim ary
Ġma jor
Ġ J
Ġt yrosine
ub icin
Ġcon tr
duc tion
Ġto x
Ġde f
Ġmic ro
r isk
es is
2 1
Ġrece ptor
Ġsam ples
( +)
Ġs im
Ġrece ived
Ġprogres sion
Ġmet hylation
ve re
Ġ .
is tic
Ġsign al
Ġcontro l
Ġcom mon
at ure
Ġwith out
Ġin te
Ġ1 2
Ġass ess
c ess
n e
ab l
Ġspec ific
Ġgene tic
ator y
Ġd ose
Ġl i
Ġl ine
ĠM D
Ġv it
f er
ve al
ver se
Ġrev iew
Ġc las
Ġre veal
tor y
Ġa ut
iz ation
00 1
t ho
c ted
t ran
A T
Ġe p
Ġsugges t
f ul
re ase
1 6
Ġm ain
Ġs ensi
1 3
Ġmalignanc ies
P M
f ication
ĠO S
C L
Ġper form
Ġimmun e
Ġd el
Ġsy stem
on al
Ġd ays
ĠO ur
Ġs h
Ġs er
Ġstr ateg
tho ugh
olog ic
aus e
Ġco un
Ġ V
ĠC I
Ġanti b
Ġdiagnos ed
Ġlow er
Ġch an
Ġeffic acy
Ġp op
Ġmyelodysp lastic
Ġc ol
s ing
H D
tiv ity
raf t
and ard
Ġprolifer ation
O S
Ġdemonstr ated
s or
om et
Ġex t
Ġf inding
Ġblas ts
ĠH ere
Ġe arly
Ġre ac
Ġr ates
a z
A C
vers us
Ġvit ro
u tion
Ġre f
Ġd i
te ro
Ġsup pres
olog y
tic al
M DS
Ġse qu
Ġo l
enc y
anc ed
Ġ1 9
Ġgen er
Ġ y
y cl
ĠThe re
Ġcyt arabine
Ġprom o
Ġin iti
ensi ve
g ative
Ġinc idence
Ġad v
Ġinhib ition
Ġne oplas
r y
Ġre duced
ro ugh
p o
Ġrepor ted
Ġst andard
ip her
Ġimpro ve
ff ec
Ġd a
5 3
1 7
Ġc urrent
Ġexpres sed
qu i
S F
ere d
Ġsyndrom e
os ph
Ġf urther
Ġocc ur
Ġk ary
Ġcyt otox
Ġcon cl
Ġwh en
2 2
le uk
Ġgroup s
v ing
ipher al
Ġreg ul
y m
as s
3 3
Ġinduc ed
ec tion
Ġtranscrip tion
ĠA l
Ġ [
k e
IT D
Ġmic e
e x
Ġp os
ol id
Ġanaly zed
d ine
Ġantib od
6 0
re at
1 4
Ġlym ph
l ine
ph a
Ġp ost
b lastic
Ġex am
Ġcon dition
ĠT o
Ġm g
Ġa im
Ġimp act
ati ents
Ġ ran
Ġen h
Ġreveal ed
Ġc ase
or ubicin
Ġpro f
Ġm in
ho d
Ġmark ers
ort ality
Ġcons id
Ġd id
5 6
enc ing
em ent
Ġnum ber
ĠA LL
Ġfinding s
tain ed
9 5
er i
Ġmechanis ms
Ġpat ho
t al
a re
Ġper ipheral
P L
Ġth ree
Ġm ortality
m ed
p t
Ġachie ved
Ġchild ren
Ġmi R
ĠA T
at ures
Ġde ath
Ġv alu
Ġph en
at us
Ġeffec tive
il ar
ic i
Ġinvestig ated
Ġactiv ation
Ġdete cted
Ġabnormal ities
cr ib
Ġprev ious
Ġf ail
gen itor
ĠF urther
G F
Ġtrial s
Ġst atus
ing le
iv o
Ġv ivo
Ġdevelop ed
Ġidentif y
Ġperform ed
Ġtherap ies
er r
u ce
o tic
1 9
p ar
Ġb ec
er g
av or
Ġsignal ing
ĠT KI
Ġrelap sed
Ġre port
a f
pl ic
ge ted
Ġfor m
in duced
ro up
Ġag ain
B P
i ly
Ġshow n
Ġse ver
ari ate
Ġl ar
Ġe m
Ġn ucle
Ġ +
i as
rac tory
te red
Ġs ome
Ġre pres
Ġ1 5
is tr
si ble
Ġs ingle
b ased
Ġsim ilar
Ġ2 0
edi ate
Ġhe tero
im al
Ġdes crib
Ġth rough
ar k
Ġevalu ated
ĠP h
Ġblas t
am m
ĠI L
ol d
Ġ9 5
A LL
Ġtumor s
ocy tic
Ġpro genitor
a x
Ġtox icity
is m
cy tic
Ġagain st
ul ts
Ġp ositive
Ġpres ence
Ġrespon ses
Ġpar tic
Ġchromos ome
om al
D H
e p
spec ific
is hed
m ents
ĠN PM
Ġpop ulation
E T
Ġen d
Ġinc rease
se qu
2 0
Ġd own
M P
Ġc yc
Ġad ult
Ġmet hod
Ġ ML
Ġcharacter istic
Ġbet ter
ĠI I
Ġcomp ar
Ġwh ile
Ġimpro ved
g er
ation al
Ġc ri
Ġl ess
ĠP atients
Ġne ed
Ġsever al
it her
Ġt es
Ġin dependent
avor able
Ġpo lym
i al
Ġrel ated
al th
Ġclas si
st an
Ġfe atures
c k
Ġl im
Ġcor rel
c ute
Ġb ased
Ġsho uld
Ġam ong
oc yt
ene tic
edi ated
et y
Ġre le
Ġw or
) -
Ġ er
ab ility
Ġwith in
Ġab err
ro p
Ġa ffec
ĠH LA
Ġrec o
Ġra re
% ),
Ġpathw ay
Ġd ue
ven tion
Ġw ill
vere x
H SCT
p ositive
y d
Ġremain s
Ġm RNA
v o
Ġap p
Ġcontr ib
ĠM RD
Ġcomple x
re ct
at ric
Ġkn own
Ġs m
s et
Ġdec reased
Ġco h
v ir
Ġm or
o res
c es
Ġprotein s
Ġprov ide
ac k
Ġol der
d ose
Ġpro p
c in
V HD
Ġne ut
en ted
in t
H R
Ġad verse
y s
Î ±
3 8
Ġd o
Ġ1 4
Ġ1 1
Ġconf ir
Ġres idual
is ing
Ġr ati
Ġinc reas
pro lifer
m ac
Ġtarget s
Ġre qui
ot yp
Ġkary otype
Ġto tal
Ġda un
Ġ es
ig enetic
edi atric
em ic
C s
tin u
Ġ -
C I
Ġchan ges
ate r
Ġstud ied
Ġwhe ther
ical ly
tran s
Ġev idence
Ġm y
i qu
Ġmechanis m
ĠA s
Ġcharacter ized
â ī
2 5
Ġfollow ing
A K
cent r
Ġad min
Ġtrans form
ĠD N
g o
Ġinvol ved
ene f
Ġf usion
er m
est abl
o ver
t ype
Ġc aus
a ce
vel y
Ġac id
Ġmulti ple
Ġco ur
is e
j ec
Ġcon centr
Ġcor related
prolifer ative
Ġ1 3
Ġneoplas ms
g ra
Ġlympho blastic
ran ul
Ġb enef
c hed
ĠN K
der ived
cy te
C SF
B C
Ġnew ly
A L
v al
Ġ1 7
Ġon c
A R
is s
ate ly
iz e
0 5
term ediate
Ġtar geted
tiv ariate
Ġme as
Ġhetero gene
ĠI t
ar ran
ul ating
ĠAl though
Ġpartic ular
m ore
un g
Ġ2 00
der s
Ġprov id
Ġhigh ly
Ġvari ous
Ġo verex
Ġre tro
Ġev ent
b ility
l es
Ġep igenetic
t he
Ġ establ
Ġref ractory
Ġlymph oma
Ġappro ach
' s
ro ph
Ġstrateg ies
Ġa v
Ġwhe reas
Ġ1 8
om ic
Ġ3 0
Ġe ither
M R
er ase
M D
Ġsel ec
Ġm at
x im
Ġ versus
Ġ2 01
ĠĠ ĠĠ
0 2
he s
en ic
it s
iv ing
ĠFurther more
reg ulation
Ġmalign ant
reat ment
Ġdis or
em b
ĠR NA
ter s
ĠML L
l ic
ogen ic
os ide
Ġt ype
en ia
en s
Ġhe alth
Ġm ight
Ġav ail
ĠM ore
li ke
ĠW T
iv idual
Ġcharacteristic s
Ġno vo
Ġexp os
I n
Ġcol on
Ġcell ular
al id
Ġb as
Ġhemat ologic
yd ro
iv en
i x
Ġint ensive
pho log
Ġinvestig ate
it abine
lo t
Ġ5 0
ĠA n
Ġin termediate
oci ated
Ġm it
/ -
Ġcoh ort
spec tive
Ġtarget ing
Ġ1 6
Ġprevious ly
g roup
b las
d om
Ġpathw ays
an e
A cute
ab ol
Ġrati o
Ġt iss
ant s
% ).
ly c
ass ociated
Ġfail ure
Ġdaun orubicin
Ġg ranul
Ġcyt omet
S T
Ġal ter
Ġcytotox ic
Ġ x
ogen esis
Ġqu an
Ġconsid ered
Â ±
Ġman y
Ġinte rac
oc l
Ġpro b
Ġtrans loc
ĠB M
Ġne gative
re ated
Ġp ediatric
Ġd er
rom b
Ġsignific ance
Ġs et
Ġh ist
in al
Ġdisc us
p on
Ġsequ encing
O R
Ġbe fore
ar ia
2 3
Ġleukem ias
Ġsm all
Ġc ult
Ġsyndrom es
u red
5 0
reg ulated
Ġinclud ed
arran g
Ġmy el
Ġpre c
o k
A P
le ar
Ġsensi tivity
Ġind ividual
1 8
Ġvalu e
Ġ2 4
o od
Ġsuppres sor
Ġ loc
or ding
Ġg raft
Ġcoun t
P CR
Ġf low
Ġassoci ation
Ġcyc le
p ite
Ġcombin ed
us e
Ġconcl usion
Ġcytogenetic s
t y
Ġ >
gen ous
Ġregimen s
Ġv ia
Ġmark er
Ġmodel s
T o
% .
Ġs af
ur al
Ġh owever
ocyte s
Ġpatho gen
Ġinf lu
t reated
res ist
Ġmor pholog
Ġph osph
Ġdeterm ine
at in
ti ll
I C
Ġt r
Ġreg ion
Ġd os
U N
Ġad ults
Ġevalu ate
Ġrec ent
olid ation
0 4
Ġsecond ary
Ġmin imal
Ġst ron
ti l
ĠI m
e v
yt h
Ġantibod y
w ent
Ġresist ant
Ġth romb
W e
Ġavail able
Ġcancer s
Ġass ay
Ġsub set
Ġag ent
m ut
Ġrele v
Ġs till
Ġpat tern
ti dine
Ġfollow ed
m ediated
Ġ6 0
Ġhemat ological
Ġcl onal
Ġf our
Ġdemonstr ate
ĠC om
ate le
Ġmyelo genous
Ġc ycl
ĠC h
Ġdiagnos tic
t umor
ane ous
Ġb inding
stan ding
Ġrece iving
Ġexp lo
ĠM P
Ġdifferen ces
Ġmet abol
Ġs us
0 3
Ġpromo ter
Ġfrequ ency
em at
ies is
Ġal one
vention al
Î ²
Ġop tim
Ġd ay
Ġindic ate
âī ¥
Ġbi om
Ġstr ati
Ġun c
Ġlar ge
Ġs o
der ly
Ġsuc cess
on s
olog ous
Ġfrequ ently
Ġ rap
ĠMore over
Ġf am
vir on
Ġy oun
Ġdis tin
z ym
Ġprof il
RNA s
Ġa ra
othe rap
Ġiniti al
Ġcyto k
or ter
Ġincreas ing
( -
Ġp las
Ġev ents
Ġt ypes
ech n
u es
Ġdete ction
os s
ĠTh us
in d
Ġcons olidation
am e
Ġper cent
e k
Ġbiom ark
Ġclassi fication
F N
v es
x t
Ġpos sible
yc in
Ġphen otype
Ġc are
Ġconfir med
Ġpro t
ul es
Ġcontrol s
Ġman ag
Ġanaly ses
u le
C C
yth ro
Ġmon itor
yl ation
Ġcontrib ute
ĠA d
e uk
Ġpl atele
Ġsub group
Ġt echn
Ġcondition ing
Ġlympho cyte
Ġpro te
Ġc ap
Ġre arrang
u ra
Ġind uce
Ġblo ck
Ġlim ited
Ġab out
istr ation
Ġdi rect
Ġtranscrip t
viron ment
Ġbe ing
Ġcytomet ry
Ġ very
B M
3 0
O X
Ġra di
ell ular
Ġs ite
ar mac
2 6
Ġthe y
oph en
3 7
f ace
Ġel derly
Ġprom ising
as atinib
Ġtransform ation
un d
Ġexam ined
Ġ1 00
ĠA m
Ġd om
Ġcour se
Ġenh anced
m a
ĠO n
Ġhealth y
Ġresul ted
Ġcon ventional
ran ge
Ġch ain
Ġaddition al
Ġob tained
ĠDN MT
Ġbenef it
Ġappro ac
Ġlympho id
2 4
E BP
i ally
ti al
Ġbi ological
Ġsugges ting
Ġpathogen esis
s ub
ĠJ AK
ol ution
Ġstron g
os up
eri or
Ġmul tivariate
Ġf avorable
Ġe ach
Ġpro cess
I S
Ġunder standing
Ġantigen s
i lot
Ġle ad
UN X
Ġapproac hes
A b
Ġdeterm ined
Ġachie ve
reas t
Ġstrateg y
ho od
Ġ2 5
Ġuse ful
Ġcar cin
ĠI DH
Ġdise ases
resist ant
a ges
I L
anc es
ul l
) /
Ġbec ause
Ġc r
Ġg ra
or ph
) (
i od
et hyl
ĠR A
get her
oc hem
an s
Ġab s
Ġinhib ited
is h
a ir
k in
er ation
M A
Ġdifferen ce
tain ing
ĠH L
Ġof ten
Ġran dom
Ġmyelo proliferative
it ing
Ġl oss
ib le
Ġ ir
Ġs tim
um ul
Ġb reast
Ġ4 0
os ine
ati vely
ab ly
Ġl ack
ĠA PL
re m
56 2
Ġexpos ure
l amm
Ġacc ording
Ġ2 1
Ġ( <
Ġex hib
Ġmo use
Ġdef ined
ĠS t
Ġmet hyl
Ġcomp ound
Ġf oc
Ġestabl ished
ĠC N
Ġrec ently
u ally
Ġcorrel ation
Ġrap id
it al
Ġre com
Ġdistin ct
p lo
Ġcontr ast
ri or
ĠH SCT
ĠThere fore
Ġprom yelo
Ġassess ed
rac ycl
Ġinf orm
ĠN o
ul ations
Ġpl ay
y n
er ated
Ġre p
if ied
Ġer ythro
H CT
Ġmanag ement
is tered
ro sis
Ġt er
Ġk e
Ġan y
Ġdec itabine
k n
Ġaut ologous
et hylation
Ġinter val
2 7
ati s
D AC
om y
us t
ĠW h
I R
Ġdes ign
Ġfam ily
Ġp ur
in ation
Ġa z
ll ed
om es
Ġsur face
Ġ "
Ġh is
Ġinf ec
Ġph armac
Ġchromos omal
Ġadv anced
Ġsub sequ
Ġmonitor ing
Ġsup por
ĠA ll
ĠL euk
in s
is ion
oc ol
oc h
ot ypes
go ing
Ġv aria
Ġoverex pression
Ġf lu
Ġinf ection
ilot inib
pec ially
ti de
f ied
al pha
iti dine
Ġdel e
Ġd asatinib
Ġac tive
Ġresul t
Ġfunction al
ĠR es
ac tiv
ĠA t
Ġre duction
urren ce
% ;
Ġantibod ies
Ġcon tinu
th racycl
l ed
3 5
ĠR ec
Ġrepres ent
Ġcri tical
Ġen c
all en
s enic
uc t
Â ·
Ġal low
Ġen g
n al
Ġk ill
ac itidine
ĠG VHD
Ġim plic
ne gative
Ġquan tit
ĠMD SCs
Ġpar t
Ġcl on
Ġfrequ ent
Ġs u
Ġheterogene ous
Ġv alid
Ġes pecially
Ġfoc us
Ġreac tion
Ġp rior
Ġcolon y
Ġimmun ophen
Ġn ec
ĠP CR
Ġli k
l ong
r al
Ġprot ocol
C A
Ġdonor s
Ġm emb
as c
Ġen zym
Ġtes ted
Ġper iod
in k
Ġun f
Ġplatele t
T KI
lo b
Ġch allen
Ġap pl
Ġdur ation
Ġde pend
roph il
o f
Ġsam e
Ġsh ort
+ </
en ing
Ġto l
Ġpolym orph
B F
Ġ ess
Ġim m
leuk emic
ly ing
Ġke y
ĠU n
ar com
Ġc ur
umul ative
Ġs um
Ġalter ations
Ġsh orter
yelo id
Ġconcl ud
) ;
Ġsub t
Ġmet ast
Ġpromyelo cytic
Ġoccur red
Ġt ri
ĠA ra
res t
ĠS T
a ding
D R
C P
Ġreg ulation
enc ed
am ide
kn own
Ġline age
Ġdisor ders
ir c
Ġdete ct
Ġis ol
I I
N F
Ġo x
Ġan thracycl
Ġg re
ti es
er ic
4 5
otyp ic
ar ch
EBP A
Ġparticular ly
b id
otherap eutic
> +</
ant ly
Ġse vere
C N
c al
um our
Ġc ause
ce p
oc k
E R
g r
Ġab ility
N K
Ġapp ear
ĠA B
tran splant
o id
2 9
ĠAm ong
ator s
Ġal tern
las ia
Ġin s
Ġacc um
Ġcytotox icity
ĠB cl
Ġphosph or
âĢ ĳ
Ġexp er
is ed
Ġ2 8
in ce
Ġsaf ety
sp ectively
Ġpro long
00 01
ocyt osis
el ph
Ġse en
ĠC on
ĠF or
c ence
Ġsum m
ĠO ver
Ġrequi red
Ġchild hood
op ro
c on
Ġwe ek
Ġ âī¥
il tr
Ġaim ed
iqu e
Ġess ential
Ġstrati fication
Ġpot ent
Ġ u
Ġpres ented
ph osph
Ġ+ /-
Ġsensi tive
Ġdos es
P D
os ed
e ro
Ġcurrent ly
Ġsyn erg
Ġpredic tive
Ġtox ic
d ay
M S
d uce
ten ance
Ġdescrib ed
Ġsubt ypes
Ġm ed
Ġtransloc ation
Ġev en
ĠA fter
e w
Ġpro por
ut ure
âĢ ¯
Ġmicro en
Ġth us
Ġn ilotinib
g an
4 0
ĠP D
: </
ici ent
ip i
tic ally
Ġ2 2
d ed
rac ellular
Ġdom ain
Ġinvol ve
g ing
Ġmalignanc y
g ed
Ġser um
ar b
Ġexp eri
u tive
r id
Ġlik ely
ur ine
al lo
Ġreco gn
Ġtrans f
ra m
Ġplas ma
F LT
ĠC T
Ġpot enti
Ġs olid
sist ent
w ard
Ġfe w
g i
lic ations
ĠT P
Ġindic ated
00 0
Ġmolec ules
h ip
Ġl ung
' -
Ġsc re
Ġthere fore
Ġl ig
9 0
Ġidentif ication
it u
Ġimmun osup
or ing
Ġthe m
Ġimmun otherapy
Ġneut rophil
cl inical
Ġc umulative
Ġv ir
Ġor ig
em ents
Ġl ed
Ġmain tenance
Ġmicroen vironment
Ġtreat ments
Ġle ast
Ġg iven
Ġsuccess ful
Ġcon c
Ġadmin istration
I M
ti s
Ġmajor ity
I P
Ġdescrib e
Ġform ation
esti m
k g
N P
Ġel ev
m ic
m edian
ĠH CT
Ġgen omic
ens ity
ocl onal
Ġunder lying
ran e
a i
8 0
in ally
ĠMD SC
Ġ if
arcom a
en tical
Ġquantit ative
Ġun known
Ġun related
Ġsugges ts
Ġprof ile
Ġ estim
ĠI FN
os p
Ġle ading
Ġset ting
Ġl if
Ġcons tit
Ġevalu ation
M RD
Ġf ive
Ġcon duc
op enia
xim ately
Ġexper im
l ication
Ġaberr ations
Ġinform ation
on ucle
Ġunder went
Ġar senic
Ġclinical ly
ap se
es pite
az a
Ġall el
D A
h ydro
Ġmut ated
Ġconcentr ations
ĠB CL
ce pt
ura ble
Ġpredic t
Ġrel ations
Ġsup port
Ġyoun ger
Ġtiss ue
Ġcaus ed
Ġl ab
Ġm ac
Ġc irc
Ġag gres
ĠR UNX
Ġt umour
Ġsugges ted
d rug
R M
Ġinf usion
Ġinflu ence
Ġpropor tion
o h
Ġha emat
Ġwor k
as p
Ġrelations hip
Ġreco very
S P
um ab
Ġrec ipi
Ġdec rease
ĠM cl
Ġaccum ulation
at ched
Ġdis pl
ul in
Ġd ied
Ġinf lamm
Ġsyn the
Ġhe l
n er
c ed
Ġ2 3
Ġisol ated
A F
Ġ X
Ġre se
Ġhist one
ic e
Ġmark ed
pt om
8 8
Ġoptim al
ĠU sing
Ġal though
ĠO f
gen eration
z e
h ost
enc es
Ġprogenitor s
Ġc ent
Ġpolym erase
tr ib
res pon
li al
Ġneed ed
as is
po int
7 0
Ġcri ter
Ġf uture
3 6
ĠMP N
Ġg u
Ġhyp er
Ġpercent age
Ġre al
ap opt
Ġclas s
Ġmon oclonal
Ġl ip
res s
Ġm edi
Ġhigh l
Ġder ived
Ġgre ater
Ġsc ore
ĠP ro
d s
Ġaz acitidine
Ġanti tumor
Ġresul ting
and id
ĠI M
H O
ĠAT RA
Ġinclud e
Ġmut ant
C h
l ing
opro tein
ĠOver all
and s
Ġneut rop
ul f
ub le
Ġn ow
Ġconcentr ation
Ġst atis
e an
y b
Ġran ge
ĠLeuk emia
Ġmethod s
Ġconduc ted
Ġre tin
Ġpar ame
A M
at ural
opo ietic
Ġhel p
a ren
Ġprop er
ĠC EBPA
ĠW ith
Ġ2 6
Ġlif e
ec t
Ġass ays
osp ital
Ġs ix
ĠE x
G VHD
pres sive
asc ular
Ġto gether
9 8
ur sor
Ġs il
Ġaberr ant
Ġ year
or k
Ġe t
en ter
blas t
Ġhematopo iesis
Ġprovid es
1 00
Ġal pha
Ġregul atory
Ġ2 7
Ġrandom ized
Ġg ood
m end
Ġc er
Ġaggres sive
Ġhyp omet
Ġinvolve ment
Ġpromo te
ĠM edian
Ġaltern ative
ph yl
a de
ple te
im in
Ġpro duction
Ġeffic i
Ġw ild
Ġcriter ia
Ġpro phyl
Ġstr uct
o ic
Ġbiomark ers
elph ia
Ġrec urrent
Ġactiv ated
il ad
or s
ilad elphia
Ġrelev ant
fer ase
Ġconf idence
Ġinf iltr
och ond
T h
Ġu til
Ġassess ment
Ġs p
apopt otic
os omal
Ġpro duc
ĠM R
7 5
ros s
Ġre duc
Ġlong er
pres sed
Ġ i
Ġc al
f old
Ġunc lear
Ġc andid
Ġto ward
Ġan tic
Ġchem otherapeutic
Ġh ow
ti ally
Ġadmin istered
4 4
Ġunder st
Ġ2 9
Ġd ys
Ġhyp othe
ap p
Ġad j
Ġor der
od ing
Ġcult ure
Ġen ro
op lastic
o red
E GF
Z A
om as
Ġd up
ĠT reatment
c yt
Ġr at
Ġrese arch
2 8
Ġprec ursor
Ġelev ated
Ġretro spectively
Ġst age
Ġpl us
Ġdispl ay
ĠM ul
ores cence
Ġp an
6 5
Ġmit ochond
Ġcarcin oma
Ġphosphor ylation
it t
ĠC M
L I
Ġ enti
Ġdiscus s
Ġx en
Ġh om
Ġdisc on
Ġrecom mend
y tidine
ĠPh iladelphia
ĠC l
Ġp osi
ĠH R
blas ts
Ġimport ance
ateg or
ow led
s tim
b il
Ġunder going
ĠO ne
Ġm uc
Ġpotenti ally
Ġappro ximately
Ġpos si
Ġ3 5
i el
Ġl ink
Ġf ib
Ġinfec tions
Ġpredic tor
l d
Ġgra de
Ġsubsequ ent
tim e
and em
Ġd am
od y
Ġpop ulations
Ġbi ology
Ġconsid er
Ġb est
Ġtranscription al
e g
Ġsy m
ĠTKI s
C M
ak en
Ġt est
Ġinte gr
es ion
om ycin
d en
Ġtran sp
Ġhe re
Ġweek s
Ġl en
Ġs arcoma
Ġcomp lications
Ġs ide
in ts
Ġl esion
ĠC LL
Ġn atural
Ġreceptor s
in f
Ġabs ence
Ġpattern s
Ġcoun ts
t ar
Ġ4 5
Ġretro spective
Ġkn ock
Ġachie ving
ra y
Ġunf avorable
A PL
istr y
Ġcompound s
g p
o uld
ox ide
Ġmeas ured
ĠP B
Ġp rac
Ġlymphocyte s
pec ted
o ve
ĠD FS
asp ase
owled ge
k ing
D N
Ġw ould
Ġbas is
ĠMD R
Ġop tions
t o
Ġm urine
gra m
Ġneoplas m
Ġcycl es
Ġinhib it
Ġcommon ly
Ġt andem
Ġac tion
Ġg l
Ġ3 3
ĠE FS
ific ation
Ġda ily
Ġhe p
Ġinduc es
Ġconclud e
Ġaffec t
Ġprofil es
Ġfunction s
Ġremain ed
et a
Ġinterac tion
Ġcol lec
ul ate
Ġnucle ar
Ġan emia
om on
Ġwh ite
Ġm el
iz ing
ĠM S
ĠH e
(- )
Ġpl ays
] ,
Ġcytok ine
Ġ3 6
Ġexp an
Ġc ategor
Ġad he
A D
Ġthromb ocyt
Ġto ol
ĠC P
ar ubicin
oph il
Ġparame ters
Ġch im
Ġcondition s
ar ding
Ġf ree
or por
Ġli ver
Ġm es
yb rid
Ġwor se
Ġprolong ed
Ġin si
ox yc
Ġinter fer
er n
Ġem erg
d es
Ġ ver
m g
re am
9 9
i um
L C
Ġlympho cytic
Ġsym ptom
Ġdiscon tinu
u ted
M N
Ġ4 8
E B
Ġmat ched
m it
Ġc he
Ġc lear
com p
Ġobser v
Ġint ra
Ã Ĺ
ĠE R
g h
Ġy et
Ġinvol ving
Ġth en
ĠL SCs
oph ag
Ġev olution
id entical
re ak
Ġcon sis
Ġimm ature
u z
or ts
Ġdevelop ing
p er
d own
is on
em al
ochem ical
A s
X L
r ing
Ġenro lled
Ġc ho
Ġinv as
l ess
Ġre st
Ġun ique
ra di
al og
Ġli ter
Ġdele tion
Ġtiss ues
5 7
Ġst rom
u rop
st ream
I F
ar t
Ġgranul ocyte
Ġexplo re
Ġsub type
Ġsubgroup s
ine tic
Ġrepres ents
ĠC ancer
Ġappro ved
Ġwhe re
ĠB MT
Ġrel ative
in ing
Ġbi op
Ġh ydro
uz umab
Ġh ybrid
Ġmemb rane
Î ³
Ġst ain
Ġkn owledge
Ġex pl
om atic
ac et
Ġinc orpor
ĠF inally
ex pression
Ġcl in
Ġ3 2
Ġ ly
p re
Ġs al
op oside
Ġcons ec
mon ths
Ġdec ision
ax is
Ġb ur
Ġme an
t reatment
3 2
Ġtri oxide
Ġliter ature
ri tic
âĢ Ĭ
Ġsite s
Ġneutrop enia
Ġac qui
Ġleukem ogenesis
Ġ7 0
Ġse em
ĠT ET
ĠN F
Ġad d
ĠĠĠĠ ĠĠĠĠ
Ġinsi gh
Ġcomp on
Ġselec ted
Ġc le
end ritic
Ġsynerg istic
Ġab le
Ġh arb
Ġext ra
6 7
ĠST AT
Ġf rac
in c
Ġheterogene ity
Ġorig in
Ġint racellular
> =
j ug
Ġtranscrip ts
Ġser ies
o le
hyl ating
Ġantic ancer
lym pho
Ġapopt otic
Ġmolec ule
an ted
Ġgener ation
Ġpro spective
Ġv en
Ġreg arding
raft ment
Ġsu ff
Ġpo ly
V I
Ġexpan sion
Ġ8 0
Ġcap ac
jec tive
oxyc ytidine
Ġadv ances
Ġl ate
ox orubicin
b eta
Ġproper ties
Ġcar di
Ġ3 8
Ġsup erior
Ġhyp erm
c ap
Ġb reak
Ġanthracycl ine
A l
Ġex cl
Ġan alog
com e
if ically
Ġdam age
Ġint ro
Ġloc al
ĠM CL
omon ocytic
Ġmain ly
Ġimprove ment
Ġrearrang ements
Ġag ed
M E
rap h
ĠM Y
Ġ3 1
rel apse
T P
Ġor al
ĠT wo
Ġinhibitor y
trans ferase
ĠG roup
D C
Ġsub stan
or bid
Ġrel atively
Ġbec ome
ĠA S
Ġexpres sing
Ġmel an
Ġpo int
4 7
ĠD C
Ġf emal
ĠR T
Ġselec tive
ĠC yt
e f
ĠD espite
2 00
ĠAT O
Ġconsec utive
Ġ j
ent al
aly sis
Ġsel ection
H L
mut ated
ai red
Ġreg res
Ġsub jec
Ġs ib
Ġxen og
Ġtes ting
Ġstrong ly
Ġreg ard
Ġun treated
P S
o gene
Ġprev ent
Ġaffec ted
ron t
ĠC X
Ġexhib ited
res ting
P B
rem ission
ur ation
ocl ax
Ġcapac ity
oh ist
amm a
Ġm ediated
Ġg as
itt le
C B
Ġha plo
Ġ Â±
en ib
op y
3 1
ull ary
Ġw id
Ġmyel omonocytic
Ġvalu es
s te
Ġsib ling
Ġ4 2
Ġsystem ic
w ork
R T
Ġma de
lud arabine
Ġsup pression
Ġet oposide
s y
g kin
Ġinvestig ation
o tide
Ġmitochond rial
Ġup on
Ġp ub
lo phosph
Ġs itu
Ġd endritic
Ġexpres s
od gkin
lophosph amide
Ġrelev ance
Ġprophyl axis
ĠB y
Ġcyt osine
Ġh ospital
et work
Ġregres sion
Ġrecipi ents
Ġpredic ted
12 3
Ġc aspase
Ġnec ess
o ugh
f ib
ĠS CT
de x
Ġeng raftment
b ers
n d
ul atory
pres sing
Ġtransf usion
Ġ3 4
ĠC BF
Ġre duce
Ġg lyc
00 2
ung al
Ġb ody
tit ution
Ġprob ability
Ġv ac
Ġof f
log ical
onucle ar
leuk emia
Ġdo es
Ġdisor der
B MT
Ġmyel oma
Ġcytok ines
ĠL SC
abl ative
Ġmac ro
acy tidine
Ġlab or
Ġretin oic
r u
Ġar tic
Ġenzym e
A S
x y
Ġt ra
IS H
Ġerythro id
8 6
r up
am in
Ġ3 7
Ġin tr
ĠE urop
ĠII I
L R
. ,
Ġre verse
Ġinf erior
Ġfe as
Ġpresent ation
Ġprofil ing
Ġcr is
Ġe qu
ur viv
ur ing
Ġsumm ar
Ġallel e
Ġcontinu ous
Ġbur den
Ġar rest
ak ary
Ġmal e
Ġnum bers
Ġacc el
Ġcompar ison
lob ulin
Ġindividual s
Ġvari ant
Ġpar tial
Ġro les
Ġcl one
Ġindic ating
p ri
Ġl ast
F U
id ed
Ġbet a
y ing
3 9
Ġs plic
Ġprogres s
ph ase
Ġrec urrence
iti s
og raph
spl anted
med ullary
Ġ4 4
r one
Ġ9 0
om ide
Ġonc ogenic
Ġacqui red
te en
ĠB oth
> -
Ġimmunosup pressive
Ġrece ive
p ose
pha ges
G S
Ġc ure
Ġlesion s
el ine
Ġop tion
Ġar m
Ġhypomet hylating
TKI s
p G
Ġsubset s
Ġincreas es
Ġcaus es
MP N
n ess
m i
ĠG O
Ġsel f
ab il
Ġmelan oma
ir d
v age
Ġde g
bin ding
ĠAd dition
Ġp ep
o lec
Ġara bin
Ġs omatic
Ġ4 6
Th is
Ġir radi
Ġmon ocytic
Ġacc oun
f unction
Ġcl us
Ġcompar able
Ġkill er
Ġ6 5
Ġcent ral
Ġprac tic
4 9
ot her
Ġdup lication
hem ia
Ġgener al
Ġcon t
Ġse ven
ut aneous
ak e
Ġal tered
am icin
or d
Ġd oxorubicin
et oclax
Ġabnormal ity
Ġrepor ts
Ġ7 5
uc id
Ġde ple
Ġcris is
Ġt yp
9 7
Ġhis tory
Ġmetabol ism
Ġdepend ent
h igh
Ġmeas ure
Ġspec ifically
Ġan gi
Ġdirect ly
6 17
Ġtol er
P h
is ms
Ġr s
tr ic
Ġcur ative
i er
A z
MD SCs
ĠP R
am ic
Ġclon es
Ġ5 5
Ġgen otype
Ġan t
Ġpre clinical
Ġrespon sible
Ġrearrang ement
em ber
Ġcour ses
Ġ Q
Ġinterfer on
o v
Ġvari ety
Ġaut ophag
otyp ing
Ġk in
Ġprovid ed
Ch ronic
Ġchan ge
Ġs te
ĠF AB
cep ti
Ġint ensity
ever al
m atched
Ġm ature
at ho
gen ase
Ġdesign ed
Ġradi ation
ec ted
Ġstatis tically
Ġman ner
Ġvari ants
Ġrequi re
Ġlig and
im mun
P R
om erase
Ġde ep
ero x
Ġel ucid
u ro
ĠM E
Ġappl ied
Ġpan el
D NA
Ġd et
Ġenh ance
ĠWh en
Ġl ittle
b y
ĠP ML
Ġme g
Ġcer tain
Ġdis trib
Ġcombin ations
6 8
ĠC C
RA S
m al
Ġ3 9
Ġtransloc ations
om in
Ab l
Ġs or
Ġkin ases
o b
is ts
Ġst ate
Ġtreat ing
P A
ĠIn te
t uzumab
de f
b ly
ĠCN S
iff eren
Ġid arubicin
Ġoccur s
Ġinter nal
leuk in
Ġtoxic ities
n c
Ġin depend
si zed
Ġwho le
Ġinhib its
op er
fib rosis
Ġsus cepti
od es
Ġcar ri
Ġgener ally
6 6
y si
yl ate
ig ible
Ġf ludarabine
Ġeffec tor
Ġne xt
Ġanti leukemic
ĠH DAC
T OR
Ġflu orescence
ĠE T
Ġdiff ic
Ġinterac tions
Ġ '
Ġsal vage
Ġm ass
ĠT ran
Ġcon te
Ġvaria ble
Ġcom orbid
Ġvir us
l or
Ġdo uble
ĠM T
ro g
Ġpolymorph isms
Ġstrom al
Ġac t
Ġst ress
ĠI C
Ġadv ant
ĠK IT
i an
Ġep it
Ġanaly ze
Ġimmun ohist
went y
F R
re cted
Ġsuppor tive
f eren
ĠT NF
Ġint ensi
o ly
S A
Ġd ysp
Ġtran si
Ġestabl ish
ed ing
Ġdes pite
ĠB ec
Ġmacro phages
Ġus ually
Ġartic le
pri ate
re c
Ġappl ication
v ari
de oxycytidine
4 3
Ġmon onuclear
Ġreview ed
Ġp ast
ĠV EGF
7 7
ĠC pG
Ġend othe
Ġs ince
Ġmeg akary
A ra
Ġmutation al
ĠA BC
ra in
Ġtran splanted
Ġhighl igh
Ġdifferenti al
I V
en ed
ĠWh ile
Ġtol erated
Ġbiomark er
Ġdiscus sed
ĠMul tivariate
Ġlead s
Ġcon sistent
Ġstain ing
Ġspec imen
Ġder iv
Ġcon taining
Ġcal c
Ġtrans l
line age
m l
Ġ4 1
om en
ult aneous
Ġarabin oside
Ġiniti ation
stim ulating
Ġconte xt
Ġconfir m
Ġgener ated
Ġche ck
Ġpred omin
g ely
Ġover come
Ġox id
Ġknock down
Ġpro duced
ĠP re
yn amic
Ġlar gely
Ġ5 6
Ġs kin
Ġp anc
Ġfrac tion
Ġn etwork
Ġsynthe sis
Ġappear s
Ġhybrid ization
T C
4 8
Ġmyelo fibrosis
op ath
Ġpractic e
E L
Ġd oc
il it
Ġat ten
Ġdown stream
Ġprop osed
H P
roph age
er v
Ġgen ome
Ġsymptom s
4 6
Ġ4 7
Ġimplic ations
Ġcyc lophosphamide
Ġre ver
Ġh al
os in
alid omide
Î º
Ġcon sequ
Ġh ost
ĠEurop ean
Ġdel i
Ġhyperm ethylation
Ġse par
en se
E FS
Ġcyt oplas
Ġg reat
ant rone
Ġcirc ulating
enc ies
ĠCl inical
Ġextra medullary
Ġactiv ities
Ġ Z
Ġf ar
Ġfac ilit
Ġl ater
ist ance
urviv al
Ġexperi ence
Ġor gan
Ġcytogenetic ally
4 2
Ġat t
Ġmetast asis
cap e
Ġst able
raf ts
id es
f ractory
Ġe ight
lo bin
Ġmorpholog y
Ġprev al
Ġimplic ated
ĠM yeloid
iz es
Ġman if
in ten
ĠP I
h ensive
Ġrep air
Îº B
o genetic
Ġpoor ly
4 1
ĠW BC
az ard
Ġvalid ated
Ġmulti drug
v ious
Ġqu ality
Ġ Y
M F
Ġ4 3
% -
5 5
e ffec
Ġprotocol s
y g
r ia
ensi tive
Ġsil encing
9 6
Ġd r
iqu es
ĠA L
gen ic
Ġc at
str ic
Ġdef ine
Ġquan ti
x ed
8 7
Ġestim ated
ĠM ost
ad es
ĠBec ause
ĠB A
âī ¤
ari ly
Ġirradi ation
ox antrone
Ġleuk ocyte
Ġs ol
resting ly
Ġperform ance
Ġmat uration
Ġd ri
Ġtechn iques
comp an
acet yl
Ġre stric
Ġter ms
W T
Ġinflamm atory
ĠB cr
Ġscre ening
Ġcollec ted
ag ing
Ġd iv
p os
Ġac compan
Ġautophag y
he st
Ġst ages
N PM
ogen ous
Ġchromos omes
ici ency
op atho
Ġrele ase
s ity
Ġto po
Ġinfiltr ation
Ġclin ic
Ġexplo red
ĠH igh
Ġshow s
st ate
o very
Ġoverex pressed
ĠE VI
Ġr ational
Ġmon ocytes
R R
ĠG M
Ġref lec
Ġocc urrence
e tic
Î ¼
af enib
Ġclassi fied
Ġendothe lial
inten sity
Ġmorpholog ic
it inib
Ġsim ultaneous
ĠN ot
H C
re fractory
Ġimmun ity
6 2
Ġwid ely
Ġde gra
Ġ5 3
Ġsc hed
Ġcr uc
Ġinter leukin
Ġrapid ly
Ġdiscontinu ation
ĠG S
Ġol d
D FS
Ġpro ble
Ġappro priate
Ġpredic ting
Ġth ough
Ġdisplay ed
z ard
ĠA p
ol ar
ĠI g
Ġha zard
anc y
Ġven etoclax
Ġcon jug
Ġf ront
m et
Ġg ain
Ġdiffic ult
Ġcomp re
iel d
Ġne uro
B I
Ġfemal e
ac tive
Ġchrom atin
ĠTh ree
GF R
Ġmarked ly
Ġha ving
ĠRec ent
Ġfail ed
Ġin dex
Ġinduc ing
l ished
az acytidine
Ġbiop sy
) )
iv ariate
Ġne oplastic
Ġrecogn ized
Ġis s
Ġexperim ents
00 3
Ġwh om
Ġlink ed
Ġlabor atory
Ġsec re
ĠDN R
Ġ %
Ġhig hest
Ġnecess ary
Ġlim it
Ġcruc ial
Ġam pl
Ġth ird
Ġtr ig
i tive
ĠA cute
Ġan imal
activ ation
8 5
r ation
Ġl at
Ġb ro
T D
ear ch
Ġblo t
Ġunderst ood
Ġaccel erated
activ ated
Ġcomp are
Ġt el
az ole
Ġindepend ently
aren t
p op
Ġimp aired
Ġconc ern
e ared
ĠInte restingly
Ġ Î²
G M
ren ew
Ġmethyl transferase
Ġdetect able
Ġcandid ate
g th
Ġex er
Ġaut o
AT A
Ġer ad
Ġro ut
Ġqu es
Ġn an
Ġpro gram
ĠS everal
w ide
ar r
Ġregion s
Ġmyelo ablative
Ġtim es
Ġs our
g lyc
Ġf ra
f t
Ġmi RNAs
Ġwh ose
i or
os ome
Ġob jective
ro und
com it
Ġ5 4
Ġgu id
Ġse x
Ġf at
ec tive
Ġ5 2
Ġser ve
Ġreac tive
Ġdoc um
7 9
Ġg em
Ġsuppres sed
Ġ5 1
Ġchallen ge
Ġmes ylate
Ġne g
Ġcor d
ĠA ZA
ven ous
Ġup regulation
id ase
Ġyoun g
Ġsubjec ts
ting u
Ġter min
Ġshow ing
Ġbas eline
ĠA N
si gn
Ġdel ay
Ġdistrib ution
en in
Ġpur pose
7 3
am ine
E N
Ġpredic tion
Ġg li
ur in
Ġspecific ity
Ġmi xed
os omes
Ġvia bility
6 4
3 15
Ġsequ ence
Ġdisc overy
Ġchem ores
A G
z og
ochem istry
h azard
ĠS ince
es tern
ĠAS XL
Ġdeple tion
ĠIm mun
vers ely
7 1
Ġ lo
Ġremission s
ĠSt ud
MD SC
ĠI V
Ġst ar
ĠM M
Ġcomp r
Ġsuccessful ly
ĠB C
all el
Ġmit oxantrone
Ġhal f
ĠIm atinib
Ġcar ry
Ġgranul ocytic
y r
n ing
Ġpresent ing
Ġpub lished
ib ility
Ġdiff er
Ġsensi ti
Ġ ul
Ġex on
en ome
osin ophil
Ġmul tic
Ġinte rest
ĠJ an
T K
ĠRec ently
Ġpolymorph ism
Ġ6 7
Ġdown regulation
end ed
Ġspecimen s
Ġper s
ia c
zog amicin
Ġas p
Ġon set
inetic s
en ess
Ġm ast
ĠM N
RA R
p ati
Ġ5 8
Ġsumm ary
p ared
Ġleuka emic
Ġinsigh ts
Ġal ong
Ġap plic
Ġregul ator
ĠS e
ex pressing
Ġ7 2
Ġaffec ting
r h
Ġintra venous
Ġeffec tively
Az a
C LL
it able
ĠT aken
6 9
Ġreg ulated
Ġde hydro
st inal
z yg
Ġup regulated
ĠRes ults
Ġcon comit
Ġ ve
Ġmorpholog ical
ere g
Ġtransplant s
Ġ5 7
Ġmi RNA
2 01
I m
Ġf ul
Ġdis s
ĠS NP
I D
O C
P C
5 2
Ġsystem s
- -
9 37
Ġmetabol ic
s c
Ġper sist
c tive
Ġph ys
Ġpro ced
ĠD ec
- ,
m ost
Ġxenog raft
C F
Ġmetast atic
i otic
Ġrespon d
Ġspec ies
Ġmuc h
Ġadvant age
8 3
Ġre as
Ġde p
respon ding
vari an
Ġmyelodysp lasia
Ġprocess es
5 4
u sive
Ġ6 1
Ġadhe sion
ut inib
atic ally
ĠT wenty
ulf an
Ġ log
Ġm ig
Ġdec ades
Ġp ul
ĠM y
s el
on es
og lobin
er ate
Ġex pected
ĠH OX
Ġmin or
Ġcheck point
Ġtrans fer
ĠRA S
b les
Ġkary otypes
Ġacc ur
Ġo zogamicin
Ġsub pop
Ġad en
E M
ĠS ix
Ġrec ru
yl ated
eric an
ĠIm port
Ġclus ter
Ġd ram
Ġdet ail
A m
Ġs pl
Ġrat her
Ġactiv ating
ic he
00 5
Ġhaemat ological
ĠC ell
Ġat tem
ad y
Ġb el
Ġdis tingu
Ġthrombocyt openia
y R
tiv eness
9 2
Ġv ascular
Ġg o
ap an
lo geneic
Ġcompre hensive
00 4
ros c
Ġaccompan ied
in te
ri tis
Ġo varian
Ġs ple
7 6
ag on
rial s
Ġli ke
> ,
Ġox y
Ġexam ination
Ġdehydro genase
a emia
Ġdis rup
B CR
ĠG ATA
Ġdemonstr ates
Ġ6 6
ĠIn tern
Ġemerg ing
hem at
ĠR IC
osi tion
Ġonc ogene
if y
cl usion
d ation
od e
Ġfra g
U C
l ab
Ġrecom bin
Ġrep e
Ġreac hed
Ġexam ine
ĠA cc
ĠW HO
Ġreac tiv
Ġin j
is omy
Ġhep at
Ġexperi enced
M yeloid
Ġmor bid
ĠJ apan
5 1
ti des
Ġcho ice
f ac
Ġinflamm ation
ĠN B
ĠG ST
Ġdat ab
ĠB ased
Ġdec reas
Ġext rac
tar geted
Ġsign ature
renew al
Ġal ive
a un
Ġre nal
Ġsub c
Ġcult ures
Ġanthracycl ines
Ġexpl ain
Ġremain ing
Ġdef in
glyc oprotein
Ġs ize
Ġfor ms
Ġdegra dation
6 1
m e
AT RA
Ġvaria bles
Ġpharmac ok
Ġthere by
AL C
Ġmanif est
Ġcharacter ization
Ġ6 4
ĠS im
Ġ4 9
Ġc ross
ia ble
ĠC ox
Ġful ly
c at
Ġpossi bility
ĠImport antly
ard iac
Ġ her
Ġposi tivity
Ġre pro
ĠI R
C G
Ġinhib iting
ver si
ĠM ut
yelo dysp
Ġfrequ encies
O L
Ġprecursor s
Ġem plo
Ġre pl
Ġsam ple
Ġam oun
Ġext rem
Ġsubstan tial
Ġ6 3
Ġincreasing ly
t ake
B L
l im
cell s
Ġsubsequ ently
Ġant agon
ĠIn c
g l
Ġbe h
in duction
ren ch
Ġmicro ar
Ġaut h
H odgkin
Ġv in
ĠAB L
ric hed
Ġal k
Ġdeli very
ĠCX CR
ĠF our
ĠThe y
Ġintro duction
Ġis o
f y
AP K
Ġlack ing
Ġbro ad
Ġd ate
mit ted
Ġan other
Ġdifferenti ated
Ġ6 2
n ot
Ġregul ators
Ġexperim ental
oc ar
ĠIntern ational
Ġ5 9
ĠA b
Ġdem ethyl
Ġup take
Ġspec tr
Ġn ine
c o
Ġco re
Ġmorbid ity
olec ular
ici ans
m ark
us ted
ap h
S D
an ti
Ġcarri ed
ow er
og lobulin
Ġc ost
po ints
Ġcoh orts
Ġhypothe sized
ir ty
ĠR FS
Ġmicro M
8 4
C d
Ġdeg ree
Ġsor afenib
Ġin st
8 9
Ġo ste
ET O
ĠCD K
Ġsuscepti bility
Ġrelap ses
mon ary
Ġtumor ig
ĠK IR
Ġinvas ive
Ġangi ogenesis
ĠCM ML
r in
on azole
Ġd ereg
Ġe very
Ġac ross
Ġregul ate
Ġenzym es
ĠHe alth
ff in
blast oma
yelodysp lastic
8 2
Ġidentify ing
ĠH MA
Ġex ist
Ġpep tide
r ine
Ġoxy gen
id ine
otox icity
k t
Ġatt rac
r ich
Ġb ind
Ġstim ulation
Ġdysp lasia
is ting
ĠS c
re x
et in
us ulfan
Ġutil ity
Ġin n
Ġel imin
ol er
Ġcontribute s
Ġsus tained
Ġmet h
ĠT LR
Ġpro state
Ġab ove
Ġantib iotic
ĠAddition ally
t ment
Ġde acetyl
ĠHere in
Ġseem s
F I
5 9
Ġs w
in ated
ot ing
E S
Ġmed ical
ud ing
Ġepit he
d el
os yl
ines e
7 2
Ġexp and
Ġenh anc
Ġimmunophen otype
KI T
Ġmo bil
or ld
Ġapp eared
t ur
Ġsple en
log ic
Ġ6 8
Ġimp air
Ġad ap
A N
ĠD AC
Ġcor responding
Ġrequi res
n is
Ġm ism
ear ing
Ġtoward s
Ġ7 1
Ġem b
6 3
Ġn or
Ġe osinophil
Ġachieve ment
Ġs i
Ġneutrophil s
Ġchim eric
B CL
Ġma xim
Ġev id
Ġcult ured
Ġgo al
Ġcorrel ate
Ġel igible
Ġhighl ight
Ġ( >
7 4
ins ic
Ġext ensive
ĠAB T
ĠCh inese
tar get
Ġrecommend ed
Ġother s
ĠA A
ĠC AR
R UNX
Ġregul ating
Ġir on
Ġdocum ented
I FN
m od
ĠF rench
U T
op ic
Ġp e
Ġmethyl ated
Ġoccur ring
ati ves
Ġdeacetyl ase
Ġcompon ent
ox y
ĠAT P
9 4
Ġac et
P I
Ġ ÃĹ
Ġinter vention
Ġconcomit ant
Ġstruct ure
cat enin
H LA
ĠM K
Ġ ill
ic ine
Ġpreval ence
pl atin
erox idase
Ġev ol
ST AT
Ġp a
Ġre d
ĠC SF
Ġtre nd
es e
Ġpromote s
Ġinc om
A ZA
Ġc ardiac
R ec
ĠH D
Ġex cess
Ġmig ration
Ġpo ints
Ġmin im
Ġnucle otide
Ġtr isomy
Ġ Î±
Ġcontro versi
8 1
ĠO r
Ġm im
xim ab
Ġprim arily
Ġste p
Ġcombin ing
Ġ z
Ġconf er
Ġchim er
E C
Ġimpro ving
Ġf ind
ero us
m ethyl
Ġlen alidomide
Ġad op
Ġlymph omas
Ġsplic ing
Ġprolifer ative
en z
aria ble
Ġreg istered
Ġpar tially
rex ate
R FS
Ġdem ethylation
Al though
Ġiniti ally
lob al
us ed
Ġdeath s
mon th
l in
an y
Ġp ap
Ġcytoplas mic
Ġon going
Ġdys function
Ġb rain
Ġunderst and
Ġv ol
res is
b earing
cr ist
ver age
ĠA P
ĠS R
Ġanaly sed
Ġsu itable
Ġal most
R es
Ġh our
ĠC Y
Ġ ,
Ġapp arent
l an
Ġd ynamic
ar a
at a
d r
et al
ud e
ĠL FS
Ġmod ified
crist ine
el ines
A n
Ġconclud ed
11 7
Ġprovid ing
Ġwe ight
Ġvac c
in ant
Ġm ust
Ġm ember
Ġt w
Ġhem oglobin
9 3
con taining
Ġconsis ted
Ġdi verse
ot rexate
b i
Ġcharacter ize
Ġhaemat opoietic
ific ations
u ary
Ġen abl
Ġb ack
u an
Ġassoci ations
Ġcompon ents
ifferen ti
Ġreduc ing
Ġg erm
Ġcap able
Ġpre feren
Ġiso form
Ġc is
ĠN O
ĠR e
v HD
Ġprogres sive
Ġhypothe sis
erv ous
Ġsign atures
Ġ Â
em i
vers ity
Ġat trib
] .
Ġm TOR
oc om
00 6
ure a
Ġmemb ers
Ġrisk s
Ġeffici ent
Ġpredictor s
Ġmicro RNA
Ġimmunophen otypic
opath y
C on
vir us
Ġgas tric
Ġeffec tiveness
Ġn ervous
Ġexpos ed
Ġpossi bly
Ġhaplo identical
ograph y
Ġb le
ici al
ĠF ive
Ġg amma
Ġpre gn
w ise
Ġp ower
lu x
Ġauth ors
ĠBA ALC
str uc
Ġsurviv ors
r ate
ore r
Ġindic ates
Ġpharmac ological
Ġrout ine
M Y
ĠEx pression
Ġ âī¤
Ġsel ectively
Ġv ar
ĠI D
ĠC urrent
Ġun ivariate
Ġdown regulated
Ġs pon
Ġf ungal
> <
Ġimmunosup pression
or rh
Ġpo orer
c oding
Ġa min
Ġof fer
Ġun til
Ġsaf e
M M
ĠD Cs
Ġno ted
Ġrare ly
I N
Ġpul monary
Ġen vironment
Ġchemores istance
Ġprob ably
Ġspectr um
ĠF ISH
Ġcl os
+ /-
Ġpro duce
Ġpo lyc
Ġsour ce
Ġrem ark
tern al
Ġphen otypic
Ġt em
ec ond
Ġcycl in
und red
Ġchallen ges
Ġl nc
ĠD LI
Ġsequ ential
Ġcontroversi al
Ġ7 8
Ġevalu able
Ġ6 9
Ġimmun oglobulin
Ġgem tuzumab
ĠM MR
P atients
is omerase
er ing
s ensitive
Ġmain tained
Ġb usulfan
ĠP V
uc h
Ġcomp lication
ritis h
LA G
Ġrati os
Ġblock ade
Ġasp ir
ensi tivity
Ġexhib it
ĠS y
Ġfe ature
Ġradi otherapy
Ġoxid ative
Ġprop ose
A A
ite s
in dependent
d C
Ġf ever
ĠC ol
Ġchan ged
Ġtumorig en
S S
5 8
oper ative
O G
ot al
et hod
L SCs
i i
Ġbi o
+ ,
Ġcomorbid ities
ĠS M
Ġpromo ted
Ġsc ores
ĠM F
ar row
Ġ4 00
Ġcandid ates
Ġrespon ders
ĠR el
Ġgl ut
Ġobserv ations
ĠCyt ogenetic
te s
I DH
ĠCom bin
os pho
us tr
Ġresp ect
Ġver a
ĠT reg
9 1
Ġ200 0
ĠC AL
Ġtrans duction
7 8
Ġb lastic
ĠS ub
ĠH emat
v ant
Ġly s
Ġdifferenti ally
ĠAcc ording
gan ization
ĠCM V
min istration
Ġemerg ed
Ġdiv ided
Ġsub str
Ġins titution
ph en
Ġsuppres sive
transplant ation
ove red
Ġpanc re
t aneous
ML L
Ġharb oring
P V
a di
Ġare a
Ġrestric ted
otherap ies
E s
Ġproble m
u ff
Ġep id
Ġextrem ely
Ġend ogenous
et h
ol es
Ġfeas ible
Ġconc urrent
ĠR OS
Ġchem ical
Ġ7 6
Ġtechn ique
Ġh undred
Ġobserv ation
ĠOn c
Ġfat al
ĠA D
Ġvalid ation
Ġhour s
Ġol ig
Ġphen otypes
Am erican
Ġen riched
ĠJan uary
ĠP K
Ġattrac tive
Ġpartic ip
Ġtherapeutic s
id s
ment ation
ĠC o
Ġas sign
Ġcon ver
Ġpre par
ĠOn ly
Ġmeth otrexate
ib r
Ġse p
Ġvin cristine
Ġl ight
ĠG ene
Ġerad ic
g amma
Ġmultic enter
si vely
Ġincom plete
Ġm id
Ġpersist ence
u tively
Ġf ull
ĠD rug
Ġmod ifications
Ġcl ar
Ġtermin al
go v
Ġsuff icient
Ġem ph
Ġgranul ocytes
Ġcle arly
Ġb l
ĠP T
tiv ariable
mi R
op e
Ġinvas ion
Ġe ar
ĠOr ganization
d T
Ġg lobal
ĠB one
Ġmicroar ray
Ġcompar ing
ĠMY C
enc h
Ġ8 5
yp ical
yt hemia
gnos tic
inte stinal
E P
ĠW estern
Ġatten u
Ġnec rosis
n t
Ġunder go
Ġex cept
Ġsignal s
Ġem er
Ġrational e
Ġampl ification
ĠH SP
ĠR eg
ren ce
Ġchallen ging
Ġguid elines
Ġ201 6
Ġh ome
mic ro
en ding
Ġmost ly
raf ted
Ġemplo y
c ancer
Ġevalu ating
olog ies
Ġbi ologic
fer red
ethod s
o ura
Ġeff lux
Ġfib ro
Ġmod ulation
Ġdatab ase
Ġfeas ibility
Ġmedi um
Ġrecommend ations
Ġw ide
ic k
Ġenc oding
ti ous
Ġs he
B ritish
Ġext ent
app a
Ġcomplete ly
Ġcytomet ric
Ġ7 3
Ġel ec
k it
ĠAML s
m yelo
Ġ ur
Ġtransp ort
is p
ĠK G
Ġ â
Ġpre treatment
u rac
Ġm as
Ġn g
dition al
Ġrecombin ant
a urin
Ġmon otherapy
00 8
Ġeff orts
Ġdecision s
Ġemb ry
v iew
Ġ7 4
s ess
ere b
os por
Ġconstit utive
Ġappro val
Ġp ut
U P
duc ing
ĠD uring
Ġcontro lled
H A
an alysis
um in
0 6
tro intestinal
Z H
xy urea
lamm atory
Ġf ield
el s
Cd R
O N
Ġin activation
ap s
Ġcarry ing
ec tin
g in
Ġchimer ism
Ġsi RNA
Ġspon taneous
il arly
ĠS F
ĠTh irty
Ġcorrel ates
Ġd urable
ak ing
Ġnucle oside
Ġrecipi ent
Ġgu ide
um p
Ġtransform ed
PS S
Ġ7 7
R P
b e
ĠCom plete
Ġprim itive
Ġb al
Ġh and
effec tive
th al
Ġenti ty
Ġb or
Ġepithe lial
lo od
Ġfocus ed
Ġtopo isomerase
Ġmyelo blastic
Ġcomple ment
itu ximab
Ġfacilit ate
Ġtransi ent
f ungal
ĠW orld
t wo
all ing
Ġkill ing
Ġproduc t
ĠTo gether
o ff
Ġc en
k inase
U D
Ġmod ification
ĠT RA
Ġe ti
ĠĠĠĠĠĠĠĠ ĠĠĠĠ
D espite
Ġinc ub
Ġallow s
Ġgl uc
Ġdram atically
S G
ĠC H
Ġloc ated
Ġn one
er tain
Ġlen gth
E G
Ġun de
cyte s
Ġsur ve
m L
ĠB H
Ġma king
ĠA K
Ġas pec
Ġcoun tr
Ġaccur ate
M e
it ro
n ed
am ycin
Ġl ands
Ġmain tain
zyg ous
lo id
Ġdele tions
Ġdemethyl ating
F ISH
Ġmet a
Ġ200 8
Ġclos ely
Ġmon os
opo iesis
ac tic
ĠCom pared
Ġper sistent
inf lammatory
ĠC FU
p rom
Ġpred nis
> .
Ġp ain
Ġhyp ox
Ġenti re
Ġdiss em
Ġallow ed
Ġrecogn ition
Ġm amm
ic ro
Ġques tion
Ġor g
DN R
Ġsw it
ost aurin
Ġmod erate
Ġconsis ting
iv al
abil ities
Ġc op
ĠD e
os min
po iesis
ise ase
Ġw ay
it in
av o
oph osmin
Ġlig ands
Ġconsider able
N T
pro tein
Ġdisc rim
Ġinflu enced
m an
is es
Ġfront line
DN MT
Ġvir al
ĠE p
ĠM C
Ġcis platin
Ġb cr
port un
Ġpredomin antly
G A
cyt osine
Ġtumorigen esis
Ġ8 1
Ġadd ress
Ġdistingu ish
Ġp aren
ill ance
Ġble eding
ĠAn alysis
om ib
en ias
c ol
em ias
Ġme ans
Ġadd res
Ġtw ice
+ /
e qu
Ġs l
ĠMR P
Ġaccoun t
g aly
ges t
MD R
Ġsched ule
Ġpro ven
Ġmic rosc
Ġm is
Ġcontinu ed
Ġdelay ed
gra ms
ĠT GF
ub iqu
os ts
Ġincorpor ation
Ġv ary
Ġcoun ter
Ġt ur
Ġcategor y
Ġph ysi
ĠOnc ology
Ġproduc ts
ac ute
ĠA r
Ġro b
cell ent
ĠI d
ĠW nt
Ġneg atively
otox ic
Ġbeh av
r ib
in iti
ri le
Ġdaun omycin
Ġcategor ies
ar m
Ġmon th
ugh t
rect al
avo urable
Ġa ug
an gi
ĠO ther
Ġop portun
C l
Ġsc oring
Ġd ual
Ġp r
Ġreactiv ation
AR P
Ġrob ust
MR C
ra z
Ġhydro xyurea
ec ts
Ġlar ger
Ġpancre atic
tim al
Ġsuppres s
lo rectal
ĠP FS
Ġim pl
Ġexpression s
Ġimmunohist ochemistry
c tor
Ġc enter
Ġex cellent
v s
ĠM ed
li er
Ġregul ates
Ġinc id
Ġprom oting
Ġim aging
ĠA c
ĠD own
op enias
Ġinclud es
Ġimprove ments
Ġn ature
ĠE n
ĠE L
Ġstruct ural
D L
Ġc opy
ĠD S
Ġgen otypes
C H
ĠCT L
ol ute
m ented
Ġlands cape
t ase
Ġcon tain
Ġha em
ĠH SCs
ed ed
Ġenc oura
Ġtool s
Ġp le
ym al
Ġstatis tical
Ġsubc utaneous
Ġnum erous
Ġgas trointestinal
ĠC B
00 7
Ġpro ved
ost at
Ġelec tro
Ġbenef its
ER T
p eroxidase
O T
ĠN ew
Ġtes ts
ĠAN LL
D Cs
Ġpost remission
aun orubicin
qu is
Ġint oler
p ut
om an
lo f
f lu
on ic
gra de
ĠIn hib
Ġclon ogenic
Ġvari ation
Ġis l
av age
Ġmyelo blasts
C BF
the less
ĠSy stem
z omib
ph ysi
Ġeffici ency
Ġinter n
Ġthough t
Ġul tim
ĠT HP
on atinib
ĠR AR
Ġdifferenti ate
> /
Ġ q
Ġn iche
ĠP P
ĠF if
Ġvalu able
ag ent
ne um
Ġproced ure
Ġthrombocyt hemia
ĠStud y
ĠP C
Ġun d
Ġaffec ts
Ġsummar ize
Ġser ious
Ġexpand ed
Ġpolyc ythemia
Ġar ray
Ġinsigh t
O H
Ġso ught
m ission
x in
Ġcontrib ut
Ġdis mal
ffin ity
ĠH CC
at ase
Ġsign alling
Ġf l
Ġy iel
Ġmod ul
ĠTran splant
Ġab rog
Ġmicro RNAs
Ġtechn ology
Ġlat ter
0 7
> )
Ġanti fungal
Ġchem o
Ġpar allel
Ġ8 3
Ġintr at
c yc
Ġext racellular
el ing
Ġmon ocyte
Ġimmun ological
Ġc ut
ĠU CB
Ġcompar tment
C yt
b rile
mac rophage
II I
mac yt
Ġtumour s
or y
Ġbenef icial
er ved
Ġsimultaneous ly
Res ults
ch ing
ol one
form ing
ĠH SC
Con clusion
Ġdef iciency
Ġrel iable
u tions
Ġth ym
ĠT R
ĠMP O
Ġinst ability
) :
Ġp air
ra w
ĠS IR
Ġcont ent
Ġrecru it
Ġ8 8
Ġmuc os
d ays
resist ance
Ġtyp ically
en es
Ġco lorectal
w h
cl uding
Ġblock ed
ĠS urvival
ĠRNA s
re ady
Ġhem orrh
as ion
0 8
i one
ĠM MP
Ġcyt openias
Ġmut ants
Ġph ases
Ġw omen
y ond
Ġb is
ov ascular
Ġsubpop ulations
ĠE ight
ĠPro gnostic
Ġpregn ancy
ild ren
Ġgenetic ally
Ġa verage
Ġiniti ated
Ġve ctor
Ġear lier
tur b
Ġdiff use
th ree
Ġreas on
Ġal ready
ĠN e
Ġmac rophage
Ġcountr ies
Ġprec ise
pati ent
Ġc ereb
Ġcon cept
Ġconstit utively
Ġloc us
Ġrest ored
lof arabine
ĠAd ministration
ĠA C
ol low
hem otherapy
Ġs earch
Ġwe ak
Ġpatho physi
ri x
Ġ7 9
Ġf as
Ġcar b
sequ ently
ĠS ome
Ġ8 6
Ġclinic opatho
G O
ĠTran s
ĠM V
l ink
ar tic
Ġrel ation
Ġcan not
om od
ĠE ZH
t a
at form
z ing
Ġs AML
Ġst ability
te zomib
ĠP U
r ant
crip tion
ar ing
Ġdef ects
Ġt rac
Ġm Ab
ĠH odgkin
ensi vely
or ation
ĠF rom
Ġph ospho
Ġconstit ute
y ro
Ġanimal s
Ġer a
Ġpers onal
w w
ti d
ĠF as
15 5
Ġline ages
Ġabs olute
E D
re arrang
Ġreac tions
Ġtrig g
Ġad ded
Ġat ypical
Ġpre vention
Ġgrow ing
Ġtransp orter
Ġdri ver
g ue
oc ellular
Ġpro spectively
las si
ĠW he
Ġexam ple
Ġrec ons
Ġsequ ences
Ġthromb osis
ost asis
Ġlip id
Ġr ib
Ġ8 4
Ġon ce
Ġinfec tious
Ġhe av
Ġdi rected
Ġpap er
ench ymal
Ġmod if
Ġdec ade
Ġintr insic
Ġmed icine
Ġmonos omy
we ek
Ġ8 7
m ycin
Ġt en
Ġa x
ĠI PSS
V L
Ġres id
Ġcur ve
Ġcon sist
Ġplas macyt
Ġsubstan tially
Ġderiv ative
al an
AT O
Ġb cl
ĠS ign
all ed
Ġinn ate
Ġcen ters
p r
Ġmaxim um
Ġsh if
Ġclear ance
immun e
B V
al ities
ĠNot ably
Ġstim ulated
Ġelucid ated
Ġemer gen
g round
ĠE v
lec tively
Ġn am
ix ed
Ġmyel osup
Ġc utaneous
Ġover view
Ġderiv atives
Ġnon relapse
Ġonc oprotein
lu orescence
Ġpl atform
Ġimmunophen otyping
Ġinj ection
M yelodysplastic
Ġ Î¼
ĠT ar
Ġdemonstr ating
Ġeffici ently
Ġemploy ed
Ġp neum
ost atic
HD AC
Ġbec ame
Ġw oman
os utinib
Ġdetail ed
Ġimmun od
ria mycin
M C
ve red
s tit
Ġfac t
ĠMPN s
Ġsim ple
Ġphen omen
L FS
e ti
Ġm ild
Ġcon struc
Ġsuppor ting
def icient
Ġmul tivariable
te ct
con tro
ĠT dT
ven ess
si es
g or
log y
ĠO ut
Ġpl ace
Ġpatho logical
Ġleuk ocytes
Ġinvol ves
Ġlip osomal
u vant
Ġreduc es
Ġamoun t
Ġiss ue
Ġamin o
Ġplatele ts
gor ith
Ġscre ened
Ġhighligh ts
ĠCY P
Ġt aken
Ġur g
in hib
ĠC CR
cep tion
Ġdisc overed
f or
Ġ( âī¥
Ġvac cin
ic t
Ġprom ise
ĠU S
Ġ9 6
Ġavail ability
ĠCol lectively
Ġl ost
ĠA R
quis ition
l t
Ġd imin
id ne
ĠB i
ĠN on
Ġregard less
Ġmyelo peroxidase
Ġop en
Ġaspec ts
Ġal gorith
ĠN UP
com mon
th rough
ĠRA EB
Ġput ative
o blastic
Ġgli oma
as ome
si veness
Ġmet aph
Ġm en
Ġpos sess
Ġfe brile
Ġg rafts
g reg
Ġle ft
all mark
Ġdos ing
di rect
Ġalk yl
ĠD L
cept able
g al
arran ted
k appa
Ġin effective
ax el
Ġfib rosis
Ġid entical
ok ine
Ġh allmark
ĠM echanis
ĠG iven
ogen es
Ġimmunod ef
Ġalter ation
Ġbreak point
M K
re ction
Ġre ach
Ġun s
Ġa vo
Ġpres ents
Ġbe yond
Ġsl ight
el ed
it ored
Ġintensi fication
ocar cin
ĠN ever
Ġtra ditional
Ġelucid ate
ĠT RM
ch an
ex pressed
Ġcle avage
Ġr ituximab
Ġadhe rence
Ġen tered
Ġimmunohist ochemical
Ġintern ational
O D
Ġmon itored
Ġb acter
Ġ201 7
Ġ ubiqu
al ian
ĠPre vious
ad j
ĠHOX A
U S
elo w
Ġch lor
di rected
Ġimm ediate
n on
ĠD ata
ĠN RM
jec ted
f our
Ġcalc ulated
Ġw arranted
Ġk idne
Ġes cape
Ġs low
SC C
Ġpl an
initi ating
tin ue
lo ad
Ġmal es
Ġun us
Ġsurviv in
Ġhep atic
ĠNever theless
. <
Ġblock ing
Ġbiop sies
Ġcop ies
Ġill ustr
- (
Ġex c
ho l
ĠP gp
ĠS he
ort y
Ġpharmacok inetics
ĠÂ ©
Ġpower ful
ĠF ollow
Ġhis tor
Ġtyp ical
Ġr h
ok al
m ol
or b
enome galy
CT P
ograph ic
Ġpo ol
ap lo
Ġenti ties
Ġ= .
Ġinvestig ations
Ġscre en
Ġsol uble
Ġb il
Ġwor ld
w ing
Ġd ensity
Ġac quisition
F AB
Ġrespon ded
Ġcounter par
s urvival
Ġcomp lic
rearrang ed
Ġst art
ac tivity
ĠM APK
ĠP er
Ġres c
Ġ8 2
Ġchem os
ĠT BI
Ġsep sis
O b
il ms
RA ME
Ġstrati fied
Ġultim ately
ĠER G
ot ent
Ġsplic e
def ined
CM ML
i etin
Ġde x
Ġimmun omod
D M
Ġb elow
Ġiss ues
M MR
r s
red uc
rim ary
ific ant
Ġad oles
Ġcontrib ution
ĠK MT
Ġcomplex es
Ġphosph atase
ores cent
Ġassign ed
ĠCh ronic
ĠDec ember
och rom
Ġtur n
Ġp onatinib
Ġgen der
ĠT CR
he resis
atis fac
Ġne ither
Ġext ended
Ġplasmacyt oid
imin ary
ti f
ĠC K
Ġne arly
O P
Ġt et
Ġmolecular ly
ĠK ap
iv es
Ġmod alities
Ġmid ostaurin
ĠF DA
ĠI TD
u x
Ġpre ven
Ġremark able
L SC
I ST
de ed
I s
D LI
Ġover l
pec ific
Ġpr inc
Ġdescrib es
t rials
Ġal log
Ġcycl ospor
Ġallow ing
Ġincid ences
Ġaim s
ĠTRA IL
Ġen rich
Ġneed s
ĠD R
Im atinib
ati tis
Ġtransl ation
op timal
ĠD A
T NF
Al logeneic
dr iven
Ġd ia
Ġpneum on
oly tic
qu id
ath ione
Ġcardi ovascular
Ġst op
00 9
Ġbor tezomib
J AK
ĠA z
emb rane
Ġstim ulating
ĠM olecular
term inal
Ġquanti fication
ĠA SCT
Ġatten tion
it rate
if orm
Ġattem p
Ġv is
ĠS uch
ĠH ospital
Ġpur ified
Ġstar ting
ĠN RAS
Ġpar ad
Ġenh ances
Ġdom inant
Ġgreat ly
SC LC
Ġad equ
Ġprogres sed
verex pression
oly sis
ed uc
ĠS econd
Ġresp ir
Ġgerm line
P T
Ġco up
ĠI FI
oc c
Ġdr iven
Ġdecreas es
ol ic
Ġun common
Ġspec t
ber rant
Ġunus ual
re tin
Ġactiv ator
ĠER K
S R
â ģ
elph alan
tect able
Ġle uc
Ġ9 2
Ġma gn
N C
G R
Ġposi tively
MPN s
ĠMut ations
ab in
Ġgener ate
E x
Ġf avor
d im
Ġintegr ated
Ġcat aly
c ting
Ġspec ial
Ġrever sed
Ġsecre tion
Ġf it
Ġ201 3
H G
Ġclassi f
Ġcolon ies
Ġrecruit ment
Ġh ar
Ġun ex
Ġhypox ia
M B
a gen
Ġeti ology
Ġrec or
ĠPK C
Ġimmun otherapeutic
Ġmod ulate
Ġmanifest ations
ad en
Ġ9 1
Ġth res
ĠB lood
hydro xy
A r
Ġprote omic
Ġoff ers
>- </
F A
Ġm ediate
Ġcaus ing
Ġfam il
Ġw arr
ĠPh ase
Ġnan op
Ġmobil ization
ĠCAL R
ĠA kt
ren t
zym e
Ġpreferen tially
ign ant
Ġanti apoptotic
ĠJapan ese
i versity
Ġencoura ging
P H
Ġen able
ĠBM I
Ġsus p
E F
tiv es
R IC
ĠUn ited
ir ing
V EGF
res h
ĠF orty
ĠN CT
Ġes cal
b al
Ġin ser
ĠSR SF
er c
Ġlocal ization
C AR
Ġr ise
Ġdeterm ining
ĠSe ven
Ġim ple
oid s
N CT
Ġevent ually
Ġar ms
Ġprob abilities
Ġflu id
Ġmeasure ment
on c
un it
ĠP A
ĠAn ti
Ġhypomet hylation
Ġor ally
Ġco ag
Ġvari ations
a ve
Ġnucle ophosmin
Ġsurviv ed
13 3
Ġrev olution
l it
ĠO R
Ġtrig ger
Ġenhanc ing
f ive
Ġne ar
Ġinter pre
Ġvar ied
t ox
Ġadj usted
Ġattrib uted
N et
a ut
it ation
ar n
Ġcardi otoxicity
Ġr ight
Ġunc ertain
Ġattem pt
in ternal
ar abin
Ġex isting
th ym
Ġk inetics
Ġqu ies
Ġvacc ine
Ġa ffinity
Ġac ceptable
Ġsuppor ts
Ġb o
ch lor
ĠRes earch
Ġincorpor ated
) ]
Ġbel ie
S L
Ġleuka emias
Ġrat s
Ġep is
Ġestim ate
Ġtransp or
Ġb osutinib
Ġag on
ĠG vHD
ĠM any
ĠB u
C EBPA
Ġup d
Ġsm ok
Ġlimit ations
Ġ9 3
ar di
Ġprom in
Ġtel om
Ġc ured
ĠS ET
Ġ8 9
m TOR
Ġdissem inated
Ġf ram
ur an
H T
pro genitor
ĠN ine
Ġprophyl actic
Ġstar ted
ĠIR F
Ġkidne y
Ġenrich ment
Ġ ion
Ġf etal
Ġbe aring
ifferenti ated
ra ys
ĠP RAME
Ġra d
Ġb ound
Ġrepl ication
ox id
atisfac tory
M G
ĠF MS
vir al
Ġas c
Ġso le
ĠRes pon
Ġcontribut ing
lympho id
m yeloid
ap pro
Ġso ft
Ġparen tal
Ġun iform
Ġdeterm ination
Ġsystem atic
ĠAl logeneic
Ġfew er
Ġbel ong
M ethods
eren ce
kappa B
ocarcin oma
Ġin direct
Ġdereg ulated
Ġbehav ior
Ġsuppor ted
Ġtel omerase
Ġemph as
Ġ #
Ġrem o
Rec ent
ĠKap lan
o virus
Ġth i
Ġly sis
Ġsummar izes
0 9
Ġpot ency
Ġallel es
ĠABC B
Ġsub cl
Ġstim ul
Ġvaria bility
Ġsepar ate
re active
Ġabs ent
Ġst abil
ĠT F
us c
ĠI GF
Ġnanop artic
ĠS p
Ġdys regulation
Ġsign s
phosph ate
Ġclar ify
ĠAK T
Ġcl ose
ĠCh ildren
l ation
ĠN ational
Ġpersonal ized
Ġprote ctive
Ġhuman s
Ġar ter
Ġtoler ance
ĠN GS
s ide
las s
Ġmeas urable
orm ally
C K
ĠS D
Ġactiv ate
ĠAra C
Ġintro duced
Ġcyt openia
P FS
as one
Ġeradic ate
N RM
Ġac ts
Ġ201 0
Me ier
Ġphenomen on
duc ible
Ġdiscontinu ed
Ġdep ending
Ġemergen ce
Ġc lofarabine
Ġre pression
Ġleuk ocytosis
pec t
ran d
ĠP ARP
19 9
Ġother wise
ĠG en
ER K
Z F
ĠF ood
Ġ3 00
Ġselec t
Ġdiscus ses
Ġsetting s
Ġattenu ated
ll ing
S NP
ic ations
ĠI T
ĠB ax
Ġhe art
o tides
ĠLeukemia Net
Ġd one
si x
ag ed
ĠNot ch
Ġdecreas ing
Ġli quid
ad ap
Ġorg ans
ati gue
ĠC a
Ġtechn ologies
57 1
+ ),
Ġf resh
ran k
ĠF OX
ĠG r
Ġcarcin ogenesis
ĠFollow ing
Ġma ke
Ġrepe ated
Ġphysi ological
Ġmim ic
ot ran
Ġt end
Ġl act
am eth
ĠAT G
Ġfemal es
ur y
Ġimpro ves
Ġmism atched
Ġepid emi
Ġmeas ures
Ġre ferred
Ġbi ochemical
Ġstandard ized
app ing
link ed
r as
Ġel ements
ĠM AC
Ġ9 4
o blastoma
ĠH ence
Ġonc ogenes
ens us
Ġrelap sing
Ġconsequ ence
Ġax is
] )
oc itrate
ĠS okal
ival ent
ti ple
ĠS out
Ġapplic ations
Ġhe ad
Ġtranscript ase
Ġreac tivity
Ġmes enchymal
Ġidentif ies
Ġv iew
qu iring
TK D
ameth asone
Ġe as
ĠH ox
Ġext ensively
Ġreflec t
e ight
Ġcorrel ations
ĠM arrow
ĠABC G
Ġevid ent
im ination
Ġcon tained
Ġutil ized
Ġpercent ages
ĠMS D
Ġdynamic s
T BI
Ġcon st
Ġpharmac ologic
Ġcomplex ity
ĠInhib ition
et ween
Ġab und
Ġmat rix
Ġelimin ate
Ġpathophysi ology
Ġmain taining
ĠCC yR
Ġmicrosc opy
Ġt erm
Ġinter ven
ĠFif ty
Ġb enz
Ġconcern ing
Ġglut athione
Ġmyelosup pression
Ġ ide
ĠC ons
Ġmod est
Ġunde tectable
adap ted
A d
p osed
ati d
ĠB PD
feren ce
ĠC A
ar c
Ġalkyl ating
es ides
ĠF lt
ĠE arly
Ġtoler ability
Ġeosinophil ia
Ġpa ediatric
form ation
Ġconjug ate
Ġadop tive
Ġle thal
ĠL C
Ġel imination
ĠUn iversity
Ġmast ocytosis
Ġconsist ently
i pro
Ġprote asome
Ġ ent
s m
ment al
Ġsever ity
Ġprevent ing
Ġaddres sed
Ġleukem ogenic
ĠCon versely
M yc
Ġun its
ĠAl so
Ġtransi tion
ĠN HL
in os
ĠF c
Ġcompar ative
Ġfusion s
Ġeng ine
Ġpair s
in cluding
reat ening
clinical trials
Ġsil enced
Ġpe ak
el f
ost atin
Ġindic ator
op le
Ġcomorbid ity
Ġantibiotic s
in ter
ĠI DA
ĠM on
Ġne ver
Ġcontrib uted
u ed
Ġm elphalan
Ġde b
cal e
CR i
M ML
u sively
Ġhom o
W BC
Ġimp ac
po lym
Ġinterval s
ĠBPD CN
Ġvaccin ation
tiv ir
Ġisoform s
35 1
Ġques tions
n ine
Ġsub optimal
ch ar
Ġfunction ally
olec ule
ĠT FR
Ġadj uvant
ran ial
Ġare as
Ġob tain
Ġm ate
ex t
Ġflu orescent
ĠC G
ĠM G
Ġdiff ered
Ġpredic ts
Ġrap amycin
Ġavo id
w ays
on ine
Ġar ising
ho ut
P ro
Ġbind s
gl ut
I AP
oun ced
L euk
Ġ /
Ġp ron
erg ill
Ġloc i
F L
Ġp iv
Ġd im
ac lit
ĠRel apse
aclit axel
ĠI ts
Ġmulti par
ĠSt ates
ĠM UC
Ġprof ound
Ġp y
Ġe th
rap eutic
Ġinfusion s
Ġto p
ĠP o
Ġun it
7 37
Î ´
ĠSNP s
Ġsubstr ate
Ġth ro
Ġdepend s
Ġxenog rafts
ol itinib
v ity
ur k
ĠS ur
Ġwh at
of uran
Ġorig inal
Ġacet ylation
c an
m ean
in ducing
Ġpiv otal
et ry
ri ef
Ġbas ophil
ĠCurrent ly
Ġeff usion
urac y
Ġpromin ent
M ut
ĠGS K
Ġauto immune
ĠP MF
cell ular
Ġneutrop enic
ud ed
Ġimmun otherapies
a ro
os tim
Ġpro ce
p ed
Ġsynthe tic
es ted
Ġr ing
Ġdri ve
or in
Ġex ception
Ġenc odes
Ġmism at
Ġback ground
Ġfocus ing
en sion
Ġ2 001
ĠS H
ĠE le
Ġintegr ation
Ġsurve illance
ug hout
Ġcomp osed
Ġre tained
Ġprinc ip
ĠH yp
Ġimmun op
ĠS P
Ġdefin ition
ux olitinib
re es
ĠP G
ĠSc oring
m olecule
Ġ201 2
ame ter
respon ders
Ġanalog s
Ġfocus es
Ġestim ates
Ob jective
Ġal ways
Ġd ig
ĠC CA
Ġex pect
Ġ9 7
res pec
et ing
Ġcare ful
Ġconsequ ences
Ġpreven ted
Ġequ al
ĠD ifferen
ochrom e
I G
T reatment
Z D
he cal
Ġpneumon ia
m ing
ri king
ort un
Ġpred isp
Ġacc uracy
Ġa round
retin oic
Ġc osts
ten sion
Ġincub ation
N HL
par ag
S M
ĠG erm
Ġtransfusion s
Ġt ub
as et
Ġdup lications
Ġrepe at
de ple
ad der
ar g
tit ative
s ure
ater al
Ġstrom a
Ġpharmacok inetic
Ġrespir atory
P TD
Ġb ar
Ġn M
Ġg ran
Ġant ine
Ġreas ons
a u
Ġkary otypic
ethyl ated
Ġclin icians
l ip
ĠG enome
bil ical
se ven
ĠL ow
ĠA g
contro l
Ġthro ughout
T R
er ating
res tric
Ġcyt ostatic
Ġimmun ocom
uan ine
) =
x imal
ĠIn ter
ĠK n
Ġprob es
Ġpep tides
Ġinterven tions
Ġran ging
Ġc re
lympho cytic
Ġpron ounced
in ate
or a
Ġperiod s
Ġins uff
ho ld
am il
row th
inf iltr
Ġspl enomegaly
Ġg ive
ĠP TP
8 16
Ġlnc RNA
Ġref erence
Ġsynergistic ally
ĠM SCs
Ġco oper
ĠD isease
Ġdat aset
Ġdete cting
yro id
Ġparad ig
Ġ200 5
Ġhemorrh age
Ġdimin ished
ĠW ilms
or o
Ġ Î³
Ġel ic
ĠStud ies
M y
ten tion
inhib itor
Ġanti proliferative
Ġclass ical
ofuran osyl
A kt
Ġad mission
Ġprote ction
e b
mal ignant
Ġphys icians
ĠG ra
Ġproportion al
ĠIg G
adj usted
Ġadequ ate
le vel
ĠS er
Ġa w
Ġb rief
ĠR R
Ġfrag ment
v as
Ġdos age
th reatening
lim iting
MY H
ortun ately
Ġtranspor ters
er y
Ġf atigue
c ents
e ff
Ġvit amin
Ġphosphor ylated
Ġproble ms
ĠSim ilarly
Ġper sis
ĠCom par
Ġmamm alian
ent ric
Ġcomplic ated
Ġantine oplastic
D P
Ġmegakary ocytic
Ġexer t
T ERT
Ġprim ing
Ġcytoplas m
Ġtelom ere
Ġcons ensus
Ġnam ely
c ho
ger y
angi ogenic
an ger
ĠF A
Ġprogram med
Ġintoler ance
tero id
ac onazole
ĠF low
The re
Ġprob e
Ġsubpop ulation
Ġdisrup tion
ĠMechanis tically
or pholog
Ġf avourable
Ġcomple ted
ĠCX CL
Ġhighligh ted
Ġimmunomod ulatory
C y
T L
an g
ter ing
Ġmetabol ites
ph oma
Ġcontro lling
Ġassess ing
target ing
Ġrecons titution
ol ved
M SCs
Ġn odes
Ġcon tinue
Ġvalid ate
k ed
ĠT r
com es
mut ant
Ġsus pected
Ġenhanc ement
Ġcounterpar ts
h y
ĠC enter
Ġel ect
Ġa GVHD
od ed
01 5
Ġyiel ded
sequ encing
ult ure
reg ulate
Ġexcl usively
Ġf inal
Ġenh ancer
Ġtransform ing
Ġindividual ized
ĠAddition al
Ġsuscepti ble
Ġ um
ĠT umor
Ġdis app
ĠN R
Ġpanc yt
Ġinc l
Ġnew er
Ġm ess
Ġre n
ce ptor
lif e
Ġgenetic s
Ġintrat hecal
B A
sion al
ĠP L
ap heresis
Ġdeg rees
Ġinter ference
w t
Ġis ocitrate
ĠB P
Ġdiagnostic s
ĠO verexpression
Ġar g
em ory
ĠT K
Ġcyto reduc
rec ip
H MA
ĠM o
ĠS oci
trans fer
Ġhere in
Ġ %)
un c
Ġinf ants
ĠCI R
Ġincl usion
ĠId entif
Ġm usc
ĠM e
crib ed
Ġform ulation
Ġproced ures
Ġb ul
Ġ15 0
ig her
Ġpre l
Ġits elf
Ġmulti lineage
Ġc GVHD
ad her
Ġes ter
Ġreg istry
ari al
Ġlo ad
ec itabine
leuk ocytosis
Ġcoup led
Ġepis odes
- )
n ucle
v i
Ġmechanis tic
ac rine
cyc le
f ront
Ġre quiring
Ġ9 8
Ġpart ner
Ġfrac tions
Ġtrigg ered
Ġs enes
S t
od ium
ĠH IV
ĠS K
Ġum bilical
Ġran ged
x L
Ġmeasure ments
Ġlnc RNAs
Ġob vious
ĠST I
Ġser ial
Ġdys regulated
Ġharb or
Ġdex amethasone
Ġs qu
ĠE BV
Ġrepro gram
com ing
ĠG y
Ġsc i
the rapy
b o
ĠSix ty
ell ing
ĠI K
oc al
Ġy ield
Ġrepres ented
C ancer
ex isting
ĠSim ilar
Ġgluc ose
Ġunf it
adher in
C Y
12 5
Ġevol ving
2 10
ĠN one
ĠSIR T
polym erase
Ġsur g
cl usive
Ġcer v
Ġspect rom
w ith
Ġc DNA
d iagnos
ces sive
Ġ200 7
Ġc oding
Ġex ce
s ense
Ġreveal s
Ġexist ence
%) ;
Ġe ct
Ġinf ant
Ġintensi fied
ĠF irst
Ġisl and
Ġund ifferentiated
Ġc ry
ĠA ut
Ġconf ers
Ġdeterm in
Ġthres hold
hemat ologic
h i
H SCs
Ġheav y
Ġslight ly
Ġex ists
Ġprognostic ation
Ġpromo ters
Ġerad ication
Ġvol un
ĠThe ir
Ġappear ance
Ġp ts
Ġcom mun
Ġeffic ac
Ġequ ivalent
Ġover t
Ġmitochond ria
Ġinter f
Ġmedi ators
Ġw ww
ĠG C
Ġaberr antly
ĠH IF
Ġonc ology
Ġlocal ized
m ism
ĠM icro
RA RA
Ġexcl uded
(+) /
Ġgra des
Ġre vers
ĠP MN
um e
Ġbas ic
Ġl as
Ġrepresent ing
Ġshif t
oc rine
CA M
Ġcompr ising
Ġsensiti z
Ġindic ations
ause a
ĠMT T
TC H
Ġmucos itis
1 95
Ġs par
ĠIn deed
Ġob st
T RM
d raw
ĠJ un
R OS
otyp ically
ing er
ogen icity
Ġmetast ases
Cl inical
Ġar ise
Ġstruct ures
u ly
Ġhom olog
Ġolig onucle
Ġin versely
Ġrem od
erg y
ĠCh rom
Ġm ach
ĠH A
ipro cal
Ġsur gery
Ġset s
yn the
t ation
Ġcyt os
respec tive
ĠSoci ety
p s
el i
de hy
ĠU RD
Ġstim ulate
Ġp aclitaxel
ĠPB SC
ĠT en
Ġpro grams
Ġanti oxid
Ġsub unit
Ġc alled
ĠD ue
Ġ201 5
Ġple ural
parag inase
Ġobst ac
dehy de
on in
Ġtrans genic
Ġlow est
Ġcalc ium
D s
ĠT AM
ĠF LAG
Ġag greg
Ġadj ust
d ds
Ġm emory
pos ing
P K
R CC
Ġre tic
Ġimmun ore
ater nal
Ġadap tive
olog ists
osi te
Ġcon j
01 1
infiltr ating
m embrane
se ud
Ġabrog ated
Ġrepor ter
Ġdereg ulation
Ġtransf ected
ĠM ean
ev ent
ĠAA CR
Ġimmun ologic
Ġclas ses
Ġ201 1
Ġsensiti zed
Ġprel iminary
Ġad mitted
Ġlim iting
restric ted
ĠE m
Ġmicro g
Ġinj ury
Ġpredisp osition
Ġradi o
C E
Ġp H
Ġn ode
Ġchem okine
Ġbiological ly
Ġa id
Ġh old
Ġadoles cents
C X
w ed
ĠE P
Ġf und
Ġsurviv ing
01 3
Ġrevolution ized
it one
am ous
tero l
Ġ200 6
01 6
Ġiniti ating
Ġmate rial
Ġdifferenti ating
Ġdisc over
Ġanalog ue
Ġbul k
r ight
st age
ĠL A
ĠL ong
c itabine
IP SS
mi RNAs
Ġbal anced
Ġmetaph ases
i ver
ĠE MR
ne xin
Ġprednis one
Ġfibro blasts
t ol
Ġbe gin
Ġ200 9
Ġapplic able
j ection
Ġdef ining
Ġres olution
Ġpreval ent
Ġexer ts
Ġin her
Ġex osomes
CN S
ĠAccording ly
Ġacc ess
ĠTar get
Ġphys ical
um b
atid yl
Ġpancyt openia
transfer ases
Ġmyelo cytic
ĠL y
Ġocc up
Ġnucle i
Ġ201 4
til ity
v ent
Ġprom pt
Ġdi arr
Ġinterfer ing
mism atched
Ġdomain s
sel ected
en h
Ġre tention
Ġinvestig ating
Ġsynthe sized
Ġposi tion
ĠCP X
Ġsecre ted
ĠMed ical
Ġbar ri
Ġconsid eration
Ġr uxolitinib
Ġbi os
Ġsched ules
Im mun
Ġcomp rom
Ġparadig m
i ers
ĠM PL
Ġamoun ts
Ġrespon ding
Ġreg ular
of luorescence
Ġbacter ial
is ation
os arcoma
ur ally
Ġdis t
Ġtri ple
rog ate
Ġwith draw
RA F
Ġend point
Ġimpair ment
Ġman age
ĠM CF
Ġinflu encing
ĠTransplant ation
he rent
88 2
Ġalk al
Mut ations
ĠTreg s
Ġvary ing
S E
W HO
a e
c are
Ġ9 9
RA EB
ĠUn f
ĠCon sequently
ier arch
Ġmanifest ation
k el
ati vity
id enib
ĠH O
ist ant
Ġaut og
Ġtransf ection
Ġchemos ensitivity
( +),
Ġdec line
av ail
Ġcarcin omas
ord ance
in a
Ġad riamycin
Ġ200 4
Ġn ausea
Ġsho ck
Ġaberr ation
Ġminor ity
b ody
is ons
ĠH igher
Ġnanopartic les
ig u
Ġne ur
Ġend points
ĠNK G
Ġaden ocarcinoma
m C
it ol
Ġha ir
ĠE C
Ġadv ent
Ġvolun te
e al
in ely
is c
F C
Ġb en
Ġfor med
Ġmetabol ite
Ġconver sion
G T
Ġh orm
ac ed
ĠF L
Ġlat ency
P s
en ger
ĠB e
Ġunc on
ĠC d
pres ent
ĠMD M
Ġgra d
recip itation
u arial
Ġlact ate
Ġm il
N GS
Ġ ibr
ĠI A
ĠIn t
ĠR Q
Ġrever sible
Ġsup er
od ynamic
wh ile
A c
Ġcr yp
ĠME K
3 00
respon sive
pati bility
ĠGST T
M O
i ety
l ig
Ï ĩ
reg ulating
Ġchrom at
I g
L F
am inase
Ġma k
Ġglyc oprotein
Ġex act
ĠP l
ĠH ist
Ġsmok ing
Ġs ulf
ĠIn duction
ĠR as
ĠMY D
al k
qu in
Ġreview s
Ġhome ostasis
C FU
c adherin
Ī ¼
Ġsc al
Ġexhib its
arabin ofuranosyl
Ġrev ised
ne g
Ġprac tical
I t
tor s
12 0
Ġallel ic
G vHD
ĠF unction
ĠS h
Ġpre pared
Ġir respective
PB SCT
Ġ ed
Ġspectrom etry
B u
1 01
b l
Ġper turb
Ġpos aconazole
Ġbreak points
ĠInc reased
Ġsqu amous
ĠUn der
Ara C
Ġconfer red
D a
H SC
P re
ur ip
ter ior
Ġrec iprocal
through put
Ġcardi omy
Ġfund a
ĠF ox
ĠCBF B
Ġvacc ines
ĠSign ificant
Ġconstruc ted
A SCT
Ġch ance
Ġinvestig ational
oplas mic
ĠET V
v ascular
os ity
Ġap lastic
um i
ĠIn d
Ġco expression
PM F
Ġmit otic
ĠAL DH
Ġsusp ension
Ġsenes cence
ro us
enti ally
Ġalgorith m
os es
Ġsaf ely
The rapy
Ġrandom ly
01 2
CC yR
Ġprednis olone
an ding
ve c
ort al
Ġhuman ized
Ġinterac t
stim ulated
vas ive
s en
Ġtrans ferase
Ġcollec tion
ĠCDK N
on y
Ġp aired
at al
om ing
Ġcom m
Ġv es
Ġind ication
Ġpe ople
Ġenvironment al
Ġn od
Ġtim ing
Ġoptim ize
arcom as
Ġhighligh ting
8 35
p ing
r d
ĠN SCLC
Ġbenz ene
ĠM A
di tive
Ġconsider ing
Ġhyperm ethylated
Ġbl adder
Ġsurg ical
ĠD D
form ed
Ġsm ear
Ġint rac
m o
Ġinte resting
ati ent
01 7
ĠK i
Ġantagon ist
am ily
Ġrespon siveness
Ġser ine
ĠA F
ad rib
Ġpl urip
Ġneut ral
Ġuseful ness
C V
f usion
ĠA Y
ĠMT X
B D
all i
tr as
adrib ine
Ġab dom
Ġph ag
Ġblot ting
Ġt ended
Ġtrans duc
Ġblock s
Ġaccur ately
Ġ12 0
Ġcol l
Ġsuff ering
Ġlog istic
iche amicin
I NK
d aunorubicin
Ġg lobulin
Ġ19 90
Ġben ign
v itro
Ġm ening
Ġcomp eti
ĠK RAS
Ġqu al
pr ising
Ġibr utinib
ro l
Ġimportant ly
lympho blastic
ĠM HC
ĠL DH
Ġsh ared
Ġselec tivity
cyt arabine
Ġj u
Ġsc a
Ġhist ological
Ġthromb ocytosis
Ġsubstr ates
deple ted
ot rop
ut ri
ĠP BM
Ġconjug ates
Ġpers ons
Ab s
Ġpart ly
ĠCell s
sm all
tivir al
Ġcyt ochrome
Ġdel ine
Ġanalog ues
Ġnetwork s
pro ximately
p in
w ay
GF RA
Ġmegakary ocytes
Ġquies cent
Ġves ic
ĠM a
Ġenc oun
Ġlip osomes
Ġin jected
Ġbal ance
Ġmultipar ameter
er ve
Ġdi rection
Ġto m
Ġpathogen ic
ia z
Ġcon n
Ġins tit
Ġincorpor ating
ĠID O
F D
Ġimmun o
ome gal
Ġmim etic
as umi
Ġmon osomal
cl onal
Ġhyper leukocytosis
U R
ĠC E
ĠL ym
Ġprolifer ating
opath ic
Ġengine ered
Ġb ac
Ġat tained
Ġap lasia
ĠE M
og uanine
Ġimmunophen otypes
Ġswit ch
omegal ovirus
P N
Ġc asc
Ġrec ur
erm al
BF M
Î Ķ
ĠM UD
raf ting
ici an
Ġparame ter
Ġsour ces
Ġhepat ocellular
Ġcontain s
Ġb ase
Ġsur rogate
Ġhem opoietic
18 1
Ġcoag ulation
Ġmak es
ul ates
Ġindic ators
in form
Ġv ess
Ġmod ulating
ĠB R
Ġcol lab
Ġtr ue
a emic
Ġw estern
pres sor
com plete
te t
ĠH uman
ĠR em
Ġext end
Ġhelp ful
tic ular
ur ora
Ġdi versity
myelo ablative
Ġs odium
em tuzumab
ĠP ost
Ġlabor ator
eli hood
ĠF T
Ġcyclospor ine
Ġres our
Ġrespon sive
Ġel usive
Ġacid s
Ġopportun ities
et ric
Ġtr yp
Ġrout inely
ĠGra de
Ġst ates
Conclusion s
H V
ĠB etween
Ġmo tif
el igible
ĠA RA
ĠT L
Ġpatho logy
Ġdram atic
ĠUnf ortunately
M CL
P P
he a
Ġtrans duced
Ġlim its
allel ic
l ines
s a
op es
viv o
Ġcor rect
ĠEL N
Ġclinicopatho logical
r il
Ġmit ogen
Ġcerv ical
a fter
Ġsur v
Ġrelationship s
N E
h ion
ro tic
ch ain
Ġembry onic
Ġdetermin ants
Ġefficac ious
x l
ĠT w
ĠO ct
Ġlik elihood
Ġproduc es
thym ocyte
Ġg el
ĠmRNA s
activ ating
Ġlys ine
R s
p a
Ġh ierarch
Ġelectro pho
Ġworld wide
Ġhomo zygous
c ons
f amily
Ġd ie
Ġanti sense
Ġocc asion
Ġsibling s
ostim ulatory
T reg
Y K
uc if
Ġcom b
ĠO CT
CM V
Ġplace bo
str ati
13 2
ĠDL BCL
us ting
ant h
th ase
Ġfollow s
Ġcirc um
b or
m aking
s h
Ġout side
Ġfol lic
Ġsuppres ses
Ġurg ently
m t
es ity
ĠCR C
ocar di
ol in
tero ids
Ġcomple tion
ĠEx per
Ġth yroid
tic os
ĠM ay
her n
Ġsynerg y
H igh
i DAC
Ġtrans membrane
Ġneoplas ia
Ġresp ective
Ġsup ple
Ġerythro po
ol ip
Ġenabl es
Ġelect ron
Ġconj unction
y e
un itinib
Ġde ox
od ds
rel ative
15 0
ch rom
Ġacc umul
Ġcur ves
Ġgem citabine
gen ital
ĠUn ivariate
Ġinher ited
Â ®
Ġab n
Ġman ip
chan ged
ucif erase
en tion
Ġhetero zygous
CI R
Ġprepar ative
p atients
Ġp al
id in
umor al
Ġtrac t
Ġuns atisfactory
Ġo dds
Ġhis ti
respon se
Ġprom p
Ġsim ilarly
Ġinn ov
ump tion
r c
te ced
Ġp alli
ĠA ZD
Ġtherapeutic ally
Ġcontinu es
Ġimmunodef icient
Ġr as
Ġcyt ochemical
Ġharb ored
Ġconcern s
p red
em a
ĠC s
ĠC or
V P
ro lim
Ġ5 00
Ġdef ective
ust ine
adi ly
m RNA
Ġn ic
ĠK asumi
cep ted
H SP
Ġf il
ĠI f
ĠAl lo
Ġneuro blastoma
Ġtem por
Ġfunda mental
N B
Ġleuk apheresis
ver sion
Ġv al
Ġsurv ive
el ve
ĠF uture
Ġco vered
Ġexpos ures
Ġantioxid ant
Ġimmun ofluorescence
Ġh TERT
Ġste ady
om iting
Ġk ind
Ġimmun os
Ġmod ality
Ġaccoun ts
Ġo c
Ġcomp osition
ap amil
ĠE r
Ġregard ed
Ġenabl ed
K it
S I
ĠC L
Ġter med
RAR Î±
Ġun changed
Ġnucle us
ĠPh armac
ulf ite
OC S
ĠReg istry
% <
fer on
ĠAB MT
rolim us
ensi ti
ĠC AG
CT L
pres s
M icro
S e
d m
Ġbas al
Ġeng rafted
Ġknock out
Ġmess enger
Ġtom ography
Ġv ul
ĠR isk
Ġqu in
Ġinte stinal
ĠMul tiple
Ġmodif iers
Ġinsuff icient
A MP
ĠB esides
ĠV PA
les terol
Ġreduc tase
Ġcategor ized
CB T
5 00
Ġp ilot
Ġan teced
Ġpre transplant
Ġsuppres sing
Ġbec oming
Ġ201 8
Ġgli oblastoma
AN LL
ĠWhe reas
stit ute
h aplo
in ery
ĠH ep
ĠG VL
Ġside ro
inform atic
Ġn ull
ĠL RP
Ġadvant ages
Ġz inc
Ġimmunocom prom
am b
Ġhist ocom
ĠSt at
Ġdele ted
ĠMF C
ĠCombin ation
ĠO CI
01 4
Ġtranscript ome
ĠAt las
T yrosine
Ġb rom
se q
ĠP atient
Ġad ditive
Ġdevelop ments
Ġerythro poiesis
ĠPD GFR
si an
ep tide
Ġintravenous ly
Ġcut off
Ġhistor ical
Ġmusc le
o L
ĠS A
th i
Ġpatho logic
Ġoff ered
T E
Ġ %,
myelo proliferative
Ġup stream
Ġcompr ised
Ġtre n
Ġprot o
Ġclus ters
Ġact uarial
ĠTarget ing
ti b
ĠC CL
ap sed
Ġtransl ational
Ġextrac ted
Ġhist opatho
Ġbreak s
ĠDec itabine
Ġlaborator ies
si l
Ġclinicopatho logic
Ġan aemia
Ġf ms
if ying
ĠG enetic
Ġsyn thase
ĠWith in
Ġrest ore
ĠJun e
Ġ )
si ze
am ination
Ġres emb
Ġplan ned
I Cs
o yl
Ġn ormally
ĠL i
01 8
Ġlar gest
ĠCon sistent
EL N
Ġc od
Ġac cepted
Ġch ap
Ġcons erved
HO P
Ġspl enic
/- )
Ġadj usting
o te
q PCR
ĠC O
Ġcl adribine
b one
Ġinf used
Ġmulti p
Ġkary otyping
Ġexhib iting
phosph or
Ġmedi ates
ĠS U
Ġrele ased
chlor ide
ous ly
omet ric
Ġextrac t
Ġs in
ĠP S
Ġinc on
por ted
ĠN or
Ġcryp tic
I A
tr insic
Ġlympho proliferative
G G
Ġst riking
Ġdis par
Ġper me
Ġactiv ates
Ġpro of
ac ent
Ġmagn etic
ĠA ge
ĠP IM
ir th
Ġanteced ent
. )
Ġc a
Ġm yc
Ġh r
ĠT T
AK T
ĠRe al
Ġunex pected
ĠS up
Ġen ergy
ill ary
Ġneg ativity
Ġchromat ography
Ġs ear
od ies
Ġinflu ences
Ġimmunocomprom ised
Ġmicro grams
MN s
orb ol
Ġvolunte ers
N OS
c umin
Ġh ope
h yp
m yc
Ġhe at
Ġresid ues
G L
um ed
Ġstudy ing
zyg osity
Ġfas ter
Ġmach inery
Ġencoun tered
] ;
ĠS pec
Ġprec ision
EBP Î±
Ġpro apoptotic
ain ed
oci ation
Ġsyn geneic
12 10
Ġdeli ver
M APK
R el
Ġt rough
Ġc ess
om er
Ġac tin
trans l
ĠAB O
Ġsuff ered
Ġconjug ated
0 21
d a
Ġs oci
er ative
ĠJ uly
Ġeas ily
te ction
IS A
Ġreflec ted
otran splant
Ġreprogram ming
tol erated
n a
Ġel ement
Ġintegr in
ĠSe qu
E p
Ġt ake
SC ID
ĠV P
Ġlo op
Ġbegin ning
ĠA berrant
ym ptom
b ack
amin o
ex ist
MP O
ĠPT EN
G r
Ġt aking
Ġsc hem
ĠJ MML
Ġreco vered
Ġvol ume
Ġaug mented
Ġdiarr hea
Ġf err
Ġth or
ag ic
Ġenzym atic
Ġven ous
urac il
Ġa ges
ĠP F
Ġmod e
Ġprop ensity
otyp ed
Ġvia ble
Ġsepar ated
ĠCR EB
Ġy r
at um
Ġon es
Ġdiagnos es
pho ter
ĠNo vel
ol ent
MT X
Ġconsider ably
ĠGST M
Ġmod ern
ĠAp ril
mod ified
ifferenti ation
Ġbil ateral
ĠM arch
Ġar ch
Ġferr itin
p es
s AML
le x
im e
Ġutil ization
Ġex ogenous
Ġmar g
Ġproduc ing
photer icin
Ġco operative
Ġpot ently
Ġgener ic
rem ia
prising ly
) ),
i re
Ġh ence
ho g
ĠH U
anti gen
Ġmismat ch
ĠD iagnos
ĠF B
Ġexplain ed
Ġin verse
Ġpro ve
ut able
Ġ2 50
AG E
Ġre induction
ĠAn g
l nc
Ġha m
ĠL T
imen sional
Ġprote ct
Ġvir t
Ġreduc tions
Ġeffector s
Ġasp ergill
Ġopportun ity
) ).
lo red
Ġhom ogene
Ġhazard s
ĠHMA s
phen otypic
Ġp olar
as tim
gnos is
Ġad ip
entif ic
Ġenc oded
E K
b ut
Ġg al
Ġmod ulated
Ġphosph atidyl
methyl ated
Ġimmediate ly
Ġcess ation
Ġchem otherapies
Ġinf requ
otrop ic
Ġcyt omegalovirus
Ġthromb otic
Ġinfec ted
gr astim
Ġtend ency
B cl
l ined
p tion
yn ucle
FR P
Ġwithdraw al
Ġpredomin ant
Ġrecru ited
Ġc ytidine
ĠS LC
ĠP ub
ĠB E
Ġform er
i ent
re ceptor
Ġf inally
Ġquanti fy
Ġgain ed
Ġcomplement ary
b umin
n es
Ġt e
ple x
ive red
Ġline ar
jec tives
Ġretro viral
Ġchemores istant
ĠJan us
ĠUCB T
Ġc ys
ati ble
Ġcor ticos
Ġdr iving
S V
T ET
reas ing
Ġquanti fied
ĠL e
Ġmodel ing
Ġdistin ctive
Ġnec k
ĠMS I
Ġexcl usive
Ġhospital ization
Ġsummar ized
f il
ac in
ĠP rimary
tim es
trans cription
Ġcal icheamicin
Ġdistingu ished
h uman
Ġper spective
Ġra ised
ok ines
hemat opoietic
or tic
ff ic
Ġid i
tro gen
Ġallo HCT
Ġhaem opoietic
Ġg ave
Ġad ding
az acitidine
Ġlack ed
Ġpur ging
to gether
RAR alpha
ĠCo operative
Ġubiqu it
event y
C AL
M ul
c hem
ol l
ste p
ĠCB T
Ġimmunop recipitation
Ġallo SCT
G y
r f
em p
ĠH b
Ġind olent
ĠU K
11 0
Ġsh RNA
ĠPer ipheral
par tment
ĠF C
Ġun met
ĠL DAC
ĠCI K
ĠCh ina
Ġmas sive
Ġisl ands
ĠRespon se
Ġabdom inal
C CR
b ial
o gn
Ġp en
Ġcon genital
Ġun able
de g
I DA
Ġf ixed
ge hog
rac tion
Ġrestric tion
ar ate
os ing
Ġinter s
Ġdeple ted
Ġurg ent
Ġinser tion
> (
ai lored
Ġexcl uding
Ġequ ally
immun otherapy
Ġcat he
ĠGerm an
ir teen
ĠS HP
Ġne o
ord ant
ĠWhe ther
H N
Ġs arcomas
Ġst ra
ĠS C
Ġso on
- /
S everal
m m
ĠD onor
ĠS W
Ġ200 3
art inib
0 25
le m
ĠV ari
Ġintensi vely
Ġs em
oc on
ĠCT LA
Ġrecor ded
s cale
ur pose
ĠS OCS
Ġpred is
Ġexplo ited
Ġsubjec t
flu oro
tox icity
Ġv omiting
Ġover load
we ight
ĠAs s
Ġhydro x
itone al
Ġpalli ative
O K
ine age
Ġallo genic
Ġsystem atically
14 0
fac tor
Ġarg inase
Ġnon coding
sel ective
ĠNO D
Ġarter ial
4 00
b it
ĠA MP
pos ure
Ġbios ynthe
A IR
Ġt ail
iz artinib
Ġhep atitis
Ġdeep er
Ġconst ant
ĠFunction al
Ġrest oration
Ġf inger
oxy genase
Ġremod eling
it amin
Ġmyelo poiesis
Ġcho lesterol
201 7
in ting
ator ial
Ġrearrang ed
ĠPB SCT
Ġemph asis
C o
g one
n ic
Ġp eg
Ġunder gone
col or
I ON
Ġmon o
ĠL Y
Ġform ing
Ġinnov ative
ro x
ĠB a
Ġev asion
ock down
Ġelectropho resis
t umour
in termediate
ti tial
ĠF GFR
lassi fication
â Ĥ
Ġanaly zing
Ġpre treated
Ġnucle ated
Ġbac te
Ġerythropo ietin
Ġvul ner
P G
lo x
Ġsc an
Ġfl av
Ġuniform ly
ran dom
Ġdis turb
Ġinduc ible
ch aracter
Ġver ified
Ġcontinuous ly
Ġp erox
Ġ1 10
Ġse g
Ġdi et
Ġcondition ed
Ġelev ation
ĠPTP N
t ure
Ġchan n
Ġmedi ating
ĠR I
12 6
ĠJ NK
Ġprocess ing
Ġremark ably
Ġbelie ved
ĠCons id
ub in
Ġmultiple x
Ġmodul ators
Ġwarr ant
ĠSout hern
H I
on ance
Ġp arent
ĠS N
ĠN etwork
Ġpatho genetic
Ġshort ened
Ġmedi ator
Ġattrib utable
M cl
MS A
Ġagon ist
Ġaspergill osis
ĠH sp
Ġv ast
ĠB AL
ĠF ac
ĠG BM
Ġmy ocardi
Ġretic ul
w n
Ġs hed
ic es
Ġimpl ication
Ġfamil ial
Ġtransplant ations
Ġstron ger
Ġbio avail
0 22
Ġb irth
Ġn a
AT G
AC S
ĠAm erican
Ġtransduc er
gres sion
omic s
l der
on ical
it ud
ĠIn stitute
Ġdef icient
Ġinfiltr ate
c lass
Ġan omal
ĠB ET
Ġag ing
Ġrepor ting
oph age
Ġmorpholog ically
Ġminim um
ĠSub sequently
Ġidi opathic
or atory
et ho
ĠM ethods
Ġconsis ts
Ġubiqu itin
R I
Ġup front
Ġadv anc
Ġtr unc
ĠLeuk emic
Ġaccumul ate
H OX
Ġin term
ve illance
Ġprognos es
Ġmet allo
Ġrecogn ize
Ġneutrophil ic
V s
Ġs unitinib
Ġde oxycytidine
ĠH u
Ġanti leukemia
ĠE GFR
pre ad
Ġaug ment
A Es
Ġin herent
ĠBCR P
02 6
Ġunf avourable
gin ine
Ġn ude
Ġimmun ogenic
Ġdel ivered
Ġcri tically
loid y
Ġhar ves
> :
er al
Ġst ren
Ġsci entific
lympho cyte
Ġapparent ly
Ġimple mentation
Ġtren ds
M yelo
Ġa ff
Ġc oc
Ġd raw
os ides
Ġinter rup
Ġ200 2
ĠEle ven
or gan
th ird
Ġpar a
10 5
Ġoptim ization
CC N
plo id
te ad
Ġg old
ĠS or
Ġsurvival s
UT OS
ĠÎ¼ M
A p
t ub
Ġrec ap
Ġam photericin
Ġdo ub
lab el
be tes
c arb
ĠE ven
Ġenc aps
d imensional
Ġex cessive
ĠM ET
01 9
Ġfib rin
Ġfrag mentation
Ġinterf ere
Ġac l
Ġno te
ĠNO TCH
Ġsubcl ones
tr uct
opo ietin
38 8
Ġdepend ence
ĠIn f
Ġimmunodef iciency
G C
Ġc ros
ĠD n
ew ork
Ġbio informatic
M ed
a emat
ĠM i
ĠP ar
Ġ19 97
Ġrep er
ĠX IAP
Ġoverl apping
Ġide al
Ġadjust ment
er tib
Ġre inf
ate st
crip t
Ġsec tions
Ġvit al
Ġins tead
ĠQ uan
arabinofuranosyl cytosine
i vers
Ã ¯
Ġd erm
li um
ĠEight y
Ġres onance
ĠU p
Ġrepro duc
ĠmTOR C
ĠL D
01 0
Ġinter cal
Ġweek ly
Ġseem ed
Ġfram ework
n ers
Ġa CML
ĠC umulative
Ġrel ia
Ġdevelopment al
Ġiniti ate
Ġver apamil
Ġglyc olysis
Ġcluster ing
Ġâ Ī¼
Ġescal ation
ĠTw elve
Ġp or
op res
ĠH N
Ġconsequ ently
Ġwarr ants
ĠMean while
R Q
Ġmic rom
Ġmeas uring
Ġgre atest
Ġaccoun ting
Ġspar ing
ĠC CN
et te
ĠD el
ĠS ep
Ġchemotherapeutic s
A X
Ġin eligible
uc tion
ĠP ediatric
ag ement
Ġestablish ing
Ġdatab ases
Ġresc ue
Ġsidero blasts
Ġre adily
Ġb and
ĠAl together
03 2
Ġoptim ized
Ġpropor tions
ĠEurop e
Ġdysp lastic
ophage al
Ġrecap it
Ġs olution
Ġlab eling
Ġcer amide
Ġcataly tic
Leuk emia
Ġf er
Ġout patient
Ġprec eded
Ġn m
ir ubin
ĠS OX
Ġmethyl transferases
EN T
Ġreper to
al ing
om ain
Ġper ic
Ġnon lymphocytic
ch ronic
Ġup per
ĠP E
Ġantagon ists
Ġbo y
T G
s ur
Ġconf lic
Ġremo val
Ġect opic
0 38
f ying
m ature
t ri
Ġan n
Ġag re
Ġover coming
Ġcompar isons
Ġmedi ast
col ony
Ġhorm one
ocon jug
ĠF lu
Ġph ot
Ġsurve y
n s
is ter
Ġobser ve
Ġ19 99
02 4
Ġampl ified
aut o
Ġscal e
ĠI s
Ġint act
leuk aemic
Ġ18 0
Ġmat ching
Ġexperim ent
onc ogene
o z
Ġab ol
ast atic
Ġ12 5
os ter
ĠH is
Ġelimin ated
Ġaspir ate
Ar senic
Ġplurip otent
re tic
Ġo wn
Ġun selected
lot arg
Ġstrati fy
(- /-)
Ġrecor ds
Ġhistocom patibility
as paraginase
Ġdef ect
H E
ĠM SC
Ġres olved
Ġob esity
av ing
ĠSt andard
ĠMy D
ph al
str uct
Ġcombin atorial
Ġsmall er
T ran
n o
es pread
Ġwid espread
in ary
en g
Ġe con
ĠThe rapy
ol ate
in ess
Ġd og
ar ity
lym phoma
Ġconfir ms
u tis
Ġpre ferred
Ġunder l
acet ate
c hemotherapy
MR P
Ġul tras
Ġstep s
Ġinters titial
Ã¯ ve
ĠT G
ĠH OT
Ġag o
tro lled
asc ul
Ġaccum ulated
Ġrequire ment
Ġreason able
diagnos ed
Ġqual it
Ġp ump
Ġre tain
ir l
ĠR S
Ġgener ating
Ġevid enced
H yp
k ely
ear ly
Ġcyc lo
Ġoverex pressing
Ġevol ved
T umor
p at
ĠCon clusion
Ġinfiltr ates
Ġutil izing
PB SC
ĠCTL s
G B
P E
T T
u tical
ĠC OX
ĠD r
Ġmegakary oblastic
enh ancer
O M
O CT
ute s
Ġmean ing
Ġepit opes
% ]
Ġp seud
Ġapplic ability
S IR
l en
er ythro
Ġeff ort
ĠN ext
arm ace
Ġrevers al
Ġobstac le
ĠIn iti
Ġtes ticular
int ensive
Ġgrad ually
v alu
Ġm aternal
ro gen
Ġdel ta
Ġsh are
Ġpatho log
trans formed
Ġtoler able
gl uc
ĠHOT AIR
ary n
Ġfe ed
hydro x
ibr ary
m ethylation
ĠS eventy
Ġar sen
Ġdisc re
Ġlymph atic
Ġrad ical
K s
a ved
h yd
in ducible
Ġt ailored
ra ble
ĠTh rough
AT P
Ġfollic ular
t aken
ĠM in
Ġpub lic
Ġbarri er
ing ly
ox in
Ġchan ging
Ġstron gest
Ġsymptom atic
ring t
lab eled
ro sp
Ġsome times
phen yl
H AM
Ġac ting
tiv ation
04 5
Ġprepar ation
Ġsear ched
ĠS CI
PL C
ob ox
lig and
A berrant
p ond
Ġn utri
res olution
od omain
opt osis
ect omy
is hes
Ġb rid
Ġg irl
ĠN AD
Ġ19 98
ĠAz acitidine
Ġpromp ted
Ġcyto ly
KI R
Ġprob able
Ġbis ulfite
Ġfas hion
lem tuzumab
B T
Ġf if
ĠM AGE
Ġpre leukemic
Ġhyper tension
pre hensive
mi RNA
Ġvar ies
ĠA LC
ĠD OX
Ġmut agen
Ġloc ation
Ġirradi ated
Ġincub ated
inhibitor y
R E
Ġp g
Ġfol d
inos itol
T rials
ct ure
li kely
Ġsitu ation
deg ib
las degib
ĠS o
Ġat tain
de oxy
Ġsus tain
ĠLeuk aemia
Ġsp re
Ġfrag ments
Ġmamm ary
c enter
Ġin active
Ġw t
Ġh osts
ear ance
Ġprognostic ally
11 6
OL M
P urpose
Ġ( -
Ġst rain
iz umab
ĠL SD
Ġop erating
Ġexer ted
Ġattemp ts
bal anced
character ized
ĠQuan titative
Ġd ip
ra d
Ġcom mit
T CR
Ġm er
ĠH HT
Ġj o
Ġalgorith ms
Ġresc ued
ĠA CA
Ġsub s
Ġunder taken
Ġ10 4
g rowth
u ter
Ġmarrow s
Ġox ide
75 4
armace utical
ti le
Ġin oc
ĠC BL
ĠR D
ven ile
Ġpost transplant
02 8
Ġfraction ated
b ound
Ġma ximal
Ġbec omes
Ġpharmac odynamic
Ġcur cumin
Ġcompr ise
Ġbis pecific
ĠSET BP
d L
or ic
ĠTh en
Ġobserv ational
Ġsubjec ted
Ġfat ty
Ġminim ize
ĠCs A
ringt onine
res pond
Ġex ons
ĠB RD
Ġco inc
Ġcarri ers
cons olidation
Ġanomal ies
h om
t ments
Ġ urine
it ary
Ġh sa
uc cess
Ġdevelop s
ĠAd v
Ġconfirm ing
Ġaspir ation
Ġintoler ant
R S
t op
ĠT ME
cy cl
Ġser ved
Ġprote cted
F LAG
ain ing
ĠF LA
oph osph
Ġqu ite
ĠImmun ohist
Ġtem per
ĠAr g
h mC
ed ded
er b
ĠM ethylation
00 05
Ġwor s
Ġdiv ision
Ġextrac ts
Ġimpac ts
' ,
X R
n ull
ĠT ox
ment ary
oc ortic
Ġpart ners
Ġe IF
ĠT ERT
ĠP res
Ġ19 95
ER G
emp tive
Ġen ter
Ġsugges tive
Ġunder sc
entric ular
Ġp ure
ran ded
Ġrese arc
Ġenabl ing
ĠTar geted
Ġexpect ancy
Ġw ater
op l
Ġinduc er
Ġacc es
ĠCom prehensive
Ġmanag ed
Ġtra ining
Ġaden osine
P ML
Ġ< .
Ġstain ed
Ġdr ives
prom oting
SNP s
rosp inal
ic o
tem ber
Ġtim ely
tal ian
Ġorg anis
Ġvesic les
C om
ĠE S
ĠL EF
Ġpl ant
Ġdefin itive
load ed
arn ib
Ġstren gth
id ing
ĠE l
ĠL PS
Ġprec eding
Ġaz acytidine
ze b
ĠAp proximately
Ġreperto ire
Q OL
m ber
op sy
ĠE nd
bi ological
ĠNe ither
Ġinterpre tation
F lu
Ġc ranial
Ġo wing
ate ll
ĠM od
Ġcom mitted
Ġv ascul
Ġen l
ult ured
ĠK ore
02 7
atele t
Ġclass ic
en etoclax
ĠA sp
ĠG P
Ġallo c
kel etal
Ġcod on
ĠI talian
Ġab sor
Ġconstitute s
ymptom atic
ĠA ug
reg ulates
16 754
04 8
B B
v ated
Ġaccoun ted
Ġcont act
ĠMa jor
g u
Ġle th
ĠP im
ĠN ilotinib
omet hylating
Ġclon ed
Ġd il
om at
ĠT N
las t
AML s
Ġnot ably
Ġcharacter ised
Ġmic ros
Ġcor respond
Ġ12 3
establ ished
Ġepigenetic ally
oh ar
Ġexpl an
ĠIGF BP
Ġcollab or
P BM
Ġre tur
Ġf used
ĠM al
ĠThe rapeutic
Ġde aminase
Ġir re
Ġpersis ted
las ma
ĠIm pro
present ing
Ġval pro
Ġconflic ting
K L
o tid
ĠF luorescence
Ġdeterm inant
22 3
ĠAn other
Ġparticip ate
Pre vious
Ġs pite
st rand
ĠW ork
Ġbi phenotypic
Ġlong itud
AR C
b p
b ic
ot inib
ĠF R
Ġun likely
Ġhyper p
Ġfacilit ated
ĠÂ µ
ĠSor afenib
H CC
Ġ zeb
Ġc utis
Ġlymph aden
Ġ100 0
Ġins ulin
MY C
Cyt ogenetic
ĠIK ZF
Ġcompeti tive
G ST
W h
ad s
13 7
Ġplas m
met abol
Ġrepro ducible
Ġs teroid
ĠB im
Ch rom
ohar ringtonine
o ber
st ances
ĠN S
Ġfar nes
ĠSecond ary
a res
g ranul
res ted
loc al
Ġj us
ĠAz a
orin ostat
ĠSep tember
B s
pro te
ffec ted
Ġre jection
ar s
omet ry
Ġantic ip
pos es
G VL
in ety
ar ge
Ġvector s
Ġattemp ted
Ġprincip al
ĠDD X
l and
ĠA I
Ġdis cl
ĠO b
ĠTh irteen
Ġtri phosphate
ĠTP A
Ġdataset s
Ġt rim
as i
ĠM OLM
ary otype
mut ation
ĠS E
Ġint ron
CT LA
Ġexcl usion
educ ed
Ġdeb ate
Ġcry opres
Ġcoll agen
Ġbacte remia
oric onazole
ĠS ingle
ĠS CF
ĠL oss
RA CT
Ġreveal ing
16 3
04 7
ev elop
03 9
Ġindepend ence
Ġdistinguish ing
Ġtrigg ers
Ġstabil ization
B E
c hes
h aps
al s
ac char
Ġl uciferase
ĠP rom
ĠNK p
Ġsuppressor s
k s
ĠM yelo
ĠS L
Ġint ense
10 9
Ġrepres sed
G E
ot in
ĠF eb
Ġes ophageal
AS XL
opl atin
O ver
c ulture
Ġac tions
Ġpur ine
Ġproteomic s
ĠAY As
M MP
ĠA xl
ĠT yrosine
ĠC ycl
ĠD IC
CX CR
Ġdis char
Ġ10 5
10 3
IS PR
ru ary
Ġuncon trolled
Ġpara ffin
ath y
Ġsepar ately
M I
p ir
ĠN T
ance rous
Ġes trogen
Ġplay ed
Ġsor ting
Ġsubcutaneous ly
E VI
F v
d isease
Ġa ven
ĠA Es
Ġreflec ts
ĠCombin ed
Ġdiscrim inate
Ġarch ite
m er
ĠC SCs
ĠI G
Ġl ay
ĠP SC
Ġcons umption
ass ette
Ġtr ich
Ġassay ed
Ġmicroar rays
Ġeosinophil ic
Ġdia betes
appro ved
ve mber
ĠT I
ĠD asatinib
Ġprev ents
Ġisol ation
M on
Ġn it
Ġn itro
Ġsub d
Ġob jectives
hes in
ĠUn like
Ġmobil ized
ĠKn ockdown
en ari
Ġth alidomide
ĠI N
las es
ĠB U
19 3
ĠNo vember
Ġmediast inal
Ġ iv
Ġco ver
rac t
Ġspec ified
20 3
Ġtoler ate
Ġrequire ments
Ġsc enari
Ġmetaph ase
Ġvis ual
Ġstra ins
ari um
Ġsam pl
Ġadj acent
Ġdocum ent
6 00
D e
Ġper mit
Ġ10 3
13 0
14 6
Ġrecombin ation
Ġoste osarcoma
ĠOut comes
urk itt
Ġbiosynthe sis
ific antly
Ġad versely
00 02
Ġphen otypically
Ġcyclospor in
T RA
c tin
on om
erg ing
Ġlate st
Ġemplo ying
4 12
on ly
ĠS rc
Ġgen otoxic
Ġsensiti ze
Ġheav ily
Ġtrigger ing
H uman
a der
he x
as idenib
Ġmi xt
Ġdesign ated
Ġsor ted
Ġoverl ap
Ġform al
Ġ13 1
Ġconstit ution
ade qu
Ġpen et
B H
R C
Ġn ative
ĠT IM
Ġr ub
Ġra b
Ġdisplay ing
a ffected
Ġin version
ant le
Ġhemat ology
rib ose
o bin
ĠC V
Ġas ymptomatic
Ġcon cep
op enic
ĠS pecific
Ġsc ar
Ġlo ok
Ġabund ant
ĠConsid ering
Ġagre ement
Ġcommit ment
C urrent
os f
Ġun ivers
Ġmethod ology
AM HD
cyt osis
Ġj ust
tion al
Ġallo HSCT
Ġcre ate
C AT
Ġex ternal
ĠCCA AT
H emat
Ġh ot
ĠA u
Ġun methylated
04 9
ĠHemat opoietic
ĠAr senic
Ġillustr ate
ĠM O
Ġactiv ely
int oler
Ġwork ers
Ġtransl ated
Rec ently
ĠFeb ruary
] ).
r ies
Ġa lemtuzumab
re onine
Ġm and
ĠT A
Ġal bumin
Ġcomp li
Ġpres sure
sup pressive
12 4
Ġless er
Ġcirc ulation
Ġestablish ment
Ġstimul i
) %
t reat
Ġp ict
os c
Ġco exist
Ġspec tro
Ġ14 0
Ġinform ative
ĠFour teen
Ġent ry
Ġren der
Ġg ives
ĠH ER
ph ing
Ġco gn
Ġam el
Ġinfiltr ating
Ġclassif ications
Ġdog s
ĠP BP
Ġindic ative
02 9
Ġdispl ays
ĠCl in
cap top
Ġimpair s
ĠHox A
ut rophil
Ġcomp ens
pl ay
Ġar ises
Ġdi hydro
Ġbreak through
Ġcereb rospinal
ĠOct ober
T FR
p y
14 5
eff icient
Ġhold s
Ġin adequ
Ġhetero genous
Ġmemb ran
Ġproce eded
Ġoligonucle otide
m olecular
Ġc av
it ude
Ġal le
ĠF CM
Ġcompar tments
Ġfoc al
Ġmanage able
ar ning
Ġ( "
ĠT SA
Ġmut ually
Ġen sure
Ġimm ortal
ĠGS H
Ġpreferen tial
A g
R Î±
id emi
jec t
ĠCom p
inf ected
Ġact ual
Ġminim ally
tox ic
Ġsin us
ĠVari ous
ĠAug ust
yc osis
Ġmegakary ocyte
Ġtransfer red
Ġhome obox
Ġfamil ies
f l
in ion
Ġto o
Ġrecurrent ly
p an
an ib
un its
Ġop inion
Ġprec ed
Ġangi ogenic
cyc lophosphamide
Ġvess els
Ġamel ior
A DR
w ild
Ġn as
ĠH iDAC
Ġen comp
Ġmod ify
Ġhyp ers
Ġprolong ation
Ġoste o
Ġstop ped
Ġconcep ts
4 50
N S
Ġ ~
in v
om ized
Ġh yd
Ġrel ies
ĠN ucle
ĠE UTOS
ĠV AF
ep tid
Ġclassi fy
jug ated
yr ate
Ġspl en
ii i
ĠExper t
Ġs ial
Ġpro inflammatory
ĠC ON
Ġperform ing
Ġ19 80
prolifer ation
Ġconc ordance
bil ities
Ġpredomin ance
Ġmodul ator
Ġupd ate
ĠLi ke
D O
M ost
(+) )
ne oplastic
ĠMD A
13 5
20 4
ĠRes istance
Ġsepar ation
ĠIg M
ĠImmun ophen
M AC
Ġf ung
ĠC hemotherapy
ĠB D
ĠS yn
Ġne ph
Ġstem ness
Ġcompr ises
Ġbelie ve
nucle otide
Ġham p
Ġacl arubicin
= .
Ġse ro
Ġcondition al
Ġhetero zygosity
Ġorig inally
Ġretin oid
Ġglyc os
effec ts
Ġpool ed
Ġemphas ize
Ġdeox ynucle
ĠSpec ifically
m yelodysplastic
Ġ err
Ġb u
Ġcon struct
ĠH C
iti g
Ġpolym er
) ].
ur t
Ġpro drug
Ġle ctin
Ġcomp uted
ĠD ose
ĠHemat ology
Ġfibro blast
Ġcytoreduc tive
Ġmultip otent
Ġm dr
Ġd in
ĠE ach
Ġsevere ly
rec ogn
Ġmyocardi al
Ġalle vi
c alled
i red
Ġre generation
ĠA urora
ub ation
Ġra ce
ĠJ ak
22 0
Ġrandom ised
app ed
Ġindirect ly
Ġcareful ly
Ġdisapp eared
Ġdiscover ies
ĠS anger
Ġun like
ĠE xt
Ġnormal ized
opro te
sel ectin
Ġtemper ature
Ġob struc
og ram
Ġpromyelo cytes
econd ary
els on
P Î±
Ġf ast
Ġres ection
03 5
Ġerythro leukemia
Ġlab eled
lassi fied
âģ º
ĠDn mt
Ġ iod
oc clusive
Ġco ord
hemat ological
Ġgluc ocortic
Ġdissem ination
man ip
Ġvirt ually
Ġmeaning ful
c er
Ġw ays
Ġm ill
Ġl iving
and mark
dition ally
istr ies
ĠSur prisingly
Ġcytoreduc tion
atell ite
D I
f a
Ġc urable
le e
ĠA sian
ac ement
ĠN rf
Ġsub stit
ĠCR ISPR
ĠMP AL
Ġacqui re
Ġback bone
Ġinstit utions
Tran s
manip ulated
ĠH ID
ĠC MR
tem por
ĠL AK
Ġref ine
02 3
ern at
Ġester ase
U RD
en riched
Ġre ly
ĠS ALL
NA s
Ġchem okines
Ġph orbol
Ġ6 00
rim idine
ĠK D
Ġadv ance
iss ense
Ġhist ologic
ĠME C
Ġrib onucle
Ġupd ated
ĠIdentif ication
Ġcasc ade
B arr
si a
am etric
Ġun affected
Ġqu izartinib
leuk aemia
MK L
Ġabol ished
if t
ĠI HC
ĠB urkitt
Ġimmun ocyt
Ġinter phase
acet ylation
Ġconstitution al
c ts
ĠH P
26 5
Ġadop ted
Ġembry os
Ġthor ough
F M
Â µ
os en
ĠM an
az ine
Ġaim ing
Ġcarri er
ĠVEGF R
Ġallog raft
uccess ful
G l
s w
le rosis
Ġg over
ĠD MR
Ġco hesin
17 2
Ġflu or
Ġresour ce
Ġtrich ostatin
A E
Ġwh y
ĠR CC
rac tor
25 0
Ġrep op
Ġxen otransplant
ĠEL ISA
0 34
P gp
d em
Ġcon formation
ĠH MG
ĠIC U
Ġprepar ations
urk at
Ġv oriconazole
Ġar rays
In c
Ġwork up
AD P
MF C
N O
ĠA DA
Ġ1 11
ĠS m
Ġep ig
BM I
co hol
ĠOut come
, "
s tein
if arnib
Ġst om
Ġ1 01
ĠS wed
Ġser ves
Ġpotenti ated
urviv in
ĠBC OR
ĠHOX B
Ġasc ites
Ġecon omic
lee vec
Ġm M
or i
ĠB IM
ĠS tem
Ġdem ographic
Ġpost ulated
ĠFif teen
Ġscar ce
ar ray
Ġf ate
ĠN et
Ġ8 00
Ġcar ries
Ġdef ines
Ġintra vascular
Ġn at
Ġprop ag
Ġepit ope
ĠZ NF
ĠUnder standing
s on
s yn
ell ar
ĠM orpholog
ĠN D
Ġimmun ogenicity
Ġinduc ers
ms acrine
ĠK DM
Ġqu ick
Ġmed ia
ipi ent
ĠPro tein
ĠEp igenetic
F or
Ġm itig
Ġco op
Ġref ined
Ġdiscus sion
Ġincorpor ate
Ġreflec ting
ĠRAS SF
captop urine
. (
H U
ul ed
str um
Ġbeh ind
Ġaspir ates
Ġclassif ier
ĠDifferen t
ĠH T
ĠCyt arabine
Ġgal ectin
yl transferase
ĠG G
par t
Ġexpl oring
Ġexpress ers
âģ »
C S
er ately
Ġex ome
rom bin
itor ing
Ġapp ly
Ġdesign ing
Ġhomogene ous
fluoro uracil
im atinib
Ġne on
ĠL IN
Ġinter play
ST RACT
bil ized
Ġswit ching
Ġp lastic
Ġfol ate
ractor iness
ĠA G
ĠH GF
ĠCR i
Ġinterac ting
03 1
Ġcap ability
DL BCL
Ep igenetic
ĠAMP K
Ġcompli ance
m arrow
ed gehog
ĠB as
spec tives
Ġnum er
met astatic
Ġguid ance
Ġepidemi ological
Ġbrief ly
Ġc assette
ox yl
17 0
Ġill ness
Ġâ ĳ
) %,
Ġch osen
ĠS AMHD
ech an
av ir
Ġleuka em
Ġassess ments
ĠAd verse
Ġsynerg ism
blast ine
thi oguanine
Ġqualit ative
U L
s yc
et ro
et ent
Ġgoal s
s k
re activity
Ġs phing
si RNA
ran ce
Ġun manipulated
Ġper spectives
Ġonc ogenesis
function al
Ġdisrup ted
Ġc ostimulatory
OR R
Ġphosph ate
Ġthromb o
Ġhaplo type
Ġdefin i
= </
ĠH M
Ġper haps
Ġm issense
ĠA UC
ĠP O
Ġus age
Ġaut ocrine
raz ol
onom ous
F DA
Ġas sist
ĠL in
micro bial
Ġrecur ring
D T
Ġin strum
ve olar
ĠC y
Ġex port
um erous
Ġmed ication
ĠPC NA
Ġlymphaden opathy
v itamin
ĠF ms
Ġbi allelic
Ġ10 2
ĠRA D
ĠCT N
Ġhypothe size
eg akary
AD M
Ġlongitud inal
Ġsampl ing
Ġcomp ut
ĠN a
ĠG F
ip ifarnib
Ġlung s
M o
o uble
ul ph
ĠP TC
am p
Ġalter ing
ĠHSP Cs
aro xin
ĠCompar ison
Ġreticul um
osf amide
0 33
E MR
n g
en sor
Ġl ibrary
ĠTh ose
Ġpur s
ins uff
asp ases
effec tiveness
Ġspontaneous ly
Ġhemorrh agic
ĠLym pho
Ġnic hes
Ġper m
ĠL yn
Ġcons olid
Ġhydro ly
Ġsmear s
Ġvalpro ic
re ported
Ġre plic
ĠB MP
00 04
Ġrece iver
Ġhealth care
O ut
Ġp ass
Ġf av
anc ies
Ġsup ernat
Ġsimilar ity
Ġunc overed
Ġartic les
Ġred ox
os aroxin
ĠB L
ĠB ut
Ġven o
EG s
W ith
ad ic
Ġnon specific
Ġnucle ic
sequ ent
AL DH
NP s
Ġoxid ation
Ġreach ing
Ġa msacrine
he l
om ab
10 7
Ġcoun te
err ing
ĠCom mon
ĠME IS
ĠAp optosis
Ġbioavail ability
I K
Ġne urop
dition ing
04 6
aza C
CG A
Ġdiscrim in
Ġsplice osome
Rel apse
d ens
f rom
Ġc reated
Ġs por
00 03
19 6
03 6
ĠEx posure
Ġconcurrent ly
len gth
b right
Ġin activated
her s
ĠR BC
sup pressor
Ġhaemat opoiesis
Ġnecess it
Ġpanel s
Ex per
sur face
d onor
Ġt wenty
an ol
ation ally
Ġl andmark
st andard
ĠS YK
rel apsed
Ġexpl oration
Ġcle aved
Ġdig ital
Ġcomm erc
Ġtrunc ated
T LR
i ated
m ax
p osite
s in
ĠU pon
Ġclar ified
ĠmAb s
Ġ1 15
CD K
Ġdep th
ĠPub Med
O ne
c ardi
Ġdis ap
ĠD aunorubicin
ĠR ep
Ġanti microbial
Ġint ention
Ġgroup ed
21 4
Ġ19 96
Ġconsider ations
Ġorgan ic
Ġmodul ates
Ġcereb ral
Ġhistor ically
Ġinadequ ate
M UD
d le
as tern
Ġd en
ĠH edgehog
ĠS FRP
Ġhyp ere
Ġcarcin ogen
Ġcontinu ing
Ġpoly clonal
ĠMe is
Myelo proliferative
evelop ment
om orpholog
ence phal
Ġbi as
Ġsequ enced
Ġsep tic
ĠIFI s
Ġcoag ul
ĠR ev
po inting
ax ine
Ġneuro logical
ĠEp stein
Ġsca ff
intoler ant
Ġpict ure
recogn ized
M SC
h al
er min
ig enic
com pl
Ġlympho blasts
Ġser a
> ),
ĠB TK
form in
Ġexam ining
Ġapp lying
Ġcellular ity
Ġrandom ization
Ġkill ed
Ġlig ase
ĠMR C
ĠNine teen
Ġcytoly tic
obin ostat
L y
es cal
Ġr arity
Ġconf erring
ĠSD F
Ġinfrequ ent
Ġchann el
razol ium
B R
] -
Ġan tiviral
ac r
Ġcyt ological
Ġdiagnos e
Ġhist amine
ĠIFN Î³
Ġhom ologous
chan ge
T c
d am
h aus
in vasive
Ġp eroxidase
id ation
Ġ1 60
ĠH aplo
ĠD ay
com b
Ġmod erately
so zyme
ag ul
Ġphys ician
aun omycin
ĠSub sequent
Ġnam ed
Ġaggreg ation
Ġt ight
Ġc reat
ĠS el
ast atin
ild hood
CA G
Ġmagn itude
Ġc ul
te can
Ġal cohol
Ġmain st
Ġcycl ing
ĠTNF R
ĠEp idemi
Ġq PCR
c GVHD
al c
ĠA reas
im ental
Ġg iving
Ġreg istries
Ġpre mature
Ġstr ict
ĠJ urkat
allo SCT
Ġexplan ation
Ġhamp ered
L D
o verex
Ġt esti
he rence
ol us
Ġanaly se
Ġint rap
Ġdes tr
Ġconf ig
Ġrepres sor
Ġsm o
Ġstim ulatory
Ġhom ing
Ġtyp ing
Ġsensitiz ation
Ġc Gy
ge al
ĠL ICs
Ġdemonstr ation
Ġinterac ts
ĠMR I
Ġexc re
Ġmetallo protein
E X
re pt
is ted
Ġpro ximal
ĠC hem
Ġass emb
Ġmo iety
ĠCD C
ĠN E
oun ding
Ġcontr ary
Ġdistin ction
Ġver sion
Ġdisap pointing
as ertib
ur on
ĠI S
Ġar ginine
Ġhyp ocellular
Ġdepend ency
Ġhydro chloride
Ġabund ance
phosphor ylation
Ġnat urally
T AM
an titative
op hyl
ĠIn v
Ġtra ffic
Ġagon ists
ĠPG P
Ġabn ormally
on omic
Ġre fer
id ic
rel iminary
Ġop posite
istr ib
Ġselec ting
Ġgenomic s
Ġdistrib uted
Ġfacilit ates
Ġmanif ested
T M
te st
tic s
Ġg lasdegib
ĠD OK
Ġactiv ators
ĠNPM c
erv ation
Ġconver ted
Ġstop ping
occ ur
Ġintrac ranial
Ġmarg inal
i Ds
sp ot
Ġanti thymocyte
de term
AB STRACT
ch in
Ġrepresent ative
Ġconcomit antly
ĠMut ation
te ine
an ine
ch ron
ile y
Ġprote ase
ĠCP T
Ġresid ue
Ġnit ric
P ARP
Ġ urin
ĠC oun
et he
ver sible
Ġde pression
Ġcomp atible
ĠD M
ĠD OT
ĠW NT
Ġ10 9
Ġintegr ity
Î¼ L
Ġmis sing
Ġrelia bly
d ecitabine
Ġn ested
ĠT M
iv id
ther n
ĠV LA
MDS s
Ġgain s
Ġgli omas
Ġmimetic s
L V
Ġv entricular
ĠIn dex
ĠW iley
Ġsuc c
Ġqu ar
Ġinst ances
Ġevid ences
HMA s
Ġras h
P F
n ec
op ho
ĠH S
ĠU V
Ġgranul es
Ġpur poses
Ġmodif ying
Ġepidemi ology
ĠHN SCC
5 49
x iety
Ġcaus ative
PD GFR
Ġmed ications
vari ates
Ġadap ted
ĠPrevious ly
Ġcommun ication
Ġc ation
Ġcomp eting
ens able
UN CAT
ĠTR UNCAT
Ġweak ly
ĠSK M
Ġexce eding
Ġsubs titution
Ġurin ary
ĠTRUNCAT ED
e tion
p ly
ot ential
ĠD U
Ġgrow n
CL US
Ġy e
Ġ[ (
Ġmat ter
ev alu
Ġj unction
Ġju venile
aryn geal
CLUS ION
s ho
Ġ &
ent ral
Ġen s
Ġimmun oconjug
Ġapp rec
ĠAn aly
ĠCon ventional
Ġet c
erox ide
Ġconfirm ation
+ .
A t
i ation
or g
ell ed
Ġpro spec
Ġdis p
am ples
ĠW OR
Ġab lation
Ġsimilar ities
ĠMul tivariable
Ġhospital s
Ġorgan ization
ĠY et
ĠDL X
b etic
p rim
on yl
Ġs CD
Ġand rogen
Ġne ural
pro ducing
Ġdec lined
acter ial
Ġprolifer ate
PM N
Ġfour th
Ġerythro cytes
Ġparticip ants
ĠWOR DS
C a
d l
v in
Ġs atisfactory
emb edded
Ġepid ermal
Ġquies cence
Ġkind s
in ine
er atin
Ġf ulf
Ġle t
ĠD AS
ĠN PC
Ġwe igh
Ġnon myeloablative
icin al
raf ish
Ġantigen ic
otox in
Ġhist ology
Ġtranscript omic
Ġproper ty
ĠPR L
ĠSign ificantly
Ġarchite cture
c or
si bility
Ġcom mentary
ĠP lasma
Ġout line
Ġimpac ted
D OX
U n
ĠA MKL
ur idine
ter itinib
14 3
Ġform ulations
glut arate
Ġcircum vent
ĠFac tors
Â ²
in ostat
Ġst rand
ĠB r
ous e
Ġcol i
hod amine
contro lled
Ġdisapp earance
ethe less
T F
w are
Ġre gen
Ġn ational
ph ine
eri atric
37 8
Ġillustr ates
Ġsucc umb
Ġ educ
ĠU SA
ocyt openia
Ġve in
Ġbroad ly
ĠCCN D
T r
in ations
Ġinf ar
ad C
ĠRNA i
ĠPD GFRA
Ġmanip ulation
Ġleth ality
v able
he re
Ġc aspases
Ġb ron
ho ur
ĠPA X
ĠFOX O
Ġjus ti
e ven
ĠA E
igh teen
Ġun balanced
Ġhe ight
Ġprogres ses
Ġcaus al
Ġhom ology
ĠET S
Ġcarb oplatin
V A
is ely
un ding
Ġ10 7
ĠAl tern
In t
Ġconclusion s
Ġpharmac ology
Ġver ify
Ġdri vers
Ġbioinformatic s
A RA
X Y
os ses
ĠC irc
il teritinib
BP D
Ġirre versible
Ġmill ion
B one
R B
Ġp ent
ĠT CGA
et abol
Ġher pes
B i
L S
Ġan e
Ġm antle
ĠT CD
Ġex trinsic
Ġ1 16
Ġv orinostat
ĠR ho
Ġpre cl
requ is
20 6
Ġaggres siveness
Ġche lation
ĠAb normal
Ġthym idine
Ġadoles cent
Ġoccasion ally
Ġmembran es
F B
O ur
n k
re le
ĠA f
Ġcomp osite
Ġinc re
Ġthere after
Ġdescrib ing
Ġintegr ating
Ġvin blastine
ĠFOX M
Ġcommun ity
Ġcytos olic
retic ulin
Ġj ud
Ġrepl aced
ĠEP O
Ġcys teine
N e
S H
f low
ĠD H
ĠG l
Ġro ute
Ġ10 8
12 2
aren ess
ĠBA X
ĠSP ARC
ĠBR CA
Ġderm at
ĠCON CLUSION
Ġmainst ay
F as
M any
Ġk appa
Ġcap ture
rec ipient
Ġtesti s
A UC
ĠB I
ĠB RAF
ĠN CCN
Ġar th
Ġpromo tion
ĠAd ult
ĠÎ¼ g
N SD
b cr
t yrosine
ĠH er
form ance
Ġsc at
RD M
loc king
Ġ19 94
ĠAT M
MS D
ĠMY B
Ġswit ched
Ġbehav i
% (
g ent
ic s
od al
ĠB ak
osi tivity
Ġpolymorph ic
ĠCl onal
Ġcooper ate
Ġpor tion
Ġin deed
Ġf ace
Ġleuk openia
ĠG AS
Ġclon ality
Ġpa uc
Ġmas ses
overex pressing
id ium
Ġen ough
Ġgen otyping
IT C
val ent
Ġcompre h
ĠAb l
Ġintrat umoral
Ġleuc ocyte
Ġsensitiz es
B U
F T
a GVHD
g ulatory
il ineage
st ud
Ġfail ures
ind ividual
Ġmanag ing
Ġsp erm
Ġsusp ic
Ġelic ited
Ġdiscl osed
Ġspor adic
ac erb
th reonine
iti de
pt osis
MP D
Ġly sozyme
Ġbacter ia
ĠMG MT
strati fication
H u
y el
ar ib
il st
Ġim pressive
ĠH I
ĠL R
Ġro und
Ġam b
Ġref ractoriness
Ġorigin ate
Ġtransl ate
Ġoligonucle otides
Micro RNAs
transl ational
Ġhyperp lasia
Ġcav ity
Ġan nexin
ĠT otal
ĠM I
Ġk b
Ġanti angiogenic
Ġtranscription ally
Ġnucle otides
jec tions
hydroxy vitamin
id ostaurin
Ġprec isely
04 2
Ġwhere by
Ġexc ision
Ġpauc ity
D el
S ince
p eptide
t t
um ably
Ġha p
Ġ15 2
Ġmaxim ize
Ġdestr uction
C as
R II
p ur
ĠT c
im ent
ĠC r
Ġal fa
ĠF ew
oh ort
Ġautophag ic
Ġcomb ine
Ġzeb rafish
b enz
Ġp DC
Ġf ore
Ġ( âī¤
ve ment
Ġex acerb
ĠN inety
ĠE MT
ĠL ip
Ġcan onical
ens in
mut ations
ĠImmun e
ĠSc i
Ġoccup ational
ĠGP X
TRA IL
0 20
2 21
b ital
ig ibility
Ġcon tempor
qu e
ĠS V
ĠS cale
Ġpresent ations
Ġexam inations
allo HCT
Ġphosphatidyl inositol
Ġpredis posing
Ġfeed back
Ġsubd iv
Ġd rop
ĠC aspase
ce in
ical s
ĠG emtuzumab
Ġint ent
Ġ201 9
Ġtri ed
PD GFRA
ĠMy lotarg
ĠInhib itor
Ġq RT
Ġload ed
Ġharves ted
F CM
ï ¼
Ġp syc
ec re
ec an
ĠF IP
ox if
mon ocytic
Ġsh ap
Ġtra ditionally
Ġglut amine
Ġalkal ine
Ġchap ter
C ons
L M
ĠP rior
ĠP reliminary
Ġdiscon tinue
ĠInc reasing
Ġphag ocytosis
ĠPBM C
ĠRem ark
istrib ution
N ucle
ro unding
Ġexam ples
ĠInte gr
rosc opic
j o
k et
ĠC HOP
ĠD i
Ġdiff ers
Ġran ges
04 3
Ġprolong s
Se q
2 53
V D
ĠW M
Ġachie vable
ne x
qui red
Ġem pir
Ġunc over
Ġstruct urally
Ġeradic ating
Ġfresh ly
Ġcorticos teroids
Ġspectro sc
G AL
Ġt ax
Ġm echan
al so
ML LT
Ġsur rounding
pl ified
Ġimmun ob
Ġpre requis
CSF R
Ġwork ing
ĠCBF A
ergill us
Ġperic ardi
i rable
ac c
ol ated
ĠP red
og lyc
Ġ19 93
Ġenro ll
Ġact ually
Ġed ema
Ġdeoxynucle otid
z es
Ġst ay
Ġ1 12
Ġl on
ĠD is
min omycin
Ġevol ve
Ġmixt ure
Ġt ipifarnib
tiv ities
com bin
orph ic
ĠGST P
Ġyiel ds
Ġscaff old
K D
Ã ¼
ar ged
Ġb anding
ut lin
Ġde terior
Ġend oplasmic
Ġnumer ical
lo ok
et axine
hem atic
mac etaxine
18 0
Ġess entially
ĠCombin ing
Ġhypox ic
transcription al
Ġcomput ational
b s
ĠP M
Ġab l
Ġse greg
Ġpres umably
Ġtarget able
ALL A
trans f
Ġsil ico
ophag y
Ġspre ad
T wo
© ¾
ul ties
Ġleuk ostasis
Ġl osses
las ting
ĠR OC
19 0
Ġer yt
MA D
Ġpolymorph onuclear
hydroxy glutarate
Ġnod ules
Treg s
os a
ĠA M
Ġn ation
ra medullary
Ġst aging
ĠM UT
Ġen asidenib
Ġimmun ost
Ġdes cription
loc ation
Ġlig ation
Ġcheck points
Ġoxid ase
Ġhair pin
Ġmil est
erythro id
BPD CN
+ ).
ĠM ac
ĠM yc
ĠP ET
15 7
Ġenc ode
Ġexpan ding
Ġimple mented
Ġreinf or
J un
N R
i pl
gen esis
15 3
Ġref in
ITD s
erg ic
atin um
Ġsuff er
TC GA
Ġrecons tit
E Cs
m ia
ent re
ly s
ĠC SC
ĠF e
ĠS urvivin
Ġnot able
Ġper itoneal
ĠG ram
26 3
itt ent
ĠEle vated
Ġsca ven
ĠSCI D
ĠAf ric
c he
h ans
Ġh OCT
Ġex tension
Ġex haus
se vere
ici ently
Ġtechn ical
ĠQ u
Ġdiffer ing
be it
Ġprincip le
pred nis
pat hw
Ġane up
f e
Ġpro gen
ĠO RR
Ġ13 0
Ġsitu ations
ĠSix teen
ĠEv idence
Ġbelong ing
Ġobvious ly
Ġju xt
ivid ually
ĠS S
ĠR ever
SC F
ĠG A
ag ents
ĠCh an
ĠME F
Ġcardiomy opathy
oprote ctive
Ġg eriatric
st alk
de p
apopt osis
Ġpossi bilities
quin one
Ġtryp tase
Ġpolar ization
G en
m ul
er ves
Ġb esides
om ies
uc il
di ploid
Ġchem ot
Ġgen otyped
03 7
ĠCon c
Ġsp an
Ġelimin ating
Ġproce ed
anger hans
HOX A
ĠP AR
Ġ10 6
Ġtox in
ranul ocytic
Ġepigenetic s
LR P
amb ucil
Ġb ox
ĠB CP
ĠW E
ĠN SG
AB MT
viron ments
Ġhom oharringtonine
raz il
Ġdim ethyl
Ġ ÎĶ
in in
Ġde plete
ist one
Ġprogres sively
Ġthromb opoietin
Ġestim ation
Ġdiffic ulties
Ġaddres sing
ĠEv alu
ĠHox a
Clinical Trials
lnc RNAs
hematic al
ĠB razil
ĠS CL
Ġpathogen s
Ġara C
Ġye ast
Ġfulf ill
L DAC
T A
id i
ĠB V
Ġelic it
ĠSer um
ĠEm erging
ensiti z
ĠHep G
ĠNor thern
> ).
Ġp ack
om ated
ĠN ormal
Ġco variates
ron ectin
Ġtrans gene
ĠG enes
Ġunder way
34 35
AC K
Ġfail s
Ġpartic les
Ġche st
Ġnan om
Ġdisrup t
ĠP N
Ġk Da
Ġob taining
Ġsup eroxide
Ġstandard ization
Ġgra m
ste ine
ĠCa uc
Ġdig es
Ġdirection s
ĠRemark ably
S B
f act
f ord
ar ies
ig or
ol ism
ĠIn tr
LT S
Ġdur ations
Ġimp ly
orbid ity
Ġhaplo insuff
Ġexc iting
Ġcounterpar t
Ġtempor al
acchar ide
ĠCycl in
L DH
w orld
Ġg ilteritinib
Ġpl atinum
Ġmicro tub
Ġ19 92
Ġend omet
Ġcoagul opathy
Ġcreat inine
T GF
Ġfor ward
Ġco verage
ĠK LF
ias is
Ġins ensitive
ĠEC OG
truct ural
Ġmutagen esis
ox ane
Ġnormal ization
ex ome
Ġretro virus
Ġmit osis
NP P
Ġtopo tecan
Ġincomplete ly
flu or
P rimary
el ec
ĠT et
Ġv i
duc ts
Ġun ra
ĠE D
Ġel igibility
10 6
Ġdiscrim ination
Ġion izing
Ġrad otinib
E arly
p ts
er t
Ġre agents
os idenib
Ġn erve
ow el
Ġinvestig ators
Ġar rested
ful ly
Ġche l
Ġdet ox
week s
Ġresearc hers
G I
g R
Ġ %),
uc onazole
ĠO p
ĠE ighteen
Ġsub stances
ack ground
ĠQ OL
Ġlys osomal
Ġmaintain s
Ġplatform s
Ġsoft ware
Ġhierarch y
Ġdeoxynucleotid yl
k Da
Ġt am
Ġp ip
Ġs a
or adi
ic l
ĠA DR
ur ia
Ġpro st
Ġ1 14
ĠH TL
ĠD es
Ġen tering
Ġra ise
VI D
ĠHDAC i
EP O
Ġcros stalk
escal ation
m es
p e
Ġan sw
ul a
Ġ1 13
Ġorigin ating
Ġschem e
Ġinfar ction
te l
or age
ĠA ustr
ud den
ĠB T
ri um
pro gnosis
ĠAn d
ĠClinical ly
Ġneur onal
a genic
Ġf in
Ġcon form
ĠD EK
Ġus es
tro duction
Ġerythro blasts
Ġaltern ate
ĠTox icity
F MS
Ġs emi
ĠP MA
ĠV enetoclax
cin ate
ĠAd riamycin
Î¼ M
Ġbl ue
Ġbasophil s
ĠPDGFR B
Ġabsor ption
t otal
Ġthe ore
ut ing
Ġac compl
Ġmon oblastic
Ġassoci ates
li oma
/- </
Ġpers on
Ex pression
erc ul
CTL s
Ġunderl ie
valu e
Ġcoop eration
S ign
] :
he um
Ġin ability
ro phages
ĠT im
yelo cytic
ĠP EG
ĠH EL
gn etic
Ġanaly tical
ĠL ittle
ĠK inase
36 2
HO DS
Ġdet rim
Ġencomp as
Ġd CK
Ġd ye
Ġb ands
ec onomic
Ġcyt omorpholog
ĠJ Q
MP s
Ġrecogn izing
Ġaccel erate
4 86
A ut
N SCLC
a ffinity
al se
ol or
ĠP DAC
ĠH PV
ĠS omatic
Ġcyt ochemistry
Ġk inetic
eri od
ĠX RCC
ĠPro spective
cyt otoxic
Ġtransfer rin
Ġdia betic
Ġstimul ates
ĠWork ing
M PL
ur ance
uk ary
ĠM ain
Ġdis tal
ir ubicin
our se
Ġhyp o
rough t
Ġter ti
000 7
ĠRespon ses
Ġdeline ate
8 00
Ġa ir
Ġf o
Ġpro survival
CR L
ĠE ffec
ĠL en
ad ministration
MN C
ĠPL K
eptid ase
Ġhypere osinophil
L OH
Ġd uc
id ol
ĠA ff
im etic
ac he
ĠM yelodysplastic
Ġhemat ologists
ĠL ab
Ġu ro
Ġcomprom ised
Ġc y
CR C
Ġmulti kinase
Ġshort ly
ĠMul ti
Aza C
mer captopurine
Ġhot spot
Ġerr or
Ġleukaem ogenesis
Ġconfig uration
Ġcompreh ensively
6 38
Ġal beit
Ġcomp l
ap lastic
ĠU l
Ġfail ing
Ġexperi encing
Ġbrom odomain
ĠIniti al
ĠPBP C
L a
Ġn mol
us ing
Ġv osaroxin
Ġout growth
ail ure
Ġhist ones
Ġchain s
ME K
Ġatt ack
Ġhypers ensitivity
Ġprogen y
H e
K G
Q O
c ar
c irc
Ġin jections
Ġal ters
ĠG raft
Ġprogres sing
Ġreac ted
Ġ11 8
Ġdefin ite
Ġide a
lip id
Ġnation wide
Ġmon ocytosis
Ġind ividually
In f
Ġly tic
ĠMT H
Ġoffer ing
Ġmonth ly
ĠNon etheless
Ġremo ved
otran s
Ġm ir
at uration
ĠM ll
orm ycosis
ĠR adi
ĠG FI
ren ol
otyp ical
Ġshort ening
CG H
Ġhierarch ical
T dT
Ġs ke
Ġd orm
Ġpro jected
Ġst res
ĠF GF
Ġres er
ĠO lder
ĠG IST
Ġnon responders
13 1
(- ),
Ġsp e
Ġimmunos orb
c ourse
om aly
ĠC LAG
Ġbe gan
Ġag ar
rac ted
ĠL M
ail ed
RA P
Ġfunction ality
are t
Ġmat hematical
ĠSt atis
Ġconstruc ts
Ġmening eal
Ġassoci ate
ad emic
Ġran k
lot inib
ĠRec e
Ġfib ronectin
erv ised
UT R
Ġeas y
D uring
Ġb owel
Ġinc urable
Ġper man
oth rip
Ġar ma
po ly
Ġwor st
Ġquantit atively
Ġlimit ation
ĠReg arding
Ġdetrim ental
othrip sis
Ġarma ment
M olecular
Ġb ad
Ġb rought
Ġe ye
ĠN Y
Ġanti metabol
tr al
Ġhypomet hyl
Ġthrombo emb
ĠHTL V
tion ed
Ġas tro
Ġrel ate
iz ations
ĠE stim
14 8
Ġoptim izing
Ġcal reticulin
200 9
201 6
Ġneur ons
Ġfibrin ogen
Ġimmunosorb ent
U CB
Ġde partment
Ġnon malignant
Ġpl ate
li ter
Ġgeneral ized
Ġsol ely
Ġtumorig enic
Ar g
Ġarter y
Ġhair y
Ġna ive
ĠTN BC
Ġmand atory
Ġprerequis ite
ĠMUT Z
P o
Ġb odies
ho ugh
Ġde ad
Ġint ended
Ġappro pri
Ġclus tered
ote pa
7 20
B ackground
a CML
h r
n ai
Ã ©
re al
Ġl ist
ol ab
Ġrep ur
Ġgre en
dim er
ĠPBM Cs
ĠSequ ential
Ġdoub ling
ĠMET HODS
ĠKore an
M an
T SA
os pl
ĠP oly
Ġmo tility
ie u
ĠR B
ox a
ten ding
ĠmiR s
04 4
ind ow
ĠIM iDs
Ch ildren
Ġhelp er
Ġadj un
ĠGen omic
inter feron
Ġdist ant
Ġinterm ittent
Ġcryopres erved
Ġdin ucle
o ter
Ġt i
Ġm apped
at rol
ver atrol
Ġde ac
ĠH h
ĠR h
Ġlympho blast
Ġmark s
ĠU L
Ġmethod ologies
ĠAn nexin
emal e
Ġcho ices
>- /-</
ĠMicro RNAs
ĠAdv ances
Ġan th
ac rolimus
Ġex em
ĠE GF
erm ethylation
ĠPre clinical
Ġbelong s
Mul ti
Ġtraffic king
D MR
K B
h ic
y le
Ġim bal
Ġon to
ĠP H
trans duced
ĠMP D
bi ased
Ġdim er
Ġseg ment
Ġbrid ge
y al
Ġthe ms
Ġe c
ur veillance
Ġpre fer
ĠL TC
ome res
Ġpost transplantation
ety lases
ders on
allo geneic
opath ies
ĠAN D
ĠSR C
Ġthym ic
ĠÎ³ Î´
Ġintrap er
/ /
C HOP
s s
in dex
Ġcon ven
ĠN eu
Ġmul tim
Ġme et
Ġme eting
cal c
Ġlen tiviral
Ġsuff iciently
Ġplasm id
: //
N D
m Ab
p m
Ġw a
ĠC ases
ĠE astern
37 5
Ġlip osome
Ġmyelosup pressive
Ġimmunore gulatory
Ġautog raft
Ġchap er
A ll
f ludarabine
Ġ $
Ġs ick
Ġbe g
Ġg e
st able
pro p
Ġco expressed
Ġgen omes
11 8
ĠSt riking
ĠSe vere
hol ds
ĠHu M
T s
T ar
c is
d ensity
el ves
Ġf alse
Ġe ukary
ĠC al
Ġdiagnos ing
Ġnon hematologic
ĠU SP
li vec
Ġaut osomal
ĠAn derson
23 1
ĠME G
Ġeosinophil s
ĠBe fore
Ġthems elves
B N
F c
F LA
b r
f avorable
Ġp rone
Ġan omaly
Ġm other
Ġth irty
Ġst ably
ĠP os
ĠL og
Ġob ese
tumor igenic
Ġfacilit ating
Ġdetail s
gal act
Ġescal ating
ĠChrom osome
Ġobstac les
Ġann ual
Ġarmament arium
u si
at ur
Ġg ing
ĠS al
Ġcor on
Ġaltern atives
ĠCytogenetic s
Ġlas er
Ġxenotransplant ation
Ġdeac etylases
un t
ol i
ĠH CL
ĠD evelopment
Ġun ac
Ġres ol
tr um
Ġno tic
Ġallo reactivity
ocyt oid
Ġke ep
Ġimplic ate
ĠDifferen ces
gu ided
Ġarth ritis
A sp
R O
T O
X C
h is
w ell
Ġt as
Ġd ich
im er
ĠR ap
ome galy
Ġnon leukemic
Ġinter im
reg ulatory
Ġresemb ling
fil grastim
I d
P SC
i ance
on ate
Ġe ver
ac tin
ĠI F
rac onazole
Ġpl aced
int uzumab
Ġsp inal
Ġsecre te
IN G
Ġsoci o
2 000
Ġs udden
Ġre ne
ul ose
Ġor th
ĠB FM
Ġno tion
ĠU D
ass ay
Ġprote cts
Ġu ter
Ġcent res
Ġgl and
Ġhallmark s
Ġaw areness
St ud
or f
pl ication
Ġprim ers
Ġsequ entially
Ġwor th
Ġvirus es
mod ifying
bi ology
Ġactin omycin
C lin
on set
Ġid enti
Ġbut yrate
av es
Ġdi ver
04 1
Ġprocess ed
Ġpub lications
ĠPre treatment
Ġassign ment
Ġca ution
V PA
X X
c il
Ġre t
AB C
10 4
Ġdisc ordant
Ġpotenti ate
oh yd
Ġintro duce
Ġregard s
Ġrepl acement
ĠMed ic
ĠSIR PÎ±
Ġchlor ambucil
inos itide
Ġoc ular
Ġperme ability
Ġrab bit
1 000
C pG
P EG
ĠC EM
Ġass umed
rac ting
UN D
Ġaz a
orbid ities
Ġglyc olytic
Ġlo ading
Cyt arabine
Ġalloc ated
Ġenroll ment
' .
B lastic
h ift
Ġ 000
Ġf ine
ĠR educed
Ġinf er
Ġeng agement
Ġhydro gen
Ġtransi ently
Ġconsequ ent
Ġlas ting
Ġunra vel
v astatin
Ġw indow
ran g
Ġ19 86
Ġgener ates
Ġdep r
ĠRAR Î±
Ġimmunos urveillance
Chrom osomal
E MA
P O
b anding
p en
ĠC andid
ĠH es
oplas ia
ass ess
NK T
oid al
stim ulatory
Ġbro ader
Ġchemical s
Ġrib osomal
Ġsubcl one
Ġsuper family
] ),
f it
p air
om orphic
Ġun defined
Ġsub lines
oph orin
ĠAT L
Ġcontrib utions
ĠNK T
ish ing
EB V
Ġmicrosc opic
da ily
ophosph ate
Ġneon atal
Ġdefini tions
T IM
Ġn orm
Ġst rept
Ġpres cribed
az one
Ġstandard s
ĠML D
ind le
ĠTP O
Ġguid ing
Cd A
for ced
Ġthres holds
Ġanticip ated
oxif en
G N
g lobin
Î ¶
Ġ ult
Ġ vers
er lin
ĠT rials
ĠC S
ĠM AT
Ġch ond
Ġha ms
am ustine
inc ubation
Az acitidine
Res istance
transl ated
Ġtight ly
J NK
U G
i ar
id ent
Ġde acetylation
Ġg est
ĠH aemat
Ġrel ie
Ġsub units
end amustine
vo ir
ĠAs sess
ochem ically
ew is
Ġmid dle
GR O
aden osine
Ġfram es
Wh ile
c G
t on
Ġc e
Ġc ot
Ġre ad
lo op
ĠC lass
Ġas paraginase
ĠI FD
Ġk g
ĠG u
Ġpres ently
Ġ19 88
eri al
OR TC
ock ing
Ġconc ordant
Ġhyper cellular
ob ese
Ġve hic
Ġallog rafts
Ġmil ieu
Ġjo int
Ġquick ly
s uch
ic tion
ut rop
Ġk it
Ġaddition ally
tran splanted
38 2
the rapeutic
IR F
ef itinib
Ġmultic entre
Ġphysi ologic
Ġcry st
Ġdischar ge
Ġreser voir
- .
. "
u ximab
Ġp ig
it us
ot opic
pres ented
ir m
Ġen tero
Ġallo reactive
21 3
Ġem ission
200 8
Ġacet yl
Ġentire ly
Ġbasophil ic
mo bilized
f R
ĠA HSCT
ĠT hough
12 7
Ġexam ines
pre c
Ġmucos a
dim ethyl
ĠPo or
Ġcasc ades
Ġwors ening
Ġplastic ity
) ],
D rug
K ip
Ġs teroids
et axel
tiv ating
Ġmed icinal
ĠPD CD
Ġpan obinostat
opatho logy
ĠIg A
ĠPP AR
Ġfit ness
ĠIT GA
Ġregular ly
ĠMin imal
S econdary
Ġd n
ant ation
ĠP TK
od ip
Ġmut agenic
ĠR etro
Ġmet formin
Ġnan o
ĠCAR T
An ti
ĠSM C
ĠAK R
ĠRem ission
" )
Ġt acrolimus
Ġp i
Ġl ive
ĠR ac
Ġit raconazole
Ġcharacter izing
Ġsensi tivities
ĠV CR
Ġclon ing
ĠNF ÎºB
ĠTNF Î±
ĠZ F
Ġdiscrim inated
Ġthym us
Ġfavor ably
Ġeth nic
D asatinib
J MML
en zyme
he ad
ĠM IC
ĠS il
all s
Ġcent r
ĠHe La
inte gr
ĠEv ent
PK C
Ġsplen ectomy
Ġimmunoconjug ate
Ġsuspic ion
T S
c aspase
p rimary
ho le
Ġ1 19
ĠCD A
Ġsub mitted
CT s
ex posed
Ġinflu x
Ġexplo it
Ġretin oids
micro L
ĠEn g
Ġslow ly
ĠPo lym
Ġdispar ity
ĠNAD PH
Ġcontempor ary
ĠT oll
ac yt
ĠH BV
ĠL OH
Ġob sc
Ġep irubicin
des ign
Ġillustr ated
Ġhead ache
ĠIdentif ying
etho x
Ġunivers al
Ġexcre tion
Ġterti ary
G al
I H
P U
Ġp as
as ic
it he
ig aret
et ter
ĠI P
ol ed
Ġal dehyde
Ġr hodamine
ĠS MAD
ĠN umerous
Ġhem ophag
Ġdown regulate
Ġdos ages
Ġnec ro
ĠCX XC
Ġaspir in
ĠChrom osomal
ps in
Ġresour ces
V al
n R
y es
ere x
od ophyl
ĠF AK
ĠR a
ĠL ast
ĠL ys
Ġsuperior ity
Ġiod ide
M HC
S er
t opo
Ġm apping
Ġd ict
ĠM it
st randed
Ġmic ron
Ġ14 8
ĠABC C
ĠCH FR
ĠSA HA
C OG
el in
ul monary
ĠA AML
Ġas ked
ay er
ĠN OX
yc lo
ĠK O
Ġdifferent ly
Ġclon ally
ĠX PD
lympho cytes
isp an
Ġchlor o
Ġassemb ly
A cc
M et
e a
m ention
ĠT EL
ad ays
ist in
spec trum
Ġdef ense
Ġnucle olar
Ġ20 6
Az acytidine
-- >
Ġbarri ers
raction ated
Ġmicros atellite
Ġretur ned
Ġimmunost aining
renol anib
Ġsick le
mention ed
8 33
M el
Ġp DCs
id entif
ĠT ime
qu antitative
ĠD EGs
ĠN G
Ġpl ants
Ġfunction ing
Ġra ises
Ġimp ed
Ġreco ver
Ġgra di
Ġresult ant
Ġrest oring
Ġquestion nai
raz oxane
Ġvess el
Ġhaploinsuff iciency
" ,
K MT
s ensitivity
Ġn arrow
ĠT S
Ġun iqu
CR p
Ġph armaceutical
Ġprote ome
Ġubiquit ination
ĠAsp ergillus
Ġcoexist ence
w an
Ġan xiety
um ing
Ġr heum
ĠF ACS
Ġconf ined
Ġsp ot
Ġvac u
Ġantagon istic
Ġincon sistent
ĠAss ociation
ĠHOTAIR M
Ġhypomethyl ated
os ulfan
ec tions
ĠT ie
ĠP eriod
ĠO DN
Ġro ot
ak es
20 5
Ġ13 7
Ġflu x
Ġcriter ion
ĠTGF Î²
Ġslow er
ĠFT Y
Ġhistopatho logical
Hemat opoietic
+ -
n icity
ĠA CM
Ġphen yl
Ġder ive
201 8
CF C
ĠMy el
Ġhepat ospl
ĠSy k
ĠCH K
Ġmucos al
Ġallog rafted
ĠSeven teen
Ġspectrosc opy
Ġmechan ical
p i
im eric
ĠE OC
Ġmet al
ple tion
Ġpl ac
ĠK B
ill er
Ġcorrel ating
In ter
Ġsp ace
Ġnecess arily
Ġdr as
Ġsched uled
ĠAcc um
Ġrevers ing
ĠImmunohist ochemical
ĠEpidemi ology
ĠInv estig
I GF
O lder
S K
X W
f lox
i ant
le b
id al
Ġap art
Ġco efficient
Ġsub mic
sist ently
ĠK aryotype
Ġdeterm ines
Ġ12 6
Ġdel ays
Ġser ially
racycl ine
con jugated
rank f
Ġpy rimidine
ĠAut ologous
ĠInd ia
Ġduc tal
odophyl lot
d ifferentiation
ran ular
ĠM et
il ed
Ġover weight
tro l
Ġcol itis
over all
ĠBM SCs
aria bly
MS O
Ġfra il
co agul
rection al
adj uvant
Ġorganis ms
ĠAu er
l ived
in one
Ġp ort
Ġb ond
ia m
ĠC U
Ġex change
Ġex tending
ĠM ol
Ġ2 25
ĠR P
vers y
tumor al
bil irubin
ĠPR R
Ġdisrup ting
del ta
Ġthi oguanine
Ġsulf ate
Ġfil grastim
na Ã¯ve
Ġidenti ty
M in
z en
Ġc AMP
ati o
Ġ1 34
Ġl ap
ir ds
ĠD I
ĠIn termediate
Ġun mutated
ĠR and
ĠE ff
Ġevalu ations
ĠU se
Ġ12 2
Ġloc ally
Ġmig r
Ġinoc ulated
sk y
tt p
j i
Ġt AML
re presented
Ġf lan
gen ome
Ġ1 38
Ġev ade
ad herence
Ġprov ision
Ġprote as
Ġexper t
Ġclin ician
ĠGS E
ĠKn owledge
ĠAfric an
Ġjuxt am
B ACK
S MM
o blast
v is
x af
Ġp olic
ac itabine
ĠM B
ĠP e
di hydroxyvitamin
Ġimmun ology
Ġout put
ĠTh romb
Ġhyp oplasia
Ġaut omated
Ġcycl ic
ĠDA U
CAL R
Ġflav on
ĠBAL B
Ġacces sible
ĠDes ign
GRO UND
BACK GROUND
A I
c ultured
y stem
Ġd ro
vel s
Ġbi ogenesis
af ety
Ġ15 1
ram e
Ġorigin ated
Ġund erex
ĠPres ence
F ox
b oth
Ġh or
ĠS tr
ĠE wing
Ġsub cellular
requ ency
Ġop er
Ġregion al
Ġaccum ulating
Ġadhe rent
Ġaccompan ying
ode oxy
VEGF R
Ġinterpre ted
Ġiv osidenib
Ġscenari o
Ġrefer ral
opho re
v est
le u
Ġb olus
am ate
Ġind isp
Ġel ong
ĠU nex
Ġtr ilineage
Ġequ il
Ġemer ge
ĠDe tection
Ġtub ercul
ĠFox p
Ġte am
Ġpreced e
ĠCoun cil
Ġo v
Ġe cho
Ġto day
ĠC ase
oc occ
ym et
AM KL
ĠCl us
Ġdifficult y
Ġacet ate
Ġemphas izes
Ġimmunocom p
Ġpersis ting
HAM M
F s
Q oL
h en
he res
Ġp yro
ro se
ĠT W
las ts
pl ained
ycl ine
Ġquantit y
Ġaspec t
ĠEn gl
appro priate
chrom osome
Ġvulner able
ĠStriking ly
0 53
Ġthe r
ell es
Ġmyelo blast
Ġ1 21
Ġcom e
Ġg ang
am er
Ġinv ariably
ĠL eu
11 9
loc k
Ġcol or
lot ting
Ġsp indle
Ġdoc etaxel
igu ingly
ĠCONCLUSION S
ĠUnex pected
E xt
L ong
M Cs
U CBT
qu ine
MT D
Ġsequ el
ophil ic
Ġconsec utively
ĠFas L
Ġsmok ers
Ġprofound ly
Ġaw are
ĠInd ividual
Ġcover ing
ĠLike wise
Ġjuxtam embrane
m yb
Ġin patient
Ġon com
Ġor bital
Ġtim ed
Ġaut onomous
Ġoverex press
ste ad
ĠTAM s
Ġdiet ary
Ġobsc ure
o lo
Ġc ust
ĠT C
ĠM b
ĠO X
Ġpres erved
Ġhe par
Ġhe lic
Ġachie ves
lot ypes
Ġlink ing
ĠAb s
Ġplan ning
Ġeffusion s
ĠTL S
sil on
Ġdiscre p
xaf or
B r
m ain
v ac
ac id
Ġ1 17
Ġtre phine
ĠP RDM
ĠS AR
Ġres veratrol
Ġreg istration
Ġdes irable
Ġkn ow
Ġdef ic
Ġ19 89
Ġdisrup ts
angi ogenesis
Ġparallel ed
ĠMV D
ww w
Ġmimic king
Ġna Ã¯ve
Exper imental
Ġrefin ement
W ilms
on ym
Ġan not
Ġde em
Ġse e
ĠL angerhans
Ġexp ensive
par tic
ĠAD M
HSP Cs
ĠDiagnos is
Ġfer tility
asi rox
ĠSwed ish
rankf urt
F low
n itro
Ġc m
es ter
es sional
Ġto ok
tiv ated
ĠL ewis
term ined
Ġ8 33
34 0
Ġ12 8
Ġemergen cy
Ġmen tioned
prednis olone
" .
2 12
G emtuzumab
N atural
is ib
op eptidase
Ġal veolar
Ġch ick
ĠIn stead
com plex
Ġint ake
Ġmod ules
Ġneoplas ias
ores cein
Ġexper ts
Ġmuc ormycosis
Ġclinic o
Ġauth or
Ġdiscre te
ĠImmunophen otyping
Ġmilest ones
Ġuniqu ely
. -
T ME
b odies
Ġs keletal
Ġm olar
Ġ( +
ĠE N
IT R
Ġplay ers
Ġdemethyl ase
Ġmas ter
tif icial
Ġtet razolium
Ġnanopartic le
Ġmultipar ametric
ĠGerm any
Ġrepeat s
ĠBE AM
Ġmer its
ermin al
Ġmetalloprotein ase
Ġamb igu
b ase
Ġc ancerous
ĠC lassification
ĠH em
Ġr ich
Ġsug ar
Ġcombin es
Ġnon random
ag land
Ġchrom othripsis
Ġdown regulating
Ġ17 0
Ġabs cess
Ġscre ens
Ġorigin ates
AS E
Ġreactiv ated
rin ting
ES O
Ġcomprom ise
dam aging
occur ring
ĠChan ges
R OC
t DNA
on ad
as ian
ĠC are
op ir
Ġwh ilst
dition ed
Ġall oster
li x
Ġrepres sive
NK G
MS P
Ġendothe lium
ĠAN C
Ġimpl ies
Ġphenomen a
ĠSur veillance
Ġperme abil
opir idol
B etween
Ġan aplastic
an aly
Ġd ying
ĠI NPP
Ġanti tumour
Ġtrans mission
ĠK BM
ag ged
ĠU C
21 9
ĠUn til
Ġhelp ed
met h
Ġul c
Ġhepat otoxicity
ĠMut ational
Ġthi otepa
ĠMon itoring
oz ol
Ġstom ach
Ġneurop athy
transf ected
D G
D ecitabine
Ã ¶
re plete
on a
Ġre act
ĠC x
Ġr ationally
ĠB l
ĠN an
oun t
Ġindic es
ach ment
Ġ12 7
Ġ14 5
Ġprolong ing
allo HSCT
Ġlen tivir
ĠCBF Î²
ĠMT D
phen otype
Ġcereb ellar
ĠLA IP
ymet rix
Ġdeem ed
ozol omide
Ġm m
ĠM ice
ĠP artic
Ġ2 10
Ġph yt
Ġpre emptive
Ġerythro cyte
29 4
aren tal
Ġinfiltr ated
Ġdiscontinu ing
Ġunex plained
Ġasc ertain
Ġappropri ately
K O
N UP
T I
u fact
Ġd ocking
ĠP ur
Ġat he
Ġmo bility
Ġdev ast
po or
Ġer lotinib
ethyl ene
Ġreproduc ibility
Ġcorrespond ed
Ġdihydro chloride
Ġtheore tical
C O
Ġch ron
Ġun ve
Ġcyt ology
ĠCh ildhood
Ġradi ological
Ġcho osing
Ġxenog rafted
Ph iladelphia
Ġneuro toxicity
Ġtermin ation
ĠAb out
eti tive
Ġepidemi ologic
âĤ Ĥ
L O
f rame
m imetic
v ess
le uc
ĠH as
ĠO ral
Ġacc ordance
10 8
cy steine
Ġup regulate
20 9
AR T
Ġinser tions
Ġframes hift
SMM HC
ĠUnexpected ly
e ted
Ġ ip
re ater
re ening
at s
res tim
iv ation
il ities
ĠB last
ĠD DR
ĠS et
Ġun res
14 7
ung in
Ġintegr ate
ĠZ R
Ġlat ent
ĠAc tivation
Ġpreven tive
Ġfram e
Ġaggreg ates
GL IS
organ ic
Out comes
determ inate
ithe lial
Ġdevast ating
C r
S SC
on i
Ġw ent
Ġcon v
ph ospho
Ġchem ically
Ġen orm
ĠG TP
Ġro ds
cell ulose
Ġdef er
Ġcol um
Ġsynerg ize
ĠSim ultaneous
Ġhar vest
Ġhisti ocytic
ĠSW OG
Ġendomet rial
igaret te
A HN
Ġs ap
ell a
Ġpre transplantation
Ġidentif ier
ĠV TE
ock et
Ġpanc reas
sign ificant
Ġimmunore activity
Ġcollabor ative
Ġ( â
ĠA PC
ĠM ST
op ically
ĠF US
ĠS B
pro duction
ĠN oxa
âĢ ĵ
LT s
Ġnon lymphoblastic
ĠDNA M
Ġpatho biology
In d
ĠPD K
Ġcardi otoxic
ĠInc idence
Ġpregn ant
Ġexce eded
ĠPl atelet
ĠLe vels
Ġnutri tional
ĠRever se
Ġret ard
( Â®
Ġ1 33
ĠS amples
(+) -
GF P
of ib
Ġstain s
Ġharb our
ĠLym phoma
lnc RNA
Ġcathe ter
ĠBa F
Ġmicrom ol
Ġaven ues
Ġobstruc tion
B cr
R N
Ġm u
Ġre tri
at t
ter ations
anis h
Ġquantit ation
of sky
Ġmicroenvironment al
ĠY oun
Ġtel omeres
Ġâ ©¾
arn ofsky
ĠComp ound
B ET
L ym
d PCR
k b
y go
um ber
Ġtre mend
od erm
ĠD F
ĠCD X
Ġper mitted
ĠG PI
ĠG rowth
ĠL CH
Ġhe x
Ġblood stream
11 2
Ġcontro versy
Ġsel en
Ġ19 91
25 5
Ġadmin istr
Ġmat ch
plo red
Ġnecess ity
renew ing
Ġstep wise
Ġring ed
Ġgran ular
Ġpeg ylated
A Y
d isc
g able
k a
s ulf
Ġim age
Ġad ren
Ġun recognized
Ġap heresis
Ġro om
ag er
Ġcar minomycin
ex on
mic rog
Ġhyper diploid
Î¼ g
ĠHyp er
ĠInter feron
ĠAY A
Ġfif ty
Ġult ra
prec ursor
8 22
Ġm l
ic ate
Ġf oci
Ġb us
Ġb ring
Ġfor ty
ĠS erial
ĠN CI
ĠR C
tro ph
Ġ13 2
Ġoptim um
CN SL
Ġhelp s
Ġcollec tively
radi ation
Ġsol ub
Ġneuro logic
Ġmultic olor
Ġsw elling
ara C
Ġcooper ating
Ġcogn itive
ĠHMG B
ĠIntr iguingly
Ġmicrotub ule
Ġdetox ification
Ġrepur posing
Ġproteas omal
- [
B lood
h aemat
te cted
Ġn et
ĠN atural
ĠR E
ne a
Ġamong st
Ġaltern atively
Ġsple ens
Ġparad ox
Ġcoc ulture
his ti
Ġretri e
Q B
n l
Ġt rap
ĠS ox
Ġun responsive
Ġchem oradi
ĠK PT
Ġimp lying
Ġmin ute
ĠPh en
Ġins urance
Ġconstit u
Ġtumorigen icity
Ġchemo immunotherapy
Ġavo ided
Ġturn over
Ġspect ra
GAL S
Ġeukary otic
ĠPeriod icals
Ġimmunocomp etent
- <
E l
H ep
ph asic
de ath
ĠG R
ĠE BMT
Ġsub line
Ġlack s
ins titution
Ġhyper bilirubin
per formance
ob acter
Ġepithe lium
methyl cytosine
ĠEv i
ĠCO VID
ĠIG HV
% /
K A
it ting
Ġh ard
ĠA UR
ĠT OP
Ġac ademic
th romb
Ġcl ues
Ġtrans activation
pl ate
rac h
ĠTh y
Ġ12 4
14 4
IC U
Ġplas min
Ġeng raft
Ġlink age
Ġinternal ization
lan gi
Ġultim ate
Ġoncoprotein s
IG N
Ġexce ed
haplo identical
F rankfurt
T wenty
v ate
an k
Ġ( +)
Ġth ous
ĠT opo
ĠC AM
ĠM er
olog ist
ct opic
ĠK arnofsky
Ġam en
Ġstrati fying
local ization
ĠHas ford
s ts
t ocol
Ġle arning
ĠC an
ĠP at
ir al
ĠB etter
ĠW hole
ĠO SCC
ĠE G
urren ces
ult ures
Ġop posed
Ġ19 85
eri xafor
ĠML LT
Ġ14 1
200 5
lim ited
Ġz one
Ġparticip ates
ĠEn h
Ġadequ ately
Ġinterpre t
Ġdil ution
ĠImpro ved
onym ous
N o
Y N
r it
Ġh umoral
ip odophyllot
ad d
AB T
ĠCI P
Ġ13 9
AD D
Ġabrog ate
Ġdraw n
i ples
n M
Ġp ose
ec ting
ĠI ll
Ġlympho cytosis
ĠU GT
Ġaut opsy
ĠII alpha
Ġcent re
Ġgl omer
sc ore
EC OG
Ġpossess es
Ġprinc iples
FL IP
Ġbasophil ia
ĠMicro array
ĠTI MP
Ġnas oph
Ġthromboemb olism
ĠEstim ated
L N
P er
a ud
g ral
ĠC HR
Ġun stable
Ġconf ocal
Ġ19 87
Ġprof essional
ranul ocyte
AL M
Ġcur ing
Ġelucid ation
Ġextrac tion
Ġpossess ed
ĠBu Cy
Ġhisti ocytosis
identif ied
Ġenorm ous
E r
V H
Ġp ec
Ġp yr
Ġb uff
ĠT ra
im ited
ig lec
ĠM ark
anc ial
ap lasia
ĠU T
Ġmulti agent
effec t
ĠHemat ologic
Ġaw a
ĠHb F
Ap proximately
dep th
C MR
c ies
m yel
up led
Ġg lob
ud es
sis ted
11 5
lyc ythemia
Ġexperi ences
comp atible
Ġrepe ti
Ġpancre atitis
Ġescal ated
Ġgrad ual
Ġcorticos teroid
Nucle ophosmin
Ġorth otopic
Ġalloster ic
G ATA
b is
is sive
ĠH B
anc oni
Ġhem e
Ġsyn chron
ĠK it
Ġman ufact
ym ethyl
14 2
Ġ15 5
03 0
ĠMechanis tic
Mul tiple
d ia
ĠR HAMM
drom e
Ġhyp erg
LA M
Ġ19 84
tal k
In vasive
(- )/
cyt ogenetic
Ġhydro pho
ĠCombin ations
Ġpool s
Ġmyc ophen
Ġencaps ulated
que ous
ipl inary
/ =
E o
L BL
p las
Ġf us
Ġexpres ses
Ġmon ol
Ġsuc cessive
18 7
ĠCh k
Ġdom in
Ġmes othe
Ġdiss ociation
ĠTR EM
Immun e
ori ented
Ġsupernat ants
Ġging ival
S c
ro zen
Ġb ran
Ġon t
Ġg p
ĠD isc
315 1
Ġextrem e
Ġimpair ing
ĠSub group
ĠDe partment
wh ich
Ġdispar ities
atum umab
Ġepig enome
encephal opathy
ĠSCL C
Ġconform ational
Ġsocio economic
Ġdepr ivation
s ecre
ti g
or al
Ġb p
Ġfor ced
Ġl intuzumab
ĠD ef
ĠV alid
AL SG
Ġlab el
erc etin
Ad v
Ġsupple mented
Ġmarg inally
Ġdip loid
Ġglucocortic oid
ĠAnaly ses
K K
f iable
g lobulin
l ies
Â °
Ġf ig
Ġh ind
Ġst a
Ġk eratin
ĠK e
Ġinte gral
ĠCon sistently
Ġretin al
gram med
Ġwid er
Ġelucid ating
ĠHDAC s
Ġrever t
Am B
Ġble omycin
ĠRAR S
ĠMo Ab
ĠHist one
Ġglycos ylation
ĠMTH FR
H iDAC
O verexpression
Ġan ces
ĠC ellular
ĠM nk
Ġg amm
Ġg efitinib
rom eric
ĠD em
ĠE g
Ġtransplant able
Ġlow ered
ist ate
Ġimplic ating
Ġaltern ating
rid ine
Ġconduc t
iel ds
rec ting
Ġcat abol
Ġembry o
Ġfl uconazole
ĠTrans cription
ĠBi o
ĠPG E
Ġgran zyme
ĠCor rel
etho xy
ĠÂµ M
Ġhap lotypes
Ġnotic ed
ĠAssess ment
ĠLast ly
Ġecho cardi
L eu
i o
t rial
Ġg et
ĠN U
Ġel ast
Ġpredic tions
10 2
ĠĠ Ġ
Ġhaemat ologic
Ġlip opo
Ġbur st
FL P
ĠInt ensive
Ġcollab oration
granul ocyte
Ġpurs ued
Ġperm its
ĠLen alidomide
Ġspe ed
Ġlentivir us
C BP
it ness
ĠT E
ĠM IR
ĠH o
ĠO PN
Ġper i
Ġunder pin
yc es
Ġfound ation
par ameter
Ġ15 8
SP C
Ġsensiti zing
wh at
diagnos is
kel et
Ġperturb ation
antigen s
Ġhydroly sis
ĠEvalu ation
Ġaccompl ished
n an
Ġin determinate
es sive
ra hydro
ĠT CF
Ġis chem
de ox
and ed
Ġra ising
ĠJ oh
ĠV D
ĠAT F
Ġ13 5
omon as
Ġcategor ization
Ġdiv iding
Ġunde termined
Ġincid ent
rd U
Ġbrom ide
Ġtam oxifen
Ġfin ancial
Ġindisp ensable
Ġischem ic
H b
a HR
b rain
n eu
Ġs ensor
ro genic
Ġf ields
Ġb endamustine
im umab
ut on
so red
Ġsc Fv
17 3
ores istance
anti body
Ġcarb ohyd
Ġinsuff iciency
Ġsoci al
Ġinterrup tion
A SP
N ew
d ouble
Ġan at
Ġh ttp
am pt
Ġrec essive
Ġpres umed
ad vant
amm alian
Ġcap illary
PB SCs
Ġcont amination
Ġrespir ation
Ġenl arged
Ġbu il
Ġvehic le
I HC
e res
l av
t AML
u it
ĠT CL
ran ulation
Ġr un
ĠB is
ĠR ef
ĠG PR
ĠE t
Ġmulti functional
Ġ19 83
ward s
RAR S
ĠNe utrophil
Ġdeline ated
Ġpeg filgrastim
Ġsa fer
ĠCandid a
ĠEng raftment
Ġhyperbilirubin emia
C hemotherapy
a qu
e IF
ol ine
ĠP ol
ĠB erlin
ĠCD H
Ġ19 73
24 4
DR B
GS K
ĠPl k
Ġinfrequ ently
factor ial
Ġencaps ulation
PBM Cs
Ġnitro gen
Ġamen able
P BP
a em
re t
Ġc renolanib
Ġmet aplasia
Ġpre existing
Ġ12 9
Ġmicroen vironments
asp in
Ġcont ra
ĠAP Cs
An thracycl
ĠAc hie
Ġphospho inositide
Ġengine ering
Ġbeg un
G P
b x
w or
in ite
Ġt rop
ĠA Z
us p
ĠM AP
ĠE ORTC
ĠL N
ĠL P
Ġsome what
Ġrepres ses
Ġreactiv ate
Ġdex razoxane
Ġuncertain ty
ĠHyp ermethylation
Ġformal dehyde
Ġtubercul osis
D F
q RT
re en
an ucle
ar in
ĠT B
ĠT UG
un related
if lu
sp or
op tive
ĠE ctopic
rac tions
ip t
Ġcan ine
Ġprim ed
Ġ17 5
ĠCom plex
Ġisol ate
Ġsynerg ized
ĠPro gnosis
ĠPR MT
Ġeradic ated
Ġimmortal ized
Ġimmunocyt ochemistry
L ys
d oxorubicin
Ġc as
Ġs k
or ylation
at ch
ib rium
ĠB N
ri an
Ġun biased
ĠN QO
ĠR O
ad a
AR F
ĠPro te
Ġspectr al
ES U
ĠHist ological
Ġneo adjuvant
HE J
Ġenl arg
ĠLIN C
Ġbron ch
Ġrheum at
A AG
G enetic
Ġd ense
es tic
Ġre nd
Ġh arm
Ġh yal
em ble
ter ious
ĠI CAM
ĠS w
ĠN CR
NA c
Ġse ek
Ġpost operative
Ġacid ic
CB L
ĠZ AP
Ġexer c
Ġdemethyl ated
Ġparticip ating
Ġosteo blasts
Ġbehavi our
ensitiz ation
ĠTW IST
ampt othe
D ata
u ing
v ation
Ġm DC
ic ted
Ġre agent
ĠT AD
Ġl amin
Ġinter cellular
04 0
Ġmethyl prednisolone
Ġphosphor yl
ĠPro gression
200 3
cer amide
Ġeduc ation
ĠSil encing
ĠRa ji
] /
f olate
t d
ĠT SG
Ġg ate
ĠP IP
ĠH ES
ĠO K
ich ia
ser ine
Ġstr ing
12 8
Ġmicro biological
Ġ16 3
micro l
Ġrib osome
St at
atum omab
Ġelong ation
disc iplinary
Ġrend ered
, +
H IV
P SCs
T N
c ause
k B
t oph
he p
ot ency
ĠP seud
Ġdis advant
ĠF N
Ġap t
ĠL ess
Ġgenes is
ex p
iven ess
ok ed
Ġblock age
con ditioned
Ġrecommend ation
Ġpoly comb
ĠMN DA
lin atumomab
Ġuns uccessful
ĠCL EC
ĠSU MO
omat ous
ĠPO U
ĠRev iew
Ġpec ul
lies t
amptothe cin
al i
Ġth rombin
ĠP atho
ĠF ailure
ĠN OS
Ġhemat o
ĠL GALS
ĠK I
KI P
Ġimp erative
Ġradi olab
Ġglyc ophorin
Ġple i
ĠStatis tical
Ġhepatospl enomegaly
ĠValid ation
ESU LTS
P AR
g ia
Ġa queous
Ġc igarette
is tering
ur ate
ĠP AP
00 00
ear rang
iz er
MT G
ĠCh IP
24 8
Ab elson
Ġchallen ged
sign al
ĠHD M
Ġhaem oglobin
Ġhaem opoiesis
Ġenhancer s
igu ing
Ġmotif s
Ġunexpected ly
Ġhydropho bic
Ġmycophen olate
Ġelast ase
C ell
R G
e tions
â Ī
Ġs izes
ul lo
ĠC ALLA
ĠS CN
ĠG LI
ĠL AM
Ġar gue
13 9
ĠIFN Î±
comp etitive
ĠME L
Ġhaem orrh
ĠPC a
Ġspecial ized
Ġren ders
Ġcardiomy ocytes
Ġscan ning
nec ess
Ġjud ged
ecan oyl
Ġreconstit uted
L in
R b
S O
U sing
a q
b lood
l igible
v elop
Ġp ay
Ġb re
os omy
Ġpro ject
ĠC LA
uc l
ol uble
ĠP eg
ĠH DC
ĠB FU
ĠD T
ĠV DR
ĠX PC
Ġintegr ative
Ġhospital ized
Ġmanif es
Ġneg ligible
AN C
Ġparticip ation
ĠId arubicin
ĠTrans cript
Ġprospec ts
Ġscaven ger
Ġresol ve
Ġuter ine
Ġhelic ase
Ġathe rosc
G ranulocytic
H is
d c
f irst
Ġp un
Ġm ol
Ġ( +/-
et us
Ġmyelo proliferation
Ġ2 15
Ġr ising
ĠE SCC
ĠL EN
Ġar tificial
LA K
Ġ18 1
Ġposi tions
ord ic
ĠCC gR
ĠSout hw
Ġnever theless
olip id
ulph an
Ġsmo oth
pathw ay
Ġchemot axis
Ġdorm ant
Stud ies
V CR
h ing
Ġt akes
en ol
Ġh ENT
ĠH ow
ĠS I
ĠS OD
Ġun necess
Ġus ual
Ġidentif iable
Ġind ole
Ġprognostic ators
Ġmore over
Ġmin utes
Ġend ocytosis
ys regulation
mac rophages
Ġattenu ation
Ġchlor oma
Ġextend s
na ive
Ġhams ter
b ox
Ġ lob
Ġo macetaxine
Ġin appropriate
Ġw ound
Ġst ored
ap arib
ĠE sc
Ġcor ner
Ġcor rection
ĠPh ys
Ġmethyl cellulose
Ġretin oblastoma
ĠPB L
Ġtem ozolomide
Ġmimic s
ĠSh ort
Ġrub omycin
Ġcompens atory
etabol ite
Ġhypereosinophil ic
Ġimbal ance
flox acin
Ġpyro sequencing
E ZH
c utaneous
in ted
ly ce
Ġn om
ĠB SC
ĠCR M
Ġsc lerosis
Ġmicro gram
Ġter at
Ġdele terious
Ġintr iguing
Ġcont amin
immun ity
ĠATP ase
ĠHemat ological
EP T
Ġunex plored
Ġbo ost
Leuk emic
Ġalkal oid
Ġundersc ore
Ġglucocortic oids
Ġcarcinogen s
Ġdefer asirox
Ġrepeti tive
at osis
ĠT H
am ed
ĠS afety
Ġat taining
ex cluding
ep tides
Ġsil ent
ĠVEGF C
Ġhepat oma
Ġlys ates
Ġeth nicity
Ġcre ating
Ġfarnes yl
icl ib
Ġperman ent
Ġdras tically
Ġsequel ae
1 34
S m
o blasts
Ġt ry
Ġan ch
al ase
ĠC och
uc cinate
ab dom
Ġen forced
Ġinter rog
Ġmulti step
Ġpos es
Ġ16 5
ĠCon tinu
Ġmel ting
Ġinvas iveness
Ġmelan omas
sc Fv
Ġher al
Ġshif ts
Ġfavor ing
Ġsubdiv ided
combin ed
Ġnanom olar
G leevec
W G
in come
it oclax
Ġf rozen
Ġn ur
Ġst orage
Ġun modified
yc lophosphamide
Ġep ipodophyllot
ĠAT R
Ġmed ullary
ai wan
ode ox
ĠSystem ic
Ġradio immunotherapy
Ġscenari os
Ġmicron ucle
Ġgradi ent
Ġnasoph aryngeal
Ġenlarg ement
Ġs ter
Ġs FRP
ĠT aiwan
si m
im etric
her ichia
Ġco valent
ĠG lobal
Ġimmun ization
we et
12 9
Ġ[ <
Ġ13 6
ĠCon ditioning
ĠPD L
Ġpoly ploid
Ġpractic es
Ġoste oc
Ġallog rafting
Ġimple ment
cho line
Ġconn ected
ĠFB XW
Ġflav opiridol
PBM C
Ġshap e
O V
on ucl
Ġf ood
ot a
Ġcomp uter
ĠN P
ĠR IT
lec t
Ġimmun ostimulatory
ĠTh r
Ġpl au
Ġcontr as
Ġsh ut
ĠRec urrent
ĠCT A
000 6
ĠCBF beta
osyl transferase
Ġchlor ide
Ġbil irubin
thym idine
Ġlas ted
Ġdist ress
ĠMi R
Ġsubmic roscopic
C hem
el ic
Ġd ile
ĠC As
ĠI PA
Ġim ages
ĠP CD
ĠN M
Ġhyp odip
Ġmulti factorial
Ġ17 2
ced ented
pre cedented
fib rotic
allel e
can onical
Ġautog rafted
Ġadvanc ements
Ġempir ical
Ġplate au
Ġadjun ct
Ġprovision al
M s
O n
Ġp ocket
ĠN A
ĠN ow
ĠR ESULTS
ĠE po
18 8
Ġglyc ogen
Ġsol utions
Ġadop tion
ĠHyp omethylating
Ġgran ule
ĠACA s
ĠBas eline
Ġfav ored
Ġprost agland
Ġdro ple
- /-
N G
i ol
i ary
ĠC lofarabine
et oposide
ĠB ay
ap ses
ĠW P
ĠN H
Ġab er
ĠG leevec
ĠE B
Ġpre metastatic
Ġop ening
05 9
Ġcontinu ation
Ġisol ates
Ġdup lex
cyt ometry
Ġaden ovirus
Ġattrac ted
umin a
ĠDe pletion
for in
CY P
ĠADA M
che str
ĠLab oratory
Ġtremend ous
g f
it onin
Ġf all
ĠC CI
Ġl ic
ĠM idostaurin
enc aps
Ġsequ es
Ġfurther more
CC A
Ġnec rotic
Ġorig ins
Th r
Ġantic o
ĠHR QOL
Ġexcl ude
ĠBH AC
Ġpathophysi ological
Ġpneumon itis
Ġpeak s
CV AD
Ġschem es
ffic acy
Ġcommerc ial
sho p
Ġpericardi al
ĠRetro spective
ĠEg yp
ĠCoch rane
b ac
c ohort
m egakary
ve ments
ra ining
ĠI CT
ĠP a
Ġun w
ĠO NC
pl atelet
Ġag gra
Ġantib acterial
Ġ18 8
Ġlip oprotein
Ġaction able
Ġrest ores
ĠZ EB
Ġcat alase
201 0
Ġaden ine
Ġhepat ocytes
link ing
Ġtub e
Ġed iting
Ġrecapit ulated
Ġinoc ulation
Ġacces sibility
ĠAff ymetrix
Ġcryst al
coagul ant
Ġcolum n
> </
Ġt able
ul ins
Ġg ap
ĠN MR
ad ir
Ġmicro vess
Ġcommon est
Ġser v
sing le
17 7
Ġradi onucl
Ġke pt
Ġpotenti ates
Ġlif es
Ġbur dens
Ġrh G
Ġdia me
Ġhomolog ue
Ġfif th
Ġattain ment
Ġeryt hemat
Ġchaper one
Ġquestionnai re
kelet on
' )
H azard
R FLP
b its
m u
t ail
v ariate
Ġw all
Ġe chin
sp ring
ĠM ass
ĠW il
pro gression
Ġanti leukaemic
sup ervised
Ġlympho histi
tin ent
Ġmark et
Ġthrough put
Ġend ocrine
ĠML N
Ġonc olytic
23 5
Ġprote cting
30 9
Ġpur ged
ins ically
yr ib
Ġadap tation
Ġrh IL
Ġemphas izing
Ġtop ic
ĠPharmac ological
hyp er
otin amide
Ġneph ro
C SCs
O DN
al in
Ġre app
Ġ( '
Ġle ar
ac ill
ĠI U
ĠD AP
tim ately
Ġinter view
Ġwild type
Ġpharmacological ly
Ġapproval s
ĠFox M
Ġrecapit ulate
Ġambigu ous
Ġm om
an oma
ĠIn di
ĠR N
Ġgen otypic
Ġimmun otoxin
ĠL AA
and on
ĠV RE
Ġhetero chrom
Ġonc ologists
Ġcent ros
Ġsplic ed
Ġdeg ranulation
ĠCC G
Ġdysfunction al
Ġimpl anted
ĠGr b
ĠDiagnos tic
Ġlay ers
osa ic
V Î´
Ġ rac
Ġm ap
ic lo
om eric
Ġex osome
ĠP an
Ġad ducts
Ġun des
Ġco existing
Ġtrans cribed
Ġprim er
ĠV Î³
ex press
Ġer up
18 5
Ġins ide
Ġhel d
PB X
EN L
Ġyiel ding
igor ous
Ġconven ient
Ġcoron ary
N ilotinib
Q R
b ed
Ġm tDNA
Ġd ed
ĠT D
un x
et inib
Ġcon dens
Ġun precedented
Ġprim e
Ġpotential s
Ġam plic
Ġ16 1
Ġplay ing
IR C
Ġtransf used
EGF R
LI Cs
amb da
Ġtail or
Ġchemoradi otherapy
Ġplasmin ogen
Ġlymphohisti ocytosis
f ms
Ġt ag
Ġin ev
id amide
ĠA NK
ĠA PR
Ġ1 56
Ġor chestr
ĠB locking
am id
Ġad ds
Ġgro und
dom ain
Ġmed ically
Ġlip ids
Ġmuc in
Ġequ ip
ĠBec lin
pati ble
Ġbor der
ĠÎ¼ mol
Ġexpect ations
BA ALC
Ġadvanc ing
ĠNucle ar
Ġcommerc ially
E MT
P ET
m orbidities
ĠI TP
Ġor tho
ĠF LI
tr ation
Ġhyp ot
az adC
17 75
14 1
CI P
IC E
90 9
Ġthrombocyt openic
Ġtur ned
Ġadmission s
Ġperturb ed
bor n
Ġpropag ation
Ġcorner st
G BM
L Cs
Ġm osaic
Ġb in
red itary
ph an
ĠE ph
ros arcoma
ĠK IF
ĠML FS
MD M
ĠPD X
Ġcirc RNAs
ĠPro gram
Ġharb ors
Ġspar se
fe til
Ġdiver gent
F lt
s q
im ents
uc ose
ĠP ositive
Ġmo fetil
ĠN C
ĠN ordic
ĠL arge
ĠK S
The rapeutic
Ġqu ercetin
tit utive
Ġmethod ological
Ġ> /=
IC C
Ġunc o
Ġinform ed
Th irty
ru vate
present ation
olip osomes
Ġhistopatho logy
Ġdeliver ing
Ġreproduc tive
ns ter
Ġribonucle otide
Ġjusti fy
Ã¼ nster
idi rectional
Ġbus ulphan
hep atic
Ġpecul iar
ĠEsc herichia
A MSA
G s
H HT
I AL
W AF
at he
ra g
ĠC OL
um ines
Ġr ule
tr yp
Ġgroup ing
Ġsc ored
Ġmulti t
Ġmin i
ĠPh armaceutical
activ ator
ening eal
29 9
Ġdam aging
EB MT
Ġbl ack
ick ed
Ġâ ħ
Ġretic ulin
Ġaven ue
ĠCTN NA
mes enchymal
Ġsolub ility
7 01
D X
O nc
Ġp p
Ġw itness
as ing
ĠA UL
ĠC entral
ug e
anc omycin
ĠD AT
ĠD MSO
ĠF M
Ġun identified
ren e
ĠL ate
enc oding
13 8
zym es
Ġsu ic
Ġanalog ous
def inite
Ġdysp nea
ria p
ĠIg H
umb ar
ĠBD CA
Ġscat ter
Ġaneup loidy
Ġstring ent
R isk
i tic
Ġ %.
Ġa lo
ec tious
Ġn adir
ho logical
ĠP HA
ĠIn formation
th iaz
gres s
est a
ĠV OD
ici encies
Ġ14 2
05 5
Ġlink er
49 4
ĠSc reening
aro t
Ġmening itis
Ġpseud o
Ġpenet ration
Ġregen erating
ĠInhibitor s
Id entif
' t
in trinsic
if ies
Ġ1 53
rom atic
ĠH PLC
Ġdis ulf
Ġcyt ologic
Ġsub f
Ġhyp og
Ġhyp oplastic
Ġimp ending
ans w
Ġconjug ation
met ho
rad ecanoyl
ĠCTN NB
Ġdinucle otide
Ġplei otropic
Ġaber ran
bac co
R e
i k
Ġp ortal
Ġs IL
Ġb ench
gen ce
ce ived
Ġbe vac
Ġg ut
Ġg ating
anc re
ĠG as
Ġrece ipt
ip p
LT C
Ġcor rected
16 9
Ġadmin istering
In hib
In troduction
Ġarabin osyl
Ġadap t
Ġincon clusive
Ġdisturb ances
Ġlay er
Ġexhaus tion
Ġtas k
Ġpolic y
Ġcontra ind
Ġunnecess ary
Ġbevac izumab
G ene
en sed
Ġb right
id arubicin
ab ase
ĠP CA
Ġby p
Ġrel ating
por ts
ĠN RP
ĠR RM
ĠE PH
tr ig
Ġdev iation
PM I
Ġref ers
CI K
Ġ16 2
ĠEx amination
67 6
AN CE
ĠPU MA
ĠAnti gen
Ġultras tructural
Ġretain s
Ġwors ened
Ġthorough ly
ĠEffec tive
Ġov ary
Ġlear ned
C EM
F OX
P l
u ity
is ome
Ġf lex
ot or
ant inib
00 001
Ġab ilities
ĠE uro
ĠE Vs
Ġover production
Ġpo ison
ast uzumab
Ġman us
go od
osup pression
iltr ation
ĠMN C
Ġbio active
Ġear liest
Ġaddres ses
Ġtrac king
Ġphag ocytic
Ġstriking ly
Ġcathe psin
Ġultras ound
Ġfarnes yltransferase
org anis
Ġcondens ation
S omatic
or n
Ġbe ads
ab s
ĠB ID
ĠS CC
ĠG I
Ġpar ts
34 2
Ġprolifer ations
Ġpos terior
Ġphen otyping
Ġ14 3
Ġhyper calc
Ġi NOS
Ġver te
Ġtermin ally
Ġinst ance
flu idic
Ġneutral izing
ĠEr ythro
638 45
ali platin
D E
H ere
H IF
W M
Ġ ;
ar ts
ĠI CR
ĠI AP
um a
ĠD et
Ġrespon ds
Ġab andon
Ġro se
ĠK ary
Ġoptim ally
Ġmed ullo
Ġi NKT
Ġdam aged
ĠQ T
-- --
Ġvol asertib
Ġweak er
Ġdeb ated
ĠTK D
Ġadjust ments
Ġorganis m
Ġvascul itis
ĠWE HI
toph an
Ġp el
is tein
ic ated
ph orbol
por tive
othe lial
Ġgro ove
ĠE MD
ĠE TP
Ġdec ipher
Ġcharacter izes
Ġtox ins
Ġaccording ly
Ġintegr ins
Ġcho langi
Ġaccel er
Ġinser ted
Ġavoid ing
phosphor ylated
CAL GB
lys accharide
ĠEgyp ti
f s
p ost
Ġtre osulfan
st ine
Ġcomp ares
Ġne igh
pro b
ĠN VP
ĠG L
Ġpre malignant
Ġsup posed
Ġ12 36
22 5
ane oplastic
Ġcap t
DR G
Ġsal ine
Ġadap tor
Ġpregn ancies
dC yd
ĠHSP C
Ġweak ness
SR SF
Ġnod ular
Ġvascul ature
Ġfulfill ed
ĠGu id
Ġoncom etabolite
Ġcust om
N on
f osfamide
y loid
Ġin activ
Ġin organic
ĠT el
ĠH ispan
hem a
ular ly
CD A
Ġocc ult
Ġsim ulation
omet hyl
Ġ19 0
Ġ19 82
Ġmor pho
In ternal
ĠOn ce
Ġdepend ed
CP X
Ġevolution ary
Ġsal iv
TP A
Ġintr insically
Ġaccel eration
Ġcontribut or
lassi fiable
ĠSH IP
My lotarg
Ġperturb ations
Ġperox ide
ĠImmunohist ochemistry
M yb
P IM
R as
f ocal
z ygo
te e
Ġf u
ul ator
ac ting
CR EB
Ġhe reditary
Ġpat h
Ġmod ule
ech st
mon ocyte
ag glut
Ġ20 4
ĠSt age
Ġvalid ity
ĠRT K
Ġoff spring
ĠBA G
Ġauto immunity
HDAC i
Ġepis ode
ĠFOX P
strati fied
Ġchann els
Ġalloc ation
Ġunivers ally
Inc reased
Ġsuccumb ed
ĠAltern atively
ĠCauc asian
Ġunres olved
Ġmesothe lioma
ĠJoh n
Ġrheumat oid
B ec
I MA
N RAS
S N
s qu
z er
Ġm DCs
as al
Ġh it
ĠC ri
Ġex isted
Ġl ose
ĠM ZF
Ġout lined
Ġout look
Ġ15 4
Ġpreferen ce
ĠTRA F
Ġinterf eres
enh anced
urt inib
Ġcoord inated
ĠSm all
otrans ferase
esta urtinib
M UT
V AD
Ġ </
Ġa urora
Ġan ion
ro bor
Ġex tran
Ġde phosphorylation
Ġv ag
ĠD LC
Ġco factor
ĠE st
ĠL IF
Ġprotein ase
21 8
Ġmat ur
ĠDC K
Ġattenu ate
prom yelocytic
Ġarsen ite
ĠClin ic
ĠSci ence
El derly
A Z
d ifferentiated
d gehog
al den
Ġf ounding
ut ch
ol s
Ġv ancomycin
Ġun equ
ph thal
der ing
Ġhe dgehog
Ġro d
Ġfe at
og l
17 8
Ġpost induction
UN EL
27 5
ĠEx cept
ĠAp pro
olar ization
Ġtem plate
Ġproblem atic
Ġconn ection
ĠKore a
Ġcot reatment
ĠEff orts
Ġconv inc
ĠIll umina
ĠIndi an
d aunomycin
f requency
it um
Ġd ot
er ly
Ġb ab
ĠC AF
ot omy
Ġst atin
oc cal
Ġg lobin
ĠF H
Ġun answ
ĠR are
Ġ9 00
Ġpar acrine
Ġbi le
ven tive
LA IP
16 8
19 2
Ġ14 9
jec ts
Ġestabl ishes
Ġblock ers
yn ure
Ġgre w
Ġlip ophilic
Ġutil ize
Ġdep osition
Ġantagon ism
gl ia
co upled
Ġadop tively
tet radecanoyl
ĠTc R
ĠSouthw est
Ġunansw ered
K RAS
L e
P TP
m ixed
Ġw arning
si ent
Ġpro xim
ĠM H
ĠR IST
ĠL DL
Ġspec ulate
ateg ies
Ġreported ly
33 9
ALL s
Ġsus taining
Ġkill s
IF D
Ġinternal ized
Ġrever sion
Am ong
tes tis
Ġconver t
ĠPT L
Ġproce eding
Ġpatholog ies
4 01
M Ã¼nster
a im
m n
o in
y x
ti tion
Ġs aturation
om ark
Ġex tr
Ġcomp elling
Ġun less
th rombin
ĠR unx
ĠG al
ĠE MA
Ġtumor al
Ġel even
ĠCR p
ke ep
ĠCh aracter
ĠCyt otoxicity
Ġpub lication
ob iotic
Ġmis sed
Ġdimin ish
ĠFac tor
Aut ologous
Min imal
G ra
P ediatric
R BC
n T
r p
ti um
it ron
Ġb randed
ĠA ct
ĠT aking
ter al
ĠM FI
ĠP onatinib
ĠF AS
ĠS te
ĠE V
Ġpo inting
Ġpar am
reg s
Ġpartic le
ĠNK D
Ġ17 9
ĠWh ite
con cept
Ġsp ati
IF IC
Ġacet ylated
Ġfibro tic
Ġshif ted
occ urrence
ĠPA I
appro ximately
ĠSequ encing
Ġmitig ate
Ġmultit ude
C SA
L P
S YK
g ar
m Abs
p erm
Ġm aspin
os te
os idase
Ġr IL
ĠS IGN
ĠO wing
ĠG ab
oun der
ĠL nc
ip arental
ers en
Ġnon obese
gres sive
11 4
RA K
Ġmulti disciplinary
Ġsh ar
ĠIt aly
Ġclon ogenicity
ME C
BCR P
Ġoste ogenic
Pro tein
ĠGF P
stud y
Ġlymphoblast oid
Ġchond ro
ĠHo echst
Ġunderpin ning
ancre atic
ynure nine
IFIC ANCE
ĠSIGN IFICANCE
R af
V enetoclax
f ixed
f inger
g uanine
s Ab
en og
Ġm old
ĠP TCH
ay ers
Ġsur prisingly
ĠD ex
ĠD KK
ĠF K
ĠS DS
th irds
Ġchem op
ĠE CD
Ġfac ed
Ġevalu ates
LA C
Ġrev ision
Ġmicro bi
Cs A
25 9
ĠMY H
ĠClinical Trials
inte racting
Ġrepl ace
ĠNO P
reduc ed
Ġoccup ancy
Ġalkal oids
Ġtrim ethylation
ĠProm oter
ĠMain tenance
ĠZR SR
Ġlifes pan
i ke
p tin
s us
an il
Ġb ax
ĠC AT
ut ral
ĠM AL
Ġor phan
iz able
Ġdrug gable
Ġdem and
AB SI
Ġacc r
12 1
Ġmicro fluidic
Ġprec ip
Ġloc ations
Ġflu ids
Ġsix ty
Ġphospho lip
unc tiv
Ġoccasion al
Ġcomb at
Ġresearc hes
ĠMorpholog ical
Ġjunction s
Ġincre ment
Ġgest ation
Ġhemophag ocytic
d oc
h istone
m ammalian
p ositivity
Ġt ric
Ġo il
Ġan terior
al dehyde
at abase
ĠT aq
ho ea
ĠI DR
Ġcon ve
ĠD O
ĠCD I
21 6
22 4
Ġ18 7
18 4
29 3
Ġleuc ocytes
PH OS
avail able
ĠCd c
Ġsinus oidal
Ġrepop ulation
TO F
n umber
o ted
Ġt al
ĠP LT
pec ia
Ġevent ual
Ġcolon ization
Ġrecogn izes
Ġstatis tics
Ġxen obiotic
Ġmis diagnosed
Ġmodif ier
Ġmismat ching
Ġvulner abilities
Ġcation ic
Tar geted
Ġlap atinib
S urvival
om ers
Ġh ub
ĠA CT
im od
ML H
ĠH om
ĠB or
ĠD APK
ĠD ifferentiation
Ġper ipher
ari ant
Ġhe aling
Ġop ened
Ġmicro organis
Ġsh ares
AR G
Ġcandid iasis
ĠPB X
Ġexplain ing
Ġincom patibility
Ġimpl antation
ĠMon oclonal
Ġradical s
ĠFLA MSA
Ġdischar ged
Ġsupernat ant
Ġdeterior ation
ĠOp timal
Multi drug
A CT
C ore
F GFR
d is
al isib
ic an
os itis
ec ycline
ĠT ax
qu ar
Ġcyt oprotective
Ġ4 50
Ġexp ense
Ġnon invasive
Ġme pes
Ġdown regulates
AL Y
ok inetic
26 6
Ġ28 0
ĠCT C
201 3
Ġpul se
Ġhepat omegaly
ĠAD CC
Ġcountr y
inhibitor s
ĠEl derly
Ġobstruc tive
Ġmepes uccinate
% Â±
C MP
M al
S OD
g el
v L
re ptom
as hi
ĠA MG
Ġg yn
ĠP LC
st rom
ĠS ide
di p
Ġfac ial
Ġsub family
ĠL o
ĠL ower
ip oside
34 7
ch icine
Ġconf ounding
15 2
Ġep silon
Ġ19 70
33 8
25 1
Ġmetabol izing
Ġox aliplatin
con t
000 9
Ġexpl oratory
Ġrever ted
Ġhal ving
ĠCAL CRL
Ġcop per
TR EM
Ġuncon jugated
Â® </
Ġtempor ary
Micro RNA
Ġbioavail able
ĠSCI N
At ypical
Ġheight ened
Ext ramedullary
Ġcarbohyd rate
ĠNOP HO
> Â®</
K DM
S ET
p atho
u ous
om bin
ĠT fR
im id
ur g
Ġac ted
Ġfor ce
il imumab
Ġv enti
Ġv ision
Ġres ected
ad ecitabine
Ġcor robor
ĠK CL
ĠU PD
ĠHe tero
Ġmacro globulin
immun op
sign aling
Cl onal
Ġresemb led
ĠDel etion
Ġstom atitis
ĠBr uton
yrib onucle
ĠDet ailed
S ome
V IM
Z L
c ase
s al
ti tis
ĠT rial
ĠT AK
Ġle ptin
ĠB inding
Ġco variate
Ġab st
Ġunder to
Ġmodel ed
Ġpharmac ogenetic
Ġtransf ect
Ġpotenti ation
ĠPro tocol
Ch IP
Ġminim izing
âģ ¹
onc ogenes
Ġupd ates
Ġsubcl onal
Ġdist ance
Ġplurip otency
Ġsem iqu
Ġadvanc ement
truct ure
BE AM
ĠMEC OM
Ġexem plified
Ġhypercalc emia
Ġunderto ok
G BL
M ol
d o
Ġc amptothecin
Ġb ov
ĠA HR
ĠM IT
od i
ĠH AM
Ġmon ocytoid
Ġhem opoiesis
ĠL I
Ġel ab
Ġop tical
18 3
24 3
Ġj a
ĠPR C
Ġpersist ently
aun o
Ġsubc lassification
Ġexplain s
mod ulation
dC K
Ġrepeated ly
ĠCompar ative
St andard
Ġrecur red
Ġphosphatidyl serine
Ġte a
eng ine
Ġrender ing
Ġinstrum ental
Ġstrict ly
Fas L
integr in
Ġmanus cript
X A
k ine
Ġt it
Ġc ures
at her
ĠT NT
ter one
ĠP r
ĠP cG
ĠB ad
Ġse vent
ĠL IC
depend ently
min imal
rect omy
02 01
Ġmit omycin
rophil ic
Ġwork flow
Ġlink s
Ġchim a
200 6
Ġamin opeptidase
Ġunde restim
ĠRAR beta
Ġcytos ol
Ġpharmacodynamic s
Ġcoinc ided
Ġcryopres ervation
Inc reasing
TAM s
ĠDi rect
istin ct
Ġexerc ise
Ġmom ent
Ġwitness ed
C OX
u v
Ġa rose
Ġp aternal
Ġs arc
ĠC lo
ĠM c
ir us
th y
th ora
Ġass umption
Ġres ide
Ġper f
ĠK U
crip tase
Ġsec tion
ry ostatin
Ġ14 7
roph yl
ĠBM S
18 2
ĠCom orbidity
ves ic
ĠAm eric
Ġcarcin ogenic
Ġpur posed
Ġimm o
Ġrest ing
55 8
Rec urrent
Ġattemp ting
Gl n
ĠSwed en
Ġpip eline
ĠPos sible
ĠPe ople
Ġfig ures
ombin ant
C HR
F ACS
H aplo
O p
v ar
Ġt ro
an es
Ġg all
duc t
ĠD HA
Ġhe lix
ores t
osup pressive
Ġsu it
itu itary
Ġgu anine
Ġsubstan ti
Ġoxy genase
co ated
micro RNA
chlor o
ĠMe as
CX CL
ĠCE A
Ġinterm edi
Ġnecessit ating
ĠNeu ro
ĠRand omized
ĠEgypti an
D IC
n aph
r ig
Ġc odes
an in
si te
ig ecycline
gen es
ĠM uch
ĠH V
di oxygenase
Ġexp on
loc ations
Ġer yth
ST M
23 0
Ġunc lassifiable
ochem otherapy
Ġrecogn ised
IM EMA
Ġhepat ocyte
Ġtet ram
Ġmodest ly
ĠMo Abs
sil enced
Ġpredis pose
Ġdiscrimin ating
Ġprecl ude
Ġdead ly
abdom y
al tered
ĠT MD
Ġch art
ĠP otential
ĠN Ps
Ġhem olytic
ĠL AP
Ġmod es
Ġam yloid
Ġlower ing
ĠCh ar
Ġprofil ed
lob ulins
Ġpoly peptide
Ġcris es
Ġul cer
Ġclos er
Ġconstruc tion
Ġvaccin ations
Ġcoup ling
Ġhar ness
Ġstabil ized
ĠInter leukin
ĠChrom atin
Hyp er
Ġrab bits
Ġamelior ate
Ġfung us
Ġrepop ulating
Ġantimetabol ite
ĠPPAR Î³
Ġaccr ual
D ifferen
H M
f emale
g raft
j un
t ypes
Ġf em
Ġb ed
Ġst ro
ff e
ĠF anconi
ĠS Y
Ġres emble
Ġmar ine
Ġover comes
Ġbi phasic
Ġup regulates
Ġinte restingly
ĠV er
Ġ17 6
Ġ17 7
Ġinterac ted
(- /
Ġpur ification
Ġsubt le
ĠST AG
Ġreal ized
Ġinsi gn
IF I
Ġcapac ities
Ġcalc ulate
ĠPI K
Ġple thora
Hyp omethylating
Ġosteo blast
Ġallevi ated
Ġdiges tion
Ġmedullo blastoma
ĠGuid elines
F rench
I QR
s ection
en al
Ġo uter
at ases
Ġe yes
ĠC ur
Ġl in
ĠM uc
ĠM CP
ĠH PC
Ġ2 30
ĠF rance
pro grammed
ĠO mn
Ġup regulating
Ġop eration
Ġ15 7
Ġbenef ited
Ġ18 6
ĠCon trol
Ġimmunosup pressed
sy stem
ĠY M
Ġpul sed
Ġwarrant ing
hydrox ymethyl
pur ged
Ġsuic ide
riap ism
itum omab
Ġproxim ity
reptom yces
v oc
Ġ ),
Ġa eti
Ġa GvHD
Ġt un
Ġc ere
ĠC SA
ac tion
od ay
ĠH K
Ġcl osed
ĠN IH
ĠE fficacy
Ġinvestig ates
Ġdes crip
Ġinte stine
Ġ19 8
Ġdaunorubicin ol
yth aemia
Ġvaria bly
cep tions
Ġcirc ular
ophil ia
yr in
Ġrecru iting
Ġparen ch
Ġopportun istic
ĠNew er
Ġhistopatho logic
ĠNor th
ĠIniti ally
CDK N
Ġexceeding ly
ĠEngl ish
iclo vir
C bl
S ystem
m el
on st
en em
gen ases
ĠP t
Ġdiff usion
ĠO GG
form erly
Ġpl erixafor
12 08
Ġ19 4
Ġflu oro
of lu
Ġconc ert
Ġcent ury
Ġsil ence
ĠVEGF A
Ġuns u
ĠCompar ing
Ġdiarr hoea
ĠYoun ger
E V
N eu
P LL
en sing
Ġc ock
is en
Ġto bacco
sion s
ĠI ran
Ġch ances
ĠD atabase
ĠR G
ĠL FA
ĠL QB
Ġrec onstr
enc oded
Ġmul tin
Ġfirst ly
Ġmechanis tically
Ġexplo res
Ġprote olytic
27 80
ĠCpG s
ĠDec reased
Ġchimer a
ĠDown regulation
hion ine
ĠSup pression
Ġhydrox yl
Ġperox idation
ĠAI DS
design ed
Ġplac ental
Ġequil ibrium
Ġgang li
Ġdefic its
Ġacceler ates
d t
Ġt rip
ti p
Ġthe ory
or ub
Ġd ermal
Ġb r
ĠM ixed
Ġch idamide
ri z
Ġcoun sel
14 98
val ently
26 77
Ġsp p
ĠAb elson
Ġmonos omies
Ġclassif ying
Ġtelom eric
ĠTF PI
Ġmismat ches
Immun otherapy
NE ST
ĠCor responding
Ġubiquit ously
Co V
ĠLY N
ĠAustr al
ĠRece ptor
Ġdiame ter
ĠEPH X
. ).
L ittle
a P
g reater
k L
Ġc ir
Ġb ig
gen cy
if ug
op ulation
ĠS ection
Ġover c
ad m
Ġdef iciencies
Ġadv oc
Ġ14 6
Ġcolon ic
OR E
Ġtr uly
Ġsuccess es
Ġaz anucle
ER C
ER IAL
29 6
con tinu
Ġgu ided
ĠPro b
Ġcollec tions
(-) )
Ġadd iction
Ġten iposide
Ġbo ys
ĠBR E
cycl ing
ĠDU SP
Ġprospec t
Ġansw er
ĠUl timately
ĠMAT ERIAL
haemat ological
ĠKe y
R L
T HP
b rom
c m
i j
o vir
s ue
Ġc lo
Ġh in
ĠA LT
ĠA MC
Ġn av
ĠT re
ĠP PI
Ġres erved
ĠL AT
term in
ĠV al
Ġ14 4
Ġapproach ing
Ġ16 4
Ġeng ager
Ġlife time
ĠMy Ag
inhib ition
My D
Ġoc clusive
Ġthor ac
Ġrelia bility
GST M
F GF
G AP
S p
e os
n ose
Ġin os
Ġm L
om b
em erg
ĠT IG
Ġl estaurtinib
um ented
th yl
Ġchem istry
ĠG livec
ĠE spec
Ġpar aneoplastic
Ġdem onst
11 1
par tial
Ġcompar atively
Ġmy r
Ġcap abilities
yn am
ust rian
ĠPD T
66 2
EL ISA
ĠCSF s
Ġpolyc hemotherapy
Ġcarb onyl
ĠDifferen tial
ĠTr isomy
Ġhope fully
Ġbu ild
Int ensive
ĠCirc ulating
Ġcornerst one
yx eos
D onor
F ew
U PD
s econdary
or ption
Ġ( -)
ĠC IT
ĠR ates
ĠR educ
Ġper forin
ox ic
Ġpres ervation
otox ins
13 6
Ġgranul opoiesis
Ġprote ases
arb oxyl
Ġamin otransferase
Ġbelong ed
itone ally
Ġmening i
Ġdisturb ance
Ġpublic ly
Ġcounte ract
acr yl
Ġprefer able
Ġdisulf ide
/ (
d asatinib
m or
as ia
ĠM us
ĠThe r
tor ically
enti sts
Ġk et
pro por
ĠR PS
ĠG RFS
Ġag lyc
rac ts
ox ia
ome ter
Ġdec ided
Ġsim pl
Ġprop oses
und ant
ĠSt reptomyces
CA s
Ġ29 3
mal e
NT R
Ġsupple mentation
Ġhepar in
Ġharbour ing
Ġances tral
Ġbov ine
5 01
E n
G roup
Ġf ish
ĠA Q
ĠA RT
Ġpro caspase
Ġpro coagulant
Ġl up
ĠB AD
ĠS uccessful
Ġco expressing
Ġrespon der
Ġhemat oc
Ġdev oid
form e
ĠCR P
33 0
ĠPh osph
Ġtr is
ĠĠĠĠĠĠĠĠ ĠĠĠĠĠĠĠĠ
ereg ulated
me as
Ġmas sively
Ġimmunological ly
Ġkidne ys
anth racycline
Ġtail oring
gluc ose
Ġimmunocyt ochemical
âģ» /
hal f
Del ta
Ġimmunob lotting
Ġflan king
Ġradiolab eled
Ġaberran cies
Ġdemonst rable
l act
â ħ
as tic
Ġh MLH
Ġis ot
Ġst and
ĠAML CG
ap t
Ġse ed
ĠL LC
Ġvari ance
Ġqu ad
Ġsim ulations
20 2
IC AM
Ġdom inated
ĠWh at
ĠY AP
Î¼ l
Ġmaxim ally
Ġpossess ing
Ġmate rials
Ġinstit ute
Ġcogn ate
ĠMan agement
rele vant
Ġpsyc hological
acyt arabine
Ġheterochrom atin
B S
C CL
a ment
al f
Ġb ud
od in
st atus
ular ine
Ġrec lassified
Ġdev ised
Ġdes ired
Ġdes erves
Ġpur ity
Ġcal f
ĠPB SCs
ef ined
SA ID
ĠAp plication
Ġlog s
Ġparticip ated
ĠMed icine
arabin oside
ĠIT GBL
Ġcorrect ly
Ġintercal ation
ĠTox ic
Ġsubstit uted
Ġsubstit utions
Ġgover n
syn onymous
evalu ated
iment in
Ġlon gest
Ġlipopo lysaccharide
earrang ements
Ġalo pecia
Ġextran odal
( +/-
B oth
b f
Ġ ile
he sion
Ġto t
ut arate
ri end
ĠN IL
ĠG E
ĠE NEST
inding s
KI Rs
Ġol aparib
In duction
Ġlab elled
ĠPR K
Ġdistrib utions
Ġguid eline
ĠCAL M
Ġbl ind
ĠAnti body
ĠTr x
Ġcircum stances
Ġgal act
Ġcoc ultured
ĠUL BP
ĠBl ack
ĠOK T
ĠEspec ially
A fter
B ased
D PB
d R
m pl
p DC
Ġt ap
le y
le rotic
ut uzumab
um ol
Ġg rafted
ĠF CH
ĠR ad
tro viral
Ġcoun ting
17 4
yd aunorubicin
Ġsu ited
Ġunf old
Ġhomo zygosity
utri tion
ĠEr k
Ġdisturb ed
Ġpatholog ically
Ġallevi ate
Ġpack age
Ġunac ceptable
ogl utarate
. </
B ax
D own
O s
b reak
c ore
Ġa fore
Ġin definite
Ġre sequencing
id el
ĠM Cs
ĠM yb
ost ine
Ġpres erve
Ġdec ay
Ġmulti forme
Ġaut otransplant
Ġadmin ister
Ġimplic ates
ero bic
Ġsynthe tase
ored oxin
Ġadvantage ous
Ġabrog ation
ras tim
Ġbios ensor
Ġhistological ly
Ġexperiment ally
Ġintraper itoneal
Ġretrie ved
aud i
ĠSw it
Ġshut t
Ġdrople t
< </
D endritic
N OD
S ix
r ide
Ġp ren
le thal
Ġf air
Ġf irm
if ostine
ĠH HV
anc iclovir
ĠS OS
ĠS MN
iz on
Ġout per
Ġ6 77
ensi fication
ĠK ing
ĠCR T
Ġext rap
Ġmin d
Ġ17 1
dom inant
Ġexplo iting
ĠCAL GB
ĠRAR alpha
ĠCCR F
ĠSout h
ext racellular
Ġcooper ates
Ġmusc ul
Ġaff or
ĠUp regulation
rad ic
Ġgover ning
Ġepig en
ĠLog istic
Ġdich ot
Ġafore mentioned
) <
B SC
x or
ati le
Ġd ura
ĠA part
ia e
Ġle g
ĠC MA
ot ri
Ġun available
ĠG AB
ĠE ML
ĠL imited
ĠL SPC
Ġinter genic
est yle
Ġdes tro
li ters
Ġprolifer ator
ĠV ery
Ġtr astuzumab
IL s
ĠCT SL
Ġelev ations
Ġcirc RNA
ptom eningeal
99 9
rup tion
Ġdiv ide
ID O
ĠDR I
Ac tivating
bl ind
ĠMedic are
Ġip ilimumab
Ġchemop re
Ġoverc ame
> >
H GF
I B
R alpha
c ross
ic idal
ĠA v
ib us
ĠM ic
Ġun iparental
Ġrel ates
di hydro
ĠE GR
est abil
ne utrophil
ĠALL s
In k
Ġprot otype
Ġorgan ized
ĠAp p
Ġdiss ect
Ġevol ves
ĠHemat ol
Ġlys osomes
Ġeti ologies
Ġcataly zes
Ġpersis ts
with out
Immun ophen
Ġham per
PDGFR B
lyce rol
Ġmicrovess el
ĠFCH SD
B AL
D isease
O I
V AF
Ġm CR
Ġd F
ec yl
Ġl ambda
ĠS GI
Ġcl aim
Ġen um
Ġmon ophosphate
ip er
ad verse
Ġind ustr
Ġexp ands
ag ulation
10 62
ach ing
22 8
Ġend ow
Ġsp ac
Ġly sed
Ġpoly phen
Al lo
Ġmim icked
ĠAD P
Ġpain ful
inter leukin
bl ue
olip ids
Ġubiquit ous
Ġretur n
Ġamelior ated
Ġdisp ensable
imer ism
thiaz ol
Ġverte b
Gra de
Ġstro ke
- ).
H S
k ip
k aryotype
n os
Ġm IDH
Ġb ases
ĠA O
Ġl umbar
Ġ2 70
ĠB rdU
ĠD ox
ĠD ays
ie ties
ĠE nc
Ġimmun og
ad min
ad herent
ĠCR s
Ġsc ant
Ġ20 5
GS H
Ġelimin ates
adi an
Ġemphas ized
ĠCG E
Ġgran ted
Ġvulner ability
Ġfung i
Ġpass age
ĠAltern ative
Ġcytomorpholog y
prob able
3 24
8 12
b re
m yr
w ere
ĠC ar
Ġas cribed
ĠW alden
Ġco valently
Ġspec ulated
MT S
Ġref used
Ġnucle osides
Ġ17 4
Ġradi os
Ġtra jec
ĠAL OX
Ġsi RNAs
Ġlys ate
ĠDe ep
quis ite
aut ologous
aut onomous
Ġcerv ix
Ġweigh ted
Ġthous ands
Ġborder line
Bec ause
omark ers
doc umented
Ġmicroorganis ms
Ġgyn ec
Ġventi lation
ĠOmn ibus
Ġlup us
idel ity
3 20
F P
G IST
c ancerous
i op
p osition
he xim
is tingu
Ġf ounder
Ġe jection
ĠC EBP
ot ensin
ver ted
ĠM at
Ġch ip
Ġdis omy
Ġad opt
ĠD X
ĠS J
por ting
Ġinter individual
16 5
Ġrepres s
ins ensitive
ĠRec ogn
Ġproper ly
Ġmean while
RT K
Ġangi opoietin
Ġcomprom ising
Ġwithdraw n
Ġmono allelic
Ġseg ments
local ized
ĠExt ramedullary
- ),
4 21
H sp
M ixed
S W
l ase
m eg
Ġp it
Ġs ense
ic ular
Ġf um
id ib
ve rolimus
ra ms
ĠD P
ĠS weet
Ġk i
Ġph age
ore fractory
ad riamycin
AT H
Ġcol chicine
Ġ20 8
20 7
Ġadult hood
ink ing
orpor ation
Ġintro ducing
Ġcalc ulation
ospor in
olone y
Ġsimple x
Ġimmunomod ulation
Ġstabil ize
Ġabund antly
hom ologous
Tr p
053 1
wor thy
Ġhaemorrh age
ĠBay es
engine ered
voc idib
emerg ent
b B
l f
Ġs aving
Ġre expression
Ġb linatumomab
ter ia
Ġv as
ĠB MD
Ġ3 50
ron g
ĠG ata
CR P
Ġpl acent
yc arb
Ġins ensitivity
Ġpep tid
lor o
Ġgain ing
Ġaug mentation
Ġencoura ge
Ġencoura ged
Ġabrog ates
ED D
stit uted
Ġvis ible
ĠCons olidation
Pro gnostic
Ġtub ulin
ĠIK K
Ġautog rafting
Ġhydrox amic
Ġbrid ging
Ġsmo ke
ĠPN H
Ġwa iting
Ġport end
Ġhor izon
Ġselen ium
Ġmacroglobulin emia
hexim ide
C yd
R eg
c ing
c ord
g ths
i em
al veolar
Ġf a
at able
ul itis
yp ing
ĠF ZD
ron ate
Ġtrans amin
Ġnon adherence
PM A
Ġ19 6
Ġ15 9
Ġconcentr ated
MR I
ĠAd j
ĠPD GF
ram etinib
Ġsal t
rin ted
Ġquestion ed
SE ER
ĠPharmac okinetic
Ġsem is
acchar ides
osc opy
ĠRep e
utrop enia
nR NP
294 002
ĠBis ulfite
9 13
E le
Ġt on
Ġm mol
ar ginine
Ġf ix
Ġb idirectional
Ġh ur
ĠM el
ĠM ex
ute ro
tem pts
Ġ4 21
Ġop tic
12 36
AC E
ither to
HR s
Ġtransform ations
Ġtransloc ated
27 6
CP T
Ġsynerg izes
Ġconstit uted
ĠPB B
Ġspl it
lab oratory
Ġundergo es
ĠSh p
Ġformer ly
Ġann ually
SIR PÎ±
prim ed
Ġmigr atory
Ġhyperg lyc
Ġamplic on
Ġspati al
riz z
myr istate
H CL
H ID
T SG
c aus
w as
te ch
ĠA XL
ac hed
ol ation
Ġde al
ĠB ritish
ĠIn s
Ġun reported
âĢ ħ
Ġpo inted
end ocrine
Ġdec ide
ogen omics
Ġphosph atases
Ġdepend encies
Ġhom ogenous
mit otic
ĠQ oL
Ġtransl ating
201 4
ĠMut ated
anti bodies
osyl ceramide
Ġrh GM
ĠSET D
Ġquin acrine
ĠSA MD
Ġfav our
ĠPseud omonas
Ġprostagland in
Ġhypot ension
Ġunequ iv
rizz led
b ur
m at
v ia
Ġ utero
Ġp ituitary
Ġin activating
Ġs ister
it ated
it ine
Ġd ere
Ġf ide
Ġf iltration
Ġb ona
os amine
ĠA DC
Ġpro l
ĠC opy
ĠC FC
Ġsur fac
ĠL td
ard less
oph istic
ĠV IM
Ġ19 81
Ġcorrel ative
Ġapp eal
ĠRA F
CA N
ĠCT X
ME L
Ġsubc ategor
Ġolig odeox
Ġchemos ensitive
Ġvis c
Ġsci entists
ĠEm base
Ġsuspension s
carb on
Ġprodrug s
Ġreplic ated
ĠConc urrent
Ġrene wed
ĠAccum ulating
ĠClus ter
Adv ances
ĠCorrel ation
System ic
Ġcock tail
3 17
C entral
L ow
R IT
b enef
c AMP
p aired
el ong
el alisib
ra C
Ġex ec
ĠI b
ĠM ortality
Ġcomp an
ĠS DAC
Ġgen istein
Ġinv ariant
ox ib
Ġid elalisib
ne y
19 4
roph y
ĠRA RA
Ġplay er
ĠPro lifer
Ġcont ents
Ġhundred s
Ġelectro por
Ġconst ants
ĠCG L
Ġadip ocytes
chem ical
ĠDonor s
Ġaff ord
Âµ M
ĠPH F
Ġintraper itoneally
ĠPDL IM
Ġneigh b
ĠBayes ian
M it
b locking
y ed
Ġd estabil
im ine
ĠM IF
il iated
um es
Ġdis mut
ĠS ch
ĠG ADD
Ġout lines
opo lym
Ġlympho kine
cy tidine
15 6
Ġdi alysis
ass emia
33 5
Ġform ula
Ġprot on
und ice
Ġcho ose
Ġher b
methyl transferase
micro liters
Ġphospho protein
Ġrh abdomy
Ġsplice osomal
Ġion s
Ġthi oredoxin
Ġcre ates
ĠIdentif ier
ĠLA As
ĠFox O
Ġpermit ting
Ġdisp osition
Ġaneup loid
Ġpermeabil ization
ophistic ated
5 21
M AP
w here
Ġt igecycline
Ġf ell
Ġe GFR
ig ration
un ting
ĠH SV
ĠB lasts
ĠR PMI
Ġen jo
lym ph
ĠK m
Ġsim ply
Ġ19 1
17 1
ĠAn thracycl
24 5
Ġprior iti
45 1
Ġbreak age
ĠCyt otoxic
201 1
Ġpathophysi ologic
inhib iting
NC aP
Ġelect ronic
Ġdispar ate
ĠDel ta
ĠOb jective
ĠMO LT
Ġconsolid ated
Ġbron cho
odeoxy uridine
thromb otic
Ġkeratin ocytes
vesic les
5 15
F e
I DAC
N CCN
d an
Ġm enin
Ġd ic
Ġd ynam
ar ma
Ġf uc
Ġ( ~
Ġh ab
Ġle aves
us arium
ĠP EL
ĠH SA
ĠB IRC
Ġrem ove
Ġchem orefractory
Ġper in
ĠG em
Ġcomple ting
og rastim
Ġop ens
Ġmulti targeted
po ietic
par ative
ĠCon f
Ġpoly s
Ġaug ments
Ġtet rap
Ġnic otinamide
tri phosphate
Ġanticip ate
asi ans
Ġpenet rance
Ġcul min
Ġbehavi ors
Ġdn r
Ġdomin ance
ĠAPR IL
Ġparam ount
Ġimmunog lobulins
D iagnos
H ER
H istone
U SP
f pi
o geneic
Ġ ie
Ġt rametinib
er ving
ic tive
Ġ( Â±
ĠC NA
ut h
Ġas th
ĠI CI
red i
ĠS mac
ĠN utlin
ĠR ET
spl ic
Ġse rop
ox ins
Ġpred efined
Ġvit re
Ġmultiple xed
Ġmetabol ized
Ġunc lassified
ĠAd optive
Ġmethyl ome
Ġly se
ru it
Ġfrag ile
Ġpap ers
Ġunde tected
Ġasc er
Ġconst antly
Ġneutral ization
acin omycin
ĠImpro vements
Ġge ographic
Ġindole amine
encaps ulated
Ġpit f
T el
m ma
Ġo ct
te x
Ġs ophisticated
ic ines
os um
Ġpro angiogenic
ĠC BP
ĠC ardi
ac iclib
oc occal
Ġch arge
ĠP AT
ĠH SF
st olic
ĠD ros
ĠS till
Ġper fusion
ĠG H
ren d
we igh
Ġnon toxic
Ġdes erve
Ġ19 3
MP ATH
trans cript
orph isms
ĠRA G
ĠAt g
Ġimmunophen otypical
ĠST R
ĠER Î±
TP O
ĠCyt okine
Ġoxid ized
Ġconcern ed
Ġpy ruvate
ĠAut ophagy
ĠInt racellular
Ġhomogene ously
hyd rop
Ġconstitu ents
enol ide
Ġcholangi ocarcinoma
quar tile
3 26
G MP
T CD
l ia
Ġt a
ati bility
er ge
Ġre direct
Ġf ron
Ġf its
ly l
ĠT UNEL
ĠI CC
ĠI BD
Ġl um
ĠM ar
Ġbe ar
ĠD EC
di phenyl
ĠG T
Ġhem angi
Ġappro xim
Ġdete cts
ch i
ĠV itamin
MP S
ĠDNMT s
Ġlif estyle
Ġsynthe size
Ġhybrid s
ĠRe ports
man n
PT EN
Ġeth yl
Ġefficac ies
ote can
Ġperox isome
ĠAdv anced
Ġencompas sing
Ġanth rac
Ġnecro ptosis
Ġunderex pressed
AY As
Per ipheral
2 15
5 89
C er
G TP
L PS
T B
z h
Ġm umol
ed ical
ar ger
id ity
os keletal
si bly
ter in
Ġl a
Ġg erminal
ĠCD DP
ĠR PL
Ġgro ss
ĠTh at
Ġunder weight
Ġsup ply
min ant
ep ithelial
trans criptase
BC P
ĠPD E
AF F
Ch ildhood
Ġcle ared
Ġpoly p
uro spor
ria d
Ġful minant
ĠMut ant
lim ersen
Ġemploy ment
for ward
orb ic
OP P
Ġview ed
Ġprincip ally
Ac quired
ĠLT B
omat osis
Current ly
Ġperm issive
rele ase
Ġpas sive
ĠStr ategies
Ġbuil t
Ġhemato lymphoid
Ġnom ogram
ĠTaq Man
ARG ET
urospor ine
A HSCT
E po
M ST
en vironment
Ġc ode
as si
Ġn utlin
ĠC CC
un translated
Ġac kn
Ġl ac
ĠB est
ĠS EM
Ġmo ve
Ġhemat og
Ġrec urrences
ari osis
ill in
og rams
Ġmicro d
Ġmicro glia
Ġ19 2
Ġhetero dimer
AL K
ST I
ĠHL H
Ġflu orescein
inf usion
Ġrever ses
Ġorgan elles
ĠAL K
Ġoste op
mod ulating
Ġpap ill
col itis
Ġmicrosc ope
tet razolium
Ġsupple ment
Ġcyclo heximide
cycl ic
Ġpreced es
ĠSAR S
metho xy
Ġelab or
Ġunfold ed
istingu ish
3 50
E v
d n
y lo
Î µ
ti les
Ġre taining
Ġb uc
ĠT es
Ġfor k
Ġde ubiqu
Ġg onad
ĠD CAG
00 32
ĠCD w
ĠCD DO
ĠN SC
ĠR uxolitinib
ĠR atio
Ġdev ice
str Ã¶
CD C
ak ed
Ġli vers
14 9
Ġdesign s
long ed
Ġlif elong
Ġconduc ting
Ġantitumor al
PC NA
Ġrobust ly
Ġleuc ocytosis
Ġautog rafts
alk yl
Ġdraw back
ĠHis torically
Ġunderl ies
Mo Ab
ĠNOX A
Ġharm ful
Ġja undice
Ġunsu itable
(+/- )
D ysregulation
m ir
re presentation
Ġc ipro
Ġin efficient
Ġb ones
id onin
ĠT echn
ĠT oday
im etry
ĠC SL
ĠI ÎºB
ĠM BD
st ance
Ġinc ome
ĠD oxorubicin
ĠW IF
Ġun translated
iz ers
Ġind istinguish
Ġma x
ĠK iller
ill s
16 0
Ġsystem ically
rop athy
Ġ18 5
In te
ek ing
37 0
27 7
Ġprior ity
CN U
cept ably
Ġcirc uit
MN Cs
inc ip
Ġdeple ting
ĠCC AT
Ġeti ologic
Ġcataly ze
Ġaccess ory
ĠInt ra
Ig G
Ġcardiomy ocyte
âĤ ĥ
Ġformal in
Ġsphing osine
elec tro
Ġunve il
ĠNU MB
Anthracycl ines
Ġdile mma
Ġmuscul oskeletal
Ġdismut ase
> ;
G H
N a
U p
f i
Ġ lot
Ġc N
Ġc up
an n
le t
ĠA sia
et s
Ġl avage
anc ing
ĠO x
Ġmon ke
ĠG W
ox o
Ġup coming
Ġconcl usive
Ġpost ulate
Ġmor ph
Ġcap s
MS I
radi ated
ĠRT Ks
Ġmegakary opoiesis
Ġantagon ize
del eted
Ġpa ve
ocarcin omas
ĠSur face
Ġmach ine
Ġcytos keleton
Ġimmunore active
Ġbulk y
ĠPharmac ologic
ĠSel ective
ĠPoly comb
Ġannot ated
arot ene
odi alysis
strÃ¶ m
3 03
4 80
b ile
d in
g ered
h TERT
l uciferase
o ke
r ituximab
u venile
is o
Ġb ryostatin
ĠC SP
gen erative
ĠH MC
Ġor idonin
ĠN CA
com mitted
Ġper tinent
ges terone
Ġnon sense
ĠU PA
fer rin
38 7
Ġmat uring
ens ely
Ab normal
uct u
ĠTNF alpha
vari ant
rh yth
ereg ulation
OC K
ĠHD MP
Ġpolyc ythaemia
eff ici
Ġvolunte er
Ġhorm onal
Ġdeox yribonucle
Ġharves ts
Ġgirl s
ĠMyelo proliferative
ï¼ Ī
Gen omic
Ġflavon oids
Ġ(â Ī¼
ĠMus ashi
4 60
K LF
K FB
N s
R educed
l son
w al
ĠC NAs
ib ly
Ġg anciclovir
ĠS iglec
Ġun pred
Ġsub clinical
AC s
22 2
Ġrepres sing
Ġapp ra
Ġ16 9
Ġ24 0
mit oxantrone
ĠBA Y
Ġdegra ded
ĠNew ly
Ġalkyl ator
Ġcompeti tion
Ġinterrup tions
ĠIntegr ation
Ġabl ative
Ġnephro toxicity
section al
hydroxymethyl cytosine
Ġhematoc rit
Ġindistinguish able
2 11
G livec
K P
c enti
d ered
v ents
Ġ %).
it on
Ġf ed
ĠC F
ĠC ross
ĠM or
ĠN AN
Ġanaly tic
ĠWe b
CR T
end othelial
az id
22 6
Ġnucle oli
MP AL
ok ing
Ġdistinct ly
tis one
ophil a
ĠAS H
Ġphys ically
ĠTLR s
Ġz eta
EG G
ĠFunction ally
Ġresemb les
Ġpump s
ket oglutarate
mul tiple
Ġske wed
atur ated
assess ment
Ġcentr ifug
ĠGTP ase
ĠEG CG
Ġplau sible
ĠCIT ED
admin istered
effici ents
4 19
A u
P TC
R F
T et
e able
h l
Ġf etus
ur onic
ac ts
il le
las ses
ĠS NA
ore x
ĠL NCaP
15 8
ĠV III
ĠML F
25 8
ĠDN X
Ġ25 8
yn chron
ĠCon comit
40 6
cyt okine
ĠY B
ĠImmun ological
ĠBC G
Ġchimer as
Ġattenu ates
Ġtranspor ted
ĠAut o
Ġquin olone
Ġadip ose
Ġmetalloprotein ases
Ġquar tile
ĠUl tras
Ġcentr ally
AHN MD
ĠBN IP
Ġtot ally
Ġcipro floxacin
E A
G as
R h
s r
w hel
re troviral
Ġm ere
ar th
ul sion
ĠA gency
Ġn oc
ĠC ho
ĠC ity
Ġac quiring
Ġal ign
ĠH ck
ĠF U
ĠF requ
Ġat omic
Ġrel atives
ĠN HEJ
ĠR OR
Ġcons erv
ocy an
Ġnon hematopoietic
ucle ar
Ġneed le
over l
Ġ16 8
Ġ24 3
Ġvalid ating
Ġunf ortunately
Ġpredict able
ochond rial
Ġadhe sive
Ġatt achment
Ġemb edded
ĠAD AR
micro liter
ĠMC yR
Ġchemo att
ĠPL ZF
tet rahydro
Ġpromp ting
Ġlook ed
Ġnas al
stud ied
Ġstatin s
Ġackn owled
ĠNAN OG
M UC
W B
t inib
Ġin put
om ically
ĠC ro
ĠM SP
ĠF ludarabine
Ġun il
Ġco efficients
ĠE ast
oun ders
ĠL MO
Ġnon s
Ġma fosfamide
Ġar bit
Ġcar m
Ġser ving
Ġiniti ates
Ġmin eral
Ġ20 2
Ġprop idium
lyc er
phosph atidyl
ĠCEBPA dm
Ġsecre ting
Ġdistingu ishes
Ġparen teral
Ġpsyc h
Ġunac ceptably
Ġadren al
ĠEt oposide
ĠCLA RA
acill us
Op timal
Ġfix ation
Ġarbit r
G EM
M ore
P ost
y lases
Ġp mol
Ġd y
Ġd ry
id omide
ĠT p
ĠT yr
im es
ĠC ertain
gen erated
Ġcon ges
Ġg ot
ĠB AK
qu ality
Ġmo ving
Ġco ugh
ĠO T
Ġreg ained
ser ved
RNA i
cent re
Ġmulti focal
Ġpost consolidation
Ġ20 7
omal idomide
ura min
NK L
Ġnow adays
ĠEx p
Th ree
ĠQ D
ĠImmun otherapy
Ġparen ts
Ġimpl ied
Ġfavor s
Ġstimul us
Ġtrim ester
Out come
Ġcul tivation
Ġencompas ses
Ġpyr ro
Ġdisadvant ages
agglut inin
ĠBor tezomib
Ġtetram er
Ġsurfac es
Ġcarm ustine
K i
L GL
M ET
l on
Ġp Rb
an us
ar ting
ec al
ra x
ĠT iss
ac ing
Ġde amination
ĠB SI
am s
ĠD ual
th at
pro cess
ĠR b
ĠE gr
Ġsy stolic
bin utuzumab
ĠV it
leuk ocytic
Ġ17 3
PD X
ĠER BB
Ġste re
ĠET O
rec ts
aph ase
del etion
ĠAP AF
ĠCH IP
ĠDe term
Ġpr ur
Ġtrac k
ĠCA SP
ĠFc gamma
Ġabdom en
Ġpal p
ensiti zed
ĠIs olated
Gl c
Ġprecl udes
ï¼ ī
Ġeryt hema
Ġfo ot
Ġantimetabol ites
Ġbuff er
Ġster ile
tetradecanoyl phorbol
adm ium
& #
) âĢĳ
C ycl
D i
F ms
R a
l ands
s ided
at oclax
ho use
ĠM n
ĠP RT
Ġ2 11
Ġ2 37
ĠR o
ĠO C
Ġimmun oma
Ġprognostic ator
form ations
Ġallo BMT
ion ine
Ġhyp oth
Ġsc ope
af ungin
Ġprovid ers
Ġprec on
18 6
18 9
ĠLeuk emias
Ġcent romeric
Ġderiv ation
Ġsubc lasses
Ġinstitution al
ĠDrug s
Ġcomplic ating
CAR T
Ġagon istic
Ġtryp tophan
Ġshed ding
Ġencomp ass
Exper t
Ġexacerb ated
Ġtax ol
ĠCauc asians
Ġkeep ing
ĠCan ada
Ġrac ial
Ġsaliv ary
ĠFH IT
Ġsuit ability
termin us
Ġbuc cal
C lo
L G
N U
S ingle
h aemia
as sisted
ĠC ardiac
ĠM oloney
Ġ2 14
Ġcomp e
ĠF emale
ĠN AC
Ġreg imes
ĠE ither
Ġinter face
Ġ10 âģ¹
Ġconf ounders
Ġantigen emia
Ġhetero dim
ax ia
vo virus
Ġ16 7
Ġ25 9
Ġglyc osyl
49 24
vious ly
Ġquanti ties
NPM c
Ġsecre tory
ĠPV T
miR s
Me is
Ġpal sy
exist ence
Ġcyclo oxygenase
utrop enic
ĠEN L
Ġsap acitabine
institution al
Ġinsign ificant
Ġcounsel ing
propor tion
assi um
9 00
P RAME
h u
n atal
Ĩ Ĵ
Ġc ame
es pecially
Ġn aph
ot t
et ence
Ġl osing
ĠM r
ĠS PI
ĠR CTs
Ġres ides
Ġmet ach
ĠL ack
Ġrec tal
row ing
ensi fied
01 25
CT N
Ġprov iral
Ġdown loaded
)- -
ĠBM A
OR T
Ġcult uring
ĠCT CF
90 7
Ġincorpor ates
Ġste adily
ĠHD T
ĠAR F
Ġabn l
Ġglycos ylated
Ġsegreg ated
Ġexem pl
Ġcatabol ism
aqu es
Ġapt amer
ĠPCD H
ĠEst abl
A ge
M ac
M IC
N CR
V ascular
â Ħ
Ġ encephalopathy
an i
el erated
as m
es trogen
ell itus
Ġn ick
ra ined
ĠM ax
ĠH i
Ġ2 98
ir t
ub ated
ĠR ituximab
Ġrem in
Ġhem odialysis
end azole
Ġtwo fold
Ġimp rinting
Ġdisc ern
oplas m
Ġassess able
Ġaut ophosph
ĠV yxeos
sor ption
AC A
ĠAl most
rop yl
AP C
BM SCs
24 2
ĠCN L
ĠAt tempts
Ġglyc ol
ĠSF K
Ġparadig ms
TL D
Ġradio immun
Ġtryp an
Ġrub id
ĠMO Z
Ġcoord in
dem ethoxy
Ġdefini tively
amp ath
ĠMyel osuppression
4 24
G RFS
b usulfan
m ast
r ically
Ġp estic
al mit
el even
ĠA SP
ĠA lox
Ġpro hib
Ġpro ptosis
if e
um m
Ġcom ing
ĠP CNSL
ĠH ydro
ĠH pa
ĠH CMV
ĠD CC
ĠD ouble
ĠS ensitivity
ĠO cc
ĠL SK
Ġcons ult
Ġar rhyth
omet h
Ġ18 3
omy el
40 9
Ġthrombocyt haemia
Ġintra hepatic
HL H
olec ules
Ġsomatic ally
Ġimmunohist ochemically
Ġclinic s
Ġdep olarization
ĠReg ardless
Ġphospho lipid
ĠAut opsy
ĠLong er
strati fy
ĠPF KFB
Ġintercal ating
ĠNucle ophosmin
Ġcounte racted
Ġentero colitis
ĠPharmaceutical s
keep er
Ġchima er
ĠChar lson
meg a
Ġappeal ing
Ġdynam ically
3 02
C NAs
D ox
E m
J D
f en
n m
o ub
on ed
Ġm ellitus
al ine
Ġth ick
ĠT n
Ġcom es
Ġde pressed
ĠH AA
Ġun supervised
ph ot
Ġph leb
Ġpre p
ag s
ag rel
Ġinte rested
ĠV CAM
Ġref eren
Ġend s
Ġonc ological
roph ic
Ġ18 9
Ġpromyelo cyte
BMT R
ĠHDAC Is
SD F
ĠRel ative
TNF R
Ġdetermin ations
ĠEr bB
Ġjo ining
Chrom osome
ĠLympho id
ĠHI DAC
lock ade
troph ic
Ġascer tained
M IN
l ining
Ġc CD
le rogenic
im inib
un ted
et uximab
Ġcon versely
op ag
ĠP rim
ĠP eking
ĠH G
Ġ2 16
ĠF l
ĠS ons
ĠN early
Ġro utes
Ġbi od
tim ulation
our nal
Ġsc arc
acy tic
ĠJ M
HD M
Ġem odin
Ġend onucle
Ġrare r
romb opag
Ġtr iaz
Ġaz oles
Ġgu adecitabine
Ġoff set
Ġcat as
ĠBi ological
GR N
aden ine
Ġaw ay
ĠEM I
Ġcytoly sis
Ġinstrum ent
Ġquar tiles
pathw ays
PBP C
trig gered
squ are
B TK
E urop
I ENT
P ancreatic
U A
b ine
m k
w a
Ġin hal
ĠT ype
ĠT DT
Ġle ak
ĠH DA
de velop
Ġper centi
Ġmal formations
ser um
21 7
PCR s
Ġbiom edical
BM A
Ġimmunophen otypically
PB A
Im pro
Ġher bal
Ġz ero
An gi
ĠRel ev
III a
Ġconcept ual
Ġsearch ing
Ġleuc ine
Ġtend s
ĠCA MPATH
ĠCG P
sh RNA
Ġreinf usion
ĠWork shop
ĠRev ised
Ġcy st
Ġcompl ain
Ġatherosc lerosis
ĠKing dom
ĠPAT IENT
overl apping
3 60
V ari
V ON
on ing
on ia
is al
os u
om i
ot o
ĠD ep
por ter
itor y
ĠE MB
Ġse rous
Ġout standing
oth i
ard ia
ast asis
Ġbi otin
Ġman nose
Ġsel dom
AC C
Ġgener ations
33 7
Ġend oc
val idation
Ġ18 2
37 3
sub stituted
27 0
Ġif osfamide
Ġinflamm asome
anti fication
enz a
CH T
Ġcontribut ors
ĠMG CT
hyp omethylating
ĠFlu orescent
ATP ase
BT B
Ġimmortal ization
oglyc an
ĠWE E
Ġdiges tive
Ġec otropic
Ġdict ate
ĠPartic ularly
ka ros
Ġhard ly
myel oma
Ġerythemat ous
acryl amide
Ġplacent a
âĦ ¢
agrel ide
ĠPATIENT S
V OD
X ome
f et
m ouse
n utrition
Ġt MDS
Ġo phthal
ul ators
si b
ur red
oc in
ĠP f
ĠH F
ĠH IC
ĠD LTs
ĠD istinct
ĠF CR
pro ven
Ġreg rowth
Ġgen ital
ĠL arger
ĠU PR
Ġimp rinted
Ġmicro bial
sor s
60 3
ĠPh arma
OR s
AP Cs
24 1
ans h
Ġerythro cytosis
CBF A
Ġcarb on
ĠEP Z
Ġoc clusion
HN SCC
ĠSC ORE
ĠADA MTS
Ġdemographic s
ĠPTC y
nR H
ĠInvestig ation
ĠAUR KA
Ġglob ally
Ġsta urosporine
Ġinev itable
Ġoligodeox ynucle
Ġunpred ict
2 95
B y
X N
d ate
Ġc GvHD
Ġc opolym
ic acy
Ġto lerogenic
om ical
ĠA MD
ĠA PA
ĠT op
ĠT rib
Ġac uity
ine al
ol ding
Ġ2 56
Ġ2 38
ap ed
ĠF is
ĠS n
ĠS pl
11 3
Ġprolifer ated
loc ated
PM s
Ġpop ular
17 5
ĠML AA
vention ally
group s
ĠSt able
Ġsix th
cyt ometric
Ġgl ands
86 9
ĠQ Tc
ĠY ork
pop ulation
Ġdelay ing
ĠAr ray
ochrom osome
onc ology
Ġcytostatic s
Ġprompt ly
Se e
Ġmicrom olar
Ġqualit atively
Ġzeb ularine
ĠImmunophen otypic
avir in
Ġquar ter
Ġapprec iated
Ġske wing
Ġastro cyt
usi tis
assess ed
ĠPolym erase
Ġfrail ty
oblast omas
Ġmonol ayers
anil ide
auno Xome
Ġchemoatt ract
) +
) [
. ),
< .
D LT
H AP
Z N
d ecan
k i
m as
p id
u ated
en a
Ġc IAP
id aza
ĠA im
ig in
ĠI MA
op tim
Ġdis proportion
Ġ2 60
Ġun stimulated
ĠG ranulocyte
Ġro ugh
unction al
ail able
ill ing
ĠV EN
ĠV AEs
19 99
ck point
Ġradi ographic
Ġhyper ther
LI G
inf ection
Ġthym ocytes
ĠMAPK BP
ĠCd x
Ġcomm enced
ĠMay o
ensiti zing
Ap optosis
Mon itoring
Ġweigh ts
Ġvers atile
Ġglomer ular
Ġosteoc last
ĠANK RD
Ġmosaic ism
Ġmeningi oma
iem sa
benef it
orex ia
D EGs
E LL
E UTOS
F rom
F our
om ycosis
ĠI RAK
ĠH E
Ġ2 33
st abil
ĠD CL
ĠE SA
Ġmet ric
Ġimmun otoxins
Ġse iz
Ġover look
Ġdec om
Ġall ergic
ĠV IST
ex posure
Ġform ulated
BP s
25 7
Ġpur p
Ġclass ically
ĠMR K
Ġcollec t
69 1
ĠCol ony
ĠPK M
ĠCB A
ĠBi omarkers
ĠKap osi
MG MT
ĠSp anish
teroid al
Bu Cy
Ġoccasion s
ĠExper imental
ĠExper iments
Ġsear ches
Ġmixt ures
Ġdin aciclib
Ġregen erative
ĠLip osomal
ĠRece iver
galact osidase
ĠSal vage
Ġdiscrep ancy
Br P
ĠCare ful
secre ting
uv ants
Ġintermedi ates
Ġaeti ology
mel anoma
ĠDros ophila
ĠVIST A
l ich
t andem
te ll
Ġp STAT
Ġd on
ic a
Ġh nRNP
ter y
se par
ĠI r
Ġg ent
ĠH CV
Ġ2 29
Ġr ules
ĠB ar
anc t
ĠD au
ĠD utch
ĠF avorable
th enolide
ĠL ibrary
Ġprom ises
ĠK P
HD C
HD T
Ġ19 5
Ġmit ogenic
50 6
uct ase
Ġappear ing
yg l
Ġelec tr
Ġbor n
ĠAc tivating
ĠPer formance
inos a
Ġmess age
Ġnote worthy
Ġundersc ores
Ġundersc oring
ĠÂµ g
Ġincre mental
Ġspan ning
obacter ium
umines cence
Ġtransfect ants
Ġunderestim ated
Ġacknowled ged
othi ocyan
3 100
V E
Ġm ental
es enchymal
os sible
ĠA PBSCT
ĠM si
Ġcom pression
ĠP rac
ĠB osutinib
ĠN ALM
cl one
ĠU MRD
ĠJ H
ĠJ ALSG
ĠV in
60 9
erg istic
Ġend ocytic
Ġend ostatin
ys mal
05 1
Î² RII
Th y
Ġknock ing
radi ol
ĠCyt osine
Ġcont radic
ĠIC OS
Ġdegra de
Ġneuro endocrine
Ġauto HSCT
Ġcore pressor
enz ene
Ġsl ides
Ġcarb oxy
Ġexception al
press ant
ĠAza C
Ġdimer ization
Lym phoma
microg lobulin
Ġfus ariosis
Identif ication
Ġflex ible
l ate
Ġo binutuzumab
Ġs es
Ġd dPCR
ĠA SC
ĠT ri
ĠI MP
Ġl actic
Ġdis per
ies ter
ĠD aunomycin
ĠF usarium
Ġtrans aminase
Ġhemat oma
get ing
Ġpar as
ĠV Î´
ĠAl ong
Ġpos itron
ep ine
Ġprop os
ĠRA GE
DA U
47 3
ĠDC leu
Ġtra ce
Ġcalc itonin
Ġdiss ection
Ġaden ocarcinomas
Ġher itable
Ġhome ostatic
Ad ult
ĠDD I
ĠFT Is
anth ine
Ġpolymer ization
part ate
Ġdrop ped
Ġreinfor ce
Ġvi ro
Ġretard ation
ĠEnh anced
Ġhypodip loid
Ġinactiv ate
Ġimmo bilized
ygl ucose
% ],
D D
E CM
F F
P AP
S LC
V AX
Ġ Ïĩ
Ġa ph
Ġf re
id ans
Ġto ll
ra emia
ĠH H
ir radiated
ĠB reak
Ġun limited
ĠL ig
ĠL ung
Ġpot assium
RA C
Ġsc ans
KI I
ne utral
abl es
ma jor
Ġperiod ic
Ġevolution arily
Ġj e
Ġcont rac
Ġcertain ly
ĠDe ath
Ġfl uctu
Ob jectives
occ us
ĠNR F
nucle ar
ynthe tic
Ġdivision s
cor tisone
ĠConc ern
ĠRap id
ococc i
ococc us
sq m
immunop recipitation
ĠAustral ia
4 35
5 99
6 50
D n
V ECs
c ases
c hol
f ungin
Ġ edi
Ġan g
es te
Ġre ading
ra ins
ĠC EP
Ġac cept
sp ired
sis ting
ĠS mo
ĠN f
SC N
ĠE SR
Ġint ram
Ġpo isons
est radiol
LA P
ĠV SV
Ġcr ude
Ġgra ding
ĠRes idual
Ġhypothe ses
AD C
raph y
mark er
Ġmobil izing
orrh agic
Ġhand ling
ĠPP P
Ġimpac ting
eff icacy
TL S
Ġreprogram med
ĠMal ay
Ġmitig ated
Ġstres ses
ethox ydaunorubicin
ĠTranscription al
Ġhyal uron
Ġseques tration
Ġbiod istribution
ĠFis her
( +).
= -
E DC
M u
N H
N TP
S h
c ur
Ġa romatic
he ro
Ġc admium
ar atumumab
Ġ( (
ĠT AL
ine urin
Ġ2 34
Ġr up
ĠB K
Ġreg ime
tr im
Ġint ronic
ĠL MP
Ġcor tical
Ġremain der
Ġep i
AC AM
Ġ18 4
ĠAn imal
Ġrep osition
Ġaz u
ĠX X
Ġ29 9
Ġadj uvants
inc a
cap es
Ġequ ation
Ġatt ached
Ġaden o
ocar ri
DNMT s
Ġvis it
Ġphysiological ly
respec tively
ĠTumor s
Ġsenes cent
Ig H
Ġimmuno assay
Ġtrunc ating
HE MA
Ġhypers ensitive
ĠHC Q
Âµ L
dam age
Ġchloro quine
Ġspot s
ĠPat hw
Ġmicronucle i
Ġindustr y
Europ ean
Ġpercenti le
" ).
C i
D aunorubicin
I da
J T
V T
h n
Ġ *
in et
Ġc ues
Ġp riapism
Ġs HLA
an tic
it ance
ĠA a
ĠA EL
ĠT un
ML D
Ġle arn
ĠC u
ĠC OG
ut ation
uc tive
ĠI CB
iv ariable
oc and
ĠH MT
ĠH RM
ĠF usion
ĠF DC
Ġimmun oliposomes
Ġpl ans
Ġage ing
Ġmulti dimensional
Ġsh aring
Ġ19 79
ry onic
CC G
24 7
35 9
IP K
ĠX PO
Ġi PSC
Ġfib ers
per ipheral
Al terations
ĠZ BTB
Ġsol vent
Ġalong side
IFN Î±
Ġglut amate
Ġolig os
ereb ral
Ġstabil izing
Ġaggreg ate
ĠCd k
Ġstra ight
Mal ignant
ĠReduc tion
ĠAQ P
ĠProlifer ation
Ġpurp ura
f ractionated
i osp
r uct
s econd
â ĨĴ
en op
Ġc ef
Ġin ges
Ġh itherto
ĠT BF
ĠI le
Ġl ie
ĠM ethyl
ĠM IP
Ġde oxy
ific ance
ĠD AF
ĠF I
ĠCD R
Ġap ical
ĠN EC
ĠR us
ĠG AP
ĠL ineage
AB CB
Ġimp eded
Ġmulti gene
ĠV II
14 13
CSF s
kn ockdown
ĠRes tor
con f
ĠX Y
Ġreal istic
ĠCP NE
Ġhospital izations
rh osis
ĠRel apsed
ĠRel apses
Ġect opically
Ġconj unctiv
CE A
Ġglycoprotein s
oconjug ates
ĠMod el
osc opic
ĠClin icians
ĠSyn drome
Ġjusti fied
Ġscaffold s
Ġflavon oid
Ġserv ice
Ġsevent y
Ġnav itoclax
ĠEMB ASE
Ġunpredict able
0 99
F if
R Y
S U
c ut
d ec
t re
© ½
Ġd imen
ar ted
Ġe ase
os arcomas
ul sed
Ġh op
et ine
iv ol
ay ed
ĠH azard
Ġcomp etent
ĠD uration
oci al
cl ones
Ġmod elling
Ġmark eting
ĠU A
ch ip
60 7
Ġnucle osome
23 7
Ġ24 1
ĠOn going
IS ION
ĠHL X
ock out
000 8
Th romb
Ġhybrid isation
ĠTran sient
Ġtw ins
Ġent ail
amil ial
ĠCd A
Ġsulf oxide
Ġtransduc ers
Ġhisti ocytes
AMP K
Ġphot o
Ġinstrum ents
ĠRho A
ĠGl ut
Ġsperm at
mul ti
odeoxy adenosine
analy ses
Ġexceed s
Ġgate keeper
Ġabandon ment
ĠdF dC
fet oprotein
7 00
C ALLA
H PLC
L SD
T CL
p osi
Ġs atisfac
or ax
ar an
Ġh its
Ġh ouse
ĠA LA
im ycin
Ġal anine
Ġch am
ĠH alf
Ġ2 13
ĠB SA
Ġdise ased
Ġhem olysis
Ġimmun ized
Ġnew born
AT E
Ġ19 78
ĠAl terations
ĠCom mit
Ġunf ractionated
ĠCT SB
ob i
Ġpap illary
Ġmas ked
Ġmis diagnosis
ĠAc quired
ĠMG US
ĠAg ents
Ġect o
ĠJun B
Ġvesic ular
Ġpatholog ists
ĠAustr alian
Ġastro cytes
hr lich
Ġglomer ul
ĠKI AA
Ġpun cture
Ġcentros ome
Ġcapt ured
Ġthorac ic
ĠGAP DH
G ranulocyte
K Î´
M BC
V C
t led
Ġa rach
on tin
en sis
Ġs L
Ġs lo
Ġd s
Ġe g
ĠT umour
ĠC yR
Ġg rafting
gene ity
Ġass ume
ĠG ol
Ġmic elles
ven etoclax
ex cept
line ar
cin ation
Ġapproac hed
Ġeng rafting
CN L
Ġmed icines
Ġknock ed
Ġextra vas
Ġeight y
ĠSe par
Ġhome odomain
Ġphysi ology
pr incip
onc ogenic
thym ic
inter pre
Ġeth anol
Ġtop ical
Ġsurg ically
Ġacl acinomycin
ĠInf ection
Ġsial ic
encephal itis
Ġseptic emia
Acc um
plas m
Ġpay load
Ġmanifes ts
Ġcontras ting
Ġcir rhosis
Ġendow ed
bre vi
whel ming
Ġprur itus
' d
E ight
E nd
c ost
f mk
Ã §
re p
Ġp omalidomide
si rolimus
Ġl isted
ĠM t
ine xor
Ġg iant
ud ine
Ġtre e
ĠP bx
Ġcomp any
Ġcomp atibility
ĠF HL
Ġne u
one gative
ĠO LIG
iz yg
Ġab or
Ġtrans m
tr y
ĠL V
row n
ensi ties
ers onal
Ġsel inexor
ET V
AR OS
05 7
In s
Ġmyel otoxicity
ĠDNMT i
Ġ25 1
Ġlab elling
Ġ26 77
Ġsp hero
Ġinterfer ons
ĠAS M
opatho logical
Ġprogram me
ĠInc ubation
An g
MY D
Ġeti ological
ĠBi TE
Ġelic its
Ġconn ective
ĠPar tial
aryn x
Ġjus tif
ĠHP Cs
Ġens uring
Ġulc ers
Ġsynchron ous
Ġconvinc ing
ĠIran ian
Immunophen otyping
Ġautophosph orylation
ivol umab
, -
A reas
C re
F ITC
G iven
I le
m ortality
s olid
er in
ar senic
Ġf is
ĠT Y
ter p
sion ate
Ġex quisite
Ġg raph
rom a
ĠP AS
od ermal
Ġr uled
Ġne ovascular
Ġne uramin
Ġ3 44
ĠR ather
ure ment
ĠG EM
ĠE CM
Ġpre therapeutic
ĠL CL
tro p
Ġunder line
spec ified
Ġmi x
Ġam ifostine
15 4
Ġpost natal
19 8
CI s
ĠIm m
Ġcalc ineurin
ĠZ n
opatho log
ĠKIR s
Ġcontroversi es
uan osine
eth ylases
Ġur idine
ĠĠĠĠĠĠĠĠĠĠĠĠ ĠĠĠ
ĠEn asidenib
alan ine
occ i
oxid ant
Ġlact o
tol ide
Ġhistocom patible
Co A
Ġinherent ly
Ġsplen ocytes
Un der
Ġjud g
elec oxib
heres es
Ġchron ically
Ġanch orage
Ġfeat ured
Ġinos itol
Ġpapill oma
Ġmorph ometric
2 60
C irc
D CL
E valu
H h
O VA
b ec
e ither
h ospital
o y
p ain
Ġa ver
is ertib
ly te
ĠA KI
ĠT AA
im um
ig enin
oc op
oc ular
ĠP ax
ĠP rophyl
Ġclinical trials
ĠE lect
Ġag glut
Ġpres erving
reg ion
Ġmicro vascular
Ġmy ogenic
Ġ24 6
Ġtechn ological
ĠNo var
Ġfib rosarcoma
Ġ33 342
TC E
ĠRe ported
pr int
eti te
GR L
yroid ism
Ig M
Ġbiosynthe tic
ĠBET i
Ġhyd raz
Ġfore ign
Ġsegreg ation
Po lycythemia
Ġunve iled
Ġechocardi ography
Ġmicrobiological ly
ĠPa ediatric
Ġhyperther mia
ĠNovar tis
3 18
N ot
k yl
o u
Ġp ed
Ġp ow
Ġp ric
Ġan orexia
it ters
le eding
Ġst ream
Ġcom et
ĠD endritic
ĠD anish
ĠE zh
ĠK EGG
001 8
Ġprote olysis
27 3
BF U
opro tection
con ditioning
Ġmac rom
Ġi PS
LI N
pre viously
ĠĠĠĠĠĠĠĠ ĠĠĠĠĠĠĠĠĠĠĠĠĠĠĠ
ĠMY CN
PB L
def ining
opatho logic
EM I
Ġoste oblastic
Ġvol t
mTOR C
ĠFc Î³
Ġradio activity
Ġvesic le
ticular ly
Ġelectropho retic
ĠCL IP
Ġmyocardi um
ĠEl igible
Ġneon ates
Ġconsolid ative
Ġuro the
prop idium
Ġvacu oles
nitro so
ĠSet bp
Ġphospholip ase
ĠĠĠĠĠĠĠĠĠĠĠĠĠĠĠĠ ĠĠĠ
Ġepigen omic
Ġchimaer ism
ZN ep
+ ]
6 20
P oly
R Î³
S AR
f os
p enia
t able
y loc
Ġt MN
Ġt ext
Ġs ac
Ġs anct
es ide
lo ur
Ġle ptomeningeal
ĠC en
Ġr RNA
st ract
ĠD ynamic
âĢ ĥ
de oxyc
li oblastoma
12 99
ak i
reat ments
par ametric
par ticularly
05 0
Ġcytok eratin
Ġradi oresistance
face ted
ĠOn t
Ġerythro blast
Ġeng aged
Ġwork s
app rec
ored uctase
EGF P
inc ubated
47 7
RT Ks
ob enz
Ġdereg ulate
Ġolig omer
ĠCH G
ĠAC E
Ġresid ent
Ġoverl apped
ĠSH B
parag ine
restric tion
Ġelic iting
eb pa
ĠMicro RNA
Ġnod al
ient ation
Ġdoub led
Ġcollabor ate
ĠSm ad
Ġdiscussion s
ĠChem o
Ġchemot actic
br utinib
ĠLAIP s
Ġlamin in
TN BC
Ġradionucl ide
Ġparench ym
ĠENEST nd
Ġhyperglyc emia
ĠRelev ant
ĠCommit tee
apprec iated
4 65
A U
B reast
D DR
F orty
f ection
k ynurenine
p DCs
y rid
al one
Ġd ental
ate rials
ĠT SP
Ġex osomal
Ġl ies
ĠP PV
Ġr ig
ĠB mi
Ġsur prising
ĠF ITC
ĠN ME
Ġev oked
ĠL a
ĠK u
ile p
raf enib
Ġop posing
po fungin
24 6
Ġ25 4
ĠAll iance
ero yl
Ġhyper activation
AD CC
aph yloc
tur nal
ED GF
HDAC s
Ġpromin ently
ĠGra des
Ġquin one
thi o
Ġcod ons
ĠAss oci
gluc uron
Ġnitro blue
RC MD
IK ZF
ĠTM Z
cor rected
Ġti ter
Ġvers a
ĠPhys icians
Ġpoison ing
ĠLnc RNA
Ġperipher y
Ġnoc turnal
Ġremin is
sib ling
8 39
B l
O B
S BP
p p
s ched
Ġ rom
in otecan
le ural
Ġb inary
ĠT SC
Ġpro thrombin
ce ti
um er
Ġal vocidib
Ġch ose
Ġ2 26
Ġr TM
ir radiation
Ġat axia
ear son
Ġen vironments
ĠE LAM
Ġdes orption
Ġop ac
Ġdi versi
Ġform at
Ġem o
ĠII Î²
ĠDN M
ĠBM MCs
Ġoptim ism
ĠRec ombinant
ipi ents
Ġestim ating
98 059
Ġintra v
radi otherapy
IF Is
Ġintensi ties
rex ia
Ġpap ules
ĠAP P
ĠSM AR
ĠSub jects
Ġembry ogenesis
Ġslow ed
ĠPo oled
CAL CRL
Ġâĳ ł
ĠCy A
PMN s
Ġdinucle otides
Ġmother s
oled ronic
Inter feron
Ġchick en
(Â® )
Ġanat omic
ĠAchie ving
Ġechin ocand
Ġerup tion
Ġelectropor ation
dan amycin
Ġconserv ative
Ġoverlook ed
B e
G ly
H As
M MF
M CF
W E
b et
p rinting
t rend
v ic
ĠT f
ut in
Ġleuk o
Ġis ob
ĠI karos
ĠM MF
ĠP in
ĠH an
th an
ĠR etin
ĠO A
Ġover represented
Ġmod ulatory
Ġrele asing
Ġapp etite
ater n
Ġso il
orph ism
Ġcal ib
Ġequ ival
Ġidarubicin ol
Ġcataly zed
Ġrad ically
Ġpredisp osed
Ġsci ence
ĠSh h
Ġâĳ ¡
Ġâĳ ¢
Sign ificance
ĠAccum ulation
Ġphyt o
Ġantico agul
arboxyl ic
Ġsaving s
ĠCopy right
Ġta urine
ansh inone
Ġedi tion
M oL
X IAP
d ig
e po
i oid
t un
en i
it ran
ar yl
os itumomab
Ġn ame
Ġas ynchron
Ġcon ventionally
ol ization
rom ycin
Ġ2 35
yp hen
ĠF X
ĠF ab
ĠF indings
ĠS MD
ph armac
ĠN SAID
ĠR ed
ĠE hrlich
Ġsub jective
ĠL S
Ġsup pl
Ġdec iding
Ġpl aques
drom es
Ġhyp okal
ath iop
Ġ19 60
ĠThere after
Ġpost translational
Ġconsid ers
Ġpolym eric
ĠAn n
pon taneous
lamm ation
Ġimmunophen otyped
Ġ22 8
ĠTP MT
Ġbreak down
Ġadap ter
Ġtw in
Ġund oub
Ġphospho prote
Ġconsist ency
ĠCons titutive
Ġtub ular
deple ting
ĠMe CP
Ġspre ading
prote ctive
ĠMorpholog ically
ĠQu antification
zer land
process ing
Ġfis etin
athiop rine
0 75
6 13
D au
D DP
S ub
a verage
Ġd ensities
ul ind
Ġle aving
ĠC ac
ho w
sp ic
Ġch arged
ĠB al
ĠB reg
ĠD OCK
ĠS em
Ġtumor icidal
Ġmal nutrition
Ġmic afungin
Ġimp ossible
ber r
oplas ms
Ġam mon
sor ted
Ġthree fold
Ġ- -
Ġinflu enza
ĠUn ion
NP C
respon der
Ġ26 5
ĠEx amples
Ġdam p
Ġtra its
Ġgli oblastomas
Ġrecru its
Ġz oster
Ġspon ge
ench ing
Ġrecons id
Ġtet ra
ĠGen otyping
ĠPo lo
aro se
Ġcooper atively
Ġmanip ulate
ĠConclusion s
ĠÂµ mol
Ġdocument ation
fl ight
ĠExt ensive
Ġcompl ained
ĠCal if
Fox p
ĠTra ditional
Ġbyp ass
Ġxenobiotic s
patho logical
ĠWalden strÃ¶m
ĠJM JD
princip le
Ġparenchym a
H ES
P RDM
a h
d G
d U
m elphalan
s oluble
t k
on di
on ality
ed icine
Ġre ader
lo ts
Ġpro c
ĠC ot
ĠC bf
ig hed
ĠI WG
Ġmyelo d
Ġl ived
ĠP AK
ĠF PD
ĠS GN
Ġcl ue
ear man
ĠO D
Ġanaly zes
ĠE NT
ĠL GL
Ġdec on
Ġbi oph
ĠU BA
12 45
AT L
OS E
ET A
Ġmor phine
Ġonc o
Ġexpos ing
ĠMP T
Ġir reg
Ġneutrophil ia
Ġver ification
AS H
Ġaccel erating
ĠPR O
ĠAc ad
flu orescence
Ġcarb oxyl
Ġrib avirin
Ġshif ting
Ġexception ally
ocal cin
sh aped
ĠSequ ence
Ġdoub t
ĠDn r
Ġabsor bed
ĠIN CB
ĠHP RT
Ġrene wal
ĠTSG s
Ġepipodophyllot oxin
Ġlic ensed
Ġimmunoma gnetic
ĠHpa II
Ġundoub ted
o R
s itu
Î ¸
Ġp eu
Ġd PCR
Ġf ur
Ġf lor
os an
Ġl ibr
iv antinib
oc used
Ġch or
ĠP IC
ĠF D
ĠS MNs
Ġmo ved
Ġco ated
ĠO dds
ĠG reen
ĠTh ird
Ġro ad
01 26
Ġtherapeutic al
CT R
Ġaut ore
17 9
af il
specific ity
ĠML H
HR F
AP B
ĠCh i
Ġblock er
ophen yl
27 4
ust rial
ĠWh ilst
ins on
ĠPD A
ĠWith out
Ġsp ine
Ġsp ared
Ġwhere in
Ġhydro cortisone
Ġseem ingly
200 7
ĠQ ing
Ġpredomin ately
Ġdr inking
Ġsol itary
CH IP
Ġresc ues
Ġent inostat
lip oxygenase
bl adder
Ġintrac yt
Ġloop s
avir us
Ġnecessit ate
evalu ation
Ġexacerb ation
ĠBrazil ian
Sign al
Ġhypereosinophil ia
ĠToxic ities
Ġtap ering
ĠGol gi
ceti us
Ġpeu cetius
D evelopment
G EP
H ydro
L IC
M od
R adi
f o
h ap
x ts
Ġd od
Ġd uct
Ġre in
Ġb er
ĠC ohort
ot uzumab
Ġex ceptions
Ġl ag
ĠP TD
ĠD E
ĠF UT
00 15
ĠS kin
ĠS fpi
Ġ3 30
Ġper ceived
ĠG VH
ĠE RM
Ġhem izyg
ip po
Ġcan al
ag ocytosis
16 7
az op
Ġ17 8
Ġdiscus sing
Ġgu an
ĠNF AT
ME IS
49 3
Ġconte xts
oly l
46 1
Ġquanti fying
Ġaden oma
Ġrepro duced
59 3
UT O
Ġpa id
Ġvis its
ras tructure
Ġinher itance
HSP C
Ġmultip otential
Ġsem inal
PE I
ĠProm ising
design ated
Ġcolor imetric
Ġhind ered
orn ia
orub icine
Ġbroncho alveolar
Ġpitf alls
Ġlibr aries
4 37
D ue
K E
M i
W orld
p S
Ġ ).
Ġt s
he red
Ġin g
Ġs ensing
as sionate
it ney
ate ver
Ġh id
ĠC EC
un fit
Ġleuk otri
Ġl ute
ĠH AT
anc h
ĠD EX
ĠS an
Ġrel ied
Ġ3 01
Ġwe alth
yl ase
ĠR AC
ĠG ranulocytic
ĠL RR
Ġsugges tions
Ġmark ing
li oid
12 98
22 7
60 6
Ġ20 9
ep igenetic
BM C
ĠSt rong
Ġcontinu um
allo BMT
Ġangi otensin
85 8
Ġcost ly
Ġimpair ments
Ġbil iary
nucle otid
ĠBe h
ĠAF P
Rel apsed
Ġvirt ual
Ġaff lic
Ġderm is
Ġrecapit ulates
Ġnutri ent
Ġmultim odal
Ġinfer red
iam ond
ĠIndividual s
Ġdiscrep ancies
ĠBio informatic
Ġdecipher ing
zygo tes
Ġaffor ded
plasm acytic
Ġneuramin idase
eroyl anilide
Ġintracyt oplasmic
5 25
L en
f uc
f ield
p ent
p ulsed
y ric
Ġp pm
Ġs atis
Ġan al
as h
ed om
os amide
si al
ĠM CR
ol ig
ol lic
Ġv on
Ġ2 18
ĠD ys
ĠF FS
00 47
ub lic
ph ther
ĠCD D
Ġk D
NA C
cl es
ĠE GT
ad ine
ad ren
ĠCML SCs
Ġcons tell
Ġnon hematological
ĠMDS s
ious ly
Ġ19 76
Ġwhen ever
ass ociation
are a
CI MP
Ġexplo itation
arb urg
ĠPro longed
75 1
fib rom
ĠLSC C
Ġpredomin ated
Ġcat s
Ġneuro de
Ġve get
Ġantagon ized
Ġepithe lioid
Ġz este
Con ventional
ĠPV R
Ġdimin ishes
ĠRAEB T
fil ing
PG P
hyd raz
Cytogenetic ally
Mon osomal
benz yl
leuc ocytosis
No vel
Ġgamm opathy
ĠContinu ous
ĠGL UT
Ġrod ent
âħ £
ĠSwit zerland
Ġvisc eral
ĠCro hn
Ġpalp able
ĠCalif ornia
phther ia
9 22
A dr
B G
D r
P eg
R NP
S can
W F
W P
a ine
m ate
Ġc ave
Ġc alls
el ect
Ġd aratumumab
es tin
ic kn
ar il
Ġf os
at onin
Ġn os
ra CT
ĠT rich
us h
Ġl ives
ĠM eta
ĠM AD
Ġg m
Ġg lial
ud raCT
ĠH RD
ĠD a
ĠF ull
ĠF AN
ĠF YN
Ġ3 75
Ġap pend
pl ace
Ġmet ron
Ġdev ices
Ġpar thenolide
Ġbi ased
ĠU til
CT D
MT T
Ġprov ing
Ġconf ound
Ġpatho gn
ĠDN ase
Ġ24 4
Ġpattern ing
ethyl ating
Ġappl ies
ĠCon ditional
Ġfib er
Ġlocal ize
Ġfraction ation
Ġaccompan y
Ġtermin us
201 2
ĠImport ant
AA V
Ġolig oclonal
Ġtop ics
Ġerythropo ietic
Ġarchite ct
Ġcoop erated
Ġpass ages
Ġdeterior ated
partic les
ĠRE H
ĠPol ish
Ġmanifes ting
ĠNA DH
Inhib ition
Ġsemiqu antitative
rig el
Ġchemopre ventive
Ġcompe te
ickn ess
D MP
I CR
T f
Z n
m ass
z ation
Ġa ffin
ti zing
Ġan emic
or ot
el le
Ġd min
os ocial
Ġh E
Ġh ERG
Ġth in
Ġn erves
Ġn ivolumab
ĠT FS
Ġle af
ĠC HO
oc amp
ĠP ulmonary
Ġ2 20
Ġcomp assionate
ĠB id
ĠB lockade
Ġmo CEBPA
Ġmo ieties
ĠN BM
ĠN MA
ĠL DA
ĠL iver
Ġcons tip
34 4
Ġcor tex
ĠK ras
ĠJ SB
Ġsim plified
Ġaut omatic
Ġdi recting
Ġstandard ize
Ġless ons
MD A
Ġstrati f
Ab nl
Ġir inotecan
tis ense
36 3
Ġhelp ing
Ġ35 8
Ġsal v
acetyl cysteine
Ġepid ural
be ing
initi ated
Cyt Abnl
ĠBi opsy
Ġpy rexia
Ac tivation
Ġchromat ographic
ĠSh an
Ġcompeti tively
Ġdeline ation
ĠSyn dromes
ĠHM GA
egakary ocytes
vin cristine
ĠROC K
IGF BP
Ġadministr ated
Ġunw anted
ĠAv ailable
Ġcontradic tory
Ġurothe lial
Ġsanct uary
Ġconstip ation
% :
3 11
B w
C t
C OL
D ef
M b
N OP
P CA
S NF
l amed
o emb
r atio
Ġd iac
Ġd CTP
ra quinone
ĠT EM
Ġis othiocyan
Ġmyelo cytes
Ġ2 17
Ġr igorous
ĠB sAb
ĠB inet
ĠF IS
Ġ3 65
ĠR KIP
ĠO CV
ĠWe e
Ġsub stance
ĠL IM
Ġinf idelity
Ġdem ands
Ġdem ethylases
22 9
ET P
Ġmy osin
50 3
Ġdesign ation
IP S
ĠER CC
FU S
Ġsol vents
Ġrestric ting
ifferenti ating
tes ted
ibr ative
Ġantifungal s
wh ite
Ġplasmacyt oma
Ġinterpre ting
sm ok
ĠFB W
nic ulitis
ĠInf ections
ĠPar ty
Ġfer ro
De tection
Ġpropag ated
Ġpurs ue
ĠTNFR SF
Ġimmunoconjug ates
Ġcytomorpholog ical
Ġti ters
ĠMit oxantrone
Ġadministr ations
Ġmanufact ure
ĠRN ase
ĠITP R
ĠAmeric a
Ġexpon ential
ĠAO Es
Ġprol ific
Ġinhal ation
yphen yl
NOP HO
G TKI
H F
J ALSG
S up
c le
f icial
n ilotinib
Ġa ux
Ġa CGH
Ġa erobic
Ġt ach
on ous
he tero
Ġc n
al bumin
om ere
Ġth reonine
ĠA k
ec tivity
em or
sp an
ĠP CT
ĠP CM
ĠB el
ĠB AP
ĠIn clusion
ĠS EPT
Ġanti retroviral
ĠG EP
Ġpre leukemia
Ġag arose
Ġind ustrial
Ġunder lines
Ġpar ap
ast inib
ĠV E
plic ations
zym atic
of usp
Ġmetast as
Ġhyper leukocytic
ĠIM F
Ġ26 1
Ġ27 2
Ġsp ent
PR C
ĠIC H
Ġsol ved
mod erate
Ġdysfunction s
Ġglut aminase
Ġquestion able
Ġimpl ants
Ġresid ing
ĠIK AROS
iver tinib
ĠTw ist
Ġhydrox ycarb
Ġaugment ing
Ġpure ly
Ġherpes virus
Tar geting
Ġhemophag ocytosis
Ġparadox ical
Ġont ology
ĠAchie vement
Ġpolyploid y
ĠNow adays
ipp ocamp
Ġtric arboxylic
Ġindefinite ly
SW OG
Ġconges tive
rax ofusp
Ġhop ed
Ġreminis cent
5 87
G DS
L FA
M IT
P DAC
Q u
T im
T ie
V O
b red
m ectin
p g
Ġ zyg
Ġp loidy
Ġh uge
ot ub
ĠI NT
Ġcon den
ĠM u
ĠB CT
am pl
ĠW B
Ġwe b
ĠR XR
Ġnot or
Ġanaly sing
pl antation
ĠL ater
enc ement
Ġnon lymphoid
Ġsuc cinate
Ġcharacter isation
Ġacc ru
tran sp
az ol
Ġlim b
26 1
ĠIM C
Ġcollec tive
99 6
ĠER Î²
ĠIntern al
mod ulated
MM C
ĠAD E
Ġbl unted
Ġembry onal
cyc lo
Ġrevolution ary
lit azone
Ġbehavior al
Ġremo ving
glut am
Ġcre ation
ĠSK OV
Ġantioxid ants
Ġradio active
but yrate
ĠPub lished
Wh itney
pan sion
ĠLIN E
ĠRep ublic
Ġexhaus ted
Ġdorm ancy
acyt osine
yclo vir
Ġbre ath
ĠTranscript ome
Ġlob e
Ġgangli osides
Ġdestro y
Ġhab its
Ġhematog ones
Ġcentrifug ation
Ġpsych osocial
epo etin
4 95
B GRL
I CT
L E
Q PA
Q STM
W A
c en
c ine
g emtuzumab
h ot
en o
en edi
Ġp od
Ġm otor
it ating
Ġre di
ĠM dm
her lands
Ġor bit
Ġ2 27
ĠB x
Ġk its
ĠN L
ĠN CAM
ĠR an
Ġres idence
de tectable
ĠE U
ĠE HR
ĠL PA
Ġpat hom
yc ho
Ġchrom atid
ak ist
15 9
Ġreview ing
ĠV M
leuk ocyte
ys ical
Ġmy ofib
ĠAs xl
ok inase
Ġ24 8
Ġtechn ically
ish ment
35 8
Ġquantit ate
DN M
Ġintr icate
Ġampl ifications
ĠSc ore
Ġpreferen ces
Ġshe ep
OP N
Ġhar mon
ĠAnti bodies
Ġide ally
ĠBe yond
Ġcryp t
tet rap
Ġfil ament
Ġsin usitis
Ġdiscl ose
ĠNet herlands
Ġempir ic
Ġchel ator
Ġadjun ctive
Ġepipodophyllot oxins
ĠCri teria
ĠAct uarial
Ġfair ly
Ġneighb oring
phosphatidyl inositol
0 65
0 67
4 90
S ox
S DS
S EPT
T opo
T OP
d ai
d iester
re th
en n
it ably
Ġd u
le ts
id ences
Ġh ippocamp
up s
Ġde oxyc
Ġon line
ĠH ippo
Ġr Hu
ĠD audi
ĠS ymptom
ĠW est
Ġat rial
ĠN ET
ĠG IMEMA
Ġhem in
Ġpres crib
Ġbi och
ĠK lf
kn ockout
omy ositis
Ġpan niculitis
Ġhom od
ĠHR s
Ġsym met
LC H
ophag us
Ġacqui res
Ġconfirm atory
Ġlys osome
Ġgluc uron
Ġple omorphic
Ġintrat umor
ĠNe gative
Ġthi op
deple tion
PP AR
nes ota
ĠMin nesota
Ġcorrespond s
ĠMal ign
Ġvisual ized
ĠMan n
Ġperman ently
Ġgest ational
Ġread out
ĠRand om
ĠAbs ence
ĠPhen otypic
Ġbronch ial
Ġinterrog ated
Ġbench mark
naph thyl
Ġadvoc ate
ĠProb ability
Ġtris omies
ĠRecogn ition
ĠDep ending
ĠElect ron
ollic ular
Ġaffin ities
C lofarabine
H em
J uvenile
L Ps
Q ALY
T EL
a R
e ach
n el
v ision
Ġs n
or aph
Ġd op
er able
le ep
ĠI a
ĠM edi
ĠM ouse
oc ally
ĠP AD
ĠD LT
ĠD oses
ĠF G
ĠF MR
ĠS us
ĠS ES
ĠW D
Ġat rophy
Ġ3 22
Ġhemat ologist
ĠL IL
Ġdec lines
opt otic
Ġnon significant
Ġar isen
Ġqu enching
ĠV K
Ġref ining
Ġ20 3
ĠDN Ts
AP A
18 00
ĠMP A
phosph atase
ĠPro f
inf ectious
ole t
Ġ44 6
Az adC
ĠET NK
Ġcalc ulations
Ġnan ocarri
Ġtermin ated
ĠIR E
Ġpa rox
Ġtw elve
Ġmild ly
ĠPA H
chlor odeoxyadenosine
Ġdeb ul
Ġgel atin
class ical
Ġinterrup ted
Ġerr ors
Ġsphing olipid
Ġreplic ative
ĠDAS ISION
ĠAff iliated
He at
ĠGIST s
Ġstrept ococci
ĠCU DC
ĠStr ati
main ly
Lym pho
Hep at
iflu or
ĠSUMO ylation
Ġinterview s
ĠEph A
Ġunderpinning s
Ġlum inal
ĠPf izer
Ġchemoattract ant
oraph ane
5 19
A O
G erm
K JT
L oss
L DL
M AL
N CI
P y
P LA
h ybrid
o D
Ġw anted
Ġth a
ec rosis
Ġfor th
rap ies
ĠM BL
ol imod
ĠB o
ĠB MR
ies cent
am ers
ĠD SS
ĠIn fusion
ĠF gr
Ġun altered
ph il
Ġmo unting
pro gnostic
de tected
ĠG vL
iti mate
Ġpo orest
Ġrec ord
Ġlympho penia
MT H
Ġop erate
Ġmicro vesicles
ep i
Ġgranul ocytopenia
Ab stract
35 5
gi um
cyt oplasmic
ĠCM C
201 5
Ġmig rate
sel f
Ġion ization
ĠÎ³ H
ĠLA MA
carb ox
ĠSel ection
car cin
atur ity
Ġhepar an
Ġcontraind ication
ĠHispan ic
ĠDO BD
Ev idence
ometh acin
Ġrough ly
separ ated
Ġstraight forward
Ġarach id
Ġhemizyg ous
Ġparox ysmal
) ÃĹ
0 68
P CL
d CTP
w ater
Ġa ided
re a
Ġc ALL
Ġf eline
ĠT reatments
if osine
ver mectin
ĠI SD
ol dering
). <
Ġ2 23
ĠD en
ĠR II
NA E
cl ature
Ġse as
ĠTh ai
Ġmay be
ad ast
ĠK M
est he
Ġam ph
Ġspecific ities
Ġep o
ĠV H
Ġpost transcriptional
Ġsm oldering
Ġ30 8
Ġder ang
Ġprot racted
ythro poiesis
Ġ25 5
Ġeng age
Ġ26 4
Ġcer am
Ġutil izes
Ġenro lling
67 7
omen clature
Ġoxid oreductase
yr yl
Ġdehydro genases
oles cents
ĠCB R
ĠAR G
quid ar
Ġstabil izes
ĠGen eral
Ġconst ra
ped ia
ĠAg s
ĠMa gnetic
ĠSpec ial
Ġphot odynamic
ĠIs sue
ĠSE ER
jo ining
ĠSS X
dimethyl thiazol
yclo pedia
mimetic s
Ġreapp earance
adast uximab
N QO
T en
a uc
c a
g ated
i PSCs
p et
r P
u i
Ġt ill
ti se
Ġc etuximab
Ġs ent
Ġan emias
es ylate
ar ith
os us
os ylated
Ġth al
elo c
Ġex it
Ġis ochromosome
ĠM X
ĠM eth
Ġg aps
ud an
ĠP NA
ĠP opulation
ge vity
00 11
ĠS i
ĠN m
Ġpre incubation
Ġsub stitute
rac tive
ĠDNA s
Ġel t
Ġ12 98
abl ation
ĠCI N
MP Ds
ise ases
Ġ16 6
Ġdos ed
Ġshort en
CN T
ĠCon tr
DA S
Ġstatis tic
Ġi i
des cribed
Ġcho l
200 2
Ġgas tro
Ġtransl ates
yr s
Ġconver ting
Ġpr iv
ĠNon hematologic
Ġasc orbic
ang u
ĠBe at
random ized
Ġstrength ened
ĠMal ignant
granul ocytic
Mo Abs
Ġnecro tizing
Ġchloro acetate
meth otrexate
ĠRef ractory
Ġantico agulation
Ġradionucl ides
Ġclaim s
ĠEnc yclopedia
Ġgynec ologic
Ġrhabdomy osarcoma
Ġenjo y
splic ing
osu quidar
Ġcopolym er
ĠRestor ation
3 05
5 50
B W
E ffec
P RT
S tem
b acter
d A
g s
t m
Ġt RNA
Ġin exp
os om
ec urin
ĠT ex
res ts
un s
ac hes
Ġas paragine
Ġis omerase
ĠI l
Ġl inc
iv ascular
ab r
ĠP y
ug inosa
am ole
Ġrel ax
Ġ3 20
Ġmut ual
ie f
Ġ5 11
pl an
ĠG LS
CD DP
Ġimp art
tern ational
ber g
AT M
Ġadv ised
ass emb
ĠBM N
50 8
ĠX L
Ġcent rom
Ġhyper active
Ġ26 7
ĠEx ogenous
Ġxen ogeneic
Ġfib r
gh ai
ĠAA V
ĠATP syn
94 19
ĠSM O
Ġepid erm
ĠAD Cs
ĠSF Ks
ĠNe oplasms
Ġcomplic ate
ĠMon osomy
ĠTr p
Ġren in
Ġmanip ulating
ĠSup portive
Ġsem in
ĠComp uted
Ġsubstit u
hel per
ĠIntegr ated
Ġimmunob i
Ġlon gevity
ĠÎĶ N
Ġprost atic
Ġrelie ved
Ġdefic it
Ġchick ens
Ġconstitu ent
Ġphosphoryl ates
Ġfem oral
Ġfirm ly
TSG s
ĠTiss ue
1245 9419
Ġprolific ans
/ +
2 80
h it
k er
t ases
Ġc c
Ġs ti
Ġs ed
Ġan a
Ġof atumumab
er uginosa
le ge
Ġth reatening
em etic
ac arb
Ġbe ars
Ġch i
ĠH Cs
st ained
ir y
Ġad duct
ĠD XR
ĠW PSS
iff use
ĠR BM
com ple
ĠG MP
oun ting
Ġ0 1
ĠL BH
Ġmal t
Ġsyn decan
Ġsuc ces
ĠK AT
out h
Ġdes tin
Ġmulti organ
60 2
95 2
Ġ15 00
Ġpolym ers
roph agocytosis
30 6
26 2
Ġphosphor ib
Ġi PSCs
rup t
ĠCC K
Ġtransi tions
ĠAL CL
UC Y
Ġhemoglobin uria
Ġmamm als
ĠId a
Is ocitrate
usc ular
Ġbac ill
valu es
Com bin
Ġpropag ate
Ġapprec iable
ĠDis continu
Ġair way
usi asm
Ġstrept ococcal
Ġtrap ping
ĠHispan ics
ĠCharacter ization
ĠTrx R
ĠIns titution
ĠCSP G
Ġfre edom
Ġrup ture
ĠRus sian
Ġlacto ferrin
ĠAssoci ations
Ġelt rombopag
Ġinexp ensive
ĠTex as
A UL
D LTs
H ox
L EF
N MA
R ef
T MA
c lassification
en yl
Ġre qu
Ġb are
Ġe verolimus
om ed
ĠT TP
Ġch ief
ĠS umm
Ġco administration
ĠR af
cl us
ich lor
Ġlympho plasmacytic
11 52
Ġdes m
cy an
Ġprov irus
min ent
19 90
20 8
MR T
til in
osed ostat
respon siveness
Ġdup lic
opy ran
Ġpractic ing
49 1
68 2
oper atively
olar ized
Ġexer ting
ĠMM C
Ġtem p
ĠPT X
ĠEp i
ĠTrans fection
Ġcomplic ates
DLI s
appro val
Ġthi ol
ĠCompar isons
ĠSLC O
Ġfibrin olysis
ĠPE ITC
Ġneph rotic
BR CA
etabol ic
sim ilar
Ġdescrip tive
Ġaglyc one
Ġunil ateral
Ġoligodeoxynucle otides
A urora
B NP
C hip
D is
G raft
H om
T MDS
T AD
a round
c hemia
e o
h ist
q ter
Ġo mega
an yl
it ri
Ġb ic
ĠT Î²RII
im ide
ig en
Ġis chemia
ĠI ron
Ġl aryngeal
ĠM Ab
il ing
um bers
ĠH ope
ĠH FD
ri ver
ĠIn dependent
ĠS IK
Ġun iversity
Ġun characterized
Ġ3 29
Ġover representation
ĠL eb
Ġlympho poiesis
Ġsuc ce
Ġop erative
001 6
Ġdo ing
Ġachieve ments
ĠRec ipients
aza deoxycytidine
Ġreal gar
ect asia
Ġsp are
omon ic
ĠMS H
Ġ34 35
ected in
Ġdet achment
ĠMN Cs
Ġphys ic
del etions
RP OSE
Ġcen sor
ĠAr m
flu orescein
Cyt osine
tect omy
Ġpeak ed
ĠSN U
Ġperic ent
ĠRS K
%] ),
Ġmer captopurine
Ġapprec iation
ĠDH AP
ĠAM oL
ĠQu izartinib
ĠEvalu ating
Ġimbal ances
Ġprefer ably
ĠPolym orphisms
PU RPOSE
Ġbond s
ĠEngl and
ASP P
Ġded icated
Ġreconstr uction
caus ing
Ġmyofib ro
4 38
B SA
H BA
M ethylation
M VD
c idin
n ology
n amed
p ot
r asp
y st
Ġa thymic
Ġa eruginosa
en ses
Ġc elecoxib
Ġp ione
Ġs ulph
Ġan c
el ta
it ant
Ġd rain
Ġf ear
os ystem
ĠC yclophosphamide
Ġex chan
ib ular
ĠM IM
op ropyl
hem orrhagic
ĠB RCC
ĠW arburg
Ġcl ient
Ġ3 17
Ġ3 000
ĠR F
ĠL Ps
Ġpot encies
34 8
tim ing
ĠK DR
MT P
Ġcombination al
Ġmicro sp
fer r
ĠV S
iss em
Ġmyel omon
26 4
Ġ25 2
arb epoetin
Ġhybrid oma
ĠMY O
200 4
Ġmultic entric
Ġreactiv ating
ĠCAR s
Ġacet yltransferase
Ġfas ting
Ġhistor ies
Ġtransition al
ĠFL U
Ġca reg
Ġcathe ters
PG E
Ġnutri ents
Mon oclonal
Ġiod ine
ĠAbnormal ities
Ġscat tered
ĠLR H
Ġannot ation
oderm a
Ġnur ses
Ġshar ply
Ġtro pho
Ġfork head
Ġreposition ing
Accum ulating
Ġhypokal emia
Ġaccru ed
3 22
4 14
9 29
A ustrian
E U
K S
O f
b es
k D
k p
k iller
Ġp ir
Ġm aps
le ag
Ġh P
ĠA V
em ographic
em itting
ĠT CTP
ter pen
ac hex
Ġg ast
od iaz
Ġ2 12
Ġr DNA
ĠB v
ĠF v
ĠR am
ĠR ich
ĠR EL
ĠR EP
ĠG fi
Ġover whelming
ist at
Ġdifferenti ative
ĠU IC
RA Y
16 2
CL ABSI
Ġmin us
old s
vir ally
Ġconcentr ate
AR RAY
Ġmetabol omics
ĠAd ults
Ġaz athioprine
Ġ23 2
CM C
Ġregression s
pop ulations
Ġlog arith
yelodysp lasia
Ġassign ing
ĠReg ulatory
ospor ine
ĠSout he
ostim ulation
Ġreproduc ibly
ĠTG IF
GST T
ĠProm yelocytic
124 17
Ġdiscrimin ative
Ġworth y
Ġretard ed
iflu oro
âĪ Ĩ
Ġatherosc lerotic
ĠPhys ical
Ġamyloid osis
Ġpren atal
Ġdichot omized
ĠTes ting
tetrahydro folate
Ġphleb otomy
stabil izing
ĠConcern ing
Ġpathogn omonic
Ġdestin ed
ferr itin
A EL
G D
H ispan
J H
b astinib
c ategor
e oxycytidine
p H
t ra
u ation
Ġ ut
Ġc AML
Ġp sor
ĠA UTO
Ġpro gesterone
ho lic
Ġst o
ĠI ST
ĠI PI
ir ine
ĠB CNU
am ines
00 25
ĠS unitinib
Ġne vi
Ġres erve
de ep
Ġab rupt
Ġ4 20
CR s
Ġinf ancy
Ġsup ra
Ġsugges tion
ogen y
Ġ19 75
Ġnucle olus
ores istant
Ġder iving
Ġindividual ize
orph yrin
Ġvir idans
drug s
Ġ27 8
ĠHR QoL
Ġmel atonin
Ġhydro xy
Ġpoly ethylene
Ġintensi fy
77 6
RAR a
co lour
Ġmis interpre
ĠPA OD
au tious
Ġcytos keletal
Ġsuper ficial
ĠCE ACAM
ĠBE AC
ĠVari ant
rox acitabine
ĠDr r
Ġarsen al
Ġsustain s
ĠPres ent
Ġmicros omal
metabol izing
ĠIG H
BH AC
sho ck
Tr isomy
ĠDis ruption
Ġimped es
Ġont ogeny
aqu one
Ġortho log
Ġchondro cytes
ĠCur cumin
mor tem
ĠConcomit ant
Ġrubid azone
Angi ogenesis
Ġextravas ation
Ġirreg ular
leag ues
achex ia
Ġut most
D MA
S or
b cl
o tes
p act
v ol
Ġ :
Ĥ ¬
Ġin ner
Ġs acr
Ġd end
Ġf ight
Ġn inety
ĠT ARGET
Ġpro tumorigenic
ĠC ASE
ac tically
Ġas ym
oc arb
Ġde pos
Ġch arts
ĠP AF
Ġ2 19
st at
ap enem
ĠF IC
ĠS PR
ub er
Ġk er
Ġco x
Ġgen otoxicity
ĠG lasdegib
Ġpres cription
Ġpar vovirus
Ġel acytarabine
Ġar resting
Ġprev ail
Ġrev is
Ġ12 00
ĠV ers
ĠV Î²
par ty
ep id
Ġ30 9
ĠAn gi
30 8
27 9
phosph on
ĠCT CL
Ġhaemat ology
Ġhyper leucocytosis
ĠEx pl
Ġintegr ates
32 80
Ġlocal izes
ĠCyt oplasmic
immun oglobulin
Ġiss ued
Ġstar vation
ĠRe as
Ġâ Ĥ¬
ĠNe utropenia
Ġphospho diester
Is olated
Ġremod el
sh ift
Ġneo antigens
Ġarsen icals
Ġnutri tion
De term
Ġexcre ted
Ġassemb led
igor ously
Ġstres sed
Ġther mal
(Â® ))
Ġhyperdiploid y
Ġprofessional s
Ġfus es
Ġserv ices
ĠTIG IT
Ġdura bility
Fif ty
yrid amole
Ġleuko encephalopathy
ĠCac o
Ġundoubted ly
ĠLeb an
Ġcensor ing
ĠREP ORT
" -
0 61
D eregulated
E ST
E OP
I WG
K C
N HEJ
V EN
h R
i ro
i very
Ġt ivantinib
Ġc autious
Ġp ol
Ġf ores
Ġf ruit
Ġth reat
ĠA MN
ĠC MPD
Ġst ri
Ġcon ception
Ġg els
ĠP ort
Ġv imentin
Ġ2 53
AML CG
ĠR out
ĠR ING
Ġtrans well
ĠG ood
ĠL act
ĠL BC
oth ened
Ġcons uming
Ġar t
Ġacc ident
Ġmalignanc es
Ġconf usion
ĠJ ude
ĠV orinostat
Ġphen otypical
19 89
Ġform ally
ĠMLL r
ish man
Ġinform ing
PD T
Ġsix teen
Ġlen gths
Ġintra genic
pre treated
Ġcardi oprotective
Ġglyc osides
Ġmacro cytic
Ġcat ar
Ġauto antibodies
ĠMN s
ĠNB T
Ġextrem ities
ĠSc a
del ivery
bi otin
Ġput atively
ĠAc tivity
ĠMV s
MC yR
Ġchemos ensitization
otran splanted
ĠTr yp
ĠHO VON
Ġphag ocytes
Ġbacte raemia
ĠArg inase
ĠBCOR L
idic olin
hour s
Ġmilest one
Ġnanom edicine
Ġansw ered
ĠBT Z
ĠEGF L
Inter leukin
ĠMol t
Ġthous and
Sc a
ĠDisc overy
Ġtrop onin
ĠAZ T
Ġcas pofungin
ĠICR F
Ġmicrobi ota
Hyper leukocytosis
Ġstand point
Ġunequiv ocally
erge tic
Ġpolyp eptides
Ġcalib ration
Len alidomide
Ġphysic ochemical
C SC
G nT
L uc
V II
l a
n am
in jected
Ġp CytAbnl
Ġe cc
ul ing
ab oz
ĠF ound
ĠS SC
Ġ3 60
ĠE KLF
ound s
Ġ7 00
Ġpar ac
Ġpar tition
Ġbi ol
Ġocc urrences
Ġsim ulated
tho l
ĠML C
Ġ24 5
Ġsus pend
29 1
Ġexper tise
36 5
den se
Ġj ob
ĠIC E
HP Cs
Ġmobil ize
Ġz oledronic
ĠCol on
ospor ium
ĠCH I
arm acy
oman nan
Ġhistor ic
ĠTCR Î¶
DLI NE
Ġimmunore ceptor
ĠFL IP
Ac hie
Ġaccumul ates
Ġpolar ized
ĠUK ALL
Ġharves ting
Ġvalpro ate
âģº /
ĠBas ic
ĠPET HEMA
Ġdeplete s
ĠMedic ines
main tained
ĠPatho logical
Ġbyp as
perm issive
Ġshar p
Ġabst racts
Ġperf ect
Ġazanucle osides
Ġtrajec tory
ĠSJ KJT
ĠRepe ated
Vari ous
Ġelectr ical
ĠSmo othened
Ġconstra ints
Ġmalt ophilia
aboz antinib
N ase
N ext
P CNSL
S tr
U X
s CD
w in
Ġt ent
Ġp yl
or rect
Ġre a
Ġf rank
Ġf rizzled
ly sis
em in
em ulsion
ver t
ĠI X
Ġtre ph
od emographic
ĠH IP
hem agglutinin
ĠD ic
ĠF orm
Ġcyt ometer
Ġap igenin
ĠN i
Ġper ception
Ġ4 15
ĠG o
Ġout patients
Ġinf lamed
Ġcons ent
depend ence
our idine
LA T
Ġcar nos
fer ior
16 6
ass ays
Ġcharacteristic ally
les tero
AP E
ev oned
Ġcap it
Ġrep aired
ĠST ING
Ġgu aran
Ġ26 2
Ġ36 9
Ġmes enter
As s
ĠAL FA
ĠAN G
69 3
ĠCol lege
ĠCH EK
ĠMC S
Ġelectro cardi
Ġent h
ĠCG H
IG H
Ġscal es
tet ra
ĠDiagnos ed
no vo
Ġsubd ural
Ġsero status
ĠAnaly zing
253 6
Ġjoint ly
Ġpig ment
topo isomerase
Ġimped e
iam ine
ĠThromb ocytopenia
troph y
Ġmonol ayer
Sm all
LAIP s
strom al
Ġgall bladder
Ġpestic ides
Ġadeno viral
Ġjudg ment
berr ations
Ġisothiocyan ate
evoned istat
0 74
2 38
4 18
5 96
6 18
6 42
8 19
D ose
R earrangements
V DR
a que
d up
d ifferen
f ailure
k l
m atic
Ġ ign
on ography
en osis
Ġp ore
it rile
at ologic
Ġh ip
ĠA GS
ec d
ĠT ST
ur ic
ur ations
ĠC z
ĠC BC
ĠC ampath
ĠI LT
ĠI kappaB
ĠH EK
Ġ2 21
Ġr IFN
st atic
ir in
ĠB DH
ĠD ig
ĠF P
Ġun purged
Ġun appreciated
der iv
Ġ3 28
ĠN DRG
ĠN EDD
Ġco vers
ĠG ain
ĠE W
osi tions
Ġsuc cin
ser ythropoiesis
yc ardia
ĠK y
ogen in
av able
Ġprov oked
min al
ĠJ agged
Ġcoun ted
22 34
Ġ24 2
Ġprote oglycan
Ġtranscript omes
24 54
Ġmethyl cytosine
ĠLeuk apheresis
ĠIFN s
70 6
Ġhyper trophy
Ġretin opathy
Ġdys granul
65 5
LI F
ov aquone
immun ization
Ġdeep ly
omin ant
Ġatt end
Ġaccompan ies
Ġmeth ionine
Ġattenu ating
Ġunus ually
PT L
Ġstimul ator
Ġremod elling
ĠEP Cs
ĠLA MP
PN H
Ġtempor arily
ĠES HAP
dem ethoxydaunorubicin
Ġconsolid ate
Ġden at
ĠCU X
Anthracycl ine
ĠProte omic
Ġcorrobor ated
ĠHV EM
ĠSY BR
ĠLAT S
redi rected
terp ene
Under standing
Ġoligomer ization
ĠQing dai
ĠLRR C
Ġpathom echanis
Ġbioch ip
) </
G lioblastoma
M U
O r
R etin
c CML
c lassified
t um
en oyl
or igin
ĠA ctive
si ll
Ġpro line
ĠC oc
ĠC ore
ĠC ulture
gen omic
ac ogen
Ġl aun
oc t
Ġim minent
Ġch ills
ĠP art
Ġcomp etence
am mon
ĠD MP
ĠS a
Ġun ivariable
ĠN As
ĠR MS
Ġhem ostatic
rac il
ĠL BL
%) :
Ġinvestig ator
Ġmulti faceted
AT F
Ġcol leagues
Ġdi oxygenase
53 3
PL K
Ġes ters
trans location
ranul ocytosis
AL P
ĠBM MNC
Ġdiagnostic ally
sub type
con jug
ĠCT D
ĠIM PL
Ġ27 5
Ġcal cein
44 9
Ġdys megakary
Ġ35 1
Ġorgan omegaly
ĠY KL
MF I
ĠAp optotic
Ġvascular ization
Ġsize able
Ġsi rolimus
IN T
Ġlands capes
Ġintern ucle
ĠTrans formation
ĠPKC Î±
amil ies
Ġhorm ones
cons uming
Ġfil es
tub ulin
ĠHN RNP
ĠStandard ized
pat tern
Ġlook ing
Ġsial yl
ĠSyn ergistic
Trans cription
Cons id
Ġreinfor ced
Ġcy an
Inf ections
ĠUL K
Acc ording
Ġnonrandom ized
ĠRC MD
ĠMark ed
Ġhypodip loidy
Ġundes cribed
ĠGas trointestinal
Ġtal irine
Ġfluoro uracil
Neu ro
Ġalign ment
Em erging
Ġviro therapy
Ġslo pe
Ġneovascular ization
ondi aldehyde
Ġsalv aged
oemb ryonic
ecurin ine
Ġsti ff
C EL
G lu
L Y
N umerous
V TE
a CGH
f DNA
p aclitaxel
Ġ 00
Ġc ran
Ġs ig
ro red
os ylation
Ġth irteen
im olar
Ġac ceptor
ĠM urine
ĠM Abs
op terin
Ġor ientation
), +
ĠB TG
ĠD ZNep
ĠS AA
ĠS timulation
igh ts
ĠN J
yl enin
Ġab ivertinib
Ġen de
ĠG D
ĠG reater
Ġmet als
ĠL PL
ĠL atin
ip ping
Ġcyto fluor
ucle ated
Ġsh or
Ġdi phtheria
Ġ19 7
Ġy rs
Ġmin ing
Ġmat ured
Ġcycl ins
EBP alpha
IP A
onucle otide
75 9
Ġprac tition
oxyc ycline
ĠPre vention
met hionine
Ġneuro fibrom
Ġtrig lycer
cat aly
Ġepithe lia
Ġemb olism
Ġmaxim izing
Ġred istribution
ĠÎ± Î²
ump ing
ĠDS B
CBF B
Ġbil ayer
ĠSecond ly
MB TL
Ġdeb rid
ĠGC LAC
bor ne
Ġvirt ue
ĠHu R
Ġcros sed
Ġreinf used
Ġspectro phot
inv olved
Ġribonucle ic
Ġdiscrimin atory
Ġversion s
acc elerated
prednis one
Ġmir rored
Ġce phal
Ġunderex pression
ĠPur ified
Ġbuil ding
Ġcontamin ated
Ġinterrog ation
Ġimplement ing
amid ronate
ĠHetero geneity
ĠTre ating
Ġisot ope
Ġblind ed
ĠMex ico
ĠPathw ay
ĠUtil izing
orot ate
ĠShan ghai
Ġdrain age
issem inated
- ;
8 14
D ec
G PCRs
V idaza
b reast
f ect
h ang
l ight
l oss
l arge
r Hu
ã Ģ
Ġ ÎºB
ti fied
Ġc itrate
Ġc achexia
Ġp lots
Ġs leep
Ġan agrelide
Ġd Cyd
Ġd oxycycline
er ally
ith ine
ra red
ĠT PL
ĠT dt
ĠC utaneous
se where
ĠM g
Ġch ori
Ġtre tin
ĠP earson
ĠG li
ĠG AL
ĠE udraCT
Ġmet am
Ġpre operative
Ġover ride
ĠL TR
ocy steine
Ġinter patient
Ġadv is
37 1
Ġgra ded
ĠCN DAC
eric ardi
ced osporium
Ġ23 9
ĠPro gress
Ch imeric
AM s
ĠEx cluding
Ġinfiltr ative
Ġhere by
Ġ45 4
ĠCP I
per t
ĠGroup s
ĠQ ual
PR S
ob acterial
def iciency
SA A
Ġ56 2
Ġsepar ating
Ġneuro genesis
Ġantagon izes
Ġconver ts
Ġemer ges
ĠTGF beta
Ġfl t
ĠTR EC
ollow ing
Ġmen og
ĠDR B
HT LV
ĠGen omes
inter quartile
vi olet
Ġcomprom ises
Ġcomm encement
Ġqual ified
bor ns
Ġplasm ids
Ġcompens ate
ĠMorpholog ic
ĠLympho cyte
occur red
Ġdermat osis
Ġpericardi tis
ĠMulti drug
ĠRadi o
Ġgang ren
ĠDF X
AY A
Ġtable t
Ġundes irable
ĠTNT s
Ġhin ders
Ġgalact omannan
Ġtransamin ases
Ġsemis olid
PTC y
ĠSNA I
Ġendonucle ase
Ġleak age
anch nic
Ġhydroxycarb amide
Ġpir arubicin
Ġcarnos ic
2454 206
Ġtretin oin
0 66
6 70
L ip
M esenchymal
c ultures
t MDS
Ġ âĢ
Ġ ure
Ġo val
Ġo mic
Ġin gu
is platin
an a
it ric
at o
os m
ĠT MP
sp on
ab out
ĠP Y
ĠP ark
ĠP akist
ĠH Y
ir med
ĠB AFF
ĠF PA
ĠF DG
ĠS tructural
Ġrel iance
ĠR ab
Ġen velop
Ġper ivascular
ĠG e
Ġno gal
Ġpre m
ĠL ife
pho lin
Ġob atoclax
Ġ7 50
Ġpar alog
Ġnon cytotoxic
Ġnew borns
Ġ8 94
Ġcor p
AB CG
CD P
Ġsim vastatin
sor b
19 1
Ġblast ocy
25 4
gra d
Ġonc of
ĠAd ding
Ġaz ole
IM iDs
Ġenro l
Ġderiv es
HP V
Ġprogram ming
ĠImmun ol
Ġbeh ave
Ġclar ifying
Ġelectro chemical
Ob esity
CAR s
ĠPL X
with standing
Â® )
Ġtren ded
Ġadip ogenic
Ġpatholog ist
Ġlongitud inally
Ġsero logical
syn drome
ĠLympho blastic
Ġnecessit ates
214 662
Ġrefin ements
ĠOX PHOS
Ġechin omycin
ĠErythro id
Ġvag inal
Ġeryth rophagocytosis
ĠGE O
Ġapproxim ate
ĠIÎºB Î±
Ġmere ly
Ġprep are
Ġcatas trop
ĠProphyl actic
spic uous
Ġconden sed
eloc ity
Ġcc RCC
ĠCz ech
Ġingu inal
Ġcatastrop he
) "
3 34
D OK
E ML
E MD
M X
P cG
R IL
S rc
T ILs
c RA
d istribution
p rone
p urin
s aving
t oler
y oun
Ġ logical
ti ated
on ok
on ecrosis
Ġc CR
Ġp in
ro le
Ġd m
ar ic
om olar
ĠT rip
Ġpro tumor
if unctional
ĠI NF
ĠM Ï
op ard
Ġg ins
Ġv ice
ĠB reast
yp ically
ĠD ll
ĠD BA
Ġwe ighed
SC NP
âĢ Ļ
ĠE lec
ĠE Cs
Ġcomple mented
Ġind omethacin
Ġro set
Ġnon canonical
ill ed
og litazone
Ġam ine
oph y
16 1
19 26
38 5
Ġdaun orubicine
05 2
Ġcycl ase
37 2
Ġbenefit ting
Ġrecom m
Ġimm aturity
II A
MS H
Ġthem e
Ġhyper acetylation
Ġprophyl actically
Ġproduc tive
Ġtransp os
Ġexpl osi
ĠRT PCR
ĠCyt ometry
HL F
Ġtra uma
PR L
87 2
Ġindex es
Ġgo ing
anti le
ĠCytogenetic ally
macyt oid
week ly
Pro gnosis
Ġsulf ide
Ġnod ule
Ġqual ify
Ġderm atitis
Ġstrength en
Ġfung emia
lys ine
che ckpoint
ĠHaemat ology
leb rand
ĠDem ethylation
Ġsk ull
558 296
Ġmyr istate
Ele vated
Diagnos is
Ġmicrod iss
Ġelabor ate
ĠSn ail
Ġhyaluron an
ĠOnt ology
AU Y
Ġemo tional
Ġzyg omycosis
Hom oharringtonine
onok iol
558296 88
+ ;
3 28
3 99
C ur
E OC
H BV
M a
M antle
O A
P red
S eventy
T ERC
b and
c otropic
f ocused
g ical
i NOS
he ther
Ġo s
Ġp ull
er a
Ġ( [
Ġb a
Ġb sAb
ul der
ĠA ID
ĠT DM
ĠT NC
si ed
ĠC e
ĠC le
ig il
Ġis otype
il ate
Ġim id
ĠP ICC
Ġv el
ĠD ysp
ĠS OC
Ġap par
ĠR M
SC Cs
ĠO LF
tem is
ĠG lyc
ĠE LL
Ġinv alu
lec tion
oun ter
Ġprognostic ate
Ġfol ding
Ġel sewhere
Ġar yl
ion ic
11 57
Ġmicro be
Ġreac ting
Ġdi phosphate
33 3
19 7
Ġmy riad
Ġtr ia
OX PHOS
ĠLeuk aemic
of lav
ĠAmong st
IP I
Ġeffici encies
Ġdys cr
Ġhom ogen
Ġemerg ent
Ġintra epithelial
ĠME DLINE
mal arial
Ġrepl acing
Ġextrem ity
ES As
methyl guanine
Ġmust ard
ĠTrans location
lassi fy
hol ate
MB A
aut ophagy
Ġpal mit
ĠAllo SCT
Ġcys titis
Ġcoc ultures
ĠMod ern
ĠIN D
alc one
Un til
Ġsuspic ious
ĠMyc obacterium
ipl ostim
Ġwa it
pen et
Ġbran ching
Ġcomputer ized
gf br
Onc ology
ĠTel omerase
ĠVit D
Ġdisproportion ately
Ġje opard
Ġinges tion
Ġcham ber
Ġped ig
elect ron
ĠContr ary
Ġenth usiasm
Ġshor test
Ġappar atus
ĠOLF M
Ġinvalu able
7 39
D OT
F usion
H a
L imited
c s
d ull
g itimate
k y
o a
o zygous
r itinib
v omiting
Â ¹
Ġ 001
Ġa ud
Ġt yros
en zymes
Ġc oded
Ġs s
Ġs out
Ġs TREM
el arabine
Ġf are
at uzumab
ate chin
ith i
Ġn i
ĠT LC
gen erating
ac quired
Ġst och
ĠM ethod
Ġde generation
ĠP uma
ĠD aunoXome
ĠIn vasive
ĠF riend
Ġsurviv or
Ġat om
log rank
Ġco express
Ġ5 71
com parative
ip arib
Ġblo ts
sup porting
ĠK Y
ĠU NC
Ġdes per
Ġimp eding
Ġdi athe
53 1
14 11
Ġcase in
BC NU
ĠBM F
ĠCh imeric
Ġyoun gest
37 6
Ġerythro leukemic
rid in
Ch i
Ġsp in
Ġ29 2
Ġtransfusion al
ĠAL P
ĠMM M
Ġbeh enoyl
Ġtem sirolimus
ĠSM s
Ġolig oblastic
Ġeradic ates
DNMT i
Ġrobust ness
ĠEL F
Ġcereb ell
Ġcereb lon
ĠÎ¼ m
Ġchlor omas
Ġillustr ating
Ġvis ited
Ġent rap
Ġarg uing
ĠFirst ly
SE A
ĠFT I
sil encing
but yl
ĠDel ayed
ĠEl ucid
ĠNa B
ĠStatis tically
ĠMass ARRAY
Ġmatur ity
Ġenum eration
Ġsubcategor y
ĠAnthracycl ine
GEM M
Circ ulating
Ġopac ities
Ġasynchron ous
6 31
B last
G vL
L angerhans
R eal
R XR
Y E
i ence
m A
r ated
s tis
re pair
Ġp ace
Ġb an
Ġh sp
Ġh osp
ĠA ST
Ġn ight
tic e
ur ies
Ġfor tilin
Ġex otoxin
Ġleukem ogen
ĠI MR
Ġcon gen
Ġde als
ĠH elic
ĠD iv
ĠF il
ĠS udan
ĠW t
ĠW YE
ĠR BP
Ġimmun ochemotherapy
ĠL CA
end s
ad ed
ĠV I
sor tium
Ġpost treatment
Ġend or
stan tial
CI I
MD C
Ġthromb opoiesis
mut ational
24 0
ĠSt ate
ĠAra b
blast oid
Ġsp ans
65 7
stim ulation
ĠDC LL
dex amethasone
97 18
68 7
ĠET C
Ġmegakary oblasts
Ġampl ify
Ġbro ther
Ġdiss ecting
micro RNAs
oura bly
ump tions
Ġreason ed
ote ch
ĠSU V
1210 477
ĠRI Z
Myelo fibrosis
Ġmutagen s
Ġfarnes ylation
prote asome
ket o
Ġunravel ing
ĠInvestig ations
ĠYoun g
ĠAUR KB
Ġheral d
Ġunco up
ĠCorresponding ly
Ġendoc an
ĠVin cristine
otub es
Ġdebul king
Ġepo etin
acarb azine
odiaz epine
' ).
5 92
B a
B MP
C CI
H SV
O ME
P rom
S al
T yr
T NC
V M
V LA
W H
c urrent
m idostaurin
s IL
on ectin
Ġs ch
Ġs atellite
Ġm atric
Ġre ads
os amin
ell ip
ĠA si
ĠT CA
ML FS
od end
Ġv inca
Ġ2 24
ĠD CP
ĠS EL
Ġun regulated
Ġun ilineage
ĠR et
ron ous
Ġper cutaneous
Ġsub eroylanilide
ĠL L
Ġob limersen
ocy stis
ast aurin
Ġbi ocom
Ġpl ating
yc le
aus al
ag o
reg ulator
Ġ19 9
60 32
Ġcomplex ed
HR QOL
Ġes ophagus
Ġselec tin
Ġmit oses
Ġ24 7
(- /-
ĠCon sortium
IM ATE
hydro lase
AF P
Ch k
66 3
Ġdiffic ile
Ġrever sibility
Ġlater al
Ġrestric t
ĠIg E
sc id
Ġaden omas
Ġmobil isation
Ġcen sored
prom oter
ĠNon relapse
Ġslow ing
Ġfunda ment
Ġirre versi
Trans location
Ġfluor ometric
ĠCorrel ations
ĠTaiwan ese
ĠEB NA
Ġerythemat osus
mu rafenib
Ġulcer ations
Ġperin atal
419 259
Glc NAc
cur ative
Ġazu rophilic
Ġsphero ids
Ġmetron omic
ĠBx PC
Ġphosphorib osyltransferase
Ġtreph ines
Ġdysgranul opoiesis
ĠAsi ans
/ *
5 56
F orm
H K
H g
M t
P r
P PI
P OT
S LL
S IN
d orf
h ab
o ylation
r ates
Ġc T
Ġm ock
Ġre jected
ar lier
Ġf ing
ĠA MML
res ident
ho u
ĠM eg
pres ses
Ġch ar
Ġad mixed
ĠF ran
00 20
ĠS olid
ĠS IN
ĠW BP
ĠN ur
Ġco activator
Ġ5 99
ess ential
ĠO l
Ġmar gin
Ġtrans it
pl us
ĠG B
ĠG old
ĠL ine
ĠL OS
Ġdev oted
Ġmal ondialdehyde
Ġbi ases
ser v
Ġel ution
ĠMD C
CL IP
Ġ19 50
Ġ20 20
ĠAs c
ind es
ĠAt ypical
ĠUn treated
NK p
Ġ28 5
Ġ28 8
PD L
Ġcirc adian
Ġwork shop
ect able
inten se
Ġrestric tive
ĠAp af
ĠImmun ofluorescence
Ġbel inostat
ĠHD CT
Ġminim ise
Ġattrib utes
oura ging
Me as
Ġthym ocyte
ĠSIR P
VL B
PK B
mo bility
Ġcoll a
ĠHU VECs
lem ia
Ġpredis poses
Ġcros sing
gluc an
Ġfif teen
Previous ly
Ġfluor ochrome
acr itinib
test ing
Ġandrogen s
Ġkappa B
Ġscat tering
Ġhap p
Ġtax ane
Ġimmunob lot
Ġpi oglitazone
ĠCompound s
Ġawa ited
Ġanat omical
ĠWil lebrand
cont ent
sal vage
oflu orescent
Ġvolt age
smok ers
MTH FR
ĠFound ation
0 56
0 70
2 56
: :
D ifferentiation
P TK
p EFS
r yp
r ating
â Ī¼
Ġ ille
in ic
in um
Ġd ark
id is
Ġh ij
im ex
Ġis ogenic
ab err
ĠP ERK
ĠH ybrid
ĠH CK
ri on
ĠD iseases
00 35
ĠS taining
Ġper pet
ĠG CA
CR BN
ĠL E
ĠL G
ad v
sup portive
ĠK CN
+) -
(+) ).
Ġreac ts
az olin
az acytosine
are an
DH A
Ġprob ed
ull ar
Ġmethyl ene
Ġcategor ize
Ġinsi pid
Ġadd icted
inc reased
Ġintracellular ly
ĠCyt ochrome
66 9
ĠZ eb
Ġfar m
Ġsol ve
Ġsol ute
54 16
Ġlike wise
ĠInc orporation
rich ment
Ġminim ized
bi ologic
thal assemia
ĠCH T
raz ole
Ġvaccin ated
Ad optive
Mut ation
ĠGerm line
ĠUnf avorable
ĠSW I
Ġagre ed
ĠFLA M
osc lerosis
Ġgover ned
determ ined
tel omeric
ĠMTH FD
Ġmir r
olo l
ĠSimultaneous ly
Ġmanufact uring
Ġhyal uronic
exp anded
Ġarabinosyl cytosine
Ġcere us
Not ch
Ġinternucle osomal
Ġstiff ness
Ġhij ack
Ġinsipid us
( +/
5 20
H QPA
O SCC
P os
S el
V S
c ious
d ODN
h arb
h ave
i et
n ov
he lix
Ġc red
Ġp EFS
Ġs orter
Ġs ingly
Ġd an
ed ema
Ġre ality
Ġf oster
Ġb TCE
Ġh opes
ĠC re
ĠC ebpa
Ġg r
Ġg lycerol
ĠP CL
ĠH ierarch
am ple
ĠF ed
ĠS CE
ĠW right
Ġne omorphic
log ically
Ġ3 18
ĠO KB
Ġassoci ating
Ġpre fibrotic
Ġsub m
Ġsup ervised
Ġexp ired
Ġ8 36
ĠK H
ĠU MIN
ion al
CT X
Ġep ilep
int ensification
centr ation
ĠMP FC
(- ).
Ġradi ologic
Ġdom estic
Ġsubt yping
Ġvir ul
Ġconstit uting
Ġ26 8
Ġi ASPP
Ġpoly ke
ĠMY BL
fib rin
ĠQ ALY
SA HA
EN G
Ġoste ocalcin
Ġred undant
Ġvol umes
ĠÂ £
ĠHemat opathology
myelo peroxidase
Ġtrac ked
ĠBi ochemical
Ġfit ted
ĠMon onuclear
ĠSer ious
quin oline
fil zomib
Ġneo angiogenesis
Ġphot os
Com plex
ĠES As
ĠFR Î²
ĠMyelo ablative
Gl ut
Ġlandmark s
Cons titutive
Ġpip er
Ġaccompl ish
ĠPos aconazole
Asp ergillus
Anti body
ĠPartic ip
Hb F
Ġerup tions
FOX P
zygo te
Ġsarc openia
anes ulf
Ġdere pression
Ġlac Z
ĠMalay sian
Ġpapilloma virus
ĠCot reatment
Ġbioph ysical
Ġmicrosp heres
Ġpsor iasis
ĠReas ons
lestero lemia
purin ol
F ollowing
H B
I DR
M idostaurin
O x
P LT
m TNF
on ide
es arean
Ġh rs
ĠA lu
ĠA MM
Ġn aked
ĠT ERC
Ġpro lymphocytic
Ġac yl
Ġas partate
ho ol
ĠI ER
ĠI SR
Ġmyelo ablation
ĠM NK
il in
Ġdis similar
Ġha pt
ĠF F
ĠF ever
ĠS SEA
th ione
Ġrem itters
Ġper taining
Ġhem ostasis
Ġfac ing
Ġsub mission
Ġag ranulocytosis
Ġinf antile
ros ecurinine
Ġobser ving
ag lobulin
ĠU TR
CD R
56 5
af arnib
Ġrele ases
Ġ30 7
In ternational
UN CX
ĠCN T
Ġpharmac otherapy
Ġrecogn izable
ĠX PG
Ġcal ibr
bil ization
mit ogen
Ġhaplo id
def ective
ĠMT F
lab elled
fac tors
Ġill um
Ġfibro us
ĠTrans fusion
ĠMechanis ms
aden osyl
infiltr ated
eff lux
Ġexact ly
Ġtempor ally
Ġbrom odeoxyuridine
Ġincon sist
Ġcys tic
âĤ Ģ
Ġpathogenetic ally
Ġpor cine
Cytogenetic s
Ġnumer ically
Ġfulfill ing
Ġmicrotub ules
Ġchel ating
Sign ificant
cis platin
Ġrelie f
Ġequil ibrative
ĠUC HL
Ġulc erative
ĠTopo isomerase
ĠTranscript omic
Ġpun ct
Ġinev itably
PTP N
Ġbed side
Ġton sill
Ġhur dle
weigh ted
Ġmax illary
ĠTun is
azop anib
terpen oid
ĠRout ine
Ġecc rine
Ġnogal amycin
Ġfundament ally
8 055
B rom
G IT
G lyc
M V
T TP
a GvHD
f ort
g uan
p OS
p iper
t ailored
Ġa ortic
or der
ro tid
Ġd NTP
Ġf using
Ġh MSH
ell ow
Ġth irds
un der
Ġleukem ogenicity
ib er
ĠP rop
ĠP neum
ain t
ĠD DP
ĠW ild
Ġrel iant
ĠN LRP
ĠR earrangements
Ġanti mitotic
Ġ4 30
ad ditive
oth io
Ġnormal s
Ġmark eted
reg imen
ne o
Ġkary otypically
Ġran king
Ġgra vin
Ġeng aging
Ġquantit ated
ĠFor ced
ero l
98 6
28 3
Ġ38 4
Al a
ĠPR I
ĠPR PF
effec tor
Ġdiss ected
ĠHD L
ĠTR L
Ġimmunomod ulating
Ġtet racycline
Ġion ophore
ĠRespon ders
ĠTF s
ĠCons ensus
Ġdim ethylation
Ġimmunop ositivity
Ġdig ested
SM O
ĠPMN s
quin ones
ĠNor way
ĠBE X
itud inal
Ġintercal ated
Ġarsen ical
uter ine
Ġcoinc ident
ĠMal e
ĠIN NO
Ġdihydro orotate
Ġmembran ous
combin ation
ĠFe brile
Inf ant
ĠRadi ation
Ġhams ters
Ġther m
ITR Cs
Ġded ifferentiation
Ġmatur ational
Ġmultin ational
Ġspac es
Ġarbitr ary
Ġscarc ely
Ġastrocyt oma
Ġaph idicolin
Ġdimen sion
Ġphyto hemagglutinin
Ġleukotri ene
Ġneurode generative
ĠFIC Z
Ġpyl ori
Ġdebrid ement
Ġcerebell um
Ġirreversi bly
, </
4 25
B RAF
B rdU
D ia
G ray
G IMEMA
M BP
T oll
T dR
d les
n it
s he
Ġ encephalitis
Ġm b
is is
Ġb omb
id ylate
ĠA HD
ĠA ustrian
ra il
oc or
ĠP ep
ĠP AM
ĠB leeding
ĠD ysregulation
Ġ3 25
ĠN HD
Ġres umed
ĠO P
ĠO macetaxine
itor s
ĠG alpha
ĠG LC
ĠL ight
ugh ter
Ġcytogenetic al
Ġhematopo etic
yc h
Ġinter sp
Ġdes c
ĠCR LF
Ġsc r
001 3
Ġcol istin
po lycythemia
leuk emias
ĠAl tered
19 97
19 87
ger ing
ocyt opoiesis
25 80
ST R
pon ent
ĠAd en
Ġradi oresistant
ER S
Ġimmunosup pressant
Ġi vermectin
ored uction
Ġlen ograstim
inf ective
urviv ors
ograph ical
vari ants
HP C
Ġsubc lass
Ġadop ting
Ġcen tered
Cyt otoxic
omod ulin
Ġax itinib
Ġrh in
Ġrh am
Ġtet rahydro
inter cal
Ġavoid ance
FL U
Ġpancyt openic
alk aline
Ġconn ectivity
ĠTL E
Se vere
ĠMultiple x
Ġmicrom egakaryocytes
Ġmediast inum
oster one
ĠIN HBA
Ġpolymer ases
ĠNa Cl
ĠGl uc
Hu M
Ġcompl aining
circ RNAs
Ġcoron avirus
ĠIF IT
ĠCU EDC
ĠNan o
Ġ(â ©¾
CCA AT
ĠPan obinostat
Ġâħ ¢
ĠRare ly
Ġsubstanti ate
Ġpeptid ase
Ġhur dles
Ġvitre ous
Ġmonke ys
Ġdy serythropoiesis
ĠFcgamma RII
omyel itis
Ġophthal m
Ġseiz ures
nucleotid ase
enedi one
ĠStrati fication
Ġende avor
ĠDiv ision
Ġille gitimate
2 88
3 27
A V
B enzene
C utaneous
D MSO
E Vs
F ludarabine
G iemsa
M c
O ste
g lycerol
m M
m orbidity
r ho
r ink
u elin
Ġa AML
on itrile
Ġc ram
Ġo le
Ġo ocytes
Ġp and
Ġin verted
al m
ar f
ul o
ĠA CR
ĠC ys
ĠC lear
ho red
ĠM U
her ing
ĠB X
ĠB usulfan
ĠB tk
Ġad di
ĠF gf
ĠF rag
Ġun targeted
Ġat ovaquone
der mal
Ġmo tivated
di rectional
ĠG nRH
ĠE s
ore tin
ari an
Ġhe aring
Ġthan ks
Ġunder represented
Ġnon in
Ġnon mutated
LA A
Ġmicro particles
001 7
ĠV AE
53 5
17 76
Ġregul ations
Ġphen ocop
ĠPh ospho
prolifer ating
Ġmethyl ase
phosph ates
Ġsynerg ic
gi an
Ġcirc ulatory
ĠMul tic
ĠPB OX
Ġtra it
Ġequ imolar
Ġsummar izing
ĠGS N
ĠImmun osuppressive
OC H
most ly
Ġsurvivors hip
MY B
Ġspon sored
ĠRel atively
initi ation
CH K
Ġion ic
Ġdim ers
Ġeth idium
ynthe sis
Ġsulf oraphane
Ġpalli ation
Ġsidero blastic
Ġsoci odemographic
Ġfeed er
Ġdip lo
ĠIG SF
Ġinversion s
ĠHMG CLL
opho res
Ġretrovirus es
Ġultra violet
ĠDem ographic
ret azine
Ġdisadvant age
701 24
Ġbab ies
Differen t
ffe e
ĠAdj usted
Ġforth coming
Ġcentrom ere
Ġomic s
Ġdm CEBPA
C ip
G u
I X
P AC
T EM
T IG
U V
i D
l ives
m CR
p athy
r t
r AML
z eta
en ectomy
en zymatic
Ġc GMP
Ġp ix
Ġm H
al ent
is omer
Ġd arbepoetin
si gh
ĠC t
ĠC hib
ĠC ereb
Ġex tern
ĠI B
ĠI on
Ġcon tin
ĠM CC
ĠM CM
Ġbe ad
rom olar
Ġcomp act
ĠF LC
ĠF ortunately
00 10
ear s
ĠN ST
ĠN ER
ĠN SD
Ġco b
ĠR AP
reas es
ĠE PI
ĠL uciferase
sist ence
Ġnon complex
Ġfol ic
FS F
Ġdevelopment ally
ry ing
Ġkary otyped
ym idine
Ġcaus ally
Ġonc ologic
Ġcytotoxic ities
36 9
Ġ26 9
98 5
Ġ27 1
Ġprac tically
67 3
Ġ75 1
rec ise
EN EST
ĠMM UD
ĠBC HN
Ġve murafenib
Ġdep si
ĠMy oD
Ġspl anchnic
Ġpa rotid
ĠAP ML
ĠSub set
ĠAK N
Ġelectro lyte
Ġabrog ating
Ġcereb ro
Ġrib oside
ĠRespon ding
ĠInter val
CY T
ĠLong itudinal
Ġmyc osis
cycl es
pir atory
Ġdermat ologic
ĠCr I
Ġfore front
Ġspectrosc opic
Ġuro kinase
ĠMyel oma
ĠCAM AL
New ly
Ġconvinc ingly
Ġoutper formed
ĠCar cin
Ġappra isal
ams acrine
ersonal ized
nitroso urea
Ġarachid onic
Ġhosp ice
ĠHierarch ical
C HO
C EC
N Cs
S OCS
T ra
T ype
Z V
h ENT
j it
j ectively
w areness
Ġ uc
Ġt ensin
Ġt roxacitabine
er yth
id ental
ĠA MSA
ĠT CM
Ġac yclovir
ac yl
yelo cytes
Ġcon ce
ĠM sp
iv a
ol izumab
ĠP NP
Ġr ho
ĠB Z
ĠB at
ap sing
ĠD evelop
ĠS PH
ĠW omen
Ġun specific
low er
log ram
Ġ3 36
ĠE arlier
ore l
ĠL F
DS B
Ġob lig
Ġlympho hematopoietic
Ġallo transplant
Ġapopt ogenic
Ġar r
RA D
Ġstrateg ic
AC As
60 8
Ġran ked
sequ ential
ores c
erm ethylated
iss on
Ġav idity
emb ers
ĠAn t
Ġ40 8
Ġcontinu ally
ĠUn supervised
Ġlab ile
Ġlip ase
Ġreduc tases
Ġ29 1
ĠPB S
ophag ocytic
rup po
Ġrestric tions
rh G
ĠAcc urate
Ġhypothesis ed
ĠPK R
Ġlength y
NT s
ĠMed line
Ġcarb apenem
ĠITD s
ĠEm b
Ġmicrog ranular
ĠFox P
ĠHep at
PLC beta
Ġcoinc idence
GST s
Ġcompens ated
Ġhyd rophilic
Ġribonucle oprotein
sk olin
ĠCoun ting
Ġhotspot s
Ġdefinite ly
ĠRB Cs
Ġquestionnai res
Ġauthor ization
athe red
Ġsubf ractions
ĠCharacter istic
meas urable
ĠApp lying
Ġfa ith
Ġserop ositivity
Ġdeubiqu itin
Ġdrawback s
ĠDeterm ination
Ġhypoth yroidism
Dn r
ulind ac
itri ol
ĠKy oto
Ġenvelop e
Ġstoch astic
indes ine
harb oring
ĠSPH K
9 39
A DA
H MG
I E
M H
M ast
N rf
P CM
Q L
S urvivin
i PSC
m p
t onin
en te
Ġp OS
Ġs we
Ġre bound
Ġb at
id able
ĠT RD
ĠC ADM
Ġfor skolin
ib s
ol R
Ġal isertib
ĠP leural
Ġv entric
Ġr unt
ĠD eregulation
ĠF etal
ĠF MC
ĠE CG
Ġrec ycl
Ġ6 70
Ġpar ty
Ġnon remission
ser ies
Ġallo transplantation
yc yclophosphamide
ĠJ CS
Ġmicro culture
ĠV L
ĠV irus
Ġform idable
Ġnucle ase
Ġwor sen
38 4
OR C
EBP Î²
Ab out
ull in
ĠLeuk ocyte
ĠRec overy
Ġshort ness
40 7
blast omas
Ġi tem
Ġi As
Ġcollec ting
Ġpoly amine
rup lex
Ġcont acts
ĠIC SBP
77 4
ĠImmun oglobulin
Ġmorbid ities
Ġiso enzyme
ĠInhib iting
ĠSystem atic
link s
CEBPA dm
Ġtryp sin
ĠSup er
deg ree
ĠProm pt
standard ized
Ġamb ulatory
ĠMac rophages
Ġansw ers
Ġdict ates
Ġcust omized
ĠCan adian
ĠPat tern
ĠPan el
Ġtag raxofusp
umines cent
ffe ine
ĠMat rigel
ĠCardi ovascular
Ġheterodim eric
almit oyl
ĠPharma Flow
Ġrom iplostim
Ġnotor iously
Ġgangren osum
0 69
7 05
A HD
C al
C ellular
H H
P GRN
S equ
b a
g reen
n atural
o assay
Ġ Ã
Ġt alk
on asal
Ġo ve
Ġp B
Ġs om
Ġw k
or ac
ro ad
ic amycin
Ġre viv
os ted
Ġh CNT
ec es
ec utive
ĠC hest
ĠM emor
Ġg athered
ĠH if
Ġv ide
Ġdis abl
Ġor i
Ġinc ap
Ġsur round
ĠF ap
00 12
ĠS PA
Ġun mas
Ġass umptions
ĠN UR
ĠR ai
ĠO ATP
ost rid
Ġen for
ure us
Ġpre therapy
Ġsub con
Ġsub acute
pho x
Ġob ject
LT R
Ġbi ochemistry
Ġallo purinol
ag ia
10 60
10 99
Ġmicro transplantation
ĠV AD
PL GA
trans fusion
Ġretro virally
ens ation
Ġtr ivalent
Ġmetabol ically
ĠRes istant
ĠST C
ER CC
PD GF
ĠX PF
88 9
70 8
ĠIM Cs
Ġreduc tive
Ġi EMR
28 7
28 9
ME G
ĠCX C
ĠMT SS
Ġcalc ulating
Ġdoc tors
ĠHigh ly
ĠBC AT
Ġve ter
Ġpul p
Ġantagon izing
Ġred und
Ġvar ic
ĠEn tero
ĠEn zyme
Ġrib o
ĠSign al
Ġtet rasp
Ġbar asertib
ĠPTP RG
Ġvolun t
ps ins
Ġneur on
ĠCd h
ĠHep atic
ĠLe uc
cycl in
py rimidine
ĠCON UT
Ġeduc ated
Ġpent ostatin
galact osylceramide
ĠMit ochondrial
Ġparadox ically
Ġaggra vated
Ġunco vers
ĠUPD s
Haplo identical
Ġcompan ies
Ġculmin ating
Ġasth ma
KII Î³
Ġang le
Ġlute olin
Ġconfound ed
Ġmenog aril
1157 77
Ġpand emic
1 001
6 80
> +
E SCC
L ike
N J
P CD
T FS
T AL
W PSS
c ally
c ue
c DNA
n oid
re xed
Ġc yn
Ġc abozantinib
Ġin patients
it inase
Ġd acarbazine
Ġf ic
ith ium
om mend
ĠA PM
si zing
ML F
ĠC MT
ĠC AC
Ġst ent
Ġmyelo poietic
ine a
Ġbe x
rom ustine
her ited
ĠP aired
Ġ2 95
Ġ2 90
ĠF AT
ĠS CH
Ġ3 15
Ġk r
Ġk ynurenine
Ġco ex
ĠR IF
ĠO CLABSI
ron ch
Ġpat ent
so le
form s
Ġnon neoplastic
rim idin
ĠCR BN
av idin
Ġmulti system
ĠThere by
Ġpost chemotherapy
ĠAT C
GF I
Ġstatus es
20 40
Ġlim bs
ĠAn emia
Ġfour teen
ĠCh ain
27 1
Ġrepresent ation
cal icheamicin
ĠCon nec
cyt in
Ph armac
ĠAp c
ĠImmun ob
CG L
AN DA
Ġnone x
Ġbehav es
Ġincid ental
ĠAc tivated
Ġhemorrh ages
rearrang ements
Ġresid ential
ĠAR DS
ĠPer sistent
with in
Ġinterf ered
Ġintrac erebral
ĠCs s
ĠLD E
Ġ(- )-
Ġdip yridamole
Ġexplan ations
ĠSE MA
ĠPBP Cs
ĠFew er
acc ording
Ġbeg ins
Ġce ased
ĠMIC A
Ġchron ological
att le
Ġbran ch
Ġsta ff
ĠHistological ly
ĠMEL K
Ġâħ ¡
ĠGal ectin
Ġcere vis
Ġki logram
Ġcocktail s
transcript ome
azid ime
Ġsatisfac tion
Ġjustif ies
ĠPIC ALM
Ġconstell ation
Ġimmunobi ology
Ġbare ly
Ġvel iparib
thione in
ĠMemor ial
) (+)
7 97
8 24
M CP
b as
x us
Ġp VAX
Ġm us
Ġm CD
Ġm HA
it ter
ar ub
Ġb im
Ġe ther
ĠA po
ĠA IC
ia bility
us al
ot roph
ut ations
et yl
ac ces
ac cination
Ġst enosis
ĠM k
Ġde bil
ĠP anc
ĠH tr
Ġv an
Ġby stan
ĠB AT
ĠB SO
anc ement
ap er
ĠIn sigh
ĠF ib
tor ies
ub lished
Ġ3 10
Ġ3 24
com partment
ĠE LTS
iti des
ĠL im
ĠL ITR
Ġpar alysis
CT M
Ġimp er
lu ent
Ġthere of
ĠMD Cs
Ġcol d
Ġlymph omatous
Ġpost relapse
amm aglobulin
Ġdo or
pon atinib
23 6
ĠSt aphyloc
Ġhis tidine
29 0
ĠCT P
'- (
Ġ26 6
Th d
Ġcal or
Ġxen otransplanted
ĠNF kappaB
Ġregres sed
Ġhospital isation
ĠCNS L
ĠPre transplant
ĠY BT
003 24
GM CSF
Ġdocum ents
ĠImmun ocyt
Ġlo vastatin
Ġrepl ating
ĠCo expression
angi ectasia
Ġthym oma
ĠTR IB
ĠTrans locations
ĠAR C
Ġdex tran
Ġfit ting
Ġimmunop eroxidase
lip osomes
Ġoccup ied
Ġdeline ating
ĠCE PBA
Ġfollic les
transcription ally
ĠAss ociated
ĠItalian o
Ġleth ally
Hemat ologic
Ġsial ylated
ĠHGF s
Del etion
Del etions
ĠPred ictive
Ġchel ators
Ġanth raquinone
prop yl
Ġsudden ly
Ġrecover ing
ĠRP RM
Ġhyperg ranular
Ġapt amers
ĠContinu ed
tryp sin
ik acin
Ġ</ =
dip ine
ĠMeas urement
Six ty
loro quine
Ġcompan ion
Ġnons teroidal
Ġprecon ditioning
ĠEstabl ishing
brevi ated
atern ally
Ġdod ecyl
ĠTrich ostatin
PPAR Î³
ĠXL OC
Ġasym met
2234 593
ellip tic
ĠChib by
Ġove restim
1099 48
3 04
8 70
C ardi
J anus
P onatinib
R ap
S KI
T AA
U MRD
W hether
a ult
l osamide
w i
z olid
Ġa gen
in ating
re gression
Ġp etro
Ġre im
Ġre defined
Ġre evaluated
at enin
Ġb ott
ĠT PD
ĠC GA
un favorable
et ron
Ġac com
ac ch
Ġl ump
Ġch in
ĠB rom
qu il
qu ad
Ġsur rog
ĠIn troduction
00 31
ĠS PM
Ġmo uth
ĠR L
ĠR AL
ĠR IP
Ġanti emetic
Ġrem ed
ally l
ren yl
Ġsub lethal
Ġpres sing
ome obox
Ġcomple mentation
Ġob vi
ad ecyl
Ġsyn apse
Ġdec is
34 1
ĠK PS
Ġam ikacin
ath yroid
Ġcar til
ĠV aria
56 76
ĠIL K
Ġwill ing
ace tic
ĠAn y
Ġindividual ization
omy elin
och al
CA D
Ġenzym atically
Ġtri tiated
arb y
tis sue
Ġdiscontinu ations
Ġtra ined
ĠCC NA
ob yl
yg uanosine
Ġoste onecrosis
oxy genases
Ġz osuquidar
Ġbio tech
Ġremo ves
Ġeas ier
ĠIK B
Ġfollic le
Ġcutoff s
Ġca ud
Ġschem a
ĠMi Seq
Ġintercal ator
Ġattain able
Ġspre ads
prim ing
Ġincre ments
ĠSV T
Ġuncover ing
oglyc ans
ĠIntr at
Ġvi remia
ĠEffec ts
ss ential
main tenance
Ġauthor ities
Ġcas tration
Ġseek ing
Ġcontamin ating
Ġheral ded
Ġosteoc lasts
Ġequip ment
Ġbin der
ĠKary otypic
ĠKary otyping
ĠAppro val
Ġbab y
Ġtit ration
Ġexpon entially
Ġshutt ling
Ġfum arate
Ġportend s
Ġtetrap loidy
Ġserop ositive
Ġfron ti
ĠIntra venous
Ġmetach ronous
ĠHydro xyurea
Ã§ et
Ġdecon t
Ġflor a
ĠRich ter
Ġdesper ately
Ġdiathe sis
Ġ836 858
Ġcram ps
Ġvaric ella
Ġcerevis iae
) /-
* )
0 87
2 120
3 25
7 85
D U
D eregulation
E ll
L EN
M CR
M ACS
N IL
P ulmonary
S econd
a ise
b etween
r us
t ailed
u in
x pression
z astaurin
in compatible
Ġp AML
an ning
es ium
Ġre treatment
Ġb ip
ing ap
ith orax
id ative
Ġe yel
ĠT rem
ĠT ypically
Ġpro tumoral
ĠC EL
ĠC alc
Ġex plic
se p
ver ting
il s
Ġg a
ab ric
ĠH EM
Ġv igorous
ĠB AC
ĠD MA
ĠIn activation
ĠS arcoma
ĠS GC
Ġ3 34
yl ic
Ġ5 25
ĠO V
ĠO VA
Ġev oke
ĠE MM
Ġover growth
Ġinf rastructure
Ġcons cious
Ġbi otrans
Ġpl ates
ult uring
Ġcharacter s
ag omi
CT C
Ġsc le
ach man
ath min
AT R
Ġ19 77
95 5
erg ies
Ġtes tes
ĠIm aging
Ġmetabol izers
ĠSt rept
Ġinform s
35 2
Ġperiod on
of urin
Ġphosphor ylate
Ġ28 1
Ġu PAR
MS G
ram ycin
Ġgu inea
Ġhyper v
ĠPro filing
Ġ27 7
Ġ36 2
radi o
Ġhydro carbon
lympho blastoid
Ġ37 2
erox ycyclophosphamide
ĠMT S
Ġreflec tion
79 01
ĠReg ular
Cyt omegalovirus
Ġthym idylate
ĠTrans well
ĠAR HI
Ġrh yth
Ġinser t
Ġasc iminib
ofuranosyl cytosine
Ġsupple mentary
ĠCL O
Ġcathe psins
mm as
ĠOb esity
Ġintron s
fl av
Ġneph ropathy
Ġmitig ation
Ġhydroly tic
Ġreplic ate
ĠSel ected
ĠDH X
ecre ted
ensitiz er
Gal Cer
SSC P
Ind ividual
Ġretrie val
ĠEnh ancer
Ġawa its
ĠSCN P
Ġmicronucle us
Ġdile mmas
Ġground s
Onc ogenic
Ġsubf amilies
Ġfeat uring
Ġprecip itation
Ġperipher ally
Ġdichot om
Ġpolyphen ol
ĠConf idence
Ġconsult ation
Ġmetric s
Ġcontrac tility
Ġentail s
ĠAnn ual
Ġchol est
Ġsucces sively
Ġbacill i
Ġsacr ific
Ġbiol uminescence
Ġexplosi on
Glut athione
Ġbex arotene
ANDA RD
Ġaccom mod
ingap ore
3 98
D iamond
E t
F irst
G em
N BM
S OX
S MA
U TP
d dPCR
f alin
m ar
m ias
m DC
o ured
t azidime
Ġ urea
Ġt ositumomab
Ġt mTNF
Ġc ostimulation
Ġp S
Ġin hab
Ġw il
al loc
Ġd elo
er gence
Ġb cCML
Ġe ro
om ustine
Ġh sr
Ġth iaz
Ġth ickness
ig o
Ġac ridine
Ġleuk ap
ib inin
ĠI brutinib
Ġcon nexin
um atic
ol der
Ġg add
ĠH aving
ĠH aem
Ġv elocity
gene ous
duc es
ĠB S
ĠF in
ĠW A
Ġmo bile
Ġus ers
Ġco ffee
ĠR FC
ĠR unt
Ġ5 000
ĠO lig
Ġgen otypically
ĠE PC
Ġid ic
Ġob jectively
Ġsyn ov
AB P
11 55
Ġdes cent
hw achman
IT A
tit umor
ĠJ AR
Ġspecific ation
Ġsh RNAs
ĠV iral
17 6
Ġlymph osarcoma
int ent
HR M
Ġmy ocytes
Ġfour fold
ame ters
Ġprot otypical
ĠAd herence
Ġcap ecitabine
Ġu racil
arb ox
host in
Ġ33 1
Ġhep cidin
Ġcho line
Ġharb oured
Al tered
39 3
39 6
39 7
77 9
87 1
co holic
mod el
Ġbio activity
Ġclar ification
ĠPT LD
Ġpair ing
Ġmodif ies
ĠSign aling
reduc ing
ĠHyp oxia
Ġexpect ation
Ġsqu are
ĠSU Z
Ġmyc obacterial
Ġvisual ization
ĠTA As
Âµ g
prop ag
Ġworth while
Ġoper ational
Ġphyt ochemical
ĠUT X
Ġechocardi ographic
ĠLAM E
Ġpolyploid ization
Ġinactiv ates
ĠPhosph orylation
Ġverteb ral
Ġtrajec tories
ĠGem citabine
Ġnick el
Ġcomplain ts
ĠBreak point
Ġoligos accharides
ruct ose
Ġpric e
cen tered
Hepat ocellular
phil ic
Ġdepos its
Ġcolla genase
ĠParticip ants
Ġbystan der
alloc atechin
Ġdelo cal
0 62
9 38
A LT
F anconi
S HP
W nt
b endazole
i lection
s ome
v Î²
w af
z otinib
Ã Ń
Ġ Î´
on an
Ġo mitted
Ġp aving
Ġw ave
Ġm Ci
Ġf el
om ol
ĠT IL
ML PA
Ġas sisting
uc cin
Ġde ter
ĠH TR
Ġr AAV
ĠB acillus
am es
ĠR ub
ĠR enal
Ġreg ister
Ġmon ensin
Ġ4 10
ure tic
CR IP
ĠE ts
splant ation
Ġfac ility
Ġout weigh
rac yt
Ġdec lining
Ġnon p
ill ation
Ġcar go
Ġcar filzomib
ne al
Ġaut och
ĠV is
ep tin
MP R
ĠII A
Ġcompar ability
int ensified
CC C
Ġradi ograph
Ġanthracycl in
Ġins ults
ĠCT GF
ĠCT As
ulin ic
36 1
Ġ36 1
mit ting
pre ventive
cap s
PS L
Ġ37 9
Ġtel angiectasia
Ġreactiv ates
Ġsubc lassify
An n
Ġâ ©½
ump tive
Ġdiscrim inant
Ġelectro static
ĠSIR s
Ġdia z
ĠAnti fungal
Ġbenz o
Leuk emias
Ġpal ate
ĠCor relative
Ġnic losamide
Ġsin onasal
etho prim
Ġencaps ulating
Hyp ermethylation
hyd ration
Ġmer it
ĠAI EOP
Ġpenet rant
ĠTA Z
ĠHER V
sw it
Ġhypere xpression
evalu able
Ġfore c
Ġabl ate
Ġtheore tically
Ġhypo albumin
Ġfo etal
Ġthromboemb olic
Ġinfer tility
partic le
oderm ic
ĠTra ditionally
Ġtable ts
oste al
ĠVer apamil
Ġdescrip tions
Ġscant y
ĠAnthracycl ines
Au NPs
Ġgent amicin
dU rd
Ġhid den
Ġheparan ase
Ġrea ders
ĠElec tro
Ġtetrasp anin
Ġsurrog ates
ochal as
0 72
5 40
5 88
9 01
C ertain
Q D
R H
T CM
d on
d river
h am
k d
l ac
Ġa UPD
Ġa ureus
Ġt actic
re pe
Ġp lot
or ative
as omy
ic itis
Ġf en
ĠT or
Ġle vo
ĠC ord
ĠC EBPÎ±
Ġfor ces
ac izumab
ĠI so
ĠM ER
oc he
rom osomal
ĠH a
ĠH NK
Ġv ibs
Ġdis tor
Ġtreat able
ĠD ar
00 33
ĠS ap
ĠS ema
ĠN AT
Ġinhib in
ĠR ACK
pl ification
spl ice
iagnos ed
Ġafter wards
ox imine
Ġpo lo
Ġnon cancerous
mon ophosphate
ĠU R
ĠU s
Ġacc ent
ĠCR L
oph thal
33 6
Ġcondition ally
pt y
pt ake
Ġinterac tive
ĠBM M
Ġhist ochemical
ĠAm B
II b
Ġ23 6
Ġantitumor igenic
Ġ27 4
Ġi ii
Ġ45 2
per itoneal
Ġextra ord
Ġcytokines is
Ġhal t
sel ection
Ġevery day
Ġpain less
rearrang ement
ĠMechanis m
ĠMolecular ly
ĠAg ain
cho lesterolemia
ĠFA O
recip itated
Pre clinical
Ġphag ocyt
Ġinstit uted
ensiti ze
eral dehyde
ĠInf ectious
ĠPres ently
Com pared
GE O
Ġsero tonin
Ġcoord ination
Ġsphing omyelin
Ġround s
Ġcontempor aneous
lipid emia
Ġunravel ed
Ġgradi ents
Ġphenyl butyrate
Er k
Ġcatabol ic
Ġreapp eared
tryp tase
ĠFM MD
Ġhypog onad
Ġpel vic
ĠAppro priate
Ġphospholip ids
Ġharness ing
Ġmonke y
ĠFrequ ent
enop ausal
Ġcef tazidime
ĠMeth otrexate
Ġexchan ges
adv anced
rink age
% +/-
2 001
6 44
9 25
B erlin
F FS
O E
P t
R FI
[ <
i O
i res
j unctiv
n etin
n ithine
o zogamicin
s u
t WT
Ġs rc
Ġs keleton
Ġw r
as an
Ġd yes
ar cin
Ġf use
Ġe CMV
om o
Ġh onokiol
ĠC ost
un k
uk S
Ġas sisted
ĠM yd
). (
Ġdis ability
ĠB W
ations hip
ri ed
ĠD ist
00 005
ĠS cedosporium
Ġmo vement
ĠN ITRCs
Ġres ur
ĠO ste
Ġtrans genes
ĠG ly
ĠG lu
ĠE AC
Ġsub pathways
ox on
Ġdev i
Ġpat ch
Ġro t
Ġresist ances
Ġnon intensive
Ġpred ilection
tim ate
Ġinter ventional
ail and
ag in
ĠU DP
Ġra f
Ġconf erence
ĠV EMR
omet hylation
19 96
Ġem etine
Ġsm CEBPA
ev acizumab
Ġ25 7
ĠAB SCT
70 9
Ġ27 9
Ġsp i
cyt otoxicity
Ġmes ilate
comp ound
art DC
Ġcle avable
opy rimidine
Ġglyc olipid
86 6
ĠNot withstanding
zyg otic
Ġdiss ociated
Ġpul ses
rosc opy
lab eling
Rec ombinant
uan g
Ġfever s
ĠReg ister
Ġimpl ant
Ġax illary
ĠPer cent
reduc tion
ĠGen erally
ĠDifferen tially
ĠPTP IP
Ġoccup ations
ĠPl erixafor
Ġed ge
Ġcoll ateral
FD G
Ep ithelial
ĠPE I
intoler ance
ĠBD NF
Ġprecl uded
Ġstay ed
Ġtas ks
ĠHaemat ological
Ġreservoir s
Ġmigr ated
ĠPe ak
ĠPur Î²
Ġterat ogenic
ĠAmeric ans
Ġazanucle oside
lact am
Ġile um
Ġosteop ontin
Gas trointestinal
Ġpyrro lo
Cycl in
ĠImm ediate
sched ule
ĠWB Cs
Ġthal assemia
Ġphosphodiester ase
ĠDig ital
Ġfing ers
oresc ently
Ġautoch th
Ġhypoalbumin emia
0 85
4 05
4 75
C ol
F CR
H PR
H HV
L K
N IS
Q A
S s
S MR
T AC
T MD
c g
c CD
g us
h air
l at
m bilical
r IL
t us
t agged
v a
z he
Ġc HL
Ġp ic
Ġp LSC
Ġs fR
is ters
as ter
Ġd ib
Ġf lo
ĠA U
ĠA MO
ĠT HU
if osfamide
op ap
oc kin
Ġr GM
anc hored
am ethox
ĠF resh
ĠS CD
ĠS plic
Ġun event
ĠN LR
Ġdiff us
Ġ4 33
CR R
ĠE OI
Ġag ric
ide oxy
Ġhemat opatholog
ĠTh ailand
Ġid arub
Ġ6 17
Ġidentif iers
ion ization
CD Ks
ĠBCR ABL
Ġmicro l
16 4
ĠV NTR
ĠCI C
po ietin
ex pected
Ġnucle ocyt
HR QoL
CI C
Ġgranul o
Ġ24 9
Ġflow cytometry
ĠMP Ds
Ġtranscript omics
lob enz
ĠUn i
Ġlab els
Ġhyper proliferation
Ġsp urred
Ġcle an
inc reasing
ĠTran sp
HC Q
ĠMK N
ĠHD I
Ġolig odend
ĠPT TG
ĠTRA LI
Ġsurve ys
col l
flu fen
ĠTR IM
wh en
Ġbil ineal
retin ide
Ex posure
Ġuncertain ties
Ġarter ies
ĠMon ocytes
Ġinsertion al
Ġanomal ous
Ġfer til
ĠImpro vement
Ġlook s
Ġcoord inate
Ġleukaem ogenic
Ġpass enger
ĠCr kL
ĠPred nis
Ġpack ed
Po lym
Acc urate
Ġther mod
ĠNan og
Ġpel vis
ĠSte p
sus cepti
ĠPRK CH
Ġarrhyth mia
ĠLig and
Mu LV
ĠBK M
ĠDen mark
assemb ly
Ġlogarith mic
(+/ +)
othio ate
lobenz odiazepine
4 13
8 25
8 27
B RD
B rain
E ORTC
G el
I BD
K inase
K ras
T g
V RE
Y L
a rom
a resis
c umulative
c opy
c oxon
p ine
t w
Ġ Ï
Ġa qu
Ġa racyt
en di
Ġo edema
or ies
ic are
Ġf un
Ġf abric
ĠT an
ĠT NK
ĠT TR
im ic
ĠC as
ot ax
Ġst ret
ĠI DAC
ĠI PS
ĠM ap
il i
oc aly
oc entric
ĠH IST
Ġv indesine
st atin
qu izartinib
Ġun i
Ġun labeled
low n
ph rine
Ġ3 21
Ġ3 27
pro tection
ĠN CL
ĠR X
ĠG HR
tr ifluoro
Ġhem opathies
ĠL OX
ip per
ad elta
Ġprotein uria
%) ]
sup ported
Ġpar athyroid
ĠU PS
Ġar rests
ch imerism
Ġfe eding
15 1
Ġconcl usively
eri ence
Ġpartic ulate
MP P
ĠHLA DR
ater minal
Ġtransform s
Ġtransform ants
ace ous
ĠNK L
AR E
Ġthromb omodulin
ĠCh imerism
Ġcarcin ogenicity
allen ge
Ġisol ating
Ġelev ate
Ġaggres sively
36 8
Ġhyper fractionated
ĠEx osomes
Ġ29 7
Ġadhe re
Ġintra ocular
Ġpoly valent
ord oma
Ġangi o
ĠPR S
ĠQ ues
Ġdysp h
Ġbroad en
Ġattrac t
Res pon
ĠPT CL
EP Cs
Ġcomplement arity
Ġdistinguish able
ĠEn forced
ĠMMP s
Ġfamil iar
Ġpy rid
chrom osomal
Ġstren gths
Med icare
Ġcoinc iding
erb amine
Mon osomy
Ġcytomorpholog ic
Aut ophagy
Ġrepur posed
Ġrelie ve
ĠMark ov
Ġnur sing
Ġextr aterminal
SET BP
Sp earman
Ġbud ding
Ġautotransplant ation
Ele ven
ĠMex ican
Ġvitre oretin
Ġthick ening
Ġbiotin ylated
ĠPrac tice
Ġparas ite
Ġpropos al
conf idence
rep itant
ĠCen ters
Ġlinc RNA
Ġenrol ment
ĠBat f
Ġfel t
Ġautochth onous
Ġnucleocyt oplasmic
5 000
B usulfan
F uc
F LI
I NPP
L PD
M at
P CT
S QSTM
l amp
in ish
Ġan hyd
Ġm ist
el derly
Ġb ank
id o
ĠA VA
ĠT DL
ot ally
un mutated
et ate
if ermin
Ġas k
ĠI SL
ĠM pl
Ġbe am
od on
ĠH Z
Ġv icin
Ġdis location
yt openia
st atis
Ġinc orrect
ĠF CI
ĠS BP
ĠS DH
ĠS elf
Ġwh atever
ĠO N
Ġen gen
ĠE OL
Ġout break
end ar
ad hesion
ist ronic
Ġnon etheless
Ġinter rel
Ġinter con
IT P
Ġam bi
001 9
Ġser onegative
Ġadv ice
ep silon
Ġend oscopic
ocyt oma
hes ter
Ġsu PAR
Ġshort coming
29 7
estim ated
36 4
ĠCl ostrid
Ġdam pen
Ġ36 3
PB T
Ġsummar ise
oper ating
lor ide
ĠZ OL
Ġnan ocom
Ġsex ual
Ġstar ts
ĠMM B
ĠBC S
Ġreactiv ations
Ġrepro duce
Ġolig o
Ġconver gent
ĠReg imen
Ġund iagnosed
Ġreason ably
Ġcarb ox
HDAC Is
Ġconstruc ting
Ġcataly tically
ĠGen eration
Ġbenz amide
Ġpy raz
ĠPo isson
ĠKn ock
ĠGra vin
ĠcDNA s
enh ancing
ĠPost remission
Ġfil ter
Ġexogenous ly
Ġadip onectin
ĠIs ra
Wh en
asi tic
Trans locations
Ġcreat ine
Ġhypocellular ity
Ġpent asomy
FB XW
FT Is
Ġshap ing
Multi parameter
Ġuter us
Ġcryst all
Ġentero c
hen oyl
Ġunres ectable
ĠDF MO
Ġtry ing
ĠMH H
Ġextr usion
ĠMc Ab
Ġquad rant
Ġglycosyl phosphatidylinositol
Ġcareg ivers
ĠCoc ulture
ĠQual ity
ĠPakist an
Ġdepsi peptide
Ġdebil itating
Ġdecont amination
Ġconscious ness
zhe imer
Ġvicin ity
0 79
0 83
5 57
8 03
A im
B osutinib
C ounter
F AS
G PR
G PBSCs
M n
P ar
R CT
S ALL
S DAC
S pecific
T ri
c lear
c GvHD
c hel
i arity
m is
m dr
z hou
Ġ ix
in o
Ġt ack
ti fication
ti go
en tic
Ġc all
Ġp enic
Ġp amidronate
Ġm os
al ized
Ġre w
id ines
Ġth ink
ĠA HCT
Ġn elarabine
ĠT po
ĠT YK
ĠT MTP
ĠC RA
ot anshinone
et an
ac ademic
uc ted
ĠI rf
op us
up regulated
ĠP ten
ĠH NE
Ġacute ly
am y
am oxifen
ĠS O
ĠS erv
ĠS ensitive
der ma
ĠO DC
Ġ4 05
ĠG TI
ĠG rowing
Ġhemat otoxicity
ĠL SA
ĠL PN
ct b
Ġcharacter ise
est one
Ġchrom ium
ll able
Ġam ide
Ġdel icate
ĠV en
Ġdi os
Ġ19 74
ry o
Ġconcentr ates
AR s
the l
Ġ30 6
IC AL
Ġhematological ly
IS POT
ĠAPL s
Ġins till
ĠPro ducts
ĠCP SS
67 4
Ġ38 2
Ġ34 2
ob served
Ġimmunohist ological
rec urrent
Ġstaining s
Ġcheck ed
Ġrever ting
Ġdegra ders
hazard s
ĠMM SCs
Ġmultic ellular
CF Cs
Ġauth entic
Ġoste olytic
ĠSc hol
Ġmeth anol
ubiqu it
ĠDR C
Ġspect ac
progenitor s
Ġbound ary
ĠSp ain
Pro te
transfer rin
nucle ophosmin
diagnos tic
Ġposition ing
Ġcoll apse
Ġca ffeine
Ġreticul ocyte
GC NA
Ġunderl ining
Ġvascul ogenesis
Ġmicros omes
bic ans
ĠCV AD
wild type
NO TCH
Ġâĳ £
Ġconfig urations
Ġrefer ring
ĠGl n
Ġvehic les
Ser um
Ġmicrobi ome
ĠMc Abs
Ġtransamin itis
Ġunequiv ocal
Ġtriaz ole
ĠHDA raC
ĠALA L
ĠBal b
Ġreconsid ered
APB SCT
tetrap loid
enn ium
Ġori ented
Ġincap able
ammaglobulin emia
ĠStaphyloc occus
agomi R
propag ating
ĠVis ual
% ];
4 23
7 49
A ZD
D ys
E st
H MT
N SC
N MR
N early
O macetaxine
Z NF
g all
h undred
k k
n ia
p ublished
v osidenib
in jection
on fer
Ġc umbers
Ġp evonedistat
Ġin bred
Ġan abol
Ġan ecd
Ġw ard
as hing
ed iting
ic on
Ġre ally
Ġre plete
ar ach
Ġf asc
Ġb ifunctional
Ġn omenclature
em et
ur ines
ur ring
ĠC ycle
ter ature
Ġl iv
ĠM OPP
iv udine
ol ving
Ġg an
Ġg ated
Ġr igorously
st ar
Ġad sorption
ĠD eregulated
ĠF oc
ĠS BF
ub endazole
Ġcyt openic
Ġat RA
Ġ3 05
Ġk d
ĠR H
ĠR ER
ron i
ĠG GT
ĠE F
Ġind o
sup pressing
Ġall ergy
Ġnon tumor
ult ural
ch ond
10 66
ĠCR F
ĠCR Cs
Ġimp osed
12 00
Ġnum b
Ġcar ing
ĠJ AM
ĠV av
AC M
Ġda ughter
hod omycin
Ġcomplex ities
23 9
IL P
ĠSt atus
Ġshort age
CP s
Ġreal ize
Ġcal endar
Ġrest arted
Ġpub er
Ġseven teen
rec ision
46 2
Ġsched uling
Ġnan os
Ġsex es
ĠSe attle
Ġrepro duction
CG E
AN T
target s
ĠOr g
ĠCY R
ĠSM G
RP N
be fore
ĠAK AP
ubiqu itin
Ġple xus
CBF Î²
Ġubiqu ity
Ġturn around
ux etan
Ġleuc osis
ĠCons ecutive
neg ativity
olip oprotein
Ġmanip ulated
Ġarch ived
Ġmono blasts
carb azine
SIR T
Ġretur ning
ĠMyelo fibrosis
MMP s
Ġpict ures
Ġdeoxynucle oside
Ġallevi ation
ĠMorpholog y
Ġillness es
IK K
Ġcytological ly
Ġjusti fication
ARA C
Ne utrophil
Ġti uxetan
Ġchaper ones
ophosphate mia
Ġchond rosarcoma
Ġplac ing
Ġdras tic
deox yglucose
Ġaggra vation
ĠBMD Cs
Ġton sil
Ġsubcategor ies
hydrop eroxycyclophosphamide
alkyl ating
hl itis
ĠOT X
Ġheterodim ers
develop ed
iosp erm
Eight y
Ġabor tion
kyl ating
ĠBeh Ã§et
Ġceram idase
Ġpericent romeric
Ġsulph ate
Ġdenat uring
Ġadvis able
Ġrecomm ending
ĠSEL DI
ĠIFIT M
Ġrecycl ing
acch arom
asan utlin
onfer roni
Ġcumbers ome
( +
2 34
A UR
B SI
D ex
D ouble
E AM
F ra
N M
P PV
T rial
T CA
T erminal
b c
f lo
g ulation
m DCs
p yr
s ential
t an
y cep
Ġa te
re w
ti e
on ogenic
en oic
he al
he alth
Ġc us
Ġo range
Ġp M
Ġin spired
Ġm ug
or p
is opropyl
it ations
es ophageal
Ġb ivalent
ing e
ĠA cl
ĠA wareness
ĠT m
Ġle ver
ĠC OS
ot ine
ot yrosine
if ier
Ġleuk ocytic
ĠI VI
ĠP LA
ĠP ER
ĠP SM
Ġv adastuximab
las ias
ĠB eside
ĠS lo
ĠS audi
ĠN umber
ĠR os
ĠR ag
ĠR MA
Ġsho ulder
Ġ5 40
ost aining
Ġper ifosine
ĠG SCs
ren al
ĠE BF
Ġimmun ofluorescent
ĠTh i
Ġpres umptive
Ġmal aise
Ġdec e
Ġnon responding
ple mented
tin ction
tin ostat
Ġcor neal
Ġchrom ophore
MT V
spec ifically
Ġmulti pl
ĠJ HDM
ĠJ WA
Ġmicro transplant
Ġsim ulate
az omib
SF Ks
ĠAl zheimer
DH AP
ET S
Ġcompar ably
ocyt osine
gra des
23 187
Ġmyel omas
18 52
BM MNC
BM MCs
Ġcarcin oembryonic
ĠCN DO
plo ying
Ġerythro blastic
Ġflu orescently
ĠRes tric
ĠRes piratory
CA E
ĠAB I
29 61
Ġins tig
Ġ28 2
Ġconc ise
Ġinfusion al
Ġ23 1
Ġwid th
Ġintensi fying
Ara bin
ĠY AC
HC V
Ġold est
Ġbroad ened
ĠRe action
ĠOnc ol
Ġpain ting
Ġcop ing
ĠEn tinostat
133 1852
Ad riamycin
ĠMon ocytic
arg y
Ġsensitiz er
ĠInt ensification
ĠHist amine
bl estone
Ġcomm ens
iaz ofurin
Ġsupple mental
Ġfil m
ĠPharmac odynamic
Ġquin ine
ĠLi terature
ĠConsid erable
Ġreticul ocytes
ĠPar ameters
eng aging
ĠCycl osporin
Ġnas cent
Ġcounte racting
TLR s
143 6032
Ġdermat oses
pur ified
iment ation
ï¼ ĭ
Aut o
Ġhypercellular ity
ĠGTP ases
Ġsk ipping
ĠNCR I
Ġabandon ed
CREB BP
Ġfluoro quin
Ġreconstr ucted
Ġtrip tolide
Ġsemis ynthetic
diphenyl tetrazolium
ĠDeterm ining
ĠIr respective
Ġpow der
Ġdeoxyc holate
Ref ractory
Ġdend rim
phosphon ates
grad able
Ġchar ges
ĠISR CTN
ĠMsp I
ente sis
ĠConnec tivity
Ġunevent ful
3 139
4 16
4 99
8 01
9 36
9 706
B MD
F l
F os
L ET
O CI
O varian
P AD
R EL
S ch
c reat
d uration
f ies
l ance
Î »
in ii
Ġc ard
Ġp t
Ġin otuzumab
Ġs ized
Ġs MDS
or osis
an alog
el a
it ate
Ġd educed
Ġd raining
ed s
Ġre ady
Ġre localization
ar rays
le man
le gia
Ġb inase
Ġb ru
ĠT ipifarnib
ĠC er
ĠC CT
ĠI CD
Ġcon spicuous
ĠM esylate
ol vement
ĠP IF
ĠP OG
Ġor chi
gn ant
ap eptide
am ellar
qu iescent
ĠS APK
Ġun le
Ġne omycin
ph ys
ĠR al
Ġtrans duce
Ġmon onucle
Ġ4 12
ĠE LA
Ġhem ogram
Ġdev ise
DS S
Ġexp end
Ġcor recting
mon osomal
mon ella
mon osomy
ag ers
CT A
Ġsc ro
Ġline arly
ĠV beta
Ġreac hes
Ġdi ethyl
Ġdi oxygenases
SF RP
osph ing
Ġdid n
95 0
par tments
ĠII b
Ġdaun osamine
BC OR
AL CL
IC OS
Ġtr unk
atele ts
26 9
27 36
Ġu PA
Th rough
app earing
Ġdam ages
99 7
Ġintro duces
47 143
ĠPR IMA
mal ign
ĠIC US
Ġsol ani
Ġrecombin ase
Ġpa ved
ĠReg ion
ĠAc id
Ġintern ationally
>/ <
ĠTR F
Ġfas cin
chan ging
ĠOR s
arn et
polym er
Ġcooper ativity
Ġload s
ĠGC S
ĠCd kn
ĠFox o
ĠMA LAT
Ġcomb s
Ġmanip ulations
ĠCs nk
Ġresemb lance
phosphor yl
Ġarch ival
Ġpolar ity
receptor s
Co lorectal
Ġshed s
RI NF
ĠSL E
osc arnet
ĠSci ences
Ġscaven ging
Man agement
ĠCandid ate
Ġnano emulsion
Ġpas sed
Ġsubmic romolar
Ġbring s
dia betic
tig raphy
Ġprostagland ins
Ġdot s
gel danamycin
Ġfem ur
Ġasth enia
Ġpyrro lobenzodiazepine
Ġarrhyth mias
Thromb ocytopenia
ĠNSAID s
ĠCbf b
Ġveget ables
Ġarchitect ures
Ġredi recting
067 47143
abr utinib
Ġanc illary
Hispan ic
Ġmisinterpre ted
Ġdysmegakary opoiesis
ĠElucid ation
ĠKCN Q
orel bine
ĠSPA G
Ġexplic it
Ġbiotrans formation
Ġinhab it
Ġraf ts
ĠsfR ON
amethox azole
Ġshortcoming s
Ġorchi ectomy
2736 100
H SA
L ung
M ap
N an
N ormal
N SG
P OG
P lasma
R X
S pontaneous
W ES
b ar
c R
c n
p as
p lasma
t ans
in omycin
in activating
Ġc aro
Ġp azopanib
Ġan is
el es
Ġd C
ar idin
Ġf ructose
Ġh ands
Ġn Counter
ra q
ĠT g
ĠC CDC
ĠC isplatin
Ġwas te
uc ine
um eni
ĠThe rapies
oc onazole
Ġg lass
ĠP AN
od ine
ĠH en
Ġor nithine
duc er
ĠD B
ĠS AL
ph enic
pro be
ĠN CS
Ġco iled
yl c
de hyd
Ġen anti
ĠG MPs
ĠL ukS
LL C
Ġprom isc
ast olic
ser a
Ġinter group
ch ymal
Ġhyp ophosphatemia
Ġprov oke
ĠJ C
Ġperform s
Ġiniti ative
af ide
the sia
Ġder an
CC gR
activ ators
70 7
Ġhyper cholesterolemia
aren chymal
98 33
Ġdys myelo
ored uctive
Ġintra uterine
art an
46 4
Ġsepar ates
ĠY Y
Î¼ mol
mod ulatory
ĠÎ± vÎ²
ĠRe gression
ĠRel A
ĠHSP s
RP PA
Ġincub ations
ĠNe utropenic
arn es
MG US
Ġbackground s
ĠTr k
Ġmess ages
Ġdiscover ing
ĠPF T
emp tively
Ġmetallo thionein
Ġinterrup t
010 759
ĠMod els
Ġcoexist ent
dem ethylating
With in
Ġreconstit ute
actin omycin
Ġdict ated
Ġflan k
Ġteam s
Ġabscess es
rach ial
Ġbuff y
earrang ement
odeox yglucose
acill in
Ġmold s
SET D
Ġparench ymal
Ġbig gest
Ġspac er
Ġradios ensitivity
Ġdestabil ization
ĠTechn ology
Ġcircuit ry
Ġhypoth al
optim ization
ĠICOS L
posi um
Ġeg g
ĠRetin oic
Ġammon ium
Ġanal ges
Ġappend icitis
Ġautomatic ally
GDS PV
ĠSus tained
MAL DI
Ġrelax ation
Ġmyofibro blasts
Ġoncof usion
Ma jor
0020 9833
Ġfaith fully
Ġredund ancy
elliptic ine
omol gus
Ġtactic s
Ġlevo floxacin
Ġwr iting
ĠTDL N
Fra umeni
Ġcus atuzumab
Ġexpend it
4 53
7 19
C MA
D x
E ra
I ÎºB
M ZF
T AIR
U M
V EC
c op
c ure
c ad
e ter
f its
g ly
h romosomal
m urine
n one
p ass
x if
Ġ ]
in ol
he sive
Ġin struc
is ot
an uary
ic ago
Ġb erbamine
ate rial
Ġwith st
id a
ĠT em
ĠT gfbr
im ustine
ur bin
ot rich
ot ryp
et astatic
ĠI H
ĠI raq
ĠM embrane
ĠP it
am idine
ĠF atigue
ĠS hwachman
Ġun restricted
Ġun ifying
Ġun maintained
Ġ3 53
pro tocol
ĠN I
ĠN N
ĠN am
ĠN GF
ĠN HA
yl in
ĠR ib
ĠR NF
ĠR EF
ĠR LS
Ġab breviated
Ġtrans version
ĠG netin
Ġpre cluding
ĠL AL
ĠL ocal
Ġ6 32
and ibular
Ġpar ametric
Ġallo immunization
34 6
ag greg
ĠU ptake
av ach
IT GA
Ġcar inii
ĠJ S
ĠCI D
az o
Ġdi rects
Ġda iry
ym otryp
33 97
ex trinsic
Ġend osomes
emb ran
pon ade
ĠMP S
Ġrandom isation
ĠCN V
ĠNo te
ins ured
CA S
Ġphosphor othioate
HO TAIR
Ġinfiltr ations
Ġcal pain
ophil icity
comp etent
ĠMY ST
AS M
Ġtra bec
Ġ44 9
Ġdeli vers
Ġrestric ts
osinophil ic
Ġcross linking
ĠIR X
platin um
ocom ial
Es sential
ĠPer haps
ĠAz acytidine
Ġion ising
ĠFOX C
Leuk aemia
Ġmusc ular
ĠMDM X
Ġintrac table
ĠCor p
NB T
hyp ocellular
Ġseg mental
len alidomide
ĠFLA I
Ġleth argy
Ġtrim ethoprim
Ġdocument ing
eptid yl
Ġthrombo hemorrhagic
escal ated
ĠHaplo identical
Ġrepressor s
Nucle ar
ĠAfric a
Ġhaploinsuff icient
ĠCal icheamicin
Stud y
Ġcot ylenin
ĠClus tering
-[ (
Ġfig ure
ĠNeutrophil s
ĠKS HV
FOX O
enog raft
Ġsevent h
brom o
meas ured
GIST s
Reg ulatory
Ġperin uclear
Ġpropos als
Ġconjunctiv al
Ġguan osine
adren ergic
Ġmanufacture r
Ġmetastas ize
Ġfilament ous
ĠBEAC OPP
Ġmicrobe ads
Ġpolyke tide
Ġphytochemical s
Ġextraord inary
Ġinhabit ants
Ġderan ged
urbin ectedin
( (
. .
0 89
0 81
5 17
6 25
A CR
A ST
C yR
D DX
N ER
U K
c ri
n ish
n itine
p ter
r at
t le
Ġt ong
re view
Ġc urren
Ġs ound
Ġs ulindac
Ġan cho
Ġm cl
Ġd ors
ent a
ent in
er sed
Ġre ovirus
at inase
id amycin
os ertib
Ġto lu
om ox
ul izumab
Ġh TERC
ĠT ILs
res sing
Ġpro thrombotic
ot rophic
Ġex tinction
ran zyme
op a
Ġch r
ĠP MP
gn itive
am phenic
Ġsur m
yp t
ĠS KI
Ġun specified
Ġ3 13
pro ducts
ĠR W
ĠR PB
Ġsignific ances
Ġanti malarial
Ġrem ethylation
ost in
Ġ4 000
ĠE ras
Ġfac ets
Ġ0 13
Ġint ensely
Ġag ree
Ġrec all
and utinib
Ġhe pt
Ġcyto genic
Ġmal formation
01 347
Ġprom on
Ġcons or
Ġnon overlapping
Ġpl acement
ros ette
Ġinter rogate
ĠK v
aus es
FS E
Ġsc in
Ġme bendazole
Ġvit rectomy
AT ION
13 08
ĠCI s
ĠCI ITA
ack ing
Ġmeas les
Ġdisor dered
ĠCom orbidities
ĠCh icago
ĠAd r
24 9
sub unit
ĠSt arting
DR I
Ġ28 6
ĠCon trolled
Ġhaemat ologists
ĠPro v
Ġsil ver
Ġ35 4
ĠPB A
ĠAS O
Ġglyc ine
39 2
rog lobulin
Ġmegakary ocytopoiesis
ĠPI G
ĠGS I
ĠAN N
ĠInc reases
co il
Cd k
ĠHealth y
Ġpe jor
Ġill umin
eth nicity
Ġtur ning
ĠOther wise
ĠEL K
ĠDS Bs
physi ological
OH dG
Cyt okine
HDAC I
SR C
Ġhomo zygotes
Ġpy oderma
ĠPo int
aro l
Ġdig oxin
IG HV
eli very
Ġinteract ome
Se ven
tib odies
ĠDel etions
Ġundersc ored
Bs Ag
Hemat opoiesis
Ġhamp ers
Ġsero logic
ĠCommon ly
anol amine
Ġsubdiv ision
jo ene
Ġtam ponade
pe ak
ĠPEG ylated
FLA MSA
AI DS
aud in
Ġget ting
Identif ying
Inhib itors
Ġsaliv a
Differen tial
Ġexec ution
Ġafford able
Ġpolys accharide
Ġgonad al
ĠExp anded
demethoxy geldanamycin
599 1
iosp inal
Ġds RNA
ĠSMAR CA
Ġdiac etate
Ġprescrib ing
Ġdop amine
Ġderang ement
ĠTryp an
Ġguaran tee
Ġmesenter ic
Ġmetam yelocytes
Ġendor sed
Ġuncoup ling
Ba F
Meas urable
Pos aconazole
Ġepilep sy
Ġitem s
ommend ations
Ġmus cles
quad ruplex
Ġcartil age
Ġthermod ynamic
Ġix azomib
ymotryp sin
Ġtong ue
Ġancho red
amphenic ol
01347 996
0 76
4 20
4 66
8 602
9 45
B AC
D ay
D AT
F LC
L arge
P las
P OS
S Y
S w
S weet
X PO
] (
a C
d oses
g a
i PS
k inetic
r yl
Ġ %;
in active
ti a
he im
Ġs iglec
Ġan esthe
al gia
an not
as ts
as tric
Ġd ensely
Ġre bastinib
ĠA GO
ĠA rea
ra re
ĠT ac
ran ib
Ġl ib
Ġl end
Ġl ady
Ġl omustine
op eptide
il iary
oc et
Ġg er
Ġg am
ĠP ap
ĠP EP
od ality
ĠH ost
ĠH AL
hem oglobin
Ġ2 22
ain s
sis ts
ĠD u
ĠD BT
ĠF OS
ĠF requency
ow ing
ĠN at
ĠR hodamine
ĠO s
edi ranib
Ġanti serum
Ġtrans mitted
ĠG re
tr at
Ġmet ho
ĠL H
Ġunder lined
Ġmal ate
Ġel ective
Ġar rang
ĠCR S
Ġcar nitine
ĠOS U
PL SG
ĠAT PR
Ġform ulating
ET LAM
ĠDN T
jec ting
Ġ30 3
Ġgranul omatous
Ġmyel otoxic
BM F
iod o
Ġter tile
35 4
ĠST ANDARD
Ġ28 3
Ġ28 9
ĠCT R
Ġlip ophilicity
Ġsil ica
Ġmel flufen
ĠCyt os
Ġtyp hlitis
Ġangi ogenin
Ġcertain ty
oly s
Ġfat her
PC a
HLA DR
Ġserious ly
Ġten sion
Ġchemos ensitizing
Ġcoup le
PH F
Ġtranspor ting
Ġdeb atable
cho ice
ocardi tis
Ġval ine
Ġproto oncogene
Ġadip ogenesis
ĠSN CG
HOX D
oconjug ate
MI CL
Ġsinus es
fl ur
ĠHM X
Ġcounte racts
compl iance
Ġpremature ly
TF E
Ġdrop s
ĠOp tim
Ġstres sors
Id arubicin
wan n
ĠMol m
Ġmm Hg
Ġawa it
RG D
Ġcontras ted
ĠWil m
Ġhypog ranular
imid yl
ĠHetero zygous
Ġket oconazole
ĠRepe at
bile tin
ĠMn SOD
Ġdisper sed
Evalu ation
Ġechinocand in
Ġanticoagul ant
Ġtach ycardia
Effec tive
comple ment
Ġtemp ered
Ġsucce eded
Achie ving
Ġneurofibrom atosis
Ġsout hern
Ġvirul ence
ych loroquine
ophthal m
Ġdiffus ely
Ġidarub icine
Ġbru ising
annot ated
. :
5 42
7 04
G VH
H hex
L EDGF
M uc
N OX
O ral
P opulation
V o
b est
b anded
c re
f at
f ant
f ound
f inding
h as
k ary
m ix
p hed
v entricular
y ne
ï ¬
Ġa ur
in ins
Ġs at
Ġs ing
Ġs TNF
ic tor
Ġf oscarnet
at eness
Ġ( $
Ġb s
Ġb FGF
ĠA IF
ĠA IDA
ĠA hR
ĠA berrations
ra gue
ĠT U
ĠT AF
ĠT IF
ĠC alu
ĠC HD
Ġis op
Ġis omers
Ġst ory
ĠI k
ĠI AT
ĠI PRS
ran os
Ġl adder
Ġl agged
Ġl ithium
op terol
ol ide
ud d
Ġal bicans
ĠP aclitaxel
ĠP logrank
Ġr if
Ġcomp ositions
00 48
ĠS EF
ĠS tel
ĠS oluble
Ġass uming
Ġ3 14
Ġap repitant
eren ces
di opathic
ĠG ITR
ĠE AL
Ġmet ab
Ġfac ilities
Ġpre leukaemic
Ġpre incubated
ĠL CN
ĠL EDGF
Ġbut yric
Ġbi ode
Ġar s
requ iring
og lin
Ġprov es
LA As
fer ine
GF s
GF MS
HR IL
AP IN
derly ing
ons titution
Ġprote omes
ma de
Ġmethyl ator
ĠRes cue
ĠUn derlying
CN V
tis ol
Ġdispl acement
fold ed
65 2
Ġmitochond rion
Ġliter atures
ĠNF E
Ġtra de
97 6
immun ogenic
Ġsuscepti bilities
rog rap
ĠGS L
Ġfrag ility
Ġamoun ted
ĠInc idences
Ġamin oglyc
ĠCo lo
ĠPT R
Ġcounter balanced
inhib ited
non myeloablative
ĠPer sistence
Ġtet ras
Ġspecial ist
Ar m
bal ance
Ġfluid ity
Ġremo te
ĠTF F
Ġdeb ut
Ġarg um
isc osity
ĠHist ology
Ġcomm encing
ĠDD IT
ĠFT O
Ġfinger print
HI DAC
ĠSN RPN
Ġtrunc ation
%] ).
SIR s
ĠFR ET
MI BG
Ġexternal ization
ĠSm artDC
Ġreconstit uting
Ġappropri ateness
Mel anoma
Ġmanufact ured
Ġrevert ant
Ġterat oma
ĠLnc RNAs
ĠMAL DI
Tel omere
Ġreferen ces
ĠAnimal s
Ġferro ptosis
Ġfibr illation
ĠSumm ary
ĠVers ican
Ġsig ma
spon sored
Ġfic olin
ĠInsigh ts
ochalas in
iosperm um
( <
0 97
0 63
C lass
H AD
J anuary
P he
b b
d NK
h il
h ors
m y
p eg
r C
x yl
Ġa HR
Ġt ip
on ding
Ġp u
Ġp all
Ġp gp
Ġw ing
el c
el ev
it a
ic ious
Ġf ru
id amine
Ġto uch
Ġh im
ĠA Cs
ra xin
em y
ĠT AN
ĠT riad
si p
ia bly
Ġpro jects
Ġpro carbazine
ĠC orporation
ĠC auses
Ġleuk ocyt
ac tions
ran ged
ud ied
ĠP SA
ĠP GRN
ĠB UCY
ap hyl
ĠIn cluding
ĠF O
00 38
ĠS HC
ĠS PSS
ĠS kp
ĠW RN
Ġun infected
Ġ3 12
Ġap olipoprotein
ĠN up
NA D
Ġanti platelet
iz z
Ġ4 02
ĠE ST
ĠL XR
Ġpres s
Ġro ten
Ġdifferenti ates
ĠK RN
Ġop erated
RD W
Ġlong standing
Ġsh rinkage
ĠV MP
Ġcol loid
Ġ19 72
Ġiniti ator
19 92
erg ed
val ence
Ġav ian
Ġ30 2
hes us
Ġmit ophagy
use i
ind uce
Ġgra ve
ĠCN Vs
Ġrapid ity
Ġfunctional ized
Ġprior i
80 8
Ġconduc ive
DA s
Ġreal ization
ĠPro por
ĠPro ject
ĠIM iD
Ch an
ĠCM MoL
ĠCP A
MN DA
As sess
Ġrest rained
Ġhybrid ized
Ġexpansion s
49 2
ov itine
Ġrever sibly
MF L
Ġneuro ect
ĠAN RIL
ĠImmun op
ĠDec tin
Ġhepat o
ĠAD EP
Ġtransport ation
HA I
Ġthym oglobulin
Ġmodif iable
hol ide
Ġstimul ators
Ġent hal
Ġtub es
ĠCompar able
CX C
itone um
Ġlaborator ial
idin yl
Ġras hes
Ġvast ly
no ea
eng raftment
Ġabsor b
ĠOb limersen
Ġsampl ed
Ġrepop ulate
ĠBas el
Ġfav ourably
hel ical
Ġcul tivated
Ġsegreg ate
Ġproceed s
ĠRadi otherapy
Ġge ographical
Ġging iva
ĠSal monella
Ġnarrow ed
ĠODN s
Ġhepatospl enic
Ġoper ations
ĠClus ters
Ġambigu ity
Ġtrap ped
ĠAZ C
Ġhaemorrh agic
Ġanch or
Ġunw inding
Ġorchestr ates
Ġequip ped
MEC OM
Ġfum ig
lymph omas
ĠEstabl ished
dec reased
Ġneu ros
Ġphosphoprote omic
ĠDys regulated
Ġhippocamp us
Ġreadout s
Ġsemin oma
ĠÎĶN p
ĠHope fully
ferior ity
Ġattend ant
Ġtonsill ar
guan idine
Ġbat tery
Ġcyn omolgus
Ġdecis ive
Ġaccommod ate
Ġdysph agia
gall ate
emet rexed
otrich um
rograp holide
' âĢĳ
) %.
4 68
5 60
7 24
8 776
; =
A f
B O
C LAG
F AK
H FD
L CL
N ET
R and
S okal
T ime
T ARGET
^ -
b iotic
d os
d osing
e tel
f osf
n umerous
p ower
p olarized
t rac
y lox
z ary
in spired
ti dom
he tic
he rol
Ġc lock
Ġc tDNA
Ġp oll
Ġd ck
Ġre or
om ial
ĠT erminal
ĠC ent
ĠC ST
ĠC AS
un treated
ant ho
ant um
Ġst ation
Ġl angu
ĠP FI
ĠH MP
Ġor dered
Ġr pS
ĠB BP
ge rous
ĠD ip
ĠD PP
ĠF PN
ĠS ER
Ġne arby
Ġreg ain
di hydroxy
Ġen vis
Ġsub telomeric
Ġint ui
ĠL PD
Ġinf erence
Ġlym phed
Ġsyn cytin
Ġexp ose
Ġcombin atory
Ġdem anding
ros ing
mon ocytes
ĠK AS
AB CC
ch im
Ġacc umulative
ll ate
16 50
ĠV ENT
ĠV max
âī Ī
Ġtransform ative
ĠAn titumor
ĠBM SC
IC ATION
37 4
Ġinfec t
Ġpharmac ogenomics
ĠRec urrence
ai re
36 7
Ġmedi ation
Ġ26 3
Th ym
28 1
28 53
Ġ45 1
Ġwhite s
Ġ36 7
Ġrest art
ĠAS Nase
titution al
86 8
GS EA
PA N
met in
met astasis
Ġneg lec
ĠImmun ostaining
rh IL
anti trypsin
Ġcorresponding ly
An alysis
Ġglut amic
adi p
pr ints
ĠDA UN
Ad ditional
Ġtub ules
ĠInter pre
ĠHA ART
Ġinstit utes
ĠCE Cs
anth aridin
ticos teroids
Â® ,
ĠEr bin
ĠDiagnos es
Ġhomogene ity
Ġcoc aine
Ġperic y
Ġecon omically
Ġtemper atures
ĠTherapeutic ally
ĠMyelo genous
Ġsero logy
Ġantimicrobial s
ĠChem oresistance
Ġens uing
ĠPred ic
ĠMark ers
ĠBN ML
Ġseques tered
Ġequip otent
Ġsubf raction
Ġflex ibility
Ġmorpho genesis
218 1308
Ġconve y
Ġmultin ucleated
Ġaffor ds
ĠRecogn izing
redi ents
ruit ment
Inte ractions
Ġdeoxyribonucle ic
ĠHi wi
Ġaccept ance
ĠFI AC
multi drug
Ġechinocand ins
Ġisob avach
Ġing redients
ĠDiscontinu ation
uber tal
ĠANG PT
Ġdan gerous
Ġillum inated
Ġextern ally
Ġcontin ual
Ġkr usei
Ġcoex isted
ĠHtr A
Rap id
Ġagen cies
ĠIKB KE
ĠOrg anis
;= &#
Rand omized
fosf ate
Ġintui tively
Ġlymphed ema
ĠVENT X
Ġisobavach alcone
0 90
4 98
6 28
8 48
> );
A IP
B as
L Q
M ic
R etro
T H
T ax
W NT
b lot
b uff
f atal
h igher
h oming
l ayer
m yelodysplasia
n iche
u ate
Ġt osedostat
on ins
en ium
te xt
Ġm pl
Ġthe ophyl
or um
ic ul
ic oll
Ġe ager
ul um
Ġn t
em ergence
im mature
lo d
ĠC OP
ig allocatechin
gen uity
ter ative
Ġac ral
Ġleuk ocytopenia
ĠM x
ĠM ast
ĠM ature
Ġim pression
ol ia
Ġal do
ĠP HD
ĠP OL
ĠP NT
st ability
Ġsur ge
ĠD LL
ĠF er
00 78
ĠW ASP
igh ting
Ġco at
Ġco bal
Ġanti mon
Ġanti estrogen
Ġen vision
ĠG PCR
ĠG add
Ġhem ip
ĠL m
ĠL IR
ĠL CP
Ġob liter
01 74
Ġsyn ap
Ġnon transplant
Ġnon synonymous
ser ver
Ġcor rects
ĠCR R
av idity
ten uated
oplas ty
Ġmicro chimerism
ĠV irt
ĠCI BMTR
Ġem pty
ET C
MP T
MP FC
ĠII Î±
CI N
05 4
Ġav id
Ġmat ches
oss yp
ind lin
omy ce
Ġinfec tive
activ ate
Ġvalid ates
lob ase
rophil in
of ovir
ĠUn related
con ventional
ĠCT Cs
Ġelev ating
Ġhyper phosphorylation
Ġ27 6
Ġsp her
Ġunderst udied
Ġobserv able
As O
Ġcle aves
Ġ38 6
Ġanalog y
Ġlocal isation
Ġ34 9
amin ated
Ġcont raction
ĠHDAC I
ĠAN XA
Ġrepl en
ĠCDK s
Ġz ipper
ĠSR P
lan k
dr iving
MM UD
ĠTrans l
onc ological
appro pri
usc le
glut amate
ĠPG K
ĠLym ph
ĠPS AP
ĠPub med
âĤ ħ
Ġreperto ires
Tumor s
ĠEl acytarabine
atell ites
ĠMod erate
Ġdil utions
Ġlectin s
ĠExt ra
ĠExt racellular
Âµ l
oxyl in
Ġreplic ating
Ġscaff olding
ĠGl c
Ġshap ed
Ġlon idamine
Ġjuxt ap
Ġce RNA
ĠTS LC
Ġvacu olation
Ġtrap s
ĠHB O
Ġances try
Ġphosphoryl ase
mor pholin
Ġquad rup
Ġshutt le
ĠGAB A
ĠEnc ouraging
bur s
Ġprioriti zation
Ġtetrap loid
Ġanthrac enedione
Ġscarc ity
Ġanticoagul ants
Ġdu od
Combin ation
ĠLeban on
Ġfores e
Ġign ored
ericardi al
Ġroset te
Ġmatric es
Ġcob blestone
ronch ial
Ġleukap hereses
Ġfen retinide
Ġagric ultural
accharom yces
ycep in
Ġwithst and
Ġfumig atus
etel stat
" ),
5 22
5 90
> +/
C ho
D CA
D QB
E ps
G nRH
N SAID
P im
R ho
S EM
V ST
d b
d endritic
d raining
g lioma
re porter
en imex
Ġc lot
Ġo zog
Ġin acces
it osan
at tie
Ġb rains
Ġh BM
ĠA CC
ĠA IM
ĠT er
ĠT ur
ML C
ĠC OR
ĠC level
ĠC ultures
ot s
Ġex ud
Ġst ated
ol k
ol asertib
Ġal iqu
Ġch ordoma
ĠP CI
ĠP td
ĠB rief
ĠB GB
ĠD eg
ĠIn genuity
ĠF li
pro f
ĠN pm
Ġwe aken
ĠR he
Ġanti sera
di i
Ġchem il
Ġper it
Ġ4 35
ĠG ES
CR M
Ġpre pon
rel and
Ġhe arts
sup plemented
ist ar
ast ases
Ġcor tisol
ĠU HRF
RA s
Ġdes min
10 75
spec t
Ġimp recise
min o
Ġme ant
Ġrev ise
CL EC
ĠV ascular
Ġstandard ised
Ġhetero log
Ġblast oid
AK R
MR s
18 70
IC H
Ġradi ography
37 7
ĠAm photericin
Ġ40 6
27 2
Ġinfec tivity
of ect
ĠAB VD
ĠCT V
Ġmac ul
ĠHR X
inc idence
raph ic
rup ting
PR O
ob ut
ĠIC ER
Ġpredomin ate
TC F
ĠAL IP
Ġampl ifying
sel dorf
Ġinj uries
ĠSR PK
Ġbio en
Ġcomplement ing
ĠAc ross
Ġelectro sp
Ġpersonal ize
Ġillustr ative
Ġleuc openia
GR S
Ġbo ot
Ġview s
Pro gress
IAP s
Ġeth ical
ĠInter group
ĠPL GA
Ġradio isot
Ġoc fosfate
ĠRisk s
ĠLT BMC
ĠPar allel
Ġann ounced
oz antrone
Tran sient
Ġpseud ouridine
ĠMod ulation
Ġdil uted
ĠMal attie
Ġhyperp lastic
ĠCycl osporine
ĠHC Cs
Ġsphing omyel
Ġsperm ine
Po or
Ġmultim eric
Ġmultim odality
FLA I
ona ute
Ġtrop ical
âĪ ¶
megakary ocytic
Ġamplic ons
Ġchemopre vention
Ġosteop orosis
ĠMax imum
Ġradioimmun oassay
ĠAPA AP
Ġdecom position
roma gnetic
Ġhydraz one
Ġafflic ted
ĠBioinformatic s
ĠLIM K
Ġnanocarri er
Ġamph i
ĠPort ug
Str ing
Ġpractition ers
ĠRadio immunotherapy
ĠGe otrichum
Ġpedig rees
ĠHelic obacter
iet ins
Ġveter inary
ĠImmunocyt ochemical
Ġneuroect odermal
2853 669
ĠInterpre tation
ĠClevel and
Ġprepon der
/ +</
0 88
0 71
3 01
4 31
D EC
E ven
G MPs
H AT
H SF
H Cs
N ow
P NP
P EL
U PR
V CAM
Z ip
a a
m edi
m IDH
n em
o verexpression
r un
v an
y er
re f
Ġc rest
Ġo u
Ġs ort
Ġs Tie
al o
al fa
ĠA CF
Ġn u
im plantation
ig gering
sp ace
sp here
Ġst atic
Ġcon ceived
ĠM PM
op orin
Ġde form
Ġde plo
ab ain
ĠP AC
ĠH ipp
Ġv ign
Ġv ault
st ress
ĠB ub
00 49
ĠS PC
ĠW istar
Ġcl audin
Ġass umes
Ġ3 26
Ġ3 70
pro ic
NA T
olog ram
Ġtrans activator
Ġmon omeric
ĠG efitinib
ĠG ruppo
Ġover hang
ox an
Ġrec tum
Ġpat ents
Ġmic ellar
Ġsuc rose
ond ensation
ĠK E
ĠK ITD
drom ic
og le
Ġsc ram
min i
oplas tin
ĠJ NJ
Ġmicro hom
Ġmicro circ
tho quinone
ĠV A
ĠV IP
Ġdi astolic
53 9
Ġpost mortem
Ġcri zotinib
vo ked
Ġretro peritoneal
Ġav ascular
ĠBM Cs
ĠBM MC
50 9
ĠCh allen
Ġcap ital
BM FS
37 9
ĠAm plification
kin in
MA GE
clinical ly
yb ean
AD L
ĠCP S
Ġclear ing
comp ared
ĠER p
Ġhydro lase
Ġven a
DC K
Ġglyc eraldehyde
Ġlabor ious
erox amine
ob acillus
PA GE
FR Î²
Ġdysp o
ĠIg f
Ġnan otubes
ĠDec rease
76 1
CG s
ĠRe active
Ġattrib ute
Ġelec tric
Ġur ic
Ġsl ide
ĠNe oplastic
ĠNe utral
Ġrib ose
Ġbil ineage
PT CL
ĠTF AP
ĠSp rague
ĠAg gressive
BA X
Ġcomb ating
Ġpal ifermin
Ġinnov ations
ĠCO II
Co R
deoxy uridine
ĠFLA D
Ġcul pr
ĠDH FR
ĠIntegr ative
Ġtax anes
ĠLab or
Fc Î³
Ġimped iment
Ġov aries
Sc ore
Ġcarbohyd rates
Ġcentros omal
Ġmorpho genetic
Ġsubstanti ated
ĠMuc in
arboxyl ase
Ġisot opes
Ġextrap olation
Ġelabor ated
Ġophthal mic
Ġagglut ination
Bl ack
Ġdamp ening
ĠSymptom s
ĠSouthe ast
atologic he
Or gan
Ġmicrodiss ection
penet rating
Chi ari
quil ibrium
Ġsacrific ed
Ġhypogonad ism
Ġdevi ations
malign ancy
ĠOrganis ation
Ġeager ly
ofect amine
Ġsphingomyel inase
8 44
A SC
C alc
F PD
G W
H IPK
I MT
P ositive
S IGN
U SA
W S
Ġt andutinib
re pressor
Ġc in
Ġc dc
Ġc esarean
Ġo d
Ġo titis
Ġs ctb
Ġan aphyl
Ġw ish
ro d
as er
Ġd ithi
Ġd UTP
at ol
Ġb eside
Ġe at
Ġe NOS
ĠA H
ĠA HN
ĠT urk
ia h
ĠC AD
un known
Ġst athmin
ĠI ACS
ĠI reland
ĠM ach
ĠM OS
ĠM elphalan
ĠM ZL
Ġim ip
Ġde hydration
Ġon wards
ĠP erm
ĠP EC
Ġv iz
Ġdis sip
st rap
ĠB B
ĠB lastic
am ins
ĠD MN
ĠIn duced
ĠF AM
ĠS ingapore
th a
Ġcyt oc
Ġ3 23
ĠN bs
Ġanti de
Ġnot opterol
Ġprognos tification
Ġ4 60
ĠWe ek
cl av
ĠG iemsa
ich i
Ġsub verted
rel apsing
Ġhemat odermic
ĠL AG
Ġtransplant ing
Ġ6 31
Ġsyn onymous
Ġnon targeted
Ġnon linear
Ġspec ially
34 3
reg ister
Ġsec ure
Ġra w
Ġsecond arily
oph or
Ġqu er
ĠJ ournal
Ġdef ensin
Ġsim ulating
ĠV ZV
Ġref ines
53 2
ex pansion
ĠML Rs
CI BMTR
ater cept
AL FA
ters titial
OR IS
AP ML
Ġtr ib
ĠRA I
ĠRA NKL
Ġheterogeneous ly
Ġtri phosphates
ĠAra bin
NF ÎºB
Ġ28 4
opro tect
Ġu veal
Ġcirc ulate
SP ARC
36 62
Ġhyper coagul
ĠPro tection
Ġdys m
EGF L
Ġmelan ocytes
other mal
Ġautophag osomes
ĠNot able
Ġhazard ous
Ġampl itude
TD M
Ġauto HCT
Ġnine teen
Ġoste omyelitis
mod ulin
ĠDLI s
Ġund ue
ĠPo lycythemia
ĠSH I
ĠRR EB
ĠPL CD
bor tezomib
sh ort
press ants
Ġmono zygotic
ĠSN Vs
Ġintercal ators
ĠHis tory
Ġbrid ged
MI BI
Ġcogn ition
Ġdihydro folate
py rid
Ġhyd rate
ĠPTC Y
Tc R
Ġdistinction s
nec rosis
Ne utropenic
ĠAM kL
Ġvi rosecurinine
ĠEGF P
Ġresol ving
Ġpolic ies
Ġdro ve
ĠPhen otypically
Ġincident ally
neu ropathy
ĠLP Cs
ĠSw iss
ĠDT X
elic ited
Ġdrople ts
arot omy
Ġcontraind icated
AZ C
Ġconve yed
ĠTax ol
Ġsemiqu inone
system ic
Ġket one
Ġchip s
NCR I
ournal s
Ġcyst atin
Ġcontrac tile
ioid es
ferritin emia
Ġcatar acts
Form ula
ĠSIRP alpha
ĠRAL B
dehyd es
omox ir
Ġpress ures
Ġpoll ut
> ]
C LA
F amilial
K g
K ap
K aryotype
L ineage
R ag
R ep
S im
T RAF
a I
a is
c ement
d min
f rag
f ovir
r um
t yp
w ley
z olizumab
Ġa ids
in ning
re verse
on at
Ġp ending
Ġin ception
Ġs on
Ġw og
Ġm ort
Ġd anger
le th
Ġb onding
os ensitive
Ġh IL
ĠT AT
ĠC FA
us ual
ĠI RA
ĠM CD
ĠM MA
ĠM aternal
op eptides
il lo
ĠP RD
ĠP otent
ay a
ĠH BMT
Ġor d
Ġinc ur
ĠB G
ĠB IN
ĠB linatumomab
am a
am ping
am plified
ĠD ot
ĠD urable
ĠD HO
ĠS pontaneous
ĠW ST
pro fil
ĠR BL
ĠR EC
Ġ5 60
NA P
com fort
Ġ4 80
ĠG NA
ĠG Cs
ĠE Cy
Ġno biletin
ore gulatory
Ġpo ised
ĠL B
Ġrec h
DS Bs
ip ulation
Ġmod al
Ġmal aria
ers on
Ġsyn apses
Ġexp edi
Ġdec arboxylase
ist oyl
Ġnon acute
Ġnon adherent
Ġ8 226
Ġlympho depleting
34 5
Ġel ected
ĠU M
depend ency
CT CL
our nem
ĠCR PC
ĠCR ABP
Ġour s
Ġdef enses
Ġclas t
Ġy olk
ĠAl a
60 4
14 80
19 95
Ġbec lin
38 9
Ġav oc
Ġgranul omonocytic
ST A
ĠBM MSCs
Ġsmall est
til b
Ġthromb oses
ura bility
Ġpharmac o
Ġrepresent atives
oid an
Ġ28 91
Ġpotenti ating
osp ot
osp erm
DA G
ĠX AF
88 6
ade fovir
Ġsal ient
Ġ38 7
ĠMCL ABSI
Ġglyc olipids
Ġoff icinal
Ġequ ations
Ġelucid ates
rec urrence
48 2
Ġcruc ially
Ġnan ost
ĠMN KI
Ġtransfer ring
ĠSim ple
ĠIR C
ES R
Ġpe tech
MM M
ĠCAL CA
ĠAc tin
put ational
Ġtrac ed
Ġ96 21
Ġmagn esium
Ġcataly zing
Ġrevolution ize
Ġbo osted
Ġasc itic
ĠMSD s
Ġide as
Ġtub ule
ĠMe eting
ĠHA DS
Ġcytos ines
Ġantioxid ative
ĠTAM C
Ġencoun ter
Ġgel onin
tri ple
Ġsurvey ed
auto SCT
Ġcyclo cytidine
ĠImpro ving
local izes
RC Z
Ġsphing olipids
ulph ite
ĠRep Sox
ĠInv olvement
evalu ate
Ġexacerb ate
ĠSci entific
Ġsubdiv ide
Ġmechan ics
He alth
ĠEstim ates
ĠRap amycin
Ġread mission
Ġnano form
ĠThromb osis
Ġoper ator
ĠAbs olute
Ġchron ologic
ĠEG IL
Ġgamm adelta
ĠTE AEs
lyce ro
Ġmicrovess els
ĠWil coxon
ĠMH CII
keep ing
Ġpharmacogenetic s
ĠMIT F
rophyl axis
Ġsimpl icity
âģ»/ âģ»
splic ed
Ġgonad otrop
Ġcup like
Ġarbitr arily
Ġnaph thol
Ġcorepressor s
Ġstratif ications
glutam yl
Ġthiop urine
ĠFG FS
uns aturated
cyan o
Ġsto ol
Ġker at
Ġprevail ing
Ġsuspend ed
ĠIkappaB alpha
Ġlaun ched
Ġcerebro vascular
ĠCarcin oma
ĠPattern s
Ġdeter gent
splice osome
ĠUs ually
ocaly xin
thel min
Ġate zolizumab
Ġlever aged
Ġsat urable
Ġfru its
Chan ges
tidom imetic
ĠDHO DH
ournem outh
3 95
A ff
C ys
C ON
F K
G AS
H IC
H EL
I ron
J M
J P
L SP
M Ab
M eg
N ational
O FF
R ev
S z
T n
U GT
a id
d g
i MACS
t ap
Ġ zym
Ġa head
en ro
he ck
Ġo roph
Ġp ra
Ġs arcom
Ġs no
Ġan thelmin
Ġm RCC
al ton
as te
ed le
es cape
ar ber
Ġf ared
Ġf orest
Ġn c
ĠT MDS
lo xin
ĠC Q
ĠC entre
ver apamil
Ġl it
ĠM id
ĠM ill
ĠM etabolic
iv ely
Ġde aling
ĠP LAG
ĠP eptide
Ġv igil
red ient
Ġr hesus
ĠF ree
ĠS ex
ĠS pect
ĠS YN
Ġat tit
Ġrel uct
Ġ3 56
Ġk m
Ġco factors
Ġper vasive
Ġper itran
ĠG NF
ĠE CP
tr iaz
Ġfac ts
ore loxin
Ġover rid
Ġsug ars
Ġnon response
Ġallo antigen
mon afide
ĠU BMT
Ġar temis
11 76
Ġgrow s
Ġimp etus
min ute
ABL p
loc ked
ne w
ĠMD F
ĠCI APIN
Ġref usal
Ġiniti atives
ores pon
25 2
Ġcytomet rically
CC K
BM B
Ġ40 9
ĠCN E
ram ine
Ġfive fold
Ġproportion ally
Ġlip o
Ġsp ares
44 3
ĠPB D
gram ostim
acet amide
Ġpoly uria
urviv ing
Ġ46 8
Ġtoler ant
Ġste llate
55 9
Ġtopo isomer
ĠStud ying
TK s
inte s
CG I
Ġiso enzymes
ĠÎ± CD
An tibodies
Ġvar ie
Ġhypox anthine
Ġdimin ishing
PH N
Ġbound aries
ĠSD Z
Ġinterven ing
ĠKn own
Ġhomolog s
Ġmicrog lial
Ġscal p
VP X
ĠCO AP
Ġhydrox ychloroquine
random ised
tub e
ĠTG N
rogen esis
Ġmutagen icity
600 125
ĠAu SCT
ject able
Ġamelior ates
determ ining
Ġreinfor ces
Ġreinfor cing
ĠGA DS
ĠMulti parameter
Ġrheum atic
Ġhor se
Ġmu M
sulf oxide
Ġplau sibly
tryp tophan
ĠIAP s
imid azole
En h
Ġherb imycin
Tel omerase
Impro ving
Ġastrocyt omas
Ġseiz ure
Ġhouse keeping
Ġtransm igration
Ġexquisite ly
Ġequival ents
Ġnos ocomial
Ġglucuron idation
ĠRam an
ĠLact obacillus
differen ce
Retin oic
Consid ering
Ġcorp us
Ġimid azole
Ġhapt oglobin
ocor tical
Ġscr utin
Sequ ential
Ġarrang ement
Eps tein
Ġheterolog ous
Ġboot strap
Aff ymetrix
/ <
7 02
B ST
F AC
J ak
L ON
M pl
P BC
R CTs
f atigue
g rafting
h and
h OCT
l ung
m enopausal
n at
r ical
µ Ŀ
á µĿ
Ġ il
re port
Ġc ity
Ġc icl
Ġin efficacy
Ġm erged
ar minomycin
Ġ( =
Ġe gress
Ġh ous
ĠA ur
ĠT eff
ĠC FLA
elo id
ac ted
Ġex ocytosis
Ġl ens
ĠP IR
ĠH g
ĠH ct
st agland
ĠF und
00 26
00 39
00 64
ĠS CA
ĠS iah
Ġun responsiveness
Ġne ferine
Ġcyt osp
Ġ3 37
ĠR EN
one ph
Ġanaly z
Ġen zastaurin
Ġ4 16
ĠE ssential
Ġimmun ode
rac ranial
Ġhemat opathology
ĠL uc
ĠL ck
pec ified
Ġrec ording
ad ow
Ġinter laboratory
Ġaddition s
tern berg
Ġconf ron
ber ine
Ġdisc ordance
Ġprogression s
ĠTo ky
ep it
ĠML PA
Ġneed ing
rop enem
ĠMRD Cons
38 3
Ġes cap
trans located
ĠAs III
ĠIm paired
Ġthromb oplastin
ĠCom putational
ind ole
ĠNo onan
ĠCon jug
opro bes
con centration
arb onyl
rid ge
drug gable
ĠX I
ĠX enop
respon ses
ochond ria
75 46
inf lammation
Ġ33 9
Ġpoly neuropathy
Ġequ iv
PA I
Ġdysp noea
48 9
ĠZ h
acetyl ated
Ġdegra ding
sign ificantly
Ġvascular ity
Ġspectr at
AN XA
+/- </
ĠPT H
isp lastic
Ġâ Ī
Ġbal ancing
ĠTRA MP
equ ivalent
Ġelectro de
ĠAC Y
ĠAR V
ĠBi ol
Ġbil ayers
FA O
Ġarter itis
ĠIT T
ĠCG G
ĠCG I
Ġequal ed
ĠAg N
Ġelect romagnetic
Ġpal in
HSP s
ĠPDGFR áµĿ
ĠBE Z
Ġrecapit ulating
eng rafted
erythro blasts
Com plete
Flu oro
hex yl
145 12
Ġamelior ation
Ġ1980 8
Ġbu falin
Ġnecessit ated
max imal
rele asing
FT I
Ġimmunost ained
dep renyl
Ġencompas sed
Ġspe ak
Ġnorm ocellular
ĠAssess ing
Ġpig s
Ġ225 1
Ġlap arotomy
Ġpermeabil ized
Ġselen ite
ĠSte ady
ĠDex amethasone
ĠLo Vo
Ġworkflow s
Ġadvoc ated
Ġpolyphen ols
Ġfoot printing
Ġmetach romatic
Adult o
neutral izing
tre ating
ĠFcÎ³ RII
Ġing redient
Zn PP
Ġthiop urines
Ġepiderm is
Ġsubstitu ents
Determ ination
youn ger
ĠTunis ian
ĠPneum ocystis
Ġintersp ersed
ĠClear ance
Ġventric le
ba um
Ġreviv ed
Ġdisabl ing
Ġreim burs
Ġfronti er
Ann V
Ġambi ent
Ġpenic illin
Ġmultipl icity
ossyp ol
ĠAHN MD
Ġcicl osporin
ĠCFLA R
ĠToky o
ĠXenop us
% ])
3 29
4 17
7 46
8 30
B is
C atenin
D XR
G PI
H ist
K M
R ad
T umour
T TC
d ural
d istance
e as
g ers
i omy
n ary
y k
in ity
Ġc ope
Ġc occi
Ġc fDNA
Ġin timate
an tit
an tisense
ro ism
as th
Ġd Thd
es ts
ar ter
ar ag
le um
le ading
Ġf ecal
id ian
Ġh u
ĠA verage
ĠA HI
ĠA lemtuzumab
ĠT est
ĠC ry
ĠC GM
if erol
Ġwas hed
ĠI O
Ġcon nex
ĠM AS
ol istic
Ġal ike
ab nl
ir i
ĠB z
ĠB ac
ĠB LA
ĠB PA
ĠD op
ĠIn jection
ĠIn nov
00 0001
ĠS earch
ĠW y
ĠW ell
ph K
ĠN EP
ĠN estin
ĠN alm
Ġper ian
ĠE MS
ĠE IF
ĠE chin
tr ant
ore g
Ġpres pecified
01 1989
str atin
ator ies
Ġbi ochemically
ĠU SF
Ġman ual
cr yst
Ġme ropenem
Ġdef eroxamine
19 98
Ġhetero zygotes
Ġend ed
Ġbenef ici
Ġlymphoma genesis
Ġcolon ized
Ġthromb ophilia
Ġso ybean
ves trant
Ġprot op
Ġter nary
ĠRec ommendations
Ġrecogn ising
90 8
DA F
ĠX BP
Ġretin a
Ġpan myeloid
Ġrecommend s
57 2
ĠSTAT s
cap illary
ĠDC F
ĠCyt ochemical
ĠInte ractions
rog ation
feren tially
77 7
Ġcat enin
Ġtermin ology
osinophil ia
Ġrespond ents
lim b
Ġoste ogenesis
IFN Î²
PV R
ĠReg ulation
be henoyl
initi al
Ġpr ud
ĠDown stream
ĠRAR B
Ġfl ag
Ġresc uing
âģ ¶
ĠIT IM
ĠHox B
Ġent rop
control s
My e
Ġsulf oximine
Ġscal able
ĠEM H
ocardi al
ĠEr lotinib
Ġperme ation
ĠMi HA
ĠTG I
onom ously
ĠHP CT
egakary ocytic
ĠEpidemi ological
ĠAM V
0007 0174
ohyd rate
ĠHaemat opoietic
Ġacetyl transferases
Ġknow ing
ĠHem e
analy zed
Ġhex am
Ġsynchron ization
secre ted
ĠDef ining
Ġheral ds
Ġbin ders
metho x
perm eable
Ġhin der
Ġverteb rate
TB K
Ġcoordin ates
tery gium
Ġmacrom olecular
auc her
plan ned
Ġba ical
ĠGluc ocortic
Ġaddi tively
ĠSuper Gen
Ġpetro leum
Ġremed y
Ġinterrel ationship
Tri ple
ashing ton
hodomycin one
health y
tans ine
Ġcurren ts
ĠPredic tors
ĠLabor atories
ĠIRA IN
Ġofficinal is
Ġtopoisomer ases
3 23
4 30
4 055
6 56
7 33
> +/-</
C U
D acogen
E CD
G rowth
G ITR
L MP
M k
N CAM
R ES
R IST
S AMHD
T SP
V osaroxin
X RCC
b led
d ys
p almitoyl
r atinib
v ul
w ich
Ġ âīĪ
Ġt in
Ġt au
Ġc it
Ġs pro
Ġm ating
el uting
it oc
Ġd ell
Ġd ust
os ely
ul ous
ĠA di
ĠT reated
ĠT ATA
ig ence
Ġas partic
Ġwas hing
up ational
oc itabine
rom ine
ab normal
ĠP OT
ĠP ANC
ĠH y
ĠH MBA
Ġor ders
gn ancy
red undant
Ġr ural
Ġinc ision
ĠB lo
am ivudine
yp tic
ĠD CA
00 23
00 45
ĠW ashington
ub enimex
Ġne opterin
Ġass urance
Ġ3 16
Ġ3 19
pro duced
ĠN MP
ĠR ob
Ġanaly tes
de tection
Ġtrans ducing
Ġmon omethyl
Ġ4 47
pl ates
ĠE PA
ĠE EC
Ġimmun ospot
Ġinduc ibility
ĠL U
ĠL NA
ĠL PC
Ġid asanutlin
Ġob ste
ort he
Ġdec alc
Ġnon receptor
Ġspec ify
ple en
Ġar med
ill a
11 248
av uconazole
Ġhyp h
Ġhyp onat
tern ative
fer asirox
Ġaut onomously
Ġy ellow
emic arb
Ġmy oblasts
ĠAn xiety
Ġmit oc
AP T
03 01
BM MC
Ġradi al
EBP a
ĠRA W
ĠLeuk em
ĠUn it
con verting
PD K
Ġtoxic ological
ĠPD Cs
Ġmac roscopic
AM C
Ġutil ised
iel ding
Ġsym pat
uz z
57 3
PS A
other s
Ġdeep ening
ĠKIT mut
Ġcalc itriol
Ġsecre t
Ġmobil izers
ĠOr bital
Ġclos ure
SS S
Ġmas tectomy
Ġswit ches
ĠAc tiv
lof en
ĠPC yR
Ġcontribut ory
Ġpair wise
ĠEv olution
Ġimmunomod ulator
educ ated
occ an
Ex osomes
Ġclassif iers
ĠAnti leukemic
tox in
ople x
Ġdim eric
Ġtop ological
Ġring s
Ġmil k
Ġperturb s
Ġneutral ized
ĠPBM NC
Ġconn ecting
Ġadip ocyte
Ġte aching
ĠUp regulated
Ġarsen ate
Ġcoinc ide
ĠArg ent
Ġribonucle oside
Ġassist ance
Ġhydroly zed
Ġye asts
Ġens ured
vin ium
Bi TE
ĠSV M
sulf amethoxazole
ĠHyper leukocytosis
obacter ia
Ġrevert ants
abs olute
Ġproceeding s
ĠProb abilities
Ġextrap olated
ĠDeep er
mat ching
Ġoct ogen
erge tics
iton avir
ĠMor occan
ĠConcomit antly
ĠUltras ound
Impro ved
ĠTri ple
ĠIMP DH
Ġintram uscular
Sh ort
ĠGlut athione
Ġmix ing
ĠAcad emy
ĠLIL RB
Ġpriv ate
VII a
nam ely
Ġcapit atum
ĠIMPL ICATION
Ġchori ocarcinoma
ĠFil grastim
eryth rin
Ġbim odal
Ġwilling ness
Ġdichotom ous
Mat rix
ĠServ ice
Ġdece ased
Ġreor ganization
>+/ +</
ĠBub R
stagland in
Ġperian al
ĠIMPLICATION S
. ;
0 82
5 18
5 178
9 26
B ak
B SP
C ox
E PI
I CD
I MP
L BP
M MA
N inety
R ib
S v
S OS
S yn
U MI
b acterial
b lown
c tr
d ual
d iaz
e ably
g onal
n u
s ample
u ent
z o
z one
Ġa leukemic
Ġt rophic
Ġt iazofurin
re ment
re ad
re activation
Ġc ate
Ġp aves
Ġs lic
Ġw alk
Ġm EFS
or ylated
is posing
an ks
ro blast
el ger
as ias
Ġd BMA
er idis
ic ating
ar sen
Ġf idelity
id emia
Ġn ig
em erging
ĠT HRIL
ML R
ĠC p
ĠC at
ĠC SI
Ġac al
ac es
Ġas sists
ver ty
ib arotene
ĠI NK
Ġl arynx
Ġl idamycin
Ġcon tig
ĠM as
ĠM AF
op ulmonary
ol ones
ol ateral
Ġch a
ab elson
ĠP d
ĠP ME
ĠP ON
od aunorubicin
ĠH CCR
ĠH utch
Ġr AML
st aining
ĠD G
ĠD ie
ĠD HL
ĠD aun
ĠF os
ĠF ungal
ĠF ADD
tor ily
00 27
Ġexpression al
Ġun adjusted
Ġun amb
Ġcyt ochemically
ph ostin
Ġmo tion
Ġmo unt
Ġ3 40
Ġ3 90
Ġap ex
ĠN PT
ĠN IK
Ġco enzyme
Ġres orption
Ġres ensitized
Ġres hap
ĠO FA
iz ar
lym ers
Ġ4 98
cl usively
ĠG CN
ĠE PR
ĠE me
ĠE DO
tr in
ox azole
rel ation
Ġ6 05
Ġbut hionine
term ed
ad ult
%) ],
Ġnon myeloid
Ġnon compliance
Ġpl aque
rim idines
RA G
CD H
ak a
stem ness
tit utively
tran spor
ĠV AP
HD AraC
Ġ19 71
ĠAT CC
Ġphen otyped
19 22
plic ated
Ġend osteal
Ġdaun ting
Ġacid ification
05 98
In termediate
Ġ50 4
ocl onality
ĠAd op
Ġdom inate
kin ases
Ġaz ide
ral azine
Ġimm igration
Ġsubt oxic
29 8
ĠCon ference
ĠCon clusively
Ġcirc HIPK
ĠX MD
Ġgu ides
100 2
Ġnatural is
comp osite
Ġintra dermal
Ġpoly acrylamide
Ġcardi ologists
ĠCyt openia
Ġ37 6
Ġsummar ises
ov orin
immun ohist
Ġprogram mes
Ġsubc lassified
CG R
Ġ59 1
Ġoxygen ation
IFN Î³
ĠHD D
methyl ene
ara ffin
MY ADM
ĠAD MA
ĠMYC BP
008 99
Ġbor ders
off s
ĠTRA P
ĠCH M
OT AC
Ġtrac er
ocarcin ogenesis
educ ational
Ġupd ating
SM X
ĠKn owing
Ġspectrom etric
ĠAut hors
ĠTAM Cs
ĠEm ploying
ĠHist opathological
ĠMA Z
Ġnic otine
Ġkind lin
Ġhr AML
ĠSup pressor
SV M
ĠAss ay
ĠInf ants
Ġultras onography
Ġpseud ogene
Ġwt CEBPA
Ġjo ined
ĠRD W
ĠTN FSF
103 168
Ġopinion s
450 9706
DO CAN
Trans formation
CS K
Ġempir ically
ĠSS ST
ensitiz ers
ĠPN s
TGF Î²
calc itonin
usi vity
Ġdich roism
Ġpharmaceutical s
Ġplac es
Fox o
ĠEN DOCAN
Ġulc eration
ĠEnh ancement
Ġlipopo lymers
Ġtag s
Ġorchestr ating
Ġrod ents
ĠAustral asian
ĠRad otinib
ĠSwit ching
245 7546
ĠHSA NPs
environment al
Ġdeubiqu itinase
iso quinoline
Ġfetus es
arth ritis
ĠCho u
oplasm osis
ĠPrim ing
develop ment
Dn mt
Ġsatisfac torily
Ġfos tered
Ġseas onal
Ġsubstitu ent
ĠHNRNP K
Neuro blastoma
Ġss DNA
otech nology
ĠLine ar
Ġhyperv iscosity
Ġsynov ial
Ġdors al
appropri ately
Ġmort alities
Ġnc RNAs
ĠSYN CRIP
1176 1922
Ġconnex ins
eridis tim
Ġunamb igu
0598 72
0 86
5 53
7 67
B el
E astern
F As
G RP
G enes
L IL
M dm
M aterials
R RM
T fR
d F
d ifferenti
i tions
o form
s ensitizing
É Ľ
Ġa e
Ġa joene
Ġc Kit
Ġp acritinib
Ġs and
Ġm V
Ġm OS
as partate
Ġre evaluation
at A
ĠA PMF
ĠT CP
ĠT Ap
im m
ML V
ĠC ob
ĠC UR
ig mentation
us sus
Ġac tors
ant agon
ant adine
ĠI E
ĠI vosidenib
Ġcon gr
op ontin
ĠAML SG
ab n
ĠP X
ĠP yro
ĠF ine
ĠF icoll
ĠS AML
ĠS EC
Ġsurviv es
Ġ3 11
Ġus hered
com mun
Ġanti thrombin
Ġtrans glut
Ġmon omorphic
ĠE UR
ĠE ECs
Ġhem oblast
Ġpre B
Ġrec on
opo ietins
Ġmic elle
Ġdem yel
Ġnon academic
Ġel uted
ite ment
ĠU BE
ogen omic
Ġman ners
cell aneous
ucle otide
Ġqu antum
001 4
ĠV ariable
22 28
Ġpost operatively
PL D
ĠmiR N
Ġcomplex ation
38 0
Ġprovid er
roph osph
Ġhist ologies
ĠMP B
racycl ines
Ġerythro leukaemia
ĠAra CTP
ĠAB BV
Ġsynerg ies
Ġmed ullar
IM F
98 4
imin arily
Ġstruct ured
Ġi KIR
Ġtest osterone
Ġmel ars
Ġrest rain
Ġsal ic
Ġcle ave
cap ture
49 6
Ġtyp ed
Ġste wards
ob arb
ĠZ eal
oler ance
Ġeosinophil ias
IN D
OG G
MLL r
EG R
Ġmicrosc opically
Ġmis cellaneous
arm ustine
ĠAc a
Ġfl ight
ĠAR ID
ĠRAEB t
ĠFc R
ĠInter fant
ĠPL B
Ġprel iminarily
hi atric
sh orter
Ġsupple ments
Ġtract able
Ġvul var
Ġphosphatidyl choline
chem o
Ġfinger printing
lox acin
ĠHu h
tub ercul
Ġcros so
PLC Î²
Ġsial ylation
tempor ary
Ġdiscrimin ates
ĠChem ical
TM Z
olab eling
Ġdepr ived
ton ide
Fox P
plas min
Ġbran ched
PBP Cs
ĠPatho logy
Ġboost ing
Pl atelet
Ġfu eled
Ġchima eric
chloro ethyl
Ġclo ts
Ġnav ig
Ġhemangi oma
ĠYB X
ĠFU BP
Ġcatas trophic
Ġosteoclast ogenesis
Ġpow ered
deoxyc itidine
Ġdiversi fication
Ġammon ia
Ġsatis fied
ĠFAN CG
Ġaux iliary
Ġcrypt otanshinone
Ġnanocarri ers
Lympho id
Ġana erobic
pot enti
Ġgast rectomy
cataly zed
ĠPark inson
ĠDysp lasia
Prom oter
Ġhapp ens
she ll
orac ic
ĠVaria bles
Ġeyel id
Ġdelocal ization
Ġhematopatholog ists
ĠSchol ar
Ġdysmyelo poiesis
cri teria
Ġpejor ative
ophthalm itis
Ġbiode gradable
Ġabsorb ance
ĠKAS UMI
Ġspher ical
oprotect ant
oreg ional
ĠHutch inson
ussus ception
Ġtransglut aminase
Ġstewards hip
ĠZeal and
3 000
6 01
9 11
A HCT
C NA
C MPD
D aunoXome
E AT
E MS
E cotropic
H oxa
N LS
P rior
P HA
S MN
S ES
S iglec
Y A
a ver
h an
i LRP
l s
m B
p eptides
r ub
r hodomycinone
s kin
s genic
s teroidal
Ġ ic
on os
he ld
he aling
Ġc ited
Ġw ant
al al
Ġb itran
id ated
id one
id ene
ul ative
Ġh MICL
ĠT AP
ĠT DP
un restricted
ac ental
Ġst ap
ĠM ith
ĠM ild
op eptid
um arin
rom eg
ab ove
ĠP NAs
st en
ĠD ART
ĠF rizzled
00 37
00 52
ĠS LL
ĠS AM
ĠS odium
ĠS accharomyces
Ġun transformed
Ġun published
Ġat yp
ĠCD KI
Ġap iospermum
ĠN AP
ĠN TR
ĠN ICE
Ġdise quilibrium
ĠR IPK
com orbidity
ĠO M
Ġper tain
Ġmon otherapies
ĠG SC
CR h
ĠE A
Ġhem odynamic
ĠL Cs
ĠL AD
Ġinf using
and rol
enc a
Ġlow ly
Ġexp osition
ple mentation
Ġnormal ised
yc o
ct omy
mon o
ven tions
10 âģ¹
cell ence
spec tion
ak in
Ġkn ockin
Ġmicro angi
(+) ;
(+) ),
po oled
17 21
SF K
95 8
Ġend osomal
Ġend ocarditis
Ġdown modulation
go ides
Ġcaus ality
Ġonc ologist
Ġgranul ocyt
Ġmorpholog ies
IC B
ĠIm C
Ġmetabol omic
ĠAd ap
26 7
IS GDSPV
rem e
ĠRec onstitution
ĠST S
ER IM
29 71
Ġ28 7
Ġu ve
ĠIFN gamma
ĠPro genitor
Ġsp ong
Ġmuc oc
APL O
57 148
Ġexpl ants
VI STA
Ġ38 5
ĠRT L
Ġj un
PB B
Ġoption al
ord antly
Ph osph
Ġpreclinical ly
ĠPre incubation
Ġ56 37
Ġ47 3
acetyl ase
glyc osylation
ĠIV F
ĠGST s
Ġextrem es
co valent
del ivered
Ġemb olization
Ġnor thern
Ġz ygo
ĠSub stantial
col on
Ġdaunomycin one
ĠTransplant s
ĠAC SL
ĠTrans lation
Ġchlor amphenicol
Ġexc itement
ĠIT GB
ĠMSD T
Ad o
inter rup
ĠInter ventions
Ġdisapp ear
ĠURD s
Ġlogistic al
Ġgel danamycin
ĠOCT N
anth rac
Ġval ve
Ġte eth
Ġcys tein
Ġpen ile
ĠMi CK
auto HSCT
Ġsustain able
ĠSL IT
ĠNT SR
Ġgover ns
ĠGF s
Ġden oted
Ġseptic aemia
ĠLip osomes
Ġlon afarnib
Ġscaven gers
Ġec ulizumab
Ġnotic eable
Ġdiver gence
Ġphenyl alanine
Ġhor ses
vac cination
ĠSet d
Ġcolum ns
822 6
dia betes
plas macytoid
Ġsk ills
On ly
Ġcontraind ications
Ġfu tility
Ġbab o
ĠCAF s
Ġrevision s
Ġprecip itated
ĠControl s
continu ous
Gas tric
tre osulfan
Ġintrav entricular
Ġmyelod y
ĠhE SCs
ĠWD TC
ker atosis
Ġdesm oplastic
Ġmyelomon oblastic
Ġsupra clav
Ġblastocy st
Ġdyscr asias
ĠFed eral
Ġinconsist encies
Ġdesc ending
Ġoblig atory
ÃŃ a
opap ular
Ġfun goides
Ġfabric ated
Ġspectac ular
phys ician
Ġpreponder ance
Now adays
Ġou abain
Ġord inary
ĠWy eth
Ġsympat hetic
Ġacal abrutinib
alal ay
Ġbitran sgenic
romeg aly
Ġsupraclav icular
4 137
5 461
6 16
6 86
9 15
9 02
A Q
A IF
D isseminated
E CP
F VIIa
H igher
I CI
K n
L PC
M er
M CC
M IF
M BL
N Y
P IF
S ecreted
S ternberg
T as
T IF
T UNEL
c p
d iac
d ifferentiating
d ifluor
e ph
l ambda
m eric
m orpholog
n ight
p el
p amine
p eptidase
s ues
ti gu
he pt
Ġc DC
Ġp O
Ġan ergy
al log
ent r
ar gramostim
Ġf aint
Ġ( %
Ġe osin
Ġto oth
ĠA CL
ra ce
ĠT XN
si g
ur posing
Ġpro s
ĠC am
us sion
ot olimod
et t
et tes
ter ase
ac ial
ac ridin
Ġex ant
se g
se x
Ġleukem oid
ĠI c
ĠM apping
op sies
Ġbe ating
Ġal together
rom al
ĠP RA
od eling
ĠH ar
ĠH LT
ĠH NC
ign a
Ġr ating
Ġr itonavir
Ġtran ylc
ĠB rain
ĠB rd
yp romine
ĠD o
ĠD as
ĠD iff
ĠIn vent
ĠF ront
ĠS l
ĠS cat
igh ter
Ġun set
Ġcyt ochalasin
Ġat rium
yl glycerol
ĠR at
Ġanti thrombotic
Ġ4 40
ĠG rafts
ĠG RP
ĠE very
ĠE PS
Ġpre formed
Ġ0 9
Ġpo verty
ĠL O
ĠL CGs
Ġinf rared
ĠTh anks
Ġrece ives
we ed
form yl
ĠK ong
ven ted
ĠU PN
av itoclax
og ic
+) ](
Ġam antadine
ath ion
ne xt
Ġsensi tively
HD MP
Ġ19 69
Ġnucle oporin
DH X
ger m
23 92
Ġdos imetry
vironment al
ĠJAK i
iod ine
opro l
Ġtransf ecting
Ġlig ases
hydro genase
Ġhyper trig
yb ut
98 3
Ġsil ibinin
Ġproduc ers
Ġintra medullary
pre leukemic
Ġsuff ers
Ġpoly unsaturated
ĠAS S
47 1
47 4
GS E
97 4
ĠQ RT
Ġste ep
PA H
nc RNA
ĠHDAC is
48 7
ĠZ f
HC ST
Ġneuro trophic
ĠMM oR
Ġdep icted
lab ile
co gnitive
ĠMK W
Ġpa res
ĠOr gan
ĠNO V
Ġprepar ing
ĠHSP G
ĠDe po
Ġhaem olytic
Ġfl ubendazole
Ġcompartment al
ĠTrans duction
ĠWhe re
MC S
for dii
Ġuns olved
Ġbacter i
SL N
Ġthi o
inter val
aro x
Ġdig it
lip osomal
ĠAg on
Ġarg ues
Ġposition ed
Ġcircum vented
sh RNAs
pred ictive
amb ogic
hyp ermethylated
Ep idemi
mm aya
Ġseg mented
Over all
ĠVAF s
insuff iciency
Ġconsolid ations
Ġcircumvent ing
ĠRho H
ĠBI X
Ġuro logical
Ġske w
tral ine
Drug s
ĠRetro viral
ĠEvent ually
Ġrecover ies
Ġsequel a
ĠPartic ular
leuc ine
ĠZR F
wor ds
lect omy
amid o
ĠEph B
Ġcapt uring
ĠWalden strom
Ġdeal t
ĠSch iff
ĠConf irm
lycer idemia
ĠSpl enomegaly
ĠTAL E
Ġmacrom olecules
Ġsac ral
ĠTSP O
Sor afenib
Ġspectrophot ometric
Ġgins eng
Ġmirr or
Ġrham nos
Ġcalor imetry
allyl amino
ĠStrept ococcus
Ġcholest atic
1155 4137
repe at
ĠMER TK
Ġdistor ted
hair pin
Ġpic omolar
Respon se
clear ing
ubiquit ination
ĠFoc using
âĤħ âĤĢ
Ġmacul opapular
profil er
Ġrech allenge
Ġprud ent
Ġtranylc ypromine
ĠInvent ory
Ġunset tled
Ġhypertrig lyceridemia
5 82
7 28
8 04
C x
C ure
C EBP
C OP
D PMNs
G OT
H MMR
I brutinib
K asumi
K TS
P AM
S AK
W o
c i
f uran
h ttp
l ated
p rior
p ersonalized
r atic
s afety
v ae
Ï ĥ
ti ocytic
on omy
Ġp orphyrin
Ġin appropriately
al ed
as partic
it roph
ed d
es tion
ic entric
le vant
Ġb ra
Ġe igh
os id
ĠT Î±
ĠT aspase
si zes
lo ading
ĠC el
ĠC ap
gen otoxic
Ġst ake
Ġmyelo blastoma
Ġl ists
ĠM AR
ĠAML profiler
Ġim etelstat
ol a
ĠP ir
ĠP BC
ĠH hex
ĠH BsAg
Ġv Ph
qu ate
yp ro
ri e
ri tion
ĠD VPX
ĠF lav
00 95
Ġun idirectional
Ġ3 88
Ġ3 47
pro MMP
ĠN EM
ĠN umb
Ġco hesion
yl lium
ĠR oman
ĠR BPs
ĠR enca
Ġ5 15
Ġ5 16
Ġ5 36
Ġanti folate
iz ome
de gra
de quate
Ġen ocitabine
Ġper ceptions
Ġmon omer
Ġ4 19
Ġ4 77
ĠG RA
tr ate
Ġimmun opro
Ġse a
Ġout lining
ĠL GFMS
Ġ6 39
and a
osi ted
ult y
ĠDNA m
ĠK indlin
Ġel astic
imen s
av ituximab
12 96
Ġsecond ly
atic s
Ġme val
oplas ma
ĠJ L
21 64
ne edle
ĠV X
33 1
56 42
ĠAT X
Ġphen formin
af e
Ġlar vae
Ġem esis
ark able
Ġend emic
25 82
Ġbas ement
ĠAn tic
Ġmit ozantrone
Ġprob abil
Ġindividual izing
Ġphosph otyrosine
Ġtr ithorax
ĠCh lor
Ġprote ogenomics
Ġcarcin omatosis
Ġir respectively
IR IS
Ġkey words
CP n
MS DT
ĠPD TC
Ġcirc PAN
70 82
ect omized
ĠEx c
Ġcer tif
ĠMR S
LI NC
Ġenti tled
Ġ35 2
Ġbest atin
Ġ45 9
inc tive
Ġpoly glutam
Ġlate x
Ġcardi opulmonary
ĠGroup e
Ġglyc oside
Ġ37 1
Ġ37 4
ĠIII A
eline xor
Az C
Ġautophag osome
immun oblastic
ĠMT A
ĠPre p
ĠPre parative
Ġatt rition
ĠAL X
Ġneuro toxic
Im Cs
Ġhepat ocarcinogenesis
Ġattrac ting
Ġsw abs
Ġhemoglobin opathies
IDH s
Ġendogenous ly
Ġconver ge
ĠCH F
>. <
ĠEn richment
ĠRAR G
Ġpersonal ised
Ġax es
ĠBi k
Ġmen str
Ġuns us
OD E
Ġexc ised
Ġimmunomod ulators
DM APE
PT LD
ĠPKC Îµ
VEGF A
ĠNCT U
Ġbelie f
Ġrad on
oxid ation
ĠSp i
Pro lifer
Ġimmunop ositive
Ġbar coding
Ġgran ulation
My ocet
Ġaccess ed
ĠBe ing
Ġuncon ditional
Ġneutral izes
Ġconn ections
inform ative
anth in
Ġquin idine
ĠInf lammatory
hydrox yphenyl
hom oharringtonine
Com p
Ġdil ated
Ġirre levant
oplatin um
203 2582
Ġvisual ize
Hemat ological
Ġhyd rop
ired oxin
echan ical
ĠEpidemi ologic
Ġcy CD
ĠRap tor
104 5642
Ġnorm o
Ġstrept avidin
Fox O
Ġoper ates
Ġsolub il
Adv anced
Ġhind rance
Ġphosphoryl ations
Chem oresistance
Ġnephro toxic
ĠKary otypes
Ġvag ina
perm e
Ġcorrobor ate
Ġgangli oside
Ġtrip tonide
Ġclo retazine
ĠSOS T
ĠIKK Î²
caus ed
Ġdic entric
Ġcaps ule
Ġpestic ide
Ġdamp ened
hydraz ine
Ġhippocamp al
Ġhomod imer
APA AP
Ġtha wed
ishman ia
Ġbypas sing
ĠGo ogle
ãĢ Ģ
DOT A
Sal vage
Ġsubm andibular
ĠPep E
Ġconce iv
Ġswe ats
Ġwil fordii
ĠDist inctive
lat ency
Ġdios metin
ĠHen an
Ġstation ary
Ġcobal t
leth ally
idian in
Ġbenefici aries
androl one
Tas igna
Ġprobabil istic
0 78
5 41
6 000
8 10
8 20
? )
B SO
C SP
E LA
H omeobox
I l
I NF
O RD
P CI
S ER
S OC
S MNs
c ount
d iv
d ronate
d ideoxy
f an
i os
n ol
p ol
t raining
Ġa ort
Ġt ib
re activated
on ary
on amide
he ckpoint
Ġc ations
Ġc ance
Ġp us
Ġp DCL
Ġm ll
al t
ro t
it ative
ic idin
at ology
Ġ( .
os al
Ġh inge
im aging
lo dipine
un ivariate
ter ile
ĠI PL
ĠI RM
ran ging
Ġg ar
Ġal ert
ĠP las
ĠP urpose
ĠH CR
ĠH BC
ir on
Ġtran spl
Ġcomp action
ĠB er
ĠB ournemouth
am ides
ĠD MT
00 36
ĠS qu
pro duct
Ġap hereses
Ġco ating
Ġanti CD
itor ies
tem ia
Ġ4 23
Ġ4 45
ĠG v
ĠE SC
Ġinv ade
Ġinv aded
Ġ0 5
ormal dehyde
ore ceptor
ox al
ĠL NK
ĠTh om
Ġpres erves
ĠCML s
Ġro sc
ard ed
ĠK R
ĠK YN
Ġcharacter izations
11 15
ABL O
ath rin
fer ing
Ġep ist
Ġperform ances
Ġser traline
ĠV STM
Ġpos ed
Ġpost therapy
Ġprof icient
Ġnucle osomes
ep am
cute ll
lic ting
In trat
ĠAn not
dom inal
Ġinflu ential
Ġgra y
ĠSt op
Ġrep os
IR ES
ĠRes ult
Ġeng agers
Ġu GRS
Ġtoxic ology
Ġhyper activity
ĠIM I
ĠEx cess
ĠEx isting
cyt ochemical
28 91
Ġgl ia
99 4
Ġintra individual
Ġ37 3
Ġarabin ose
Ġarabin ofuranosyl
49 45
ĠPR Os
RAS SF
ĠPre v
87 4
ĠBA VC
Ġdri ed
ĠNB s
ĠIR IS
rin ary
Ġevid ently
ĠNO AC
ĠSy rian
ĠSub optimal
Ġepid id
ĠGene Chip
ĠCH MFL
ĠOther s
ĠTrans genic
Ġten der
Ġuns atis
Ġavo ids
Ġrh EPO
Ad ministration
ofuran oside
SM s
ang le
Da wley
rd heim
Ġphag ocyte
Ġfil tering
ĠSup port
âĤ ģ
truct urally
Ġpseud okinase
ĠLeukaemia Net
ĠFLA NG
ĠPres ented
ĠAu NPs
DI ABLO
ĠMan ipulation
Ġexport in
Ġperm is
LS K
Ġdermat ological
CSFR IV
Ġvi ol
Ġperson nel
Ġmeeting s
ĠMedic aid
Ġdn AML
Met astatic
BET i
Ġadren ocortical
ĠTOP K
rit ten
dia mm
usp atercept
Ġlob ular
Ġnur se
Ġheterochrom atic
Ġneigh bor
Ġpath s
Ġanion ic
Ġperf used
ĠVer a
GAP DH
Ġaglyc ones
riend ly
Ġenum erate
hydrop y
Ġhematog one
electro por
Ġinput s
posi tes
Ġrig osertib
umer ical
Ġautore active
ĠBel gium
ĠDic er
Ġpathomechanis ms
Ġtriglycer ide
Ġentrap ment
Ġbiocom patibility
intercal ating
ĠCt IP
Ġcarbapenem s
Ġresur gence
trifluoro acetyl
ĠIVI g
Ġexpendit ures
Ġtetras omy
Ġroten one
prof icient
Ġamphi philic
Ġhyph ae
onos etron
opeptid ases
Ġatyp ia
Ġuve itis
Ġrosc ovitine
ĠAnnot ation
) Â·
0 77
0 92
3 19
4 70
4 32
5 97
6 60
7 35
7 90
8 15
A KI
B IRC
C or
C EP
C EBPÎ±
D isc
D EK
G rowing
H aem
K m
L PL
L OX
M edian
P a
P atient
U MIN
W R
c ALL
c ardiac
c occus
h im
j p
p b
s ymptom
y sis
Ġa k
Ġa rom
Ġw atch
Ġm LDAC
Ġm APCs
Ġthe ta
ro ute
it ain
Ġand rographolide
Ġd GTP
ul ting
Ġh um
ĠA SCs
ec e
ĠT ag
ĠT BC
ĠT OM
ĠT OB
si ella
ML P
ĠC rem
ĠC renolanib
ĠC ETLAM
gen er
et o
ter ation
ac ral
ĠM BC
ĠM ZH
ĠM aterials
op lan
Ġg rand
Ġal dehydes
ĠP LL
ĠH BL
Ġr icin
ĠB enef
ĠB ORIS
am ents
Ġsur fact
ĠD PB
ĠD kk
ĠF S
00 65
ĠS CP
ub ritinib
th ix
ph aly
Ġ3 35
pro thix
ĠN u
ĠN AE
ĠR V
Ġ5 21
Ġ5 05
Ġ5 50
ess or
Ġrem edi
Ġgen u
ĠG AGE
ĠE Î¼
tr is
Ġinv ited
Ġse eded
ide psin
ox etine
ĠL K
ĠL ef
ip ar
Ġnon tumorigenic
Ġpl ated
Ġpl um
ĠK leb
Ġra ft
li omas
Ġprov ince
cent ric
Ġme flo
loc us
Ġam id
ath ic
ath ies
Ġ. </
osph amide
Ġ[ -
19 84
19 93
Ġhetero zygote
Ġend ophthalmitis
sequ ence
ĠML KL
trans genic
trans formation
trans locations
Ġonc ogenicity
AR DS
ens ter
In iti
ĠAn tisense
Ġloc oregional
Ġsaf role
BM Cs
ĠWh atever
Ġpur ge
ĠRec ruitment
CA SP
ĠUn ique
ĠST OP
phosph onate
gan ese
ĠPD C
oh aem
AM ML
Ġsp here
28 2
Ġprac inostat
Ġ36 4
EB L
comp rom
Ġhydro quinone
Ġpoly ps
Ġlocal izations
ĠCyt okines
Ġprevent able
CB A
ĠPR CA
ĠPR ED
Ġdeep en
77 21
Ġoxid ant
Ġdiv ides
Ġ67 6
Ġdep osited
rosc opically
Ġadap hostin
UT X
Ġincom patible
ĠÎ± KG
methyl ating
ĠSM I
ĠCombin atorial
ĠHSP A
Ġfibro blastic
SG I
Ġmis localization
ĠCTL p
Ġencoura ges
Ġbis ulphite
omod ulatory
Ġchlor prothix
Ġoverl aps
Ġimmunotherapeutic s
chlor ophenyl
ĠSp earman
ĠSD FA
ĠGr MDSC
ĠCG RP
glut athione
Ġthro at
Ġexpect ancies
anger in
Ġaggreg ated
Ġmil der
ĠInt ensified
ĠMA O
ĠAF F
Ġhierarch ies
chrom atic
ĠSpec tral
MAPK BP
ĠFC MRD
ĠSN ORD
ĠMi HAs
eng zhou
Ġpseud odip
deoxy adenosine
ĠTME M
0005 587
Ġestrogen s
Ġgalectin s
Ġpurs uit
ĠBL U
omorpholog ical
ĠNE IL
Ġapprec iably
Ġweigh ing
ĠBr itain
Tr x
Ġpent raxin
Bi o
ket one
Ġpericardi um
combin ations
Ġpip elines
ĠAustr ia
circ ulating
Ġwa vel
Ġaza C
integr ins
ĠTC NAs
ĠDef in
ĠOK M
Ġcrystal log
Pl k
Ġfu el
ĠDex a
patho logic
ĠReduc ing
âħ ¡
Ġhamper ing
ĠBrdU rd
Ġanthrac yl
ĠBest atin
ĠTechn ical
ĠAuto immune
Ġcoordin ately
Ġses sions
Ġdimen sions
Ins ulin
glucuron idase
tun ing
pharmac odynamic
Ġsuppl ant
Ġchor oidal
Ġber yllium
transp orter
ĠRan GAP
Ġsymmet ric
carcin oma
Ġpartition ing
ĠEW SR
ĠTrip terygium
Ġmethylene tetrahydrofolate
Ġphenocop ied
Ġunmas ked
Ġsubcon junctiv
Ġmononucle ated
Ġtolu idine
ï¬ ģ
Ġantimon y
1870 84
ĠZh engzhou
ĠMAS Q
Ġsand wich
Ġmelars oprol
Ġeigh th
ĠKleb siella
Ġmeflo quine
Ġchlorprothix ene
0005587 4
0 96
0 64
5 11
5 26
8 36
8 96
9 53
B id
C UR
C yclophosphamide
E SC
F G
F MK
G fi
L i
L o
L PA
M IP
O wing
R ed
S AM
b irth
c ured
c armustine
d ated
f oli
g P
i KIR
k en
m elo
t wenty
u its
y an
z ens
Ã ±
Ã ´
Ġt agged
en afil
Ġc otrans
Ġc lotting
Ġm aternally
an asal
Ġre quisite
ing ol
Ġh olistic
Ġn if
Ġn arr
ĠT andem
Ġle iomy
ĠC FSE
Ġex tingu
Ġl urbinectedin
op eration
op sied
Ġg arn
ĠP u
ĠP lan
ĠH ap
ĠH EV
Ġdis odium
gn e
ĠB ody
ĠB enzene
ĠB udd
ĠD MPS
ĠF V
ĠF OL
00 75
00 152
ĠS IM
ph asis
Ġ3 95
ĠN AG
ĠR FA
ĠO phthal
olog ia
Ġanaly zer
di al
Ġper ior
Ġgen us
ĠG CSF
ĠG PCRs
CR ISPR
Ġsub lethally
Ġout ward
DS PE
Ġcomple ments
Ġstem line
Ġdec oy
ast inal
Ġnormal isation
Ġop ioid
IT T
Ġlong term
oph ospho
ĠJ PLSG
Ġinte ll
Ġassess es
CL O
ĠV i
ĠV UD
ĠV imentin
az ide
az oline
ex c
95 4
are r
Ġsm ad
CI S
Ġmy b
centr ations
ace ae
Ġ30 4
ĠRNA seq
Ġprob and
ĠBM B
ĠIm mature
26 71
air y
rem odeling
Ġrep olarization
Ġimm ense
Ġconclud es
29 2
Ġhyper ferritinemia
44 2
cyt o
Ġhom ocysteine
ĠCl adribine
CM MoL
Ġfree zing
Ġ48 1
ĠER alpha
ole amine
Ġexcl usivity
ĠCyt openias
PB D
amin ophen
Ġtyp ified
ĠME N
68 5
77 29
Ġhal ted
Ġquanti fiable
pos itron
Ġlat ently
Ġmast oid
Ġful vestrant
Ġdiss oci
SD IE
Ġacet onitrile
Rec e
An emia
orrh age
IN S
ĠHemat olog
Ġincub ating
EG IL
protein s
ĠAr tificial
ĠMV A
ĠPU FA
idne y
Ġalkyl ators
four th
PT X
Ar f
Ġfamil iarity
Ġsmok ed
ĠCA RD
ĠLC S
ĠSur gery
ĠHyp omethylation
ĠSer b
Ġarg ued
nucle oside
Ġmach ines
ĠLA IR
umb ia
Ġoccup ation
ĠSh b
mt DNA
Ġquin azolin
ĠTT T
ĠBE CN
ĠAss uming
Ġfibrin olytic
ĠFlu Bu
Ġstrength ening
Ġcav a
pan obinostat
Ġhyd ration
Trans forming
Ġdisappointing ly
cor relation
Ne gative
Ġprerequis ites
KD EL
fe eding
ĠRever sible
elec tric
Ġattack s
He tero
Ġeukary otes
Ġnarrow ing
Ġmigr ating
Ġoncom ir
analy tical
Cr kl
Ġechocardi ogram
Sm ad
iol os
Ġblack s
RL s
Ġbud s
Ġgalact ose
blind ed
Mit oxantrone
Ġfuc oidan
Diagnos tic
Ġfron tal
Ġcaps ules
Ġprohib itive
Ġfluctu ations
ĠTumour s
Ġisob ologram
ĠFX III
Ġber berine
bacter ia
Ġduplic ated
opyran osyl
Ġgast ritis
Ġfruit ful
Ġgels olin
Ġtent h
Ġcran iospinal
ãĢ ģ
oflav in
Ġhomogen ates
aberr ant
anesulf onate
Ġrhin osin
Ġvolunt arily
Ġperiodon tal
Ġrhyth m
lac tide
Ġvitreoretin opathy
embran ous
dos age
Ġinacces sible
ĠRhe b
ĠLuc ena
ĠDie go
yco erythrin
Ġstake hol
electropor ated
oplan in
melo xif
Ġnarr ative
Ġgarn ered
' )-
5 16
5 44
5 85
5 153
6 21
A v
A cl
A MD
B inding
C AP
G ES
I IC
I RAK
J urkat
P res
P PA
R MS
R gamma
S fpi
T AP
T dt
V elc
a iss
a ided
a emias
b osutinib
d ynamic
f us
i ter
i ans
i olar
m aturation
o encephalitis
r is
t ositumomab
£ o
Ã £o
Ġ ubenimex
Ġo mission
Ġp T
Ġin acc
Ġs aturated
Ġthe ories
Ġthe ranos
an ford
as ting
es ters
Ġre approval
Ġb id
Ġb rachial
id ases
Ġe up
os umab
ul us
Ġth r
ec tor
Ġn arc
Ġn estin
ĠT X
ur ity
ĠC yp
ĠC MP
ut y
et tering
et ocin
ib b
ĠM est
op ine
op sis
iv ial
ĠP c
ĠP am
ĠP SP
ĠH AML
gn ogenic
Ġcomp iled
ĠB an
ĠB CC
qu er
ĠD iffuse
00 62
00 662
ĠS b
ĠS HG
ĠS tructure
ĠS cutell
Ġass ure
Ġ3 38
ow ard
AML AA
pro BNP
ĠN X
ĠN ec
yl line
yl amino
Ġ5 49
Ġ5 43
com ponent
ĠO zogamicin
de pr
Ġab road
Ġgen omically
ĠG CT
ĠG reat
ĠE duc
ĠE co
Ġactiv ations
Ġsub therapeutic
ore al
ĠL MR
pho retic
Ġrec alc
Ġlow ers
Ġsup ers
Ġcons ervation
Ġ8 16
ĠK PC
Ġinduction s
ogen s
ill aries
ined ichlor
dysp lastic
12 47
Ġreview ers
pt otic
Ġphen olic
19 88
Ġnucle osomal
Ġhetero cyclic
Ġmy ocyte
AL S
05 17
emb rol
pon ectin
Ġmyel osarcoma
ĠCom plications
ind bis
Ġprot otypic
ĠAd d
ĠAd olescents
30 7
air s
MA RA
ĠSt anford
of ection
ĠST MN
45 2
45 8
Ġins ured
ĠCon tro
ĠCon focal
ĠIFN alpha
ĠX pert
Ch lor
oprotein s
98 1
Ġsil ences
Ġ35 5
ĠHe at
Ġmean time
Ġ38 9
Ġlocal ised
Ġj umping
ĠQ ue
ĠME S
ĠY NK
ĠGS D
Ġneuro blastomas
ĠAN L
rh GM
ĠHOX D
ĠGST O
CG CG
Ġvin orelbine
74 39
enz yl
ĠAP N
bi phenotypic
ĠRel ated
ĠReg istries
ospor on
EG CG
Ġphysi opathology
Cyt okines
ĠFas cin
Ġabsolute ly
MK s
Ġturn s
Ġleuc oreduction
ĠOR F
ĠChildren s
Ġengine er
ĠMon o
ext ra
Ġren aiss
ĠBP Cs
ocal c
ĠEm phasis
Ġibr itumomab
ĠInd ications
ĠRem o
ĠPS B
Ġmyc ological
ĠCREB BP
ĠLT A
ĠQuan tit
Ġintercal ates
sur gical
Ġcoinc ides
ĠAI RAP
ĠProtein s
HU VECs
CS s
ĠLympho cytic
Ġneurop syc
Ġens ures
acc um
Ġdimethyl sulfoxide
Ġsa id
car rying
Ã© zary
Ġconven ed
Ġnorm oxia
ĠEff lux
ĠPat A
Ġpyr vinium
ĠDisc ov
trial register
ĠscFv CD
ĠAntigen s
enog rafts
cont act
ĠMeas urable
break ing
Ġgynec ological
Ġpitf all
multiple x
ĠExp erience
Ġdiscern ible
Ġprep ubertal
ĠPrim itive
ĠMalay sia
Ġaver aged
eni us
Ġcave ats
1800 872
Ġrequ est
Ġrequ ested
Ġtropho blast
Ġrevis ited
Ġstri ve
ĠColon ies
Ġtriglycer ides
Ġpiper acillin
ĠSap acitabine
ĠSplic e
ĠLOX L
ĠCRA E
Ġinstill ation
Ġfasc i
ĠSlo an
Ġpromisc uous
ĠTrk A
Ġtransversion s
bb ing
Ġcolloid al
Ġscram bled
ĠSpect ra
oneph ritis
Ġpalin dromic
Fluoro uracil
itoc ine
ĠPyro sequencing
SAK K
Ġmeval onate
comprom ised
Ġsubconjunctiv al
Ġperior bital
ĠHAML ET
embrol izumab
Ġrenaiss ance
0 73
5 05
7 87
8 41
9 19
9 04
B v
C hester
G As
M CM
M arrow
M embers
N LR
P c
P ub
P seud
Q uan
V NTR
X S
c K
d ox
d ichlor
f el
f ly
h a
j ournals
m echanis
m oid
m RUNX
m imic
n ested
p LSC
p ulmonary
Ġt k
Ġc d
Ġc alling
Ġc adherin
Ġin spection
Ġs en
Ġs IgM
Ġs argramostim
Ġm t
or pho
is olated
it ted
ent an
ar aldehyde
Ġf alls
at ley
om ally
Ġh oc
ve y
ĠA GR
Ġn ations
ĠT able
lo tho
if era
Ġleuk osis
se ous
Ġcon tigu
ĠM ix
ĠM NP
ĠM esenchymal
op ress
op iper
Ġde generative
od ia
ical c
ĠH ong
ĠH SD
ĠH Gs
Ġdis comfort
ĠB ank
ap ritinib
Ġare na
Ġad ef
ĠF at
ĠF SC
00 67
00 68
ĠS G
ĠS Cs
ĠS IA
ĠS phK
ĠS indbis
ĠW ill
ĠO ff
ĠO mmaya
âĢ ¦
di ox
Ġchem oprotective
Ġmon ochemotherapy
pl er
cl uded
ĠG a
ĠG DC
ĠG RAF
ox amine
ĠL intuzumab
ip ated
ad vert
01 84
Ġprognostic ated
oth ia
Ġdec l
Ġdec arbox
Ġprom etastatic
Ġpar asitic
Ġpar anasal
Ġmul tiv
Ġel eg
ĠU ND
reg ulations
CT G
RA PL
Ġsec ured
ucle us
Ġqu alities
ĠJ UN
Ġvit amins
Ġaut oradi
Ġep im
CL IN
ĠV HL
ĠV inca
ĠV accination
ĠV DAs
Ġ19 40
ĠAl kylating
Ġran ks
plic able
Ġnucle olin
Ġmy of
Ġav apritinib
ĠBM X
ok inetics
AP P
18 008
Ġ100 3
ĠLeuk ocytosis
activ ates
CA F
Ġshort ens
CP NE
II B
Ġaltern ation
ĠCT ORC
90 6
Ġhel ical
ĠX III
Ġ29 4
Ġ35 7
Ġlink ers
Ġsym posium
Ġintegr ations
orpor ating
Ġbiop sied
Ġsal inomycin
Ġangi opoietins
ĠABC A
ĠÎ² catenin
Ġauto SCT
Ġcord ycepin
ĠAN T
Ġfrag mented
Ġemplo ys
ĠAb dominal
Ġoste osclerosis
IFN alpha
Ġz ones
ĠAP cK
Ġconver gence
Ġsep tal
ĠHSP Gs
ĠCH IT
Ġbleeding s
Ġmis folded
ĠAR HG
ĠDL D
ĠGen otype
ĠGen istein
Pro grammed
ĠSur gical
lip ase
My Ag
TL s
Ġinclusion s
Ġremod eled
olin ium
NB Cs
Micro array
thi otepa
ĠPub lic
SV T
chem okine
Ġtail s
ĠInstitute s
len ograstim
aryn g
Ġsubs id
Ġinoc ulum
hom ozygous
erb B
Com mon
ĠMajor ity
ĠTN M
inv asion
ĠMan tel
Inc idence
UL BP
ĠSel ecting
ĠUV B
Ġjunction al
TF s
Ġeduc ational
benz o
benz oyl
Ġreinfor cement
fe brile
Ġrelie ves
Ġroot s
CO VID
phospho hydrolase
Ġtremend ously
Ġchemoradi ation
LN s
myel osis
ĠDef ects
ĠJoh ns
Ġsensor y
Ġcontras ts
Ġdiame ters
Ġinterview ed
Ġgrouping s
ĠCAF C
Ġmoment um
Ġgall ium
ĠmL ST
Ġmeningi omas
Ġpren ylation
Ġleg s
207 2671
Ġhorizon tal
Ġfuc osylated
Ġappra ise
ĠTiss ues
CTN NB
Ġexempl ify
irt uin
Ġcomplain t
Ġcarboxy fluorescein
Ġses qui
Ġazu rophil
SU MO
Ġecto enzyme
Ġgraph ene
Ġcanal icular
Ġprescrib e
Germ line
Ġderang ements
clus ter
ĠSouthe astern
Ġpol lu
ĠFP GS
deriv ative
Ġsuccin imidyl
ammon ium
ĠMÏ ķ
Ġtria d
Ġcongen ita
Ġdeubiquitin ating
ĠFin nish
ĠJAR ID
ĠClostrid ioides
Ġconsor tium
Ġlangu age
Ġgonadotrop in
Ġdecalc ified
oplex es
Ġcrosso ver
Ġmicroangi opathy
Ġarom atase
ohaem agglutinin
Quan titative
opress in
Ġadef ovir
0184 24
18008 96
% ãĢģ
3 13
6 88
A xl
C u
E CT
E fficacy
F IP
G PL
G LI
H EK
K Î³
N OG
O HP
S PMs
S HAI
T W
U s
W D
a rest
a acr
b R
f atin
h aem
h sr
i C
i NKT
j pg
l er
m uscle
m IFNÎ²
o ul
o osperm
s ant
u ros
v elled
Ï Ī
Ġ erg
Ġ Îµ
Ġ ellipticine
in eligible
Ġt ied
Ġt ung
ti amine
en gth
te ur
Ġin timately
Ġm MDSC
Ġm Dia
al es
or r
is atellite
an hydro
Ġd izz
ic ting
Ġre si
Ġf s
Ġf alling
Ġf illed
ul ae
Ġh CD
Ġth w
ĠT rough
ĠT SS
ĠT aked
ĠT IPS
si RNAs
ĠC AP
ĠC ultured
ĠC max
us ually
ĠI AG
ĠM atched
il iation
oc ho
Ġde partments
Ġg ag
Ġg eared
ĠP OS
ĠH ung
ĠB os
ĠB evacizumab
ri te
ri ers
ĠD er
ĠD AL
ĠD DA
ĠD VT
ĠD acogen
ĠF rail
00 70
00 46
Ġun ified
Ġun antic
ĠR ow
ĠR earrangement
Ġ4 88
Ġ4 65
ĠG RB
ĠE AS
ĠE verolimus
Ġph i
Ġtumor ous
Ġint ox
ĠTh alidomide
ad al
Ġcons umed
opt ysis
Ġpar ti
Ġnon selective
Ġ8 35
Ġlympho depletion
Ġinter change
crip ts
Ġwhe at
MT A
Ġmi PD
12 71
IT IM
Ġsh all
ĠV osaroxin
ĠV idaza
Ġiniti ators
Ġstandard isation
ke weed
Ġmin isatellite
56 3
Ġend oscopy
Ġcompar ator
38 1
Ġdo zens
Ġselec ts
ĠAn agrelide
Ġ16 40
ĠBM s
18 01
Ġphosph atid
ves trol
Ġcap illaries
Ġmethyl ations
27 97
Ġsum oylation
45 4
Ġweek end
ĠBCL XL
Ġtumour igen
Ġwork ed
36 18
ĠIM GN
HO VON
44 7
app earance
Ġadj unc
Ġpan myelosis
inf rared
Ġ45 8
comp uted
ĠER RF
Ġj anus
Ġ34 1
Ġ37 7
Ġangi oplasty
Ġangi oregulatory
Ġdegra des
003 19
Ġauto BMT
ĠDec ision
Ġaden ylate
ĠFour ier
ĠAb rogation
ĠCY A
ĠCY BA
Ġvar ieties
ĠID OL
eth nic
initi ate
ĠEL ISPOT
ĠCB X
ĠRAR Î³
Ġthym ine
ĠWhe atley
non HSCT
ĠCK MT
Ġunex posed
Ġtop ology
can res
lip ids
Ġuncon tro
Ig A
ĠHist opathologic
ortal ized
Ġtransduc es
MCL s
hern obyl
ĠSC Cs
ĠAss ays
ĠSep sis
sur ance
Ġfeed ers
Ġdip eptidyl
Com par
ĠEnd points
ĠDIC ER
Ġmand ate
Ġbreakthrough s
Ġhyd ralazine
ĠSyn ergy
son ized
Ġmitig ating
UL K
Ġveno occlusive
ĠChem otherapeutic
ĠChem okine
Ġfulf il
Ġpent amidine
ĠBRAF i
stud ies
ĠMI XL
Ã¼ pp
Ġdeterior ating
ĠPN ET
Ġterti les
Ġec osystem
ĠZF P
Ġvacu olization
ĠMet aphase
Ġflan ked
Hep atic
Ġsynchron ized
cytogenetic s
secre tase
Ġperi operative
Ġbre ad
ĠXPC rs
Ġanch oring
ĠRIT A
Ġaggra vate
Ġlipoprotein s
Ġorchestr ate
Ġâħ ł
ĠCri tical
Ġconve ys
ĠHom ozygous
Ġeryth rom
ĠPt ch
oflu or
ĠTre osulfan
neutrophil s
Ġpolyphen olic
Ġpolys accharides
ĠOx idative
Mac rophages
Mu enster
Ġspermat ogenesis
Ġagglut inin
Ġrom idepsin
ĠSMAR CB
fo ot
fo tiamine
ĠDE AD
ĠDrr B
ocarb amate
ĠSPR Y
Ġoval bumin
Ġblastocy sts
Ġpin point
ĠTrip tolide
Ġgins en
Ġpix el
Ġsurround ed
Ġobvi ate
RH EBL
Ġaracyt ine
endi x
ĠGHR H
Ġfascin ating
Ġexplicit ly
Ġperit umoral
ĠMach ine
tilb ene
lofen ac
ĠCSI SCN
transpor ters
Ġzygo tes
Ġmyelody spl
aacr journals
Ġdizz iness
ĠTaked a
Ġunantic ipated
Ġadjunc ts
Ã¼pp el
3 21
4 39
5 10
6 11
6 53
6 22
6 67
7 50
7 98
8 11
A LA
B ar
B DH
B IM
B leeding
B UCY
D oxorubicin
D iffuse
E ph
F ive
G CSF
G EF
N ov
O Cs
Y S
a OR
d x
f amilial
h CD
n etwork
n mol
o epid
s odium
s uccess
t ag
t ured
î ĭ
re ferred
Ġo sm
Ġp DLI
Ġin jectable
Ġs ore
Ġs ave
Ġw ood
Ġm ith
al low
an one
as ive
Ġd ox
es c
Ġre ass
Ġre treated
Ġre assessment
Ġf eces
os ensitivity
Ġh MRP
Ġth igh
ec lamp
ra den
ĠT on
im p
res enius
ia betes
Ġpro xy
Ġpro erythroblasts
ĠC PD
ĠC AN
Ġst yryl
Ġmyelo cyte
Ġmyelo pathy
ĠM etabol
rom etry
ĠP MRD
ĠH EX
Ġr ice
Ġr utin
ĠD Ã¼
ĠF ast
ĠF amily
ĠS tim
ĠS MS
ĠW W
Ġun rem
Ġun separated
Ġat las
ph armacy
Ġap o
ĠN ag
Ġco herent
ĠR AB
ĠR GS
SC D
Ġrem n
Ġen ergetic
Ġtrans differentiation
ĠE DS
lec alc
Ġno reth
Ġ6 38
Ġind irubin
Ġro tation
01 34
ort mann
Ġbi ore
Ġbi oconjugates
Ġpred e
Ġnormal ize
mon ocytoid
ĠK ML
ĠK inetic
ag ger
ĠU RE
11 30
Ġhyp oglyc
og el
Ġsc RNA
Ġconf used
15 00
Ġqu ery
fer ring
Ġsh unt
ĠV GS
omet rial
Ġext ents
AC B
Ġdi terpene
ĠAl pha
14 87
56 9
ax x
Ġless en
Ġapp endix
Ġmor gan
trans cribed
lic ensed
Ġindividual ised
Ġloc ked
ĠCh r
Ġmetabol ize
MS Ds
aza uridine
Ġcirc uits
ĠX p
36 6
Ġhyper ammon
ĠMR CC
cyt ochrome
ĠCl ose
ĠHe ad
ĠCP G
57 8
Ġsal ts
Ġharb inger
Ġextra med
Ġpoly oma
opy on
Ġglyc an
Ġartic ular
Ġtra vel
ĠIII Î±
Ġ44 3
Ġ46 1
Ph en
ĠQ LQ
ov in
ĠFAB P
Ġmeg al
Ġcontext ual
48 1
Ġrepair ing
Ġneuro sphere
Ġbro ken
sign alling
Ġve ins
ĠAcc ess
ĠSim ulation
ĠInc rease
ĠSc hool
ĠAA A
An nexin
ĠRe ed
ibr utinib
cancer res
Ġput s
ĠDe pression
Ġmis leading
07 01
Ġvaccin ia
Ġslow s
ĠDA CT
Ġleuc ovorin
Ġlact one
TKD s
Ġinterven e
Ġpy ridine
My el
Ġcommun icate
Ġaid ing
vent ing
Ac tivated
quin imod
Ġneutral ize
ĠTw in
idin o
Ġmyc otic
ĠReal gar
Ġgeneric s
OK T
Ġdiet s
Ġmetallo prote
Myelo ablative
Ġabol ishes
hydrox ycho
Ġwors ens
Ġmicros atellites
hex a
Ġcompli ant
py rene
py rimidin
tempor al
ĠAG P
insuff icient
Ġden aturation
Ġpent ose
ĠMI B
ĠLip ofectamine
ĠDi verse
ĠChan ging
Ġendomet ri
Ġstres sing
Ġconven ience
ĠMet astasis
phospho choline
ofib rous
Hep atitis
Ġaggra v
Ġadapt ations
Ġinsign ificantly
Ġtun ing
isen ox
Ġshutt les
Ġelectropor ated
Ġla romustine
Ġreferen t
ĠHDA RAC
chol ines
Ġdeoxy adenosine
Ġglomerul onephritis
Ġhid raden
Ġarchitect ural
Ġhomod imeric
ĠMalign ancies
Ġchief ly
opyran oside
Ġrevis it
Ġcatar act
Ġpathomechanis m
ĠâĢ ĺ
Ġtranspos on
Ġselectin s
Ġfarm ers
Ġdiplo p
ĠDevelop ing
suscepti ble
Ġangio immunoblastic
Ġnanocom posites
ĠRestric tion
ĠNat l
Ġneglec ted
Ġpericy tes
Ġforese eable
ĠREN CA
Ġreimburs ement
Ġhexam ethylene
Ġaort a
Ġrecalc it
inedichlor oplatinum
orpho us
adal afil
lecalc iferol
Ġnoreth androlone
ortmann in
Ġmorgan a
+ +
3 10
5 45
7 56
7 69
8 50
8 237
A ctive
B im
C ohort
C bf
D Q
D DI
E E
L ac
M af
M ethyl
N RP
S pr
T re
T otal
V ery
e e
g em
i oma
j e
j u
k illing
m OR
m aternal
p imycin
r Gel
t x
t yping
u PA
w s
x i
z el
in ases
in activation
Ġc g
Ġp et
Ġp embrolizumab
Ġin oper
Ġm ech
Ġm cg
ati l
or dial
an ing
el ection
ic ase
ar rested
Ġf las
Ġf inely
at ching
Ġb atch
ing s
Ġh y
ĠA round
ĠT e
ĠT ween
ĠT Es
im ethyl
ĠC bl
ac hie
Ġst ran
uc in
ĠI BC
Ġcon duction
ĠM ir
ĠM AG
ine phrine
oc idin
Ġg ambogic
Ġal b
ĠH AGE
ĠH APLO
hem ic
ir idinyl
ĠB IIB
ĠF RA
ĠF ED
ĠF CGR
ĠS KIP
ĠS QSTM
ĠW ES
Ġun rel
pro to
ĠN MD
ĠN AMLAA
ĠR ps
Ġ5 32
Ġ5 66
Ġres ume
Ġanti diabetic
Ġmon om
Ġmon ocentric
Ġ4 34
cl adribine
ĠG NB
ĠG eriatric
ĠE cotropic
Ġsub pathway
ĠL CK
term inally
ari ans
tro sc
tin s
Ġpl ug
ĠK re
ĠK cl
ĠU P
ĠU PC
Ġar ranged
est ra
RA CE
RA NKL
Ġimp r
li ximab
12 09
ten otroph
IT L
Ġsh ielding
ĠV OR
ĠV olasertib
omet rically
ĠHere by
Ġdi terpenoid
leuk em
95 1
PL ys
19 86
DH FR
ĠML V
Ġwor d
ĠNK CAs
CSF RÎ±
Ġpediatric s
OR F
Ġtr b
04 44
ĠIm pact
Ġthromb opoietic
Ġplas mon
Ġprot ons
Ġbenefit ted
Ġpharmac ophore
Ġeng ulf
of acial
CP SS
cep ting
Ġins ult
con served
ĠTP T
000 99
Ġthem es
Ġvir ion
tis ation
88 5
andid a
ulf ate
ĠEx cellence
Th irteen
28 5
ĠCM s
eg inning
Ġ36 6
Ġhybrid ize
Ġpoly phosphate
Ġcardi oprotectant
Ġ38 1
Ġbreak ing
DC leu
ĠDC MP
Ġant agomiR
ĠME D
ĠIC O
rec ursor
Ġfraction al
ĠZ MY
Ġneuro cognitive
Ġnan oc
Ġnan od
glyc ophorin
79 3
EN D
ĠMN T
69 4
EM H
hemat ology
ode oxycytidine
lim ination
ĠCol lab
ĠCo administration
ĠGene Scan
Ġclar ity
Ġtur meric
ĠDS RT
ĠCB Y
Ġparallel s
ĠMPO g
Ġtrac ts
Ġax onal
arabin o
ĠCa M
Mut ational
Ġimmunop recipitated
DP P
Cy A
ĠTr pm
draw al
ĠHA IC
ĠPBSC H
Ġretic ular
ĠEP G
Ġdist ances
Ġdist amycin
Ġcardiomy ogenic
ĠMA X
ĠARA C
Ġpal e
ĠCor onary
ĠSU A
EBPÎ± p
MAPK s
otransplant ation
oll en
rox ylin
character ised
ĠBAL M
carb azole
eng ers
TT F
Ġmer idianin
Ġsubs ided
ĠEnd othelial
Ġexplan atory
Ġcollabor ates
ĠFR O
prote ome
Ġcompens ation
Ġsial osyl
Ġfluor ide
part um
Ġden otes
Un like
SH IP
ĠIntegr in
ĠPred icted
ĠFe LV
ĠPAR I
Ġendomet rium
Ġchel ate
Ġtam ibarotene
Ġfo amy
Inf lammation
ĠPH B
Ġdn mt
ĠZF X
vess el
ĠMer kel
Ġawa iting
Ġdomin ating
ĠKe ap
Ġsensor s
ĠRO IIC
Ġnom ograms
Chem otherapeutic
Ġcentros omes
azadC yd
Ġabst racted
Differen ces
Ġcir cles
Immunophen otypic
Ġclaim ed
Ġindustr ies
Ġverteb ra
ĠCEBP alpha
ĠDX SCNP
bur icase
Ġexec uted
ĠOcc urrence
Ġses sion
Ġmyelod isplastic
fuc osyltransferase
Ġsatis fying
ĠMu LV
plan ocin
Ġsed imentation
ĠAV N
Ġprem ise
Ġdyscr asia
OME N
Ġbiocom patible
(-/- ))
Glyc ogen
Ġasymmet ric
Ġbiotech nology
2120 91
ĠOV CAR
flav one
swit ch
ĠUni CAR
ĠTpo R
ĠVisual ization
Ġunle ash
Ġscin tigraphy
Ġenthal py
Retro spective
ĠDeg uelin
Ġweaken ed
Ġculpr it
Ġdissip ation
ĠMill ennium
ĠDop pler
ĠMAZ E
Bel gian
Ġdemyel inating
acridin ylamino
Ġrhamnos us
Ġconceiv able
7729 269
Rece ptor
ĠHematolog ÃŃa
Ġnarc otic
icalc itol
âĢ¦ )
Ġdecarbox ylation
Ġparti tioned
ĠHEX IM
Ġhidraden itis
Cbf b
Ġinoper able
Ġstran ds
tenotroph omonas
00099 10
% ].
5 70
5 84
6 98
7 18
8 43
= <
A oa
B low
B ad
B urkitt
C andida
D IP
D aunomycin
E SA
F ig
F DC
G DC
G enome
H X
H er
L BC
M AB
M OLM
N m
N ine
P ICC
R beta
S us
T ac
T op
W GS
Y B
a el
b ul
c T
c HL
f rail
h CB
i osis
m H
m id
m us
p eriod
r A
r g
Î ¨
Ġa kin
Ġa fl
in troduction
Ġt ors
ti te
Ġc f
Ġc anc
Ġc KIT
Ġc ediranib
Ġin ert
Ġin advert
Ġan k
an olic
as ibility
Ġd ies
er cept
ar it
ar get
Ġb esylate
Ġwith held
ĠA pt
ĠA NAE
ĠT ALL
im paired
ĠC yclo
ĠC hernobyl
Ġex agger
se rop
Ġst orm
ĠI AL
ĠI PF
ran olol
ĠM en
ĠM ab
il ag
Ġg on
Ġg lu
ĠP he
ĠH SM
duc tive
ff er
Ġinc lu
ĠB rown
am us
ĠS onic
ĠS Ã©zary
th ic
log ists
Ġmo tiv
Ġk cal
ĠR EDD
ess enger
Ġanti metastatic
Ġanti angiogenesis
Ġreg iment
Ġper itoneum
Ġ4 17
ĠG HA
ĠE dn
Ġpre targeted
Ġ0 199
Ġ0 295
Ġpo intes
Ġpo keweed
Ġ6 000
Ġdev ising
Ġ7 60
Ġsyn genic
Ġnew est
Ġbi weekly
ser tion
Ġpl umb
Ġstr ata
Ġinvestig ative
mon oblastic
Ġinter ior
ĠK L
ĠK up
ĠK yn
Ġel der
ag lyc
Ġar tif
CT ER
11 20
ch imeric
Ġacc ord
RA L
10 80
og raft
CD I
Ġmedian s
ric e
Ġcontr al
ĠMD CK
ĠV T
ĠV y
ĠCI MF
sor bed
ipher ing
ke y
yd oxorubicin
ater ally
trans duction
val idated
Ġgranul opoietic
AP AF
Ġthromb openia
ĠMP P
Ġara CTP
Ġprote oglycans
ĠAm ifostine
MA A
ĠSt romal
Ġmethyl ating
Ġtri phosphohydrolase
ĠAB STRACT
ram er
ram es
Ġlab our
ling s
Ġcandid emia
44 4
65 8
Ġsym b
Ġgl auc
ĠMS K
mit ochondrial
Ġcho lec
Ġhyperm utation
Ġsitu ated
Ġmacro autophagy
amin ergic
Ġintr al
Ġtoler ating
ĠME P
ĠCC GG
EL s
met hod
Ġlat rophilin
ĠImmun ologic
ĠStud ent
Ġlog rank
Ġminor ities
fac ilit
Ġbeh aved
Ġ(> /=
ĠAA I
IFN s
Ġevol utions
Ġback ward
Con f
ĠSub cutaneous
ĠHemat o
Ġgluc osylceramide
ĠDe tectable
Ġmis expression
Ġmis car
Ġcounter balance
ĠÎ¼ L
ĠCCR T
Ġtranslation ally
Ġnanop ore
MG DF
ĠGen der
Ġren ov
ocal in
Ġsensitiz ers
ps ycho
PK cs
isc um
ĠPl uronic
BD CA
ÎĶ Ct
ĠAllo genic
Ġperme able
Ġschem as
ĠLT CIC
ĠInf rastructure
Ġabol ish
struct ured
hydrox ylase
metabol ite
ĠIN DO
ĠDMR s
dem ographic
DT A
max imum
ĠRep urposing
Ġden ote
Ġdestr uctive
Ġarth ral
pur ic
ĠInhibitor y
transf used
ĠÎĶ Ct
Inf ection
Po lo
ĠRh iz
br ates
ĠPolym orphism
Ġlap a
leuc yl
LN Cs
Cell s
134 5
Ġcornerst ones
ĠAct ually
ĠPt PT
Ġinos itide
bur den
Ġcaps id
ĠFrequ encies
WB Cs
Ġdiscern ed
Four teen
ĠSepar ate
ĠSepar ating
ĠLV EF
Ġdiversi fied
Ġsuppl ied
Mod ern
hydraz one
ĠLDA raC
ifluor omethyl
AO Es
osom otropic
Ġduplic ate
Ġtropho blastic
ĠLeban ese
Ġtranspos able
ĠCle arly
Ġtyros inase
ĠFran Ã§
iber cept
ĠCereb rospinal
Ġvide o
Ġga uge
Ġradiograph s
Ġforec ast
ĠTransp ort
ĠPrednis olone
Ġanecd otal
Ġnanos ized
Ġpromon ocytic
ĠWeek ly
Ġquer ied
Ġpetech iae
Ġentrop y
Ġnavig ate
Ġmucoc utaneous
Ġepidid ym
Ġstakehol ders
serop ositive
6 30
6 40
6 99
6 46
7 60
> )-
B onferroni
C OR
C ord
C ampath
G GT
M ethod
M ammalian
P AF
S MC
V itamin
l ay
r Î³
s ol
s MDS
w arning
x S
Ġ ],
Ġt all
re v
re tt
Ġc urability
Ġan aphase
is ations
is ulind
el ected
el ective
as mon
it our
Ġf r
Ġf ire
Ġb rad
Ġb rown
Ġb avituximab
ul tivation
Ġth rice
ĠA CH
Ġn ail
Ġn edd
ĠT J
Ġpro stratin
Ġle ave
ĠC SE
Ġis omer
uc ci
Ġmyelo geneous
ran ulated
ĠM Z
ĠM BP
ĠM MTV
op en
il ateral
ine tically
ol on
Ġde phosphoryl
Ġg ad
Ġch itosan
ĠH RAS
Ġcomp ose
ĠB acterial
Ġsur pr
ĠD x
ĠD up
ĠD RD
ĠD AG
ĠD PN
ĠF E
ĠF EC
00 96
ĠS MMC
ub e
Ġun methylation
Ġcl itocine
Ġcyt od
Ġcyt arabin
Ġmo uld
ĠCD S
Ġ3 45
Ġ3 97
Ġus er
ĠN ig
ĠN omenclature
ĠR on
Ġ5 17
Ġ5 20
NA R
com plicated
Ġev ac
Ġev iction
ary ing
Ġnot hing
ron ged
Ġen ig
Ġtrans endothelial
Ġper iton
lym arin
Ġ4 22
Ġ4 14
Ġhem isp
Ġpre processing
ich ael
ĠL ac
ĠL ap
Ġinf irm
Ġ6 60
Ġ6 97
ad ox
str ate
sup pressed
Ġall icin
ator in
osi alin
Ġcor tic
yc el
ond in
ct n
Ġinter related
ĠK a
ĠK d
The se
11 68
ll ment
10 31
10 89
MT Z
CD X
12 84
Ġconf erences
loc i
ĠJ A
Ġmain stream
CL C
ĠV ia
ĠV irc
AC h
56 1
56 14
Ġpatho biological
19 85
ĠAs n
establ ish
MR FS
In v
ST IM
Ġinterac tors
Ġ100 58
omy osin
Ġpur in
Ġpur ify
35 80
of t
ening ioma
ER Î±
ĠAB W
ero cytosis
MS K
ĠPD PN
mic e
aza CdR
Ġhyper t
ĠPro c
Ġsp ond
75 8
Ġi terative
28 68
Ġhom otypic
bil iary
Ġfib res
ole ic
dex tran
68 1
Ġdr ink
Ġ% <
TD T
76 3
Ġdisrup tions
fac tory
Ġ49 4
gl it
Ġbroad ening
ĠAb lation
Ġcost al
Ġmaxim ise
ĠSM Is
Ġepid emic
ĠPT T
aps hot
icro bial
Ġintoler able
Ġfl at
Ġtrac ing
Ġplan ar
Ġspecial ists
Ġclassif ies
MB D
rent uximab
EF b
ĠOR Y
ĠCA MS
Ġpneumonia e
CE PBA
Ġtriple t
Ġdirection al
Ġconn ects
Ġpal onosetron
CTL p
Ġmultip ly
Ġpolar ize
Ġte en
ĠLe ptomeningeal
Ġflav one
Ġseg mentation
ĠPar vovirus
ĠLD LT
Ġpor tions
ĠIs ocitrate
Ġcyclo pamine
ĠExt ended
Ġpropag ating
PDGFR alpha
Ġregen erated
Bi phenotypic
ĠCr kl
BN ML
ĠIF Ds
ĠPPAR gamma
Ġdiscrep ant
haemat opoietic
neu ro
ĠProte omics
âĪ Ĵ
Ġster ic
Ġduplex es
encaps ulation
Ġrac es
ĠReceptor s
Ġclo dronate
break point
Ġoutper forming
ĠBMD C
Ġpeptid yl
ĠIns ulin
Ġrhabdomy olysis
Ġaneuploid ies
lymph atic
electro lyte
Ġdy st
Ġendoc rin
Ġdecom pression
ĠTri oxide
opatholog ically
ĠCbf beta
Ġstratif ies
Ġceram ides
win ia
Ġelectrocardi ogram
Transcription al
Consid erable
Cur ative
Ġleukemogen s
SIN E
ĠOl aparib
ĠGold man
ĠAsc iminib
Ġribo zyme
ĠLim itations
Ġpyraz olo
orp oreal
Ġcommens al
Muc ormycosis
Ġbs scFv
ĠTransl ational
Ġozog amycin
Ġpra vastatin
Bis pecific
orthe ast
Ġcha etocin
ĠmiRN ome
Kn owledge
Ġremedi al
Ġintell igence
eclamp sia
ĠKup ffer
Ġmiscar ria
Ġrenov ation
itour inary
Ġnedd ylation
Ġperiton itis
ĠVirc how
0 60
3 56
4 45
5 13
6 986
7 34
7 27
9 18
9 68
A HR
B high
H ost
H RD
H aemat
I diopathic
K V
L CN
M si
M IR
O dds
P AS
P elger
R em
S J
S n
S uccessful
T LC
W i
X pert
Y R
Z AP
[ (
a ff
b ectedin
f ile
f etal
f raction
f Luc
f inish
g ic
g amm
g rafted
i ram
k ada
m ay
m FISH
m emory
n or
n ow
n ous
p seud
p pm
t ures
z ole
Ġ 004
Ġa KIR
in we
en om
he cally
Ġc ast
Ġc ities
Ġp oli
Ġs ati
Ġs ICAM
ent h
ent anyl
Ġre targeting
at ous
Ġb ivariate
ing olimod
os pecific
ra isal
ĠT ypical
si tion
si tes
lo l
lo reth
Ġpro calcitonin
Ġle ader
ĠC aki
ot onic
ut hen
uk a
ter t
ter rane
ce ae
ac ridine
ant ar
Ġis oflav
ĠI Cs
rap arib
ĠM ad
ĠM ID
ol ating
Ġde activation
Ġg um
Ġg avage
Ġal coholic
ĠP ast
ĠP MS
ĠP GR
ĠP SL
ĠP recision
ĠH m
ĠB c
ĠB NP
anc ements
yp ropyl
ĠD ul
ĠD iamond
ĠD IMATE
ĠIn herited
ĠF u
00 006
ĠS MA
ĠW DR
Ġcl ub
Ġcl athrin
ph y
ĠN ic
ĠN IS
ĠN IMA
ĠR UX
Ġres umption
ĠO DE
edi ted
Ġmar ital
ost omy
Ġtrans c
Ġper ip
Ġmon ocyt
Ġ4 44
pl ied
ĠG CTs
tr unc
Ġinv ag
Ġinv ading
Ġhemat uria
DS G
Ġprognostic ating
Ġdec idual
Ġprom otor
pend ent
Ġnon mutant
Ġnon responder
Ġnon immunogenic
Ġnon covalent
Ġ8 68
Ġspec ulative
Ġel apsed
ĠU mbilical
ch ym
drom al
Ġprim ordial
our ney
Ġsc hol
Ġchromos omally
Ġam ended
ĠV ice
az ones
az epine
az aki
po inted
leuk ins
Ġlymph angiogenesis
Ġpost allogeneic
ĠALL G
19 80
MP A
)- (
set ron
establ ishment
MD AP
pon ential
50 4
Ġ24 00
Ġsaf ingol
atin s
ev olution
CC NA
Ġprote osome
ĠOn co
ĠDNMT I
sub types
Ġpharmac ogenomic
ĠRec ipient
Ġsubt ractive
ock ed
Ġtoxic ants
Ġinvolve ments
Ġtransf ers
Ġimmunosup pressor
osp ondin
Ġsynthe ses
ĠEx isulind
Ġet omoxir
Ġproduc er
Ġi at
Ġdys lipidemia
Ġcategor ised
ĠCP E
Ġche aper
Ġrest arting
67 2
47 8
ĠCyt omegalovirus
Ġj ourney
ĠCBF alpha
Ġtra umatic
amin opeptidase
Ġ37 8
Ġdoxorubicin ol
tric t
ĠPR F
ĠPR V
immun ized
Ġ39 2
Ġinternal izing
Ġcat alog
pos sible
Ġampl ifies
Im pact
Ġtransfer ases
Ġvascular ized
hemat opoiesis
fac ial
Ġextrac ranial
Ġ49 3
Ġdemethyl ate
mark eting
Ġdereg ulates
ES I
nis hes
Ġnor th
RUNX T
Ġacet aminophen
An xiety
ĠPK A
ĠPT GS
Ġmas quer
ĠMC V
CH M
Ġintrat hecally
ĠTR G
omod ulation
ED M
lt rombopag
ochrom atosis
Ġvis ually
educ ation
retin al
Ġcataly ses
Ġrevolution ised
arn estra
ĠSD MA
ĠPARP i
Ġmake up
Ġbenz yl
ĠMon otherapy
Mut ated
ĠInter im
ĠInter phase
ĠMe ier
ĠGC V
mism atch
Ġoccup y
Ġben fotiamine
ĠHist ologic
Ġintrac hromosomal
CV Es
ĠEM HP
anth racyclines
Ġthyroid itis
sil ent
ĠCO I
ĠSequ enom
Ġmetallo id
Ġaff iliated
carb oxyl
ĠMi RNAs
Ġecon omical
ĠArg onaute
omat ine
Ġanticip ating
Ġsero logically
Trans fusion
ĠPO LR
Ġcomput ationally
ĠEpidemi ol
Ġintrap atient
vin blastine
Ne utropenia
ĠHer pes
Ġabl ated
ĠMEF V
Ġdimethyl ars
Ġair space
yle th
fit ness
ĠHaemat opathology
Gal NAc
Ġchloro form
Ġelong ated
olo ur
death s
ĠTopo tecan
ĠCAM KIIÎ³
ĠDem onstr
ĠNCR s
Ġsmooth ened
abdom inal
ĠNP BC
ĠDAP I
Ġhypot onic
ĠHom olog
Ġhyperglyc aemia
ĠSTR ING
Ġhemangi omas
ĠFrequ ently
Ġgent leman
Ġje jun
ĠPathw ays
brevi ations
ĠTY MS
ocop herol
Ġrig ors
Ġfur nishes
Hydro xyurea
ĠhE SC
carbox amide
Ġtemp ting
ĠExpl oratory
Luc ena
ĠIMPL s
Ġcytofluor imetric
ĠGAL IG
ĠKY O
Ġentrap ped
ĠdNTP s
ĠFrag ment
ENEST nd
ĠEmb elin
ĠEntero coccus
ĠImmunob lot
797 7
Ġcaud a
radio active
ĠBS Is
ĠTor rent
Ġanhyd ride
Ġtack le
Ġliv in
AUR KA
ĠVirt ually
Ġbioen ergetics
Ġvign ettes
Ġlit term
Ġil iac
Ġcompartmental ization
ĠCel gene
diamm inedichloroplatinum
ĠCrem ophor
gener ational
Ġtung sten
Sus tained
kada ic
inwe i
loreth amine
uthen ium
terrane an
) %;
3 14
4 04
5 43
6 43
8 21
8 05
8 47
9 03
9 88
C hol
D p
D CAG
D EX
G US
H m
H EPO
L OS
L IM
L DA
M MS
M ounting
R enal
T ST
T CC
b ax
b server
g on
i ate
k es
k ines
l onal
l isib
n owled
p al
s rc
s ynucle
s seldorf
z ero
Ġ estradiol
Ġc osm
Ġo st
Ġp uzz
Ġs ul
Ġs CR
Ġm P
al a
ati zed
ro tein
Ġd ps
Ġre established
at ation
id en
ĠA CD
ĠT amoxifen
tic le
Ġst ands
ĠI AC
ĠI BMFS
ĠM OL
op ical
il ding
Ġde phosphorylated
ĠP RACT
ĠH Q
Ġtran st
ĠB ro
ĠB CA
ri ve
ĠD ick
ĠIn form
ĠF d
ĠF ung
ĠF atal
00 004
ĠS LAP
Ġ3 80
Ġk eloid
ous es
Ġco activators
ĠR ats
Ġ5 31
ĠO c
ĠO Bs
Ġnot ing
pl acement
ĠG p
CR c
ĠE c
Ġimmun ogenetic
Ġsub vert
Ġover activation
ĠL TLS
Ġinf liximab
port in
Ġprotein osis
Ġunder treatment
Ġsup erv
Ġsyn ergetic
esti b
Ġdec ondensation
sup pression
Ġnon genetic
Ġfol ds
Ġstr ides
Ġappro x
Ġdete ctor
ĠU MP
requ ent
Ġsec tor
av ior
Ġfunction ed
spec ies
CD D
Ġcontro llable
Ġimp ose
12 90
ten sity
Ġchild bearing
RD B
Ġspecific ations
ĠOS I
Ġsh adow
ĠV f
ĠV p
ĠV ero
ĠCI F
az in
Ġsequ ester
53 6
60 2868
Ġem power
Ġnucle ases
ep oxide
ep ime
ĠML R
Ġprop osing
Ġneut ron
iqu one
roph agic
xim e
ĠAn tim
ĠAn alog
Ġhist ogram
Ġmyel in
Ġprec a
ok es
IC US
04 01
04 57
Ġexplo its
ĠAd hesion
Ġradi ochemotherapy
Ġfocus sed
lob ulated
of in
DR s
PD A
Ġdispl acing
ĠX LA
Ch aracter
Ġsp ur
Ġsp ouses
Ġi C
ĠCl onogenic
ophil s
Ġver tigo
ĠBMT B
Ġextra vascular
ole v
Ġpoly pharmacy
Ġexcl udes
ME F
ĠCyt oreductive
RT PCR
Ġ44 1
>- <
97 8
97 9
Ġkin ome
immun osuppressive
PR R
Ġdifferential s
HP CT
Ġ47 4
Ġ47 8
Ġneuro trans
Ġfat ality
Ġ57 8
sc RNA
005 8
Ġinj ured
Ġiso zyme
Ġspectr in
rin ogen
ĠSc opus
Ġz f
ĠRe activation
ĠRe bastinib
Con current
Ġtem plates
Ġglut araldehyde
adi um
ĠAD T
ĠPK D
Ġmas king
Ġhand ful
Ġhand led
prom oted
ĠDe ferasirox
ĠEp R
ĠMed icinal
ĠAc quisition
enes cence
Ġten fold
ĠAR CH
Ġdimin ution
Ġbacter ium
Ġadoles cence
TNF Î±
Ġcoup lets
dim ethoxy
PH ICAL
onc ologists
Ġ89 12
uran ofin
ĠIT H
Ad herence
ipro cally
ĠIDA raC
ĠSur vey
ĠChrom othripsis
PK M
ĠEP OR
Immun osuppressive
avail ability
Ġperturb ing
ĠMA GS
ĠAF M
Ġgel atinase
Ġcircum vents
Ġaccumul ations
Ġhisti ocytoid
ĠGenetic ally
Ġbirth weight
ĠSor ted
Med ical
Ġperic entric
ĠPE CAM
Ġultras ensitive
enhancer s
GST P
granul ocytes
local ize
Ġmand ates
py ridine
Ġallevi ates
ĠKDM s
Ġquick er
0004 277
ĠIS APL
tt ps
ĠLip id
acc ine
Inf ectious
Ġec chym
ĠGu adecitabine
ĠPTK s
TI MP
Ġkeratin ocyte
deox yguanosine
DF X
Ġlamin a
Ġortho gonal
Ġaberran cy
ĠTel omere
Ġspati ally
ĠHom oharringtonine
Ġelab oration
Ġbed s
Ġoperation ally
Ġmyr istoyl
BS Is
ĠDP Cs
Ġfavour s
Ġneighb our
Ġhab it
Ġdeoxyribonucle oside
Ġfed ratinib
Ġstere otyped
ĠFcgamma RI
Cycl er
âĦ¢ )
trim oxazole
obi ologic
Ġpric es
Ġvolt amm
SAR S
Be fore
Ġphosphoprote omics
Radi ation
ĠNFAT c
ĠDa ily
Ġparap legia
ĠNL GP
Ġtha wing
Ass ociation
rHu MGDF
youn g
ophy tic
ĠcT nT
ĠNano String
Mc Ab
ĠCharacteristic s
ĠCMT M
ĠIntrat hecal
ĠDar win
Ġpatch y
Ġmist aken
chel ating
Ġanabol ism
Ġindo or
Ġanalges ic
ĠIraq i
Ġillumin ate
buff ered
Ġduod enal
ĠPtd Ins
Ġmicrohom ology
Ġhypercoagul able
ĠREC K
Ġvarie g
ĠGRA PHICAL
Ġcance rogenesis
ĠAdd ressing
ĠRow ley
ĠDÃ¼ sseldorf
Ġunrem arkable
Spr ycel
atil ity
ĠKre bs
1209 18
Ġexagger ated
( *)
) )-
4 03
6 90
8 23
8 37
A AML
A DH
A den
C HD
C max
E SCs
E HR
F atigue
G AG
L BCL
P bx
R FC
U MP
V yxeos
W alden
c et
c dc
d NTP
d rew
e GFR
f lan
f ollow
g els
g onad
l apse
m ine
p otent
p aro
r Ã¼ppel
t MN
u ense
Ġ Îº
Ġ Î¶
in oc
re vers
re cr
re act
re ement
en one
Ġc ec
Ġc ullin
Ġp im
Ġin effectiveness
Ġs atur
al imumab
an z
an al
Ġre directed
ar ched
ar tite
Ġf ist
Ġb ony
Ġb izar
Ġwith drew
ul si
Ġh GH
em on
ĠT AR
ĠT MA
ĠT GM
ĠT NBCs
res sed
ĠC eb
ig r
gen in
ut um
ce RNA
ce phal
Ġex omes
Ġis avuconazole
Ġst ore
Ġst aphyloc
ĠM CT
ĠM ounting
ĠM embers
oc how
Ġg rip
Ġg rant
ts uka
ute in
ĠP ilot
ĠP araffin
od ar
ĠH p
ĠH id
Ġdis tension
ff ucci
Ġinc urred
ĠB PR
ĠD ana
ĠF ig
ĠF CN
00 66
ĠS Q
ĠW GCNA
Ġun interrup
Ġcl amping
Ġ3 99
enti a
pro staglandin
ĠR SV
ĠR OPN
Ġchem erin
Ġen v
ĠG AG
CR PC
ĠE th
ĠE met
Ġph armacy
Ġpre phase
Ġhemat ogenous
Ġrec lassification
DS A
ip ital
Ġob uense
Ġmod ulations
Ġmod elled
so ft
Ġind els
01 15
Ġdec rement
Ġdem ise
Ġnon parametric
ros atellite
Ġinter quartile
Ġblood y
Ġapopt osome
Ġar gin
CT SL
RA I
Ġmulti stage
ĠJ CML
13 347
sor ting
Ġstandard izing
Ġpos ts
Ġpost pon
ĠAT N
par tially
Ġem py
ĠIL S
ep sin
Ġes capes
trans retinoic
Ġacid osis
gra ma
Ġ50 6
Ġ50 8
Ġgranul ocytosis
ĠBM E
Ġthromb ospondin
(- );
ethyl en
IR IT
Ġpur puric
Ġtri phasic
cal es
cep tin
con ferring
arb onate
itu x
80 9
onucle ase
Ġrese arched
cyt openia
57 7
Ġhydro gels
ole ucine
Ġpoly aden
ĠCyt ological
amin obenz
Ġsummar ised
Ġ90 9
abil ization
97 1
Ph ospho
immun o
Ġimmunohist ologic
48 5
Ġconjug ating
pop ulating
Ġmast ocytoma
sc at
Ġaden oid
Ġsw ollen
Ġminim izes
Ġble bbing
uff icient
ĠCo Cl
DL EU
>/ </
Ġfl a
ĠTR E
ĠTR PM
ĠTR PV
Ġfas test
Ġmen tion
Ex o
Ar ginine
SL P
Ġsubcl oning
ĠNHL s
ĠMG C
Ġpy rophosph
Ġinsuff iciently
ĠTK s
nucle otides
RAEB T
Ġmak ers
Ġrecur s
SI LAC
ĠCO ALL
ĠCO MP
ĠCO PD
Ġincon ven
ĠSup ervised
ĠHU VEC
Ġlinear ity
Ġscan ned
Ġaff iliation
opres erved
erythro cyte
ĠMin istry
ĠSo ochow
Ġwt FLT
Ġjo ints
ĠOb ese
ĠOb atoclax
TRA P
Ġcompens ates
Ġpreced ent
ĠHM W
ĠCy TOF
Int ra
Ġexhaus tive
Ġpack aging
Ġduc ts
Ġbromodomain s
Ġmeet s
ĠMIC B
pi rox
phospho lipid
Ind igo
GP X
ĠProte ome
ĠPeg interferon
iol itis
ĠTD Z
ĠEuro cord
ĠAppro aches
Ġtro ub
Ġtun ed
Ġhin dering
Ġmyr istic
ĠPhosph atase
HGF s
ĠApp arent
ĠAO E
ĠAdj usting
245 34
Ġprioriti zed
Ġculmin ates
Abnormal ities
Ġcentrifug al
Ġoligodeoxynucle otide
ki lobase
Ġparas ites
ĠLig ation
Ġfluctu ation
conf irmed
ĠTY RO
ĠFcÎ³ R
Ġdoubt ful
Radi otherapy
Ġlag ging
Ġconstell ations
ampl ing
Ġpod ocalyxin
0011 1345
Effec ts
Ġprovirus es
Ġsto ichi
ĠEW S
Ġcran i
739 358
Ġban ks
osamin idase
Ġnonin feriority
ĠmH ags
Tra ditional
Ġarr ived
Ġsom nol
bas eline
Ġimper fect
Ġimper atorin
ĠIsra el
Arabin ofuranosylcytosine
Ġdendrim ers
Sch iff
review ed
ĠProv ince
ĠImmunop recipitation
Ġsynap tic
omyce tes
Ġchemil uminescence
Ġantide pressant
ĠArabin oside
Ġnanost ruct
Ġattit ude
Ġoverrid ing
oform ycin
Ġae ros
ĠEUR O
sig ma
germ line
ybut yrate
Ġimmunopro file
Ġpollu tion
Ġinclu sive
Ġepididym is
Ġgad olinium
glit azone
yleth anolamine
Ġvarieg ation
Ġbizar re
Ġuninterrup ted
ĠEmet ine
Ġempy ema
Ġsomnol ence
% âī¥
0 84
5 12
7 12
9 23
9 274
A H
B IR
B BL
C Q
D on
E LTS
F O
F V
F luorescence
G CB
H BMT
H IGH
K DR
L X
M uch
M ouse
N HD
S a
S yk
T IL
T EFb
b lock
b FGF
c lofarabine
d p
f GO
f GN
f riendly
g uanosine
h ymotrypsin
k op
n our
p ay
p ox
r ase
s d
u itive
x a
z ia
z mB
Â ³
Ġa GPCRs
Ġt edi
Ġt MNs
on ographic
en vision
Ġc CAR
Ġc antharidin
Ġs E
Ġw al
Ġw ritten
Ġm rp
Ġm otolimod
or ig
an ed
el otinib
as y
as tro
it oxic
ed otin
Ġf avo
Ġ( +),
id ia
ly tes
Ġh ob
Ġh MYADM
ĠA dequate
ĠT IP
ĠT beta
si glitazone
ĠC ause
ĠC arb
Ġis othermal
ĠI SM
Ġmyelo fibrotic
ĠM il
ĠM MRD
ĠM arg
ĠM Ã©
op ietic
um ycin
oc o
Ġch air
ĠP al
ĠH MCLs
Ġr isen
st ages
ĠB am
ĠB eta
ĠB fl
am ol
ĠD iss
00 28
00 43
ĠS ite
ĠS ocal
ĠS irt
ĠS urvivors
ĠW an
ĠW ides
Ġ3 98
ĠN MHC
ĠN umerical
ĠR HO
Ġ5 34
Ġ5 22
Ġres ts
Ġmar itoclax
Ġanti inflammatory
Ġanti leukaemia
iz oline
de amino
Ġchem oprotection
Ġen ergies
ĠE limination
lec ting
Ġimmun ochemistry
iti bine
ich en
Ġsub analysis
Ġsub arach
Ġinduc tive
ĠL PHN
Ġ6 30
enc er
Ġhe ading
ms a
opo etic
%) ].
01 294
Ġall ergies
ocy anine
Ġnon clonal
Ġnon melanoma
Ġ8 82
Ġpl ag
rim o
Ġel a
ĠU CN
ual in
Ġman ganese
RA M
Ġdes fer
Ġprim ates
ile ged
li quid
Ġmulti protein
LA Q
RD s
Ġme ter
Ġqu enc
Ġdef ence
Ġmicro b
Ġcommon place
AT C
Ġep ox
CL U
ĠV ector
53 8
19 94
19 81
par in
erg ualin
Ġ+ ,
ĠPh ysi
20 36
Ġer as
25 22
AK t
val erate
Ġx ero
23 2
Ġthromb ocytes
mut agenic
(- )-
ind ol
BM M
IS M
HCT s
ĠRes veratrol
ĠUn ivariable
PD CD
Ġimmunosup pressants
Ġvir ally
Ġconc re
ai ke
aza D
Ġwork place
ulin a
98 02
Ġi CD
Ġchemotherapeutic al
Ġhypothe tical
28 11
ĠMul tid
Ġ33 258
Ġcytokine tic
Ġcategor izing
AD CP
Ġsymptom atology
ĠER EG
Ġexpl anted
>= -
DC OG
Ġmelan in
dex trin
Ġoff ice
Ġdeg ranul
ĠPR EF
immun otherapeutic
PR Os
ĠME SF
DNA M
Ġstate ments
odes ine
Ġatt ach
ĠY EAT
MF s
WT IP
glyc ans
tingu ishing
ĠMM URD
Ġsensiti se
ID s
ĠDec iphering
rosc lerotic
ĠNB S
Ġextrac utaneous
me is
ĠIR EM
Ġalk ylation
Ġinst all
Ġoste osarcomas
ĠSc d
ĠHD ara
Ġcontroversi ally
Con genital
ĠCol umbia
Ġbio assay
Ġclar ifies
ĠPT F
ĠPT G
ĠPT N
micro chip
Ġfibro cytes
SG N
ĠMC LA
portun istic
ĠAr rays
raz osin
Ġelectro chem
ĠTHP O
ĠPP X
Ar ray
erc ury
ĠOR G
thym oglobulin
Ġasc ending
ĠGen erate
ĠMG D
ortun ate
cho lesterol
ĠFA CT
Ġspectrom eter
Ġspar ked
Ġmicrog lobulin
CE Cs
Immun ological
Ġneur ite
lig ands
Ġsulf onyl
ĠSh orter
ĠDD Is
alli ative
Ġmening es
Ġimmuno editing
ĠFT T
pred isposing
ĠAllo HSCT
Ġintestinal is
Ġincon sistently
Mul tivariate
ĠUK MRC
Ġneo in
Ġsoon er
Ġdraw ing
ĠPar adox
tri um
ĠIs sues
ĠMin or
Ġacces sion
Ġcollabor ations
metabol ic
inv estig
ĠImmunophen otypically
Ġreplic ates
Ca uc
FB S
Ġdermat ologists
Ġexacerb ates
ĠAM U
ĠÎĶ NPM
idi opathic
Ġunra velled
ĠED D
car minomycin
poly acrylamide
Ġmultim er
104 2522
Ġflux es
Ġmyeloblast omas
ĠBl ue
Ġcatheter ization
Ġadministr ative
ĠNU MA
Ġrun ning
PBP CT
Sm oking
ĠHom o
Ġja w
ĠNeuro kinin
ĠSY TO
Ġtap ered
Ġradios ensitive
ycarb onyl
ĠIKK Î±
ĠUltras tructural
Ġexempl ifies
Ġrubid omycin
ĠOcc asion
Ġthick ened
ĠSn MP
trim ethyl
ĠZn PP
ĠFX IIIa
Ġflor id
Hydro x
ĠSan z
ĠTEM s
ĠAk irin
ĠAk aike
Ġsn apshot
carcin ogenic
anyl ger
Ġcautious ly
conjug ate
Ġpractition er
ĠDCP S
Ġperpet uation
ĠMNK PL
ĠFcgammaRII a
Ġphenocop ies
ĠImmunob lotting
Ġoligodend ro
otax us
Ġstret ch
ĠQues tions
Ġpuber tal
ĠAcl a
Auto immune
creat inine
Ġscro tal
Ġger anylger
ĠCytos cape
ĠTIF A
Ġelectrosp ray
Ġpollut ants
ĠActin omycin
enro lled
Ġvigil ant
Ġperitran splant
Ġanalyz able
epit ope
Ġescap ed
ĠâĪ ŀ
ĠAdi ponectin
Ġcate chol
Ġslic es
LIL RB
ĠCob ll
ĠTXN IP
Ġexant hema
Ġpares thesia
Ġrepos itory
ĠNX F
ocalc emia
ĠFrail ty
Ġhy gi
ĠEdn ra
Ġiat rogenic
Ġfavo ured
ĠWides pread
ĠYEAT S
* ,
- ]
2 33
4 11
5 28
6 27
6 29
8 56
A mut
C yclo
E ff
E MSA
F ib
F NA
F arnes
G CG
J I
K PS
L B
L u
L CR
L og
L CA
L SPC
M ass
M ZL
P Y
P Cs
S pl
S olid
T w
V it
b endamustine
b locked
d ib
d AzaC
e rom
f ol
g old
k head
l actic
l lect
n og
n eling
o ceptor
p ocket
p ericardial
s CR
s FasL
s ensitized
u is
y rene
Ġ îĭ
Ġa febrile
re pressed
re ference
re plication
Ġc ebpa
Ġo kadaic
Ġp orph
Ġs aved
Ġm s
Ġm ine
Ġm ortal
ati de
ro pho
it ates
Ġd oll
er ted
Ġ( #
Ġ( %)
Ġb m
id ide
ul am
Ġh MDS
Ġh OGG
ĠA X
ĠA NP
ĠA HA
ec k
ĠT AC
ĠT TC
ĠT CE
ĠT ermin
ĠT adalafil
ML N
ig hest
us ine
et ting
if er
if erous
if anib
ac ies
sp odar
uc ur
ĠI ES
Ġcon tention
rap ped
ĠM s
ĠM off
ĠM IG
op artic
ol t
Ġg ermin
ab ases
ab sorption
ĠH ind
ĠH As
ĠH itherto
Ġv oreloxin
Ġr HEPO
st yle
ĠB Q
ĠB PH
am pin
ĠIn ducing
00 55
ĠS phing
ĠS oft
ĠW GA
Ġun inten
Ġmo ab
pro B
ĠN utrition
ĠR UN
ĠR NR
ĠO B
isk y
Ġanti di
Ġanti myeloid
Ġreg isters
Ġeffec ted
Ġtrans activated
ĠG ranul
ĠE E
ĠE d
ĠE NC
Ġph thal
Ġhem ochromatosis
Ġpre adip
ĠL OC
Ġ6 40
Ġ6 86
Ġstem s
Ġind el
01 09
Ġexp enses
oth iaz
Ġ9 205
ines in
Ġnon erythroid
Ġcor ds
ros ome
ĠK CTD
Ġel utri
anis idide
Ġwell s
ch ard
ysp ergualin
our ce
og ones
Ġmicro deletion
istic s
Ġinte llect
13 01
Ġcoun s
sor afenib
az an
az ob
Ġol factory
Ġadv ise
ym eth
ĠAl isertib
ex ons
Ġlymph otropic
ĠAT LL
ĠPh arm
Ġend otoxin
Ġlim ma
yd aunomycin
ĠMRD co
Ġrati ometric
Ġmy x
Ġmy opathy
ĠAs PC
MR Cs
Ġ50 9
Ġcytotoxic s
04 31
ĠCom mission
Ġoptim isation
24 02
Ġir r
Ġir AEs
27 607
35 7
35 48
Ġquantit ating
Ġunf ortunate
ĠUn c
Ġcur atively
Ġphosphor us
ĠFor khead
allo p
Ġconc ur
Ġconc urrence
Ġproportion ality
asp inal
ĠMR T
75 7
44 8
Ġdys keratosis
65 9
Ġ45 7
Ġrest rains
Ġhybrid omas
Ġpoly dip
Ġcardi oprotection
Ġgeneral izable
97 7
Ġ55 9
Ġdistrib ute
ian g
feren tial
ĠVEGF Rs
77 2
ĠPre fect
Ġcat alysis
Î¼ m
Ġdegra der
Ġlat encies
Ġtermin ates
Ġdetail ing
005 9
UC HL
ĠIR S
ĠInc orporating
ĠAb n
aph orin
methyl adenine
Ġglut athion
PV T
ĠHSP B
ĠEp id
ĠEp CAM
ĠCB S
Ġcut ting
ĠSome times
ĠBi ologic
retin oin
SR s
ĠGen otypic
Ġhead aches
Ad ults
ĠMon osomal
SM ase
ĠRR s
vas ively
ĠTr iton
ĠTr iggering
Ġmess engers
ĠTK i
atidyl inositol
Ġsuper co
arabinofuranosyl uracil
Ġed itor
Ġed ges
ĠBR G
strati fying
Ġdeox yguanosine
Ġpromp ts
pred ominant
ĠCL ABSI
ĠTT F
ĠFC S
ĠConsid eration
class ic
Ap c
carb onyl
GC S
Ġcros ses
ĠCCN E
Ġpump ing
Ġcyclo ph
phenyl alanine
TCR s
ĠMod ifications
PBM NC
Ġsteroid al
ĠMyelo peroxidase
Ġmand ibular
URD s
Âµ mol
Ġnat ri
RB Cs
ĠTCD D
benz ox
idi ob
Ġdetox ifying
Ġastro cyte
liter ature
Ġanth rop
pair s
ĠCS NK
ethox yphenyl
AI HA
Ġbring ing
Hep G
Ġengraft ments
Ġhind limb
ĠLN Cs
ĠPseud o
ĠATR X
Chem o
hyper diploid
Ġorchestr ated
Ġpeculiar ities
squ ared
Ġvag ue
401 01
ĠDex razoxane
strom a
urg ical
ĠHV G
ĠMuc ositis
ĠCEBP E
Ġvas opres
dan setron
Ġgross ly
ĠMor isky
azid o
MIC A
Ġcoordin ating
antic hymotrypsin
Ġneu rom
Ġsphero id
ĠCen ersen
Ġaux otrophic
transp os
Ġsn ail
ĠSi Ha
ĠDrr A
ĠSPR ED
Determ ining
Achie vement
deriv atives
ĠGAL V
toler ance
Ġpalmit oyl
Ġjeopard izing
Ġban ked
Ġcalibr ator
Ġinconsist ency
Gu o
HMG B
Ġribo zymes
Cardi ovascular
Ġbott om
Ġscle ro
ĠImmediate ly
Ġoligodend rog
Ġfertil ization
tw ice
Ġintercon n
mis sing
625 27607
Ġgam et
Ġmetho xy
Assess ment
Ġtropical is
Ġmicrocirc ulatory
Ġdyspo iesis
frag ment
Ġscrutin y
Ġunsus pected
Ġtheranos tic
accum ulation
Ġresi li
Ġmith ramycin
Ġdiplop ia
1120 212
Ġcontral ateral
psycho tic
Ġfire fly
1168 36
Ġcec um
scat ter
Ġwal king
Ġconcre te
Ġdegranul ate
Ġpolydip sia
0 93
3 039
4 28
7 81
8 75
9 30
9 46
A XL
D er
D AP
F arber
K d
L NA
L BH
P d
P ACs
R Î²
R HAMM
T AT
U se
U be
W af
X V
b an
e itic
k o
k x
k ill
l um
l ck
m Tc
m atch
p AML
s ulph
s TRAIL
s ensitization
s ynthetic
t g
t omatine
x s
Î ¦
Ġ ZA
in ium
ti az
Ġc el
Ġc itric
Ġo t
Ġo HA
te remia
Ġp CR
Ġp ayer
Ġp rene
Ġp ounds
Ġin ex
Ġs Î²
Ġs ink
Ġs FLT
Ġs onic
Ġm dm
Ġm Sv
al though
is ory
an ercept
it an
Ġd ub
ic oplanin
Ġe ighteen
ly sin
Ġh ype
Ġh olding
ec ho
si mon
ĠC i
ot opically
et her
ac itibine
ho c
Ġis oleucine
Ġst ents
ib e
Ġl ichen
Ġcon tem
op ular
pres sure
il ution
ol ase
Ġon dansetron
Ġg rim
Ġg DNA
Ġg ossypol
Ġch ry
ab an
ĠP arental
Ġv estib
hem opoietic
Ġr FVIIa
ĠB irth
ĠB BB
ĠB eginning
ri oxamine
ĠD oc
ĠD SF
ĠD axx
ĠIn surance
ĠF AD
ĠF It
ĠS ho
ĠS ole
ĠS urviving
igh ted
Ġun committed
Ġun irradiated
Ġeff luent
Ġmut KIT
ĠN IC
ĠN TBI
aly tic
ĠR ICs
Ġ5 45
Ġdiff raction
ĠO L
ĠO v
de ad
Ġen ters
Ġ4 13
Ġ4 95
pl ating
ĠG V
ĠG ICs
ĠG ilteritinib
ĠG lioma
ĠE to
ĠE APB
Ġinv est
Ġimmun ogen
Ġno x
Ġno Day
Ġse eding
Ġ0 4
Ġrisk y
Ġhemat oxylin
Ġtar trate
ĠL ic
ĠL DC
ĠL MB
ĠL ille
ĠL eridistim
ari o
Ġro siglitazone
01 38
01 28
01 06
Ġcan n
Ġpar simon
Ġall ostimulatory
Ġ8 14
Ġspec ulation
Ġdifferenti ations
tim ibe
mon oclonal
Ġinter disciplinary
ĠK OR
ĠK rÃ¼ppel
crip tions
Ġapopt in
ĠU SD
CT Cs
CT As
11 12
Ġpredic tivity
Ġfe el
Ġprim es
MT s
Ġhyp opyon
og aster
CD w
Ġconf luent
cr isis
Ġme at
Ġkn ee
Ġqu eu
ĠJ e
Ġmicro liter
Ġaut ofluorescence
Ġdel eting
ĠV DAC
ĠV GE
ĠCI BP
17 999
ym oma
af olin
Ġform ulate
Ġform ats
Ġem an
DH L
ep ilep
ep igallocatechin
20 3580
ĠII B
HSCT s
vo flur
Ġprop ranolol
CI D
ĠDN P
AR S
05 03
MR Ps
Ġbas olateral
Ġgranul osa
ST AG
Ġthromb us
Ġ60 6
Ġexplo itable
ves pimycin
BM E
BM SC
MA N
Ġpharmac ists
35 44
Ġclon otypes
lob ases
Ġtri terpenoid
Ġgre y
ĠOver weight
ĠAfter wards
40 8
Ġestim ator
oh orts
Ġhaemat o
SP T
AF X
ĠX meis
ze timibe
ĠPro state
ĠPro jected
Ġneutrop a
ĠEx ome
Ġsil vestrol
Ġyear ly
Ġ27 3
Ġsp utum
Ġi HR
LI NE
Ġmuc ilag
Ġfib ril
Ġtransp orts
Ġtransp osition
Ġ33 2
Ġmes op
99 2
Ġ48 5
per cent
Ġcle aving
Ġcle arer
inc rease
VI N
Ġmelan ogaster
Ġj asmon
RT S
Ġ34 3
Ġtra ils
Ġequ ina
Ġequ itoxic
Ġangi ography
cepti bility
PA OD
48 4
erv ical
Ġhal o
Ġorgan izing
Ġorgan elle
ĠPI GN
ades h
Ġsol GM
acetyl gluc
ĠGM B
Ġreflec tive
Ġexon ic
Ġ57 4
Ġdiss olved
ĠMy Ms
005 109
ĠGST A
Ġher bs
gl adesh
ES HAP
Ġadap tors
AN N
Res earch
ĠRe pro
ĠRe porter
orrh iz
phen ol
Ġolig omers
ick man
Ġshe ath
Ġhand le
put ation
Ġconcept ually
Ġresid ents
ĠBi om
ĠBi opsies
Ġhar ms
erc ular
ĠAnti biotic
)] ;
ĠSp red
Ġselect able
ĠATG s
ĠMon ocyte
ĠSP IRIT
ĠTr isenox
Ġarg u
Ġhomolog ues
FC S
ĠPl atelets
tras ting
anth raquinone
ĠAllo HCT
NB s
TE AEs
ĠSup erior
Ġaspergill us
Ġdisturb ing
Myelo peroxidase
Ġframework s
HE X
Ġultras tructure
omat oid
ĠAI RAPL
ĠCV C
ĠClin iMACS
MAC E
Ġâĳ ¤
ĠNa AsO
ĠLympho cytes
acr ylate
ĠHaplo type
ĠUV RAG
prim arily
ĠPRL s
Ġsuccumb ing
ĠDH H
oxif ylline
ĠDis tinguishing
mul tivariate
ĠPN U
fluor omethyl
ĠLen tiviral
Ġwindow s
Ġnorm oxic
Gal ectin
igaret tes
Met astasis
ĠMol Rec
ĠADM ET
Ġsap onin
Er ythro
Ġgamm are
ĠLN s
0000 370
ĠSouthw estern
ĠRN ases
Ġ156 31
DE VD
Ġcapt ures
SN HG
AZ T
Ġtransfect ant
Ġsimpl ify
Ġtris omic
ĠGAB ARA
Ġki lobases
Ġglycosyl ase
Ġexempl arily
Ġendonucle ases
Ġdisper sion
Ġconjunctiv itis
obi ological
Ġdecon v
Ġautore activity
Hydro xy
hetero zygous
ĠBel inostat
ampl ification
ĠMalign ancy
1800 871
Dis ruption
Ġanc ient
osystem s
Hispan ics
Ġparac entesis
oct adecyl
ericardi tis
igil ance
Ġni raparib
ĠSIN E
serv ations
Ġcalibr ated
ĠMultic olor
Ġvibs anin
ĠQues tion
674 563
Ġubiquity lation
Ġfluoroquin olones
Ġenanti omer
entin an
Ġsing ular
Ġaminoglyc oside
Ġargum ent
ĠEST IMATE
Ġenvis aged
498 67
morpholin o
Ġquadrup ole
ĠTurk ish
Ġcytoc idal
Rev iew
Ġoroph aryngeal
Ġhous ing
Ġspectrat yping
asth enia
ĠBLA ST
ĠGlucocortic oid
Ġhyponat remia
Ġoctogen arian
Ġunambigu ously
dF dC
commun e
ĠScat chard
Initi al
ĠHap Map
meloxif en
Velc ade
ĠBan gladesh
ĠSIA DH
Ġsubsid ies
ĠEAS IX
Ġmyelodyspl atic
Ġosm otic
Ġprede termined
Ġenig matic
olev ulinic
ĠParadox ically
ĠMoff itt
Ġuninten tional
Ġintellect ual
Ġresili ence
voflur ane
005109 26
3 90
4 26
B AK
C ostimulatory
D istinct
E zh
F Y
F IR
I O
I U
K T
L PN
L ewis
M Ï
M ax
N ur
P rim
P ick
R o
R BL
R oche
T SC
T po
T MP
T MM
T IN
V RCZ
W estern
a ued
a gnetic
b iqu
h d
k dc
p ow
p ep
p erson
q ing
s HLA
x il
x pressing
Ĩ s
Ġa SCT
in el
Ġt err
re actions
re populating
en ec
Ġp Y
Ġp ush
Ġin jecting
Ġs Le
Ġw el
Ġm Gy
ati zation
is in
is ulam
an xiety
ed ding
es in
ic ates
Ġre lying
ar res
ar rest
Ġf entanyl
Ġb lank
id em
id ov
id azole
Ġe uch
os emicarb
ul is
Ġh TR
ĠA CB
ĠA PI
ĠT O
ĠT at
im a
Ġle aching
ĠC AK
ot enti
gen s
gen icity
ere osinophilic
Ġac r
ac l
ac cin
ac tors
sp e
Ġst acking
ĠM CA
ĠM CLL
il one
um ulated
Ġg ab
Ġal ph
ĠP b
ĠP ex
ĠP DH
ĠH ST
ĠH NF
ĠH GS
Ġdis opro
st ood
Ġcomp osing
ĠB m
ĠB ul
ĠB ind
ĠB NS
sis ter
Ġad hering
ĠD V
ĠD isseminated
ĠF ixed
00 57
00 72
00 266
Ġun insured
th re
Ġeff erocytosis
Ġmo vements
ĠO MA
ost ring
Ġper mutation
Ġmon ograph
Ġ4 03
Ġ4 26
Ġ4 92
Ġgen itourinary
spl enomegaly
ĠG an
ĠG ANT
ĠE ltrombopag
Ġ0 14
Ġint ran
Ġint ussusception
rac heal
Ġover activated
Ġrec iprocally
ip hered
opo lysaccharide
ĠCML BC
Ġsup ern
%) ).
01 29
Ġdec iphered
Ġ9 42
Ġnon reactive
Ġnon permissive
34 74
Ġnormal izing
ĠDNA zymes
crip ta
ĠU TP
ĠU rinary
Ġar son
RA GE
av y
Ġsc hool
Ġup ward
ucle otides
dysp lasia
Ġam eb
Ġmicro bes
Ġinte rests
tho quinones
az arabine
60 295
Ġpost menopausal
ĠTo ol
56 8
med ical
19 75
19 61
Ġem ulsion
ep s
Ġwor ds
Ġ14 00
Ġmy le
iqu id
CSF r
AL OX
Ġ16 00
lyc ythaemia
Ġprob ing
ĠMP SSS
Ġsus pect
Ġso y
Ġ40 7
ĠHSCT s
ĠWh ich
Ġdepend ently
ĠUn biased
Ġtri um
ĠST A
ĠST SS
ĠST EMI
cep tive
ĠCon centrations
NP Y
ai ro
80 6
Ġhaemat ologist
Ġhyper activated
Ġhyper forin
Ġreal m
ĠPro cess
ĠPro grama
Ch imerism
Ġet anercept
Ġcer tified
Ġfrac ture
Ġxenog rafting
CB R
RT L
Ġmacro cyclic
Ġburden ed
39 1
ord inate
tric itabine
ov igilance
Ġdeep est
ob rom
Ġstate ment
ĠInte raction
Ġinternal ize
ĠMT AP
ened iamine
Ġ47 6
ĠZ D
ĠZ IC
Ġcat tle
87 9
ĠBA SP
glyc erate
sign ature
ĠMN NG
ĠSe oul
005 144
Ġhepat ocarcinoma
ĠSc anning
Ġadap ting
mod ulate
ĠMK s
lan gu
Con temporary
IN C
ĠCo hesin
EP OCH
Ġshe ll
ĠTR IP
ĠNe ut
ĠAC V
ĠTrans duced
Ġexc it
Ġpool ing
ĠPer ifosine
ĠPer coll
ochrom es
Ġleuc ostasis
hydroxy ethyl
tives icular
aut omated
inter fering
ĠCCA s
ĠSer ine
ĠFA ST
Ġremod els
ĠEm atologiche
Immun omodulatory
ĠMPL W
Ġsuper im
sen sing
ĠMA LT
Ġimmuno affinity
sh aring
ĠEr winia
SI K
ĠPDGFR Î²
ĠCCL SG
Ġsin ensis
Ġloop ing
back ground
ĠPF OS
Ġadip openia
ĠFC SS
Ġperox ides
Ġinterrup ts
Ġinterrup ting
hydrox yl
armaceutical s
Ġdil tiaz
ĠAI HA
ĠSE A
ĠIN SR
Ġpenet rate
Ġhot air
fl uconazole
inv olving
ĠNucle otide
Ġsplen ectomized
Ġerr one
ĠHP F
Ġfluor ine
ĠHT B
ĠTc m
Ġpsyc ho
ĠEffec tor
circ RNA
Ġplate aued
Ġdich loride
Ġorth otopically
Ġacetyl choline
ĠRemission s
ĠMB Z
Ġreferral s
Ext racellular
Ġnonrandom ly
ĠNan ostring
ethylene tetrahydrofolate
Ġhex okinase
ĠRC UD
ĠDef ined
ĠBio envision
Ġpay ers
Ġwound s
iclo pirox
abs ence
agglut ination
LP Cs
Ġunderestim ate
Ġhydroxyl ase
Ġoutper forms
Ġdestro yed
Ġprol actin
Ġprioriti zing
Fe brile
Di et
NU MB
wa it
ĠSpl enic
optim ized
ĠBar rett
Ġintram olecular
Ġabor tions
Circ ular
Evalu ating
tun e
ĠBal anced
ĠTrich osporon
place bo
ĠINT ERIM
Ġharmon ization
omed ullin
vol ume
ĠâĤ¬ /
Ġtent atively
toler ant
Ġmicrodiss ected
Ġhomogen ate
ĠArab ia
Ġsch iz
Ġsch wann
Pr kdc
Sel ective
adenosyl methionine
Ġpunct ures
under stood
Ġtetrahydro uridine
Ġdiplo type
Ġvolunt ary
Cardi otoxicity
Ġantiemetic s
Ġbiotech n
su PAR
ĠPercent ages
coll agen
BMD Cs
none xpressing
Ġrif ampin
Ġleukocyt apheresis
Ġenvision ed
Ġhemip aresis
ĠGlc NAc
ĠKE AP
ĠMid dle
Ġartemis inin
ĠFcÎ³RII b
ĠConfirm ation
Ġgenu ine
Ġwavel ength
ĠPlan ned
depr ived
Pub Med
Ġsen ile
Ġglauc oma
Ġarthral gia
rev ised
Ġbrad ycardia
ichael is
Ġpurin ergic
Ġschol ars
MDAP atA
Ġpreca utions
Ġtroub les
3548 25
epilep tic
idov udine
Ġdisopro xil
00266 136
cripta id
60295 0
005144 88
langu age
Ġdiltiaz em
5 48
7 16
7 53
7 25
8 273
9 42
A ld
C g
C w
D em
D CC
F unctional
F resenius
G Cs
H CMV
J apan
K iller
L ate
M urine
M eth
O Bs
P e
P DH
P lex
R IF
S i
S ep
T es
T TR
T AX
T oday
U mbilical
V en
Z inc
] =
a ec
b t
c em
c lassi
d y
e voked
f ed
h abil
i ra
m r
m RNAs
m olecules
p etic
s ug
s ely
t ocopherol
v um
y ment
z in
Ã ¡
Ġ Ë
Ġt ables
en richment
he k
Ġc os
Ġc igarettes
Ġo mitting
Ġp emetrexed
Ġin sp
Ġin qu
Ġs okal
Ġs omat
or us
as ms
Ġd actinomycin
ic ators
Ġre def
Ġre location
Ġf ates
Ġf ilms
at am
Ġb arc
Ġb ryo
om uc
ul se
Ġh ollow
Ġn ationally
ur ge
ot sub
ot axine
ut yryl
Ġac romegaly
se e
Ġst rip
ib rate
ĠM emory
ĠM aspin
iv us
up on
ĠThe ore
Ġde amin
Ġon ward
ab und
ĠP PA
ĠP MI
ĠH MD
ĠH IM
ĠH MF
ĠH dc
Ġdis tention
ĠB ER
ĠD os
ĠIn stit
ĠF es
ĠF OR
ĠF AP
00 56
ĠS f
ĠS ant
Ġun even
Ġsign ifies
Ġmo le
pro state
ĠN b
ĠR oche
Ġ5 19
Ġ5 26
ĠO H
Ġanti hist
Ġtrans itory
Ġmon ot
Ġmon ohydrate
Ġ4 38
Ġ4 04
ĠG US
ĠG aucher
CR D
ĠE b
Ġimmun ot
Ġse voflurane
iti ous
Ġpre emptively
Ġsub G
Ġbet amethasone
Ġover active
ĠL os
ĠL BP
ĠL andmark
Ġid en
Ġ6 34
Ġ6 57
ad ically
LL O
Ġpar icalcitol
Ġnon transformed
Ġnon infectious
Ġ8 61
Ġbi ologists
ser vation
ros arcomas
mon itoring
ag gressive
Ġdur al
ĠU CA
ĠU DLI
Ġar c
ch aemic
ĠCR IP
ucle ation
12 75
ak otsub
oph ren
15 95
15 85
15 73
Ġqu inte
act am
Ġsim ian
OS T
az ane
Ġdi oxin
95 7
Ġvalu ed
par an
Ġhetero genic
Ġpolym y
rop sy
Ġmy algia
AL OR
Ġheterogene ities
ix a
ST K
Ġpathogen icity
Ġthromb ophilic
sub cutaneous
sub distribution
IS R
IL K
IR E
Ġinfec ting
ĠLeuk aemias
ĠRec urring
CA Fs
Ġtri os
II a
Ġins id
ĠCon version
Ġrecogn ise
ĠCT CAE
Ġdispl ace
ĠX i
ĠX enograft
Ġhyper uric
HO C
ĠEx pansion
98 2
Th alidomide
Ġi ALL
itt ently
Ġhere after
(-) ).
Ġadhe red
AD Cs
comp atibility
Ġrest raining
Ġcle ft
lympho proliferative
Ġpoly cyclic
TP MT
Ġmelan ocytic
Ġ34 8
AS Nase
86 1
amin opyrimidine
Ġintr ic
mi RTS
Ġdeep ened
66 336
Ġfacilit ation
ĠY I
96 4
ĠAL V
Ġquanti f
87 6
Ġampl ifier
Ġsubc utis
ĠIR P
Ġmeth anesulfonate
AN D
oxy gen
ĠCY T
Ġaspir ated
Ġglut amin
ĠOnc ogenic
urac ies
Ġput ting
ĠDe oxycytidine
ĠEn vironmental
DL s
Ġelectro lytes
ĠNe oplasm
Ġax ial
HDAC is
ĠUS B
ĠAz adC
âģ µ
Ġleuc apheresis
arabin ofuranoside
Ġsmok er
ĠGr B
Ġabund ances
Ad j
Ad olescents
Ġtop ography
TR EC
CAM AL
CE ACAM
Ġdeline ates
Ġimmuno inhibitory
ĠMUD s
ĠPost induction
Ġmitogen s
ĠCs f
ĠCor ixa
haplo SCT
Ġsidero blast
Ġmyc oses
ĠHU MARA
ĠLe iden
Ġneo antigen
PG DH
Ġinterm ittently
carb ons
ĠInf ant
Ġmicrom et
Ġultras onographic
gluc oside
hydrox ys
ĠEnd ogenous
ĠGP x
prote omics
Over weight
treat ments
ĠHER C
recogn ition
Ġspor adically
ĠCoun ty
Ġweigh ting
Ġinfar ct
Int racranial
Ġdrop out
Nucle oside
Ġsa w
Ġconform ations
Fc gamma
ĠSal via
Ġresol ves
Ġtas quinimod
ĠIll ness
Ġbran ches
oral es
nan omolar
ĠRef erence
Ġbronch iolitis
Ġexerc ised
ODN s
Ġdisulf iram
ĠLo uis
do or
Ġsarc oid
Ġintermedi ary
tip otent
Ġbr us
Ġculmin ated
Ġlum en
Ġla id
ylo xy
Ġnaph thyl
Ġcopolym ers
ĠSpl enectomy
Ġdisproportion ate
ĠhnRNP K
Ġfluctu ating
Ġinges ted
ĠOnt ario
umer ary
azop arib
Ġleukotri enes
Ġtach yp
ĠNET s
Ġdop aminergic
uns ter
Hox D
Ġbic arbonate
Ġpione ering
ĠForm ation
Ġmesenter y
cataly tic
Ġcephal otaxine
Ġpedig ree
Ġtyros in
fibrin ogen
Mast ocytosis
Cal reticulin
Ġnonex pressing
Ġcaud al
Individual s
ames hek
ĠElectro phoretic
ĠÏ ī
ĠIsra eli
Ġenteroc occi
Ġnumb ness
Ġfluoroquin olone
ĠRal A
pas sed
Ġhept ad
Plas macytoid
NET s
Ġobliter ans
Ġaliqu ots
ĠHipp el
Ġwog onin
ĠPRD X
Ġclast ogenic
Ġspro uting
obarb ital
rub omycin
Ġgar lic
Ġcd k
Ġcontigu ous
Ġdecl ared
Ġtumourigen esis
Compar isons
cholines terase
Ġmech lorethamine
ĠFranÃ§ ais
Ġspond yl
ucur bit
azob actam
Ġsupern umerary
Ġtrium ph
Ġschiz ophren
abund ance
akotsub o
azane planocin
/ +)
4 10
6 976
8 45
9 33
9 75
A yer
B z
B ut
E ast
E ct
F u
G a
L U
N ICE
O cc
P ol
P NA
P leural
R V
R IP
R ON
T m
W GCNA
b ridge
c ip
d ic
f ications
f indings
g row
l ite
n odal
o oth
p arental
r ctn
s em
s til
s arc
s ynthe
s TREM
v ariable
x ico
Ã «
in activated
in avir
Ġt yr
ti orrhiz
on omics
Ġc iclopirox
Ġo roxylin
Ġp heresis
Ġp AKT
Ġs tig
Ġw ortmannin
al ias
is rctn
ro om
ro blastic
el ements
Ġd imensional
Ġre joining
Ġre initiation
Ġre habil
Ġb ot
Ġb ags
id er
ul sions
Ġh ys
Ġth yro
ĠA Is
ra ine
ĠT MS
si gar
ur ium
Ġpro dromal
ĠC op
ĠC min
ĠC airo
ot ria
ter ial
sp erm
Ġst randed
ĠI EMR
ran in
Ġcon stric
rap id
ĠM is
ĠM olecules
op sonized
oc etin
Ġde arth
rom atin
ĠP le
ĠP edi
ĠP PM
ĠP SG
ay ing
ĠH s
ĠH ickman
Ġdis pos
Ġdis abilities
Ġor bits
ĠB rug
ap sigar
am eric
qu at
Ġad mix
ĠD eline
ĠD HE
ĠIn k
ĠF LL
ĠF PR
ĠF olate
ĠF amilial
00 77
00 85
ĠS ial
ĠS uccess
Ġun re
Ġun planned
Ġcyt oprotection
Ġeff lu
ph or
pro ximal
pro pan
ĠN ox
ĠN OR
ĠN PV
ĠN kx
Ġco regulator
ĠR s
ĠR IG
Ġ5 23
Ġ5 30
Ġ5 24
Ġ5 28
Ġres ensitization
Ġreg ios
Ġeffec tivity
Ġ4 36
ĠG VT
ĠG ranzyme
ĠE DTA
tr ue
tr isomy
Ġimmun orespon
iagnos is
Ġpre f
Ġpre implantation
Ġpre malignancy
Ġag ranular
Ġover night
ox icity
ĠL AF
ĠL KB
Ġ6 04
end ous
port al
Ġstem ming
ad c
Ġind uration
Ġ7 86
01 46
form at
Ġnon relapsed
Ġnon fatal
Ġ8 63
Ġbi ob
ple ting
Ġpl ak
Ġstr atum
ĠK T
ag it
ch ildren
Ġacc idental
ĠCR CI
av oid
Ġimp arts
Ġmulti target
IT Y
LA MP
Ġqu atern
Ġmyelodysp lasias
Ġmicro v
13 05
Ġdel ib
ĠCI MP
Ġdi aste
Ġ19 64
SF s
14 97
Ġlymph omatoid
par g
ys m
Ġmy otubes
ST OP
Ġx anthine
Ġset tled
Ġcult ural
Ġprec ious
Ġtr in
Ġoptim ise
ind ices
Ġcap ped
26 48
iod obenz
kin je
IR s
Ġ" -
ision al
ĠAt tenuated
ĠST IM
Ġappear ances
ĠAB AT
Ġtoxic ant
mic roscopic
aza CR
Ġsynthe sizes
ĠX N
ĠX R
ĠX PA
HO O
ĠEx cessive
imin odaunorubicin
Ġutil ities
Ġsp atio
Ġdys regulations
ĠCM MRD
CM SCs
Ġclear ances
per sister
Î³ Î´
31 01
Ġglyc emic
Ġglyc osphing
86 2
function ing
ĠQ B
ov a
omin antly
66 6
77 87
Ġorgan izer
ĠY e
opatho genesis
ĠAp oll
met al
Ġneuro protective
Aza CR
sc reening
inte raction
ode oxyc
ĠGST pi
Ġcross links
ĠAb ove
Ġemb edding
+/- ,
ĠHemat opoiesis
ĠPK H
Ġur s
RP E
ĠDe pleting
NT ES
col lectively
ĠAr bor
Ġmucos ae
ĠAC K
link er
Ġexc itation
orb ate
Ġchemos ensitizers
Ġcoup les
ĠPKC alpha
FA CT
SL E
Ġion omycin
ĠCons titutively
sm ooth
Ġpy omyositis
Ġeth n
aro yl
ĠTr atam
ĠPl us
ĠHist opathology
CV D
Ġconn ect
Ġimmuno assays
Ġimmuno electron
Ġca ver
Ġelement al
ĠAng eles
ĠVari ants
ĠLY L
ĠBa P
Ġinterm olecular
Ġaff airs
105 01
carb oxy
Ġfer ric
ister ia
ĠHis ti
erythro poietin
ĠNAD P
RE LA
Ġnitro so
ĠPBP CT
Ġsinus oids
ĠBD F
Ġneph rectomy
Ġsubstit uting
Ġfluor odeoxyglucose
dem ethyl
dem ethylation
egakary oblastic
Ġpurs uing
Ġden ied
ĠHaplo insufficiency
Ġmainst ays
overex pressed
Ġens ued
ĠDis rupting
ĠMac rophage
fluor ocytosine
Ġpip obrom
ĠLen ograstim
FLA M
Ġorth ostatic
Ġvers atility
PKC Î±
ĠMyel omonocytic
ĠInvestig ating
ĠMet formin
Ġoutput s
ĠThromb ocyt
Ġhelic ases
Ġascertain ment
ĠPur kinje
Ġtrop ism
anucle otide
Ġbronch oscopy
Ġphosphoryl ating
His tiocytic
Ġcontamin ant
Ġinterrog ating
ĠEpo R
PTP RG
Ġparam agnetic
Ġperf oration
ĠLAP s
Ġaeti ological
PLL A
Ġbig ger
Ġgovern ment
ĠPRK CD
Ġautotransplant s
Ġdura bly
ĠdF dCTP
Ġfa ecal
Ġdere pressed
Ġvisc osity
Ġconjunctiv a
Ġgraph s
ĠLa romustine
sched uled
Ġcarboxyl ic
Ġrein troduction
ĠBeh cet
0047 1497
adren oceptor
Ġneurode generation
Ġcave at
Ġleaf let
cle aved
Ġparap rotein
Ġmetastas ized
ĠSus ceptibility
Ġsent inel
Ġsucce ed
ishman iasis
Str ategies
Ġguaran te
Ġlaun ch
Lip osomal
Ġcorp uscular
Chi CTR
ĠFran cis
Ġhapp ened
ĠHybrid ization
Ġcred ible
Ġphotos ensitizer
nit ros
ĠCereb lon
Ġbott len
ĠRub icon
Ġspi ked
ĠFresh ly
Prote asome
Est abl
Ġpuber ty
Ġhypothal amic
Ġhypothal amus
Ġisop ren
0048 1247
ĠPropor tions
Ġhepato biliary
ĠSER PI
Ġtheophyl line
NSAID s
Ġdeplo yed
ĠDMN Q
Ġzym osan
Enh anced
Mye KO
Ġmonomethyl ars
AQ P
difluor odeoxycytidine
allog raft
ĠFront line
Ġcrystallog raphy
7439 21
Ġfasci itis
ĠWill iam
Ġrecalcit rant
Ġplumb agin
Ġcholec ys
Conf licting
Ġhemisp here
avior al
flan king
gonad al
igr atory
kop f
nour ished
ĠMÃ© xico
Ġdoll ars
ĠENC ODE
Ġelutri ation
Ġprene oplastic
Ġmucilag inosa
ĠBind arit
cem id
1595 48
Ayer st
ĠPSG L
apsigar gin
Ġplak oglobin
Ġdiaste re
2648 1585
ĠApoll on
ĠTratam ient
Ġpipobrom an
* '
* /
0 98
5 02
5 23
6 15
8 98
9 10
9 12
9 0009
B RA
C CD
D B
D ZNep
E AC
E PA
E UD
G AA
H i
I SCN
L s
L PM
L ex
L OR
M om
M VP
O ct
P RD
P reliminary
P riapism
P recursor
R PS
S Q
V inc
X I
X PC
Z IP
] );
a GC
a Ã±
c fDNA
e z
f u
f ast
h if
k al
m uc
m CD
m ata
o ik
s ince
s omatic
t oc
t ax
t reme
t azobactam
w k
y et
Ï ģ
â ©½
Ġa uranofin
in sertion
Ġt RA
re plic
re pressive
re ader
re acting
on as
Ġc ro
Ġc ensus
Ġp si
Ġp ERK
Ġs emic
Ġs PLA
Ġan ted
Ġm EBMT
or ated
ro ple
ro ughout
Ġd ATP
ic it
Ġre sisted
Ġre induce
ar alysis
at oid
Ġb ag
id ents
Ġe AML
ly tic
ul ter
Ġth apsigargin
ĠA ch
ĠA ALL
ĠA ck
ĠA ES
ĠA iolos
ra quinones
ĠT s
ĠT rac
ĠT EX
ĠC CD
ĠC cr
ĠC cR
us ers
us oidal
gen ol
uk ast
if olia
Ġleuk osialin
sp aÃ±
Ġst aged
ĠI real
Ġmyelo gram
ran s
Ġl oses
Ġl ights
ĠM OK
op heresis
il ation
up loidy
oc at
ĠAML L
Ġg pt
Ġg MDSCs
rom e
Ġch ylo
Ġtre es
ĠP Z
ĠP en
ĠP ent
ĠP FN
ĠP CP
ĠP NC
od s
ĠH cy
Ġv ial
Ġr uthenium
st rong
ir idans
ĠB ex
ĠB OB
ri ally
ĠD J
ĠD h
ĠD min
ĠD ev
ĠD ensity
ĠD MDR
ĠD ido
ĠD ameshek
ĠF a
ĠF FI
ĠF BA
00 69
ĠS ir
ĠS MF
ĠS UP
ĠS uv
ĠW ang
ub a
Ġun rest
Ġun bound
th en
th ane
Ġne arest
low CD
low ering
por teur
yl and
ĠR oc
ĠR CL
ĠR ational
ĠR yR
ĠR othia
Ġ5 80
Ġ5 57
SC H
SC M
ĠO ld
Ġanti apoptosis
Ġanti tubulin
de acetylase
de hydrogenase
di oxo
Ġtrans crib
Ġmon ocytopenia
Ġ4 75
ĠG yp
ĠG Ã¶
CR A
CR S
ren ds
ĠE CL
ĠE osinophilia
ĠE spaÃ±
Ġhem optysis
Ġsub optim
ari etal
ensi tivities
Ġ7 72
Ġunder c
Ġsup ram
01 12
01 04
Ġ9 44
Ġ9 91
ist al
Ġdem entia
ocy cl
Ġnon transplantation
Ġnon lethal
Ġnon irradiated
ser onegative
Ġpl k
wo od
Ġcor yl
ond on
Ġinter strand
Ġinter leukins
Ġhuman ization
depend ant
11 05
11 28
ch allen
Ġpotential ity
ĠCR D
icin a
Ġhyp of
li ver
12 31
Ġmulti plication
oph ene
act y
act one
Ġep oxide
Ġep inephrine
PM R
PM AS
ĠOS M
ĠV alu
ĠV oriconazole
HD I
ex change
Ġpost partum
ĠAT DC
trans lation
erm oid
Ġconcentr ating
ĠNK RLs
BC GF
Ġav idin
Ġhealth span
Ġbas ically
Ġmit ral
Ġprob ands
Ġhist ograms
23 247
Ġflow cytometric
ĠCh orn
ind au
BM S
IS D
orph onuclear
Ġcompound ed
Ġaz id
ĠRec iprocal
Ġsubt otal
ĠST AB
opro be
Ġu DLI
Ġeven ly
IP RS
ĠHCT s
Ġsynthe sizing
Ch inese
Ġretin itis
AM I
ĠEx pressed
Ġcal modulin
44 1
28 6
ĠCM M
ĠCM olR
CM s
AD E
Ġfree ze
99 13
Ġrest ra
Ġhydro carbons
jug ular
47 92
ĠDC E
ĠCyt ok
opy ruvate
Ġhospital ised
Ġpep tidomimetic
97 3
Ġangi ocidin
ĠPR s
ĠPML RARalpha
oper azine
Ġpredomin ates
46 9
ĠClinical trials
ĠZ IP
ĠAL D
WT H
Ġrational ize
ĠGM CSF
ft pb
315 7
ĠJan et
Ġ58 9
Im plications
Ġdep ot
Ġgo es
ĠNB R
61 95
Ġvin yl
Ġ59 4
ĠAb undant
Ġemb oli
ĠCAR M
Ġevol utive
ĠAP O
ĠAP TO
bi opsy
ĠRe activity
ĠSM ZL
Ġlys osomotropic
ĠAD GR
Ġbiologic s
ump s
Ġmicrosc opical
Ġmis localized
angi otensin
ĠMed icina
ĠEn ro
Ġhaem ostatic
Ġintern ally
ĠmicroRNAs including
Ġbis phosphonates
ĠSign s
Ġnam es
Ġbacter icidal
Ġrh Epo
agen esis
chlor ambucil
HT N
Ġnanopartic ulate
rand rine
ĠGen omically
Ġhomo zygote
Pro spective
Pro state
ĠHyp othe
Ġimmunop aralysis
ĠFA H
ĠMe ad
Cancer s
Ġradio iodine
Ġalkal i
ĠInt rap
CFU c
CCyR S
Ġplurip otential
otrop y
ĠCE PC
PP P
chrom atin
ĠPharmac okinetics
ime tidine
Ġpen alized
PG J
random ly
ĠGBM s
ĠMi SL
ĠUp front
Ġreproduc es
Ġfer mentation
hydrox ybutyrate
Ġlymphatic s
ĠES AM
Ġhyperp olarized
Ġhyperp igmentation
ĠCycl es
De oxycytidine
ĠPBP K
Ġimmortal ize
Ġallevi ating
ĠHMG N
Ġpass aged
Ġden omin
ĠNE ACT
Ġens emble
vin yl
ĠBr C
Ġdermat omyositis
ĠBI BW
ĠCr ypt
Cons olidation
ĠIncreasing ly
ĠDi et
Ġsegreg ating
transf ect
ĠConc ordantly
olab eled
DMR s
ĠÎ³Î´ T
PU MA
SK Y
Cr kL
Ġsap onins
Ind oleamine
Ġadren omedullin
Î¼g RNA
Ġinterpret able
ĠEt v
iflu operazine
Ġnom inal
ĠNP Y
ĠPa Ca
Ġundes ired
PET HEMA
riap ine
ĠErythro poiesis
omark er
ĠHom ology
ĠLI alpha
ĠNeuro blastoma
naph thoquinone
ĠNPs N
ĠMuc orales
Ġunsu ited
Ġsimpl er
lact osamine
Ġseed s
Ġpolys omy
ĠMar yland
ĠUltras onography
ĠFU ra
ĠFl T
ĠBar asertib
ĠDeath s
Fif teen
Ġphoto affinity
Ġspermat og
Ġglomerul i
ĠProphyl axis
region al
Ġintrav ital
fuc osyl
Ġdiac ylglycerol
Topo isomerase
Py MT
ĠPy k
Ġpione er
414 23247
emin omatous
693 955
ĠHY U
Ġ894 999
ĠFed eration
ĠQALY s
Ġaccomplish ments
Brom odomain
ĠBX H
TIG IT
Ġarr ival
Ġchin ensis
2120 90
Ġdiaz iquone
ĠIso lex
Ġaccent uated
ĠPrednis one
ĠRX Rs
inish u
Ġgan gl
IÎºB Î±
ĠNote worthy
ĠLH ME
complement ing
Ġaur anti
Ġpu romycin
Ġradioisot ope
ĠChallen ges
Ġreluct ance
Ġequiv ocal
Ġtin y
Ġmitoc an
ĠPON TIN
Ġcongr uent
eph one
ĠMAR K
Ġpus hed
symptom s
gne tically
ĠScutell aria
Ġintox ication
Ġuncontro llable
Ġpolyoma virus
0444 9913
Ġnanod rug
Ġafl ibercept
Inv estig
Wi SE
GalNAc OH
synucle in
1290 81
Ġneurotrans mit
cephal us
Ġepox ides
Ġnatri uretic
FIR I
Ġhyperuric emia
ĠBrug ada
EUD RACT
oik is
ĠAck nowled
Ġsuboptim ally
Ġsupram olecular
PMAS G
ĠChorn obyl
7 70
7 388
8 29
8 42
A ug
A sian
A berrations
B al
C lassification
D OR
D NP
D MDR
E to
E vent
F etal
F FL
F lav
G i
I MS
K SR
M ER
M orpholog
M unster
N p
N EC
N LRP
N DRG
P IP
R ing
R FA
T CTP
T eff
T UG
T aq
T NTs
V OR
V GS
V UD
Y AP
a UPD
b ies
b ronchial
d isp
f r
f ollicular
h sa
l uc
m ode
m essenger
n I
t omy
u tility
Ġ ].
Ġa monafide
Ġa gnogenic
in ent
re pression
re action
ti que
on oids
on atal
Ġc M
Ġo esophageal
Ġs po
Ġs terol
Ġs irtuin
Ġs CLU
Ġw ished
Ġw aves
or ations
or ds
el ia
el igibility
Ġd w
ic ts
ic tions
Ġre ward
Ġre evaluate
Ġre initiate
le omycin
Ġ( ,
Ġb arb
Ġb EMD
id ae
os ic
om otor
om nia
ul dering
Ġh o
ĠA ISA
em ph
ĠT i
ĠT AS
ĠT rends
im ers
Ġcell ulitis
Ġpro MMP
ĠC w
ot actic
un ate
gen otyping
if ene
Ġis oc
Ġst ays
ĠI CP
Ġl umb
rap amycin
ĠM MS
op ram
iv inostat
ab lastic
ab eta
ĠP PR
od iamine
ĠH IN
ĠH undred
tiv orum
Ġv edotin
Ġr K
ĠB O
ĠB road
ap ro
ĠD IPSS
ĠD river
ĠD elivery
ĠIn ducible
ĠF ANC
00 34
ĠS AS
ĠS FI
ĠS emi
ĠS IG
ĠS ecre
ĠS pleen
Ġun transplanted
Ġun licensed
Ġmut ator
ĠN V
ĠN CD
ĠN SCs
ĠN SE
ĠN HE
Ġco localized
ular y
ĠR NP
ĠR RT
ĠR ank
Ġres ampling
ess el
SC L
ĠO PG
Ġrem ind
iz ole
tem izole
Ġ4 56
ĠWe ighted
ĠG VAX
ren s
ĠE up
Ġhem o
Ġimmun izing
Ġse pt
Ġactiv in
Ġsub enti
Ġout dated
ĠL Z
ĠL on
ĠL ox
ad ec
ad olescents
eu rop
01 37
01 27
genetic s
Ġcan y
Ġnon viral
Ġnon comparative
Ġ8 50
ast in
Ġbi of
Ġallo transplanted
ĠK C
ĠK inases
Ġobser vers
AB SCT
ill ion
av alin
og ranin
KI s
Ġra ds
Ġconf lu
ne utropenia
ĠMD I
Ġaut onomic
Ġaut opsied
Ġser ver
HD CT
az iridinyl
ass aemia
ex ate
PL IC
20 25
Ġdaun o
Cs s
25 45
Ġcaus ation
AL G
AL IP
blas tin
Ġx yl
Ġx rs
18 46
Ġtr ivial
Ġtr ifluoperazine
ĠIm plementation
Ġthromb ocyte
ĠMP V
zym a
Ġbenefit ing
ĠRA M
MA LT
ĠCN I
ital opram
Ġpharmac ist
CN I
umour al
Ġins omnia
allo reactive
ĠTP R
IP AM
Ġcent uries
Ġlip ogenesis
yb enz
ĠEx on
Ġsp iri
Ġ29 6
28 97
28 558
inf ant
AD I
Ġmes o
EB E
Ġcardi o
Ġlocal izing
ME D
ef inostat
Ġpep M
ĠPR alpha
ov atol
ĠWhen ever
Ġ39 6
ĠInte rest
SA MD
ĠPre gnancy
Ġorgan izations
pos ures
Ġrational ized
Ġnan oliposomes
Ġtermin ating
ĠImmun osuppression
ĠIV S
Ġconcomit ance
Ġdep ict
Ġiso zymes
SD KP
59 1
Ġsw ift
del alisib
mod ality
Ġill icit
Ġpa rous
ĠHD MTX
Ġminim ising
Ġenvironment ally
ĠSM AC
tes unate
ĠAD I
Ġur tic
ĠTGF B
ĠAr c
rib o
DL X
DL CL
Ġhaem ostasis
ĠRAR s
neum onia
ĠNe ph
Ġpneum atosis
ĠBi Q
non TLD
ĠTCR D
ĠDA MP
Ex p
arn osic
Ġthi ols
Ġarter i
Ġarter io
ĠIT I
ĠIT RT
ĠFOX A
ĠFc mr
Pro gression
Pro gressive
Ġpy rimidines
ped ic
ĠHyp ermethylated
lip osome
ĠMo DC
ĠSoci al
Ġinterf ollicular
Ġimmunore gulation
ĠCd R
Ġsuper sed
Ġintrac ardiac
fil ament
Ġpeg interferon
Ġencaps ulate
ĠStandard ization
gluc ans
Ġsubs cales
ĠImmunohist ochemically
Ġstrength ens
ĠGP IIb
Ġtrim ethyl
ĠTI RAP
De oxy
TRA MP
Ġspectro fluor
Ġneurop ilin
here after
Ġmillion s
ĠMI AT
ĠPred iction
ĠAM H
TA As
Ġastro cytic
Ġdead liest
Ġge ometry
ĠClass ical
Anti gen
Ġpi lo
Val proic
odophyllot oxin
Ġunderex plored
Ext ensive
ĠEN G
ROC K
Ġphyt ohaemagglutinin
sulf ophenyl
Ġadren ergic
haemat ologic
ĠRE LA
Ġbuff ered
myel omonocytic
ĠSI AMs
Ġterat ogen
ĠNH AC
Ġhypog ammaglobulinemia
Re ports
Ġverte brates
ĠCri tically
Ġchondro itin
ĠPLC beta
Ġtit le
Ġsarc oplasmic
Ġlin oleic
Ġile oc
BAL B
Ġhomogenous ly
Ġdnr I
Tel omeres
Ġcompe tes
Ġpopular ity
260 3618
glucuron osyltransferase
pharmac ological
ĠLGL s
MIT O
TOP K
ĠMedi astinal
ĠMedi terranean
Ġana esthe
categor y
Ġabrupt ly
ĠAngi ogenesis
Ġjob s
differen t
Ġaud itory
ĠcT nI
Ġsubm uc
anesulf on
Ox idative
ĠAden osine
Ġsubcon tinent
ĠmHA g
Ġero sion
Ġvibs anol
Ġphagocyt ose
Ġrot ating
Polym orphisms
isopropyl acrylamide
Ġdiethyl stil
Ġcaro tid
HOTAIR M
opa enia
Sw it
ga uge
Ġpall or
Ġreplen ish
ĠMOS ECs
tha wing
0026 1846
ĠAgN OR
cryst all
Ġobste tr
ĠLeukem ogenesis
Ġreshap e
ĠAdop tively
767 491
Ġcystein es
ĠAgon istic
CEBP B
Ġpolyglutam ates
div iding
Ġtranspl acental
Ġepist axis
Ġpseudodip loid
Acl a
Chlor oma
Ġextramed ullar
rames hift
facilit ated
lay ered
ĠPRACT ICE
ĠDick kopf
ĠHid ac
Ġtedi zolid
Ġhob bies
ĠTIP E
ĠMarg aret
Ġplag ued
Ġela idic
Ġdesfer rioxamine
Tw elve
Ġvestib ular
Ġeman ating
Ġargu ably
Ġgab exate
Ġstig mata
Ġauranti um
ĠAcknowled ging
PLIC ITY
Ġspiri tivorum
" ;
5 95
5 80
6 10
7 15
8 77
9 66
A CD
A msa
B OM
B RE
C min
C AC
C BC
C aspase
E OI
F H
F riend
H AA
J CML
L ine
M ain
R ituximab
S terile
T Y
T rip
T iss
T Es
U BMT
V is
X BP
] [
a ults
c ode
c Kit
d iss
e y
f irmed
g os
g ability
g lasdegib
g rowing
g lycero
h avioral
m j
m orbid
n ell
o ylated
p tic
p otential
p Rb
s ack
z af
â ©¾
in ar
he pati
Ġo min
Ġp icked
Ġw inter
Ġm AMSA
Ġm PSL
al ate
or pholin
Ġd UCB
Ġd Guo
er ations
Ġre transplantation
le en
Ġf alc
at p
at r
Ġe uth
om yc
ĠA the
ĠT CC
ĠT ID
ĠT BL
ĠT EC
im ilar
ur onal
ur itic
Ġpro jections
Ġle ishmaniasis
ĠC ov
ĠC MPDs
un responsive
Ġac ylation
Ġas ide
Ġex porter
sp leen
Ġmyelo lip
oc opy
Ġde af
Ġal d
ab sorb
ĠP ersonal
ĠP acritinib
od azole
ĠH PA
Ġv WF
las ic
Ġha ven
st in
ir ation
Ġinc ipient
ĠB GC
ap art
am an
qu estion
ĠD Q
ĠD MSA
ĠD TT
ĠD auno
ĠIn patient
00 83
ĠS AT
ĠS HA
ĠS CAR
Ġcl av
AML L
pro gressive
ĠN CAL
ĠR ELN
ĠR KO
Ġ5 88
ence phaly
ĠO Cs
ĠO UA
ĠO atp
di ol
Ġ4 25
pl ated
ĠE rdheim
Ġimmun oblastic
Ġpre treating
Ġout door
ox oguanine
ĠL IS
ĠL ondon
bin o
Ġpres criptions
Âł Âł
ad ate
ad hesive
tro ducing
Ġ7 23
01 19
Ġdec tin
ocy tidine
Ġnon transplanted
Ġnon curative
Ġnon smokers
Ġ8 80
Ġbi ogenic
ĠK RT
ĠK han
ĠU reth
est atin
est osome
CT OR
11 99
Ġacc idents
Ġprim ate
ĠCR I
av alent
cell omycin
spec ial
og els
Ġimp arted
cc RCC
12 036
ak ers
Ġmulti genic
Ġdisc ipl
Ġme tic
loc ks
Ġam lodipine
Ġocc ipital
tit uted
ĠJ uvenile
ĠJ IMT
Ġvit ality
Ġaut om
tran sition
16 63
omet hing
az imine
17 16
ym e
ym ethylation
33 2
Ġ[ >
ex clusion
Ġpos ter
14 95
19 91
par ate
Ġnucle os
ĠIL C
20 76
BC G
Ġretro transpos
MD F
02 84
ok emon
AP O
Ġmetabol izer
Ġoptim istic
ues e
Ġcr ist
rem itting
ĠRes ear
of ix
Ġaltern ations
rid one
Ġconc erted
IM C
Ġestim ators
osp here
SP E
AF M
AM B
Ġsp asms
75 5
Ġantic arcin
44 6
Ġ29 61
ĠHR MDS
(-) ),
AD PR
Ġ48 6
ÃĹ /
ophag ic
down regulation
Î³ R
ĠNF kB
Ġpoly functional
Ġpoly chromatic
ME A
ĠMY XV
Ġj ournal
Ġglyc opeptides
ru x
AS O
rup pel
ograph ically
olec tomy
ĠQ C
PR F
Ġ39 3
PA X
Ġendothe lia
Ġatten ding
46 3
Ġsepar ase
ĠZ O
Ġdr ift
ĠAL s
Ġcat ch
Ġdegra d
BI D
ĠAN O
ĠImmun otherapies
Ġ57 6
Ġaden omatous
Ġhepat oblastoma
ĠSc ot
FI AC
osyl cytosine
Ġpe aking
Ġacet one
Ġz VAD
bi CEBPA
bi ocin
ĠPV RL
dC l
Ġbl unt
ĠReg istered
micro M
micro gram
Ġshe et
myelo blastic
Ġsl ipp
DL K
lof azimine
ĠPC Z
Ġfl ags
Ġbis acetamide
ĠPU FAs
tid inol
Ġ84 98
ĠDR EAM
NC OA
Ġspecial ty
ĠGen otypes
Ġconst rained
inos itides
Ġdim ethylated
Ġdim orphism
ĠSH M
Ġ97 88
ĠPTP ase
Cy TOF
ang ial
ĠHA I
ĠTen ofovir
Immun oglobulin
ĠBe adC
Ġsulf ur
ĠInd ones
mo CEBPA
ĠMa ffucci
FD D
Ġhisti ocyt
pred ictor
pred ominantly
Ġquin ones
ote re
ĠSup ernat
ĠSpec imens
Ġsoci ety
ĠFB S
Ġte icoplanin
ĠSN HG
ĠMi RNA
ĠPar is
Ġconflic ts
ĠFlu or
ĠTG ase
Hyp oxia
pat ent
Ġbrid ges
Ġ(- /-)
Ġcoinc idental
RS K
Ġcollabor ating
ĠOb jectives
Ġrub ra
Ġrub oxyl
ĠCV Es
py raz
Ag gressive
Ġsial yltransferase
ĠAMPK Î±
Ġsmo uldering
PDGFR Î±
sho ps
prim itive
Ġeduc ating
Hu Ã«
Ġexacerb ating
Ġsubdiv iding
osa hexa
ĠSS c
Ġchel ated
mes artan
tel ukast
ĠMulti lineage
Inf ants
Ġdiver ged
ĠHaemat o
ĠMet astatic
Ġ225 41
ĠHem oglobin
ĠHem ophagocytic
Ġpermeabil isation
Ġradiological ly
ĠHyper diploid
thromb ocyt
Ġinterpret ations
Ġglob e
ĠDef iciency
Â° /
deox ydoxorubicin
Ġsensor ium
Ġseek s
Ġseques tering
megakary ocyte
Ġground breaking
Ġortho pedic
Ġunco upled
ĠEPH B
FOX M
abs ent
sus taining
ĠTaq man
ĠLo oking
Ġtit rated
ĠPr x
Ġimmo bilization
ĠMeas ure
Ġtun icamycin
ij ing
Ġbuild s
male imide
Ġ350 7
ĠAdj uvant
Ġenjo yed
Ġapproxim ated
Ġheterodimer ization
ĠNSC LCs
Ġconserv atively
NCR s
ĠMax imal
ĠBreak through
antic ancer
Ġhouse hold
ĠSepar ation
terp enes
Ġ-- >
nucleotid ases
Ġcave olin
Def ects
Hem ophagocytic
ĠProf essor
Ġbacill us
Ġcareg iver
categor ies
ĠVers us
Ġelectrocardi ographic
Ġcyan ide
Ġsig moid
Ġneurofibrom in
ĠCle aved
Ġaud it
Ġatom s
Ġmatric ellular
ĠZeb ularine
Ġhijack ed
ĠTunis ia
Ġintersp aced
Ġole ic
ĠEs cal
MH CII
ĠBrom odomain
ĠBAC H
ĠAgain st
Ġaqu atic
Ġrew iring
Ġinstruc tive
Ġtrabec ular
peg ylated
Ġwing less
ĠPortug al
ĠPortug uese
Ġsno RNA
Ġconfron ting
ĠEchin omycin
ĠRob o
ĠActiv ator
ĠPME PA
Ġhemoblast oses
2228 001
tubercul ous
Ġspong ing
Ġsurfact ant
ĠOphthal m
Ġthr ust
ĠRemo val
ĠMix l
ĠGa As
ĠWW OX
Ġunrel iable
Ġnanoc aps
Ġlapa roscopic
Ġlitterm ates
Ġvoltamm etry
Ġaeros ol
Ġsubarach noid
Ġmicrob ub
ĠOccasion ally
allop ian
Ġparsimon ious
biqu itin
pow ered
Tes ticular
Ġiden tically
Ġglutamin olysis
Ġspondyl itis
Ġrehabil itation
agit tal
Ġtrin ucleotide
acty ly
Tiss ue
sack ie
zaf ibrate
hepati tis
Ġomin ous
ĠSHA NK
ĠSCAR B
ĠNCAL D
ĠUreth ane
Ġslipp age
ĠBeadC hip
osahexa enoic
, (
3 12
3 16
4 40
7 11
7 44
7 48
8 31
B ER
B etter
B ank
C adherin
D c
D USP
E CG
E ng
F ree
F vs
G lioma
H CR
I AC
I NP
J C
K ettering
L Z
L SCC
L KB
L YN
M CD
M Abs
N BP
P an
P ten
P rd
P otential
Q AS
R EF
S hi
T em
T OS
V AEs
W j
Y T
Y AC
b rel
c hers
f in
h P
h t
h ar
l atform
m c
m HA
n r
u sia
y tid
z f
z mann
in clusive
in stability
Ġt ang
on vul
te sp
Ġp IL
Ġs ild
Ġs ALL
Ġs omething
Ġan oikis
Ġm UC
Ġm ush
ati ds
or ice
or ough
an emia
an nexin
el ian
Ġre expressed
Ġre ject
Ġf allopian
at ran
Ġ( *
Ġb rac
Ġb rand
om ast
ul try
Ġth y
Ġth yrosine
ĠA CNU
ĠA ITL
Ġn ong
Ġn omin
ĠT IR
ĠT igecycline
ĠT ORC
tic les
ur sin
res id
ia p
Ġpro B
ĠC RAC
if est
if uge
ib ed
ĠI SC
Ġmyelo p
Ġl ck
Ġl ivid
Ġl amivudine
ĠM ML
ĠM IS
ĠM enin
ĠM others
ĠM ichaelis
il ine
ĠAML Fusion
ĠP ers
ĠP ancreatic
od ular
ign an
Ġdis assembly
ĠB F
ĠB en
ĠB ML
ĠB ach
ĠB BI
ĠB PT
ĠB onferroni
ap illary
ĠD ck
ĠD OR
ĠIn dependently
ĠIn tensity
ĠF red
ĠF ractionated
tor al
00 44
00 73
ĠS PMs
ĠW SU
Ġun tested
Ġun blinded
Ġcyt otypes
ph ene
Ġk inesin
AML SG
ĠN GR
ĠN ausea
ĠN LCs
ĠN ASH
Ġwe ap
Ġco res
Ġco activation
Ġco administered
ĠR U
ĠR omide
ĠR Es
Ġ5 44
Ġres timulation
Ġev oking
isk ott
âĢ ©
Ġanti par
Ġanti myeloma
Ġen ric
ose greg
Ġ4 18
Ġ4 70
CR F
ĠE omes
ĠE EG
ĠE AE
tr imeric
tr ifluoromethyl
Ġhem im
Ġsub version
Ġover treatment
ĠL Q
ĠL ev
ĠL amin
ĠL ARP
ĠL aser
ĠTh roughout
ĠTh orough
Ġ6 11
end elian
ip ol
ip rid
ari ates
Ġmod ular
so ur
tro genic
Ġ7 25
Ġ7 39
Ġ7 81
Ġro adm
%) )
01 13
01 24
Ġ9 90
ist atin
ines ted
Ġnon ablative
Ġnon cycling
Ġnon mast
osi tes
Ġ8 59
Ġbi lob
Ġmul tivesicular
gres ses
Ġpred ec
Ġpred iabetes
Ġallo antigens
ond ensed
Ġhuman ised
ological ly
ĠU r
ue bl
ch ase
ĠCR h
av ourably
Ġhyp op
Ġhyp ofib
Ġop ted
Ġthere in
loc arb
15 71
ĠJ ud
ĠJ AG
21 90
Ġinte ro
Ġsensi bility
Ġsh ot
Ġsh ik
ĠV ST
ĠV PS
ĠV BL
Ġdi re
tero car
Ġy ou
ycl ic
po lyc
22 97
ym ic
ass oci
ĠAl teration
ex clusive
60 5
PL ZF
af etinib
Ġhetero trimeric
ĠIL EX
ax in
20 2190
Ġdown modulate
Ġsm el
38 6
prolifer ations
trans forming
iqu imod
ĠAs tel
over weight
BC C
AR I
Ġvarious ly
MD ACC
Ġmat rigel
Ġbas igin
ane tesp
Ġgranul omatosis
ST S
ST IC
ĠBM Fs
Ġloc ate
ĠIm pressive
ev asive
ĠCh idamide
Ġbiom olecular
xt nd
ĠAd o
BM IM
ĠAm p
ĠRA NK
MA M
MA U
ĠSt aging
Ġrep urpose
ins oluble
long ation
Ġunf avourably
of ten
BF C
Ġimm ortality
ĠUn balanced
Ġox alate
ĠTP EN
ĠIFN GR
SP NS
Ġhyper proliferative
Ġhyper trophic
Ġlip ocalin
Ġneutrop enias
Ġsp ring
Ġpan ning
Ġpan hand
Ġ35 9
eg L
Ġlen ding
DN X
AD s
Ġ48 3
Ġbur sts
Ġextra hepatic
Ġhyperm ethyl
ĠMY L
Ġglyc o
Ġmale ate
Ġcont ractions
ord inated
ov ani
68 4
nc RNAs
oper fusion
ĠMT RR
77 1
ĠPre emptive
ĠZ INC
Ġorgan ize
Ġorgan oids
ĠY ang
87 8
ĠMost ly
acetyl transferase
Ġrational es
arr hea
ĠImmun ization
RAR B
Im paired
Ġproced ural
ĠRAS AL
005 1
lim id
Ġbeh alf
mark ing
ĠSR Y
ĠRe pressive
Con tro
Ġspon ges
MM SCs
ĠAD s
ĠCo agulation
Ġsep tin
ĠReg istration
Ġur ban
HA ART
ĠSF s
Ġlength ening
ĠId entical
ĠMed ication
ĠAc etyl
CH FR
07 03
Ġbis benzyl
ta u
Ġphospho glycerate
Ġimmunod ominant
ĠBi ochem
Ġuns aturated
chan nel
Ġchemos ensitizer
ochrom ic
ĠDA UR
ĠPKC Î²
ĠBu ilding
oxid ative
ĠCa ution
inos uccinate
ĠMon te
polym eric
ĠMG I
glut aryl
ĠSP AC
ĠSP Cs
ĠAg a
ĠInter ruption
level s
Ġdisapp ears
ĠPL S
Ġrevers ine
Ġlas so
ĠHA MA
RAEB t
ĠEC V
ĠPl GF
quin imex
ĠMa gn
ĠRem aining
NB S
ĠCL B
ĠPDGFR s
sil osis
Ġmyc obacteria
Ġhope ful
ĠLT BP
Mul tic
CCR F
Ġinters ection
organ ized
carb am
ĠCCN G
ĠMSC V
Tran splantation
ĠEnd ometrial
ĠAsp a
BE Z
treat able
Ġinadequ ately
ĠComp uter
ĠHID s
ĠProtein ase
ĠEpigenetic s
ĠHM s
Ġneurop eptide
omorpholog y
Ġcoagul opathies
Ġintrap arenchymal
etabol ites
ĠSV Z
Ġpsyc hiatric
ĠQu iescent
fe asibility
ĠConc ordance
Ġdimethyl amino
ert inib
mes ylate
ĠBT N
ĠEffec t
Ġhypomethyl ator
Ġmultim ers
All iance
ĠIF OS
Ġvers ican
Ġnarrow ly
ococc osis
Ġroom s
Ġpyr rol
Ġglob ulins
bis pecific
ĠDisc rep
Ġanat omy
lav ine
lav inone
Ġrun s
ĠReview ed
ĠSCN T
ĠSI B
Ġlic ensing
Ġburdens ome
Ġmucin ous
Ġpseudo time
enog elin
enog aril
Ġmicrobi ologic
Ġtric eps
Ġmicroorganis m
CMP Ds
Ġabst ract
ĠPr incip
Ġtro lox
Ġtrip eptide
ĠPPI s
Delta Ex
apt omycin
ĠMel anoma
Ġexec utive
ĠSch wann
Ġphosphoprotein s
Ġpolyp osis
Inte gr
ĠOx ford
din itroph
ĠCASP ASE
ï¼ī .
Ġimmunoma gnetically
Ġradioimmun oconjugates
omi phene
Ġdon ated
Ġdon ovani
Ġviro logical
ĠConcern s
Ġepi allele
Ġcham bers
Ġaver aging
Ġcytokeratin s
Ġintrav it
ĠRetin oids
Ġreconsid er
Ġproc aspases
Ġparap silosis
Ġnotor ious
LE CPs
Ġseas on
Ġlogarith m
Ġbypas sed
conjug ating
ĠâĢ ¢
ĠDysp lastic
Ġpalmit oylation
WH IM
ĠNur ses
fibrin olysis
327 65
ADA M
ĠEMM s
TAC G
ĠAU Cs
Est rogen
Ġindo locarb
creat ine
Ġscro tum
eles in
ĠNam ely
Ġanesthe sia
Ġjuxtap osition
Organ ic
ASC O
GW AS
ĠConjug ates
Ġprotop orphyrin
arsen ite
ĠHLT F
Epidemi ological
Ġpermis siveness
tris phosphate
ĠEduc ation
ĠQuantit ation
mechanis m
mimic king
Ġepim utations
oepid ermoid
Ġmegal oblastic
Tre ating
ju ven
ĠMAG ED
Ġmonom yelocytic
ĠZMY ND
ĠRhiz opus
Ġsurpr ise
Hm dUrd
Ġstaphyloc occi
Ġdeconv olution
enec id
Ġintran uclear
Ġtroubles ome
Ġinqu iry
Ġmicromet astases
ucurbit acin
ĠEspaÃ± ol
1128 503
challen ged
Ġileoc ecal
Ġdeaf ness
1716 1961
Ġcrist ae
HuÃ« t
Ġnanocaps ules
Wj l
Ġmush room
ĠAMLFusion Chip
ĠRomide psin
Ġenric hes
Ġroadm ap
uebl a
terocar pan
ĠAstel las
anetesp ib
Ġpanhand le
' '
0 95
0 94
4 22
4 67
5 46
5 83
8 17
8 38
9 20
B AP
B eta
B lasts
C isplatin
D APK
D DM
E LAM
E EDC
F ocal
F usarium
G PS
K Î¶
K EGG
L GALS
M echanis
M ll
M yd
M ix
M MRD
M MTV
M ethylenetetrahydrofolate
N umb
O DH
O tsuka
Q SAR
S HG
S kp
T u
T alalay
V NP
W W
g ran
g raphy
h orb
k illed
l un
m OS
o C
o lymphoid
p d
p ase
s n
s MR
u ard
u til
w est
x ine
Î ·
Ġa HSCT
in dependence
Ġt ell
Ġt il
en ergy
Ġc PARP
Ġc osegreg
Ġo sc
Ġo xime
Ġp I
Ġp m
Ġp aus
Ġp CSs
Ġs GC
Ġan onymous
Ġw ar
Ġm ys
Ġm emor
Ġm ubritinib
al wa
is etron
an lisib
as tigo
ed er
ed ged
es cin
Ġre assess
ar itin
Ġf uran
Ġb utein
Ġe pend
os yn
os terol
os uccin
Ġh MSCs
ĠA x
ĠA lo
ĠA NA
Ġn yst
ĠT anshinone
ĠT span
ĠT otally
si lic
si Mcl
im pro
Ġle v
ĠC APE
ĠC uba
ot umor
et ylation
ac am
ant agomiR
Ġwas hout
Ġl angerin
Ġcon verse
ĠM W
ĠM ART
ĠM sr
il ent
il itis
oc iclib
ĠAML MRC
Ġg zmB
Ġal vespimycin
ĠP riapism
ĠP ersonalized
ĠP gP
od oxorubicin
). "
ĠH IS
Ġv ent
Ġr im
Ġr Nm
Ġcomp ly
ĠB LC
ĠB rc
ge usia
Ġsur passed
Ġad sorbed
ĠIn tention
ĠIn trinsic
ĠF AC
ĠF BP
ĠF els
ĠF ingolimod
ĠS ol
ĠS BC
ĠS ON
ĠS MRT
Ġresp ects
ph rosis
enti st
vel isib
ĠN ras
ĠN icl
ĠN NAT
Ġco inhibitory
ĠR IA
Ġ5 14
com mit
SC A
ĠO OS
ĠO verex
Ġ4 24
Ġ4 27
Ġ4 32
pl atelets
ĠG X
ĠG amma
ĠG IG
ĠG DT
CR G
Ġimmun ochemical
Ġimmun oprote
Ġafter ward
Ġ0 6
Ġ0 34
Ġ0 72
Ġout we
Ġout set
Ġout grow
Ġpo res
Ġtransplant ability
Ġoutcom pe
ip razole
tro se
Ġ7 71
Ġunder reported
Ġunder appreciated
01 20
oth re
oth orax
Ġ8 11
Ġspec ifying
Ġbi CEBPA
Ġlympho kines
34 55
Ġimpro per
rip iprazole
The rapies
ion ate
Ġacc uracies
ĠCR E
av ia
Ġhyp ophosph
og a
CD DO
Ġcontro ll
12 55
cr yptic
IT PR
Ġme p
Ġme is
Ġmicro spec
ĠMD V
fer ons
ĠV HR
ĠV RP
ĠV adastuximab
ĠV iability
ĠV accine
Ġantib lastic
HD Is
omet abol
Ġdi phenyl
53 2545
Ġcytotox ins
22 06
Ġpos ing
Ġpost graft
Ġend om
Î± CD
Ġ14 14
Ġmy DC
establ ishing
ched ule
AL E
roph in
MR M
In formation
In version
Ġgranul oma
Ġtransloc ate
Ġmyel osarcomas
Ġcount y
Ġsaf eg
UN T
04 06
ĠCom ple
ĠCh TCR
03 03
Ġaz adC
asc orbic
Ġimm ensely
ĠUn usual
Ġsubt raction
Ġtri terpene
45 7
ĠOver coming
con version
allo reactivity
IM Cs
80 7
AF T
ĠX V
ĠX q
Ġhyper lipidemia
ĠPro ble
Ġretin ol
AM N
AM kL
100 290
imin ished
Ġutil ising
Ġantic onvul
Ġdys geusia
65 83
65 508
Ġxen o
ĠCl aire
Ġposi tives
Ġmuc ous
Ġmuc oepidermoid
ĠMDR O
Ġmel t
Ġmel ena
Ġmes oderm
Ġdiscontinu ous
Ġche ek
Ġintra oral
ÃĹ )
Ġevolution al
57 6
IF T
Î³ H
pre p
Ġpoly amines
ME S
ĠMY BMIM
ĠCyt ochemistry
Ġgas oline
Ġwid ening
ĠCBF b
Ġglyc ogenic
Ġglyc ans
Ġglyc oconjugates
Ġdeg uelin
Ġarabin ofuranosylcytosine
Ġ65 1
Ġcont rad
Ġ75 4
97 2
PR OTAC
ĠME CP
ĠMT C
ĠMT G
Ġstress ful
FR ET
feren ces
rec overy
Ġ47 1
Ġdr r
87 13
Ġdiv alent
RR s
Ġbro th
glyc olide
Ġtermin i
Ġlo ose
ĠMM s
yr ase
PC yR
fac itinib
Ġcore ceptor
Ġdeacetyl ates
Ġsw ab
del exon
Ġmobil ised
mod ifier
An aly
ĠRe h
MM oR
PV RL
ĠAD D
Ġolig oclonality
Ġshe ar
Ġhypox emia
ĠAr f
ĠAc SDKP
Ġple ura
07 05
07 02
ĠAC LA
ĠTrans ferrin
tid ylic
ĠEv idences
ĠAR S
ĠAR IH
ĠDL K
Ġpowerful ly
orb ital
TNF alpha
Ġnanop latform
chlor oma
ĠTF E
adap tive
Ġmimic ry
ĠCG Is
IG HT
TR L
amil ast
eff iciency
ĠSK NO
ĠBe Wo
101 209
Pre transplant
oming ton
ĠBR IGHT
ĠFT IR
HV D
cons titutional
sh if
Ġfil ters
ĠCL PB
ĠPS MA
Rel apses
back s
ĠFB XL
ĠLe ishmania
ĠSN S
Ġubiquitin ates
auto HCT
oz elesin
Ġpseud op
Ġfeed forward
ĠSo Sa
rad ication
Com orbidities
ĠMod ification
Ġtrim esters
ĠMyelo blastic
ĠSL FN
MI BC
ĠNT AL
De ep
py ridin
Ġhyd atid
ĠNucle oside
Ġfung aemia
Ġglycos amin
ĠHT S
Ly BC
LV D
Ca T
Ġpent oxifylline
FT IR
oxif ene
ĠCyclin A
fluor ouridine
icl amilast
Ġair borne
Ġuro genital
He ad
ĠIF NAR
ĠPPAR delta
Ġdict ating
Ġnarrow er
Ġvacu olar
Ġvacu olated
ĠEff icient
amer a
Br uton
Ġlentivir ally
ĠFN III
ĠPeg ylated
Ġfood s
Ġplau sibility
Ġpocket s
ĠNH AL
Ġadenovirus es
encaps ulating
hyper cellular
Ġsuic idal
Pl GF
oste um
Ġchondro cyte
Ġprecip itate
Ġtal db
imid az
ĠKU MC
ĠNeuro logical
ĠCur ative
Ġlin age
ĠPt rend
ĠTre o
ĠPhosph orylated
CCL SG
Reg ulation
mat rix
Ġenjo ying
Ġoct amer
ĠTes ticular
Ġunil amellar
Ġconges tion
ĠExp anding
Ġprecon ception
Ġprohib it
phot on
TNFR SF
ĠFl k
Ġinstrument ation
mas ked
Ġdon ation
ĠBK V
ĠTun icamycin
Ġrealistic ally
Ġjudg ement
Ġrig id
Ġequival ence
ĠSem enogelin
Ġsponge an
Ġproc urement
afil omycin
Ġdod ec
ĠDys function
Ġappend ectomy
229 1075
Ġharmon ized
tetrap loidy
ĠRandom ization
Germ any
Ġbic istronic
Ġpione ered
ĠPAF c
Ġcapit ata
Ġoncof etal
âĢĻ ,
ĠCe phal
Ġjeopard ize
Ġcongen ers
Ġophthalm ople
rho tic
arf arin
UV BL
ĠpB AD
Ġenfor ce
ĠLeuc ocyte
ĠTrem endous
sep ithelial
swit ched
tus sis
Ġaracyt in
Ġengen dered
Ġanecd otally
Ġgan glia
Neutrophil ic
ĠRos well
ĠNam alwa
ĠDu essel
flur idol
ĠOptim ization
Ġaminoglyc osides
Ġargum ents
ĠCAS R
Ġtheophyl lin
1075 8713
spect rometry
Ġradioisot opes
Ġdithi ocarbamate
Kap lan
Ġavoc atin
Ġnanoform ulation
tap sim
LON p
Ġcytosp in
ĠBlo om
ĠArgent ina
ĠPX D
Ġic aritin
Ġbabo ons
ĠPir ibed
ypro gesterone
degra ding
ĠAntic ancer
alt ons
Ġeup afolin
gem citabine
Ġevac uation
Ġhypert ensive
988 3101
rinogen emia
ĠDarwin ian
Ġpostpon ed
Ġsulfonyl hydrazine
ĠRUN DC
ĠQuestion nai
Ġbottlen eck
Ġgangl ion
2897 047
12036 333
iprid ones
Ġshik onin
EEDC K
horb ia
ĠNicl osamide
Ġoutwe ighed
3455 41
Ġsafeg uard
65508 26
ĠDuessel dorf
ĠPiribed il
) >
- /-)
4 33
5 29
5 013
6 48
7 75
9 44
A min
A CL
B reak
B AG
C ase
C IT
C opy
F es
F indings
F dUrd
G CTs
G reen
H ow
H BE
H Ms
K a
L MR
L ncRNA
M etabolic
N GF
P at
P earson
Q C
R ab
R BPs
T gfbr
V BL
Y D
Z R
a BOM
b rown
c tively
e NOS
f ate
i ren
l pr
m and
m ight
m igration
o int
r IFN
r heum
s ec
s hel
v orinostat
v arying
x azide
z oster
Ã Ł
Ġ âĢĳ
in duc
he pat
Ġo es
Ġs lot
Ġw et
Ġw alls
Ġm ined
al ph
is omers
el e
el ast
Ġd if
ic os
Ġre defining
Ġf illing
at ography
os oma
os olic
Ġto facitinib
om ir
Ġh int
Ġh ints
Ġh ttps
ĠA EG
ĠA MB
Ġn s
Ġn ose
ra min
Ġpro lyl
ĠC ast
ĠC ep
ĠC ER
ĠC UL
ĠC etuximab
ot omies
un ning
gen der
gen otype
et rosis
Ġfor tun
ac quisition
Ġst ark
Ġst ores
Ġst alled
ĠI MS
Ġl uspatercept
Ġcon gresses
ĠM aturation
ĠM yelodysplasia
ĠM endelian
op urine
il encing
oc ardia
Ġg ather
ab alin
ĠP ts
ĠP AB
ĠP urine
ĠP CH
ĠP FA
ĠP HOX
ĠP ositivity
ĠH PS
ĠH Cl
Ġr he
Ġr ises
duc tor
Ġcomp eted
Ġinc o
ĠB arr
ĠB elow
ĠD erm
ĠD ST
ĠD IA
ĠD istribution
ĠIn otuzumab
ĠF orest
ĠS ym
ĠS BE
ĠS ample
Ġun sorted
Ġun treatable
th orax
Ġcyt ot
Ġcyt osin
ph atic
ph rin
ĠN ap
ĠN otic
ĠN omo
Ġco umarin
othe c
ĠR IN
ĠR ober
ĠR NS
Ġ5 13
NA MPT
com pletion
ĠO CA
edi one
edi pine
Ġanti myc
Ġanti psychotic
olog ique
de pression
tem in
Ġper tussis
ĠG uang
ĠE uros
Ġph ylo
Ġhem ic
ĠL umbar
ĠL omb
Ġinf arc
port ant
ome w
ad o
Ġ7 61
01 99
LT BMC
Ġdec orated
Ġdec ursin
Ġnon metastatic
Ġnon favorable
Ġnon homologous
Ġ8 13
Ġ8 75
Ġ8 47
Ġlympho cytopenia
Ġfollow up
Ġinter tw
ĠK ruppel
AB O
AB W
Ġ10 603
Ġsc id
Ġsc lerotic
ateg ic
Ġinvol ution
12 61
oplas t
Ġam l
Ġam n
oph ae
Ġtox oplasmosis
Ġmicro biology
Ġmicro spor
ĠV WF
Ġcol cemid
HD L
az z
Ġ19 51
ex amination
Ġpost transcriptionally
Ġphen yle
Ġphen ocopy
19 00
ĠIL D
DH ODH
Ġend oglin
ĠII a
Ġmy op
Ġmy oglobin
BC S
AR CH
02 47
In activation
Ġ50 3
Ġgranul omas
Ġx anth
04 69
Ġdistin ctively
sub strate
IL E
plo re
Ġter t
ĠWh ites
IR R
ĠRec ords
ening itis
Ġanthracycl ins
CN C
ĠCon A
ĠCon genital
ram atic
SP RY
ĠX G
Ġgu arded
ĠPro grammed
Ġsp ind
28 4
ĠCl osely
inf ants
Ġche ilitis
ĠER O
As n
Ġwhere upon
pre B
>= .
Ġpoly ethylen
Al ternative
Ġmelan ocyte
47 2
ĠCyt ology
Ġprevent ative
39 4
Ġcentral ized
Ġpractic able
ord ered
PR MT
uro xazide
68 9
ob odies
ĠMT Z
ĠBec n
vari ance
Ġcalc ification
Ġcheck ing
Ġpredomin ating
HP F
ĠZ inc
ades ine
HC l
ĠIg V
met te
Ġneuro be
Ġnan oprobes
glyc ogen
79 4
Ġmultic olour
ĠMy Ã©
Ġspl itting
ĠAcc elerated
Ġextrac orporeal
mark ed
anti thrombin
89 4
Ġsw ord
AN CA
Ġpe er
Ġz o
bi allelic
Con tinu
ĠSM ase
Ġlys ines
ĠCo lorectal
Ġur ate
Me CP
col i
ĠPP Cs
Ġintrat umoural
Ġcereb rum
Ġpersonal ization
Ġpersonal izing
Ġpneum ococcal
ĠNon hematological
rs f
Ġpneumon ias
Ġescal ations
Ġinser ts
erc ise
Ġbelie fs
Ġrad icul
09 41
Ġpy ran
ĠSP N
PTD s
au er
ĠAg ilent
ĠTr ithorax
St age
ĠSK Y
ĠChrom osomes
ĠHist opathologically
Pre treatment
Pre ferentially
mo bil
ĠHuman Methylation
anth rin
olip in
Â® ),
Ġras buricase
Ġval spodar
ĠCL DN
haplo type
Ġincon spicuous
Ep id
Gr b
ĠHU WE
but hionine
but yric
Ġpen is
ĠSC Es
rox yprogesterone
Ġperox iredoxin
Ġmyocardi tis
022 9
ĠBET P
Ġgold en
Ġintercal ate
ĠaCML s
ĠCCN U
erythro blast
ĠMin i
ĠMAGE A
Ġsubd istribution
ĠSyn decan
FM CA
amp icin
Ġneurop athies
Ġden gue
Int ensified
ĠCirc ular
Ne oplastic
pur ging
Ġshap es
Ã¼ n
transf ection
ĠGA VE
Gen eration
ĠOp en
Ġhypo acetylation
Ġfo etus
Ġanth raquinones
Ġec ological
Ġrene wing
Ġidenti ties
ĠLys ine
Ġmicron s
Ġimped ance
Ġphenyl acetate
ĠMB q
Ġpyro ptosis
Ġmyeloblast osis
ĠHem orrhage
meth anesulfon
ofib rosarcoma
ĠHyper CVAD
Ġultra deep
langi ocarcinoma
add icted
Er yt
udes onide
Ġdomin ates
Ġdomin antly
ĠHo ok
Ġperi portal
ĠBis pecific
ret astatin
ĠSI X
elic a
Ġpel lets
Ġmorpho lin
rp S
Ġconve ying
ĠPLC H
ĠPLC Î³
ĠPr k
Ġharness ed
ĠPhosph atidylinositol
Ġbud get
ĠNIL G
ĠMat rix
Ġvas o
Ġdere presses
Mit ogen
Ġdestabil ized
Ġdestabil izing
methoxy estradiol
Ġunveil s
Na B
Ġdeoxyribonucle otide
wal d
ynchron ous
ĠUltras tructurally
Ġmineral ization
Di rect
ĠOcc upational
Ġhydraz ide
Ġasynchron y
Ġchor ionic
Sup pression
Ġweb site
ĠrHu G
ĠrHu EPO
ĠRandom ised
ĠMedi ator
Ġarachid onate
clus tered
thol omew
Dec reased
Dec ember
Cur cumin
Pred ictive
Ġdissimilar ity
Ġrham noid
Mc Abs
ĠPanc ytopenia
Ġoverestim ation
Ġforec asting
ĠSplic ing
Ġenteroc occal
Dys regulated
tan ide
quadruplex es
NAD PH
trac king
ĠBrief ly
medi um
ĠChallen ging
CLA RA
new ly
ĠInnov ative
Ġcit rus
imm ortalized
ĠNEM O
ĠExc iting
Ġviol aceous
Ġneighbor hood
ĠLef t
Ġanthracyl ine
ĠFOL FIRI
exc itation
Ġinacc urate
Ġbread th
ĠTon B
trosc opy
Ġvertebra e
Ġank le
Ġgon ads
Rem ission
Ġdimethylars inic
Ġfist ula
Ġeditor ial
Ġanthrop ometric
Ġnox ious
Ġfibril s
ĠË Ĥ
ĠDeline ation
phor ase
ĠQB END
Ġspo res
ĠSupernat ants
omast ocytic
Ġhypofib rinogenemia
Ġbisbenzyl isoquinoline
othre itol
Ġophthalmople gia
shel f
ĠNotic eably
Ġinfarc ts
Ġrhamnoid es
' (
- </
0 80
4 27
4 36
6 96
7 03
7 26
7 45
7 40
8 32
A di
A dC
A NAE
C arcin
D cl
F red
G p
G ain
H MBA
I on
I CIs
J UN
L indau
M as
M PM
N ST
N LC
N LG
O PC
P eptide
P sim
R GG
R Fs
S NA
S out
S PM
T AK
T hough
T MTP
V ec
V SV
V accination
W I
W t
X RT
Z eb
b randed
d ue
d iam
e osin
g iven
i tem
i tively
n odes
n avitoclax
o ate
p P
p ic
p rem
r or
s ine
t RNA
t anthrin
v r
v ital
w ave
x CD
y rone
z s
Ġ {
Ġ ell
Ġ encephal
Ġa u
in ner
Ġt onic
Ġt efinostat
re tro
ti ter
ti zed
en otransplantation
Ġc am
Ġc HSP
Ġc FLIP
Ġc imetidine
Ġo ocyte
te c
Ġp he
Ġp ineal
Ġp HTN
Ġs HD
Ġs phen
Ġs VEGFR
Ġan omer
Ġan xi
Ġw arfarin
al tern
al cohol
al ternative
is ocitrate
an um
ro blasts
it azones
ent ri
ent ary
ent ry
er atinib
es sion
Ġre analysis
ar se
ar inone
Ġf ati
Ġf als
at adine
Ġb reas
ation wide
id azine
Ġto cil
om orph
om acet
Ġh umer
Ġh iPSCs
ĠA MF
ĠA RP
ĠA HSP
ĠA ffected
Ġn r
ĠT au
ĠT AX
ĠT oward
ĠT riapine
ĠC ES
ĠC itro
un insured
et ocho
Ġfor ks
Ġex ces
se al
se ro
ĠI delalisib
Ġl or
Ġl ing
Ġl umi
ĠM af
ĠM orph
ĠM igration
ĠM egakaryocytes
ĠM EBE
op rop
op ulations
il m
il es
um ar
Ġcom ment
Ġim balanced
Ġg MDSC
ab d
ĠP i
ĠP SCs
ĠP HL
ĠP amidronate
ĠP emetrexed
od il
od eg
ĠH ann
Ġv entral
Ġdis ag
Ġr ation
ff i
ĠB Cs
ĠB iod
ĠB leomycin
anc ytopenia
ap arin
ri er
ĠD W
ĠD OL
ĠD AN
ĠD urations
ĠIn complete
ĠF yn
00 24
00 42
ĠS X
ĠS AG
ĠS PT
ĠS UR
ĠS Ã£o
ĠW itness
Ġun induced
Ġun MGMT
th res
Ġcl ivus
Ġcyt opathology
Ġat m
Ġat tested
Ġmo tile
por ph
pro gram
pro lyl
ĠN W
ĠN ature
ĠN ortheast
Ġco ined
Ġco herence
Ġco injected
ĠR ating
ĠR LI
Ġ5 01
Ġreg iments
Ġeffec ting
di um
ĠG ray
ĠG CK
ĠE ED
ĠE cho
ĠE zetimibe
tr ich
Ġfac es
rac tical
ox ome
ox aline
Ġfactor y
ĠL at
ĠL ately
bin ol
Ġob jec
Ġ7 97
Ġ7 91
01 54
oth ymidine
Ġnon complete
Ġnon consolidation
Ġ8 055
Ġma iled
ct GMCSF
ĠDNA emia
ĠK ATO
ĠK idney
Ġ10 60
ĠU E
ĠU bx
ĠU GCG
Ġman n
ll a
ĠCR VO
Ġimp ractical
ucle ate
min or
cent romeric
12 147
ten y
Ġam end
Ġocc ured
ĠJ mj
Ġ12 10
ne utropenic
ĠMD X
Ġep ip
13 11
CL CA
ĠV LR
ĠV LP
ĠCI HDAC
Ġref lex
22 78
ĠAl dehyde
ex ponential
line al
Ġpost infusion
eri enced
Ġem itting
Ġblast osis
ism odeg
Ġend opeptidase
Ġdown ward
ger minal
vo id
HR S
Î± LA
Ġmy o
Ġacid ity
Ġconcentr ative
gra dation
AR Bs
les ter
ST C
Ġx ant
Ġder ailed
Ġprec ancerous
IC P
IC ER
Ġ60 9
Ġcap ping
ura m
BM ED
Ġcarcin oid
ĠRA NTES
MA F
plo iting
CA RD
Ġox az
CN KI
NK O
elph i
gi os
DA UN
oh yp
Ġdispl aced
88 1
Ġgu ardi
Ġhyper inflammatory
Ġreal izing
Ġlip osarcoma
ĠPro MACE
AM oL
Th iop
ĠCM K
ĠCM GA
ĠCM GAs
Ġlink ages
Ġfib rom
Ġgl itazones
Ġadhe siveness
ĠCP P
99 1
ĠER Y
As c
67 76
Ġpoly chond
ĠRT EX
ĠCyt ometric
Ġregres sing
AS I
amin obut
ograph ies
Ġ44 2
Ġpractic ed
Ġgeneral ization
Ġcont racted
ĠPR RT
ĠPR ES
ĠQ Ch
PR RT
ĠME Ps
Ġsor cin
oper ate
ĠTNF AIP
oly sin
ĠPre valence
Ġ56 1
Ġ56 3
Ġsynthesis ed
EL ISPOT
Ġgenome wide
ĠZ he
ĠPI GA
ĠWBC ratio
ĠY ou
ĠAL S
Ġtel ephone
ior idazine
EN U
Ġchemores idual
ĠIV IM
yr ins
Ġsensiti sed
Ġ67 2
Ġ58 4
ĠSe pha
83 13
iche ver
Ġextrac hromosomal
Ġ59 3
aph osph
Ġdeacetyl ating
ĠDAC i
Ġred ness
Ġincom ing
Rec iprocal
ara CTP
ĠRe pression
struc tive
MY BL
ĠAD CP
be yond
DNMT Is
ĠDS X
ĠHSC C
lassi fying
Ġrib osom
pr t
ĠNon adherent
gal ectin
CTP P
Ġvis fatin
Ġuncommon ly
PH Ns
ĠPA LA
arn itine
Ġtelom estatin
HT R
Ġion ophores
Ġasc orbate
Ġuniform ity
CK D
ĠCA AT
inter ference
nine teen
Leuk ocyte
ĠSP O
Ġdig est
Ġpredisp ositions
TR F
ĠGra ffi
ĠSer a
Ġantineoplastic s
St ate
Ġspar gan
Ġoccup ies
Ġoccup ationally
Ġneur itis
ĠBe ijing
present ative
ĠGSTT I
Ġscal ed
ĠTL X
Ġdeox yspergualin
Ġhisti ocyte
Ġinnov ation
Ġfil tered
ĠSA DA
ĠCCL G
ĠPS O
Ep i
plex es
HN s
Ġfinger prints
nic otinamide
Ġmultiplex ing
Ġpara quat
Ap lastic
ĠInf lammation
GC LAC
sur veillance
Ġconflic t
hydrox yc
Ġdip yrone
ĠFLA GM
Chrom atin
ĠAza D
Bs Ab
MI H
ĠTI E
obin utuzumab
ĠSm oking
Ġepig astric
echan ically
functional ized
ĠCy CD
Ġhydroly zing
ĠRep rimo
ĠNE LL
ophyl line
Ġapprec iate
cor responding
ĠFOXO s
ĠLip oplatin
acc el
Ġstay ing
ĠTet ramer
car binol
ĠRB SP
ĠCal pain
galact ose
Fox M
Ġsap acitibine
Ġ(â ©½
Ġhex anucleotide
ĠRE V
histi ocytic
ĠTB RS
TN FSF
Ġunsuccessful ly
inted anib
ĠTH BS
Sm ith
ĠNP AS
ĠPDX K
ĠCOL O
ĠGas tric
Ġmorpho cytochemical
ĠEst rogen
sus tained
gel atinase
Ġgyn aec
ĠLo e
cont aminated
sal t
engine ering
Ġsubstanti ating
naph thal
Ġtun e
ifug ation
continu ation
propor tional
Ġsimpl ifies
ĠART S
Ġseed lings
Ġextrap olating
ĠMic roscopic
Ġta uro
Ġfoot print
almit in
Ġinhal ed
omi Rs
ĠBar riers
DD IT
Ġreposition ed
ĠICB s
Ġdeoxy uridine
ĠFI BA
Accum ulation
ĠMt g
ĠChi CTR
ĠDE VD
ĠhE ag
smok er
hetero zygosity
Ġpod ia
Ġredi rects
Ġsymmet ry
Ġepiderm oid
tra umatic
Ġmisinterpre tation
Ġ253 6
Ġdenat ured
conjug ates
ĠCe acam
ĠKY SE
ĠHelic ase
657 6776
dODN s
Ġgr ise
Ġscr atch
Ġpix els
ĠVL B
0012 3474
Ġenfor cing
Pharmac ological
Ġoverestim ated
Ġcholest asis
MPR IN
junctiv itis
ĠPercent age
statis tic
statis tically
Ġoutbreak s
ĠSO FA
ĠThi oflavin
Fl k
osphing osine
cn LOH
Ġillumin ating
Ġars entri
elev ated
ĠPropor tional
Ġneuros urge
ylox ycarbonyl
Ġenvis age
Ġaliqu ot
ĠNeutral izing
Ġimip ridone
Hist amine
ĠInnov ations
Ġnig er
ĠSLL P
anthrac ene
Ġcertif icates
Prolifer ation
perme abilization
ĠGv T
Ġquinazolin ones
ĠHung ary
cT nT
Ġmiscarria ge
ĠBCA A
Ġgrant ing
Ġelectrochem il
Ġneoin tim
ĠSoft ware
Ġantidi uretic
Ġcouns elling
Ġglutathion ylation
ĠJe ho
ĠACB Rs
Ald rich
Ġantihist amines
ĠPedi atr
Ġcaver nous
ĠFrancis co
Ġunrest rained
Ġrestra int
Ġisoc ratic
ĠLon afarnib
2297 141
Mechanis ms
ĠProble ms
Ġanticonvul sant
ĠCephal otaxus
ĠCast leman
ĠMyÃ© lo
Ġradicul opathy
ĠPrk ch
Ġanxi olytic
Ġfals ely
Ġbreas ts
Ġtocil izumab
omacet axine
Ġhumer us
ĠCitro bacter
Ġexces sively
12147 254
ismodeg ib
Ġpolychond ritis
Ġarsentri oxid
' :
) %]
3 002
4 34
6 26
7 88
7 66
7 42
7 96
8 60
8 46
A AD
A nd
A round
A ID
C ap
C ardiac
D aun
G v
G lobal
G lasdegib
G ADD
I AG
J ECT
L CM
M ortality
N N
N ove
P ure
P HD
P AK
P EP
P otent
P TCH
R x
R uxolitinib
S j
S HR
T ag
T RD
T HU
U H
W ide
c ope
d P
d ac
d ock
e es
e val
e ters
g un
g Rs
h nRNP
h QPA
i lo
l one
m ember
p C
r unt
s uccin
s ensitize
t ine
u ously
w en
w ares
x enograft
y las
y rimidine
z a
â Ķ
Ġa C
in er
in ition
in ones
Ġt ion
re combin
re aching
he zia
Ġc ute
Ġc ostim
Ġo ught
te b
te langi
Ġp odophyllotoxin
Ġp terocarpan
Ġin quiring
Ġs CAR
Ġs kelet
Ġs FasL
Ġm ercury
al azoparib
or able
is tem
is otopic
an im
an other
el algia
Ġd ent
Ġd iester
Ġd TTP
ic us
Ġre occurring
Ġf ile
Ġb Zip
id ze
Ġe phrin
os h
os itol
Ġth ioridazine
ĠA OM
Ġn itrate
Ġn ests
ĠT LT
ĠT IA
si as
si ves
im b
im ally
im ides
Ġpro active
ĠC ure
ĠC ong
ĠC osts
et rexate
et uin
ce gene
Ġas part
se ver
Ġmyelo ic
ĠM Î¦
ĠM echanically
op tic
op ause
op erated
up take
um on
um ine
Ġim ported
Ġal bino
rom o
ts s
Ġch yl
Ġch ym
ĠP ut
ĠP aternal
ĠP okemon
ĠH op
ĠH AD
ĠH Ã´
ĠH ighest
Ġv igorously
red ited
Ġr t
Ġr yan
Ġtran sepithelial
ĠB ryostatin
ĠB ilateral
ge oning
ap o
ap orin
qu al
qu amous
Ġad nex
Ġad sorb
ĠD AB
ĠD og
ĠD MF
ĠF uc
ĠF ix
ĠF BL
ĠF DP
ĠF ocal
00 21
00 86
00 61
00 74
ĠS eg
ĠS tenotrophomonas
ĠW S
ĠW ales
ĠW iskott
th alidomide
Ġcyt oxan
ph ases
pro gres
pro voked
ie x
ear ning
ĠN DN
ĠN umbers
Ġco localization
ĠR ictor
SC R
ĠO AP
ĠO per
âĢ Ī
Ġanti tub
Ġrespon sibility
Ġtrans activating
Ġ4 29
Ġ4 90
ure tics
Ġgen ders
ĠG raph
ĠG FM
Ġinv ariable
Ġse ros
Ġtumor ogenesis
Ġsub sp
Ġsub variant
Ġ0 7
ormal in
ĠL ST
ĠL IG
ĠL eptin
ĠL isteria
pho resis
Ġ6 19
end o
end ron
Ġhe al
Ġcyto gen
dition s
ad iaz
tro duced
Ġ7 33
Ġ7 67
Ġ7 82
Ġunder methylated
Ġunder diagnosed
Ġmal function
01 03
Ġprognostic s
Ġmic onazole
Ġpar af
ocy anin
ocy temia
Ġnon optimal
Ġnon small
Ġallo responses
Ġpl ain
ct DNA
ĠK MS
ĠK Cl
ĠK lotho
AB V
ĠU O
ĠU rine
ĠU bc
reg ulators
ill es
ch ic
ĠCR c
Ġtime point
12 06
12 462
Ġconf id
ten ess
cr y
Ġmulti resistant
Ġdisc o
Ġdisc ouraging
Ġnum eric
Ġmyelodysp lasic
ĠJ asp
ĠJ EG
13 77
Ġcoun term
az e
Ġdi uretics
Ġregul atable
ĠAl vocidib
19 83
par allel
par acrine
Ġnucle otid
Ġend ure
MP V
Ġmor ning
Ġprop ria
Î± KG
Ġdaun orub
Ġes c
ise q
05 8
Ġoverex presses
the se
Ġnovo biocin
Ġcolon ize
ĠAn ecd
23 65
Ġflow er
Ġphosph ates
ĠCh ile
Ġmonitor s
Ġprote oliposomes
30 25
ĠDNMT Is
Ab breviations
Ġ25 00
ethyl enediamine
MA s
ĠSt ability
ĠSt ress
yn amin
Ġter rest
Ġaz ac
ins urance
och lor
Ġcontinu ity
Ġclon ogeneic
lob ated
of requency
ĠUn known
CP S
ĠPD MP
rid il
ĠCT SG
Ġconduc tivity
Ġmac ules
Ġmac aques
SP HK
ĠOf ten
Ġhyper phosphorylated
ds RNA
98 01
ĠMR s
ĠMR SA
Ġresearch ing
Ġhom ed
Ġcategor izes
ĠCP EC
Ġmes angial
99 90
Ġche ap
per ceived
Ġexpl ant
Ġexpl orative
acet one
Ġbur geoning
Ġextra gonadal
lympho blasts
Ġven om
RT Q
Ġ34 6
rone phrosis
97 88
ĠPR OX
ĠQ U
Ġmeg abases
ĠCC gRs
lor a
ĠKIT LG
Ġimmunohist ology
rec iprocal
Ġderiv ates
ĠZ Y
Ġ% ]
Ġlo osely
allel ically
ĠRAS GRP
Ġrepro grams
Hodgkin s
Ġiso electric
ĠCMML s
Ġemb rac
PI A
ĠÎ± IIb
ĠOr ig
Ġz idovudine
ĠAD Es
ĠPK S
ibr itumomab
Ġbl isters
Ġsignals ome
008 01
Ġbor ne
ĠCH X
ĠCFU s
Ġmis diagnos
flu ence
Cyt aBOM
turb ed
ĠNe o
Ġcarb amate
ĠTrans mission
Ġtrac es
Ġphospho peptides
Ġpneum othorax
ĠBi ology
Ġimmunodef iciencies
DM H
Ġtet rach
Ġtet randrine
aden opathy
)] -
HT S
Ġsoft wares
Ad V
inter ventional
Pro longed
Leuk aemic
Ġpy rone
Ġimmunop eptid
bo ok
Ġaggreg ometry
Ġbios imilar
Immun ohist
Ġmil tiorrhiz
lig ibility
quin avir
quin azolin
Ġencoun tering
Ġtom ographic
ÎĶ ÎĶ
ĠPost treatment
cons id
Ġpal m
haplo insufficient
ĠNor we
Ġca ught
ĠTT FT
ĠAng elica
Ġubiquit inated
Ġmono amine
Ap pro
Ġpor ous
ĠDel aying
Ġfer tile
auto BMT
ascul ature
ĠMod ified
Ġenl ar
ĠAug mented
Ġlymphaden opathies
Chrom othripsis
ĠAI MP
mer captop
Ġmand ated
Ġinadequ acy
Ġhyd ronephrosis
Ġribonucle ase
ĠMan ifest
syn ergistic
ĠLin omide
cardi ography
ĠNE H
ĠTM Q
Ġsperm idine
Hu G
benz ene
Ġdeoxynucleotid yltransferase
Ġscaven ge
fluor odeoxyglucose
Ġfin ishing
Ã© m
yal gia
ĠCal mette
ĠPos sibly
Ġnotic eably
dimethyl amino
ĠSil ibinin
Min imally
AI EOP
Ġimmunocomp etence
ĠLeu cegene
Ġoncom i
(Â® ),
Ġgranular ity
ĠPhen otype
ĠPhen formin
ĠGR K
dia phorase
Ġgingival is
Sc le
ĠPol and
ĠRO BO
exp erienced
His torically
ĠShort ly
ĠContinu ation
ĠNP Cs
Ġhub s
dis parate
Ġmacroglobulin aemia
ĠMuc ormycosis
Ġgangli one
brom odomain
Ġhematoc hezia
Ġdestro ying
ĠCEBP Î²
Ġoligodeox yribonucle
benef icial
Mit ochondrial
ĠTechn iques
Ġmax illo
phosphatidyl choline
More over
Ġnaph thoquinone
almit ate
ĠHF E
ĠBar tholomew
Ġrup tured
Ġcef epime
ĠRestor ing
Ġds DNA
Ġpayload s
ĠZn O
nitroso guanidine
ĠHan over
Ġequival ently
sial yltransferase
Sup pressor
cyclo hexyl
Ġdeoxyc ytid
Ġgelatin ous
ĠMX D
ĠSi lymarin
Ġpriv ately
Ġsucces sion
ĠPresent ation
DMA G
ĠAngi opoietin
ĠLact ate
Ġconsent ing
Ġchori o
Pred iction
Ġdan azol
Ġillum ination
ĠProp ensity
ĠFcgammaRII B
Ġdisabl ed
ĠVaria bility
ĠIntrat umoral
Ġrhyth ms
Col ony
Ġdib utyryl
Ġstret ches
Ġvitreoretin al
Ġanhyd rase
ĠClostrid ium
star ved
Ġanis otropy
Class ical
Thym oglobulin
ĠTur key
ĠNeutral ization
Ġdithi othreitol
typ ic
Rad otinib
arag inase
ĠCry opreserved
ĠArgent ine
differenti ate
differenti ative
Ġtender ness
Ġunsatis fied
Ġwatch ful
foli o
ĠSerb ian
Ġrhinosin usitis
Pseud omonas
opiper azine
Ġsesqui terpene
Ġginsen osides
Ġhyperammon emic
Ġaggrav ating
aglyc one
Ġsati ety
Walden strÃ¶m
Ġargin inosuccinate
itux an
Ġpolyaden ylation
ĠBam HI
Ġgeranylger an
Ġinterconn ected
Ġqueu ine
Ġjasmon ates
Ġgammare troviral
ĠHGS OC
ISR CTN
Ġbrus atol
Ġtachyp nea
Ġschizophren ia
otria zole
ĠAch illes
Ġdenomin ator
ĠEup horbia
europ a
ĠResear chers
Ġhistiocyt oses
Ġsild enafil
Ġthy roglobulin
Ġantipar asitic
Ġbilob ed
Ġintero bserver
Ġshot gun
Nove mber
âĶ Ģ
Ġpterocarpan quinone
Ġryan odine
Ġterrest rial
% </
, )
- )-
3 53
5 34
6 65
6 244
7 709
9 21
> âĪ
A FS
B or
B ase
C assette
C orrect
C heckpoint
D KK
D OCK
E I
E BC
E FI
F ront
F rance
G e
G old
G add
I r
K LAK
L p
M x
M ark
M IS
M VA
O rig
P ER
Q ual
R III
R ING
S o
S kin
S EF
T PL
T rib
V AC
V HR
V ZV
a SCT
a mental
b lo
c N
d f
d h
d ish
d Thd
f inal
f ew
h orm
h yth
k azaki
o economic
p ediatric
s tic
v ular
v oriconazole
x enografts
y lyl
Ġ âĢĵ
Ġa usp
in feriority
re presenting
on oside
he at
Ġc ow
Ġp RB
Ġs emia
Ġs ending
Ġs NKG
Ġm U
Ġm GM
or ide
an omer
el ement
as sign
as parg
it as
er adic
ic ator
le g
Ġf ighting
at ypical
Ġ( </
Ġb ir
ith romycin
os ure
om il
om bs
Ġh NTs
Ġh iPSC
ĠA HCC
ec tic
em itter
ĠT rop
ĠT ER
ĠT RP
ĠT MC
ur gery
ML T
lo us
Ġpro drome
ĠC ran
ĠC MD
ĠC SS
ĠC FB
ĠC MPs
ĠC ables
Ġleuk openic
ac on
ac ia
ant oic
Ġst asis
Ġst alk
ĠI CA
ĠI vermectin
Ġl pa
Ġl entinan
ĠM ong
op enta
iv arox
Ġcom mission
Ġcom utation
Ġim ag
ol enic
Ġde aminated
Ġg ly
Ġch ymotrypsin
ĠP PMs
od icentric
ĠH SL
ĠH airy
ĠH HEX
Ġv ismodegib
Ġor derly
Ġor meloxifen
Ġr in
Ġcomp osites
ĠB J
ĠB HRF
ap ant
yp ed
ri o
ĠD us
ĠD PMNs
ĠD ifferentiating
ĠD KC
ĠF inding
ĠF ram
00 76
ĠS q
ĠS MR
ĠS IL
ĠS itu
ĠS ulf
ĠS CM
ĠS teroid
ĠS usp
ĠS elinexor
ĠW inner
ub stituted
Ġun per
Ġun involved
Ġun transfused
der mia
ow a
ear t
ĠN ALP
Ġco lo
Ġco arse
ĠR K
ĠR obin
Ġ5 75
one ogenesis
ĠO W
ĠO BF
ĠO TS
ĠO VC
Ġmar ried
Ġreg aining
all ic
all antoic
cl onogenic
spl enectomy
ĠG U
ĠG ran
ĠG AD
ren gth
ĠE DC
ĠE CFCs
ĠE ligibility
Ġinv oked
Ġmet aplastic
Ġimmun oc
Ġimmun olabeling
Ġno ise
Ġno tified
oun ts
Ġsub chronic
Ġsub variants
Ġ0 2
Ġhemat opathologic
Ġ6 13
DS T
row s
ip ped
lud in
we ak
ad one
Ġ7 69
Ġmic row
Ġ9 000
Ġcan ertinib
Ġall ied
Ġ8 41
ses thesia
tin ence
Ġallo immune
ĠK IS
ĠK NT
ĠK arach
Ġblood s
AB I
aus sian
ĠU CHT
Ġacc redited
Ġfe ared
ysp lastic
cy tidylic
Ġsec urin
Ġra y
ber ry
Ġdisc s
Ġam orphous
Ġqu o
ĠJ I
ĠJ SH
Ġtox ophore
21 71
ĠCI CC
Ġy es
53 63
22 38
22 49
22 68
ĠAl b
Ġpos ses
Ġexam s
ici ally
af ur
plic on
Ġem ulsi
Ġnucle atum
Ġ20 60
Ġhetero cl
ism uth
Ġend ophytic
MP C
ĠML Cs
Ġ14 94
gra fter
ranul in
AL s
Ġonc otherapy
AR ID
the sias
02 37
18 26
Ġthromb oxane
ĠMP R
Ġmetabol ome
Ġunc heck
oss a
ĠAd P
Ġblock ades
sub eroylanilide
ĠJAK s
Ab M
ĠRA E
Ġrandom isations
ĠSt ra
ĠSt ron
Ġpromyelo id
Ġany where
ĠAt tention
Ġeng ages
CA FC
ening oencephalitis
ĠUn its
Ġsubt yped
Ġins ectic
con ditional
con sisting
Ġu MR
PD C
ĠPD N
Ġelev ates
osp heres
Ġmac rophagic
Ġdispl aces
ze ylas
Ġreal time
Ġmedi al
Ch E
ĠWith drawal
Ġ27 80
imin o
ĠMR PL
75 2
Ġenro led
ĠCl pP
Ġposi tivities
inf used
inf ections
Ġgl imp
Ġcategor ical
Ġthrombocyt opaenia
Ġemerg ently
des methyl
Ġ48 7
57 9
Ġhydro gel
pre valence
Ġdecision al
cap t
TP R
ĠDC lo
ĠCyt o
Ġwid en
Ġmacro cytosis
Ġmale imide
49 7
49 88
Ph f
ĠPR OTAC
ĠQ CC
Ġligand ome
Ġdet ach
oper ational
ĠET osis
77 62
Ġtransl atable
ĠPre B
46 94
46 437
ĠZ arnestra
ĠY inishu
Ġquanti fies
Ġscreening s
met HuG
Ġampl if
Ġfat hers
Im m
sc ores
Ġdep icts
Ġdisrup tor
Ġreactiv ities
fac ts
Ġ49 1
BL STM
ĠFour th
anti plasmin
Cd elta
AN OVA
Ġpap ul
Ġvol atile
ĠRe plication
ĠÂ °
MM s
Ġbio assays
Ġepid oxorubicin
ĠOnc ogene
Ġolig omonocytic
Ġparticip ant
ĠCo upled
ĠCo ombs
Ġear ned
Ġshe ets
be am
ĠCH MP
Ġaspec ific
Ġpain ts
NT X
ĠAr sen
Ġelectro physiological
OT ACs
Ġcarb onic
ĠTrans forming
Ġax ons
ĠSign atures
ĠAR LVD
ĠBi phenotypic
OD Y
Ġbil aterally
ĠPer tinent
Ġchemos ensitized
Ġdex trose
PT H
PT M
hydroxy glut
RIC BT
onc ologic
ĠPA QR
Ġtend encies
atid ic
ĠIDA ol
ĠSP F
ĠNR BC
ĠMo ving
Ġbul lous
ĠEBV aGC
Ġcommun ications
Clinical trials
ĠURD T
Ġoccup ying
mC EBPa
GT G
MO LT
MO MP
Ġsulf hyd
BD D
BD NF
Ġimmuno ad
ĠEM atologiche
chain s
ĠDLBCL s
olip oplexes
ĠPharmac ogenomics
Ġquin tile
ĠCO BE
Gr Ã¼n
ĠFB T
ĠBE VA
OK B
Ġemphasis es
PG K
Ġ110 9
Ġaff irm
Ġencaps ulates
Ġintercal ative
Ġjo in
hom ogene
cycl osporine
Ġcav ities
Ġamelior ating
MAC IF
ĠHC S
oprote ase
Ġintention al
BPD E
ĠDi OC
ĠChan ge
Ġdiges ts
fact omed
TGF beta
ĠTim ely
Ã© mat
Ġge ometric
actin in
ĠHaemat ologic
Ġce ase
Ġread mitted
Ġpi eces
integr ated
ĠEng agement
Ġimped iments
Ġprovision ally
Ġproteas omes
Ġauthor ized
ĠCx cl
ĠNan ocarri
Ġphyt osphingosine
Cr ypt
Ġselen ocysteine
thromb ocytopenia
Ġont ogenesis
ĠDem ethylating
ĠRef ractoriness
Ġtrop onins
ĠTSG A
134 6
ĠTD ZD
rag matic
ĠErythro poietin
oste oc
Ġventi l
Ġcorrobor ating
ĠChar les
ĠVer sion
ĠRG D
Ġile us
ĠPRK ACB
Six teen
otri enol
loro acetate
Mit ochondria
ĠCardi otoxicity
Ġhemangi osarcomas
infusion al
ĠSiglec s
PTC Y
Ġstere ochemistry
ĠPRT N
Ġprohib iting
Ġtriaz oles
ĠBiological ly
By ar
stabil ized
ĠHH IP
599 49
Ġhyaluron ectin
ĠRus sia
Ġentail ing
ĠTY P
ĠLCL s
Ġhydraz ine
Ġerythroblast osis
Sub stantial
Mod el
0015 1255
Mi RNA
Peg C
Peg IFN
ampl ifications
ĠrHu Epo
Hem e
ĠProf ound
hybrid ization
068 127
Ref ractoriness
Ġdesm opressin
Ġmyofibro blast
Ġsacr um
Ġdend ri
epid oxorubicin
ĠExpl oring
Ġfores kin
Ġperfect ly
Ġpigment osum
irin apant
cs bp
ĠElucid ating
Ġhapt ophore
Ġtonsill itis
ĠProp osed
ĠLight Cycler
ĠPhospho inositide
ĠEmb ry
ĠHepat otoxicity
Pharmac ologic
Ġfertil ized
Ġengen der
pyr ro
Ġdendrim er
Ġcard s
Ġwaste water
gly oxal
ĠNI SCH
Ġlib eral
kary otypic
Ġhemip legia
590 22
ĠKE Y
Ġod d
Ġdysm orphic
ĠGNA Q
Ġanthelmin tic
ĠAgN ORs
ĠPOT E
Rib osomal
immunohist ochemical
immunohist ochemistry
Ġsalic ylate
ĠNTR K
akin ra
race utical
arox ysmal
Ġmenstr ual
Ġtib ia
ĠTag raxofusp
0065 1261
953 97
Ġoncomir s
Ġmultiv alent
ĠARHG EF
ĠCaM KIIÎ³
ĠFRO UNT
ĠFE PS
ACh E
ĠDemonstr ation
Ġjejun um
00004 128
ĠMultid imensional
erom in
Ġms DLI
Ġpreadip ocytes
arres tin
Ġerrone ous
bt b
Adj uvant
ĠTratamient os
Ġchylo thorax
ĠSir pa
Aug ust
Ġconflu ence
Ġsubmuc osal
Ġeuth an
ĠAthe rosclerotic
absorb able
resid ue
Ġintravit real
ĠcPARP s
astigo tes
Ġsphen oid
telangi ectasia
ĠLST RA
7709 207
asparg ase
eradic ating
openta ose
ivarox aban
ĠKarach i
2249 650
2268 276
Ġuncheck ed
zeylas teral
Ġglimp se
4694 362
46437 86
Ġsulfhyd ryl
factomed in
ĠNanocarri ers
5 14
5 27
5 47
6 23
6 35
6 190
6 189
7 14
7 43
8 95
8 18
8 80
8 99
> Â·
A hR
B AF
C MT
C CDC
D LC
D BA
D ifferentiating
D icentric
D CTER
E EC
G o
G ab
G reat
G ruppo
H DS
H edgehog
J X
L DC
L MC
M ON
N L
P FI
P ERK
R RT
R SS
S odium
S MAD
S udden
T erm
T LI
T AN
U SF
V ALOR
X T
X change
a ortic
b urg
b aric
c odon
c ultivation
d d
f used
f olding
l r
l rp
o eb
p ital
p urine
r rAML
s amples
t TA
u rafenib
v ah
w ig
w elling
Ġa ro
Ġa il
Ġa CEC
in yl
Ġt ex
Ġt iling
Ġp ho
Ġp ink
Ġin osine
Ġin struct
Ġs un
Ġs anger
Ġs Ig
Ġs TIM
Ġs uramin
Ġs agittal
Ġan tin
Ġm FISH
ati b
an at
as trol
Ġd CMP
ent ation
er ner
es trol
Ġf lud
Ġf allen
at ally
Ġb afilomycin
id ox
os ch
os ynthesis
Ġto d
om icin
ly sozyme
ul ted
Ġh os
Ġh prt
ĠA st
ĠA min
Ġn ab
em inal
em urafenib
ĠT BP
ĠT MI
res idual
Ġle verage
ĠC up
ĠC od
ĠC atenin
ĠC heckpoint
ig i
ig ation
un altered
Ġac etic
Ġac quis
Ġac ryl
Ġac adesine
ac ific
Ġwas h
Ġst one
Ġst rug
ĠI od
ĠI de
ĠI TC
ĠI SG
ĠI BR
ĠI PMN
ĠI diopathic
ĠI owa
Ġl and
Ġl ays
Ġl ining
ĠM ia
ĠM IA
ĠM NPs
ĠM GFs
ine ered
oc rit
Ġim iquimod
ol f
ity l
Ġg BCR
rom as
ĠP Cs
ĠP rem
ĠP atched
ĠP GM
ĠH AdV
Ġv inc
Ġdis h
Ġdis k
ug ar
Ġr al
Ġr BMT
Ġr CEC
gnos es
Ġcomp ilation
ĠB s
ĠB et
ĠB ag
ĠB ackground
ĠB lock
anc a
Ġtreat s
ap ent
qu o
yp hil
ĠD omain
ĠD oub
ĠIn direct
ĠF TBI
00 81
ĠS ites
ĠS ecreted
ĠW a
ĠW GS
Ġne ov
Ġcyt ome
Ġmo DC
ĠN itro
ĠN LS
ĠN asal
ĠR ay
ĠR ight
ĠR PM
ĠR FI
Ġ5 56
Ġ5 92
NA DH
ĠO kazaki
Ġev ading
Ġmar cellomycin
Ġanti human
Ġchem otherap
Ġtrans verse
Ġper il
Ġ4 67
ĠG el
ĠG le
ĠG ree
ĠG CM
ĠG PT
ĠG TG
ĠG DF
ĠG HVD
tr uctive
Ġmet ac
Ġactiv atory
Ġfac ile
Ġpre term
Ġsub ordinate
Ġint end
rac in
ore activity
Ġover whel
ox ime
ox ymeth
ĠL ir
ĠL OR
ĠL PB
ĠL UC
Ġmay tansine
Ġit ching
Ġ6 29
Ġ6 48
Ġ6 46
DS F
ensi bly
str atum
Ġsyn cy
ort in
Ġwho l
Ġ9 60
Ġ9 05
Ġnon treated
Ġnon apoptotic
Ġnon adverse
Ġnon self
Ġnon mutational
Ġ8 46
Ġallo antibodies
Ġfound ations
ĠK el
ĠK GF
ĠK LK
ag ocytic
ag lycero
ion yl
Ġchrom ogranin
ch r
Ġsec urity
av beta
av iscum
Ġhyp omorphic
Ġhyp ocalcemia
Ġra z
12 21
ak ii
IT GB
15 02
15 24
Ġqu est
Ġcar gos
ĠJ ul
ĠJ ones
Ġmicro deletions
AT CG
Ġsensi tisation
ĠV C
ĠV OC
ĠCI A
Ġdi hydroxyvitamin
Ġ19 68
ry st
Ġda u
33 29
Ġpos tim
60 38
Ġprof ib
95 471
ĠAT T
ĠPh ot
Ġend osome
MP B
ĠML T
ger in
Ġpolym icrobial
ys in
ys terol
Ġ14 25
Ġtotal ing
Ġmy ogenesis
ĠAs an
ĠDN TT
emb les
ens it
Ġprob enecid
ĠBM C
pon ents
ok u
18 39
18 007
till ation
Ġdos imetric
yth ymidine
Ġthromb ocytemia
ĠCom mun
Ġbiom olecules
Ġprote oly
BM MSCs
ma gnetic
osup pressor
Ġinform atics
yn yl
Ġter fen
Ġdesign er
ĠPCR s
Ġperiod ically
ĠAra bid
45 9
CN Ts
transplant able
Ġaltern ately
PD s
IP AP
osp amide
MRD pos
hydro xyurea
Ġmac ular
Ġtumour igenic
asp ir
Ġsynthe tically
88 4
36 15
Ġhyper chem
Ġhyper fibrinolysis
ulf ide
AM M
ĠEx ercise
ĠMR E
44 76
Ġpan leukemic
65 98
ĠCM F
Ġtest able
Ġ45 5
ĠHe parin
Ġver bal
Ġver ifying
Ġly ophil
pre treatment
pre emptive
Ġsal es
Ġextra hematologic
Ġextra dural
67 63
Al kylating
ĠRT S
Ġhaplo SCT
Ġwid ened
ough ly
ĠSCT s
Ġoff icial
Ġtra verse
abil ized
Ġ65 5
Ġste alth
PR OTACs
DNA m
ob aviscum
ĠInte stinal
rec ons
77 8
Ġcontext ure
ĠPre venting
48 90
48 46
EL F
HP RT
ĠZ ap
ĠZ hang
ĠPI s
96 9
Ġrational izing
ĠGS SG
ĠAp r
ĠAp plied
ĠIg VH
Ġsecre tions
Ġsecre tes
Ġtrig eminal
ĠÎ² I
Ġtermin ator
ĠNB MPR
me ter
co efficient
Ġoste openia
mod ium
UT M
Ġexcess es
Ġz orubicin
lin olenic
ĠAP F
Ġvacc ae
uan a
Ġpolyc istronic
Ġcyclin D
ĠRel iable
ĠCMV pp
eth al
eth anolamine
ĠGene Xpert
Ġbl urred
ĠPT Ms
UD P
Ġmonos pecific
ĠCFU c
prom azine
ĠEp im
ĠEn zymatic
ĠEn caps
Ġintrat racheal
ĠTR C
enes ulf
Ġbis ulfate
ĠAC ER
ĠAC OT
Ġcarb am
Ġphospho inositides
ĠOut side
Ġglioma genesis
-( (
ĠMAPK s
ĠDA H
Ġbo ard
oxid ants
ĠGen ike
Ġbenz idine
Ad hesion
Ġtransition ed
ĠIDA ra
ĠMon tanide
Ġdeb ates
ĠPG Cs
DP Cs
Ġcytoplasm atic
ĠNR I
ĠIdentif ied
Ġbul let
nucle ated
bo estrol
Ġspectrom eters
ĠMicro biological
Ġlas ts
mo bilization
Ġqual ifying
Ġbac ulo
ĠPost transplant
ĠPost mortem
Ġsurv ial
Ġhistopatho logically
hyp ophy
Ġcess ations
hog ranul
Ġcys ts
okines is
chem okines
Ġflav us
Ġmetallo peptidase
CCN D
carb oplatin
oz oosperm
Ġpseud otumor
116 95471
Ġdip eptide
hom ocysteine
ĠTox oplasma
Ġvascul itides
ĠItalian a
Ġdil atation
Ġcorrespond ence
ĠÂµ l
Ġplasm ocytoid
ars in
ĠMyelo blasts
Ġiv BU
De po
ĠTIM s
Ġsial oglyc
Ġneph ritis
Ġsero type
itig ation
AE W
Ġmitig ates
ĠNE UT
istrib uted
Ġens ues
Ġens embles
Un related
Ġregen erate
Ġpent avalent
Ġane ur
Ġcompreh ension
Ġamb itious
Ġhap pen
ĠCr yptic
ĠRemark able
Ġdetox ify
ĠADR B
ĠLab eling
Ġattack ing
poly comb
poly cytidylic
FLA D
Ġult rac
Ġult raf
Ġchond rogenic
Ġpig mentation
ĠMit ogen
ĠNG P
ĠThromb ocytosis
ĠThromb opoietin
Ġoper able
ofib ers
ĠTra ining
Ġunderpin ned
nan ofibrous
ĠLP XN
toph ysin
Ġradiolab eling
ĠDT ctGMCSF
Ġunnecess arily
Ġlic ense
Ġlifes aving
Ġhypog ranulated
Ġadapt able
Bec lin
finger print
ĠSDS E
ACT RN
sal ic
ĠMuc or
ĠDox il
iop sis
Ġpeptid ases
276 32
Ġdestabil izes
Ġprioriti ze
Ġdnr N
Ev asion
Ġlot us
iso form
ĠSNA P
0125 4890
Ġreferen ced
ĠHG SC
Impro vements
Ġbiotin ylation
Ġaph idis
Ġaccept ability
ĠMethyl transferase
ĠGlut amine
Ġspermat ocytes
Ġjustif iable
Ġaver ages
deoxyc oformycin
Bl adder
berr antly
Ġreconsid eration
ĠFPD MM
Ġchor oid
hap loid
227 6598
olig o
Ġfos tering
Ġmetron idazole
ICR F
ĠKras G
Ġcn LOH
Py omyositis
Ġcentrom eres
ĠPresent ing
Ġortholog ous
Ġremodel ers
ĠHNRNP A
ĠPakist ani
ĠAID s
penet rance
(-/- ),
piper idin
Ġdimension ality
Ġconce ive
ĠBZ LF
ĠHepat ocellular
Ġbip otential
Ġeyel ids
Et oposide
Ġoutweigh s
ĠHa CaT
ili ximab
Ġintercon nec
Ġnanos cale
Ġinstig ation
Ġinstig ated
ĠGITR L
elev ation
LCL s
trac k
ĠTur ner
Ġdeform ability
Ġdeplo yment
Ġcin nam
Ġwog onoside
Ġexpedi te
Ġsarcom atous
Ġreluct ant
Ġbaical in
Ġinterrelationship s
GITR L
ĠRob ust
Ġstap led
Phosph atase
entr ifuge
Ġbra akii
ĠFlav opiridol
hydropy ran
him urium
Ġplum ule
ï¬ģ c
Ġnif uroxazide
ĠFat ty
Ġautoradi ography
ĠJohns on
Ġphosphatid ylethanolamine
ĠStim ulated
Ġremn ant
ĠNMD AR
Ġglu fosfamide
Ġartif act
ĠLap atinib
Ġisoflav one
Ġperip ancreatic
Ġost ensibly
Phospho inositide
Ġinconven ience
ĠProteome Xchange
ĠDiss ection
Ġheading s
ĠAbn obaviscum
Ġgamet ogenesis
Ġalph avbeta
ĠPex a
Ġsuperim posed
Diet z
Ġsomat ostatin
Ġredef ine
sperm ine
1305 1066
ĠThrombocyt hemia
Taq Man
diss ected
Ġnucleos temin
Tem ozolomide
ĠBPT ES
ĠPrincip al
Ġindolocarb azole
Ġantimyc otic
Ġintertw ined
Ġphenyle phrine
ĠHann over
0154 6038
Ġxant hogranul
ĠLoe ys
ĠJeho vah
idze in
ĠHÃ´ pital
Ġseros al
Ġchorio allantoic
KLAK LAK
Ġheterocl itic
Ã©mat ologique
Ġstrug g
aglycero por
Ġproteoly tically
Ġterfen adine
ĠArabid opsis
Ġbaculo viral
- ?
4 56
6 34
6 12
6 33
6 32
6 39
7 107
8 02
8 040
B AD
C CT
C arb
D ep
F o
F in
G ate
G MR
G VT
H es
I Q
I p
I LT
I CLC
L H
L ight
L yn
M ature
N f
N IR
N ES
N SE
P ark
P EC
R CA
R earrangement
S an
S OR
S AF
S urvivors
S pleen
T yros
T echn
T CP
T Î²RII
T osedostat
U BA
V p
V in
V enc
V Î²
V RP
W hole
Y oun
a ALL
b elow
b evacizumab
c assette
d ata
e osinophilic
f lux
f ang
g ib
g ain
g ren
g lial
i ens
l ide
l intuzumab
l amellar
l ighting
m V
m oidal
m eningoencephalitis
n ate
n Ã©
p lying
p DLI
p neumonia
r ally
r TM
s cribed
s TNFR
v edi
y ria
Ï ī
Ġa erial
in determinate
in ducer
Ġt ears
re porting
on ce
on co
Ġc p
Ġc res
Ġc MET
Ġp rion
Ġp arietal
Ġs ides
Ġs yphil
Ġm oloney
al g
or ous
or ines
an ia
ro ads
el baum
Ġd ates
Ġd rip
ent rapped
er itoneal
er zs
ic ola
Ġre elin
Ġre initiated
Ġre juven
ar geting
at ri
at uximab
at ologia
Ġb rentuximab
id ul
id azone
id ofovir
Ġe rection
os seous
ul line
ul are
ul dipine
Ġth ings
ĠA PS
ĠA GM
ĠA DNR
Ġn ut
ĠT a
ĠT HC
ĠT yro
ĠT acrolimus
ĠT alalay
im etinib
ur m
ia d
ĠC ard
ĠC rad
ĠC gR
ĠC ulturing
ĠC dCl
us ters
us ariosis
ut ated
Ġac cepting
ce eding
Ġfor get
ac cepted
Ġis otopic
Ġst ock
Ġst anding
ĠI DC
pres sively
il atin
oc iaz
Ġde pressive
Ġg ondi
ud in
ud il
Ġch alcone
ĠP GF
ĠP lt
ĠP evonedistat
ĠH ut
ĠH alo
Ġdis able
ug g
Ġ2 157
yt osine
yt hemic
st a
ir ming
ir AEs
Ġcomp ri
Ġcomp lim
Ġcomp endi
ĠB w
ĠB endamustine
Ġad alimumab
Ġad ozelesin
ĠD BC
ĠD UT
ĠD PH
ĠD alton
ĠD MDAPatA
ĠD ADI
ĠF re
ĠF EV
tor is
00 29
ĠS aint
orm ant
Ġun parallel
th ickness
Ġcyt oxic
Ġeff aced
ph ar
por al
Ġk a
pro v
pro phyl
pro filing
ĠN CF
ĠN UC
Ġco al
Ġco er
Ġco hesive
yl thio
ĠR p
ĠR UVBL
Ġsignific ation
ĠO varian
ĠO GT
ĠO AZ
âĢ ¢
ary otic
Ġanti proliferation
Ġanti fibrotic
Ġrem ittent
ron ucleus
Ġab use
Ġen chond
Ġen olase
all man
Ġmon oxide
ĠG i
ĠG PC
CR LF
ĠE ti
ĠE SCs
ĠE DR
ĠE LR
Ġph arynx
Ġsub st
Ġ0 8
Ġag ammaglobulinemia
Ġfactor ial
Ġinduc tively
ĠL u
ĠL AS
ĠL OI
pec ting
Ġ6 22
Ġ6 80
Ġ6 71
Ġdev olution
Ġpres epsin
row ding
sist ency
so il
Ġind isc
Ġ7 04
Ġ7 49
Ġro lling
Ġresist in
Ġpar aspinal
Ġdem arc
Ġnon re
Ġnon responsive
Ġnon functional
Ġnon standard
Ġnon redundant
Ġnon preleukemic
Ġnon anxiety
Ġnew s
Ġ8 18
Ġ8 04
Ġ8 42
Ġallo reactions
ros omal
ĠK W
ĠU CMSCs
Ġar ti
ene baum
Ġman eu
CT CF
ill ain
11 01
Ġchrom atids
ĠCR BP
av ages
av ian
MT C
MT OR
spec ifying
Ġimp arting
Ġprov okes
12 57
Ġmulti institution
LA TS
act uarial
ĠJ ew
ĠJ azz
fer til
001 72
16 66
13 17
ĠV ER
ĠV LC
ĠV KA
ĠV RCZ
ĠV emurafenib
Ġdi hydroxy
Ġol factomedin
Ġadv ising
Ġstandard ly
14 20
56 7
95 822
Ġphen obarbital
19 07
Ġtes ticle
ocyt otic
int ra
HR C
25 93
Ġonc osuppressor
Ġretro grade
Ġselec tions
02 87
ĠBM NC
ĠBM MSC
Ġhist omorphological
AP RIL
18 16
Ġ60 3
Ġoptim izes
Ġbiom aterial
ind amycin
Ġcap sa
Ġradi i
24 24
sub population
ĠRA JI
Ġir rig
ĠSt atins
Ġmethyl glyoxal
Ġerythro leukemias
Ġpharmac ovigilance
ins ulin
ĠRes ulting
Ġfocus sing
NF H
cal modulin
29 93
Ġins oluble
ĠCon trasting
rid onin
IP Y
Ġwork shops
SP ES
Ġhyper ploid
Ġhyper baric
ĠPro t
ĠPro of
imin ating
Ġproduc tivity
44 11
Ġdys arth
app arent
ored up
omas tia
ĠCl oning
Ġhep ate
ĠBMT s
Ġhydro cephalus
Ġexpl orations
acet amol
Ġextra ocular
67 44
Ġ80 6
cap to
ME SF
47 6
47 9
HL X
PB S
AS S
AS NS
LR RC
Ġseven fold
97 34
Az adc
ĠPR IT
immun ologic
ĠCC CTC
66 4
ĠMT N
ĠIC F
ĠPre conditioning
ĠPre ferential
HP G
ĠZ M
ĠY L
ĠY in
55 4
ĠBA GE
acetyl lactosamine
ĠGS Is
Ġneuro imaging
85 4
Ġnan or
arr hyth
glyc olic
EN aC
ĠBC SG
sc an
54 23
Ġaden opathy
005 187
Ġdefin able
Ġher n
Ġher petic
CG TACG
mark ers
aph thoquinones
anti oxidant
Cd r
89 3
Ġoste oprote
Ġdereg ulating
ĠHealth care
Ġadap tively
Ġsi Mcl
Ġpa resis
methyl glutaryl
enz o
An aplastic
Ġtw ist
ĠRe expression
MM Cs
Ġlys ophosph
eth idium
ĠOnc ologia
ĠPK B
Ġconver ged
Ġprepar atory
micro environment
HA DS
ON E
ĠSF M
be i
prom ised
+/ +
ĠTGF BR
ĠCB V
Ġbis phosphonate
Ġcarb onate
aring enin
Ġtrac hea
Ġheav ier
for cing
ĠAR H
ĠAR L
Ġalgorith mic
OD IPY
non response
Ġrh abd
Ġtet rac
ĠHospital s
HG s
ĠPA O
ĠPA AD
ĠGen eric
ĠCa ro
ĠMAC S
ĠEle vation
Ġgran isetron
lip tin
infiltr ation
ĠÎ³ c
Ġcry o
ĠEm atologia
isc overed
Ġnod osum
Ġlogistic s
ĠEM MPRIN
ĠTL D
Ġhierarch ically
anth rene
Ġfollic ul
ĠIf i
ĠHep atitis
ĠSA Es
ĠCO OH
hyp oxia
Ġsoci etal
exist ent
ĠFB MD
Ġcorticos ensitivity
Ġinters ti
Ġhydrox ymethyl
ĠHsp s
Ap plication
tub ule
ĠPediatric a
ĠIs ochromosome
oz ide
no ise
ĠTG CA
Ġcyclo pent
OM s
gluc osamine
phenyl indole
phenyl aminopyrimidine
Ġwater s
Ġmicros cale
Ġcollabor ated
PBM NCs
prote cted
ĠSE NP
ĠTI As
Ġnit rite
hex idine
Ġrub ber
ĠComp etitive
pan el
inv igor
ĠImmunophen otypes
ĠSyn thase
023 95822
Ġfluor ophore
ĠBas al
ĠBas ophils
ĠBMP R
Ġcoagul ase
ĠNE AT
ĠDM APT
At tempts
Tr iggering
NR W
Ġbox es
Ġdetox ified
Ġfin ite
ukary otic
ospl enic
yal uron
ĠNeu rop
Ġrene w
Ġgland ular
orf man
Ġce iling
ĠDI SC
Ġindisp utable
ĠHem ostatic
analy tic
phospho lipase
Ġhex ose
ĠMark er
ĠDisc ordance
Lys ine
Genetic ally
Ġradiolab el
ullo blastoma
Chem otherapies
ĠEB ER
ĠPa ulo
Ġpel let
Ġsupposed ly
Ġweakness es
oin osine
Protein s
KDM s
Ġcorrobor ates
immunop recipitated
Ġsarc openic
ĠClo retazine
ĠMeas uring
230 6744
Ġaglyc on
apt ured
Ġoutper form
ĠMic roscopically
ĠApp elbaum
Ġki lobase
via bility
ĠADC Y
Ġfuc osyl
Ġfuc osyltransferase
ĠMar ine
ĠTes ts
Inte raction
Up regulation
Ġnoc odazole
ĠCho p
Ġalign ed
ometh ane
ĠQTc F
Ġchemoattract ants
Ġfre ely
Sh h
Sh p
PBL s
Ġphosphoprote ome
spic uously
ĠCot ylenin
ĠThird ly
Ġrein troduced
229 3157
hot spot
Ġdu velisib
ĠrHu GM
Ġsymmet rical
ĠSumm ar
KS HV
ĠRam os
Ġker atitis
Ġattend ance
ĠPart ly
Ġspectrophot ometry
Ġcephal osporin
Ġparalog s
Ġpin pointed
Ġsout hw
serv ative
ĠMDC KII
ĠAsc orbic
PTK s
Ġmirr ors
Ġvirul ent
fibrin olytic
onide gib
ĠAden ocarcinoma
Ġendeavor s
ĠTRD V
ĠÃ Ł
Ġfronti ers
Ġscle rosing
Ġperiodon titis
lac Z
ĠStep wise
ĠSDH B
Ġcrystall ine
ĠRH BDD
Neutrophil s
BCOR L
ICOS L
Ġcaro ten
gly cin
ĠPit x
Seven teen
ĠGre enebaum
Ġrif ampicin
Ġmetab onomics
antho lysis
ĠDip loid
Bas eline
Ġmicrocirc ulation
Ġdyspo ietic
Ġbootstrap ping
antit atively
Ġobste tric
antagon ist
Ġstap le
Ġbabo on
morpholog y
ĠZf x
ĠDepo Cyt
Ġbacteri ophage
Intrat hecal
Ġunsatis fying
ipar um
ĠDefin itive
Hetero geneity
ĠDecision s
Ġerythrom elalgia
Bar asertib
Ġsore ly
Ġmetalloprote ase
hydroxycho lesterol
ĠCollab oration
MAB s
mH ags
Î¨ m
Ġtors ades
Ġpoli ovirus
ĠNic otinamide
Ġmonocyt ogenes
ĠHomolog ue
ĠInform atics
Ġshadow s
recr u
Ġsatur ating
Ġquenc hed
Ġcycloph ospamide
ĠPseudo zyma
opular iopsis
0138 5423
Ġneutropa enia
osemicarb azone
Ġquinte ssential
Fcgamma RI
Ġsarcoid osis
sarc openic
0146 4411
Ġquatern ary
ĠSIG NR
Main tenance
Ġfalc iparum
Ġdiscipl ines
Ġmetic ulous
1663 26
rux olitinib
ĠLev ine
Ġepend ymoma
osyn cr
ĠAx itinib
Ġinco herent
Ġamn iotic
Ġpolyethylen imine
Sout hern
diam idino
trich ostatin
Ġskelet rophin
Ġenlar ging
Ġgeranylgeran ylation
Ġacquis itions
ĠGree k
Ġwhol ly
aspir ate
vedi lol
Ġsyphil is
ĠCrad dock
ociaz ione
Ġgondi i
ĠHalo Plex
Ġcompendi um
ĠDUT T
Ġunparallel ed
Ġindisc rim
Ġcapsa icin
Ġdysarth ria
Ġosteoprote gerin
% %
. '
. /
. ].
5 98
5 86
6 47
7 10
7 83
7 112
8 40
8 90
9 95
9 35
A AT
A rea
B Z
B MR
B linatumomab
C an
D es
E Î¼
E nl
E udraCT
F ab
F CI
F PA
F Ps
F ADD
G ro
G AB
G CT
H EM
H alf
I Y
I VI
I ADL
J V
L DM
L Vs
N u
N EP
O l
O CR
P aclitaxel
Q Ds
R IN
S NS
S cedosporium
S elinexor
T X
T able
T BF
T FA
V K
V iridans
X O
X PD
b A
b ones
c III
c uma
d op
d ide
d aun
d itary
d ried
e verolimus
f es
f if
g ranzyme
h at
h MDS
h anded
i As
m PD
m illion
n L
n ode
n imustine
p A
p her
p STAT
p arenchymal
p ridil
s TNF
t rip
u ating
v udine
w ho
x ar
y a
Ġ ug
Ġ lying
in term
in osine
re ading
ti ered
on to
en um
Ġc rop
Ġc br
Ġc lofazimine
Ġp PCL
Ġin born
Ġs it
Ġs tilbene
Ġan aemic
Ġm yd
Ġm iss
al ive
al tering
as ense
Ġd d
Ġd f
er ia
ar ms
ar temis
Ġf ission
at en
at ine
Ġb und
Ġb ols
Ġb ismuth
Ġb irinapant
Ġto cop
Ġh olid
Ġh ilar
Ġh CG
ell enic
ĠA AC
ĠA GVHD
ĠA HF
ĠT UR
im pl
tic a
ML I
Ġpro tr
Ġpro jection
ĠC yr
ĠC EF
ig us
ot rophy
un adjusted
un detectable
ut omated
ere tin
Ġfor odesine
if en
Ġas t
Ġwas ting
Ġis let
Ġst ories
Ġl us
Ġl umin
Ġl akes
Ġl ags
ĠM ip
ĠM FS
ĠM ICs
ĠM issense
ĠM BN
ĠM eningeal
ĠM tss
um n
Ġcom fort
Ġde polymer
Ġbe pridil
Ġg arg
Ġch iral
ĠP yr
ĠP omalidomide
ĠP eto
ĠP opulations
od ione
ĠH z
ĠH ill
ĠH PBSCT
Ġby products
red uce
Ġr TNF
Ġr PRL
Ġcomp ute
ĠB ase
ĠB ack
ap arsin
ain amide
ĠD YR
ĠD elphi
ĠIn term
ĠIn cluded
ĠF MT
ĠF rankfurt
ĠF MLP
00 53
00 0004
ĠS ab
ĠS lit
ĠS BB
ĠS light
ĠS criptaid
ĠS chedule
Ġun t
Ġun im
Ġun identif
Ġcl umping
Ġsign ify
Ġmo od
ĠR g
ĠR PN
Ġres erves
com ine
edi on
Ġev odiamine
Ġmar ij
Ġanti fol
iz ability
di ethyl
Ġtrans dermal
Ġmon telukast
Ġ4 11
ĠG FR
ĠG nT
ĠG AMs
ĠE qu
tr astuzumab
Ġph ages
Ġph arm
Ġph ycoerythrin
Ġhem or
Ġfac et
Ġfac to
Ġtumor suppressor
Ġpre leukaemia
Ġover sh
ox ylate
ox oglutarate
ox omil
Ġpo ultry
ĠL as
ĠL et
ĠL CT
ĠL ARC
Ġinf ers
ĠTh ymidine
pec tive
Ġ6 25
ip enem
Ġcomple teness
entif ically
Ġob ovatol
Ġ7 21
01 97
01 91
01 533
form ulated
form amide
esti s
ard in
ist ol
Ġ8 15
Ġ8 78
34 9
ĠK F
AB CA
ag omir
ag liptin
Ġhematopoietic ally
ĠU k
ĠU AE
Ġar rive
Ġar tesunate
ill i
requ ently
11 77
Ġfe eling
10 40
10 65
10 63
12 01
Ġmulti state
LA SS
Ġrepor ters
Ġam ines
Ġtyrosine kinase
21 6763
Ġline zolid
ĠMD ACC
AT RI
Ġep oth
ful l
PM P
Ġsh am
ĠV IV
omet asone
ĠHere ditary
Ġref ractive
Ġsequ encer
Ġkary o
ex am
olid in
Ġpatho biologic
ax o
20 20
)- ,
Ġmor row
int ron
Î± RI
Ġ14 03
CI A
CI MF
Ġmy oblast
MD P
Ġ16 59
ĠBM AL
AP N
To bacco
04 54
Ġ60 8
ĠCh ang
ves ical
CC As
ĠOn comine
kin s
kin son
MA IC
ĠSt ar
ĠSt ata
Ġhis pid
Ġclon otypic
Ġfocus ses
ĠUn purged
Ġcur b
ĠAra U
CN DAC
Ġmed roxyprogesterone
Ġmed oxomil
Ġvir gin
80 64
ĠIFN Î²
hydro quinone
Ġwork er
ĠX P
88 3
Ġhyper CVAD
ĠPro line
Ch loro
ling ual
Th i
Th us
Ġcandid a
ĠHR G
ĠHe ight
Ġ36 8
EB NA
per ipol
emal es
Ġcho lester
acet amido
Ġly n
Ġfrac tures
Ġpoly ubiquitination
Ġtra in
Ġtra bectedin
Ġintr iguingly
LR F
39 01533
Ġgeneral izability
ord an
Ġtyp himurium
erox isome
Ġdet orubicin
Ġdistrib utes
ĠCC X
osin ic
ĠZ btb
Ġfacilit ators
ĠPI AS
ĠY T
Ġsol es
pos tive
met ach
85 9
ĠÎ² II
ĠImmun ology
Ġ67 27
rh enium
201 9
sc a
sc oring
sel ectivity
Ġexpected ly
004 165
Ġdisrup tive
me ans
Ġinst ant
89 33
Ġoste omed
Ġinn oc
AN L
74 02
mod ification
methyl transferases
ĠAP E
Ġhemoglobin opathy
Ġback bones
ĠNO MO
Ġhypothesis e
Ġattrib uting
MY CN
ĠID s
OG T
ĠSM CD
ĠSub stit
ĠHemat oxylin
Ġfatal ities
ĠKG la
ĠTRA DD
Ġeti opathogenesis
ival ence
Ġcisplatin um
MDR O
rib osomal
rib osyl
ĠEn zastaurin
Ġhaem olysis
ĠPC BP
III B
ĠTrans ducer
pr iv
ĠEv ents
ĠBi phasic
adj acent
mol dering
tif ocal
Ġenrich ments
ĠAz C
PT T
occ up
âģ ´
Ġmagn et
Ġclassif iable
Ġimmunotherapeutic al
Ġthi en
ĠTF P
ĠFc Î±RI
Ġpron ucleus
Ġpy ogenic
ĠSH H
ĠSH ARP
Ġimmunop recip
ĠPG D
Ġgran ulated
lip o
ĠPTP RO
ĠCompar atively
ĠMo A
ĠMe V
Ġsci entifically
ĠMicro transplantation
ĠMicro arrays
ynthe sized
PK A
ĠEm pir
ĠTarget Scan
Ġparadigm atic
Ġtriple x
Ġsuper ven
ĠMEK K
ĠHist oC
quin oxaline
CV C
Ġimmuno evasive
tet ram
Ġtryp tanthrin
Ġthyroid ectomy
Ġelectron s
chrom osomes
ĠCor rect
ĠEr PC
ĠPharmac ogenetic
ĠHep a
Ġmyc el
GL P
Rel ative
ime ter
Ġidi osyncr
chem otherapeutic
ĠFC DSA
Ġmono valent
tumour al
âĤ Ħ
ĠSN s
Ġreticul o
TG IF
Ġphot otherapy
Ġphot oreceptor
Ġpump ed
ĠDr p
OM ATRI
armace u
hydrox ypropyl
Ġcommit tee
uter i
ĠFLA N
Ġdiscl osing
De ath
hex adecyl
hex osaminidase
ĠHP IP
Gl ucose
Ġfluor olysis
Ġrepop ulated
ĠSm ith
syn thase
encephal ic
LV EF
Un iversity
Ġinfar cted
ĠGl axo
BU B
ĠIntegr ity
Ġtax onomy
bs Abs
lys accharides
Ġpack ing
ĠCyclin D
ĠBT s
ĠNY HA
Man n
ĠHh aI
yle thyl
index es
ĠNeu NAc
Ġchaper oning
Ġge ography
galact osyl
Ġdich lor
Ġnorm oblasts
ĠMIC M
integr ation
topo tecan
833 8
ĠStr ategic
Ġrich ness
Ġalloster ically
ĠCx cr
CO BRA
Ġdefer red
ĠDF G
Ġhex amer
sulf onyl
El acytarabine
Ġengraft ability
ank yrin
Er bB
Ġglob ular
Ġsynchron ously
Sc reening
ĠDisc ordant
Ġsta gnant
nan oprobes
arin aparsin
Ġbronch us
ali ans
0000 00
Ġpun ch
Ġterat ocarcinoma
Ġcontamin ants
Ġmicronucle ated
Ġosteoc lastic
Ġshut off
ĠNM ZL
megakary oblastic
hyper fractionated
Ġmom elotinib
Ġbin ning
Ġmini atur
Ġnadir s
orn ithine
Ġ143 6032
ĠClinic opathologic
ĠACT B
ĠACT RN
dip almitin
vesic le
Ġsuit ably
ĠTMD s
oflu o
ĠTIG AR
Ġile ostomy
neutrophil ic
Ġenum erated
ĠCar lo
ĠCEBP a
ĠConcurrent ly
Ġafford ability
Ġdnr O
Ġapproxim ation
electro phoresis
Na ive
Ġappra ised
ĠCho ct
ĠRo quinimex
ĠSPI NT
Vari ation
ĠIr radiated
ĠCu B
ĠMethyl Cap
Ġslo pes
Ġtransm its
kyl ine
Ġproc ainamide
ĠOD PC
Ġfur nit
sial ylated
TOP O
phil es
DAS ISION
Ġsemin omas
Ġsed iment
Ġhydroxy glutarate
Ġbiol uminescent
Ġbypas ses
ĠDic lofenac
ĠQual itative
ĠGlyc ogen
ĠGlyc ophorin
Ġni osomes
ĠAST A
PPI s
aberr ations
Ġperpet uated
Ġpolyke tides
Dia blo
ĠOP CML
Oste osarcoma
ĠBX P
ĠMultic enter
ĠAnt agon
Ġrebound ed
Ġreviv al
ĠApo G
Ġoverestim ate
Ġremed ies
Ġga it
Gem citabine
ĠFin land
Ġdiaz epam
Ġplot ted
Ġedge R
otax in
ĠTm x
ĠRos ai
Ġsiglec s
Ġlib eration
Ġmetab onomic
Ġpall adium
ĠEST s
Tax ol
Ġanaphyl actic
Ġtrib bles
pyrid yl
Ġincur s
Ġnanoform ulations
dg A
ĠConjug ation
ĠBlo omington
IMP DH
Ġhemoblast osis
tubercul osis
anthrac enedione
diac etyl
ĠGv H
Disc ussion
ĠBenef its
ĠSIM PLICITY
Nov ar
esc ens
Ġhypoglyc emia
Ġinadvert ently
Ġsymb ols
Ġdephosphoryl ates
Ġcytod ifferentiation
Sn MP
ĠDul oxetine
LIM K
Ġecchym osis
ĠWan fang
Cauc asian
Cyclo oxygenase
Farnes yltransferase
ĠAX IN
opartic les
Ġcontem plate
ĠOv id
ĠSuperior ity
Ġbarc odes
Ġinsid ious
Ġspatio temporal
Ġglycosphing olipids
PRD X
Ġsemic on
rople t
ĠDh aka
Gi edion
ĠHundred s
Ġdiethylstil boestrol
Ġclav atum
Ġanticarcin ogenic
thrombocyt openic
ĠMeasure ments
ĠOphthalm ological
ĠPers ons
ĠLamin in
silic o
Ġhydatid iform
ĠQuestionnai re
ĠSym posium
Ġhemic olectomy
porph yrin
aphosph orines
Ġneointim a
eval in
Ġcostim ulator
ĠDog s
chic tr
Ġembrac ing
Ġmiltiorrhiz a
Ġsemia utomated
ĠSulf oraphane
Ġposses sion
Ġail ments
osch iz
ĠPrem ature
ĠBs Abs
Ġinterconnec tions
Techn ological
Ġirrig ation
Ġtocop herol
ĠMBN L
ĠDYR K
Ġunidentif iable
Ġmarij uana
Ġhispid ulin
peripol esis
004165 98
Ġosteomed ullary
ĠHistoC heck
OMATRI X
Ġfurnit ure
) '
+ :
4 02
5 011
8 26
8 28
> :</
A leukemic
A ging
A lemtuzumab
B LT
C UX
D en
D AR
D utch
E wing
F OS
F DR
F eb
F BT
G aucher
H MP
H PA
H IST
H elic
I f
K CL
K BI
M r
M Vs
N i
O DC
P al
P td
Q T
R NS
R LS
S NAs
S PDT
V av
X D
Y n
a ware
b rid
b omb
b cCML
c up
c CR
c DC
d rop
d uring
e isis
f avourable
g ot
g ow
g lobulins
h NP
i FISH
k S
k at
k str
k ind
l acking
m FI
n ig
p cDNA
r GO
s ame
s atisfactory
s unitinib
s urvivin
t amoxifen
u a
v ille
w ox
x n
x ds
Ġ Î»
Ġ 00899
Ġa a
in ternational
Ġt ul
Ġt DLI
re ports
on ium
en ior
Ġc NPM
Ġc ADPR
Ġc ucurbitacin
Ġo HSV
te aroyl
Ġp lec
Ġp cDNA
Ġp aternally
Ġp emph
Ġp AbM
Ġs ine
Ġs oc
Ġs ure
Ġs RNA
Ġs ight
Ġs ema
Ġs UCBT
Ġs izable
Ġw ine
Ġw ake
Ġw ishes
Ġm HAs
Ġm uram
Ġm ometasone
al d
al vocidib
al coholic
or se
is y
as temizole
Ġd g
Ġd l
Ġd NK
ed ge
ic ip
Ġre analyzed
Ġre uteri
ar one
Ġf ill
at alan
Ġb ent
id us
os acral
om ponent
Ġh scFv
ve ctor
Ġth irst
ĠA pl
ĠA ura
ĠA IL
ĠA RR
ĠA xin
ĠA berrantly
em pt
ĠT LI
ĠT HL
ĠT urin
ĠT nl
Ġcell ulose
ĠC MS
ĠC CM
ĠC CB
ĠC RAF
ĠC amb
un til
un icip
ut ory
Ġac tor
ac yclovir
Ġex foli
se ed
se eds
Ġis lets
Ġis oschiz
Ġst at
uc rose
Ġl amp
ĠM NF
ĠM iDAC
ĠM echanical
op sin
op almitate
ine ural
Ġde part
Ġg ates
Ġg anetespib
Ġal umin
Ġmyeloid s
ute olin
ĠP As
ĠP OC
ĠP ower
ĠP MC
ĠP OD
ĠP ICU
ĠP LAC
ĠP BFC
od aunomycin
ĠH un
ĠH NA
ĠH ard
ĠH RA
ĠH GB
ĠH omeobox
ĠH CPs
Ġv icious
Ġor ient
las gow
yt oin
Ġr IP
Ġr uling
st rept
st arting
ir ic
duc tal
ĠB ob
ĠB YL
ap plication
am n
am v
qu itinib
ĠD SC
ĠD CR
ĠD IV
ĠD CTD
ĠD MDC
ĠD ramatic
ĠIn terstitial
ĠF it
ĠF arber
ĠF anca
00 41
ĠS hi
ĠS trict
ĠS enior
ĠW GP
ĠW olf
Ġun complicated
Ġun anim
Ġcl omiphene
ĠN ested
Ġco lour
Ġ5 70
Ġ5 65
Ġ5 67
Ġres ensitize
one y
com partments
ĠO F
ĠO IP
Ġanti infective
Ġrem itted
di en
Ġen TNF
Ġ4 01
pl akin
ĠG OS
ĠG EN
ĠE X
ĠE CC
ĠE oL
ĠE ilatin
tr b
Ġhas ten
Ġimmun onegative
Ġpre activation
ich DMH
Ġsub normal
Ġsub nuclear
Ġsub lingual
Ġsub compartments
Ġag ranulocytic
ox ine
Ġtar sal
ĠL enti
ĠL NF
ĠL osses
ĠL KP
ree x
Ġrece p
Ġrec re
Ġpres elected
Ġbut yl
ip athic
ip ifera
sist ance
opo esis
Ġ7 30
Ġ7 57
Ġ7 68
Ġunder served
01 43
genetic ally
Ġsyn cope
oth iol
Ġ9 27
sup er
ard a
Ġpar acetamol
Ġnon con
Ġnon inflammatory
Ġnon methylated
Ġnon promyelocytic
Ġnon classical
Ġnon proliferating
Ġnon radioactive
Ġ8 17
Ġ8 24
Ġspec iation
Ġbi phenyl
Ġbi oconjugate
Ġlympho proliferation
Ġpl icamycin
rim al
ĠK AN
ĠK Is
ion ophore
CT ILE
ill ar
Ġmutation ally
MT OE
og rafts
og uan
og astric
ber t
Ġmulti ples
+) ;
Ġnovel ty
Ġprolifer ates
ĠJ ust
ĠJ CV
ĠJ IH
Ġmicro chip
Ġmicro filament
ne tium
ĠMD L
AT IR
13 65
PM S
ĠOS c
Ġsh HIST
ĠV CP
ĠV eno
ĠV izome
ĠCI I
AC G
Ġ19 65
Ġ19 55
ym ethoxyphenyl
Ġpost grafting
Ġphen ytoin
19 79
Ġem itters
Ġem tansine
Ġ15 83
ax ation
ep ing
ep idemi
ep ithe
ET E
MP Ps
Ġwor rying
ĠMRD pos
ĠMRD neg
int o
HR U
HR MA
Ġdo zen
Ġmy opathies
AK A
gra di
ĠNK M
emb ered
ĠWT s
In appropriate
Ġintermediate ly
OR ETA
Ġ24 39
Ġflow ering
ĠIm id
ĠIm mu
mut KIT
Ġstill birth
ĠCom m
ĠMP s
Ġdetection s
ind olyl
ura zolid
Ġradi otherapeutic
ĠAm icus
24 01
24 91
IS BH
)/ (
Ġgra vis
iod endron
rem ic
Ġmethyl ate
Ġerythro cytic
27 157
ĠWh y
Ġpur ported
ĠAll ele
35 00
Ġprior ities
long ing
Ġunf ixed
Ġcur ation
Ġcur tail
ĠST ABC
Ġox ysterol
CN Vs
ĠCon centration
ĠCon sistency
opro genitor
PD Cs
DA VID
Ġcirc le
ulin um
ĠX RT
ĠX enografts
ĠX inwei
ĠPro B
ĠPro viral
ĠPro coagulant
ĠPro gressive
ĠPro duct
AM G
Ġsix fold
ĠEx am
ĠEx tending
ĠEx ploiting
98 9
Ġcer itinib
Th io
Ġsp ending
75 77
Ġi FISH
Ġi MC
cyt olysis
esion s
Ġexpan sive
AD MA
Ġthrombocyt openias
ĠCP Cs
Ġdiscontinu ance
MN NG
ĠER V
As xl
ĠNF KBI
67 9
Ġpoly electrolyte
Ġcardi ology
Ġcardi ogenic
ME M
DC F
ĠAS E
47 01
ĠDC OE
ĠCyt arabin
Ġpub l
nd G
BMT s
Ġmacro lide
AS A
Ġfeas ibly
ograph s
Ġpractic ality
high ly
Ġangi osarcoma
ĠPR OT
ĠQ LCs
ob server
oper idol
66 21
ĠET I
SA Es
Ġmegakary ocytosis
Ġderiv ate
Ġnetwork ing
ĠZ BC
ĠZ yg
inten tion
Ġrepair s
55 5
96 3
ĠAp g
ĠAp plicable
Ġneuro hypophy
ĠDNR ol
85 1
Ġauto antibody
Ġnan osystems
AG GG
ĠImmun oreactivity
TK i
RAR s
Ġapplic ant
sc GM
ĠHOX C
EM MT
rosc lerosis
Ġsubc ohorts
glycoprotein s
Ġpharmacok inetically
not ably
co lored
anti pol
Ġattrac ts
ĠSc hering
Ġmeth adone
59 02
Ġsw allow
74 2401
IFN a
ĠÎ± ENaC
methyl adenosine
methyl nog
Ġattrib ution
Ġspectrum s
dC SA
ĠMF CI
ĠSub cellular
phen anth
eth anol
oles cent
Ġ76 35
ĠAD SCs
ĠCo ulter
ĠGene MAN
ĠPT BP
miR Zip
Ġemploy ees
Ġgluc ocor
EG TA
Ġcop eptin
ĠDe ox
Ġsl a
Ġcounter ing
Ġcounter flow
Ġphysi opathological
ĠAc cell
ĠEn forcing
ĠCB DCA
Ġelectro des
onic idin
ĠPC OP
III NP
ĠTrans fer
ĠTrans membrane
ĠFas R
Ġrib osomes
Ġplasmacyt osis
Ġchlor promazine
non specific
Ġrh SCF
Ġrh izome
FAB P
Ġchemos ensitize
ĠDA DS
ĠDA VID
PT R
Ex pansion
ĠAnti thymocyte
ĠLC FU
Ġhomo e
Ġdim orphic
Ġimmunop rophylaxis
ĠPG L
SM Cs
Ġrepeat ability
ĠKn ockout
ĠFA I
nucle olar
Ġspar sely
Ġimmunore lated
ĠEm atologic
Ġfund us
ĠLA MPs
Ġposition al
ĠMPL V
Ġalkal osis
ĠFL ICE
Ġmak er
rd G
mo Ab
Ġmening oencephalitis
Ġencoun ters
Ġinstit uting
Ġimmuno escape
PN ET
ĠOCI M
thi oinosine
Ġproto oncogenes
Ġproto zo
MPO g
ĠLT NK
ĠLT MC
Ġcys tectomy
human ized
Ġpen al
Ġhydrox ylation
Co operative
ĠLY s
character istic
Ġ110 6
ĠRI NF
HOX B
ĠLD D
ĠFlu Mel
oz oa
Hyp aque
Ġmer ge
ĠAdv ancements
Com prehensive
ĠEnd o
048 958
BB B
Ġdil ation
Ġdil ute
ars ine
ĠOb viously
Ġtrim ethylated
Ġdischar ges
ĠClin seq
ĠClin ics
450 3
ĠImmunophen otype
Ġglycos idases
HU VEC
ĠHT SC
ĠGG CC
ĠPO EM
ĠCy CR
Mo DC
haus ted
Ġdisp ensing
Ġorganization al
ĠDLX s
ĠMI RAGE
ĠCr KL
ĠLip o
fe ed
dep ending
ĠSCL N
ĠBT LA
Ġfo am
ĠRadi ological
Ã© nÃ©
Ġanth rapy
Ġeukary ote
ĠSal v
Ġnorm ative
Ġrelie ving
Ġentero bacteria
ĠLys M
Met aphase
ĠNG DN
ĠTS Y
ĠInvestig ators
Min or
Ġsee ing
ĠHem in
Ġmm RD
ĠPur Î±
ĠPur ging
ka wa
Ġbus iness
ĠRE IC
ĠAUR OC
ĠTOP O
dia mino
Ġmonol ith
Ġgamm opathies
Ġstring ency
ĠPeg filgrastim
ĠSI LAC
ĠSOD s
ĠContinu ing
Ġster ically
Ġunw illing
Ġreapp raisal
Ġtag ging
trig gering
Ġmanus cripts
Ġacceler ator
ĠEgypti ans
Ġfu els
Ġunequ ally
Le vels
Ġwarning s
Ġprecip itating
dis rupting
ĠMIT O
tip ifarnib
termin ating
Ġile al
ĠMic roscopy
ĠMic rosatellite
dihydro daunomycin
VAF s
Allo SCT
Ġfa ulty
Ġdic arbonyl
Ġdic lofenac
GTP ase
Ġlac I
Ġmicrod osing
Ġosteop etrosis
Ġunveil ing
Au SCT
ĠMSP Cs
ĠMn ks
ĠRo yal
ĠHi Seq
Ġconsult ant
Angi otensin
VE EV
ĠPrac inostat
cur ve
Ġoligos accharide
Ġspermat ozoa
ĠsL ORETA
Ġjustif ying
ĠImm ulina
Ġmacrom olecule
glucuron osyl
pharmac ologic
ĠCac na
Ġbioph armaceuticals
Radi o
ĠRAC ER
fuc opentaose
Ġsatis fy
olig onucleotide
cle ared
cle avable
otub e
ĠMu DC
Ġharmon ize
ĠStrati fied
carbox ymethoxyphenyl
Ġamph ipathic
Ġpriv ileged
bacter ium
abr ication
ĠPy omyositis
Hox A
Dis continuation
categor ization
ocarb oxylate
epid ermal
ĠExpl orative
emin oma
Ġ00 048958
Ġure mic
Pred icting
ĠMethod ological
Ġendor se
ĠOl mesartan
ĠGold en
ĠLE UTX
HB c
Brom opalmitate
ĠPneum onia
ĠmH ag
Ġextern a
Ġdeubiquitin ases
Ġsurround s
Ġmultisystem ic
ĠRL IP
ĠCalc ium
ĠHEM rel
ĠTor onto
Ġrot ational
lactam ase
opap ain
ĠCas itas
analog ue
phosphoryl able
Ġanis omycin
Ġenanti omers
Ġpromon ocytes
Ġexecution er
ĠPEP P
olys osomal
Assess ing
ĠVirt ual
Ġduod enum
ĠPtd Glc
ref ractoriness
ĠHipp ophae
Ġcapital ize
Calc itonin
Ġanaphyl axis
Ġpollut ant
Sim ilar
Ġkerat oses
Ġoroph arynx
ĠPLAG L
ĠFcÎ³RII B
antit op
Ġmitoc ans
ĠDG KÎ¶
ĠHLT BMCs
ĠDo HH
degra dation
Ġglia din
Lo op
Ġleiomy omas
Ġextingu ished
ophospho lipids
ĠSerb ia
Ġrhinosin usal
Ġsupers et
ĠContro lling
CLIN ICAL
aryng itis
Ġthw arted
ĠBos nia
Ġdipeptidyl peptidase
success es
ĠPMRD T
ĠXp bx
Ġimpr int
Ġimpr ints
leukem ogenic
rg tm
Ġdies ters
ĠVy as
ĠNig eria
Ġcortic otherapy
Ġdrink ers
trunc ated
ĠPOLR MT
Ġpuzz ling
ĠAnalog ous
ĠADT ree
aminobenz amide
Ġpyrophosph ate
ĠApparent ly
Ġcrani ofacial
Ġporph yrins
ĠGranul ocytes
Ġirr itation
itan iae
17999 31
percent age
Ġeuch romatin
Prkdc scid
Ven ous
sug ges
ĠPPA RD
ĠYI IS
Ġquantif iability
Ġhys te
Ġdelib erate
iodobenz yl
tax ol
ĠEnro llment
ĠCrypt ococcus
770 6621
ĠSAT B
Ġmicrobub bles
Ġnomin ated
ĠISC OMATRIX
Ġweap on
Ġhemim ethylated
associ ating
ĠDiscrep ancies
commit ment
Ġimmunoprote asome
ĠazadC yd
Ġglycosamin oglycans
alph abeta
ramin idase
ĠLomb arda
Ġneurobe havioral
Continu ous
ĠARP P
ĠBiod istribution
ĠDW JM
Ġspargan osis
umon ji
ĠHop kins
9990 999
Ġmaxillo facial
Ġdeoxycytid ylate
Ġcommission ed
Ġimmunoc aptured
GrÃ¼n wald
ĠEmbry os
Ġeuthan ized
oxymeth ane
ĠLir iodendron
hydropyran yl
Ġcoer ule
Ġarti facts
Ġhepate ctomy
ĠYL ISGDSPV
Can onical
artemis inin
Ġholid ay
Ġlus itaniae
Ġantifol ates
Ġinnoc uous
Feb ruary
kstr in
nig uldipine
Ġtul ipifera
Ġpemph igus
atalan ib
Ġexfoli ative
urazolid one
Ġneurohypophy sis
ĠGeneMAN IA
ĠEmatologic a
' ),
) );
) (-)
+ (
4 15
7 29
7 31
9 60
A ct
A MR
B o
B AFF
B acillus
C e
C at
C ER
C SI
D ays
D TC
D EG
D auno
D imethyl
E ctopic
F ollicular
G RAF
H AG
H airy
I k
K ary
K AT
L ox
L CP
L IP
L ife
M AML
M imic
N I
N eg
N EG
P Q
P si
P GR
Q Y
Q RT
R are
R BP
S AML
S plic
S ial
S EC
S erial
T LT
T ID
T ests
V IP
V TC
V WF
Z OL
b ond
b ifunctional
b aceous
c v
d ecanoyl
d ithi
e at
f ucose
f ormaldehyde
g ate
g ativity
h ome
h MSCs
h uang
h oracic
i ocalcin
j an
l ap
l aden
m MDSC
n ons
n ick
n odular
p CR
p ack
p ump
p astatin
p ronged
r ather
s um
s moldering
v if
v ill
v imentin
in ogen
Ġt g
Ġt um
ti i
ti ae
on avir
Ġc EBPa
Ġp rinting
Ġp razosin
Ġp ragmatic
Ġin ver
Ġin activity
Ġan eu
al con
al amin
or tical
is othiocyan
an tion
an odine
it r
Ġd ab
ent y
ent gen
ic ib
Ġre assessed
le xt
Ġf ucose
Ġf ossa
Ġf abrication
at ka
at tenuated
ing ham
Ġwith hold
id arabine
om ogram
ell s
Ġth iamine
ĠA LI
ec rolimus
em odin
ĠT ail
ĠT PM
ĠT EP
si vity
lo ugh
Ġpro granulocytic
ĠC Z
ĠC it
ĠC os
ĠC av
ĠC ategor
ĠC XL
ĠC elecoxib
ig a
ot arget
et ria
Ġac ro
ac cess
Ġas crib
Ġex onuclease
sp hing
Ġis atuximab
uc k
ĠI OL
ĠI EC
ĠI ADL
ĠI csbp
ĠM OR
ĠM TP
ĠM ars
ĠM egakaryocytic
iv ir
il is
up ogen
Ġcom a
oc idal
Ġbe zafibrate
Ġg lo
Ġg one
Ġg ibb
Ġg ivinostat
Ġch itinase
her pes
ĠH ome
ĠH AG
ĠH iseq
ĠH Ã©matologique
Ġv idarabine
hem e
Ġdis omic
Ġdis hes
Ġr d
Ġr ist
Ġr ights
duc ers
ĠB ra
ĠB lot
ĠB BR
ap onic
am l
am is
ĠD ok
ĠD EL
ĠD rs
ĠD ifferentiated
ĠIn appropriate
ĠF en
ĠF lor
ĠS k
ĠS par
ĠS chin
ĠS ki
ĠW wox
Ġun cl
Ġun aware
Ġsign ed
log ist
log rafting
Ġus her
ĠN ip
ĠN PI
ĠN AMP
ĠN itric
ĠN ationwide
ĠN lrp
Ġco immunoprecipitation
ĠR u
ĠR PA
ĠR III
ĠR ounds
Ġ5 02
one gativity
NA SE
SC ORE
ĠO SCCs
edi yne
Ġmar iz
Ġrem it
Ġrem itting
Ġreg istr
de azauridine
di one
Ġen ediyne
Ġmon ophosph
Ġmon omers
Ġmon onucleotide
Ġ4 28
Ġ4 39
cl usi
spl en
ĠG CL
ĠG yn
ĠG CB
ĠG aussian
ĠE BM
ĠE NO
ĠE OCs
Ġsy ring
iti zed
Ġpre albumin
Ġint uitive
ox olone
rel ix
ĠL Ã¶
ĠL estaurtinib
Ġid a
Ġid er
Ġrec lassifying
Ġ6 56
Ġ6 64
ip e
ip rone
Ġhe el
Ġ7 44
01 36
ech netium
Ġ9 83
ard enafil
Ġcons angu
Ġpar then
Ġnon cancer
Ġnon competitive
Ġnon histone
Ġnon elderly
Ġnon healing
Ġnon reciprocal
Ġ8 000
Ġ8 55
Ġ8 69
Ġ8 93
Ġ8 461
Ġbi allelically
ser tional
ble omycin
ĠDNA X
ĠK SP
onstr uction
out come
Ġ10 80
Ġ10 31
Ġ10 54
ill iant
11 04
11 657
RA TIF
10 38
MT F
Ġgrow ths
og Ã©nÃ©
KI F
Ġra ys
li ve
12 03
12 24
Ġconf ront
Ġconf ounder
ach y
acy cl
LA L
LA R
Ġantigen icity
Ġantigen ically
Ġrev ascular
loc ating
Ġam putation
ath yroidism
act ol
ĠJ X
ĠJ er
ĠJ und
ĠJ UR
ĠJ ordan
Ġmicro L
Ġ12 05
Ġ12 45
AT LL
Ġcoun ties
ĠV ite
ĠV IT
ĠV RL
ĠCI S
ĠCI V
az epam
AC P
Ġref use
Ġref inery
Ġdi ph
Ġ19 53
ry anodine
Ġda idzein
17 35
Ġoccur ing
Ġcytotox in
Ġmin ire
Ġphen o
Ġform ic
Ġform ulae
ĠPh D
ĠPh orbol
ĠIL s
ep irubicin
ET R
Ġend oderm
Ġend oredup
sequ ences
Ġdown modulated
Ġpolym yalgia
yd ase
yd apt
Ġmor tem
int ended
Ġ14 45
Ġ- .
25 78
over age
gra vity
ĠNK s
MR K
Ġexpos es
In duced
In herited
ocl usters
Ġtransloc ates
Ġset backs
AP R
IC SBP
UN E
tumor ous
03 10
FN s
Ġprot uber
ĠAd min
Ġprote ostasis
und rug
Ġgra mic
Ġ40 70
ĠSt roma
ust ment
Ġaz oxymethane
ĠRes ource
ĠAt t
Ġvalid ations
Ġnec ropsy
Ġunf eas
lob ular
CP A
CP D
II H
cal cin
âĢĳ )
con omic
phosph atases
000 73
ner able
ĠX F
ĠX ist
ean ut
ĠCEBPA mut
ĠEx cellent
ĠEx tension
ĠEx posures
ork head
Ġalpha IFN
ĠMul tiv
Ġdam s
Ġtransp arent
ĠMS Ns
per sistent
art on
ĠCancer s
Ġly sing
pre gnant
Ġcle avages
ole an
ole oyl
Ġpoly epitope
VI A
ĠAS A
ĠCyt ogÃ©nÃ©
Ġj aponic
ste ps
Ġpep tic
Ġcont our
Ġ55 8
ĠQ Ds
PR s
erox ydase
ĠME A
Ġact omyosin
ĠBec k
Ġmegakary o
rain vill
Ġ56 9
yg d
96 86
ĠIg AN
GM s
Ġnan oclusters
ĠImmun o
ĠIV LBCL
69 24
201 87
Im C
ID OX
Ġdep olar
sel en
Ġ66 3
Ġrepe ating
Ġextrac ting
ĠSim ulations
ĠSim vastatin
CG ATCG
ĠMut agen
BL P
Ġdemethyl ates
co expressing
anti thymocyte
Ġoste olysis
rin otecan
Ġpe ers
Ġacet al
month ly
Ġhour ly
ĠRe induction
]. <
ĠCo existence
Ġmid line
Ġmid brain
Ġfibro genesis
Ġcop anlisib
protein ase
Ġmis regulation
Ġmis folding
raz ine
ĠEL IS
ĠCB Us
ĠRAR Î²
Ġthym opoiesis
Ġcereb ri
Ġfas udil
ĠTrans criptase
MC V
ĠBi ochemistry
Ġmen opause
OD OX
ĠPer turb
Ġchemos ensitivities
Ġtet her
JAK i
âģ ·
ĠAnti oxidant
aut ograft
Ġbo ok
Ġepis omal
09 80
Ġstabil isation
ĠBax ter
Ad verse
arc openia
Ġpron orm
Ġpy rim
SM AC
TR G
My ers
Cy te
Ġren amed
ĠPL D
Ġarg onaute
Ġcytos ar
Immun otherapies
ĠEC S
Ġuncon ventional
lig ation
Ġsulf onate
ĠSh ared
Ġpal ms
ĠCor ticosteroids
ĠLi Cl
Ġmultip ronged
Ġincon tinence
ĠSup eroxide
hyp omethyl
Rel A
na ud
Ġthor ium
ĠLe vel
ĠVari ations
fluoro adenine
Ġhydrox ymethylation
Ġpeg aspargase
Ġperox yn
ĠConsid erations
Ġdoub ly
ĠMi y
ENT RAL
HE V
eng rafting
Hyp ocellular
PE ITC
hydrox ylated
cycl osporin
ars eness
Ġanticip ation
ĠIG K
Ġcover t
ĠMO F
Ġmand ible
py ran
Ġglycos idic
Ġmill ig
dem ethox
DLBCL s
Epigenetic s
Ġpass aging
Ġneurop athic
cardi otoxic
ĠBTK i
ĠCirc RNAs
Ġjud icious
Ne el
Ġexcision al
look ing
ĠPM BL
ĠAM egL
ĠAfric ans
ĠQu in
ĠRever sal
mul tipotent
Ġdimethyl arginine
elec tivity
Ġinfarction s
Sign aling
Ġair ways
ĠMulti parametric
He paran
Ġreser pine
ĠAnnexin V
Multi potent
FLA NG
Ġkeep s
Ġkeep er
Asp araginase
Ġchond rosarcomas
integr ity
TS DR
Ġuniqu eness
Inter cellular
Ġport ended
Ġtubercul ous
ĠIndividual ized
Br PA
Ġchick s
complex es
Ġauthor ised
CO AP
ĠSet ting
sulf oximine
Ġmesothe lial
ĠDisc ussion
ĠRef lecting
GP x
Ġexerc ises
Ġlob ules
Ġheral ding
Ġlic orice
ĠPDX s
Ġmedullo blastomas
agglut inins
SN Vs
Gra des
ĠSte el
ĠPr mt
Ġtetram ers
HM GA
ĠSY NE
lact one
ĠBlack fan
ĠDX M
ĠDP YD
Ġvas odil
ĠProlifer ating
Ġtetrap eptide
ĠMar tin
Ġhemangi osarcoma
ann in
ann iocalcin
ĠCF Cs
azid opine
Ġnons eminomatous
Ġmineral ized
ĠOcc ult
Ġtriaz ene
bec ause
0018 0115
Ġopac ification
Ġsoil s
dig it
hap ten
Mi RNAs
606 985
ĠEGT A
Sup portive
Qu antification
cyclo dextrin
Ġhomod imers
ĠMalign e
QALY s
Ġseas onality
Ġamph otropic
Ġsemin iferous
Combin ed
ĠDiscontinu ations
clus ters
Ġpericent rin
Ġexchan ger
Ġmyelomon ocyte
ĠRich ard
categor ized
dup lex
Ġsuccin ct
Ġure thane
osm c
ĠTMP P
ĠMethod ology
osamin yl
Ġepilep tic
ĠAMM oL
ĠGluc uron
AV N
Ġasymmet ry
Ġhyperv ariable
ĠHaem ostasis
ĠOste opontin
hair y
Ġhematopatholog ist
ĠÏ Ģ
557 46
Ġrew ire
ubiquit inated
Ġward s
ĠTm em
ĠCOS MIC
ĠIVI G
ĠTem ozolomide
enta enoic
Ġconsor tia
ĠOptim izing
lod alton
Ġsynap tophysin
Ġreplen ishment
ĠTransl ating
Ġjuxtap osed
Ġmicrohom ologies
ĠPerm e
triaz ole
Ġartemis inins
arter ial
Ġbaical ensis
Ġreshap ing
Ġgranulocyt openic
Mer captopurine
ĠLO Y
Epidemi ologic
ĠBenef icial
Ġanthracyl ines
Ġneuropsyc hological
ĠPublic ly
orr hea
ĠDer ived
Eph A
Ġmetalloprote ases
hydroxycho lecalciferol
Ġflas k
Ġcanc eled
ĠVy atka
Ġpathobiological ly
Ġmasquer ade
carboxyl ic
Ġsuperv isory
paro tid
dp f
ĠPhysi ol
Ġxero derma
ĠPrefect ure
Ġsuperco iled
benzox adiaz
Ġmesop orous
spe aking
Ġbiotechn ological
Pe ak
Ġintric ately
Ġbot ulinum
Ġadmix ture
Ġefflu xed
ĠIntrap eritoneal
Ġho arseness
Ġcany on
mHA gs
Ġlivid ans
Multic olor
prep itant
unning ham
program ming
Ġmann itol
Ġoxaz aphosphorines
Ġguardi ans
teb ral
ĠCong ress
ĠPut ative
Ġantitub ercular
ĠGraph ical
Ġdaunorub ucin
Scle rosing
assign ed
Ġbir ths
ĠDus seldorf
ĠFram ingham
Ġtod dl
Ġacryl amide
ĠRay naud
Ġlyophil ized
recons tituted
Ġcompri zing
Ġnanor ods
Ġdepolymer ization
Novar tis
ĠImid azo
icib anil
lext a
etria mine
Ġrist ocetin
ĠSchin zel
ĠNAMP T
Ġmariz omib
clusi g
RATIF Y
Ġrevascular ization
Ġminire view
Ġprotuber ans
Ġgramic idin
Ġunfeas ible
ĠCytogÃ©nÃ© tique
rainvill amide
( âĶĢ
- ],
/ '
0 91
6 37
7 62
9 34
9 40
9 65
A x
A IC
A IDA
C OS
C ytidine
C SL
D SC
D ip
D MT
D EN
D ormant
E vi
F m
F SC
F orkhead
G AM
H p
J oh
K R
K Î±
L ink
L iver
L XR
M ent
O bi
P ur
P IC
P PC
P ortal
P ancytopenia
S pec
S AP
S IP
S SP
S ah
S ingapore
S iO
T IC
T iO
U PS
U ns
V er
V ac
b g
b rachial
b ociclib
b udesonide
c ast
c ounts
d ry
d UCB
e ated
f osine
g li
h ERG
i h
j ust
l terin
m h
m en
m gr
n ausea
o tion
p n
p ies
p enic
p aren
p Ser
r hodamine
s Ig
u od
u PAR
u lectomy
u qing
x A
x anthine
} ,
Ã ¨
Ĺ </
in compatibility
Ġt or
Ġt aut
on oid
Ġc yp
Ġc ue
Ġc TCL
Ġc idofovir
Ġo ros
Ġo estrogen
te cting
te pe
te enth
Ġp eanut
Ġin gest
Ġin genol
Ġs ensed
Ġw ax
Ġm PEG
al e
al most
is sible
an o
an oic
an ium
as aki
as paragine
it ous
le to
le ft
at trib
Ġb w
Ġb od
Ġb ore
Ġb ene
Ġb illing
Ġb lown
Ġe EF
os il
Ġto uc
ul tivated
Ġh mC
Ġh BD
ĠA ging
ĠA beta
ĠA lex
ĠA msacrine
ĠA mino
Ġn emat
Ġn Treg
Ġn aringenin
ĠT as
ĠT opic
ĠT EG
ĠT gf
ĠT allman
ML KL
ĠC ut
ĠC omet
ĠC VP
ĠC WP
ĠC LTR
ĠC unningham
ig uan
ut hw
et antrone
uk er
ter ate
Ġac h
if erin
ac a
Ġas ep
Ġas ton
se greg
ant rene
sp aring
ĠI NA
ĠI terative
Ġ1 110
Ġ1 116
Ġl ends
Ġcon d
Ġcon ting
Ġcon forming
ĠM ur
ĠM ev
ĠM ental
ĠM XR
ĠM ubritinib
um inal
oc tion
ol ane
Ġde par
Ġde pressing
Ġg rap
Ġg ankyrin
ĠP DS
ĠP SF
ĠP ml
ĠP ES
ĠP ituitary
ĠP DHA
ĠP erson
ĠP ulse
od ef
od ocalyxin
ĠH CD
ĠH ex
ĠH ans
ĠH acet
ĠH OP
ĠH PP
ĠH Vs
ĠH ERG
ĠH AND
ĠH eart
Ġr Sj
st one
ir gin
ir ona
), -
ĠB ig
ĠB GP
anc et
ap me
ap Seq
ap entaenoic
ĠD un
ĠD if
ĠD GN
ĠD KO
ĠD omb
ĠD iminished
ĠF ul
ĠF ET
ĠF PSS
00 91
00 009
00 0005
00 224
ĠS j
ĠS MYD
ĠS ftpb
ĠS rsf
ĠS kyline
Ġun matched
Ġun question
Ġun formulated
th yroid
Ġcl im
Ġcl indamycin
Ġcyt ostasis
Ġass es
low est
log ies
ph agocytic
Ġmo uthw
ow der
enti xafor
Ġk inetically
pro longing
ous tic
ĠN AB
ĠN MS
ĠN ectin
ĠN MDA
ĠN omogram
Ġwe e
Ġco regulated
Ġco localizes
Ġinhib itions
ĠR ous
ĠR est
ĠR FB
ĠR FT
Ġ5 48
SC E
ĠO AS
ĠO PC
ĠO pin
Ġanti zyme
Ġen ding
Ġtrans mitting
Ġtrans activate
Ġtrans generational
ose ptic
all ergic
Ġmon ocarboxylate
Ġ4 97
Ġgen ic
cl oning
ĠG BMT
ĠG round
ĠG NPs
ĠG RII
ĠG lioblastoma
ĠG lasgow
ĠG irona
ĠE H
ĠE BC
Ġph os
Ġph armaceu
lec tin
Ġimmun ocyte
Ġimmun ocytes
Ġpre eclampsia
Ġsub ventricular
Ġ0 26
Ġbet ulinic
Ġover produced
ĠL ith
ĠL DN
ĠL TD
ĠL DM
ĠL earning
ĠL xn
ĠL esions
ĠTh iaz
pho bil
Ġrec irc
Ġ6 83
Ġ6 93
and rogen
ari in
Ġpat ches
ensi veness
Ġcyto genomic
opo eitic
Ġ7 16
Ġ7 73
Ġ7 84
Ġunder treated
Ġro sem
Ġro entgen
01 64
Ġsyn apt
LL A
Ġ9 48
Ġ9 69
Ġdem ethoxydaunorubicin
Ġall er
pend ed
Ġnon human
Ġ8 67
Ġbi otherapeutic
Ġlympho granul
tain able
Ġallo y
34 54
Ġcor tisone
mon onuclear
ĠK mt
Ġel ude
AB VD
ag i
ag uanine
Ġ10 34
ĠU BC
reg istration
11 00
10 26
10 96
ysp lasia
MT O
og al
fore ign
Ġop t
Ġtime points
12 26
12 607
Ġmulti lineal
Ġam ygd
15 50
ric k
ĠJ B
ĠJ ian
Ġcommon alities
Ġ12 92
tran sient
ful ven
ĠV es
ĠV CM
ĠV OCs
OS IS
az aguanine
AC F
Ġref lux
Ġdi aly
ex in
Ġpost p
56 4
56 6
PL S
19 82
Ġnucle ob
Ġhetero typic
20 449
atric ide
Î± PD
erm an
Ġretro spect
omic ron
MD Cs
02 67
02 62
Ġdisor ientation
ens ins
ens zel
Ġhealth ier
ĠAn teced
Ġ16 99
dom as
Ġhist oplasmosis
ok a
18 05
Ġcount less
Ġvia bly
Ġtr ies
ĠIm plications
mut ants
ĠCh l
ĠCh en
ĠCh art
ĠMP C
ĠMP Ps
Ġmetabol izes
Ġunc or
ĠAd vant
euk emic
Ġradi um
ĠAm az
24 48
Ġcarcin oids
Ġmethyl ates
yn il
Ġrep utation
Ġerythro derma
kn ockin
Ġpur ines
Ġpharmac od
activ ities
CA I
CA MPATH
Ġess ence
ĠUn common
DR C
ER M
Ġphosphor amid
con st
40 70
ĠPD MS
90 56
Ġconc an
IM iD
IP R
NP V
Ġhaemat ocrit
SP I
ner v
ĠX TT
ĠPro ven
ĠEx ons
ĠEx osomal
Ġsil ic
Ġalpha GalCer
Th yroid
Ġsp ray
ĠMR FS
app y
cyt os
cyt okines
cyt ometer
ĠMul tifocal
Ġpan or
Ġmitochond rially
ĠCl dn
ĠCl onality
ĠPB K
des cent
ophag osomes
down regulated
Ġdeletion al
Ġwhere ver
Ġhydro dynamic
Ġly so
67 27
inc RNAs
lympho poietic
Ġpoly ubiquitin
Ġpoly arthritis
VI VIN
cap rol
Al pha
Al lyl
ME Ps
ĠMY ADM
ĠDC BT
ĠCyt oreduction
Ġsib s
Ġglyc ation
Ġglyc oprotease
86 3
86 4
Ph ase
ĠPR P
ĠPR SS
ĠQ P
ĠPML RARA
ob ile
ob alamin
IV AC
ĠPre transplantation
ĠPre ventive
Ġhal operidol
ĠZ oledronic
55 82
pos itories
Ġrational ise
HC K
Ġneuro troph
Ġauto inflammatory
ĠAN Ts
Ġphys ico
CF H
ĠRAS opathy
Ġcluster in
Ġgo at
ĠGST mu
versi al
ĠMut ants
Cd x
Ġattrac tion
ĠSc ores
Ġprostate ctomy
tur n
AN S
mod in
mod erately
ĠHD Is
Ġchimer ical
ĠCY B
An tic
bi osis
Ġble ed
ĠID US
Ġamin othiol
Ġclos est
Ġremark ed
AA A
ĠRel atives
eth amine
ĠPK Cdelta
ibr ated
ĠReg ional
myelo cytic
ereb ellar
Ġgluc agon
man agement
equ il
ĠAC S
Ġemergen cies
Ġtet hered
009 00224
dim CD
Ġcataly st
Ġhar ringtonine
appro ach
inter vention
ĠMon th
char ge
ext ramedullary
Ġpy ram
arg ine
ĠTr f
ĠPL N
ĠTK is
ĠMo bilization
Ġester ases
bo ard
CY BA
ĠAut od
ĠAut omated
Clinical Trial
Ġoligonucle osomal
ĠLA U
ĠLA NA
ĠBe ad
MO F
LF s
alk er
Pre p
Ġmitotic ally
Ġintrac ereb
fusion s
ĠPBM NCs
ĠPost operatively
NE QAS
Ġcircum vention
Ġcircum stance
olip osome
Ġpal sies
Ġinnov ating
Ġfil aments
ĠPS MD
ĠSup porting
hyp ermethylation
GL UT
Ġdeliver ies
Rel iable
antigen emia
ĠDiagnos tics
Ġpolar izing
fil es
CCR s
Ġpen fluridol
RI Î³
ĠHu H
truct ures
ĠHN SCCs
038 1
oz o
Ġabol ishment
Ġecon omy
Ġdiscre tion
dL N
Com orbidity
ĠGP AT
Ġabsor p
ĠTherapeutic s
Ġplasm ablastic
metabol ism
prote ctor
163 11
Mon onuclear
ĠCV D
osc ow
ĠComp elling
ADR s
Ġosteo arth
Ġsero conversion
ĠMan ufact
sw ap
Ġfluor ogenic
034 2
Ġ111 9
ĠDifferent ly
DT X
Ġneurop atho
anol s
ĠRep air
MUD s
Ġalcohol s
LV ET
ĠHS ulf
Ġdisp ers
prim e
Bi ologic
ĠRho x
Ne o
SH H
Ġdermat ofibrosarcoma
ĠBI OSIS
Ġround table
ĠSV C
jo int
ĠFe atures
ĠQu ercetin
Ġspan ned
ĠWE V
Ġnanom ed
ĠAnd rogen
Ġfin ished
Ġhypo acetylated
He La
Ã© rin
Ġconven i
ĠNeu raminidase
ND E
his tidinol
Ġuter i
Stud ying
Ġnorm ocytic
ĠGu illain
Ġpig ments
Ġacetyl ase
Ġpi ece
ĠEng ineered
Ġobsc ured
PU FAs
ĠAccum ulated
IGF BPs
SK M
Ġecho text
ĠOX i
silon RI
Ġabscess us
Ġreact ants
ĠSet s
Ġdefer iprone
Ind ications
thromb osis
ipodophyllot oxins
secre tory
Ġget s
ĠRef ined
wor th
DF F
ĠProte asome
ĠPBL s
megakary ocytes
Ġunw arranted
ĠAPR E
Ġorchestr ators
amid um
Ġmini ature
Ġhypog ranulation
169 44
Ġvag us
Ġmatur ating
Ġunequ al
ACT B
Mal e
cont amination
ĠHetero geneous
do ub
Ġunderestim ation
Ġimmo bil
Ġbr ighter
brom ide
apt amer
Ġtot ality
ĠENEST xtnd
Ġpren atally
Ġendow s
ĠDP PC
ĠDros ha
Ġfron to
TB NA
dn r
Inte stinal
Rh abdomy
ĠFU rd
Ġphleb otomies
ĠFl ubendazole
develop mental
ĠHF CL
Ġgent uzumab
FF PE
chol ate
Ġang iod
Ġintram ural
Ġglomerul opathy
Ġglomerul osclerosis
hospital ization
Ġirreg ularly
Ġfur nish
ĠQing huang
Mi R
Ġafflic ting
olig os
ĠFAN CF
Ġaux otrophy
Ġhydroxycarb amidum
transp ort
Ġredi rection
Ġharmon ic
Ġfibr illary
comple mentary
cyan idin
ĠRF X
414 9056
ĠNi SO
Ass ociated
Ġelectrocardi ography
Ġpigment osa
dup T
Retin oids
Ġos mol
Ġos seous
Ġpalmit ate
Ha enszel
Ġss HHT
ĠFil tering
ĠRet rie
ĠNur sing
serv ational
Glyc oprotein
ĠProp er
Gu Ã©rin
Ġcompact ness
ĠSubset s
ĠBZ M
aper one
ĠFib roblast
sep tic
ĠCas pofungin
ĠRegimen s
Par tial
Ġtack led
Ġspectac ularly
Ġanabol ic
ĠFoc us
Ġnumb ered
ĠAcl acinomycin
ĠRegion s
Ġtrabec ulectomy
ĠANN L
Sw iss
Ġgam ut
Tax R
ĠMx A
omyce te
Ġozog omycin
Ġexud ative
Ġvign ette
Ġcapital izing
Black fan
Ġimip ramine
Ġantide pressants
Ġpharmaco ec
enro llment
Ġanthelmin thic
Ġvigil ance
Ġperitran splantation
ĠAur A
ĠFund amental
arter iolar
ĠGlucocortic oids
ĠMas sive
ĠAdop ting
Ġcongr u
Ġgranulocyt opoietic
ĠAdap hostin
ĠDiff ic
Cor ticosteroids
Ġak lavinone
Ġthw art
Ġinterchange able
ALA L
Ġremn ants
Lac NAc
Ġflas ks
285 758
Ġfr atricide
ĠDup lication
ĠFu j
Ġtransc obalamin
Ġtranst horacic
Character ization
revers ing
Ġfla wed
Don nell
ĠCarb oplatin
ĠBeta ig
Ġmultimer ization
Ġoligodendro cytes
Fib roblast
Ġîĭ ¶
Ġvasopres sors
Ġinvest ments
ĠRepro ductive
fluoromethyl ketone
ĠhTR EX
ĠTcm ra
Ġschwann oma
Meth otrexate
classi fications
âģµ Â¹
Ġtyr phostin
ĠYe ast
odeoxyc holic
hif a
ĠTrac king
Ġpilo ted
ĠIndones ian
Ġtang ible
Break point
Rab bit
icos apentaenoic
ĠMaf osfamide
ĠSUR VIVIN
ĠWitness es
Ġepip od
accel erating
wen berg
iner ies
imb rin
Ġcounterm eas
ĠAnecd otal
ĠNorwe gian
mercaptop urin
>âĪ Ĺ</
ĠSq CC
Ġinsectic ides
Ġhos tile
Ġunim pressive
sca ven
cup ine
ĠKAN SL
epidemi ologic
Ġglucocor ticosteroids
Ġpenal ty
Ġmonolith ic
QY YT
amis ole
ĠFlor ida
ĠLÃ¶ wenberg
ĠJund uqing
ĠVIT RO
(âĶĢ )
Sah aran
Ġoros omuc
leto e
Ġbod ily
Ġbene ath
ĠTopic s
ĠHacet tepe
apme R
ĠDomb ret
ĠSkyline Dx
ĠOpin ion
phobil inogen
Ġrosem ary
Ġechotext ure
ĠRetrie val
% [
) (-/-)
* .
4 006
8 34
8 65
8 49
9 56
A rs
B TG
C ases
C FSE
D u
D ynamic
D MF
D EP
D TPA
D JH
E PC
E rdheim
F ungal
I MR
I EM
I ÎĶ
J ARID
K b
L t
L NK
L MO
M IM
M ean
M XR
N V
N or
N OR
N IC
P Z
P ho
P akist
P aroxysmal
R v
R SV
R ank
R unx
R UX
S en
S elf
T p
T rop
T ru
T HC
T alazoparib
W il
W inter
X inwei
Z U
b ent
b ia
b icity
b ach
b asal
c as
d dC
d iffuse
d istal
e in
e ase
f alse
g k
g as
g ranular
h s
h or
h sp
h CT
h aped
i ï¬ģc
j al
l arger
m ap
m ds
p he
p EEDCK
r ast
r ubicin
s f
s titution
s ynthesis
t ypical
t aking
v ak
v aria
v Ph
x anth
Ã º
Ġ ?
Ġ 0001
Ġa DLT
in b
Ġt ens
Ġt ank
Ġt AFP
re ticular
re acted
on com
on ally
en ozoosperm
he id
Ġc ement
Ġc Ig
Ġp ter
Ġp Akt
Ġin evaluable
Ġs ided
Ġs MIC
Ġs ash
Ġs ickness
Ġs FLC
Ġw on
Ġw ond
al emtuzumab
is ox
is obut
an imal
an oyl
ro tide
it uric
Ġd ocked
Ġd mCEBPa
Ġd ensit
Ġre induced
Ġre located
Ġre sisting
Ġre assembly
le aned
Ġf iss
Ġf azarabine
Ġb ib
Ġb ark
Ġb afetinib
ing ding
os on
om ori
om orphism
Ġh inting
Ġh olo
Ġh CTM
Ġh KSR
ĠA J
ĠA DH
ĠA LR
ĠA LAK
ĠA ripiprazole
ĠA ChE
ĠA prepitant
em tricitabine
em peripolesis
ĠT ec
ĠT rap
ĠT MK
si lyl
res cine
Ġle ts
ĠC ess
ĠC ytidine
ĠC HA
ĠC ranial
ĠC osmc
ig ma
ot spot
gen erally
ut ol
Ġac ad
ac tively
se ros
sp ray
ib rotide
ĠI NC
Ġl ieu
Ġcon spicuously
ĠM J
op ping
op inavir
iv atives
up front
Ġcom utations
oc entesis
Ġim pressively
Ġg ame
Ġg allo
Ġg yr
Ġg leevec
Ġg leaned
ĠP el
ĠP iper
ĠP recise
ĠP aste
ĠP owder
ĠP ingding
od ib
ĠH SR
ĠH PK
ĠH dm
ĠH uang
ĠH yaluron
las ies
Ġr hod
st roph
st yrene
ĠB ow
ĠB enn
ap rox
am ar
ĠD l
ĠD RP
ĠD MPs
ĠD arbepoetin
00 40
00 88
ĠS in
ĠS CR
ĠS ams
ĠS CMC
ĠW at
ĠW erner
ub r
Ġun studied
Ġun proven
Ġun avoid
Ġcl ival
ĠN ervous
Ġco localize
Ġco insurance
othe lin
ĠR ing
ĠR MN
ĠR ON
ĠR FD
Ġ5 95
Ġres haped
ĠO ridonin
Ġev ap
âĢ Ĥ
âĢ Ŀ
Ġanti epileptic
Ġgro o
Ġnot ch
Ġeffec acy
di arrhea
tem per
Ġab ound
Ġmon op
Ġ4 138
Ġgen o
ĠG ross
ĠG rand
ĠG DP
ĠG TT
CR Cs
CR KL
ĠE ll
ĠE SF
ĠE radication
tr ideoxy
Ġhas n
Ġmet allic
Ġimmun ities
Ġse baceous
iagnos tic
Ġsub additive
Ġint ubation
rac inostat
rac iclib
ox il
ĠL ov
ĠL nk
ĠL urbinectedin
ĠL opinavir
bin ders
ĠTh yroid
Ġ6 14
Ġ6 37
end othe
lud e
Ġpat ented
ensi ble
Ġcyto reduce
ad raciclib
so ever
Ġind igen
01 11
01 14
01 57
01 32
01 407
01 8933
Ġdec et
Ġ9 56
Ġcons ulted
Ġpar ity
ocy st
Ġnon white
Ġ8 37
Ġ8 45
Ġ8 31
Ġ8 66
Ġfol inic
Ġspec ulations
Ġallo PBSCT
Ġallo immunized
Ġnormal izes
Ġma gic
mon otherapy
oma gn
ĠK at
ĠK TS
ĠK AI
out side
out comes
ĠU sp
ĠU CK
Ġar d
CT GF
CT SB
11 42
Ġpredic ated
10 57
MT N
Ġhyp usine
Ġhyp okinesis
CD Rs
Ġimp utation
lu terate
min ogen
min thic
Ġconf ine
ber ger
+) )
ĠJ ia
ĠJ MD
ĠJ ames
Ġdef erves
Ġdef ibrotide
Ġmicro gravity
21 01
cess es
Ġli ters
ĠMD DC
13 38
13 181
Ġsh ield
Ġser glycin
Ġser onegativity
ĠV AV
ĠV eter
ĠV accin
ĠV irgin
az urin
53 808
ke wed
ex isted
Ġpost allograft
hod gkin
crib ing
plic ate
Ġform azan
BP H
Ġnucle oplasm
Ġ15 97
ĠPh yt
Ġ95 7
)- [
rop las
cin osis
cin onide
Î± Î²
Ġdo i
Ġ14 85
Ġmy loid
Ġmy ositis
ĠAs sistance
25 44
Ġ13 69
ĠNK X
AL I
Ġonc ogenetic
omic roscopy
02 38
02 32
Ġdisor gan
emb ryonic
ens ual
ĠWT IP
In organic
lot oxins
/- ))
Ġhist ochemistry
Ġvia bilities
%. <
04 83
ev is
Ġthromb i
ĠCh AT
ĠMP seq
03 54
Î² c
ĠAd V
Ġprote ctin
BM s
BM NC
Ġradi ofrequency
37 90
Ġ100 00
ĠAm b
IS E
Ġunderstanding s
IL S
ĠHL F
ĠSt athmin
Ġerythro dy
Ġdele te
ĠAt ra
of osfamide
ĠUn less
Ġcur tailed
ĠST OI
DR E
45 53808
cep silonRI
ER R
ĠCon nexin
ĠCon ditioned
Ġsumm ing
allo on
Ġestim ations
Ġcirc MYBL
AF Y
Ġlip olysis
Ch r
ĠEx o
ĠEx pected
Ġsil icon
Ġet a
ade oxycytidine
fold s
Ġdys regulates
Ġhom ologies
Ġrecommend able
ĠHe avy
Ġmes odermal
comp r
Ġintra vesical
ĠER R
ĠER Vs
per fusion
Ġhydro chlor
Ġ70 8
Ġpoly amide
Ġcardi ography
DC E
PB HSCT
AS D
FU O
GS Is
Ġdeg lyc
Ġpep R
Ġ46 3
Ġ46 6
Ġangi ocentric
Ġ55 2
immun oassay
PR P
68 91
ĠCC mut
mal ate
Ġsalvage able
FR Ps
Ġdysp lasias
rec ipients
Ġendothe lin
IV F
Ġdoc osahexaenoic
HP VO
Ġhal cinonide
Ġconsequ ential
Ġcytoplas ts
ĠZ este
Ġatt aching
ĠPI N
pos sibly
Î¼ DJH
HC G
ĠAp heresis
ĠAp elin
olar ic
met aphase
Ġneuro developmental
TD s
Ġnan otechnology
glyc an
allel es
yr istoyl
Ġul tral
clusion s
Ġrecombin ations
fac ed
ĠAb ivertinib
anti CD
Ġinst alled
Ġmobil izes
ĠOr ally
ocom promised
006 29
Ġamin os
ĠSub type
ĠAD L
Ġolig omeric
Ġolig opeptides
06 12
ĠWorld wide
Ġmonos accharide
Ġpain s
Ġpain t
DNMT is
ĠEp irubicin
Ġincid ents
ĠDown regulated
CH G
CH IT
Ġhaem opathies
ĠCB U
Ġarray ed
Ġfl ur
Ġfl ip
Cyt osolic
enes cent
Ġreason ing
ĠTrans formed
ĠTrans cripts
ĠMV E
Ġtrac he
Ġplasmacyt omas
Ġpneum ocystis
Ġamino acid
Ġvaccin ating
ĠAR E
ĠBi allelic
MK K
hol ding
Ġbil iver
Ġdex niguldipine
ĠTCR s
ĠDA E
ĠDA MPs
Ġleuc aemia
dim HLA
ĠPKC Î´
ĠPKC ÉĽ
aden ylate
aut ophagic
SL D
HT F
MG CT
Ġstabil izer
ĠSp inal
ĠLC Ss
Ġdeb ris
polym orphisms
polym orphism
ĠMG DF
ergill osis
Ġwhat soever
ĠPG C
SM AR
ĠAg greg
ĠAg reement
TR E
TR IB
ĠTr unc
hy retin
ĠNR G
ĠPL WH
ĠMo bilized
St able
Ġect odermal
Ġovert ly
ĠEP P
quin azoline
ĠInd irubin
ĠInd icators
ĠALDH s
atal izumab
Ġcoll ision
Ġmening oseptic
ĠCE U
anth idin
sh an
idin ium
ĠAllo reactive
ĠCL IC
ĠPharmac ists
Micro transplantation
Ġanteced ents
Ġbrom o
sil ateral
ĠLi kely
ĠSU LT
ĠPF F
oll a
ĠUK M
Ġsem aphorin
ĠInf iltr
ĠInf inium
Med ulloblastoma
Ġpor phobilinogen
ĠCCN B
ĠFlu id
Ġphot opho
Ġphot olabeling
Ġexperiment ation
struct ural
ĠIniti ative
ĠIniti ating
hyd ron
phenyl butyric
ĠSo on
rad or
hom ycosis
Ġorganis ation
Flu or
ĠAsp irin
Wh ite
Wh ites
pir ide
De pression
TRA Q
TRA LI
ĠCV E
ĠTA Q
Ġnas ogastric
DO BD
Ġdeoxynucle otide
âģº )
Ġimmunocyt ological
Âµ m
Ġfluor izoline
NO V
Ġleukaem omycin
syc h
Ġcomput ation
ĠRev limid
Ġ160 9
ĠSel en
ĠIS O
ĠDM X
Ġens ue
At t
Ġdisp uted
Un treated
Int ensification
ĠRho B
ĠDH AC
Ġcompreh ensiveness
Ġhap ten
benz amide
Ġfore most
Ġfore arm
Cons titutional
Cons titutively
ĠDis appearance
Ġdeterior ates
Ġsegreg ates
ĠMac ro
ĠOp tical
Ġ113 8
ĠRadi ologic
ĠGIST IC
Po lycythaemia
ĠPos itron
ĠHCL v
Ġdich otomy
pen alized
fit ting
Ġcryst als
Ġacetyl cholinesterase
ĠRetro virus
Anti apoptotic
Anti angiogenic
ĠLys m
ĠMit ox
ĠMet AP
ĠThromb otic
nitro quinoline
Ġclinico epidemiologic
Ġauthor isation
ĠEN MD
meth acrylamide
Ġconv ul
ĠHyper tension
Ġbus ulf
Ġhyperbilirubin aemia
rit onavir
nan o
ĠEt omoxir
arin ic
ĠPatho genic
0000 35
0000 3790
ĠPeg IFN
ĠSI Bs
Chem okines
ĠEgyp t
ĠWil son
Ġbin omial
Ġwitness ing
Re activation
Ġadapt ability
ĠTel omeres
squ amous
Ġextran asal
yx oid
LP XN
ĠFK BP
ĠDO I
dis play
quar ter
imid azo
Mol t
Standard ized
ĠMeas ures
Ġeryth romycin
section ally
ĠCur cuma
Ġlin ifanib
ĠOmn i
Ġbr ink
apt an
Ġleg itimate
ĠApp raisal
ĠmCR PC
Ġgynec omastia
FP GS
Hsp s
Ġvas opressin
ĠAdj ustment
156 9686
Ġproton ated
Diagnos ing
HER V
Ġascer taining
Ġfron ts
Ġla evis
ĠGW AS
ĠMor avia
ĠSNA IL
ĠCho osing
Ġprur itic
Ġprohib its
separ ation
ĠASC AT
chol anthrene
Thromb osis
Ġarach noid
Ġabor tive
Ġtransm ig
Ġtransm issible
ĠECM O
region s
Poly comb
glucuron ide
Ġtetra ethyl
Ġfur n
ĠPIC Cs
Ġrein st
Ġcanal icul
Peg ylated
ĠFAN CD
ĠAk ti
Ġpod ocyte
Ġpod ocytes
ĠDen osumab
ĠVH Î¼DJH
assemb led
comple xed
Ġdepos it
ĠAngi ography
ĠForm erly
Ġacceptor s
Ġcytofluor ometry
Ġadvis ory
ĠâĢ ľ
spon taneous
Ġroset ting
ĠSudan ese
Mt x
ĠOl omo
Pos terior
BrdU rd
Ġdesc end
Ġallotransplant s
ĠLeuc Ã©m
ĠmHA gs
Ġreim plantation
DU B
Ġthiaz ole
Respon ders
Ġcarbox ylation
Ġcrystall izable
Par aneoplastic
ĠVen ous
ĠSchol ars
ĠRestric ting
Ġcommens urate
PAD s
ĠdC k
Ġpromisc uity
Ġexpendit ure
ĠTem poral
ĠRW PE
ĠLH X
cre ened
Ġladder ing
ĠCent ro
Ġpericy te
buff ering
ĠMast ocytosis
CIN V
String ent
ĠDMN T
Ġcytoc entrifuge
Ġpharmaco economic
FK HR
Ġattit udes
Ġanalyz ers
Ġescap ing
asth enozoosperm
ĠCry st
ĠBac teremia
ĠSearch ing
Ġflag ell
Mye ÎĶ
Ġhyponat raemia
Ġoctogen arians
Ġrecon ditioning
Ġsalic yl
obarb ituric
ĠDas ision
ĠDiff ering
ĠSl ug
Ġdigit oxin
trifluoroacetyl adriamycin
Trx R
Ġextingu ishes
Ġdissoci ates
Ġquinazolin one
ĠTX U
Ġeleg ans
Ġmyof ibr
Ġphosphatid ic
Ġginsen oside
Ġreass uring
Ġalb um
Ġvirion s
Ġinadvert ent
ĠMab Campath
Ġcosm id
Ġtranst hyretin
Ġneighbour ing
orig inated
Ġhygi ene
ĠSphing osine
ĠPharm ion
Ġconcur s
idiob olus
Ġcel astrol
Ġinex orable
ĠBm f
Ġameb ic
ĠTheore tically
Ġdeamin ases
Ġmonot onous
Ġpolymy ositis
Ġdispos al
propan ol
Ġimmunorespon sive
Ġguarante es
Ġcholecys tectomy
toc otrienol
replic ating
ĠRoc hester
Ġhypof ractionated
Ġazid opine
Ġnanodrug s
Ġsubenti ties
Exp erience
ĠTID EL
Ġsmel ter
ĠPKCÎ² II
Ġoes ophagus
ĠCep rate
Ġmyop ericarditis
Epid ermal
Ġlor azepam
ĠDAN CR
Ġfibrom yxoid
Asc iminib
Ġgynaec ological
And rogen
recombin ant
Ġparaf ormaldehyde
ĠOrig inally
osteoc last
Ġcytome ters
Ġmetac entric
Ġaneur ysm
Fin der
Ġnut raceutical
Ġrhabd oid
Ġintersti tium
invigor ated
Ġindiscrim inate
Ġprotr usion
Ġunt oward
LASS O
Ġplec kstrin
Ġhyste rectomy
ĠMars den
Ġparthen ogenetic
ĠGlucuron idation
Fm oc
Ment en
mh TRAIL
ĠLith uan
Ġlymphogranul omatosis
ĠAdvant ages
nerv ous
Allyl amino
ĠManufact uring
Ġnanomed icines
Ġconveni ently
Lt Sz
Ġwond ered
Ġacad emia
ĠPingding shan
stroph anthidin
ĠBenn ett
ĠSams ung
Ġunavoid able
ĠLov astatin
01407 757
018933 20
ĠVirgin ia
Ġultral ow
Ġbiliver din
Ġmeningoseptic um
Ġphotopho bia
ĠVHÎ¼DJH Î¼
( >
0 98059
4 047
7 123
7 41
7 309
8 97
8 175
9 205
9 339
> .,
A st
A NK
A AF
A UTO
B SCT
B AT
C ar
C op
C MS
C ancerous
C igarette
C arnitine
D IM
E lec
E AL
F TD
F actors
G SCs
H ar
H ck
H ospital
H PS
H NC
I karos
I vosidenib
J F
J MD
J PLSG
K e
K line
L im
L ess
L iss
L PHNs
L ancet
M edi
M IDA
M eningioma
N pm
N HS
O t
P GF
P neum
P OD
P eroxisome
Q Tc
R p
R at
R ob
S b
S r
S ur
S MD
S MS
S unitinib
S ilencing
S ession
T or
T an
T AS
T RIC
T IPS
T ube
V ar
V olasertib
W IF
X LA
Y H
a ith
a Cdr
b us
b ran
b ands
c d
c lo
c ens
c DCs
c Gy
c ulturing
d low
d lan
d iseases
f lex
f erol
f requent
f imbrin
g ued
g ains
i us
i ances
i CO
j as
j uvenile
k re
k icidin
l atin
m old
m eta
o A
o ud
p us
p ted
p kb
r RNA
s emi
s ema
t ree
t age
t ene
t trium
w ri
x Ki
z opic
z oa
} -
Â ©
Ġ est
Ġ 008
Ġ ï¼Ī
ļ nic
Ġa NK
in tr
in aciclib
in terstitial
in osinic
Ġt bo
on ian
he reas
Ġc il
Ġc and
te rom
Ġp end
Ġp LKB
Ġp iclamilast
Ġin equ
Ġs tic
Ġs emicarb
Ġs DNAM
Ġan tion
Ġan ova
Ġm HDM
al ea
ati aceous
an ones
ro ut
el an
as omes
it z
it ser
Ġd dC
ent ing
es tive
ic las
ic les
Ġre b
Ġre jecting
Ġf ated
Ġf ag
at wo
Ġ( +/
Ġb icl
Ġe f
Ġe if
Ġe ts
ul as
ul ent
Ġh A
Ġh umor
Ġh CI
Ġh yg
ĠA FS
ĠA MI
ec tives
Ġn PD
ĠT al
ĠT MB
ĠT NPs
ĠT SH
ĠT ABC
ĠT ivantinib
ĠT osedostat
ĠT ERS
ĠT lr
si tis
im otecan
lo ids
lo retin
Ġpro kinetic
Ġle an
Ġle gal
ĠC ef
ĠC LFS
ĠC hol
ĠC irm
ot ag
un ich
uk e
Ġac H
ce iv
Ġex cepting
ant ron
yelo cyte
Ġis chaemic
Ġst ub
Ġst ack
ĠI CBT
ĠI dCSA
Ġl ighter
Ġcon idiob
ĠM f
ĠM l
ĠM GA
ĠM ethylated
ĠM antle
ĠM abs
ĠM CNU
ĠM CTD
ĠM oscow
op portunistic
iv astatin
pres sives
up ling
ĠAML HD
ol omycosis
Ġde aden
Ġg out
ud a
ud wig
Ġal arm
Ġch ir
ĠP J
ĠP reg
ĠP IS
ĠP LI
ĠP reex
ĠH SG
ĠH GC
ĠH ela
hem otherapeutic
Ġdis till
Ġdis omies
Ġdis utility
Ġdis tearoyl
Ġby product
ug es
yt trium
Ġr ated
Ġr alpha
ir atory
ĠB RP
ĠB rian
yp h
ĠD pl
ĠD DS
ĠD PD
ĠD TC
ĠD ps
ĠD CTER
ĠD actol
ĠIn As
ĠIn ferior
ĠF lo
ĠF EN
ĠF arnes
00 22
ĠS PL
ĠS FN
ĠS CLL
ĠS ynthetic
ĠS HAI
ĠW i
ĠW ing
ĠW AS
Ġun observed
Ġun informative
th ro
th ases
th amide
Ġcyt CD
Ġcyt omic
Ġcyt ochromes
Ġmo DCs
ĠCD P
Ġ3 33
Ġk ins
Ġk arminomycin
Ġk lotho
pro longed
Ġap icidin
ĠN CC
Ġinhib iti
ĠR x
ĠR ath
ĠR APA
ĠR olon
Ġ5 33
ĠO E
ĠO UN
ĠO raz
ĠO pa
Ġev ofosfamide
Ġanti plasmin
Ġanti fibrinolytic
di oxin
Ġtrans cellular
Ġtrans jugular
Ġper for
Ġmon ogenic
Ġmon oclonality
Ġ4 37
Ġ4 31
pl atform
ure lla
ĠG b
ĠG BC
ĠG YS
CR CI
ĠE longation
tr id
Ġph il
Ġph lor
lec ted
Ġimmun otypes
Ġpre loaded
oun ted
ich loro
Ġdiagnos able
Ġ0 135
Ġint ends
Ġ= </
Ġfactor ies
ĠL k
ĠL oph
ĠL EC
ĠL MI
ĠL LGL
ĠL sd
ĠTh in
ĠTh ames
Ġid h
Ġ6 12
Ġ6 15
Ġ6 33
Ġ6 24
Ġ6 67
Ġ6 73
end oglin
Ġpres election
Ġob jects
Ġhe ated
ensi tisation
ad in
ad omide
Ġ7 95
Ġ7 37
Ġbetween ness
Ġunder take
01 68
Ġexp iration
Ġ9 18
Ġ9 88
Ġcan ines
ist ent
ist ur
Ġnon treatment
Ġnon allogeneic
Ġnon enrolled
Ġ8 02
Ġ8 28
Ġ8 97
Ġ8 43
Ġpred ate
Ġpred nimustine
tain ment
ĠDNA H
Ġtheir s
Ġinter dig
ĠK o
Ġ10 43
ĠU sed
Ġman umycin
est ock
11 17
RA T
RA LS
Ġdes ensitization
10 24
ĠCR FS
ĠCR Ds
ĠCR KL
CD T
Ġsc ission
Ġra m
Ġra kicidin
Ġup t
Ġimp urity
Ġop poses
dysp lasies
Ġsecond line
Ġmulti omics
Ġdisc arded
oplas ts
Ġam etantrone
ath ionine
Ġcar ne
Ġcar trid
Ġdef ensive
Ġmicro emulsion
Ġmicro titer
Ġ12 79
Ġ12 73
ne ph
001 360
AT IP
13 83
CL B
ĠV on
ĠV im
ĠV ps
ĠV oreloxin
OS Pho
az ines
AC HE
Ġdi rec
Ġdi aryl
Ġ19 62
Ġgener a
Ġadv SM
Ġkary ot
22 01
14 03
Ġlymph angiogenic
Ġpost diagnosis
Ġran itidine
Ġmin ocycl
PL CB
Ġnucle o
Ġnucle ation
Ġsome one
ĠPh il
DH E
Ġmethod ologic
rop rus
cin tigraphy
ys ema
Ġes ophag
CI HDAC
ĠAs ide
25 00
ĠDN IG
Ġcaus atively
ace a
BC AT
Ġ17 70
Ġretro elements
the y
Ġav ium
MR S
lic idin
lot annin
ĠAn xa
ane uploidy
18 97
IC O
ĠMP G
Ġmetabol isms
ind el
ule tin
CC US
IS MO
MA X
ĠHL J
rem othec
ĠCN C
IR G
Ġpur ifying
Ġaz oosperm
ĠRes pective
35 156
Ġconclud ing
Ġtri epoxide
ĠST E
ĠST P
DR lo
NK s
ĠCon sequences
ĠCon ceiv
Ġsumm er
opro lifer
con vs
ero xy
ram ide
ĠCT G
ĠCT x
ĠCT MP
ĠCT HRC
000 21
Ġconc ordantly
NP BC
median s
ĠHCT CI
Ġproportion ate
Ġhaemat opietic
SP R
28 25
ĠCM Ns
Ġxen ogenic
bil ineal
esion al
inf ectives
Ġ45 00
APL s
DN T
Ġinhibit able
Ġgl argine
omon itoring
ĠCP SF
LC S
comp eting
57 438
IF EM
pre vention
pre leukemia
67 8
67 46
ole yl
Ġpoly glutamate
PS M
Ġhaplo HCT
opy rimidin
work ers
amin olevulinic
Ġintr ath
Ġ44 8
GS human
ĠGO CYT
Ġtoler ization
Ġrs TRAIL
ĠPR E
ĠPR UNE
Ġ55 4
Ġ55 02
PR K
uro blastoma
DNA JC
Ġmeg ad
ob s
ob tained
ĠMT ase
ĠIC MT
77 3
77 6746
Ġoxid es
EL IS
Ġhal ting
Ġsepar able
ĠWBC c
ĠY H
ĠY J
ĠY QYYT
Ġsol CD
Ġneuro genic
Ġneuro epithelial
85 2
Ġnan ofibers
glyc ol
Ġneg ated
Ġneg atives
ĠImmun omodulation
Ġlo x
Ġlo ts
Ġlo com
Ġstar ter
Ġstar ved
ĠMM olR
Ġsensiti sing
Ġ67 8
Ġ67 2544
RAR beta
CF F
ĠMy S
EM AC
76 47
BCR ABLp
lab or
lab elling
ĠAcc umulative
anti genic
AN G
Ġsi GL
Ġminim ization
ĠÎ± V
ĠÎ± PD
Ġmim ick
EC MP
lin a
ĠAP TT
ĠAP NKO
ara itser
93 17
Ġble b
Ġamin opeptidases
ĠPV C
uch i
SS s
Ġbio activation
ĠRel axation
Ġsubstr uct
adi one
oles ter
ĠROS A
ĠPK NOX
ĠCo inc
Ġemph ysema
ĠPT PL
EP OR
micro tubule
ick le
ospor ins
ospor amide
Me DIP
NT A
ĠEp c
ĠMC J
ĠAr terial
ĠEn rol
flu orescent
CBF beta
ĠPP PM
Ġchemo immunotherapeutic
Cyt ostatic
ĠTR I
ĠMV P
ĠPU RA
Ġphospho kinase
ED TA
ĠCYP s
ĠBi oph
ĠBi otech
ĠBi otechnology
ĠBi omarker
ĠShe lterin
ĠPer sisting
Ġtet anus
ĠDA ZAP
TNF AIP
SR Y
Ex cessive
aden ocarcinoma
aden ovirus
ĠAnti proliferative
aut ocrine
thym ine
ĠIRF s
ĠIT RA
Ġlact osylceramide
Ġ94 21
Ġhead s
Ġeas tern
ĠHox b
Ad dition
ĠCA ST
elf osine
Ġpy kn
ĠPG s
TL OL
ang li
BA Y
ĠPL P
ĠMe Wo
adher ins
Ġsci ences
with drawal
ĠAut ophagosomes
ps yc
ĠFLAG IDA
PK R
ĠEm berger
umb ered
ĠLy sis
isc her
isc eral
ĠMYD GF
quin olin
CFU s
ĠSh RNA
Ġed elfosine
101 348
ĠInd isulam
ĠAF AP
ĠMa h
Ġtom otherapy
Ġimmuno enzymatic
ĠEM Vs
HV G
chrom ene
CIR S
Ġvul va
Ġimmunocomprom ized
ĠPDGFR Î±
021 7
amino actinomycin
Ġham art
ĠPub chem
Ġcorticos terone
CAL M
emp ferol
Ġmetallo enzyme
ĠHu Arg
Ġaff ording
019 023
cript ome
ĠCCN T
sur gery
ĠIs land
struct ure
ĠDr uker
ĠMin iMACS
RE Z
RE ST
Ġcoinc ubation
ĠFR B
Ġlymphaden ectomy
Ġplasm apheresis
Ġplasm acytic
ĠSE IFEM
ĠSL P
Over whelming
Ġnit roprus
hex amide
Ġpenet rating
ĠComp osite
oprote renol
Ġiod o
Gl uc
ĠHMG CR
ĠHT ATIP
Ġhydroly zes
MSC V
Ġtesti mon
ĠIS H
ophyl lum
Ġopposite ly
sho wed
Ġheight en
VA V
Bi omarkers
ĠRho D
requis ite
Ne omorphic
ĠBI RD
ĠCr ude
ĠLip opolysaccharide
Ġtax onomic
Ġtax odione
acc ines
Ġimmunost ains
lys ophospholipids
ĠMEF s
ĠPAR K
ĠBCP V
ĠHTL p
ĠMain taining
Ġuro plakin
He J
He N
Inf lammatory
ĠLM Vs
ĠStatis tics
yle p
calc ium
ĠCal ichDMH
FLA N
Ġcoron atus
Ġaza Cyd
Ġstrept ococcus
GRO V
ĠClass ic
ĠClass ically
ĠRa RF
ĠMit otic
identif ication
ĠMyel otoxicity
vis fatin
heres ed
Ġhelic es
Ġannot ate
ester ase
ĠEN ST
meth ynil
Ã¶ gren
Ġip silateral
ĠMST N
Lym ph
ĠIll ino
Er bin
Ġbuff ers
dia meter
Ġhydropho bicity
Ġmycophen olic
187 0134
Adv ancements
Ġlipopo lysaccharides
Ġperi osteum
ĠTB il
ĠTB IC
Ġlamin ar
Ġlamin ectomy
TN M
Ġpay ing
Ġbre eding
Ġ(+/- )
ĠEB Cs
ĠNMR s
hyper leukocytosis
Ġerup tive
ĠTD MMCs
Ġâħ £
thiaz olyl
Ġmorpho line
ĠFH CRC
ĠMH CI
ĠACT G
ĠClo Bu
Ġgall ate
Ġintermedi us
Ġstro kes
Ġtun neling
Ġcock s
orub idus
Ġbr illiant
brom odeoxyuridine
ĠVal proic
Ġinos itides
meas ures
Ġextrap ulmonary
ĠAv p
ĠApp earance
ĠCar minomycin
Ġradios ensitization
ĠMat ching
Ġvas omotor
Ġrhabdomy osarcomas
Ġasth matic
ĠCardi omy
hydrop eroxy
Ġethyl ene
Ġla w
ĠALK BH
ann ual
WB RT
MET HODS
Ġstere ospecific
Ra ji
Ġexempl ar
asm uch
Ġradioimmun o
Ġprohib itively
ĠHydro x
Em b
Ġphleb itis
ĠHG U
ĠHDA RA
Vari ants
ĠddPCR WT
ĠESR RA
ĠTun neling
ĠsL DL
End ogenous
ĠTY RP
Be yond
Sub cutaneous
ĠSem iqu
ĠFD CP
GEP s
Ġafflic ts
Ġnos ological
orot rast
ĠBel gian
MIT OX
ĠMu LVs
Ġbreath ing
cen sored
Ġintratumor ally
Ġbenchmark s
ĠPAD I
Ġdebul k
Hepat osplenic
Germ an
ĠhP c
tra de
Ġasym ptotic
Ġcox sackie
Ġprevail s
Ġtent ative
emin ent
ĠSa Ãº
ĠÎ±Î² T
osm otic
Ġprem enopausal
ĠMÏ Ĩs
ĠGlyc oA
Â¹ Â³
ĠVI MD
current ly
Sel ection
Ġcred ential
Ġcred ited
ĠPCL P
piper idinyl
Ġtetrahydro folate
Oste opontin
ĠCys LT
ĠBX D
535 18
TEM OSPho
ĠDevelop ments
ĠAnt p
ĠÃ ļnic
Ġenfor ces
680 626
Ġnonex istent
ĠCss BU
ĠHtr x
Ġvan adate
ĠFib rin
quil ibrative
ĠRAL S
1155 463
some times
caps ular
Ġaccent uate
Ġphagocyt osed
omo ucine
suscepti bility
Ġfamiliar ize
Ġpyrid o
Ġmist letoe
Mn ks
Ġliv estock
ĠEF E
Ġtonsil lectomy
Dex razoxane
ĠELA NE
cop al
Ġinstruc ted
aggreg ation
Ġtolu ene
Ġsurm ised
Ġanesthe tic
ĠsTNF Rs
ĠsTNF RI
Ġbs Abs
ĠGSL s
Ġpu quitinib
ĠDip yridamole
Ġneglec ting
ĠFer tility
ĠLymph omas
Cho langiocarcinoma
Ġoverhang s
FcÎ³ R
Ġhypercoagul ability
Rep eated
ĠDot Scan
CON UT
CON CLUSION
Ġsno RNAs
Ġvarie gated
Ġrheumatic a
Ġconfron ted
epit opes
ĠBac tero
cryst al
CU EDC
Mk neg
0045 9339
Ġunambigu ous
ĠSAML S
Ġrecon firmed
mono allelic
Ġcystein yl
morpholog ic
entr ifugation
ĠIc ariin
Ġrating s
Ġelastic ity
ĠBik DD
Ġhydrop s
Ġsolubil ization
SER EX
Ġtib ial
0036 9317
ĠSqu ibb
Intrat umoral
Ġsurfact ants
ĠNu MA
ĠDefin ition
ĠFOL FOX
ĠHung arian
ĠNag asaki
Ġhypoglyc emic
Ġhyperammon emia
ĠHead ache
Ġaggrav ates
ĠCaM KII
Ġartif icially
Ġsymb ol
sol vent
Ġteen agers
Ġendocrin opathies
Ġmasquer ading
Ġspur ious
Ġzf Mcl
Ġzf BLP
Ġhabit ats
Ġposts urgical
Intra venous
ĠTbeta RII
Ġoligodendro cyte
ropho blast
ĠHind III
Ġcann abin
ĠGABARA PL
49867 90
49867 91
otenti ation
ĠBul k
Ġmyle oid
Dem ethoxydaunorubicin
ĠInstit utions
Occ urrence
Ġnitroso urea
ĠBex xar
Ġcoryl i
Ġspermatog onia
Ġneurotransmit ters
Ġdw arf
ĠSecre tion
Ġurtic aria
omyc ine
Ġmyelolip omas
Ġflags hip
ĠEscal ating
ĠUr gent
Ġpyrrol idine
ĠAlo pecia
ĠBrc a
Analy ses
Pat tern
Ġmicrospor us
Ġfati gued
ĠYou Tube
ĠSepha dex
Ġgrise us
ĠMyÃ©lo dysplasies
istem a
Ġchyl omicron
Ġchym opapain
ĠJasp amide
ĠZY J
Ġimmunopeptid ome
Appro priate
EI NASE
Ġausp ices
grafter s
ĠArsen ite
ĠWa als
Ġxanthogranul oma
Gate ways
GMR alpha
Tyros in
Vin cristine
Ġka empferol
2424 908
Ol aparib
ĠEmpir ic
Ġmycel ium
Ġminiatur ized
diacetyl spermine
ĠCamb ridge
strept avidin
ĠPROT EINASE
Ġprotozo an
feed back
Ġcoerule orubidus
Ġdiph thamide
Ġtoddl er
cast le
Ġasep tic
ĠSj Ã¶gren
ĠAnteced ent
1805 794
ĠAutod ock
Ġosmol ality
ĠPaste urella
omagn es
Ġard uous
SMAR CA
ĠOlomo uc
ĠLithuan ia
7309 123
8175 347
Elec tro
MIDA M
TRIC OM
aith ful
zopic lone
Ġantion c
iclas ine
atwo hl
ĠhCI NAP
ĠCirm tuzumab
Ġstub born
Ġconidiob olomycosis
ĠPreg abalin
ĠDactol isib
Ġkins hip
ĠRolon tis
ĠOraz i
001360 84
Ġminocycl ine
remothec ium
ĠConceiv ably
57438 36
Ġ672544 02
ĠEnrol ment
ĠHuArg I
019023 29
Ġnitroprus side
ĠIllino is
ĠSaÃº de
Â¹Â³ Â²
ĠÃļnic o
* ),
- (-)
/ ).
6 49
7 21
7 22
7 86
9 24
9 98
9 31
9 283
A a
A ur
A CDR
B GS
B right
B locking
C ad
C ST
C MPN
C MPs
C ETLAM
C ENTRAL
D et
D AB
D RA
D BC
D arby
E CN
E ighteen
F E
F X
F AM
F TBI
F PN
F olate
F rizzled
G CN
H Q
H if
H AL
H NK
H SR
I BMTR
J B
K yn
L PI
M W
M Z
M ar
M CA
M embrane
M aternal
M OPP
M IPI
M GFs
N MD
N CA
N bs
O AP
P rop
P rog
P ossible
P alliative
P acific
P lough
R ac
R OX
R ER
S et
S EL
S MF
S ensitive
S uccess
S tenotrophomonas
T x
T YK
U F
V GH
X enotransplantation
Y M
Y FP
Z O
a j
b w
b ras
b etter
c ation
c AML
c ules
c mm
c itric
c overage
d actyly
e A
e ye
f uture
f rozen
f amilies
g afur
h CG
i EMR
k m
l ins
l ights
m b
m cg
n ib
o isomers
p CytAbnl
r n
s l
s low
s olution
s uff
s teroid
s FRP
s aturated
s urviving
t z
u siveness
v elocity
x b
y ama
z inc
Â ´
Ġa ka
Ġa sial
in formed
in berg
Ġt one
Ġt af
Ġt Bid
re versible
ti fy
ti rp
Ġc LPM
Ġc amera
Ġo re
te gafur
Ġp up
Ġp DNA
Ġp ups
Ġp Ka
Ġs ot
Ġs ut
Ġs cl
Ġan hydro
Ġw bc
Ġw atching
Ġm S
Ġm d
Ġm ural
Ġm aph
Ġthe ses
ati os
or afenib
el imination
it ination
Ġd ol
Ġd ating
Ġd entist
Ġd altons
er an
er gency
er dlow
Ġf etuin
Ġb ub
Ġb iex
Ġwith holding
Ġto rem
ul ine
ul able
Ġh i
Ġh t
Ġh osted
ĠA ir
ĠA SF
ĠA ET
ĠA vo
ĠA EBP
ĠA MED
ec ium
ra ig
ĠT OR
ur ately
ML AA
Ġpro kary
Ġpro collagen
Ġle ptom
Ġle fl
ĠC PM
ĠC GR
ĠC odon
ĠC arnosic
ĠC raig
ig m
ig osertib
us sian
ot ong
un omide
un iform
Ġex tirp
ho ok
Ġis opropyl
Ġst ab
Ġst unted
ib ur
ĠI PH
ĠI SI
ĠI car
Ġmyelo iod
Ġcon us
rap tene
ĠM ec
ĠM AML
ĠM olecule
ĠM Ã¼nster
ĠM rp
ĠM uscle
ĠM egakaryoblastic
op erm
op ioid
il er
um etric
Ġcom bo
ĠAML miR
ud icated
ab ad
ĠP on
ĠP ra
ĠP ot
ĠP CC
od ic
ĠH CP
ĠH ube
ĠH otspot
Ġr G
Ġr ic
Ġr CD
st ressed
Ġexpres ser
ĠB in
ĠB ron
ĠB UN
ĠB lotting
qu es
ĠD am
ĠD av
ĠD ES
ĠD MB
ĠIn verse
ĠIn nate
ĠIn sertional
ĠF DR
ĠF avourable
ĠF TL
ĠF dCyd
ĠF ormalin
00 99
00 79
00 71
00 54
00 89
ĠS NF
ĠS SP
ĠS BD
ĠS BT
ĠS ulindac
ĠW ar
orm one
Ġun encapsulated
Ġun randomised
Ġun beneficial
th ral
Ġsurviv a
Ġmo Ab
por adic
AML miR
Ġus ur
ĠN BP
ĠN ecrosis
ĠN elarabine
ĠN atalizumab
ĠR CT
ĠR AT
ĠR SP
ĠR heum
ĠR FLP
ĠR ydapt
Ġsho res
Ġ5 12
Ġ5 53
Ġ5 27
Ġ5 96
Ġres azurin
com mentary
ther s
ĠO PM
ĠO AD
Ġanti globulin
Ġanti tuberculous
Ġreg orafenib
de azaneplanocin
Ġtrans mit
pl antar
ĠG Z
ĠG AC
ĠG IC
ĠG SPT
CR Es
ĠE ra
ĠE FI
ĠE quilibrative
tr ast
tr uction
Ġinv ent
Ġimmun ize
Ġno isy
Ġsub seros
Ġsub capsular
Ġover proliferation
ox el
ox idase
ĠL an
ĠL OD
ĠL sh
bin ase
Ġ6 10
Ġ6 53
Ġ6 50
Ġ6 49
Ġ6 42
Ġpres erv
Ġhe ro
Ġhe ating
Ġhe terom
Ġtarget ting
Ġ7 20
Ġ7 75
Ġ7 93
Ġunder developed
Ġsup plying
form ans
Ġsyn opsis
Ġcombin ative
Ġ9 16
Ġresist ence
Ġcons ume
Ġcons ulting
Ġpar alytic
Ġpar vif
Ġmalign ance
Ġnon engraftment
Ġnon dividing
Ġ8 12
Ġ8 23
Ġ8 74
Ġallo type
Ġnormal ity
Ġinter specific
Ġinter lineage
Ġinter changing
ĠK IP
ĠK ettering
Ġel uting
AB GG
ag ar
Ġ10 52
ĠU ro
ĠU ACC
Ġar te
Ġar che
Ġar ranging
reg ivers
11 16
ch ins
ch itosan
Ġdes ulf
our ces
ĠCR TC
ĠCR Es
Ġhyp orespon
Ġhyp omagnes
og rel
CD KI
Ġimp erv
Ġimp recision
min us
ak er
Ġmulti site
Ġdisc oura
Ġdisc ounted
LA D
LA CS
Ġme iotic
Ġam ple
oph aryngeal
ath ing
15 400
Ġcar vedilol
ĠJ SI
ĠJ umonji
ĠJ olla
Ġmicro f
(+) :
Ġgenetic ists
Ġvit ronectin
veal ed
tran d
Ġep ic
Ġmain spring
CL M
Ġsh rim
Ġser pin
ĠV B
ĠV LPs
ĠV APA
ĠV iet
Ġpop ulate
Ġreac etylation
Ġsequ estosome
Ġol omoucine
Ġ19 66
Ġy outh
po ol
ffec tive
53 7
SF I
Ġ[ "
ex per
olid es
pha rose
19 72
19 78
19 06
erg ism
Ġnucle ofection
Ġsingle t
Ġ20 30
Ġhetero cycles
Ġhetero genicity
Ġend anger
20 59
ocyt omas
Ġer ase
int ensively
int uitive
Ġ14 26
Ġes trogenic
Ġmy e
Ġmy ogenin
Ġmy asthenia
ĠAs ynchronous
25 49
ace pt
AL B
val anol
Ġ17 88
Ġ18 00
Ġmalignant ly
In trinsic
ĠBM MNCs
Ġmyel omastocytic
18 83
Ġmorpholog ists
Ġtr if
Ġthromb ogenicity
mut A
Ġcycl ization
ĠCh ron
03 14
Ġbiom ass
Ġunc ultured
ind olo
ind icating
FN BP
CC CP
euk aryotic
BM N
BM MNCs
Ġradi ations
ophen olate
ĠAm es
sub group
Ġgra in
iod ocytosine
Ġabs copal
Ġstim ulations
Ġfoc ally
racycl ic
kn onc
Ġfunctional ities
ĠRes onance
activ atable
Ġkill ers
Ġappl iances
of ilin
ĠUn stimulated
ĠST K
NF kappaB
arch ing
ĠAB V
29 82
0001 5
con text
PD B
PD E
PD N
MS S
MS Ns
ĠPD Z
onucle oside
Ġlab yrin
oh is
SP AG
ĠX en
ĠX iap
ice al
36 48
Ġhyper acute
Ġlip oplexes
ress a
ĠPro inflammatory
ds DNA
Ch l
oprotein emia
AM O
98 7
100 0027
Ġcal phostin
cyt oplasm
Ġpan myelo
65 4
ĠCl ones
eg s
ĠCLL s
inf lamed
Ġadhe rens
AD EP
Ġmes ench
LC Gs
MN KI
Ġ48 2
Ġ48 4
Ġ48 9
comp eti
comp ounds
Ġintra operative
alog s
IF Y
32 15400
67 437
Ġpoly amides
Ġ80 9
Al dehyde
ĠMY HI
Ġj iro
PB GD
Ġgas tr
CB Y
ĠIII a
Ġequ ine
urviv or
Ġcont racting
Ġ55 5
Ġant racycline
Ġste ato
immun ology
PR CA
erox ides
Ġmeg ac
ĠCC l
66 1
ysi ological
Ġoxid atively
Ġoxid izing
Ġsepar ator
Ġorgan ogenesis
Ġorgan otypic
Ġpreval ences
ĠY K
ĠY oud
ĠY ttrium
96 114
ĠAL WP
compan ied
ĠAp lastic
glyc ine
glyc osylated
Ġfra ught
Ġsex ually
Ġchemores pon
ĠImmun oliposomes
Im portant
Ġdiss olution
PC K
ĠDec reasing
Ġmig raine
Ġhaematological ly
ĠSim on
cat abol
Ġrepl ated
Ġinst able
ĠSc opulariopsis
del C
del ayed
Ġstep ping
Ġadop ts
crist in
lan g
lan onic
ĠRe ad
ĠRe agent
ĠRe placement
virus es
MM olR
IN HBA
ĠPV OD
Ġbio equ
tes ts
ĠSub t
ĠHemat opoetic
ĠHemat ogones
Ġlys ophospho
phen omen
PV A
Ġolig omet
ĠPT M
Ġhome opathic
micro dissected
ick ett
Ġmas k
thal assaemia
Ġbor on
Ġmamm alians
col umn
ĠAr ticles
rib ofuranosyl
ĠEn l
ĠCB SCT
Ġelectro genic
Ġelectro philic
Ġfl ares
ĠNe bras
Ġtrac heal
Ġlipid omic
Ġrib oflavin
Ġoverview ed
ĠAR MS
lt ra
ĠBi KE
ĠNon myeloablative
direct ly
Ġrh IGFBP
Ġsplice osomes
MMR s
OP G
Ġdia m
Ġdia ph
009 65
Ġmagn a
Ex pl
ĠBlood wise
ĠPA INS
Ġbo osts
ĠFMS like
ĠTF IIH
ĠCa jal
Ġbenz imidazole
Ad ap
WBC c
IAP H
Ġdim ly
ĠSur rogate
ĠHyp odip
Ġantine utrophil
cho lecalciferol
015 96114
ĠMo CEBPA
front line
ĠAut ocrine
Ġcommun e
Ġcommun icating
Clinical ly
PK D
Ġneur ones
Ac etyl
Ġed ible
Bu Flu
Pre gnant
Ġcoll aterally
Ġqual ifies
Ġju ice
UR F
ÎĶ N
cons titutive
Ġpal bociclib
Ġhisti ocytoma
pred icted
Ġvul gar
Ġquin olin
ĠGenetic s
otransplant s
Ġarch ive
ĠLe ave
Ġhydrox amate
Ġmono blast
ĠBa alc
Ġflav in
random ization
Ġdisturb s
ĠRI SCT
126 1000027
ĠNetwork s
CCN U
Ġfibrin opeptide
ĠDel hi
Ġfer rous
tri hydroxy
ĠFlu oro
ĠFlu orescein
ĠIs olation
Ġdog ma
Ġcyclo dextrin
Ġpseud otyped
BT Z
ĠDOX ol
hom ogenous
BB z
ĠWork ers
bic ides
Ġlymphaden osis
ĠOb servation
ĠProm pted
De azaneplanocin
Ġconcep tions
ĠTA O
Ġosteo arthritis
ĠSyn geneic
Ġglycos idase
Ġfluor ochromes
CS NK
sk ipping
ĠCy statin
ĠNa F
Ġconsolid atory
ĠBL M
compl iant
ĠIS EL
PARP i
ĠHS B
ĠDU Bs
ĠAnaly zed
Bi KE
rele ased
ĠGl ucose
Ġfore limb
Ġdrop ping
LM IC
Jun e
ĠCauc as
ĠOp tions
Ġsa quinavir
Ġstres sor
ĠEstim ation
Ġec z
calc emia
prop ionate
Ġdich loroacetate
Ġentero toxin
ĠRac ial
Ġethnic ities
Ġpas toris
ĠMit omycin
Inter phase
ĠInvestig ational
ĠRP PA
Ġbolus es
Ġ121 6
Ġannot ations
Ġpermeabil izes
Ġathe ro
209 0314
Ġsap iens
disc overy
sulf ate
ĠHyper calcemia
ĠTopo II
Ġnasoph arynx
Per sistence
Ġpyr in
Â° ,
Ġconduct ance
DF O
DF CI
Ġcas ual
Ġrheumat ological
Ġbehaviour s
ĠDT IC
ĠEsc italopram
Ġterat ogenesis
sim plified
sim vastatin
ĠNM U
yrib ose
Ġtag SNPs
Ġorchestr ation
MDM X
Identif y
HIF s
ĠCri zotinib
Ġanion s
Le ishmania
ĠSte ering
ĠLo DAC
do tes
ĠLI LACS
ĠMc Don
ĠNeuro logic
Hyper leukocytic
ĠCur iously
Neu rop
THP C
Ġket o
En forced
En vironmental
Ġmuscul us
Ġepigen tic
Ġspac ers
ĠSJ L
ĠSETD B
Ġneighb ors
ĠGem C
Ġlac rimal
Ġsupplement ing
Ġgonad otoxic
ĠOx aliplatin
Ġcaps ular
din arily
ĠCro ati
process ed
Cycl osporine
Di hydroxyvitamin
Ġprecon ditioned
900 776
estrogen s
Ġcyst athionine
Ġelectr ically
ĠLig ands
cur cumin
ĠMIP I
dec reasing
End othelial
ĠMt b
RÎ³ c
sched ules
pharmac ology
how ever
ĠSem aphorin
Ġproc ured
Ġonco hematological
Ġautore gulation
Ġguan ylate
Ġguan idine
Ġlute in
Ġfos ters
ĠLDA RA
Def r
Ġmanufacture rs
Sup erior
ĠVM AT
Ġbenchmark ed
ĠBo ulder
ĠSi rolimus
Ġrelax ed
Ġfibr ates
Ġphosphorib osyl
hist ochemical
terpen oids
Ġoverwhelming ly
tra ffic
Ġortholog s
iro therapy
Ġthreat s
ĠGo al
INT ERIM
Ġcephal osporins
Ġexplosi ve
Ġuncoup le
Ġpunct a
guan yl
piper azin
she et
rt TA
Ġswe at
PCD H
ĠImmunocyt ochemistry
Ġbip olar
Ġbip artite
Ġdichotom ize
ĠpS iO
Ġthiaz olidin
ĠTransp orter
Polym erase
Ġaqu aglyceropor
Ġcarbox ylate
Mn SOD
chel ated
flo p
ĠSlo vak
Ġcard inal
ĠRib e
Ġsurm ount
ains onine
olys osomes
best os
ĠTU BB
Ġmetab otropic
my osin
Ġtouch ing
ĠSER CA
Mic rosomal
ĠLm r
Ġavid ly
Ġculpr its
Calc ium
typ ed
triaz oles
Ġcytosp ins
Ġimmunode pletion
ĠâĪ Ĩ
Ġprotop orph
methox yphenyl
ĠEvolution ary
Ġmedullar is
ĠAdap ted
colon ized
Ġbra ke
osid erin
ĠChlor ambucil
Ġhomodimer ization
Pa Ca
Ġpseudodip loidy
Ġnif edipine
Ġmastoid itis
Hetero zygous
ĠEco RII
Ġeleg ant
benzo quinone
1801 131
ĠMetabol omic
achie ved
Ġplug s
Fig ure
Nine teen
bul bar
Ġtors ade
Ġtall imustine
SJ L
Ġsul piride
ĠOc ular
Ġsuperv ision
paro us
inoc ulation
revers al
anz c
ĠPTG IS
Ġîĭ º
azan avir
Ġvasopres sor
Ġsnail s
DAP I
Ġhype rox
MÏ Ĩs
thre o
ĠGan oderma
Ġexcit atory
Sep tember
orus ide
Ġthyro xine
Ġpref ers
ocat aly
Ġvial s
Bal anced
Ġlumb osacral
Ġarteri oles
ĠCov ariates
Prd m
osuccin ic
Ġoutcompe te
Ġmep olizumab
0303 0612
shif ted
rheum atic
Ġspind les
mobil izing
Ion izing
Ġau raptene
retro spective
umar ins
aparin ux
ĠJmj d
Ġniger icin
Ġconfid ential
3025 03
Ġoligodeoxyribonucle otides
ĠTrop onin
Ġmicrow ave
Ġpapul osis
Ġimmunoad sorption
Ġflud arabin
ĠKel ch
Ġpostim plantation
ĠEncaps ulation
Ġcarbam azepine
Ġstrugg le
Park inson
ĠLAS SO
Ġhern iation
ĠCaro lina
ĠSummar izing
pher d
exam ined
unicip al
Radio immunotherapy
Ġacro centric
Ġbook ended
Ġpyrim ethamine
Vac u
Ġconting ent
Ġdepar ture
ĠDun n
Ġconcan avalin
Ġneurotroph in
Antic ancer
Ġgyr us
odib enzo
ĠJia otong
Ġdisorgan ized
Ġerythrody sesthesia
ĠDMX AA
ĠLeucÃ©m ies
Ġsemicarb azide
Ġbicl onal
Ġphil os
Ġmegad ose
ECN M
Ġmaph osphamide
Ġtorem ifene
ĠAvo iding
Ġlefl unomide
ĠHube i
ĠRAT IFY
Ġimperv ious
ĠViet nam
Ġlabyrin th
Ġsteato hepatitis
ĠYoud en
Ġbioequ ivalence
ĠNebras ka
Ġvulgar is
1261000027 1000
ĠMcDon ough
* <
4 126
5 202
5 272
7 23
7 909
8 13
8 53
9 90
A GS
A lox
A part
B ac
B ron
B ody
B lockade
B KM
C DS
D J
D iff
D IPSS
D evelop
D ART
D IMATE
E very
E gr
E stim
E OV
F Q
F ever
F avorable
F MC
F ailure
G U
G V
G DI
G NPs
G DF
G IPAP
H ome
H BsAg
I kappaB
I rf
I clusig
J nk
K LR
L NP
M sp
M ice
M CSFR
M yelodysplasia
N pG
N OC
N itric
O lig
P CP
P PMs
P icibanil
R PA
R ICs
R IA
R VS
R WR
S ir
S ex
S AL
S ema
S BB
S KIP
T reatments
V AP
V ariant
Z CTR
a S
a PD
b ulinic
c ir
c old
c amptothecin
c Tf
c CRs
d osome
d eregulated
d HPLC
f use
f ected
f ractions
g lob
g MDSC
l up
m olar
m RCC
m rp
m embranous
m igratory
p ra
p yro
p aced
p ersonal
q F
r b
r x
r GM
r istone
s till
s usp
t SDS
u aries
v us
v enti
y tes
y ocardial
Ġa HCT
Ġa ero
in i
in formation
in version
Ġt PA
Ġt yro
re plating
ti ble
on ig
en na
en atide
he t
Ġc um
Ġc DCs
Ġc Bio
Ġp s
Ġp ET
Ġp ust
Ġp GP
Ġp Crkl
Ġp onicidin
Ġs ternal
Ġs LDH
Ġs TGF
Ġan trum
Ġw ri
Ġm C
Ġm ts
Ġm ish
Ġm DOR
Ġthe sis
ati al
or ial
is able
is ible
is ternal
an der
ro id
ro bial
ro toxicity
el ight
Ġd ith
Ġd ated
Ġd ull
Ġd rew
ent inostat
es opsin
ic ol
ic iclib
Ġre vel
Ġre administration
Ġre establish
Ġre organized
ar te
Ġf unding
Ġf rig
Ġb irds
ith in
Ġe icosapentaenoic
om andibular
ly x
Ġh CPT
ell ifer
ĠA MK
ĠA omori
Ġn DNA
Ġn eratinib
Ġn idul
em ulsions
ĠT oc
ĠT ight
ĠT MN
ĠT TK
ĠT ACE
im pact
lo xy
ĠC amp
ĠC erebral
ĠC PLD
ot rim
un ophen
un methylated
gen otypes
ut yl
et anib
et aphase
Ġac oustic
if osphamide
if lavine
Ġleuk otoxin
ac ry
ac avir
ac alin
Ġas ODN
Ġas bestos
Ġleukem ogenetic
Ġis other
Ġis oproterenol
Ġst ating
Ġst ature
ib ration
ĠI p
ĠI GFR
ĠI TCH
ĠI rinotecan
Ġ1 132
Ġ1 150
Ġ1 019
ran splantation
Ġl al
rap porteur
ĠM ak
ĠM ock
ĠM TOR
ĠM atch
ĠM HRF
ĠM AKA
Ġthat some
op otent
iv icin
iv Bu
pres ence
il anth
up hen
um omab
Ġbe at
Ġbe verage
Ġon ycho
ud i
Ġal er
Ġal gin
ĠP eri
ĠP yth
ĠP apan
ĠP SR
ĠP ERS
ĠP uebla
ĠP IIINP
od en
ĠH or
ĠH amm
ĠH MR
ĠH EC
ĠH TT
ĠH lf
ĠH dA
Ġv oid
Ġv ibr
hem i
Ġdis lod
yt he
Ġr PBSCT
Ġr RQ
Ġr mhTRAIL
st rength
ĠB EL
ĠB enz
ĠB IK
ĠB cor
ĠB lank
ap e
ap k
ap plicable
ĠD m
ĠD BP
ĠD AK
ĠD do
ĠIn ability
ĠIn effective
ĠF ar
ĠF uk
ĠF ES
ĠF lux
ĠF Ã¶
ĠF bx
ĠF ARI
ĠF MAU
ĠF emales
ĠF cepsilonRI
tor ic
ĠS on
ĠS ec
ĠS um
ĠS AD
ĠS XR
ĠS ymptomatic
ĠS ERS
ĠS SVM
ĠS FRPs
ĠW C
ĠW R
ub ercul
Ġun tim
Ġun associated
Ġun intended
th us
Ġsign ifying
Ġsign iï¬ģc
Ġass et
Ġmo tivation
Ġmo xif
ĠCD CP
pro line
ĠN ative
ĠN IT
ĠN ull
ĠN CB
ĠN UTM
Ġco fil
yl ine
ĠR enin
ĠR ES
ĠR EG
ĠR OM
ĠR osu
ĠR DRs
Ġsho ot
Ġ5 77
Ġres et
com orbidities
ess ors
Ġdiff used
Ġsignific an
Ġanti pro
Ġanti dotes
ost rept
de activation
di phosphate
di hydrop
di phtheria
Ġab elson
Ġchem osis
Ġchem otoxicity
Ġen ucleated
Ġtrans carbam
Ġper nic
Ġmon oc
Ġmon omic
Ġmon ochrom
Ġ4 53
ĠWe i
ĠWe ak
cl osure
spl antion
ĠG N
ĠG LT
ĠE gl
ĠE GC
Ġinv ad
Ġhem ophilia
Ġpre empt
Ġsub mit
Ġ0 3
Ġ0 20
Ġout flow
Ġout paced
ox e
ox ymethyl
Ġpo le
Ġhemat otoxic
ĠL AC
ĠL CC
ĠL VL
ĠTh rombin
pho id
Ġpres acral
ip ron
ari ous
Ġhe aled
ensi fying
Ġstem med
ad mitted
Ġtarget ability
Ġind olin
Ġ7 17
Ġ7 38
Ġ7 18
Ġ7 79
Ġ7 76
Ġunder m
Ġunder report
Ġmal onyl
Ġsup raph
Ġsup pose
%) /
01 77
01 07
01 707
Ġsyn thases
Ġmic ell
Ġexp ire
Ġdec o
Ġdec ellular
Ġ9 96
Ġ9 64
Ġprom igratory
own ed
ist y
Ġpar vum
Ġdem atiaceous
Ġnon diagnostic
Ġ8 76
Ġlympho proliferations
Ġpl enty
yc n
ond ro
Ġma esopsin
ct p
ĠDNA MT
rip tan
ĠK en
ĠK le
ĠK LRF
crip tive
Ġ10 88
ĠU tx
ĠU biquitin
CT CAE
11 19
10 52
10 82
ĠCR B
av olt
Ġhyp od
Ġhyp ochromic
og rafting
og luterate
Ġsc hemat
Ġimp oses
Ġvari ances
Ġop i
min ded
ABL I
12 34
12 60
ures is
Ġmulti lamellar
Ġprev ailed
Ġam ylase
Ġam pal
Ġlong a
15 01
ĠJ PN
Ġsim ulates
Ġcommon ality
ne uronal
ĠMD ASI
Ġvit real
fer ases
AT Ps
Ġmain land
Ġsensi ble
Ġdel imotecan
Ġstrateg ically
ĠV pr
ĠV RC
ĠCI II
Ġref ocused
Ġdi phen
Ġ19 00
Ġ19 67
po R
Ġstandard izes
17 40
17 36
22 15
22 89
leuk openia
leuk ostasis
ĠAl gorith
ĠAl lografting
ex port
Ġran imustine
eri anal
PL CH
ĠmiR anda
ĠAT AC
ĠAT IR
ĠAT CA
Ġphen ol
erg lyc
Ġform ations
Ġform yl
Ġform ulary
Ġnucle ophilic
ĠPh armacy
ax ial
Ġend olysosomal
20 210
ĠII V
Ġcri tic
Ġless on
Ġlim elight
rop sin
Ġprop osition
HR MDS
CI CC
ater s
trans membrane
25 09
over load
AL MA
Ġ17 37
Ġ17 76
AR Q
AR HI
the rapies
Ġav adomide
Ġ30 41
02 15
02 77
ĠMLL bcr
Ġcolon isation
Ġ50 7
AP I
Ġthromb olytic
We inberg
Ġ60 7
03 17
Ġunc apped
Ġrap porteur
ind olent
FN D
FN QT
CC SG
Ġprote otoxic
Ġradi ologists
ophen one
Ġ100 9
ĠAm plicon
24 1736
orph osis
iod inated
ochem osensitive
Ġbreast feeding
ĠSt a
HCT CI
omes tic
Ġsu ite
Ġdepend ant
ĠUn w
ĠUn ra
ĠST G
ĠST AR
DR R
CP P
Ġdetect ably
NK C
0001 3
ĠCon ditions
opro st
Ġu BMT
Ġsynerg izing
MS N
MS LN
ĠTP s
clinical trial
IP F
estim ate
NP Cs
mic romolar
onucle osides
SP N
SP P
SP AC
SP Cs
SP PB
ĠX SCID
Ġrese aled
ĠMPN C
Ġlip osom
ĠPro us
ĠPro duction
ĠPro to
ĠPro files
ĠIM MU
Ġ26 292
ĠEx osome
ĠEx posing
98 05
Ġ27 952
Ġsp ice
Ġsp ike
ĠMR CK
ĠCM B
Ġhom otrim
ĠHR S
CM olR
Ġlesion al
mit ochondria
ĠER S
ĠER beta
per idin
per fect
57 418
pre vious
pre ferentially
pre gnancy
Ġsal mon
inc orporation
Ġpoly pyrimidine
Ġcardi ologic
cap ing
ME N
ĠMY EOV
TP TE
ĠAS D
47 50
ogene ity
ĠCX orf
ste ady
39 98
Ġ65 4
Ġ75 5
high is
Ġant agomir
Ġkin etocho
Ġligand omes
immun osup
ĠCC US
ob atoclax
ĠInte racting
ĠInte ractive
Ġinternal isation
Ġ' '
Ġmegakary oblast
IV E
Ġ47 2
Ġhal ogen
ĠY ear
ĠAL PK
ĠAL FY
87 3
ĠHigh lighting
Ġcruc iferous
met inib
Ġnan ogels
Ġyoung ers
Ġtermin ate
ĠImmun otherapeutic
ĠImmun ofluorescent
ĠBC BM
Ġsensiti ses
Ġmultic lonal
ĠSe zary
69 2
Ġ57 2
ID FY
sc Fvs
Ġdep ths
Am plification
004 28558
ĠIntern et
cat he
ĠIR s
lim bs
ocar zin
Ġnine ties
Ġnine fold
Ġdereg ulations
Ġmeth ane
59 4
Ġsw ine
del iver
Ġmobil ising
AN ZCTR
ĠCAR L
mod eling
mod ulates
Ġpe a
Ġacet o
STAT s
ĠHD s
ĠÎ± CLL
Ġbrain stem
Ġvol umetric
ĠSR I
Res ult
bi phosphonates
Ġback ed
ocom patibility
Ġmembers hip
Ġamin opterin
+/- +/-
SS VM
ĠSM Cs
adi ene
Es ophageal
Ġolig opotent
Ġassign ments
isp osition
Ġâ ĨĴ
ON C
be en
Ġgluc oneogenesis
EG T
Ġdissem inate
ĠEp ithelial
Ġmis splicing
Ġmis classification
Ġsuppress ant
ĠAc ti
CH E
CH MP
ĠNew castle
flu enza
ĠRAR E
Ġfl us
Cyt operm
ĠSIR Ps
ĠAC Cs
ta wa
ED DS
Ġax on
alan yl
ĠOut patient
ĠAR EB
Ġmen adione
Ġubiqu inone
rs ter
ĠCK D
Ġtet hering
Ġtet racyclic
IST RAT
Ġenrich ing
Ġ92 21
GR F
GR IK
abin ol
Ġcataly sing
HG DH
ĠBlood stream
Ġescal ate
bal ances
erc ial
ĠPA CRG
Ġrevolution izing
arabin osyl
Ġemphas ise
Ġthi obarbituric
Ġthi olester
Ġstimul ant
ĠTF L
ĠGen zyme
ĠGen omics
Ġlact ation
ĠATG CC
Ġbenz odiazepine
Ad P
ĠCA MP
arc iclasine
inos us
polym orphonuclear
Ġobtain able
Pro D
Ġeth anolic
Mut ant
ĠEle ments
ĠHyp ocellular
Ġ97 47
NHL s
SM ZL
ĠAg NPs
TR IM
ĠPTP RC
Cy CD
Ġprel amin
Ġester ification
Ġpartner ing
ĠSK P
Ġreprogram ing
hi PSCs
hi kawa
Ġmach ineries
ĠEm ergence
tol aryng
SE Am
ae I
Ġadriamycin ol
FC MRD
ĠInt olerance
Ac ti
Ġcryp ts
Ġsulf ated
neg atives
Da C
urip otent
ĠInd ividually
ĠALDH dim
sen ile
ĠMA IC
ĠMa Tu
ÎĶ WT
Ġgel ation
pa ign
Ġpal mar
Ġtempor omandibular
Ġoc ul
ĠCL X
ĠCL s
ĠCAG like
Ġquin oline
ĠSA gs
Ġmyc obacterium
Ġelement ary
ĠVP Gs
ĠFB G
ĠLT M
Ġgal lotannin
Ġphosphatidyl inositide
ĠVari ation
Ġsem en
Ġhydrox ide
ĠLY Z
Ġperox idases
organ oids
ĠSor afe
carb ohydrate
Ġpor cupine
Ġphot opheresis
ĠHis tiocytic
PE CAM
ĠNext Bio
gluc onate
gluc opyranosyl
ĠMin imum
ligand ome
Ġ(- ),
rad ical
ĠRD F
ĠImmunohist ologic
erb A
Ġorganis ed
ĠES BL
ĠEl k
ĠEnd ocrine
ĠMod ulating
ĠMod ifying
Ġvascul ogenic
Ġcollabor atively
ĠFR YL
Ġlymphaden oma
Wh at
ĠNS UN
Mon o
Mon ocytic
hex anol
BH Q
ĠTA CTILE
Ġimmortal ised
Ġpreced ence
ĠBD V
Ġdeoxynucle otides
oprote omic
âģº ,
âģº -
Ġmill ili
Trans ferase
Barr Ã©
Ġimmunocyt okine
dem onstr
Ġepig allocatechin
syn onym
ĠPO MP
ĠGF AP
Ġconsolid ating
IK AROS
Exper iments
sin usoidal
ĠRev Man
escal ating
cor related
Un ivariate
Int ensifying
Ġpent a
ĠBI OME
ĠHer ceptin
itide psin
ĠMI SC
ĠMI ER
ĠTc pC
ĠCr uc
benz yloxycarbonyl
Ġexacerb ations
Ġsubdiv ides
ket ogluterate
Ġpericardi ocentesis
ĠPred isposing
ĠDis closure
Ġnation ality
Gen eral
ĠPAR ylation
ĠÎĶ WT
Ġforward s
Ġvi olet
Ġchel ates
ĠOp eration
KG DH
ĠLM W
ĠRece ipt
poly glutamate
ss I
Ġwa as
Tar get
galact oside
Ġnorm ochemosensitive
ĠMAT R
Met formin
ĠTS c
Ġvacu ole
Ġantagonistic ally
ĠPeriod ic
Ġport folio
ĠDI RAC
oblast osis
Ġindisp ensible
Ġgang rene
vac cin
ĠBl k
ĠSB DS
ĠCAM K
ĠMark et
cytogenetic ally
Ġhind brain
ĠDem ethyl
deox ydaunorubicin
Ġsensor ineural
uit ment
ĠRef in
ĠLN L
anucle ar
ĠSUMO ylated
0000 2549
ĠLAM s
Ġlob es
ĠNH W
bed side
Ġded ifferentiated
ĠTD B
amid otriazole
Ġground work
ĠFLI PL
Ġmini MEC
Onc ogene
ĠPCA F
ĠErythro cyte
Here in
Non coding
Ġfu eling
ĠAct ual
Ġchondro id
Raf pS
ĠDex ter
Ġtric istronic
293 111
quar ters
ĠNeuro fibrom
Ġeryth ron
Ġcere ana
Ġclo pid
Ġthorac otomy
Ġthorac oscopic
male imides
Delta Psim
Ġquad ruplex
ĠPRK CB
Ġblind ness
Ġpeptid oglycan
Ġprol idase
Ġbroncho pulmonary
ĠConf licting
ĠOx PHOS
oxo form
din itro
ĠMor oc
ĠROR C
Ġstere otactic
Ġprecon dition
Ġmetach rom
ĠHi DaC
mast ocytosis
umm ary
Dox il
Ġendonucle olytic
Ġocclusion s
ĠSpl it
ĠKP NA
ĠVin blastine
ĠASC L
Ġdisper sions
Ġhyaluron idase
Ġepi phenomen
ĠFI GO
ĠHLX B
ĠsL ex
Ġextravas ate
Cre ERT
ĠPAS D
trop ic
oy a
ĠReported ly
Ġstream line
Ġemo tion
Ġemo tions
bet am
ĠFab sc
Ġsuppl ies
Ġhypokal aemia
ĠAcad ra
2007 45
ĠNFAT C
Mi HAs
0047 77
Ġveget able
benzyl thioinosine
ĠUtil ization
HF TBI
ĠRan ge
Ġsymmet rically
Hem opoietic
ĠVK H
ĠBo iss
ĠBo olean
carbox ylate
osom iasis
Ġimmunobi ological
Ġsed iments
Ġana ero
hist ological
ĠIST H
ĠExpl oration
Ġstri atum
Ġaccident ally
Ġparac ancerous
ĠMarked ly
rHu EPO
Lip id
Ġure teral
ĠPY ROX
Ġprem aturity
ĠMÏ Ĩ
ĠMÏ Ī
Ġjeopard izes
Ġni hil
Ġbrother s
Ġsch ist
ĠAsc ites
aberr ation
Ġmirr oring
Ġhijack ing
Ox R
Dia betes
Ġophthalm ologic
Ġcob imetinib
ĠRAP TOR
Ġoblig ate
Ġventric les
Ġunmas k
Ġunmas king
ĠApc Min
ĠInsigh t
Ġobvi ating
Ġdecis ively
Gem C
Ġero sions
ĠOlig o
caps ule
Ann ually
0033 1
Ġcontemporaneous ly
Ġhypogonad otropic
Ġaqu aporin
Ġfabric ate
Ġnanocom plexes
mis artan
Ġdios cin
ĠMOPP ABV
ĠPER V
RX Rs
Ġinstruc tions
ĠRib osomal
aggreg ometry
Ġtrabec ulae
ĠRW R
ĠOs x
Muc in
ï¬ Ĥ
Ġars ine
628 031
Bas ophils
morpholin yl
Cho osing
Ġexud ate
Ġnu ances
ĠPEC oma
Ġexpedi tious
Ġkerat ocon
Ġzym ography
Ġsarcom eric
Ġlipo ate
Ġlipo ATRA
Ġrecording s
vul nerable
abnormal ities
ĠHy C
Ġincision al
0301 3998
methylene tetrahydrofolate
hept yl
ĠACL Y
Ġhaemolytic a
ĠConfirm atory
prior ity
ĠPir h
ĠRoman ian
ĠChlor oma
Ġcertif icate
Comp elling
ĠSqu amous
Ġepist atic
ĠStop ping
Ġpermis sible
chlorophenyl hydrazone
ï¬ģ ed
Pres ence
TAP s
ĠPc SLN
ĠRemo ving
Ġneuropsyc hiatric
SUMO ylation
sant hemi
ÏĪ m
Ġinterchange ably
Ġbiore actors
Ġbiore positories
Ġcontextual ized
Ġpet rol
ĠTe h
Ġmotiv ate
PAF c
Ġcytod ifferentiating
ĠAsn ase
MSK CC
neuro blastoma
734 693
pseud o
ĠMad in
Ġtransc end
Ġimmunosuppressor s
ĠMOL rel
ĠInform ative
Ġecchym oses
Aden osine
Ġnanostruct ures
investig ated
Eff icient
Vit D
ĠMs bA
Ġgermin ation
ĠEE IG
ĠEd itor
Ġphthal ate
Ġphthal ocyanine
ĠPrefect ural
ĠEpid ermal
Ġsonic ated
Ġdub bed
echo ic
Ġchry sin
ĠDoc um
ĠSho uld
ĠBiom edical
acl arubicin
Ġupward ly
ĠHIM eg
ĠInstit ut
ĠGUS B
ĠSial yl
Ġmicrov asculature
ĠHisti ocyte
ĠSERPI NB
Ġmonomethylars onic
lytic us
ĠValu e
ĠValu es
ĠADGR E
ĠHypothe sizing
Swit ch
orpholin o
Ġmyelop eroxydase
0124 4750
Ġpredec essors
Ġhypermethyl ations
dinitroph enyl
Ġosc ill
Ġmemor ies
Ġoutgrow ths
ĠComple ment
Ġvaso active
Ġencephal omyelitis
Ġobjec tivity
Smith Kline
Ġneurosurge ons
Ġnucleotid ase
Ġlpa at
Ġventil ator
Ġdendri tes
ĠITC Z
ĠGle vic
Ġhyperchem osensitive
ĠMicrobiological ly
Ġultrac entrifugation
salic ylic
Venc lexta
Ġcp CML
icola ou
Ġlysophosph atidic
ĠNeurop atho
Ġug ly
interm ediated
Ġmyd dosome
impl anted
Ġsuperven ed
ĠGlaxo SmithKline
Ġsemicon ductor
ĠHard y
Ġunanim ously
gradi ent
Ġsla ughter
VEEV SL
ĠJUR L
Ġpronorm oblasts
Ġperoxyn itri
Ġnemat odes
ĠHOP X
Ġmouthw ash
Ġpharmaceu tically
Ġamygd ala
Ġpyram idal
Ġgallo lyticus
ĠWat son
Ġevap oration
hydron arciclasine
Ġtetraethyl ammonium
Ke ap
Rob o
otag min
ĠLoph omonas
Ġcarne us
Ġradioimmuno assays
ĠSemiqu antitative
Ġstubborn ly
SEL DI
Ġsubseros a
Ġjiro vec
00965 224
ĠCaucas us
pra vastatin
Ġfrig ida
Ġnidul ans
ĠCPLD IDFY
Ġonycho lysis
ĠPapan icolaou
ĠDAK O
ĠFÃ¶ rster
Ġuntim ely
Ġsigniï¬ģc antly
Ġmoxif loxacin
Ġcofil in
ĠRosu vastatin
Ġpernic ious
Ġmonomic robial
01707 004
Ġschemat a
2289 195
ĠATCA Y
Ġhomotrim eric
ocarzin ostatin
ISTRAT ION
ĠSorafe inb
ĠBIOME D
Ġclopid ogrel
ĠPYROX D
ĠCPLDIDFY C
) '.
5 75
6 68
7 17
7 80
7 89
9 05
9 70
A k
A pt
A HA
A monafide
A iolos
B reg
B MDSCs
C PM
C AK
D TR
E PS
F d
F at
F UND
F usariosis
G ran
G li
G AC
G CA
G PBB
H NA
H owever
H MD
H EP
I b
I PD
J A
J umping
K dm
L MD
M g
M ay
N ras
N IH
N LCs
O ld
P ath
P ep
P GL
P arental
P araffin
P gP
P FDD
P racinostat
R ever
R ai
R Es
R oughly
S ar
S ole
S NE
S MRT
T U
T estis
U B
V PS
V III
V SSS
W BP
Z Q
Z T
Z arnestra
a ug
a ffin
a CAM
b el
b atch
b lockade
c f
c erebral
d od
d osed
d atabase
d ichloro
f re
f oc
f ish
f arious
g ement
g DNA
g anciclovir
h BM
h man
h GH
j iang
k aline
l ost
l ater
l incRNAs
m U
m im
n ier
n early
n omial
n umbered
p lastic
p ALL
r m
r he
r atric
r ants
r ategies
r FVIIa
s L
s RNAs
s atellite
s Le
s Tie
s eminoma
t ab
w hether
y z
y ce
z d
z il
z able
in complete
Ġt ear
Ġt elop
Ġt anshinone
re ce
re perfusion
ti res
ti ometry
en tered
he retic
Ġc enti
Ġc Myc
Ġp ri
Ġp BR
Ġp ets
Ġin otropic
Ġin eligibility
Ġin applicable
Ġs eren
Ġs ensation
Ġan ym
Ġan akinra
Ġw arm
Ġw ishing
Ġw aning
Ġm po
al en
or ders
or ins
or hodamine
an ubr
es es
ic illin
Ġre sis
Ġre form
Ġre transplanted
Ġre parative
Ġre emerging
Ġre format
ar ified
at tering
Ġb if
Ġb ull
Ġb rach
ing ival
ate ment
ith rin
ith ione
id oc
os orb
os quamous
om itting
om embranous
ly ase
ul s
Ġh omes
Ġh yro
Ġth umb
ĠA go
ĠA AL
ĠA ffinity
ĠA than
ec ity
Ġn ul
Ġn itidine
em itters
ĠT om
ĠT DS
ĠT DG
im el
ur ons
res cence
res olving
ML s
ML Rs
Ġpro antho
ĠC cl
ĠC asp
ĠC KII
ĠC Ã´
ot amine
un te
un determined
un olol
gen y
et umomab
uk in
Ġac rosome
Ġac antholysis
if ep
if ithrin
ac il
ac rid
se o
ant al
sp inal
ver ts
uc cessive
ib und
ĠI SS
Ġl am
Ġl enti
Ġl umina
ĠM ate
ĠM om
ĠM ist
ĠM OG
ĠM idol
ĠM aster
op recipitation
il izumab
um eration
ine oplastic
oc ortin
Ġim ine
ted ly
Ġg rasp
ud otox
ĠP ortal
ĠP FDD
ĠH mg
ĠH art
ĠH off
ĠH MB
ĠH CE
Ġv ic
Ġv ap
Ġdis association
gn ation
Ġha pl
Ġr ivaroxaban
st om
ĠB ox
ĠB MDSCs
ĠB ang
ap hereses
ap lysin
am oeb
qu am
ri tical
Ġad o
ĠD an
ĠD imethyl
ĠD omestic
ĠIn ev
ĠIn side
ĠIn hal
ĠF inal
ĠF OP
00 673
ĠS ever
ĠS ero
ĠS uccessive
ĠW AF
Ġun sub
Ġun phosphorylated
th yroidism
Ġcyt opa
Ġass er
ph i
ph age
Ġmo unted
Ġwh ichever
enti ty
pro us
Ġmut ative
ĠN ations
ĠN PD
ĠN iem
ĠN SAA
Ġco ast
Ġco elic
Ġco ales
Ġco varia
iff usion
ĠR CBT
ĠR HOX
ĠR igorous
ĠR ituxan
Ġ5 41
Ġres in
Ġres or
NA NOG
ĠO CM
Ġanti lymphoma
ron in
di aryl
Ġab ated
Ġen ucleation
Ġhigh risk
pl ene
ure n
cl im
ĠG Î±
ĠG PA
ĠG lan
ĠG RI
ren ic
ĠE US
ĠE jection
ĠE SCCs
ĠE conomic
tr ivial
Ġph iladelphia
Ġph asing
Ġhem opathy
Ġimmun omonitoring
Ġpre leukemias
Ġsub til
Ġ0 16
rac y
Ġbet anin
Ġover regulated
Ġhemat opietic
ĠL MS
ĠL NP
ĠL MC
ĠL uspatercept
ong ru
pec imens
Ġrec onc
Ġ6 01
Ġ6 23
Ġ6 96
Ġ6 87
end oscopy
Ġpres c
Ġpres timulation
and etanib
Ġbut t
Ġhe sp
ad or
Ġind welling
Ġ7 01
Ġunder representation
Ġunder reporting
01 79
form ulations
Ġsyn ucle
Ġdec aten
Ġ9 12
Ġcan er
ist olo
Ġhematopo eitic
Ġnon pro
Ġnon blastic
Ġnon high
Ġnon immune
Ġnon monocytic
Ġnon autonomous
Ġnon cleared
Ġ8 99
Ġ8 71
Ġfol k
Ġlympho poietic
ble matic
Ġallo antibody
Ġcor n
ond aparinux
ros ophila
Ġfound ed
Ġobser ver
ag atran
ĠU BL
Ġar row
est at
Ġtranscrip tions
ill amine
11 82
Ġchrom ogenic
Ġchrom omycin
Ġdes quam
Ġfe br
Ġprim aries
CD CP
Ġra mp
Ġop pose
12 54
Ġconf ident
Ġsecond s
Ġmulti domain
IT RT
ĠBCR i
RD A
Ġme but
Ġam astigotes
Ġqu asi
Ġmajor ly
ĠJ P
ĠJ nk
ĠJ ilin
ĠJ oint
Ġmicro cytosis
Ġmicro domain
16 40
13 20
13 76
PM RD
Ġcoun tires
omet rical
Ġdi oxide
Ġdi versely
Ġ19 57
Ġadv enti
Ġfurther ing
Ġkary otyp
ITD neg
14 00
Ġlymph nodes
Ġaim ins
95 295
eri an
tal king
med icine
par ation
par ities
par athyroidism
Ġem blematic
Ġnucle oplasmic
Ġblast ula
old ed
ism atched
ĠML s
ger ia
ger min
Ġer ased
Ġmor ibund
Ġ11 85
prolifer ate
âī «
Ġ13 03
ched uled
ĠNK H
AR RY
Ġretro per
the red
the ir
Ġav rainvillamide
Ġ18 46
02 66
Ġbas ing
Ġbas iliximab
ĠAn tit
dom ide
ST ING
Ġpediatric ians
Ġhist omorphology
50 382
Ġloc k
Ġpathogen eses
Ġtr ifluoro
Ġregion ally
04 38
04 99
ĠIm age
Ġassay ing
ĠCom b
ĠCom ponents
ĠCh ia
Ġsus MR
Ġcytok inin
ind irubin
ind igo
ind icators
ĠAd alimumab
Ġconditioning s
Ġradi ochemical
26 46
24 72
24 308
Ġlead ed
Ġuseful l
Ġgra v
ĠSt x
Ġmethyl omes
kn ife
Ġinfec ts
Ġprior s
ral ethal
asc us
asc ial
ĠUn ified
ĠUn doub
Ġcur c
Ġtri o
Ġtri phosph
Ġprolong ations
ĠCon temporary
ĠOver represented
con trib
con trast
iltr ate
Ġthem atic
tis h
mic roscopy
onucle otid
Ġhaemat opathologic
Ġsynthe some
ĠX CL
ĠX II
88 8
ĠOf atumumab
Ġhyper intense
Ġhyper hydration
Ġhyper parathyroidism
AM MoL
ĠCEBPA sm
ĠEx ception
Ġsp ic
Ġsp astic
Ġantic ancerous
Ġ29 20
Ġdys hematopoiesis
app ears
cyt oma
Ġcarcinoma genesis
ĠCM ap
stim ulus
CM MRD
Ġintegr ator
Ġprac ti
Ġtandem ly
Ġhep aCAM
ĠMS A
Ġtool kit
orpor ated
ern ard
Ġver tic
Ġcho lang
less ness
acet onitrile
pre fibrotic
ĠTET s
inc orporated
Ġven occlusive
Ġpoly rib
Ġpoly nomial
Ġcardi ologist
Ġcardi otonic
Ġcardi olipin
Ġhyperm ut
Al teration
47 86
PS GL
PB OX
opy r
Ġglyc ocaly
amin ations
ĠGO T
function ality
Ġpractic ability
other mic
Ġcont end
ĠPR BC
Ġ55 1
ĠQ PCR
ĠQ HP
ĠQ SAR
ĠQ PCT
immun ological
PR ES
PR ED
ĠME CL
68 3
lor odibenzo
ĠABC M
Ġoxid ases
48 3
Ġdoc tor
Ġsepar ators
Ġpreval ently
96 2
Ġquanti ï¬ģed
Ġsol ving
Ġclinic obiologic
HC H
HC VAD
ĠÎ² arr
GM ALL
Ġauto inhibitory
Ġnan ometric
Ġsensiti ser
Ġpersist ency
CF LAR
Am eric
005 163
005 901
ĠIntern a
ĠAcc uracy
ĠNB D
OL FM
co enzyme
SD IEM
ĠKIR C
ĠSc Fv
Ġinn ately
Ġsw ainsonine
Ġsi lymarin
Ġevid encing
PI K
ĠHD LM
lin ergic
Res istant
ĠCY CLIN
ara A
An tim
An tisense
Ġback cross
ĠCo Q
ĠCo gnitive
Ġbl ister
EP G
EP HX
Ġfibro genic
Ġshe l
myelo genous
Ġur chin
Ġur gency
Ġâ ģ
Ġmas ks
008 50382
Ġembry oid
Ġput rescine
06 38
ĠSF mutation
Ġbor ate
Ġincub ator
prom o
prom inent
ĠDe hydrogenase
ĠDe pendent
col la
ĠAr ticle
ĠId h
rib osylation
Cl onality
ĠEn brel
CH F
Ġple uritic
007 156
ĠRAR a
>/ =
Ġq d
Ġfl uc
Ġfl are
Ġ79 02
ĠTrans gene
Ġtrac ers
Ġphospho inositol
Ġphospho ethanolamine
Ġrib osyl
pr uritic
Ġpneum opathy
Ġamino ac
ĠAR NT
Ġalkyl transferase
Ġalkyl phospholipid
Ġuns cheduled
Ġexc ited
ĠTCR G
ĠCK K
GR I
Ex plore
dim eth
Ġspecial ization
MB T
ĠPKC Î·
PH OX
VEGF C
)] :
ĠBu Flu
ĠBu falin
Ġpromin ence
ĠRespon der
Ġthi ostrept
09 05
Ġstabil ising
ĠFOX N
ĠGr iff
Ġlact ones
ĠCons titutional
ĠCA E
inter cellular
ĠMon itor
ext ensive
glut amine
FL D
Ġtop ographies
cellular ity
Ġtub erc
Ġtub erin
Ġtub ercular
TR C
TR ECs
ĠKn ocking
816 5
ĠTr ue
015 95295
vi ro
ĠSimilar ity
Ġect onucleotid
Ġcry ogel
Ġdetermin istic
ĠMicro environment
ĠHA EMAC
ps on
ĠpH i
ĠLy on
Ġbios pecimens
ĠHO M
mC i
Ġsuper b
Ig E
ĠFunction ality
Da udi
Pre venting
ĠInd oleamine
Ġtiming s
Ġintrac isternal
alli kre
tras tructural
otrop ism
otrop ium
UR E
HV s
PP O
Ġcircum scribed
sh PIM
chrom atid
HSP Gs
ĠAllo reactivity
ĠPharmac ol
Ġknockout s
Ġsidero pho
TE X
ĠLi u
Ġmyc oplasma
ĠSup T
ĠSup ple
021 9
Ep CAM
Ġadip okine
fil tered
Ġcathe licidin
Ġneo formans
ĠAss ociazione
PG C
PG D
PG ES
Ġflav ones
ĠRI CTOR
022 3
itud es
ĠInf iltration
Ġphot othermal
ĠIs hikawa
Ġarsen ous
RE V
Ġdip loidy
hom olog
ĠAdv isory
Ġpartners hip
ĠPres ident
Ġenter itis
BB R
ĠMal es
Ġlymphaden itis
Bs Abs
prote ase
prote olytic
ĠOb served
ĠOb servations
039 53
BE AC
mer capto
Ġtrich rome
Ġnitro xyl
ĠTIM E
ĠSpecific ity
Ġdihydro erg
Ġmeaningful ly
Trans criptome
FM MD
Ġfluor ophores
Ġneon ate
ĠBas ing
DT Cs
ĠCy TBI
hel minthic
bright CD
dam aged
ĠJurkat B
TF PI
Ġpent amer
Bi ological
Ne ural
SH M
RII b
ï¼ Į
LM ICs
ket ch
Ġimmunob lots
Ġdeterior ate
ĠMUT YH
Ġprogen ies
ĠBCP s
ABMT RR
Ġmicrotub ular
ĠDes criptive
ĠLen gth
ĠLab rador
poly ethylene
ĠRh D
Ġinfer tile
pair ment
Ġce RNAs
Ġ119 85
ethox yb
Ġpas sively
Ġpas udotox
ĠMit ochondria
ĠFACS can
Inter quartile
iant o
coagul ants
Ġflavon ol
Ġtubercul oma
Br Tet
Ġclinico hematologic
CO PD
Ind isulam
ĠDF CI
Ġretrie ve
ĠAUR K
rach lorodibenzo
Ġnasoph aryngitis
LN GFR
Ġpyr ithione
Ġmesothe liomas
ĠDef inite
Ġances tor
Ġgamm ac
Ġperi osteal
ret ching
Ġcontra ceptive
usp id
Lys osomal
ada ver
ĠProte ase
Ġrheumat ologic
Ġdisadvant aged
Ġpecul iarity
ĠPatho logists
Ġbre ed
Ġshut down
Ġnephro blastoma
Ġequip otency
Ġbin ucleated
Ġunco ated
tryp tic
Re active
Inhib in
Inhib itory
ĠSCC VII
prob ability
Ġcustom arily
ĠClinic odemographic
Le uc
Ġextr ude
ĠFAS AY
Ġchondro blastic
Ġchemop rophylaxis
sus MR
FGFR s
dis ubstituted
imid azol
0201 3648
Op tim
Op portunistic
Ġsubstanti ates
chloro acetate
Hyper tension
HM W
ĠVer ification
Ġcircular ity
ynam ically
acryl ic
Ġsimpl ification
ĠĠĠĠĠĠĠĠĠĠĠĠĠĠĠĠ ĠĠĠĠĠĠĠĠ
Ġblind ly
Ġextrap olate
Ġmind ful
999 17
ĠCEBP B
ycarb amide
Ġdynam ical
ĠCardi ology
ĠMar itoclax
Ġanthrac is
Ġanthrac ene
dn f
electro spray
iso ellipticine
ĠCF TR
Ġpsych ometric
ĠTyr phostin
Ġstere os
Ġnaph thal
Ġradioimmun otherapeutic
Ġradioimmun oconjugate
Ġreferen ts
ĠFl ight
Ġcyst adenocarcinoma
âĦ¢ ,
ki lodalton
ĠDCL SG
ĠIr radiation
ĠPrac tical
ECM O
trim ethoxy
Ġepi phy
ĠALA S
TCE AL
Ġhydraz ones
Ġtext ure
deoxyc yt
OB JECT
Be h
Ġcalib er
Ġequival ency
Ġsuppl anted
Ġafflic t
sial yl
Ġnos ologic
ĠDa oy
Ġstratif ier
Ġisothiocyan ates
span ning
Ġindustrial ized
VO Cs
Ġglucuron ide
leep ing
ĠInfusion s
Ġthal ass
vol asertib
iro c
ĠNi Cl
ĠCoc ultures
ĠDMP C
ĠSa os
Ġmetam orphosis
Ġmenog arol
ĠTMP RSS
sorb ate
toler ability
Ġroset tes
Ġrecomm enced
Ġtria ge
Ġni osomal
butyl hydroquinone
Ġcongen er
Ġfing olimod
Sel ected
iber domide
Ġaddi tivity
ĠDevelop mental
ĠÃ ħ
ĠEntero bacteria
>+ +</
otroph in
ĠLim iting
propyl ene
Ġagen da
DU Bs
NIL G
ĠCEL SR
Ġthiaz olyl
Ġpyrrolo pyrimidine
Ġflo xed
ĠNLR C
Ġimmunohistological ly
Prote olysis
Ġnontumor ous
ĠPAN DAR
Ġdysmyelo poietic
Ġanalges ia
pass age
embran es
.. .
rat axin
Ġscin tillation
ĠOs aka
ĠOs seo
Ġmetho x
ĠCytos can
Ġtrade off
ĠImmunop eroxidase
Ġenthal pies
dos ia
Ġlangu ished
Retro viral
ĠhBM SC
Ġbioen ergetic
Ġelectrosp inning
Ġdeform ity
FcÎ³ RIIb
ĠPerm utation
Kap osi
Ġavoc ado
Ġnanost rategies
Health care
Cys teine
Ġoverrid es
LON G
nat ally
ĠPTH rP
Ġspro uty
imm ediate
Ġjun B
diac ylglycerol
ĠAntic o
CSP G
Disc overy
ĠRV SP
ipar atide
Ġcrystallog raphic
Ġdissoci ating
Av ailable
CGCG CG
ĠSplice osome
ĠARHG AP
iC asp
Ġerg ometer
1801 018
Nov antrone
Myel osuppression
Ġendometri osis
Ġengulf ing
Her ceptin
Ġfr ustr
ĠACH N
Ġdyst rophy
Haemat ological
aff iliated
Ġ004 28558
Ġ004 00673
Ġinvag inations
ĠMOL P
ĠFung i
recr uitment
immuno assays
Ġmention ing
Cauc asians
Ġneurom uscular
Der ived
Ġchry santhemi
Ġwel come
ĠTO PS
Ġschwann omas
ĠTheore tical
ĠDos imetry
Ġimmunot olerance
Ġpolymy xin
Ġregios elective
Ġethn ically
Flav opiridol
Ġarterio venous
Ġspectrofluor imetry
crystall ine
Trip tolide
ĠScot tish
mc L
Ġpaus ing
Ġlev amisole
Ġendom it
Ġfortun ately
Ġzo on
Ġcam paign
tec avir
altern atively
ĠMorph ometric
Thiop urine
Ġribosom opathies
Ġelectrochemil uminescent
Gv T
00801 489
ÎĶÎĶ CT
Bor tezomib
few er
Ġimag ined
Ġamplif iable
hydroxyglut aric
Ġvinc ulin
Dep ending
phar anthine
Ġsubst rains
fertil ization
ĠTGFBR II
Ġoversh adow
ĠLas so
ĠUk raine
Ġfeeling s
Ġepoth ilone
ofluo rene
Helic ase
methylnog arol
Kary otyping
otarget s
Ġglo ves
Ġuncl arified
ĠAdmin istering
paren ts
Ġphos ho
0164 0301
Ġsilic one
Ġabsorp tiometry
Ġorosomuc oid
Wil coxon
ĠTrap ianto
ĠCess ation
ĠRMN D
roplas ty
Ġflur ry
ĠInfiltr ating
Ġtransmig rate
Ot tawa
Ġinequ alities
Ġinterdig itating
Ġram ifications
neph rotic
Pattern s
Ġhero in
Ġshrim p
exper imental
ohis ti
Home ostasis
cir rhotic
ĠcBio Portal
Ġmish aps
ĠToc ilizumab
ythe rapy
strength ening
ĠREG ISTRATION
Ġtranscarbam ylase
Ġ020 24308
Ġdecellular ized
ĠAlgorith m
cathe ter
Ġmillili ter
ĠCruc ially
vaccin ated
ĠMarket Scan
ĠMoroc co
Ġnihil ism
Ġkeratocon junctivitis
ĠTeh ran
FUND ING
ratric opeptide
Ġtelop eptide
Ġseren dip
Ġanym ore
anubr utinib
Ġbrach ytherapy
Ġhyro lase
ĠAthan o
ĠCÃ´ te
ifep ristone
ĠMidol lo
ĠInev itably
Ġcytopa enias
